Submitted URL: https://info.silobreaker.com/e2t/sc2/MmZ-8yjYCXrW6zj2_M6nsGYsW7JzK5Y7LnJnQVd1GcC5Dg2KFdBBbG504
Effective URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_h...
Submission: On December 15 via api from DE

Summary

This website contacted 122 IPs in 16 countries across 99 domains to perform 778 HTTP transactions. The main IP is 2a02:26f0:6c00:296::11ae, located in Ascension Island and belongs to AKAMAI-ASN1, EU. The main domain is www.dailymail.co.uk.
TLS certificate: Issued by DigiCert Secure Site ECC CA-1 on April 29th 2020. Valid for: 10 months.
This is the only time www.dailymail.co.uk was scanned on urlscan.io!

urlscan.io Verdict: No classification

Domain & IP information

IP Address AS Autonomous System
1 2 199.60.103.254 209242 (CLOUDFLAR...)
38 2a02:26f0:6c0... 20940 (AKAMAI-ASN1)
6 2a00:1450:400... 15169 (GOOGLE)
4 2a00:1450:400... 15169 (GOOGLE)
62 2a02:26f0:6c0... 20940 (AKAMAI-ASN1)
1 2 18.195.7.149 16509 (AMAZON-02)
6 2600:9000:215... 16509 (AMAZON-02)
4 65.9.68.128 16509 (AMAZON-02)
11 2a02:26f0:6c0... 20940 (AKAMAI-ASN1)
2 2 15.237.136.106 16509 (AMAZON-02)
1 2 104.111.238.139 16625 (AKAMAI-AS)
1 2a02:26f0:6c0... 20940 (AKAMAI-ASN1)
1 2 34.250.60.119 16509 (AMAZON-02)
1 4 99.84.89.98 16509 (AMAZON-02)
22 99.84.88.20 16509 (AMAZON-02)
59 151.101.13.44 54113 (FASTLY)
1 1 185.94.180.127 35220 (SPOTX-AMS)
1 2.21.36.138 20940 (AKAMAI-ASN1)
1 2600:9000:20e... 16509 (AMAZON-02)
2 2 165.227.252.242 14061 (DIGITALOC...)
4 54.225.161.250 14618 (AMAZON-AES)
1 2a04:4e42:1b:... 54113 (FASTLY)
10 37.252.161.190 29990 (ASN-APPNEX)
3 52.59.91.38 16509 (AMAZON-02)
2 20 35.244.159.8 15169 (GOOGLE)
2 21 104.111.215.135 16625 (AKAMAI-AS)
4 2.18.232.7 16625 (AKAMAI-AS)
7 178.250.0.165 44788 (ASN-CRITE...)
7 213.19.162.31 3356 (LEVEL3)
1 18.195.225.18 16509 (AMAZON-02)
12 35.157.246.167 16509 (AMAZON-02)
2 16 185.33.221.13 29990 (ASN-APPNEX)
2 2a02:26f0:6c0... 20940 (AKAMAI-ASN1)
1 2a00:1450:400... 15169 (GOOGLE)
1 2a03:2880:f02... 32934 (FACEBOOK)
2 104.19.150.54 13335 (CLOUDFLAR...)
41 172.217.22.2 15169 (GOOGLE)
6 6 52.28.82.26 16509 (AMAZON-02)
1 1 2a00:1450:400... 15169 (GOOGLE)
1 2a00:1450:400... 15169 (GOOGLE)
1 2a03:2880:f12... 32934 (FACEBOOK)
7 2600:9000:21f... 16509 (AMAZON-02)
2 65.9.73.48 16509 (AMAZON-02)
1 1 2a00:1288:110... 34010 (YAHOO-IRD)
13 34.107.254.252 15169 (GOOGLE)
1 2a00:1450:400... 15169 (GOOGLE)
5 2a00:1450:400... 15169 (GOOGLE)
62 2a00:1450:400... 15169 (GOOGLE)
1 151.139.128.11 20446 (HIGHWINDS3)
1 2a00:1450:400... 15169 (GOOGLE)
2 5 185.94.180.126 35220 (SPOTX-AMS)
7 52.59.160.25 16509 (AMAZON-02)
2 2 216.58.205.226 15169 (GOOGLE)
4 2a02:26f0:eb:... 20940 (AKAMAI-ASN1)
7 30 2a00:1450:400... 15169 (GOOGLE)
1 2a02:26f0:6c0... 20940 (AKAMAI-ASN1)
40 2a00:1450:400... 15169 (GOOGLE)
3 4 52.30.234.204 16509 (AMAZON-02)
2 2 18.158.93.70 16509 (AMAZON-02)
2 20 141.226.228.48 200478 (TABOOLA-AS)
2 69.173.144.139 26667 (RUBICONPR...)
1 2 198.148.27.140 19189 (PULSEPOINT)
1 104.111.246.202 16625 (AKAMAI-AS)
2 2606:4700:10:... 13335 (CLOUDFLAR...)
1 34.98.67.61 15169 (GOOGLE)
1 1 52.29.85.133 16509 (AMAZON-02)
2 2 52.3.7.54 14618 (AMAZON-AES)
1 2600:1f18:444... 14618 (AMAZON-AES)
1 2 51.210.112.63 16276 (OVH)
3 5 147.75.102.200 54825 (PACKET)
1 185.64.190.80 62713 (AS-PUBMATIC)
1 2 34.251.167.52 16509 (AMAZON-02)
2 2 34.120.207.148 15169 (GOOGLE)
7 9 54.171.98.69 16509 (AMAZON-02)
1 2 72.251.249.14 29791 (VOXEL-DOT...)
1 1 35.161.8.247 16509 (AMAZON-02)
1 185.86.139.89 201081 (SMARTADSE...)
1 174.137.133.49 27257 (WEBAIR-IN...)
1 18.195.155.181 16509 (AMAZON-02)
1 2 88.99.214.77 24940 (HETZNER-AS)
1 1 178.250.0.163 44788 (ASN-CRITE...)
7 8 51.89.7.198 16276 (OVH)
1 1 35.227.248.159 15169 (GOOGLE)
2 2 77.243.60.138 42697 (NETIC-AS)
2 2 54.194.211.3 16509 (AMAZON-02)
1 1 54.171.43.242 16509 (AMAZON-02)
1 1 34.250.65.236 16509 (AMAZON-02)
1 1 172.104.121.22 63949 (LINODE-AP...)
9 11 18.197.99.6 16509 (AMAZON-02)
4 9 18.156.0.31 16509 (AMAZON-02)
1 192.132.33.46 18568 (BIDTELLECT)
1 141.226.224.32 200478 (TABOOLA-AS)
2 2 188.42.196.115 7979 (SERVERS-COM)
9 185.94.180.124 35220 (SPOTX-AMS)
3 35.201.67.47 15169 (GOOGLE)
3 35.190.91.160 15169 (GOOGLE)
1 1 185.64.189.110 62713 (AS-PUBMATIC)
1 185.64.190.106 62713 (AS-PUBMATIC)
3 2a02:26f0:10c... 20940 (AKAMAI-ASN1)
10 34.197.221.162 14618 (AMAZON-AES)
1 2600:9000:215... 16509 (AMAZON-02)
2 2a00:1450:400... 15169 (GOOGLE)
7 11 2a00:1450:400... 15169 (GOOGLE)
1 2 35.190.59.101 15169 (GOOGLE)
2 2a00:1450:400... 15169 (GOOGLE)
8 2a00:1450:400... 15169 (GOOGLE)
4 65.9.73.71 16509 (AMAZON-02)
8 2a00:1450:400... 15169 (GOOGLE)
1 35.190.40.172 15169 (GOOGLE)
2 2 35.244.255.22 15169 (GOOGLE)
2 2a02:2638:1::3 44788 (ASN-CRITE...)
6 151.101.113.108 54113 (FASTLY)
2 104.108.50.124 16625 (AKAMAI-AS)
1 2 52.29.22.19 16509 (AMAZON-02)
2 2 18.194.183.62 16509 (AMAZON-02)
1 18.159.79.175 16509 (AMAZON-02)
6 6 151.101.114.49 54113 (FASTLY)
3 104.111.216.96 16625 (AKAMAI-AS)
5 2001:4de0:ac1... 20446 (HIGHWINDS3)
1 52.206.107.130 14618 (AMAZON-AES)
19 30 2.18.234.233 16625 (AKAMAI-AS)
2 2 154.57.158.51 26558 (FREEWHEEL)
2 2 185.29.132.30 30419 (MEDIAMATH...)
4 52.94.232.32 16509 (AMAZON-02)
4 185.64.189.112 62713 (AS-PUBMATIC)
2 2 37.157.6.251 198622 (ADFORM)
4 213.174.135.2 39572 (ADVANCEDH...)
1 2a00:1450:401... 15169 (GOOGLE)
6 23.227.137.155 55081 (24SHELLS)
1 185.184.8.30 204995 (RTB-HOUSE...)
1 1 2a0c:5c81:516... 55081 (24SHELLS)
1 62.149.0.72 15497 (COLOCALL ...)
2 52.218.109.178 16509 (AMAZON-02)
2 52.1.33.51 14618 (AMAZON-AES)
3 2a00:1450:400... 15169 (GOOGLE)
1 2a00:1450:400... 15169 (GOOGLE)
1 54.195.94.143 16509 (AMAZON-02)
2 2a00:1288:f03... 10310 (YAHOO-1)
5 54.93.70.53 16509 (AMAZON-02)
2 104.111.215.68 16625 (AKAMAI-AS)
1 54.93.170.20 16509 (AMAZON-02)
3 34.98.64.218 15169 (GOOGLE)
1 54.231.40.226 16509 (AMAZON-02)
1 2a02:2638::1c 44788 (ASN-CRITE...)
1 2 35.241.57.45 15169 (GOOGLE)
1 104.225.98.130 36236 (NETACTUATE)
7 2607:f740:e61... 63911 (NETACTUAT...)
4 163.171.128.148 54994 (QUANTILNE...)
4 2600:9000:21a... 16509 (AMAZON-02)
778 122
Apex Domain
Subdomains
Transfer
111 dailymail.co.uk
www.dailymail.co.uk
i.dailymail.co.uk
scripts.dailymail.co.uk
ted.dailymail.co.uk
t.dailymail.co.uk
secured.dailymail.co.uk
crta.dailymail.co.uk
fff.dailymail.co.uk
creative.dailymail.co.uk
video.dailymail.co.uk
4 MB
80 taboola.com
cdn.taboola.com
trc.taboola.com
15.taboola.com
sync.taboola.com
match.taboola.com
sync-t1.taboola.com
cds.taboola.com
trc-events.taboola.com
images.taboola.com
vidstat.taboola.com
imprammp.taboola.com
am-match.taboola.com
wf.taboola.com
am-vid-events.taboola.com
c3.taboola.com
2 MB
76 googlesyndication.com
b1c90d68092b57f74adceeec8a58c68a.safeframe.googlesyndication.com
tpc.googlesyndication.com
pagead2.googlesyndication.com
9983081ac8e174582a7b6a6acc4b473e.safeframe.googlesyndication.com
770 KB
63 doubleclick.net
securepubads.g.doubleclick.net
stats.g.doubleclick.net
cm.g.doubleclick.net Failed
googleads.g.doubleclick.net
432 KB
40 ampproject.org
cdn.ampproject.org
777 KB
35 stickyadstv.com
cdn.stickyadstv.com
ads.stickyadstv.com
408 KB
32 adnxs.com
prebid.adnxs.com
ib.adnxs.com
acdn.adnxs.com
18 KB
26 amazon-adsystem.com
c.amazon-adsystem.com
s.amazon-adsystem.com
42 KB
23 openx.net
mailonline-uk-d.openx.net
eu-u.openx.net
u.openx.net
select-d.openx.net
taboola-d.openx.net
5 KB
22 yahoo.com
c2shb.ssp.yahoo.com
pr-bh.ybp.yahoo.com
ups.analytics.yahoo.com
14 KB
18 advertising.com
ads.adaptv.advertising.com
pixel.advertising.com
7 KB
16 userreport.com
sak.userreport.com
cdn.userreport.com
visitanalytics.userreport.com
tag.userreport.com
cdw-dcl.userreport.com
audex.userreport.com
relay.userreport.com
107 KB
15 permutive.com
cdn.permutive.com
api.permutive.com
googlesync.permutive.com
211 KB
14 aniview.com
player.aniview.com
track1.aniview.com
go1.aniview.com
183 KB
14 spotxchange.com
sync.search.spotxchange.com
search.spotxchange.com
8 KB
14 google.com
adservice.google.com
www.google.com
538 B
14 casalemedia.com
htlb.casalemedia.com
ssum-sec.casalemedia.com
ssum.casalemedia.com
5 KB
14 googleapis.com
imasdk.googleapis.com
fonts.googleapis.com
135 KB
13 selectmedia.asia
play.selectmedia.asia
player.hb.selectmedia.asia
hb.hb.selectmedia.asia
167 KB
12 rubiconproject.com
fastlane.rubiconproject.com
pixel.rubiconproject.com
eus.rubiconproject.com
prebid-server.rubiconproject.com Failed
22 KB
11 gstatic.com
fonts.gstatic.com
csi.gstatic.com
109 KB
11 skimresources.com
s.skimresources.com
t.skimresources.com
p.skimresources.com
r.skimresources.com
x.skimresources.com
24 KB
9 cedexis.com
radar.cedexis.com
rpt.cedexis.com
21 KB
9 adsrvr.org
match.adsrvr.org
5 KB
9 pubmatic.com
simage2.pubmatic.com
image2.pubmatic.com
aud.pubmatic.com
hbopenbid.pubmatic.com
ads.pubmatic.com
2 KB
9 criteo.com
bidder.criteo.com
dis.criteo.com
gum.criteo.com
2 KB
8 cedexis-test.com
cdnetworks.cedexis-test.com
p29.cedexis-test.com
203 KB
8 vidible.tv
acds.prod.vidible.tv
cdn-ssl.vidible.tv
trk.vidible.tv
112 KB
8 id5-sync.com
id5-sync.com
13 KB
8 googletagservices.com
www.googletagservices.com
228 KB
7 indexww.com
js-sec.indexww.com
7 bidswitch.net
x.bidswitch.net
grid.bidswitch.net
3 KB
6 everesttech.net
sync-tm.everesttech.net
2 KB
6 cloudfront.net
d3tsytm1wtjqo2.cloudfront.net
14 KB
5 exelator.com
loada.exelator.com
loadm.exelator.com
loadeu.exelator.com
4 KB
5 iris.tv
ovp.iris.tv
context.iris.tv
7 KB
4 crwdcntrl.net
sync.crwdcntrl.net
1 KB
4 teads.tv
a.teads.tv
1 KB
4 inskinad.com
mfad.inskinad.com
3 KB
4 dotmetrics.net
uk-script.dotmetrics.net
39 KB
3 amazonaws.com
sdsbucket.s3.amazonaws.com
s3.amazonaws.com
39 KB
3 moatads.com
z.moatads.com
px.moatads.com
146 KB
3 liadm.com
i.liadm.com
i6.liadm.com
1 KB
3 3lift.com
tlx.3lift.com
eb2.3lift.com
705 B
3 justpremium.com
pre.ads.justpremium.com
507 B
2 adform.net
dmp.adform.net
c1.adform.net
679 B
2 mathtag.com
sync.mathtag.com
1 KB
2 fwmrm.net
1f2e7.v.fwmrm.net
920 B
2 sportradarserving.com
a.sportradarserving.com
1 KB
2 criteo.net
static.criteo.net
49 KB
2 betweendigital.com
ads.betweendigital.com
1 KB
2 semasio.net
uipglob.semasio.net
1 KB
2 1dmp.io
sync.1dmp.io
829 B
2 lijit.com
ce.lijit.com
1018 B
2 rlcdn.com
idsync.rlcdn.com
797 B
2 ml314.com
ml314.com
884 B
2 onaudience.com
pixel.onaudience.com
729 B
2 zeotap.com
mwzeom.zeotap.com
880 B
2 contextweb.com
bh.contextweb.com
755 B
2 mfadsrvr.com
rtb.mfadsrvr.com
1 KB
2 google-analytics.com
google-analytics.com
ssl.google-analytics.com
18 KB
2 go-mpulse.net
s.go-mpulse.net
c.go-mpulse.net
51 KB
2 serverbid.com
e.serverbid.com
568 B
2 smartclip.net
sync.sxp.smartclip.net
931 B
2 scorecardresearch.com
sb.scorecardresearch.com
1 KB
2 and.co.uk
swa.and.co.uk
2 KB
2 creative-serving.com
ads.creative-serving.com
1 KB
2 silobreaker.com
info.silobreaker.com
3 KB
1 akstat.io
6852bd0f.akstat.io
360 B
1 cedexis-radar.net
i2-ltqwbihpujgydttmgcfzxjuwvheozf.init.cedexis-radar.net
1 KB
1 google.nl
adservice.google.nl
803 B
1 152media.com
sync.ads.152media.com
529 B
1 adtelli.com
s.adtelli.com
397 B
1 creativecdn.com
prebid-eu.creativecdn.com
173 B
1 adtelligent.com
player.adtelligent.com
12 KB
1 consensu.org
api.skimlinks.mgr.consensu.org
944 B
1 bttrack.com
bttrack.com
380 B
1 appier.net
s.c.appier.net
362 B
1 demdex.net
dpm.demdex.net
534 B
1 gumgum.com
rtb.gumgum.com
304 B
1 avct.cloud
ads.avct.cloud
447 B
1 avocet.io
ads.avocet.io
226 B
1 tapad.com
pixel.tapad.com
380 B
1 emxdgt.com
e1.emxdgt.com
124 B
1 adkernel.com
dsp.adkernel.com
233 B
1 smartadserver.com
rtb-csync.smartadserver.com
697 B
1 storygize.net
www.storygize.net
431 B
1 agkn.com
aa.agkn.com
332 B
1 mookie1.com
odr.mookie1.com
324 B
1 bluekai.com
tags.bluekai.com
329 B
1 2mdn.net
s0.2mdn.net
11 KB
1 google.de
adservice.google.de
169 B
1 facebook.com
www.facebook.com
258 B
1 facebook.net
connect.facebook.net
2 KB
1 jsdelivr.net
cdn.jsdelivr.net
939 B
1 spotxcdn.com
aka.spotxcdn.com
155 KB
1 spotx.tv
js.spotx.tv
590 B
1 anm.co.uk
hulkprod.anm.co.uk
12 KB
0 admanmedia.com Failed
pub.admanmedia.com Failed
778 99
Domain Requested by
62 tpc.googlesyndication.com securepubads.g.doubleclick.net
www.dailymail.co.uk
cdn.ampproject.org
tpc.googlesyndication.com
54 i.dailymail.co.uk www.dailymail.co.uk
41 securepubads.g.doubleclick.net www.googletagservices.com
securepubads.g.doubleclick.net
info.silobreaker.com
www.dailymail.co.uk
40 cdn.ampproject.org securepubads.g.doubleclick.net
38 www.dailymail.co.uk info.silobreaker.com
www.dailymail.co.uk
30 ads.stickyadstv.com 19 redirects player.aniview.com
www.dailymail.co.uk
cdn.stickyadstv.com
22 c.amazon-adsystem.com www.dailymail.co.uk
c.amazon-adsystem.com
20 images.taboola.com www.dailymail.co.uk
16 ib.adnxs.com 2 redirects www.dailymail.co.uk
cdn.permutive.com
player.aniview.com
player.hb.selectmedia.asia
14 cm.g.doubleclick.net www.dailymail.co.uk
12 www.google.com 7 redirects www.dailymail.co.uk
securepubads.g.doubleclick.net
12 api.permutive.com cdn.permutive.com
12 c2shb.ssp.yahoo.com www.dailymail.co.uk
11 vidstat.taboola.com cdn.taboola.com
vidstat.taboola.com
11 pixel.advertising.com 9 redirects www.dailymail.co.uk
11 cdn.taboola.com www.dailymail.co.uk
cdn.taboola.com
10 fonts.gstatic.com fonts.googleapis.com
10 fonts.googleapis.com securepubads.g.doubleclick.net
10 track1.aniview.com www.dailymail.co.uk
player.aniview.com
10 htlb.casalemedia.com www.dailymail.co.uk
player.aniview.com
player.hb.selectmedia.asia
10 prebid.adnxs.com www.dailymail.co.uk
9 pagead2.googlesyndication.com www.dailymail.co.uk
securepubads.g.doubleclick.net
9 search.spotxchange.com js.spotx.tv
player.aniview.com
9 ups.analytics.yahoo.com 4 redirects www.dailymail.co.uk
9 match.adsrvr.org 7 redirects www.dailymail.co.uk
player.aniview.com
8 id5-sync.com 7 redirects www.dailymail.co.uk
8 mailonline-uk-d.openx.net www.dailymail.co.uk
8 www.googletagservices.com www.dailymail.co.uk
securepubads.g.doubleclick.net
7 rpt.cedexis.com radar.cedexis.com
7 js-sec.indexww.com www.dailymail.co.uk
player.aniview.com
7 googleads.g.doubleclick.net www.dailymail.co.uk
7 ads.adaptv.advertising.com www.dailymail.co.uk
player.aniview.com
cdn-ssl.vidible.tv
7 crta.dailymail.co.uk www.dailymail.co.uk
7 cdn.userreport.com sak.userreport.com
cdn.userreport.com
www.dailymail.co.uk
7 trc.taboola.com cdn.taboola.com
www.dailymail.co.uk
7 fastlane.rubiconproject.com www.dailymail.co.uk
player.hb.selectmedia.asia
7 bidder.criteo.com www.dailymail.co.uk
static.criteo.net
6 taboola-d.openx.net 2 redirects vidstat.taboola.com
6 hb.hb.selectmedia.asia player.hb.selectmedia.asia
www.dailymail.co.uk
6 sync-tm.everesttech.net 6 redirects
6 acdn.adnxs.com www.dailymail.co.uk
player.aniview.com
6 trc-events.taboola.com www.dailymail.co.uk
cdn.taboola.com
6 x.bidswitch.net 6 redirects
6 d3tsytm1wtjqo2.cloudfront.net www.dailymail.co.uk
5 trk.vidible.tv www.dailymail.co.uk
5 cdn.stickyadstv.com imasdk.googleapis.com
cdn.stickyadstv.com
player.aniview.com
5 sync.taboola.com 2 redirects www.dailymail.co.uk
5 sync.search.spotxchange.com 2 redirects www.dailymail.co.uk
4 p29.cedexis-test.com radar.cedexis.com
4 cdnetworks.cedexis-test.com radar.cedexis.com
4 hbopenbid.pubmatic.com player.aniview.com
player.hb.selectmedia.asia
4 s.amazon-adsystem.com www.dailymail.co.uk
4 am-match.taboola.com vidstat.taboola.com
4 context.iris.tv ovp.iris.tv
4 sync.crwdcntrl.net 3 redirects www.dailymail.co.uk
4 play.selectmedia.asia securepubads.g.doubleclick.net
player.aniview.com
www.dailymail.co.uk
4 a.teads.tv www.dailymail.co.uk
4 mfad.inskinad.com www.dailymail.co.uk
4 uk-script.dotmetrics.net www.dailymail.co.uk
uk-script.dotmetrics.net
4 imasdk.googleapis.com www.dailymail.co.uk
imasdk.googleapis.com
3 player.hb.selectmedia.asia info.silobreaker.com
player.hb.selectmedia.asia
3 select-d.openx.net player.aniview.com
player.hb.selectmedia.asia
3 am-vid-events.taboola.com www.dailymail.co.uk
3 imprammp.taboola.com vidstat.taboola.com
info.silobreaker.com
3 u.openx.net www.dailymail.co.uk
player.aniview.com
3 eu-u.openx.net www.dailymail.co.uk
3 player.aniview.com play.selectmedia.asia
player.aniview.com
3 p.skimresources.com www.dailymail.co.uk
3 t.skimresources.com www.dailymail.co.uk
s.skimresources.com
3 15.taboola.com cdn.taboola.com
3 ssum-sec.casalemedia.com 1 redirects www.dailymail.co.uk
3 fff.dailymail.co.uk www.dailymail.co.uk
3 b1c90d68092b57f74adceeec8a58c68a.safeframe.googlesyndication.com securepubads.g.doubleclick.net
3 pre.ads.justpremium.com www.dailymail.co.uk
2 radar.cedexis.com 1 redirects
2 ads.pubmatic.com player.aniview.com
2 cdn-ssl.vidible.tv acds.prod.vidible.tv
player.aniview.com
2 9983081ac8e174582a7b6a6acc4b473e.safeframe.googlesyndication.com securepubads.g.doubleclick.net
2 relay.userreport.com cdn.userreport.com
2 sdsbucket.s3.amazonaws.com cdn.userreport.com
sdsbucket.s3.amazonaws.com
2 cdw-dcl.userreport.com 1 redirects www.dailymail.co.uk
2 sync.mathtag.com 2 redirects
2 1f2e7.v.fwmrm.net 2 redirects
2 wf.taboola.com vidstat.taboola.com
2 z.moatads.com www.dailymail.co.uk
cdn-ssl.vidible.tv
2 video.dailymail.co.uk www.dailymail.co.uk
2 a.sportradarserving.com 2 redirects
2 eb2.3lift.com 1 redirects www.dailymail.co.uk
2 eus.rubiconproject.com www.dailymail.co.uk
player.aniview.com
2 static.criteo.net www.dailymail.co.uk
static.criteo.net
2 x.skimresources.com 2 redirects
2 r.skimresources.com 1 redirects www.dailymail.co.uk
2 ads.betweendigital.com 2 redirects
2 uipglob.semasio.net 2 redirects
2 sync-t1.taboola.com www.dailymail.co.uk
2 loadm.exelator.com 1 redirects www.dailymail.co.uk
2 sync.1dmp.io 1 redirects www.dailymail.co.uk
2 ce.lijit.com 1 redirects www.dailymail.co.uk
2 idsync.rlcdn.com 2 redirects
2 ml314.com 1 redirects www.dailymail.co.uk
2 loada.exelator.com 2 redirects
2 pixel.onaudience.com 1 redirects www.dailymail.co.uk
2 i.liadm.com 2 redirects
2 mwzeom.zeotap.com www.dailymail.co.uk
2 bh.contextweb.com 1 redirects www.dailymail.co.uk
2 pixel.rubiconproject.com www.dailymail.co.uk
2 rtb.mfadsrvr.com 2 redirects
2 adservice.google.com securepubads.g.doubleclick.net
2 visitanalytics.userreport.com www.dailymail.co.uk
2 cdn.permutive.com www.dailymail.co.uk
cdn.permutive.com
2 e.serverbid.com 2 redirects
2 sync.sxp.smartclip.net 1 redirects www.dailymail.co.uk
2 sb.scorecardresearch.com 1 redirects www.dailymail.co.uk
2 swa.and.co.uk 2 redirects
2 t.dailymail.co.uk www.dailymail.co.uk
2 ted.dailymail.co.uk www.dailymail.co.uk
2 ads.creative-serving.com 1 redirects www.dailymail.co.uk
2 info.silobreaker.com 1 redirects
1 6852bd0f.akstat.io s.go-mpulse.net
1 i2-ltqwbihpujgydttmgcfzxjuwvheozf.init.cedexis-radar.net radar.cedexis.com
1 gum.criteo.com static.criteo.net
1 s3.amazonaws.com www.dailymail.co.uk
1 px.moatads.com www.dailymail.co.uk
1 c1.adform.net 1 redirects
1 acds.prod.vidible.tv player.aniview.com
1 adservice.google.nl securepubads.g.doubleclick.net
1 sync.ads.152media.com www.dailymail.co.uk
1 s.adtelli.com 1 redirects
1 prebid-eu.creativecdn.com player.hb.selectmedia.asia
1 player.adtelligent.com player.hb.selectmedia.asia
1 c3.taboola.com www.dailymail.co.uk
1 csi.gstatic.com cdn.ampproject.org
1 audex.userreport.com www.dailymail.co.uk
1 dmp.adform.net 1 redirects
1 prebid-server.rubiconproject.com player.aniview.com
1 go1.aniview.com player.aniview.com
1 ssum.casalemedia.com 1 redirects
1 grid.bidswitch.net www.dailymail.co.uk
1 loadeu.exelator.com www.dailymail.co.uk
1 api.skimlinks.mgr.consensu.org s.skimresources.com
1 tag.userreport.com cdn.userreport.com
1 aud.pubmatic.com www.dailymail.co.uk
1 image2.pubmatic.com 1 redirects
1 cds.taboola.com www.dailymail.co.uk
1 bttrack.com www.dailymail.co.uk
1 s.c.appier.net 1 redirects
1 dpm.demdex.net 1 redirects
1 rtb.gumgum.com 1 redirects
1 ads.avct.cloud 1 redirects
1 ads.avocet.io 1 redirects
1 pixel.tapad.com 1 redirects
1 dis.criteo.com 1 redirects
1 e1.emxdgt.com www.dailymail.co.uk
1 dsp.adkernel.com www.dailymail.co.uk
1 rtb-csync.smartadserver.com www.dailymail.co.uk
1 www.storygize.net 1 redirects
1 simage2.pubmatic.com www.dailymail.co.uk
1 i6.liadm.com www.dailymail.co.uk
1 aa.agkn.com 1 redirects
1 odr.mookie1.com www.dailymail.co.uk
1 tags.bluekai.com www.dailymail.co.uk
1 match.taboola.com www.dailymail.co.uk
1 c.go-mpulse.net s.go-mpulse.net
1 googlesync.permutive.com www.dailymail.co.uk
1 creative.dailymail.co.uk www.dailymail.co.uk
1 s0.2mdn.net imasdk.googleapis.com
1 s.skimresources.com www.dailymail.co.uk
1 adservice.google.de securepubads.g.doubleclick.net
1 pr-bh.ybp.yahoo.com 1 redirects
1 www.facebook.com www.dailymail.co.uk
1 stats.g.doubleclick.net www.dailymail.co.uk
1 ssl.google-analytics.com 1 redirects
1 connect.facebook.net www.dailymail.co.uk
1 google-analytics.com www.dailymail.co.uk
1 s.go-mpulse.net www.dailymail.co.uk
1 tlx.3lift.com www.dailymail.co.uk
1 cdn.jsdelivr.net www.dailymail.co.uk
1 secured.dailymail.co.uk www.dailymail.co.uk
1 ovp.iris.tv www.dailymail.co.uk
1 aka.spotxcdn.com www.dailymail.co.uk
1 js.spotx.tv 1 redirects
1 sak.userreport.com www.dailymail.co.uk
1 hulkprod.anm.co.uk www.dailymail.co.uk
1 scripts.dailymail.co.uk www.dailymail.co.uk
0 pub.admanmedia.com Failed player.hb.selectmedia.asia
778 185
Subject Issuer Validity Valid
info.silobreaker.com
Cloudflare Inc ECC CA-3
2020-06-30 -
2021-06-30
a year crt.sh
secured.dailymail.co.uk
DigiCert Secure Site ECC CA-1
2020-04-29 -
2021-02-18
10 months crt.sh
*.g.doubleclick.net
GTS CA 1O1
2020-11-10 -
2021-02-02
3 months crt.sh
upload.video.google.com
GTS CA 1O1
2020-11-10 -
2021-02-02
3 months crt.sh
*.creative-serving.com
Sectigo RSA Domain Validation Secure Server CA
2019-03-27 -
2021-04-02
2 years crt.sh
*.cloudfront.net
DigiCert Global CA G2
2020-05-26 -
2021-04-21
a year crt.sh
*.dotmetrics.net
Amazon
2020-11-23 -
2021-12-22
a year crt.sh
*.dailymail.co.uk
DigiCert SHA2 Secure Server CA
2020-12-07 -
2021-12-14
a year crt.sh
sb.scorecardresearch.com
DigiCert Secure Site ECC CA-1
2020-07-17 -
2021-06-02
a year crt.sh
dmgprivacyint.co.uk
Let's Encrypt Authority X3
2020-11-05 -
2021-02-03
3 months crt.sh
*.smartclip.net
Amazon
2020-02-29 -
2021-03-29
a year crt.sh
*.userreport.com
RapidSSL RSA CA 2018
2019-01-10 -
2021-03-10
2 years crt.sh
c.amazon-adsystem.com
Amazon
2020-08-04 -
2021-08-02
a year crt.sh
*.taboola.com
DigiCert TLS RSA SHA256 2020 CA1
2020-11-25 -
2021-12-26
a year crt.sh
cdn.spotxcdn.com
GeoTrust RSA CA 2018
2020-05-21 -
2021-06-20
a year crt.sh
iris.tv
Amazon
2020-10-10 -
2021-11-10
a year crt.sh
mfad.inskinad.com
Amazon
2020-03-28 -
2021-04-28
a year crt.sh
f3.shared.global.fastly.net
GlobalSign CloudSSL CA - SHA256 - G3
2020-10-26 -
2021-04-17
6 months crt.sh
prebid.adnxs.com
GeoTrust TLS RSA CA G1
2020-03-29 -
2022-03-29
2 years crt.sh
tracking.justpremium.com
Amazon
2020-11-26 -
2021-12-25
a year crt.sh
*.openx.net
GeoTrust RSA CA 2018
2020-06-18 -
2021-08-17
a year crt.sh
san.casalemedia.com
GeoTrust RSA CA 2018
2020-03-02 -
2021-04-01
a year crt.sh
teads.tv
Let's Encrypt Authority X3
2020-11-19 -
2021-02-17
3 months crt.sh
*.criteo.com
DigiCert TLS Hybrid ECC SHA384 2020 CA1
2020-11-17 -
2021-02-14
3 months crt.sh
*.rubiconproject.com
DigiCert SHA2 Secure Server CA
2020-06-24 -
2021-02-17
8 months crt.sh
*.3lift.com
Amazon
2020-07-04 -
2021-08-05
a year crt.sh
web.ssp.yahoo.com
DigiCert SHA2 High Assurance Server CA
2020-09-18 -
2021-03-17
6 months crt.sh
*.adnxs.com
DigiCert ECC Secure Server CA
2019-01-23 -
2021-03-08
2 years crt.sh
akstat.io
DigiCert Secure Site ECC CA-1
2020-05-06 -
2021-08-05
a year crt.sh
*.google-analytics.com
GTS CA 1O1
2020-11-10 -
2021-02-02
3 months crt.sh
*.facebook.com
DigiCert SHA2 High Assurance Server CA
2020-11-02 -
2021-01-30
3 months crt.sh
sni.cloudflaressl.com
Cloudflare Inc ECC CA-3
2020-06-09 -
2021-06-09
a year crt.sh
api.permutive.com
Let's Encrypt Authority X3
2020-10-24 -
2021-01-22
3 months crt.sh
*.google.de
GTS CA 1O1
2020-11-10 -
2021-02-02
3 months crt.sh
*.google.com
GTS CA 1O1
2020-11-10 -
2021-02-02
3 months crt.sh
tpc.googlesyndication.com
GTS CA 1O1
2020-11-10 -
2021-02-02
3 months crt.sh
*.skimresources.com
DigiCert SHA2 Secure Server CA
2020-09-10 -
2021-10-12
a year crt.sh
*.doubleclick.net
GTS CA 1O1
2020-11-10 -
2021-02-02
3 months crt.sh
*.search.spotxchange.com
GeoTrust RSA CA 2018
2019-03-20 -
2021-04-21
2 years crt.sh
*.v.ssp.yahoo.com
DigiCert SHA2 High Assurance Server CA
2020-07-29 -
2021-01-25
6 months crt.sh
wl.aniview.com
R3
2020-12-11 -
2021-03-11
3 months crt.sh
misc-sni.google.com
GTS CA 1O1
2020-11-10 -
2021-02-02
3 months crt.sh
*.crwdcntrl.net
Go Daddy Secure Certificate Authority - G2
2019-06-13 -
2021-06-28
2 years crt.sh
odc-prod-01.oracle.com
DigiCert Secure Site ECC CA-1
2020-10-15 -
2021-04-09
6 months crt.sh
*.mookie1.com
DigiCert SHA2 Secure Server CA
2020-02-21 -
2021-03-22
a year crt.sh
*.liadm.com
Amazon
2020-11-30 -
2021-12-29
a year crt.sh
*.onaudience.com
Certyfikat SSL
2020-05-28 -
2021-05-28
a year crt.sh
*.pubmatic.com
Sectigo RSA Organization Validation Secure Server CA
2019-02-22 -
2021-02-21
2 years crt.sh
*.ml314.com
Amazon
2020-02-17 -
2021-03-17
a year crt.sh
*.lijit.com
Go Daddy Secure Certificate Authority - G2
2020-03-11 -
2021-05-10
a year crt.sh
*.contextweb.com
DigiCert SHA2 Secure Server CA
2020-05-07 -
2022-05-12
2 years crt.sh
*.smartadserver.com
DigiCert Global CA G2
2020-02-03 -
2022-02-03
2 years crt.sh
*.adkernel.com
COMODO RSA Domain Validation Secure Server CA
2017-11-17 -
2021-01-05
3 years crt.sh
*.emxdgt.com
Go Daddy Secure Certificate Authority - G2
2020-05-18 -
2021-07-17
a year crt.sh
sync.1dmp.io
Let's Encrypt Authority X3
2020-11-03 -
2021-02-01
3 months crt.sh
*.exelator.com
Go Daddy Secure Certificate Authority - G2
2019-05-17 -
2021-06-25
2 years crt.sh
ups.analytics.yahoo.com
DigiCert SHA2 High Assurance Server CA
2020-10-24 -
2021-04-20
6 months crt.sh
*.bttrack.com
Sectigo RSA Domain Validation Secure Server CA
2019-03-19 -
2021-04-13
2 years crt.sh
*.spotxchange.com
GeoTrust RSA CA 2018
2019-03-18 -
2021-03-17
2 years crt.sh
*.aniview.com
DigiCert SHA2 Secure Server CA
2020-01-22 -
2021-04-22
a year crt.sh
*.gstatic.com
GTS CA 1O1
2020-11-10 -
2021-02-02
3 months crt.sh
api.skimlinks.mgr.consensu.org
DigiCert SHA2 Secure Server CA
2019-10-04 -
2021-10-07
2 years crt.sh
*.criteo.net
DigiCert TLS Hybrid ECC SHA384 2020 CA1
2020-11-17 -
2021-02-14
3 months crt.sh
*.id5-sync.com
Let's Encrypt Authority X3
2020-09-27 -
2020-12-26
3 months crt.sh
*.adsrvr.org
Trustwave Organization Validation SHA256 CA, Level 1
2019-03-07 -
2021-04-19
2 years crt.sh
cdn.adnxs.com
GlobalSign CloudSSL CA - SHA256 - G3
2020-10-29 -
2021-04-14
5 months crt.sh
pixel.advertising.com
DigiCert SHA2 High Assurance Server CA
2020-10-04 -
2021-03-31
6 months crt.sh
grid.bidswitch.net
Sectigo RSA Domain Validation Secure Server CA
2020-10-15 -
2021-10-23
a year crt.sh
moatads.com
DigiCert SHA2 Secure Server CA
2020-01-17 -
2021-03-17
a year crt.sh
*.stickyadstv.com
DigiCert SHA2 High Assurance Server CA
2019-11-25 -
2022-02-18
2 years crt.sh
ads.stickyadstv.com
DigiCert TLS RSA SHA256 2020 CA1
2020-11-13 -
2021-11-17
a year crt.sh
s.amazon-adsystem.com
Amazon
2020-08-28 -
2021-08-20
a year crt.sh
player.hb.selectmedia.asia
Let's Encrypt Authority X3
2020-11-09 -
2021-02-07
3 months crt.sh
hb.hb.selectmedia.asia
Let's Encrypt Authority X3
2020-11-22 -
2021-02-20
3 months crt.sh
*.adtelligent.com
Sectigo RSA Domain Validation Secure Server CA
2020-10-28 -
2021-11-27
a year crt.sh
*.creativecdn.com
RapidSSL RSA CA 2018
2019-01-11 -
2021-04-11
2 years crt.sh
sync.ads.152media.com
Let's Encrypt Authority X3
2020-11-29 -
2021-02-27
3 months crt.sh
*.s3.amazonaws.com
DigiCert Baltimore CA-2 G2
2019-11-09 -
2021-03-12
a year crt.sh
*.google.nl
GTS CA 1O1
2020-11-10 -
2021-02-02
3 months crt.sh
www.google.com
GTS CA 1O1
2020-11-10 -
2021-02-02
3 months crt.sh
acds.prod.vidible.tv
DigiCert SHA2 High Assurance Server CA
2018-01-24 -
2021-01-28
3 years crt.sh
cdn-ycs.vidible.tv
DigiCert SHA2 High Assurance Server CA
2020-07-22 -
2021-01-18
6 months crt.sh
trk.vidible.tv
DigiCert SHA2 High Assurance Server CA
2018-02-21 -
2021-02-25
3 years crt.sh
s3.amazonaws.com
DigiCert Baltimore CA-2 G2
2020-08-04 -
2021-08-09
a year crt.sh
radar.cedexis.com
Go Daddy Secure Certificate Authority - G2
2019-06-26 -
2021-08-25
2 years crt.sh
*.init.cedexis-radar.net
Go Daddy Secure Certificate Authority - G2
2019-11-14 -
2022-01-13
2 years crt.sh
*.cedexis-test.com
Go Daddy Secure Certificate Authority - G2
2020-05-10 -
2021-07-09
a year crt.sh

This page contains 68 frames:

Primary Page: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
Frame ID: E910D479EFC6492948E945A61EE98BA9
Requests: 489 HTTP requests in this frame

Frame: https://imasdk.googleapis.com/js/core/bridge3.431.1_en.html
Frame ID: A6D9CFF376FDC2C40E8CDB688190BE85
Requests: 1 HTTP requests in this frame

Frame: https://ssum-sec.casalemedia.com/usermatch?s=184665&cb=https%3A%2F%2Fmfad.inskinad.com%2Fudb%2F9874%2Fsync%2Fi.gif%3FpartnerId%3D1%26userId%3D&C=1
Frame ID: D1BB4134C00C4E21AC71C2CC69ECE27C
Requests: 1 HTTP requests in this frame

Frame: https://securepubads.g.doubleclick.net/pcs/view?xai=AKAOjsuOF91WtR8sfrCFlA2CK7UDL8IKdxK_9rse_wWBoYK7ETgHLQa0Gb7C1W8Opri9F8GPBoZkpMI9RnE1cjS-XneZZGivVGSn-ti4iJ2Gz3PKmDTqo1po5yvPdT0Mb_UlRwTPtUCCKNGxgrq_NTJurJJxYHC56k1JGISR2b3X3G9bhM_3p1NguNP3At0aotp9hND2xA8t7WHRwLJilVyHrdI4Mf14GfIa2jtH2PtJBPVtpIPmoWCQj5udAcgx8pvle7nyW4fbMEtBUhWHOCxOh5w1C7bpJRMq3MhBjsMP9VzbiNTFnwvqoU7tu3_g19CssItVWpDLxRils5pa&sai=AMfl-YTHVsLX0MINW0WnfPGHaHf4rtqN9oAVnvKBq1il0Qu6gDuT1mdnMXaFfhOYp43SOQhRpHd5N65KDbFktFxk-CfQ1w368X6cmI0EsnfDMF3lDrEtXmN8ZHY8IYxhU20&sig=Cg0ArKJSzKKfNRSKUbu3EAE&urlfix=1&adurl=
Frame ID: 16BB691AF982DC50477D83F2E4BA9990
Requests: 6 HTTP requests in this frame

Frame: https://cdn.ampproject.org/rtv/012010270040000/amp4ads-v0.mjs
Frame ID: 63F6205F8B9EFD6C7A28332EA94E86E3
Requests: 14 HTTP requests in this frame

Frame: https://sync.crwdcntrl.net/map/ct=y/c=10924/tp=OOLA/tpid=81242381-ab73-4352-8bed-9e7099c82ee1-tuct6d23571
Frame ID: DECF43887250F136721D84B220EF70B2
Requests: 32 HTTP requests in this frame

Frame: https://imasdk.googleapis.com/js/core/bridge3.431.1_en.html
Frame ID: DF760F41CA1DD468BF1A386A01D7E8D6
Requests: 1 HTTP requests in this frame

Frame: https://t.skimresources.com/api/v2/robots.txt?__skimjs_preflight__please_ignore__=true&rnd=0.20716357540113406
Frame ID: C69FE381E6B44223E169147F57F59800
Requests: 3 HTTP requests in this frame

Frame: https://tag.userreport.com/server.html
Frame ID: 0680893B67CB80D9DC523C02ECB2A30E
Requests: 1 HTTP requests in this frame

Frame: https://cdn.ampproject.org/rtv/012010270040000/amp4ads-v0.mjs
Frame ID: A2A2479CA0556E7B2C3A7601B74DFC08
Requests: 17 HTTP requests in this frame

Frame: https://cdn.ampproject.org/rtv/012010270040000/amp4ads-v0.mjs
Frame ID: C794121815E9294A6837B3EC7BFA0D84
Requests: 21 HTTP requests in this frame

Frame: https://b1c90d68092b57f74adceeec8a58c68a.safeframe.googlesyndication.com/safeframe/1-0-37/html/container.html
Frame ID: B8B006BB1AB3C2A761DFCCC32EE3FF3C
Requests: 1 HTTP requests in this frame

Frame: https://securepubads.g.doubleclick.net/pcs/view?xai=AKAOjsszLyA3nhQCxPE1gbKsOri1yFpZiXy-A3ho839kvzUti71jvPcJCNBEA8UUGCRejAqCSVITkO5LYBQTcV3pV7H0dZ2s-5_6-xNgWfVo-Q3e82iG5fnj0L4T7Qn4GM1x7bU_8OlZ3ZiyxV1g23r01xaFUK32ibtn9Ei3Ytk9SWhQ5LA95hikE6CKLDiMINXCWzl_cmKDFQBZBUageF-g-EENtBDi3pL3cWt1N1mXUchS3UBKc_VgaPVKTwyJueFIuMEkej8jup7H8rPjdn3NfAn0gTOoMNMr6AcjAUGPWHqZ4YjOeP0AX1X75C_DnpLipRJM8cg&sig=Cg0ArKJSzFJ4OM58SnqyEAE&adurl=
Frame ID: 93CD5CC57C7038A3F1018DF4E7669138
Requests: 8 HTTP requests in this frame

Frame: https://acdn.adnxs.com/dmp/async_usersync.html
Frame ID: 7EA7ABAE967C3E27F42B7A226B986585
Requests: 1 HTTP requests in this frame

Frame: https://acdn.adnxs.com/dmp/async_usersync.html
Frame ID: F3802BBC54A61D2D40261C5EB9FEEF05
Requests: 1 HTTP requests in this frame

Frame: https://ssum-sec.casalemedia.com/usermatch?s=184665&cb=https%3A%2F%2Fmfad.inskinad.com%2Fudb%2F9874%2Fsync%2Fi.gif%3FpartnerId%3D1%26userId%3D
Frame ID: F43489B35E48DBBFD5E09BCC02DC6874
Requests: 1 HTTP requests in this frame

Frame: https://js-sec.indexww.com/um/ixmatch.html
Frame ID: B8665E37D1FA9E574B4EEF7306C38CDE
Requests: 1 HTTP requests in this frame

Frame: https://acdn.adnxs.com/dmp/async_usersync.html
Frame ID: AF2AC040AAE3FB7088955B2EB3EA7908
Requests: 1 HTTP requests in this frame

Frame: https://pre.ads.justpremium.com/v/1.0/t/sync?_c=ak70n1608036336967
Frame ID: 66FA673099CEA9069EDEF1493459118F
Requests: 1 HTTP requests in this frame

Frame: https://eu-u.openx.net/w/1.0/pd?plm=6&ph=36664cef-3484-4aa7-9d01-fa4f6f6b2d4e&gdpr=1
Frame ID: C6E26495D2F6BB6914BA5D372F3EB650
Requests: 1 HTTP requests in this frame

Frame: https://u.openx.net/w/1.0/pd
Frame ID: 1526B2E9A9BEB5C133535D4B7DF8C42B
Requests: 1 HTTP requests in this frame

Frame: https://js-sec.indexww.com/um/ixmatch.html
Frame ID: B98B82FF33DC462A21084B087E4BC899
Requests: 1 HTTP requests in this frame

Frame: https://js-sec.indexww.com/um/ixmatch.html
Frame ID: 78CEE64222767D7A6D69D68492673B5A
Requests: 1 HTTP requests in this frame

Frame: https://u.openx.net/w/1.0/pd
Frame ID: 3687C4D23CC571220EBBC9531C7CB5D6
Requests: 1 HTTP requests in this frame

Frame: https://eus.rubiconproject.com/usync.html
Frame ID: 4A93274B04C542F00F6A1E7C7A05EFFD
Requests: 1 HTTP requests in this frame

Frame: https://js-sec.indexww.com/um/ixmatch.html
Frame ID: 0AB324445C8991D0C16198A6FD059D74
Requests: 1 HTTP requests in this frame

Frame: https://acdn.adnxs.com/dmp/async_usersync.html
Frame ID: DA5DC773C9D6D5B21112573E46FFF362
Requests: 1 HTTP requests in this frame

Frame: https://eu-u.openx.net/w/1.0/pd?plm=6&ph=36664cef-3484-4aa7-9d01-fa4f6f6b2d4e&gdpr=1
Frame ID: 5E3F8C6CFA48F7D1E5D5AB09DCB085BD
Requests: 1 HTTP requests in this frame

Frame: https://acdn.adnxs.com/dmp/async_usersync.html
Frame ID: 1ECB4F5E7C7E4F178A94A4A428063BD2
Requests: 1 HTTP requests in this frame

Frame: https://js-sec.indexww.com/um/ixmatch.html
Frame ID: 99C29DFA9A11C77DD0AC1B6B32AE610C
Requests: 1 HTTP requests in this frame

Frame: https://eb2.3lift.com/sync?&ld=1
Frame ID: A1F9641A8C63316B2612F41A7F66AD46
Requests: 1 HTTP requests in this frame

Frame: https://eu-u.openx.net/w/1.0/pd?plm=6&ph=36664cef-3484-4aa7-9d01-fa4f6f6b2d4e&gdpr=1
Frame ID: 97F6D2886F0002AA0F9FA2BB64374BB6
Requests: 1 HTTP requests in this frame

Frame: https://cdn.ampproject.org/rtv/012010270040000/amp4ads-v0.mjs
Frame ID: 2DB712271C48EDFF456B8D6CE40C2648
Requests: 16 HTTP requests in this frame

Frame: https://securepubads.g.doubleclick.net/pcs/view?xai=AKAOjsv0H54rRNjx_jkWNg_io5nLn9_Mw7zc-6fKaPX48YZMj_SuQ1sxdSXeM0E7L6QHZlFQDVySLpid1PrByodPilEMrmVnTkbEgh-q6g0hNZpL7kEP1hrB2EMzWNGczXLZouvM1DD0QJV2EmNWMIcVNlZ0IPq_0uIik42PU5M7gL-j9DF-Kkf4Xj-d-rHsExZbktZwWv3L-R91zFWzjeSBXPafEFlGxv1ObBkpimaF_EuK9wXItGoxdyRnH7pwniG-nBWVQGwqy51lh__R755zfdgFc25qjJALqk3iVZ83tqzzzADV5C4hLUvl0qaiKG9MpmQ15w&sig=Cg0ArKJSzHlBiPq9EAmNEAE&adurl=
Frame ID: 636C1859C8ADF9A5EABD06CFF6BBB547
Requests: 7 HTTP requests in this frame

Frame: https://cdn.ampproject.org/rtv/052012102342000/amp4ads-v0.mjs
Frame ID: 94F8E008F018FDBAE2FED870583A7D2F
Requests: 22 HTTP requests in this frame

Frame: https://securepubads.g.doubleclick.net/pcs/view?xai=AKAOjstO1XhPo69ltIPAjLQV5iy-42iw18FNdRdU6gIcA9uYQW_zac9eRyhz102DGMXy4TxvXlHZg7TFmxtU5kKMA_Oa0ITshe_6XsIWlTamW5Mu19DpRyHRtiky8knFDPsFG14-7UMZWespdD9_9d5AJgpYjlXpnJe5ggAQTYnsMkiLbD0UWT47O4GhIh0fWUs8GPUMw2ivs6YTAtOjTrI6G1Q-mvU6bY-BHSrEvAiqF1MsTWDqzOmcSaxLjgRCpXOJug0u5p1S6PWKfz-0EBZNM0CAn1SBYKr4dhdLVhx-gtFcCJwe6V4aPAuMQKa5YIHM9-jUTR_IQg&sig=Cg0ArKJSzAOnTmqOtwjLEAE&adurl=
Frame ID: A0A6846C7F8381F8553D4EC2AE278A02
Requests: 7 HTTP requests in this frame

Frame: https://securepubads.g.doubleclick.net/pcs/view?xai=AKAOjsvDd4GbcKKNE6MyeLtgbITanH7czj9XFpUiL9z6aI6E5JlxJ-8ebnjkfNl1eS-QbuYYR0AIU48Fbayx4tHinz3T6323dzt5oI6H10iQdEyHBd8mAX7jyRFtNY2K1RO1ExbYJ7I9zyJ6tCxTuyMf7z9hhYLtMkrpF_UGeEv7FOAe2Zgfz6LVKhEE7VU_jnst_cFJuduEjiu8uSe9bMBNJ0S8_jN1mFZ8fS8qGW5RkvEP-WOmTUzspktoR0cXLv9j-2bhxs4pmL64kA6zsdnPI-nX2E3dxrr-Einq-0EYV3aW_3stqFfEQnMVYmo3Ouok9u2G4aCWrXM&sig=Cg0ArKJSzIOKmedf4jFoEAE&adurl=
Frame ID: 0D33A2E6F09210DC44665EE9CD11BA8A
Requests: 7 HTTP requests in this frame

Frame: https://cdn.ampproject.org/rtv/052012102342000/amp4ads-v0.mjs
Frame ID: 4A6D61860AD8952BC9D2E4E49EDDD666
Requests: 13 HTTP requests in this frame

Frame: https://b1c90d68092b57f74adceeec8a58c68a.safeframe.googlesyndication.com/safeframe/1-0-37/html/container.html
Frame ID: 33EBFDF9EE583679DC5A769621CE9945
Requests: 1 HTTP requests in this frame

Frame: https://imasdk.googleapis.com/js/sdkloader/loader.js
Frame ID: DE86938BF186C75D01D28DEBA2C3FB51
Requests: 5 HTTP requests in this frame

Frame: https://player.aniview.com/script/6.1/AVmanager.js?v=1.0&type=s&pid=5e3a966128a06134f417790e
Frame ID: 9E8820C1E9356F480F82EB47B282E281
Requests: 2 HTTP requests in this frame

Frame: https://imprammp.taboola.com/st?cijs=convusmp&ttype=0&cisd=convusmp&cipid=8060095&crid=4706985&dast=V7FEQCFgODwV-BG--R_QSDwV-BG--R_QUAAAAGBuIHHMYcMTcTFonBYO0Gq91muVvsZovdZDic7YawYcwRczNhkRgM1m6w2m2Ws81iONmtBpvRFDiEZfb7DgrK6ekxuwyiouttsTucZs9BMje5QQ1Np8Pnutfrfr-7yOE0O98Op9mu8dtVX7_m43TZPS7Ty2P0Kyynp8fscisHq8FwsthLWm6Ty_O0PS1vicvusjk9TofZLXiYni676fMW-T2mv-XzlrxsL4fZLjS9zXYAAAAAeAA4kk6F-AEEAIgAAAAAkAAAAACgCKj4txC4AAAAAMAAKBC90ACg5Eigo8sgdPhcL38AADwUgAAADCiQAAyoHZUASCgkngAAAAAAAAAAsPz____HAOjx_8oAXMj19wA8-AA8EBUoFjECAAAAyKVeHTqa1AmVRRUAAEG6FcAVAECAndnbUlwYAADAwNgCPSx-v9lh1_jdLgMAAAAAAAAAMPs_-0cTgpqZSQNKzNRU-wUEAFj7BQQAYFM3AIA3AbigI2jFYLC6AZosZgcAAABw9____68HQibTyDbbeIYLl2Pi3G1MHtfEN3GMPJ7ZZrIZDLZXq2f7rFzhAtjHISyz33dQUE5Pj9llEBVdb4vd4TR7DpK5yX4TthitJpPNcjhbLiaD4Wg4Gu1PADcDnKDhcLDYDRa7xWI4WUxGg-VggQIxmOCEDEebyWq0W-0my-FkNJptJhukaNVqNtoMhqvZZLbbrYaD4XI0QorWLGaTyWI2Wu42g-VkNBhOhkOEwcVkNNkMF2uFxbdZizaryVo4cZncypVvsFxujJOVy7EWvT6m28iyWe0WWxQMKNuL4CKdiBxOs_PtcJrdkr_vIpZoThbpRHbZl0ymkW228QwXLsfEuduYPK6Jb-IYeTyzzWQzGOyLi8loshku1gqLb7MWbVaTtXDiMrmVK99gudwYJyuXYy16fUy3kWWz2i32jdlgONjMNpvdvjEbDAeb2Waz23foDN_V52y0Rbvnjs4y0y6GtpnpoHAZjN7f0SKN3Xozo8ortlhUt2D0N7EK_X6_3-_3-_1-v3djNngMBsPPZTsOP-blWnN6HBSxRHC6SCeil_F0EUskT4t0IhmMPB6Ty7VyzWyzlWE5WE0mzt3EtHDOTLblZDERS5Smi3Si13ycLrvHZXp5jH6F5fT0mF1u5WA1GE4We8nLbXJ5nran5S1x2V02p8fpMLsFD9PTZTd93iK_x_S3fN6Sl-3lMNuFprfZov6jQwxXc8liMlfsFnPZbpUAAAAAAAAAAJYwZ94EAAAA4DSQyWa4WC0X4MFoT_dHNYX1jnM8cdcFm5Pt8szIpLjx4wZyOM3Ot8Npdkv-visDPBjdMW_2TBBrtVrWAAAABNgAAAAB3Lp5CxyL5AA!&cmcv=&pix=undefined&cb=1608036344043&uv=2853&tms=1608036344043&abt=dpr6_vA!expn_vF!heavyc_vA!ntvc_vA!spa2_vB!t45!ufm_vA&ft=0&su=0&unm=WIDGET_ITEM&aure=false&cirid=F9D93BEDAA570573971761728867&excid=e22lLINE_ITEM_ID_WILL_BE_HERE_ON_SERVINGc&tst=1&docw=0&cs=true&cias=1
Frame ID: 3DBAB46098EB26780849DA4732BDEF06
Requests: 1 HTTP requests in this frame

Frame: https://am-match.taboola.com/sync?dast=V7FEQCFgODwV-BG--R_QSDwV-BG--R_QUAAAAGBuIHHMYcMTcTFonBYO0Gq91muVvsZovdZDic7YawYcwRczNhkRgM1m6w2m2Ws81iONmtBpvRFDiEZfb7DgrK6ekxuwyiouttsTucZs9BMje5QQ1Np8Pnutfrfr-7yOE0O98Op9mu8dtVX7_m43TZPS7Ty2P0Kyynp8fscisHq8FwsthLWm6Ty_O0PS1vicvusjk9TofZLXiYni676fMW-T2mv-XzlrxsL4fZLjS9zXYAAAAAeAA4kk6F-AEEAIgAAAAAkAAAAACgCKj4txC4AAAAAMAAKBC90ACg5Eigo8sgdPhcL38AADwUgAAADCiQAAyoHZUASCgkngAAAAAAAAAAsPz____HAOjx_8oAXMj19wA8-AA8EBUoFjECAAAAyKVeHTqa1AmVRRUAAEG6FcAVAECAndnbUlwYAADAwNgCPSx-v9lh1_jdLgMAAAAAAAAAMPs_-0cTgpqZSQNKzNRU-wUEAFj7BQQAYFM3AIA3AbigI2jFYLC6AZosZgcAAABw9____68HQibTyDbbeIYLl2Pi3G1MHtfEN3GMPJ7ZZrIZDLZXq2f7rFzhAtjHISyz33dQUE5Pj9llEBVdb4vd4TR7DpK5yX4TthitJpPNcjhbLiaD4Wg4Gu1PADcDnKDhcLDYDRa7xWI4WUxGg-VggQIxmOCEDEebyWq0W-0my-FkNJptJhukaNVqNtoMhqvZZLbbrYaD4XI0QorWLGaTyWI2Wu42g-VkNBhOhkOEwcVkNNkMF2uFxbdZizaryVo4cZncypVvsFxujJOVy7EWvT6m28iyWe0WWxQMKNuL4CKdiBxOs_PtcJrdkr_vIpZoThbpRHbZl0ymkW228QwXLsfEuduYPK6Jb-IYeTyzzWQzGOyLi8loshku1gqLb7MWbVaTtXDiMrmVK99gudwYJyuXYy16fUy3kWWz2i32jdlgONjMNpvdvjEbDAeb2Waz23foDN_V52y0Rbvnjs4y0y6GtpnpoHAZjN7f0SKN3Xozo8ortlhUt2D0N7EK_X6_3-_3-_1-v3djNngMBsPPZTsOP-blWnN6HBSxRHC6SCeil_F0EUskT4t0IhmMPB6Ty7VyzWyzlWE5WE0mzt3EtHDOTLblZDERS5Smi3Si13ycLrvHZXp5jH6F5fT0mF1u5WA1GE4We8nLbXJ5nran5S1x2V02p8fpMLsFD9PTZTd93iK_x_S3fN6Sl-3lMNuFprfZov6jQwxXc8liMlfsFnPZbpUAAAAAAAAAAJYwZ94EAAAA4DSQyWa4WC0X4MFoT_dHNYX1jnM8cdcFm5Pt8szIpLjx4wZyOM3Ot8Npdkv-visDPBjdMW_2TBBrtVrWAAAABNgAAAAB3Lp5CxyL5AA!&excid=22&docw=0&cijs=1&nlb=true
Frame ID: 0CFBDE925F92A0E9AC5CE63449D311CA
Requests: 1 HTTP requests in this frame

Frame: https://imprammp.taboola.com/st?cijs=convusmp&ttype=0&cisd=convusmp&cipid=8060095&crid=4901665&dast=V7_-gCFgODwV-BG--R_QSDwV-BG--R_QUAAAAGBvQHHUJZjiY0Em9DIu02o9FyMVkuZsPBZrhb7RZD4BDKcjShkXgbEmm3GY2Wi8lwNdkMVoPFYDKFDWO5TAa1QOTyfE1_w1vE8nxNf8Nb1zS53KCGptPhc93rdb_fXeRwmp1vh9Ns1_jtqq9f83G67B6X6eUx-hWW09NjdrmVg9VgOFnsJS23yeV52p6Wt8Rld9mcHqfD7BY8TE-X3fR5i_we09_yeUtetpfDbBea3mY7AAAAADwAKC2HQPwAAgBEAAAAAEgAAAAAUARU_FsIXAAAAABgABSINmgAUHIk0NFlEDp8rpc_AAAeCkAAAAYUSAAG1I5KACrKbk8AAAAAAAAAAFj-____YwD0-H9lADIO53oAHnwAHogKVosYAQAAAORSrw4dTeqEyqIKAIAg3QrgCgAgwM7sbWkuDAAAYGBsgR4Wv9_ssGv8bpcBAAAAAAAAAJj9n_2jCUHNzKQBJWZqqv0CAgCs_QICALCpGwDAmwBc0BG0YjBY3QBNFrMDAAAAuPv____XAyGTaWSbbTzDhcsxce42Jo9r4ps4Rh7PbDPZDAbbq9WzfVaucAHsqyCW52v6G966psllEB80DMvJIJjfhC1Gq8lksxzOlovJYDgajkb7E8DNACdoOBwsdoPFbrEYThaT0WA5WKBADCY4IcPRZrIa7Va7yXI4GY1mm8kGKVq1mo02g-FqNpntdqvhYLgcjZCiNYvZZLKYjZa7zWA5GQ2Gk-EQYXAxGU02w8VaYfFt1qLNarIWTlwmt3LlGyyXG-Nk5XKsRa-P6TaybFa7xRYFA8r2IrhIJyKH0-x8O5xmt-Tvu4glmpNFOpFd9iWTaWSbbTzDhcsxce42Jo9r4ps4Rh7PbDPZDAb74mIymmyGi7XC4tusRZvVZC2cuExu5co3WC43xsnK5ViLXh_TbWTZrHaLfWM2GA42s81mt2_MBsPBZrbZ7PYdOsN39TkbbdHuuaOzzLSLoW1mOihcBqP3d7RIY7fezKjyii0W1S0Y_U2sQr_f7_f7_X6_3-_dmA0eg8Hwc9mOw495udacHgdFLBGcLtKJ6GU8XcQSydMinQg2I99qttw4jKPFaGSZGRYbz8Y12RiWq81usthMxBKl6SKd6DUfp8vucZleHqNfYTk9PWaXWzlYDYaTxV7ycptcnqftaXlLXHaXzelxOsxuwcP0dNlNn7fI7zH9LZ-35GV7Ocx2oelttqj_6BDD1VyymMwVu8VctlslAAAAAAAAAIAlzJk3AQAAADgNZLIZLlbLBXgw2tP90Q5PnAA419h1weZkuzwzMilu_LiBHE6z8-1wmt2Sv-_KAA9Gd8ybPRPEWq2WNQAAAAE2AABAALdu3gLHIjk!&cmcv=&pix=undefined&cb=1608036344086&uv=2853&tms=1608036344086&abt=dpr6_vA!expn_vF!heavyc_vA!lapams_vA!ntvc_vA!spa2_vB!t45!ufm_vE&ft=0&su=6&unm=FEED_MANAGER&aure=false&agl=1&cirid=B294BFD7CD4734491291680387571&excid=e22lLINE_ITEM_ID_WILL_BE_HERE_ON_SERVINGc&tst=1&docw=0&cs=true&cias=1
Frame ID: 910A9D0AB3C665FFE0190F19864764B9
Requests: 1 HTTP requests in this frame

Frame: https://am-match.taboola.com/sync?dast=V7_-gCFgODwV-BG--R_QSDwV-BG--R_QUAAAAGBvQHHUJZjiY0Em9DIu02o9FyMVkuZsPBZrhb7RZD4BDKcjShkXgbEmm3GY2Wi8lwNdkMVoPFYDKFDWO5TAa1QOTyfE1_w1vE8nxNf8Nb1zS53KCGptPhc93rdb_fXeRwmp1vh9Ns1_jtqq9f83G67B6X6eUx-hWW09NjdrmVg9VgOFnsJS23yeV52p6Wt8Rld9mcHqfD7BY8TE-X3fR5i_we09_yeUtetpfDbBea3mY7AAAAADwAKC2HQPwAAgBEAAAAAEgAAAAAUARU_FsIXAAAAABgABSINmgAUHIk0NFlEDp8rpc_AAAeCkAAAAYUSAAG1I5KACrKbk8AAAAAAAAAAFj-____YwD0-H9lADIO53oAHnwAHogKVosYAQAAAORSrw4dTeqEyqIKAIAg3QrgCgAgwM7sbWkuDAAAYGBsgR4Wv9_ssGv8bpcBAAAAAAAAAJj9n_2jCUHNzKQBJWZqqv0CAgCs_QICALCpGwDAmwBc0BG0YjBY3QBNFrMDAAAAuPv____XAyGTaWSbbTzDhcsxce42Jo9r4ps4Rh7PbDPZDAbbq9WzfVaucAHsqyCW52v6G966psllEB80DMvJIJjfhC1Gq8lksxzOlovJYDgajkb7E8DNACdoOBwsdoPFbrEYThaT0WA5WKBADCY4IcPRZrIa7Va7yXI4GY1mm8kGKVq1mo02g-FqNpntdqvhYLgcjZCiNYvZZLKYjZa7zWA5GQ2Gk-EQYXAxGU02w8VaYfFt1qLNarIWTlwmt3LlGyyXG-Nk5XKsRa-P6TaybFa7xRYFA8r2IrhIJyKH0-x8O5xmt-Tvu4glmpNFOpFd9iWTaWSbbTzDhcsxce42Jo9r4ps4Rh7PbDPZDAb74mIymmyGi7XC4tusRZvVZC2cuExu5co3WC43xsnK5ViLXh_TbWTZrHaLfWM2GA42s81mt2_MBsPBZrbZ7PYdOsN39TkbbdHuuaOzzLSLoW1mOihcBqP3d7RIY7fezKjyii0W1S0Y_U2sQr_f7_f7_X6_3-_dmA0eg8Hwc9mOw495udacHgdFLBGcLtKJ6GU8XcQSydMinQg2I99qttw4jKPFaGSZGRYbz8Y12RiWq81usthMxBKl6SKd6DUfp8vucZleHqNfYTk9PWaXWzlYDYaTxV7ycptcnqftaXlLXHaXzelxOsxuwcP0dNlNn7fI7zH9LZ-35GV7Ocx2oelttqj_6BDD1VyymMwVu8VctlslAAAAAAAAAIAlzJk3AQAAADgNZLIZLlbLBXgw2tP90Q5PnAA419h1weZkuzwzMilu_LiBHE6z8-1wmt2Sv-_KAA9Gd8ybPRPEWq2WNQAAAAE2AABAALdu3gLHIjk!&excid=22&docw=0&cijs=1&nlb=true
Frame ID: 5A5EAE53A5D514B33717D0CEFD0C456F
Requests: 1 HTTP requests in this frame

Frame: https://imprammp.taboola.com/st?cipid=7991117&ttype=0&cirid=80515B1666570536972027914918&cicmp=1337627&cijs=1&dast=V7_scCFgODwV-BG--R_QSDwV-BG--R_QUAAAAGBugHHDhYLVYTxmw2W-0Gq81suVpsZsvBYDYcTaZgsIXP6e5uQ6A-mk6Hz3Wv1_1-d5HDaXa-HU6zXeO3q75-zcfpsntcppfH6FdYTk-P2eVWDlaD4WSxl7TcJpfnaXta3hKX3WVzepwOs1vwMD1ddtPnLfJ7TH_L5y152V4Os11oepv9-6Ln7XQPh8vdaDcazfRFz8vucQ8uCzrjdH3re6XazeyvfEqdv-PI6POJnOPPZDfSWh3Tyzc6Vi-7ltHqo819fObd2vgx7m7VpfWs1PoeJ3Fr2fiOrrOJ8poxFw0i9TDZ8e6MD-tj2B1peypx2XOMWm0xv9H3sjZnS81MOxrnAAAAAPAAQNQSDbHj29AeAQAAACDBM3KtQBFQ8W8hcAEAAACAAUAgFq4BQMmRQEeXQejwuV7-AAB4KAABABhQIAEQSCwsAXC4WzwBAAA4qJN52mb5____jwHIe2-SAaBI27gx6AF48AF4EAIAALgYOiiYUWzi7G4iKkgsYgQAAACQS706dDSpEyqLqv___38rgCsAgAA7s7euxaybk2LWMAAAgIGxBXpY_H6zw67xu132_________2_2fwaAJgQ1M5MGlJipqcYzcq2w9gsIAMD2bgAAbwJwMQdgBwAAAHD3____nwcAAKC1R8n2Wo1nj7LeZ7CFz-nurt-ELUaryWSzHM6Wi8lgOBqORvsTwM0AJ2g4HCx2g8VusRhOFpPRYDlYoEAMJjghw9FmshrtVrvJcjgZjWabyQYpWrWajTaD4Wo2me12q-FguByNkKI1i9lkspiNlrvNYDkZDYaT4RBhcDEZTTbDxVph8W3Wos1qshZOXCa3cuUbLJcb42TlcqxFr4_pNrJsVrvFHh1iuJpLFpO5YreYy3arBAAAAAAAAACwhCnzJgAAAACnQcxmk91uxY03eyaItVotawAAAABu3cgB!&excid=22&tst=1&docw=0&cs=false
Frame ID: C21706291D520B2A0ED211FF803ED63B
Requests: 1 HTTP requests in this frame

Frame: https://player.hb.selectmedia.asia/prebidlink/446676/hb_310028_7816.js
Frame ID: C77667DBD59F20B8AD0412CF57793D43
Requests: 29 HTTP requests in this frame

Frame: https://cdn.ampproject.org/rtv/012010270040000/amp4ads-v0.mjs
Frame ID: 93715A862DF0638D251B2335A8A612E9
Requests: 23 HTTP requests in this frame

Frame: https://cdn.userreport.com/companies/841e7e17-dd2b-42bd-8780-05d018493983/files/images/fd7ab9c7-63a5-4ab2-b7fe-e4f051de850e.png
Frame ID: FAB4C33EF4D1769BB1627E7E2C4D0753
Requests: 1 HTTP requests in this frame

Frame: https://cdn.ampproject.org/rtv/012010270040000/amp4ads-v0.mjs
Frame ID: CD23E195DC774D5438E85539E9808976
Requests: 13 HTTP requests in this frame

Frame: https://9983081ac8e174582a7b6a6acc4b473e.safeframe.googlesyndication.com/safeframe/1-0-37/html/container.html?n=1
Frame ID: 6BFBC0C876934C7B33EE7CC1CDD18CAA
Requests: 1 HTTP requests in this frame

Frame: https://tpc.googlesyndication.com/sodar/sodar2/219/runner.html
Frame ID: 2CDBFF1EC639AA571D1457B42D57C56B
Requests: 1 HTTP requests in this frame

Frame: https://cdn.stickyadstv.com/mustang/vpaid-adapter.min.js
Frame ID: 13471A232406361EF82877202B09AA64
Requests: 7 HTTP requests in this frame

Frame: https://acds.prod.vidible.tv/o2shim?companionId=&cpmPassback=&placementId=1206795&orgId=28230&injectCompanionDummy=&pauseOnClick=&d.vw=&d.app=&r=https%3A%2F%2Fwww.dailymail.co.uk%2Fsciencetech%2Farticle-9050821%2FRemdesivir-beneficial-patients-doctors-reveal.html%3F_hsmi%3D88974744%26_hsenc%3Dp2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8&vrid=0861bd3c-8d98-41a8-aae4-85046d00ae5f&pblob=
Frame ID: 94669A1474DC17F3764AFFB17FB30149
Requests: 8 HTTP requests in this frame

Frame: https://cdn-ssl.vidible.tv/prod/player/ad-time/local-storage.html
Frame ID: 818CDCE5061FBB081B8CFC2356FF4BCF
Requests: 1 HTTP requests in this frame

Frame: https://js-sec.indexww.com/um/ixmatch.html
Frame ID: BB10EB2405AEA140DD88F92457738DCE
Requests: 1 HTTP requests in this frame

Frame: https://eus.rubiconproject.com/usync.html
Frame ID: D2660896F3A245A49114584F23EB35CE
Requests: 1 HTTP requests in this frame

Frame: https://ads.pubmatic.com/AdServer/js/showad.js
Frame ID: 0E4A6D5ADABF35549CAC5B25CFA5C841
Requests: 1 HTTP requests in this frame

Frame: https://ads.pubmatic.com/AdServer/js/showad.js
Frame ID: 191716DCF493A77478EC7DD07D7A188E
Requests: 1 HTTP requests in this frame

Frame: https://u.openx.net/w/1.0/pd
Frame ID: 9FFD92098A891026F2F59F599A994959
Requests: 1 HTTP requests in this frame

Frame: https://acdn.adnxs.com/dmp/async_usersync.html
Frame ID: 899460A3B1871255A238F0BA049168AF
Requests: 1 HTTP requests in this frame

Frame: https://cdn.stickyadstv.com/mustang/vpaid-adapter.min.js
Frame ID: 73922961E053EFC457306F59F2C80EA8
Requests: 7 HTTP requests in this frame

Frame: https://gum.criteo.com/syncframe?topUrl=www.dailymail.co.uk
Frame ID: AE1F14C1B41B70C681117076C1EABA54
Requests: 1 HTTP requests in this frame

Frame: https://am-match.taboola.com/sync?dast=V7FEQCFgODwV-BG--R_QSDwV-BG--R_QUAAAAGBuIHHMYcMTcTFonBYO0Gq91muVvsZovdZDic7YawYcwRczNhkRgM1m6w2m2Ws81iONmtBpvRFDiEZfb7DgrK6ekxuwyiouttsTucZs9BMje5QQ1Np8Pnutfrfr-7yOE0O98Op9mu8dtVX7_m43TZPS7Ty2P0Kyynp8fscisHq8FwsthLWm6Ty_O0PS1vicvusjk9TofZLXiYni676fMW-T2mv-XzlrxsL4fZLjS9zXYAAAAAeAA4kk6F-AEEAIgAAAAAkAAAAACgCKj4txC4AAAAAMAAKBC90ACg5Eigo8sgdPhcL38AADwUgAAADCiQAAyoHZUASCgkngAAAAAAAAAAsPz____HAOjx_8oAXMj19wA8-AA8EBUoFjECAAAAyKVeHTqa1AmVRRUAAEG6FcAVAECAndnbUlwYAADAwNgCPSx-v9lh1_jdLgMAAAAAAAAAMPs_-0cTgpqZSQNKzNRU-wUEAFj7BQQAYFM3AIA3AbigI2jFYLC6AZosZgcAAABw9____68HQibTyDbbeIYLl2Pi3G1MHtfEN3GMPJ7ZZrIZDLZXq2f7rFzhAtjHISyz33dQUE5Pj9llEBVdb4vd4TR7DpK5yX4TthitJpPNcjhbLiaD4Wg4Gu1PADcDnKDhcLDYDRa7xWI4WUxGg-VggQIxmOCEDEebyWq0W-0my-FkNJptJhukaNVqNtoMhqvZZLbbrYaD4XI0QorWLGaTyWI2Wu42g-VkNBhOhkOEwcVkNNkMF2uFxbdZizaryVo4cZncypVvsFxujJOVy7EWvT6m28iyWe0WWxQMKNuL4CKdiBxOs_PtcJrdkr_vIpZoThbpRHbZl0ymkW228QwXLsfEuduYPK6Jb-IYeTyzzWQzGOyLi8loshku1gqLb7MWbVaTtXDiMrmVK99gudwYJyuXYy16fUy3kWWz2i32jdlgONjMNpvdvjEbDAeb2Waz23foDN_V52y0Rbvnjs4y0y6GtpnpoHAZjN7f0SKN3Xozo8ortlhUt2D0N7EK_X6_3-_3-_1-v3djNngMBsPPZTsOP-blWnN6HBSxRHC6SCeil_F0EUskT4t0IhmMPB6Ty7VyzWyzlWE5WE0mzt3EtHDOTLblZDERS5Smi3Si13ycLrvHZXp5jH6F5fT0mF1u5WA1GE4We8nLbXJ5nran5S1x2V02p8fpMLsFD9PTZTd93iK_x_S3fN6Sl-3lMNuFprfZov6jQwxXc8liMlfsFnPZbpUAAAAAAAAAAJYwZ94EAAAA4DSQyWa4WC0X4MFoT_dHNYX1jnM8cdcFm5Pt8szIpLjx4wZyOM3Ot8Npdkv-visDPBjdMW_2TBBrtVrWAAAABNgAAAAB3Lp5CxyL5AA!&excid=22&docw=0&cijs=1&nlb=true
Frame ID: 3229BB4E6CEF52EA35331EA9221633DD
Requests: 1 HTTP requests in this frame

Frame: https://tpc.googlesyndication.com/sodar/sodar2/219/runner.html
Frame ID: 3EE3454E104CCBC608FA15C33F760931
Requests: 1 HTTP requests in this frame

Frame: https://cdnetworks.cedexis-test.com/img/17653/iuni4.html?rnd=-1-1-12818-0-0-17653-1011161911-_CgJqMRAUGHoiBQgBEJJkKLe2lOIDMIrg4v4FOIrg4v4FQNiMrxxKEAgDEDUY7MIBIAAo7oOAoARQAFoKCAAQABgAIAAoAGABahNidXR0b24yLmFtcy5odi5wcm9kggEQCAMQnQEYsUYgACi2jICgBIgBuamvnQSQAQCYAQA
Frame ID: 8552C43C15F35CB6563E69EED93A233E
Requests: 1 HTTP requests in this frame

Frame: https://p29.cedexis-test.com/img/29/iuni4.html?rnd=-1-1-12818-0-0-29-1011161911-_CgJqMRAUGHoiBQgBEJJkKLe2lOIDMIrg4v4FOIrg4v4FQNiMrxxKEAgDEDUY7MIBIAAo7oOAoARQAFoKCAAQABgAIAAoAGABahNidXR0b24yLmFtcy5odi5wcm9kggEQCAMQnQEYsUYgACi2jICgBIgBuamvnQSQAQCYAQA
Frame ID: F107BA142FDDB876F1FA6C4DE7881A36
Requests: 1 HTTP requests in this frame

Frame: https://am-match.taboola.com/sync?dast=V7_-gCFgODwV-BG--R_QSDwV-BG--R_QUAAAAGBvQHHUJZjiY0Em9DIu02o9FyMVkuZsPBZrhb7RZD4BDKcjShkXgbEmm3GY2Wi8lwNdkMVoPFYDKFDWO5TAa1QOTyfE1_w1vE8nxNf8Nb1zS53KCGptPhc93rdb_fXeRwmp1vh9Ns1_jtqq9f83G67B6X6eUx-hWW09NjdrmVg9VgOFnsJS23yeV52p6Wt8Rld9mcHqfD7BY8TE-X3fR5i_we09_yeUtetpfDbBea3mY7AAAAADwAKC2HQPwAAgBEAAAAAEgAAAAAUARU_FsIXAAAAABgABSINmgAUHIk0NFlEDp8rpc_AAAeCkAAAAYUSAAG1I5KACrKbk8AAAAAAAAAAFj-____YwD0-H9lADIO53oAHnwAHogKVosYAQAAAORSrw4dTeqEyqIKAIAg3QrgCgAgwM7sbWkuDAAAYGBsgR4Wv9_ssGv8bpcBAAAAAAAAAJj9n_2jCUHNzKQBJWZqqv0CAgCs_QICALCpGwDAmwBc0BG0YjBY3QBNFrMDAAAAuPv____XAyGTaWSbbTzDhcsxce42Jo9r4ps4Rh7PbDPZDAbbq9WzfVaucAHsqyCW52v6G966psllEB80DMvJIJjfhC1Gq8lksxzOlovJYDgajkb7E8DNACdoOBwsdoPFbrEYThaT0WA5WKBADCY4IcPRZrIa7Va7yXI4GY1mm8kGKVq1mo02g-FqNpntdqvhYLgcjZCiNYvZZLKYjZa7zWA5GQ2Gk-EQYXAxGU02w8VaYfFt1qLNarIWTlwmt3LlGyyXG-Nk5XKsRa-P6TaybFa7xRYFA8r2IrhIJyKH0-x8O5xmt-Tvu4glmpNFOpFd9iWTaWSbbTzDhcsxce42Jo9r4ps4Rh7PbDPZDAb74mIymmyGi7XC4tusRZvVZC2cuExu5co3WC43xsnK5ViLXh_TbWTZrHaLfWM2GA42s81mt2_MBsPBZrbZ7PYdOsN39TkbbdHuuaOzzLSLoW1mOihcBqP3d7RIY7fezKjyii0W1S0Y_U2sQr_f7_f7_X6_3-_dmA0eg8Hwc9mOw495udacHgdFLBGcLtKJ6GU8XcQSydMinQg2I99qttw4jKPFaGSZGRYbz8Y12RiWq81usthMxBKl6SKd6DUfp8vucZleHqNfYTk9PWaXWzlYDYaTxV7ycptcnqftaXlLXHaXzelxOsxuwcP0dNlNn7fI7zH9LZ-35GV7Ocx2oelttqj_6BDD1VyymMwVu8VctlslAAAAAAAAAIAlzJk3AQAAADgNZLIZLlbLBXgw2tP90Q5PnAA419h1weZkuzwzMilu_LiBHE6z8-1wmt2Sv-_KAA9Gd8ybPRPEWq2WNQAAAAE2AABAALdu3gLHIjk!&excid=22&docw=0&cijs=1&nlb=true
Frame ID: 454DB72F7157DEA19489CFDC763B960D
Requests: 1 HTTP requests in this frame

Screenshot


Page URL History Show full URLs

  1. https://info.silobreaker.com/e2t/sc2/MmZ-8yjYCXrW6zj2_M6nsGYsW7JzK5Y7LnJnQVd1GcC5Dg2KFdBBbG504 Page URL
  2. https://info.silobreaker.com/events/public/v1/track/sc2/MmZ-8yjYCXrW6zj2_M6nsGYsW7JzK5Y7LnJnQVd1GcC5Dg2KF... HTTP 307
    https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.ht... Page URL

Detected technologies

Overall confidence: 100%
Detected patterns
  • headers server /^cloudflare$/i

Page Statistics

778
Requests

96 %
HTTPS

30 %
IPv6

99
Domains

185
Subdomains

122
IPs

16
Countries

10833 kB
Transfer

24946 kB
Size

16
Cookies

Page URL History

This captures the URL locations of the websites, including HTTP redirects and client-side redirects via JavaScript or Meta fields.

  1. https://info.silobreaker.com/e2t/sc2/MmZ-8yjYCXrW6zj2_M6nsGYsW7JzK5Y7LnJnQVd1GcC5Dg2KFdBBbG504 Page URL
  2. https://info.silobreaker.com/events/public/v1/track/sc2/MmZ-8yjYCXrW6zj2_M6nsGYsW7JzK5Y7LnJnQVd1GcC5Dg2KFdBBbG504?_ud=016cc9f2-9e1d-4652-8ee7-243a4fd674cf&_ch=p&_pr2=p&_pl=0&_lg=en-US&_dr=b&_ts=p HTTP 307
    https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8 Page URL

Redirected requests

There were HTTP redirect chains for the following requests:

Request Chain 23
  • https://ads.creative-serving.com/pixel?id=3140889 HTTP 302
  • https://ads.creative-serving.com/ul_cb/pixel?id=3140889
Request Chain 54
  • https://swa.and.co.uk/b/ss/anddailymailprod/1/JS-2.9.0/s23780526227545?AQB=1&ndh=1&pf=1&t=15%2F11%2F2020%2013%3A45%3A36%202%20-60&fid=22FC5A865EEA46B9-24230C8B867AAA46&ce=iso-8859-1&ns=associatednorthcliffedigital&cdp=3&pageName=%2Fsciencetech%2Farticle&g=https%3A%2F%2Fwww.dailymail.co.uk%2Fsciencetech%2Farticle-9050821%2FRemdesivir-beneficial-patients-doctors-reveal.html%3F_hsmi%3D88974744%26_hsenc%3Dp2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8&c.&gunther=17.14.0&fesbv=5.9.0&feabv=6.18.1&vbv=6.11.0-pr-503.2312&tag=fe_abv_vbv_test_desktop&pushNotificationStatus=not_supported&.c&ch=dailymail.co.uk&events=event108%2Cevent2%2Cevent25&c1=%2Fsciencetech&v1=D%3Dc1&c2=%2Fsciencetech&v2=D%3Dc2&h2=dailymail.co.uk%2Fsciencetech&l3=coronavirus&c4=article&v4=D%3Dc4&c5=remdesivir%20could%20be%20beneficial%20for%20some%20patients%2C%20doctors%20reveal%C2%A0&v5=D%3Dc5&c6=9050821&v6=D%3Dc6&c11=Logged%20Out&v11=D%3DpageName&v12=D%3Dch&c13=%2Fsciencetech%2Farticle&c14=New&v14=New&c15=%2Fsciencetech%2Farticle&v21=D%3Dc23&v22=D%3Dc24&c23=2020-12-14&v23=D%3Dc25&c24=12&c25=Joe%20Pinkstone%20For%20Mailonline&v25=D%3Dc27&v26=D%3Dc28&c27=2020-12-15&v27=D%3Dc29&c28=13&c29=direct&v31=D%3Dc33&c33=%2Fsciencetech%2Farticle&c37=DE&c38=%2Fsciencetech%2Farticle&v38=D%3Dc38&c44=D%3Dg&c46=17.14.0&c47=adBlocker%20off&v49=%21-%21EXT%21-%21&v50=D%3Dg&c51=Clicked%20a%20link%20or%20entered%20a%20URL&c53=direct%5Edirect%5Edirect&v54=NoInstart&c57=62517997&v57=D%3Dc57&v58=Guest&c59=1%5E1%5E1&v59=D%3Dc59&c65=Desktop&v65=Desktop&v67=f31f04f1-ffe1-42d6-a34a-a26e5f2873ae&v70=default&v96=1651%3A1560%3A27%3A9%3A9%3A23%3A23&s=1600x1200&c=24&j=1.6&v=N&k=Y&bw=1600&bh=1200&AQE=1 HTTP 302
  • https://swa.and.co.uk/b/ss/anddailymailprod/1/JS-2.9.0/s23780526227545?AQB=1&pccr=true&vidn=2FEC57F80515EB81-60000ACAE7ED7EC5&ndh=1&pf=1&t=15%2F11%2F2020%2013%3A45%3A36%202%20-60&fid=22FC5A865EEA46B9-24230C8B867AAA46&ce=iso-8859-1&ns=associatednorthcliffedigital&cdp=3&pageName=%2Fsciencetech%2Farticle&g=https%3A%2F%2Fwww.dailymail.co.uk%2Fsciencetech%2Farticle-9050821%2FRemdesivir-beneficial-patients-doctors-reveal.html%3F_hsmi%3D88974744%26_hsenc%3Dp2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8&c.&gunther=17.14.0&fesbv=5.9.0&feabv=6.18.1&vbv=6.11.0-pr-503.2312&tag=fe_abv_vbv_test_desktop&pushNotificationStatus=not_supported&.c&ch=dailymail.co.uk&events=event108%2Cevent2%2Cevent25&c1=%2Fsciencetech&v1=D%3Dc1&c2=%2Fsciencetech&v2=D%3Dc2&h2=dailymail.co.uk%2Fsciencetech&l3=coronavirus&c4=article&v4=D%3Dc4&c5=remdesivir%20could%20be%20beneficial%20for%20some%20patients%2C%20doctors%20reveal%C2%A0&v5=D%3Dc5&c6=9050821&v6=D%3Dc6&c11=Logged%20Out&v11=D%3DpageName&v12=D%3Dch&c13=%2Fsciencetech%2Farticle&c14=New&v14=New&c15=%2Fsciencetech%2Farticle&v21=D%3Dc23&v22=D%3Dc24&c23=2020-12-14&v23=D%3Dc25&c24=12&c25=Joe%20Pinkstone%20For%20Mailonline&v25=D%3Dc27&v26=D%3Dc28&c27=2020-12-15&v27=D%3Dc29&c28=13&c29=direct&v31=D%3Dc33&c33=%2Fsciencetech%2Farticle&c37=DE&c38=%2Fsciencetech%2Farticle&v38=D%3Dc38&c44=D%3Dg&c46=17.14.0&c47=adBlocker%20off&v49=%21-%21EXT%21-%21&v50=D%3Dg&c51=Clicked%20a%20link%20or%20entered%20a%20URL&c53=direct%5Edirect%5Edirect&v54=NoInstart&c57=62517997&v57=D%3Dc57&v58=Guest&c59=1%5E1%5E1&v59=D%3Dc59&c65=Desktop&v65=Desktop&v67=f31f04f1-ffe1-42d6-a34a-a26e5f2873ae&v70=default&v96=1651%3A1560%3A27%3A9%3A9%3A23%3A23&s=1600x1200&c=24&j=1.6&v=N&k=Y&bw=1600&bh=1200&AQE=1 HTTP 302
  • https://sb.scorecardresearch.com/r?c2=6034964&d.c=gif&d.o=anddailymailprod&d.x=3020351672&d.t=page&d.u=https%3A%2F%2Fwww.dailymail.co.uk%2Fsciencetech%2Farticle-9050821%2FRemdesivir-beneficial-patients-doctors-reveal.html%3F_hsmi%3D88974744%26_hsenc%3Dp2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8 HTTP 302
  • https://sb.scorecardresearch.com/r2?c2=6034964&d.c=gif&d.o=anddailymailprod&d.x=3020351672&d.t=page&d.u=https%3A%2F%2Fwww.dailymail.co.uk%2Fsciencetech%2Farticle-9050821%2FRemdesivir-beneficial-patients-doctors-reveal.html%3F_hsmi%3D88974744%26_hsenc%3Dp2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8&cs_ak_ss=1
Request Chain 56
  • https://sync.sxp.smartclip.net/sync?type=red&dsp=10 HTTP 302
  • https://sync.sxp.smartclip.net/sync?type=red&dsp=10&ang_testid=1
Request Chain 62
  • https://js.spotx.tv/directsdk/v1/234272.js HTTP 307
  • https://aka.spotxcdn.com/integration/directsdk/v1/directsdk.js
Request Chain 65
  • https://e.serverbid.com/udb/9969/match?redir=https%3A%2F%2Fmfad.inskinad.com%2Fudb%2F9874%2Fpool%2Fset%2Fi.gif%3FpoolId%3D9969%26poolKey%3D HTTP 302
  • https://mfad.inskinad.com/udb/9874/pool/set/i.gif?poolId=9969&poolKey=ue1-sb1-a0c4a30f-dc3f-4275-8d75-8332c4c8fa99
Request Chain 108
  • https://x.bidswitch.net/check_uuid/https%3A%2F%2Fib.adnxs.com%2Fprebid%2Fsetuid%3Fbidder%3Dgrid%26gdpr%3D0%26gdpr_consent%3D%26uid%3D%24%7BBSW_UUID%7D?gdpr=0&gdpr_consent=&us_privacy= HTTP 302
  • https://x.bidswitch.net/ul_cb/check_uuid/https%3A%2F%2Fib.adnxs.com%2Fprebid%2Fsetuid%3Fbidder%3Dgrid%26gdpr%3D0%26gdpr_consent%3D%26uid%3D%24%7BBSW_UUID%7D?gdpr=0&gdpr_consent=&us_privacy= HTTP 302
  • https://ib.adnxs.com/prebid/setuid?bidder=grid&gdpr=0&gdpr_consent=&uid=e731bccd-9047-4727-b766-9ea3c6cb3551
Request Chain 131
  • https://ssl.google-analytics.com/r/__utm.gif?utmwv=5.7.2&utms=1&utmn=745871990&utmhn=www.dailymail.co.uk&utmcs=UTF-8&utmsr=1600x1200&utmvp=1600x1200&utmsc=24-bit&utmul=en-us&utmje=0&utmfl=-&utmdt=Remdesivir%20%27could%20be%20beneficial%20for%20some%20patients%27%2C%20doctors%20reveal%C2%A0%20%7C%20Daily%20Mail%20Online&utmhid=881620343&utmr=-&utmp=%2Fsciencetech%2Farticle-9050821%2FRemdesivir-beneficial-patients-doctors-reveal.html%3F_hsmi%3D88974744%26_hsenc%3Dp2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8&utmht=1608036337085&utmac=UA-3639451-1&utmcc=__utma%3D141568423.254203172.1608036337.1608036337.1608036337.1%3B%2B__utmz%3D141568423.1608036337.1.1.utmcsr%3D(direct)%7Cutmccn%3D(direct)%7Cutmcmd%3D(none)%3B&utmjid=596898861&utmredir=1&utmu=qAAAAAAAAAAAAAAAAAAAAAAE~ HTTP 302
  • https://stats.g.doubleclick.net/r/collect?v=1&aip=1&t=dc&_r=3&tid=UA-3639451-1&cid=254203172.1608036337&jid=596898861&_v=5.7.2&z=745871990
Request Chain 150
  • https://pr-bh.ybp.yahoo.com/sync/appnexusprebidserver/?gdpr=0&euconsent=&us_privacy=&url=https%3A%2F%2Fib.adnxs.com%2Fprebid%2Fsetuid%3Fbidder%3Dbrightroll%26gdpr%3D0%26gdpr_consent%3D%26uid%3D%24UID HTTP 302
  • https://ib.adnxs.com/prebid/setuid?bidder=brightroll&gdpr=0&gdpr_consent=&uid=y-zYSbPG51lxZ8GZIEMBNwFdHG_IIemOnrddBxfhs6QVhBDVr0ygVXLYA-
Request Chain 219
  • https://sync.search.spotxchange.com/partner?source=dados HTTP 302
  • https://sync.search.spotxchange.com/partner?source=dados&__user_check__=1&sync_id=6ec57fba-3ed3-11eb-be73-1e1d47873f06
Request Chain 230
  • https://ssum-sec.casalemedia.com/usermatch?s=184665&cb=https%3A%2F%2Fmfad.inskinad.com%2Fudb%2F9874%2Fsync%2Fi.gif%3FpartnerId%3D1%26userId%3D HTTP 302
  • https://ssum-sec.casalemedia.com/usermatch?s=184665&cb=https%3A%2F%2Fmfad.inskinad.com%2Fudb%2F9874%2Fsync%2Fi.gif%3FpartnerId%3D1%26userId%3D&C=1
Request Chain 231
  • https://id5-sync.com/i/167/9.gif?gdpr=&gdpr_consent= HTTP 302
  • https://id5-sync.com/c/167/0/9/1.gif?gdpr=1&gdpr_consent= HTTP 302
  • https://ice.360yield.com/match?publisher_dsp_id=79&dsp_callback=1&external_user_id=ID5-ZHMOqMhJTrldgGJIBsru2iINA62VBTrOOYCHIcZtjg&r=https%3A%2F%2Fid5-sync.com%2Fcq%2F167%2F124%2F8%2F2.gif%3Fpuid%3D%7BPUB_USER_ID%7D%26gdpr%3D1%26gdpr_consent%3D&gdpr=1&gdpr_consent= HTTP 302
  • https://ice.360yield.com/ul_cb/match?publisher_dsp_id=79&dsp_callback=1&external_user_id=ID5-ZHMOqMhJTrldgGJIBsru2iINA62VBTrOOYCHIcZtjg&r=https%3A%2F%2Fid5-sync.com%2Fcq%2F167%2F124%2F8%2F2.gif%3Fpuid%3D%7BPUB_USER_ID%7D%26gdpr%3D1%26gdpr_consent%3D&gdpr=1&gdpr_consent= HTTP 302
  • https://id5-sync.com/cq/167/124/8/2.gif?puid=c8e333de-0161-44b0-a13a-a10c76c6062d&gdpr=1&gdpr_consent=&gdpr=1&gdpr_consent= HTTP 302
  • https://sync.crwdcntrl.net/map/c=13953/tp=IDFI/gdpr=1/gdpr_consent=?https://id5-sync.com/c/167/19/7/3.gif?puid=${profile_id}&gdpr=1&gdpr_consent= HTTP 302
  • https://id5-sync.com/c/167/19/7/3.gif?puid=960aa2c2273f6b492958f96d36bf6304&gdpr=1&gdpr_consent= HTTP 302
  • https://ads.creative-serving.com/id5_cm?callback=https%3A%2F%2Fid5-sync.com%2Fc%2F167%2F101%2F6%2F4.gif%3Fpuid%3D%5BUID%5D%26gdpr%3D1%26gdpr_consent%3D HTTP 302
  • https://ads.creative-serving.com/ul_cb/id5_cm?callback=https%3A%2F%2Fid5-sync.com%2Fc%2F167%2F101%2F6%2F4.gif%3Fpuid%3D%5BUID%5D%26gdpr%3D1%26gdpr_consent%3D HTTP 302
  • https://id5-sync.com/c/167/101/6/4.gif?puid=dfec055f-0cbe-4353-bc57-bb4ed58dc033&gdpr=1&gdpr_consent= HTTP 302
  • https://pixel.tapad.com/idsync/ex/push?partner_id=2922&partner_url=https%3A%2F%2Fid5-sync.com%2Fc%2F167%2F108%2F5%2F5.gif%3Fpuid%3D%24%7BTA_DEVICE_ID%7D%26gdpr%3D1%26gdpr_consent%3D&gdpr=1&gdpr_consent= HTTP 302
  • https://pixel.tapad.com/idsync/ex/push/check?partner_id=2922&partner_url=https%3A%2F%2Fid5-sync.com%2Fc%2F167%2F108%2F5%2F5.gif%3Fpuid%3D%24%7BTA_DEVICE_ID%7D%26gdpr%3D1%26gdpr_consent%3D&gdpr=1&gdpr_consent= HTTP 302
  • https://id5-sync.com/c/167/108/5/5.gif?puid=6fb9c801-3ed3-11eb-b7db-6e8555c96cc6&gdpr=1&gdpr_consent= HTTP 302
  • https://uipglob.semasio.net/id5/1/get?gdpr=1&gdpr_consent=&_url=https%3A%2F%2Fid5-sync.com%2Fc%2F167%2F112%2F4%2F6.gif%3Fpuid%3D%24%7BUIPID%7D%26gdpr%3D1%26gdpr_consent%3D HTTP 302
  • https://uipglob.semasio.net/id5/1/get2?gdpr=1&gdpr_consent=&_url=https%3A%2F%2Fid5-sync.com%2Fc%2F167%2F112%2F4%2F6.gif%3Fpuid%3D%24%7BUIPID%7D%26gdpr%3D1%26gdpr_consent%3D HTTP 302
  • https://id5-sync.com/c/167/112/4/6.gif?puid=BF51C9F9126D1D3E&gdpr=1&gdpr_consent= HTTP 302
  • https://ads.avocet.io/getuid?url=https%3A%2F%2Fid5-sync.com%2Fc%2F167%2F146%2F3%2F7.gif%3Fpuid%3D%7B%7BUUID%7D%7D%26gdpr%3D1%26gdpr_consent%3D HTTP 301
  • https://ads.avct.cloud/getuid?r=1&url=https%3A%2F%2Fid5-sync.com%2Fc%2F167%2F146%2F3%2F7.gif%3Fpuid%3D%7B%7BUUID%7D%7D%26gdpr%3D1%26gdpr_consent%3D HTTP 302
  • https://id5-sync.com/c/167/146/3/7.gif?puid=11f3923d-c6d0-4798-93e0-b14556a89c0a&gdpr=1&gdpr_consent= HTTP 302
  • https://sync.crwdcntrl.net/map/c=2831/tp=GDMP?https://cm.g.doubleclick.net/pixel?google_nid=lotame_dmp&google_hm=${base64_profileid}&google_redir=https%3A%2F%2Fid5-sync.com%2Fc%2F167%2F398%2F2%2F8.gif%3Fpuid%3D%24%7Bbase64_profileid%7D%26gdpr%3D1%26gdpr_consent%3D HTTP 302
  • https://cm.g.doubleclick.net/pixel?google_nid=lotame_dmp&google_hm=OTYwYWEyYzIyNzNmNmI0OTI5NThmOTZkMzZiZjYzMDQ&google_redir=https://id5-sync.com/c/167/398/2/8.gif?puid=OTYwYWEyYzIyNzNmNmI0OTI5NThmOTZkMzZiZjYzMDQ&gdpr=1&gdpr_consent=
Request Chain 237
  • https://cm.g.doubleclick.net/pixel?google_nid=permutive_dmp&google_cm&type=ddp&k=ed45e86d-a09e-4d2b-85c0-fbbd6857373e&u=b77f6280-fced-4776-aef9-89e90021e68b HTTP 302
  • https://googlesync.permutive.com/v2.0/px/sync?alias=CAESECdjrni2f179vc2nxVGfA8A&error=&type=ddp&k=ed45e86d-a09e-4d2b-85c0-fbbd6857373e&u=b77f6280-fced-4776-aef9-89e90021e68b&google_cver=1
Request Chain 267
  • https://sync.crwdcntrl.net/map/c=10924/tp=OOLA/tpid=81242381-ab73-4352-8bed-9e7099c82ee1-tuct6d23571 HTTP 302
  • https://sync.crwdcntrl.net/map/ct=y/c=10924/tp=OOLA/tpid=81242381-ab73-4352-8bed-9e7099c82ee1-tuct6d23571
Request Chain 268
  • https://rtb.mfadsrvr.com/sync?ssp=taboola HTTP 302
  • https://rtb.mfadsrvr.com/ul_cb/sync?ssp=taboola HTTP 302
  • https://sync.taboola.com/sg/mediaforcebidder-network/1/rtb-h?taboola_hm=36f9d606-76a8-4afa-b7e5-6e7d149d5651 HTTP 302
  • https://match.taboola.com/sg/mediaforcebidder-network/1/rtb-h?taboola_hm=36f9d606-76a8-4afa-b7e5-6e7d149d5651&tbid=81242381-ab73-4352-8bed-9e7099c82ee1-tuct6d23571&query=taboola_hm%3D36f9d606-76a8-4afa-b7e5-6e7d149d5651&isDirect=0
Request Chain 270
  • https://bh.contextweb.com/bh/rtset?pid=562107&ev=1&rurl=https%3A%2F%2Fsync.taboola.com/sg/pulsepointrtb-network/1/rtb-h/?taboola_hm=%%VGUID%%&orig=trc HTTP 302
  • https://sync.taboola.com/sg/pulsepointrtb-network/1/rtb-h/?taboola_hm=qY3WWD6Xbl1F&ev=1&orig=trc&pid=562107
Request Chain 274
  • https://aa.agkn.com/adscores/g.pixel?sid=9212237748&puid=81242381-ab73-4352-8bed-9e7099c82ee1-tuct6d23571 HTTP 302
  • https://trc.taboola.com/sg/neustar/1/cm?taboola_hm=164950303636000649678
Request Chain 275
  • https://i.liadm.com/s/32441?bidder_id=88068&bidder_uuid=81242381-ab73-4352-8bed-9e7099c82ee1-tuct6d23571 HTTP 303
  • https://i.liadm.com/s/32441?bidder_id=88068&bidder_uuid=81242381-ab73-4352-8bed-9e7099c82ee1-tuct6d23571&_li_chk=true&previous_uuid=8626b73be29245099a3365d61c54f4a0 HTTP 303
  • https://i6.liadm.com/s/32441?bidder_id=88068&bidder_uuid=81242381-ab73-4352-8bed-9e7099c82ee1-tuct6d23571
Request Chain 276
  • https://pixel.onaudience.com/?partner=137085097&mapped=81242381-ab73-4352-8bed-9e7099c82ee1-tuct6d23571 HTTP 302
  • https://loada.exelator.com/load/?p=1164&g=1&j=r&ru=https%3A%2F%2Fpixel.onaudience.com%2F%3Fpartner%3D161%26icm%26mapped%3D%25%25UID%25%25 HTTP 302
  • https://loada.exelator.com/load/?p=1164&g=1&j=r&ru=https%3A%2F%2Fpixel.onaudience.com%2F%3Fpartner%3D161%26icm%26mapped%3D%25%25UID%25%25&xl8blockcheck=1 HTTP 302
  • https://pixel.onaudience.com/?partner=161&icm&mapped=9dc42152e8dc6248e072f0d3a3218ac8
Request Chain 278
  • https://cm.g.doubleclick.net/pixel?google_nid=taboola_dbm&google_cm&google_sc HTTP 302
  • https://trc.taboola.com/sg/google-network/1/rtb-h/?taboola_hm=CAESEOcJWVLnpHsl-ZO-woQlv5Y&google_cver=1
Request Chain 280
  • https://ml314.com/utsync.ashx?eid=50077&et=0&fp=81242381-ab73-4352-8bed-9e7099c82ee1-tuct6d23571&return=https%3a%2f%2fidsync.rlcdn.com%2f395886.gif%3fpartner_uid%3d%5bPersonID%5d HTTP 302
  • https://idsync.rlcdn.com/395886.gif?partner_uid=3615253808165159036 HTTP 307
  • https://idsync.rlcdn.com/1000.gif?memo=CO6UGBIeChoIARCuXxoTMzYxNTI1MzgwODE2NTE1OTAzNhAAGg0I9t_i_gUSBQjoBxAAQgBKAA HTTP 307
  • https://ml314.com/csync.ashx?fp=1b141d853f9d3b173ea13075c620addcccb1639f6e0b7c9655daab11fda649fff4cb09cee1a4f8eb&person_id=3615253808165159036&eid=50082
Request Chain 281
  • https://sync.taboola.com/sg/google-network/1/rtb?redir=https%3A%2F%2Fcm.g.doubleclick.net%2Fpixel%3Fgoogle_nid%3Dtaboola_dbm%26google_sc%26gdpr%3D0%26gdpr_consent%3D&orig=trc HTTP 302
  • https://cm.g.doubleclick.net/pixel?google_nid=taboola_dbm&google_sc&gdpr=0&gdpr_consent=&google_hm=81242381-ab73-4352-8bed-9e7099c82ee1-tuct6d23571
Request Chain 282
  • https://match.adsrvr.org/track/cmf/generic?ttd_pid=054f32o&ttd_tpi=1 HTTP 302
  • https://match.adsrvr.org/track/cmb/generic?ttd_pid=054f32o&ttd_tpi=1 HTTP 302
  • https://trc.taboola.com/sg/thetradedesk-network/1/rtb-h/?taboola_hm=c1befdb7-5c1a-4d0f-b053-b3ef508e7ce4
Request Chain 283
  • https://ce.lijit.com/merge?pid=42&3pid=81242381-ab73-4352-8bed-9e7099c82ee1-tuct6d23571&us_privacy=&gdpr=0&gdpr_consent= HTTP 302
  • https://ce.lijit.com/merge?pid=42&3pid=81242381-ab73-4352-8bed-9e7099c82ee1-tuct6d23571&us_privacy=&gdpr=0&gdpr_consent=&dnr=1
Request Chain 285
  • https://www.storygize.net/ccm/4b560cdd-91f9-422b-adb7-e9dff26bc3ad?u=81242381-ab73-4352-8bed-9e7099c82ee1-tuct6d23571 HTTP 302
  • https://sync.taboola.com/sg/storygize-network/1/rtb-h?taboola_hm=37cf273d-6031-4a9e-b4c2-17b86d952301
Request Chain 289
  • https://sync.1dmp.io/pixel.gif?cid=bbd655c2-4912-4064-9036-7e0aec8fb8f2&brid=1ad3958e-57cd-4f58-80a2-9c478e047fdd&pid=w&uid=81242381-ab73-4352-8bed-9e7099c82ee1-tuct6d23571 HTTP 302
  • https://sync.1dmp.io/pixel.gif?cid=bbd655c2-4912-4064-9036-7e0aec8fb8f2&brid=1ad3958e-57cd-4f58-80a2-9c478e047fdd&pid=w&uid=81242381-ab73-4352-8bed-9e7099c82ee1-tuct6d23571&cs=1
Request Chain 290
  • https://loadm.exelator.com/load/?p=204&g=1270&j=0&BUID=81242381-ab73-4352-8bed-9e7099c82ee1-tuct6d23571 HTTP 302
  • https://loadm.exelator.com/load/?p=204&g=1270&j=0&BUID=81242381-ab73-4352-8bed-9e7099c82ee1-tuct6d23571&xl8blockcheck=1
Request Chain 291
  • https://dis.criteo.com/dis/usersync.aspx?r=29&p=282&cp=taboolaortb&cu=1&url=https%3A%2F%2Fsync-t1.taboola.com%2Fsg%2Fcriteortb-network%2F1%2Frtb-h%2F%3Ftaboola_hm%3D%40%40CRITEO_USERID%40%40 HTTP 302
  • https://sync-t1.taboola.com/sg/criteortb-network/1/rtb-h/?taboola_hm=c851c1a0-a35b-4d6a-ada8-ff9a540db409
Request Chain 293
  • https://id5-sync.com/s/464/9.gif?puid=81242381-ab73-4352-8bed-9e7099c82ee1-tuct6d23571&gdpr=0&gdpr_consent=&callback=https%3A%2F%2Fsync.taboola.com%2Fsg%2Fid5-network%2F1%2Frtb-h%2F%3Ftaboola_hm%3D%7BID5UID%7D HTTP 302
  • https://pixel.tapad.com/idsync/ex/push?partner_id=2922&partner_url=https%3A%2F%2Fid5-sync.com%2Fc%2F464%2F108%2F6%2F2.gif%3Fpuid%3D%24%7BTA_DEVICE_ID%7D%26gdpr%3D1%26gdpr_consent%3D&gdpr=1&gdpr_consent= HTTP 302
  • https://id5-sync.com/c/464/108/6/2.gif?puid=6fb9c801-3ed3-11eb-b7db-6e8555c96cc6&gdpr=1&gdpr_consent= HTTP 302
  • https://uipglob.semasio.net/id5/1/get?gdpr=1&gdpr_consent=&_url=https%3A%2F%2Fid5-sync.com%2Fc%2F464%2F112%2F5%2F3.gif%3Fpuid%3D%24%7BUIPID%7D%26gdpr%3D1%26gdpr_consent%3D HTTP 302
  • https://uipglob.semasio.net/id5/1/get2?gdpr=1&gdpr_consent=&_url=https%3A%2F%2Fid5-sync.com%2Fc%2F464%2F112%2F5%2F3.gif%3Fpuid%3D%24%7BUIPID%7D%26gdpr%3D1%26gdpr_consent%3D HTTP 302
  • https://id5-sync.com/c/464/112/5/3.gif?puid=620A8F54E31F2C38&gdpr=1&gdpr_consent= HTTP 302
  • https://ads.avocet.io/getuid?url=https%3A%2F%2Fid5-sync.com%2Fc%2F464%2F146%2F4%2F4.gif%3Fpuid%3D%7B%7BUUID%7D%7D%26gdpr%3D1%26gdpr_consent%3D HTTP 301
  • https://ads.avct.cloud/getuid?r=1&url=https%3A%2F%2Fid5-sync.com%2Fc%2F464%2F146%2F4%2F4.gif%3Fpuid%3D%7B%7BUUID%7D%7D%26gdpr%3D1%26gdpr_consent%3D HTTP 302
  • https://id5-sync.com/c/464/146/4/4.gif?puid=11f3923d-c6d0-4798-93e0-b14556a89c0a&gdpr=1&gdpr_consent= HTTP 302
  • https://sync.crwdcntrl.net/map/c=2831/tp=GDMP?https://cm.g.doubleclick.net/pixel?google_nid=lotame_dmp&google_hm=${base64_profileid}&google_redir=https%3A%2F%2Fid5-sync.com%2Fc%2F464%2F398%2F3%2F5.gif%3Fpuid%3D%24%7Bbase64_profileid%7D%26gdpr%3D1%26gdpr_consent%3D HTTP 302
  • https://cm.g.doubleclick.net/pixel?google_nid=lotame_dmp&google_hm=OTYwYWEyYzIyNzNmNmI0OTI5NThmOTZkMzZiZjYzMDQ&google_redir=https://id5-sync.com/c/464/398/3/5.gif?puid=OTYwYWEyYzIyNzNmNmI0OTI5NThmOTZkMzZiZjYzMDQ&gdpr=1&gdpr_consent= HTTP 302
  • https://id5-sync.com/c/464/398/3/5.gif?puid=OTYwYWEyYzIyNzNmNmI0OTI5NThmOTZkMzZiZjYzMDQ&gdpr=1&gdpr_consent= HTTP 302
  • https://rtb.gumgum.com/getuid/id5?r=https%3A%2F%2Fid5-sync.com%2Fc%2F464%2F441%2F2%2F6.gif%3Fpuid%3D%5BUID%5D%26gdpr%3D1%26gdpr_consent%3D&gdpr=1&gdpr_consent= HTTP 302
  • https://id5-sync.com/c/464/441/2/6.gif?puid=e_ff9d8ba4-bd30-4ba3-976b-aa6278778f22&gdpr=1&gdpr_consent= HTTP 302
  • https://dpm.demdex.net/ibs:dpid=121998&dpuuid=960aa2c2273f6b492958f96d36bf6304&redir=https%3A%2F%2Fid5-sync.com%2Fc%2F464%2F485%2F1%2F7.gif%3Fpuid%3D%24%7BDD_UUID%7D%26gdpr%3D1%26gdpr_consent%3D&gdpr=1&gdpr_consent= HTTP 302
  • https://id5-sync.com/c/464/485/1/7.gif?puid=02429134991296611824265187627393430398&gdpr=1&gdpr_consent= HTTP 302
  • https://pixel.rubiconproject.com/tap.php?v=16829&nid=2820&put=ID5-ZHMOqMhJTrldgGJIBsru2iINA62VBTrOOYCHIcZtjg
Request Chain 294
  • https://s.c.appier.net/taboola HTTP 302
  • https://sync.taboola.com/sg/appierrtb-network/1/rtb-h?taboola_hm=zKys0U2RDk6MekcJ9K_YXw
Request Chain 295
  • https://pixel.advertising.com/ups/55973/sync?uid=81242381-ab73-4352-8bed-9e7099c82ee1-tuct6d23571&_origin=1 HTTP 302
  • https://pixel.advertising.com/ups/55973/sync?uid=81242381-ab73-4352-8bed-9e7099c82ee1-tuct6d23571&_origin=1&verify=true HTTP 302
  • https://ups.analytics.yahoo.com/ups/55973/sync?uid=81242381-ab73-4352-8bed-9e7099c82ee1-tuct6d23571&_origin=1&apid=UP706d39db-3ed3-11eb-92c6-02d43f703412
Request Chain 298
  • https://x.bidswitch.net/sync?ssp=taboola&gdpr=0&gdpr_consent= HTTP 302
  • https://ads.betweendigital.com/match?bidder_id=43092&callback_url=https%3A%2F%2Fx.bidswitch.net%2Fsync%3Fdsp_id%3D429%26user_id%3D%24%7BUSER_ID%7D%26ssp%3Dtaboola%26expires%3D30%26user_group%3D%24%7BUSER_GROUP%7D HTTP 302
  • https://ads.betweendigital.com/match?bidder_id=43092&callback_url=https%3A%2F%2Fx.bidswitch.net%2Fsync%3Fdsp_id%3D429%26user_id%3D%24%7BUSER_ID%7D%26ssp%3Dtaboola%26expires%3D30%26user_group%3D%24%7BUSER_GROUP%7D&crf=1 HTTP 302
  • https://x.bidswitch.net/sync?dsp_id=429&user_id=1c93d881-2f55-525e-9eb7-0aafc16fa558&ssp=taboola&expires=30&user_group=1 HTTP 302
  • https://sync-t1.taboola.com/sg/bidswitch-network/1/rtb-h?taboola_hm=c374b576-af0f-4001-86dd-ddc2d8f91de1
Request Chain 338
  • https://image2.pubmatic.com/AdServer/UCookieSetPug?rd=https%3A%2F%2Faud.pubmatic.com%2FAdServer%2FArtemis%3Fdpid%3D267%26segid%3D10277 HTTP 302
  • https://aud.pubmatic.com/AdServer/Artemis?dpid=267&segid=10277
Request Chain 356
  • https://r.skimresources.com/api/ HTTP 307
  • https://r.skimresources.com/api/?xguid=01ESK6YKBYW08DGF8S3WVHJBE8&persistence=1&checksum=27c6d66aa694d3eaccf7a3dabbb5d985e927fafe719bffac488183a8754b2408
Request Chain 379
  • https://www.google.com/pagead/drt/ui HTTP 302
  • https://googleads.g.doubleclick.net/pagead/drt/si
Request Chain 395
  • https://www.google.com/pagead/drt/ui HTTP 302
  • https://googleads.g.doubleclick.net/pagead/drt/si
Request Chain 400
  • https://www.google.com/pagead/drt/ui HTTP 302
  • https://googleads.g.doubleclick.net/pagead/drt/si
Request Chain 401
  • https://x.skimresources.com/?provider=exelate&gdpr=1&gdpr_consent= HTTP 302
  • https://loadeu.exelator.com/load/?p=787&g=001&j=0&gdpr=1
Request Chain 440
  • https://eb2.3lift.com/sync HTTP 302
  • https://eb2.3lift.com/sync?&ld=1
Request Chain 442
  • https://e.serverbid.com/udb/9969/match?redir=https%3A%2F%2Fmfad.inskinad.com%2Fudb%2F9874%2Fpool%2Fset%2Fi.gif%3FpoolId%3D9969%26poolKey%3D HTTP 302
  • https://mfad.inskinad.com/udb/9874/pool/set/i.gif?poolId=9969&poolKey=ue1-sb1-50ee6297-b466-414e-be83-34869700d04b
Request Chain 443
  • https://pixel.advertising.com/ups/57304/sync?gdpr=&gdpr_consent=&_origin=0&redir=true HTTP 302
  • https://ups.analytics.yahoo.com/ups/57304/sync?gdpr=&gdpr_consent=&_origin=0&redir=true&apid=UP706d39db-3ed3-11eb-92c6-02d43f703412 HTTP 302
  • https://cm.g.doubleclick.net/pixel?google_nid=adaptv_dbm&google_cm&google_hm=VVA3MDZkMzlkYi0zZWQzLTExZWItOTJjNi0wMmQ0M2Y3MDM0MTI%3D HTTP 302
  • https://pixel.advertising.com/ups/57304/sync?uid=CAESEKvCJyDknWY1dCU0u5ddLbQ&google_cver=1 HTTP 302
  • https://ups.analytics.yahoo.com/ups/57304/sync?uid=CAESEKvCJyDknWY1dCU0u5ddLbQ&google_cver=1&apid=UP706d39db-3ed3-11eb-92c6-02d43f703412
Request Chain 444
  • https://match.adsrvr.org/track/cmf/generic?ttd_pid=adaptv&ttd_tpi=1 HTTP 302
  • https://pixel.advertising.com/ups/55953/sync?uid=c1befdb7-5c1a-4d0f-b053-b3ef508e7ce4&_origin=1&gdpr=1&gdpr_consent=&piggybackCookie=c1befdb7-5c1a-4d0f-b053-b3ef508e7ce4
Request Chain 445
  • https://x.bidswitch.net/sync?ssp=themediagrid HTTP 302
  • https://a.sportradarserving.com/sync?ssp=bidswitch&bidswitch_ssp_id=themediagrid HTTP 302
  • https://a.sportradarserving.com/ul_cb/sync?ssp=bidswitch&bidswitch_ssp_id=themediagrid HTTP 302
  • https://x.bidswitch.net/sync?dsp_id=409&expires=14&user_group=1&user_id=358dfaab-6bf8-4136-a294-2816f441f4c8&ssp=themediagrid HTTP 302
  • https://grid.bidswitch.net/getuids?bsw_uid=c374b576-af0f-4001-86dd-ddc2d8f91de1&ssp_custom_data=
Request Chain 446
  • https://sync-tm.everesttech.net/upi/pid/m7y5t93k?gdpr=0&gdpr_consent=&redir=https%3A%2F%2Fpixel.advertising.com%2Fups%2F55986%2Fsync%3Fuid%3D%24%7BUSER_ID%7D%26_origin%3D0&gdpr=0&gdpr_consent= HTTP 302
  • https://sync-tm.everesttech.net/ct/upi/pid/m7y5t93k?gdpr=0&gdpr_consent=&redir=https%3A%2F%2Fpixel.advertising.com%2Fups%2F55986%2Fsync%3Fuid%3D%24%7BUSER_ID%7D%26_origin%3D0&gdpr=0&gdpr_consent=&_test=X9iv9wAAAGMUcyrK HTTP 302
  • https://pixel.advertising.com/ups/55986/sync?uid=X9iv9wAAAGMUcyrK&_origin=0&gdpr=0&gdpr_consent=&_test=X9iv9wAAAGMUcyrK HTTP 302
  • https://ups.analytics.yahoo.com/ups/55986/sync?uid=X9iv9wAAAGMUcyrK&_origin=0&gdpr=0&gdpr_consent=&_test=X9iv9wAAAGMUcyrK&apid=UP706d39db-3ed3-11eb-92c6-02d43f703412
Request Chain 447
  • https://ssum.casalemedia.com/usermatchredir?s=185638&cb=https%3A%2F%2Fmfad.inskinad.com%2Fudb%2F9874%2Fsync%2Fi.gif%3FpartnerId%3D1%26userId%3D HTTP 302
  • https://mfad.inskinad.com/udb/9874/sync/i.gif?partnerId=1&userId=X9iv8oE1aeK2FeDJu3VAdAAA%261142
Request Chain 461
  • https://sync.crwdcntrl.net/map/c=7505/tp=SKIM/?https%3A%2F%2Fx.skimresources.com%2F%3Fprovider%3Dlotame%26skim_mapping%3Dtrue%26provider_id%3D%24%7Bprofile_id%7D HTTP 302
  • https://x.skimresources.com/?provider=lotame&skim_mapping=true&provider_id= HTTP 302
  • https://p.skimresources.com/?skim_mapping=true
Request Chain 470
  • https://www.google.com/pagead/drt/ui HTTP 302
  • https://googleads.g.doubleclick.net/pagead/drt/si
Request Chain 489
  • https://www.google.com/pagead/drt/ui HTTP 302
  • https://googleads.g.doubleclick.net/pagead/drt/si
Request Chain 522
  • https://www.google.com/pagead/drt/ui HTTP 302
  • https://googleads.g.doubleclick.net/pagead/drt/si
Request Chain 566
  • https://ads.stickyadstv.com/user-matching?id=11 HTTP 302
  • https://cm.g.doubleclick.net/pixel?google_nid=stickyxchange_dbm&google_hm=NTVkZGM1MTU2YmFiYTc1MGRhNTQ2MjIzOWJjZDBmZg==&gdpr=0&gdpr_consent=
Request Chain 567
  • https://ads.stickyadstv.com/auto-user-sync HTTP 302
  • https://1f2e7.v.fwmrm.net/ad/u?_dv=2&dsp_user_mapping=true&127719=55ddc5156baba750da5462239bcd0ff&rdU=https%3A%2F%2Fads.stickyadstv.com%2Fuser-registering%3FdataProviderId%3D1169%26userId%3d%23%7buser.id%7d HTTP 302
  • https://ads.stickyadstv.com/user-registering?dataProviderId=1169&userId=g037_6906463516849950966 HTTP 302
  • https://cm.g.doubleclick.net/pixel?google_nid=stickyxchange_dbm&google_cm=&google_sc&google_hm=NTVkZGM1MTU2YmFiYTc1MGRhNTQ2MjIzOWJjZDBmZg==&gdpr=0&gdpr_consent= HTTP 302
  • https://ads.stickyadstv.com/user-registering?dataProviderId=141&userId=CAESEL5FZqyURYBihCEEqGz1o34&google_cver=1&gdpr=0&gdpr_consent= HTTP 302
  • https://sync-tm.everesttech.net/upi/pid/wGbQAlJJ?gdpr=0&gdpr_consent=&redir=https%3A%2F%2Fads.stickyadstv.com%2Fuser-registering%3FdataProviderId%3D187%26userId%3D%24%7BTM_USER_ID%7D&gdpr=0&gdpr_consent= HTTP 302
  • https://ads.stickyadstv.com/user-registering?dataProviderId=187&userId=X9iv9wAAAGMUcyrK&gdpr=0&gdpr_consent= HTTP 302
  • https://match.adsrvr.org/track/cmf/generic?ttd_pid=stickyads&ttd_tpi=1&gdpr=0&gdpr_consent=&gdpr=0&gdpr_consent= HTTP 302
  • https://ads.stickyadstv.com/user-registering?dataProviderId=208&userId=c1befdb7-5c1a-4d0f-b053-b3ef508e7ce4 HTTP 302
  • https://sync.mathtag.com/sync/img?mt_exid=44&gdpr=0&gdpr_consent=&redir=https%3A%2F%2Fads.stickyadstv.com%2Fuser-registering%3FdataProviderId%3D183%26userId%3D%5BMM_UUID%5D HTTP 302
  • https://ads.stickyadstv.com/user-registering?dataProviderId=183&userId=2b0c5fd8-aff1-4b00-90a2-60308e3c734a&gdpr=0&gdpr_consent=
Request Chain 568
  • https://ads.stickyadstv.com/user-matching?id=2545 HTTP 302
  • https://s.amazon-adsystem.com/ecm3?id=55ddc5156baba750da5462239bcd0ff&ex=freewheel.tv&gdpr=0&gdpr_consent=
Request Chain 579
  • https://ads.stickyadstv.com/auto-user-sync?gdpr=0&gdpr_consent=null HTTP 302
  • https://sync.mathtag.com/sync/img?mt_exid=44&gdpr=0&gdpr_consent=null&redir=https%3A%2F%2Fads.stickyadstv.com%2Fuser-registering%3FdataProviderId%3D183%26userId%3D%5BMM_UUID%5D&gdpr=0&gdpr_consent=null HTTP 302
  • https://ads.stickyadstv.com/user-registering?dataProviderId=183&userId=2b0c5fd8-aff1-4b00-90a2-60308e3c734a&gdpr=0&gdpr_consent=null
Request Chain 586
  • https://cdw-dcl.userreport.com/gs/init/pixel.gif HTTP 302
  • https://cm.g.doubleclick.net/pixel?google_nid=userreport_ddp&google_cm&google_hm=YWQ2N2M5YjMtOTJlYTBjMjczYmE5LTc0MGI4MGMzZjAzNw== HTTP 302
  • https://cdw-dcl.userreport.com/gs/receive?google_gid=CAESEKyndV6hmDB3vvIQnDg26tg&google_cver=1
Request Chain 587
  • https://dmp.adform.net/serving/cookie/match/?party=1001&cid=20db337f-3fcf-4396-a655-03712671226e HTTP 302
  • https://audex.userreport.com/sync/put/adform?adfusr=6011690696271797576
Request Chain 588
  • https://ads.stickyadstv.com/user-matching?id=11&_fw_gdpr=0&_fw_gdpr_consent= HTTP 302
  • https://cm.g.doubleclick.net/pixel?google_nid=stickyxchange_dbm&google_hm=NTVkZGM1MTU2YmFiYTc1MGRhNTQ2MjIzOWJjZDBmZg==&gdpr=0&gdpr_consent=
Request Chain 589
  • https://ads.stickyadstv.com/user-matching?id=2545&_fw_gdpr=0&_fw_gdpr_consent= HTTP 302
  • https://s.amazon-adsystem.com/ecm3?id=55ddc5156baba750da5462239bcd0ff&ex=freewheel.tv&gdpr=0&gdpr_consent=
Request Chain 657
  • https://s.adtelli.com/mc?c=vmuid%3A227ab502478174c8&r2=hb.hb.selectmedia.asia HTTP 302
  • https://hb.hb.selectmedia.asia/mcd
Request Chain 658
  • https://ib.adnxs.com/getuid?https%3A%2F%2Fsync.ads.152media.com%2Fcsync%3Ft%3Da%26ep%3D285868%26extuid%3D%24UID HTTP 307
  • https://ib.adnxs.com/bounce?%2Fgetuid%3Fhttps%253A%252F%252Fsync.ads.152media.com%252Fcsync%253Ft%253Da%2526ep%253D285868%2526extuid%253D%2524UID HTTP 302
  • https://sync.ads.152media.com/csync?t=a&ep=285868&extuid=4247283236299145
Request Chain 689
  • https://www.google.com/pagead/drt/ui HTTP 302
  • https://googleads.g.doubleclick.net/pagead/drt/si
Request Chain 705
  • https://sync.search.spotxchange.com/partner?source=dados HTTP 302
  • https://sync.search.spotxchange.com/partner?source=dados&__user_check__=1&sync_id=7723a40a-3ed3-11eb-8a2f-1f932c7f4206
Request Chain 717
  • https://ads.stickyadstv.com/auto-user-sync?gdpr=0&gdpr_consent=null HTTP 302
  • https://1f2e7.v.fwmrm.net/ad/u?_dv=2&dsp_user_mapping=true&127719=59b88bb7e5c7986e844256cfcefb115&rdU=https%3A%2F%2Fads.stickyadstv.com%2Fuser-registering%3FdataProviderId%3D1169%26userId%3d%23%7buser.id%7d&529=2b0c5fd8-aff1-4b00-90a2-60308e3c734a&gdpr=0&gdpr_consent=null HTTP 302
  • https://ads.stickyadstv.com/user-registering?dataProviderId=1169&userId=g003_6906463559799745575 HTTP 302
  • https://cm.g.doubleclick.net/pixel?google_nid=stickyxchange_dbm&google_cm=&google_sc&google_hm=NTliODhiYjdlNWM3OTg2ZTg0NDI1NmNmY2VmYjExNQ==&gdpr=0&gdpr_consent= HTTP 302
  • https://ads.stickyadstv.com/user-registering?dataProviderId=141&userId=CAESEO0TRxlhhWFEztSREysYkUs&google_cver=1&gdpr=0&gdpr_consent= HTTP 302
  • https://match.adsrvr.org/track/cmf/generic?ttd_pid=stickyads&ttd_tpi=1&gdpr=0&gdpr_consent=&gdpr=0&gdpr_consent= HTTP 302
  • https://ads.stickyadstv.com/user-registering?dataProviderId=208&userId=eaff8365-3920-49ce-bdca-8f674a0df29a HTTP 302
  • https://sync-tm.everesttech.net/upi/pid/wGbQAlJJ?gdpr=0&gdpr_consent=&redir=https%3A%2F%2Fads.stickyadstv.com%2Fuser-registering%3FdataProviderId%3D187%26userId%3D%24%7BTM_USER_ID%7D HTTP 302
  • https://ads.stickyadstv.com/user-registering?dataProviderId=187&userId=X9iwAAAAAI9TozoG HTTP 302
  • https://c1.adform.net/serving/cookie/match/?party=18 HTTP 302
  • https://ads.stickyadstv.com/user-registering?dataProviderId=189&userId=8494150580545336307
Request Chain 738
  • https://match.adsrvr.org/track/cmf/generic?ttd_pid=adaptv&ttd_tpi=1 HTTP 302
  • https://match.adsrvr.org/track/cmb/generic?ttd_pid=adaptv&ttd_tpi=1 HTTP 302
  • https://pixel.advertising.com/ups/55953/sync?uid=eaff8365-3920-49ce-bdca-8f674a0df29a&_origin=1&gdpr=1&gdpr_consent=&piggybackCookie=eaff8365-3920-49ce-bdca-8f674a0df29a
Request Chain 739
  • https://sync-tm.everesttech.net/upi/pid/m7y5t93k?gdpr=0&gdpr_consent=&redir=https%3A%2F%2Fpixel.advertising.com%2Fups%2F55986%2Fsync%3Fuid%3D%24%7BUSER_ID%7D%26_origin%3D0&gdpr=0&gdpr_consent= HTTP 302
  • https://sync-tm.everesttech.net/ct/upi/pid/m7y5t93k?gdpr=0&gdpr_consent=&redir=https%3A%2F%2Fpixel.advertising.com%2Fups%2F55986%2Fsync%3Fuid%3D%24%7BUSER_ID%7D%26_origin%3D0&gdpr=0&gdpr_consent=&_test=X9iwAAAAAI9TozoG HTTP 302
  • https://pixel.advertising.com/ups/55986/sync?uid=X9iwAAAAAI9TozoG&_origin=0&gdpr=0&gdpr_consent=&_test=X9iwAAAAAI9TozoG HTTP 302
  • https://ups.analytics.yahoo.com/ups/55986/sync?uid=X9iwAAAAAI9TozoG&_origin=0&gdpr=0&gdpr_consent=&_test=X9iwAAAAAI9TozoG&apid=UP77852cb2-3ed3-11eb-950c-02ffdefff428 HTTP 302
  • https://ups.analytics.yahoo.com/ups/55986/sync?uid=X9iwAAAAAI9TozoG&_origin=0&gdpr=0&gdpr_consent=&_test=X9iwAAAAAI9TozoG&apid=UP77852cb2-3ed3-11eb-950c-02ffdefff428&verify=true
Request Chain 740
  • https://pixel.advertising.com/ups/57304/sync?gdpr=&gdpr_consent=&_origin=0&redir=true HTTP 302
  • https://pixel.advertising.com/ups/57304/sync?gdpr=&gdpr_consent=&_origin=0&redir=true&verify=true HTTP 302
  • https://ups.analytics.yahoo.com/ups/57304/sync?gdpr=&gdpr_consent=&_origin=0&redir=true&apid=UP77852cb2-3ed3-11eb-950c-02ffdefff428 HTTP 302
  • https://ups.analytics.yahoo.com/ups/57304/sync?gdpr=&gdpr_consent=&_origin=0&redir=true&apid=UP77852cb2-3ed3-11eb-950c-02ffdefff428&verify=true HTTP 302
  • https://cm.g.doubleclick.net/pixel?google_nid=adaptv_dbm&google_cm&google_hm=VVA3Nzg1MmNiMi0zZWQzLTExZWItOTUwYy0wMmZmZGVmZmY0Mjg%3D HTTP 302
  • https://pixel.advertising.com/ups/57304/sync?uid=CAESEN4Tt7gyEIW7MubauRbVXVk&google_cver=1 HTTP 302
  • https://ups.analytics.yahoo.com/ups/57304/sync?uid=CAESEN4Tt7gyEIW7MubauRbVXVk&google_cver=1&apid=UP77852cb2-3ed3-11eb-950c-02ffdefff428
Request Chain 745
  • https://ads.stickyadstv.com/user-matching?id=11&_fw_gdpr=0&_fw_gdpr_consent= HTTP 302
  • https://cm.g.doubleclick.net/pixel?google_nid=stickyxchange_dbm&google_hm=NTliODhiYjdlNWM3OTg2ZTg0NDI1NmNmY2VmYjExNQ==&gdpr=0&gdpr_consent=
Request Chain 747
  • https://ads.stickyadstv.com/user-matching?id=2545&_fw_gdpr=0&_fw_gdpr_consent= HTTP 302
  • https://s.amazon-adsystem.com/ecm3?id=59b88bb7e5c7986e844256cfcefb115&ex=freewheel.tv&gdpr=0&gdpr_consent=
Request Chain 759
  • https://ads.stickyadstv.com/auto-user-sync?gdpr=0&gdpr_consent=null HTTP 302
  • https://1f2e7.v.fwmrm.net/ad/u?_dv=2&dsp_user_mapping=true&127719=d513c8dd79aaf14d3c36359165d320a7&rdU=https%3A%2F%2Fads.stickyadstv.com%2Fuser-registering%3FdataProviderId%3D1169%26userId%3d%23%7buser.id%7d&617=8494150580545336307&gdpr=0&gdpr_consent=null HTTP 302
  • https://ads.stickyadstv.com/user-registering?dataProviderId=1169&userId=g018_6906463572684681576 HTTP 302
  • https://cm.g.doubleclick.net/pixel?google_nid=stickyxchange_dbm&google_cm=&google_sc&google_hm=ZDUxM2M4ZGQ3OWFhZjE0ZDNjMzYzNTkxNjVkMzIwYTc=&gdpr=0&gdpr_consent= HTTP 302
  • https://cm.g.doubleclick.net/pixel?google_nid=stickyxchange_dbm&google_cm=&google_sc=&google_hm=ZDUxM2M4ZGQ3OWFhZjE0ZDNjMzYzNTkxNjVkMzIwYTc=&gdpr=0&gdpr_consent=&google_tc= HTTP 302
  • https://ads.stickyadstv.com/user-registering?dataProviderId=141&userId=CAESELJbIhymIgHJSLxuaiPIW6I&google_cver=1&gdpr=0&gdpr_consent= HTTP 302
  • https://sync-tm.everesttech.net/upi/pid/wGbQAlJJ?gdpr=0&gdpr_consent=&redir=https%3A%2F%2Fads.stickyadstv.com%2Fuser-registering%3FdataProviderId%3D187%26userId%3D%24%7BTM_USER_ID%7D&gdpr=0&gdpr_consent= HTTP 302
  • https://sync-tm.everesttech.net/ct/upi/pid/wGbQAlJJ?gdpr=0&gdpr_consent=&redir=https%3A%2F%2Fads.stickyadstv.com%2Fuser-registering%3FdataProviderId%3D187%26userId%3D%24%7BTM_USER_ID%7D&gdpr=0&gdpr_consent=&_test=X9iwCAAAAF5Mz1LS HTTP 302
  • https://ads.stickyadstv.com/user-registering?dataProviderId=187&userId=X9iwCAAAAF5Mz1LS&gdpr=0&gdpr_consent=&_test=X9iwCAAAAF5Mz1LS HTTP 302
  • https://match.adsrvr.org/track/cmf/generic?ttd_pid=stickyads&ttd_tpi=1&gdpr=0&gdpr_consent=&gdpr=0&gdpr_consent= HTTP 302
  • https://match.adsrvr.org/track/cmb/generic?ttd_pid=stickyads&ttd_tpi=1&gdpr=0&gdpr_consent=&gdpr=0&gdpr_consent= HTTP 302
  • https://ads.stickyadstv.com/user-registering?dataProviderId=208&userId=a54550d3-e3b0-4b54-9941-4dc299eefd3e HTTP 302
  • https://sync.mathtag.com/sync/img?mt_exid=44&gdpr=0&gdpr_consent=&redir=https%3A%2F%2Fads.stickyadstv.com%2Fuser-registering%3FdataProviderId%3D183%26userId%3D%5BMM_UUID%5D HTTP 302
  • https://ads.stickyadstv.com/user-registering?dataProviderId=183&userId=30105fd8-b007-4200-ae74-c9a6af44008d&gdpr=0&gdpr_consent= HTTP 302
  • https://pr-bh.ybp.yahoo.com/sync/stickyads/d513c8dd79aaf14d3c36359165d320a7&gdpr=0&gdpr_consent=?gdpr=0&gdpr_consent= HTTP 302
  • https://ads.stickyadstv.com/user-registering?dataProviderId=199&userId=y-oC2Olah1lwTw2zU9Fq5SGDw4BZYXA9DLlvAP0O35 HTTP 302
  • https://ad.turn.com/r/cs?pid=34&gdpr=0&gdpr_consent= HTTP 302
  • https://ads.stickyadstv.com/user-registering?dataProviderId=147&userId=2675167110638126630 HTTP 302
  • https://sync.ipredictive.com/d/sync/cookie/generic?partner=stickyadstv&append=1&cb=6219189&redirect=https%3A%2F%2Fads.stickyadstv.com%2Fuser-registering%3FdataProviderId%3D690%26userId%3D HTTP 302
  • https://ads.stickyadstv.com/user-registering?dataProviderId=690&userId=7c125685-3ed3-11eb-aa79-379d7bda4b4c HTTP 302
  • https://ib.adnxs.com/getuid?https%3A%2F%2Fads.stickyadstv.com%2Fuser-registering%3FdataProviderId%3D209&gdpr=0&gdpr_consent=%26userId%3D$UID
Request Chain 763
  • https://ads.stickyadstv.com/user-matching?id=11&_fw_gdpr=0&_fw_gdpr_consent= HTTP 302
  • https://cm.g.doubleclick.net/pixel?google_nid=stickyxchange_dbm&google_hm=ZDUxM2M4ZGQ3OWFhZjE0ZDNjMzYzNTkxNjVkMzIwYTc=&gdpr=0&gdpr_consent= HTTP 302
  • https://cm.g.doubleclick.net/pixel?google_nid=stickyxchange_dbm&google_hm=ZDUxM2M4ZGQ3OWFhZjE0ZDNjMzYzNTkxNjVkMzIwYTc=&gdpr=0&gdpr_consent=&google_tc=
Request Chain 765
  • https://ads.stickyadstv.com/user-matching?id=2545&_fw_gdpr=0&_fw_gdpr_consent= HTTP 302
  • https://s.amazon-adsystem.com/ecm3?id=d513c8dd79aaf14d3c36359165d320a7&ex=freewheel.tv&gdpr=0&gdpr_consent=
Request Chain 778
  • https://taboola-d.openx.net/v/1.0/av?auid=541033703&gdpr=0&us_privacy=1--- HTTP 302
  • https://cm.g.doubleclick.net/pixel?google_nid=openx&google_cm&google_sc
Request Chain 779
  • https://taboola-d.openx.net/v/1.0/av?auid=540790697&gdpr=0&us_privacy=1--- HTTP 302
  • https://cm.g.doubleclick.net/pixel?google_nid=openx&google_hm=ZjUxMWQ1YTktOGM4OS02YmI3LTRjMmYtNDA0MjRkYWFjYzVm
Request Chain 782
  • https://taboola-d.openx.net/v/1.0/av?auid=540790697&gdpr=0&us_privacy=1--- HTTP 302
  • https://taboola-d.openx.net/v/1.0/av?cc=1&auid=540790697&gdpr=0&us_privacy=1---
Request Chain 783
  • https://radar.cedexis.com/1/12818/radar.js HTTP 302
  • https://radar.cedexis.com/1593429750/radar.js
Request Chain 784
  • https://taboola-d.openx.net/v/1.0/av?auid=541033703&gdpr=0&us_privacy=1--- HTTP 302
  • https://taboola-d.openx.net/v/1.0/av?cc=1&auid=541033703&gdpr=0&us_privacy=1---

778 HTTP transactions

Resource
Path
Size
x-fer
Type
MIME-Type
MmZ-8yjYCXrW6zj2_M6nsGYsW7JzK5Y7LnJnQVd1GcC5Dg2KFdBBbG504
info.silobreaker.com/e2t/sc2/
7 KB
2 KB
Document
General
Full URL
https://info.silobreaker.com/e2t/sc2/MmZ-8yjYCXrW6zj2_M6nsGYsW7JzK5Y7LnJnQVd1GcC5Dg2KFdBBbG504
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
199.60.103.254 , Canada, ASN209242 (CLOUDFLARESPECTRUM Cloudflare, Inc., GB),
Reverse DNS
Software
cloudflare /
Resource Hash
853f53beef052e254663adf31bff5f3096857b1b5d657d996fcf7d471c93609c

Request headers

:method
GET
:authority
info.silobreaker.com
:scheme
https
:path
/e2t/sc2/MmZ-8yjYCXrW6zj2_M6nsGYsW7JzK5Y7LnJnQVd1GcC5Dg2KFdBBbG504
pragma
no-cache
cache-control
no-cache
upgrade-insecure-requests
1
user-agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
accept
text/html,application/xhtml+xml,application/xml;q=0.9,image/avif,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3;q=0.9
sec-fetch-site
none
sec-fetch-mode
navigate
sec-fetch-user
?1
sec-fetch-dest
document
accept-encoding
gzip, deflate, br
accept-language
en-US
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:45:33 GMT
content-type
text/html;charset=utf-8
set-cookie
__cfduid=dd2ce197a76f0ac890fc6beba3969e6441608036333; expires=Thu, 14-Jan-21 12:45:33 GMT; path=/; domain=.info.silobreaker.com; HttpOnly; SameSite=Lax __cfruid=6df80f928fd818f05fec9ac6ea86e4516e54420a-1608036333; path=/; domain=.info.silobreaker.com; HttpOnly; Secure; SameSite=None
cf-ray
6020432c0b94d8f1-AMS
vary
Accept-Encoding
cf-cache-status
MISS
access-control-allow-credentials
false
cf-request-id
0708084f880000d8f13a1fb000000001
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
referrer-policy
no-referrer
server
cloudflare
content-encoding
br
Primary Request Remdesivir-beneficial-patients-doctors-reveal.html
www.dailymail.co.uk/sciencetech/article-9050821/
Redirect Chain
  • https://info.silobreaker.com/events/public/v1/track/sc2/MmZ-8yjYCXrW6zj2_M6nsGYsW7JzK5Y7LnJnQVd1GcC5Dg2KFdBBbG504?_ud=016cc9f2-9e1d-4652-8ee7-243a4fd674cf&_ch=p&_pr2=p&_pl=0&_lg=en-US&_dr=b&_ts=p
  • https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI...
419 KB
82 KB
Document
General
Full URL
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
Requested by
Host: info.silobreaker.com
URL: https://info.silobreaker.com/e2t/sc2/MmZ-8yjYCXrW6zj2_M6nsGYsW7JzK5Y7LnJnQVd1GcC5Dg2KFdBBbG504
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2a02:26f0:6c00:296::11ae , Ascension Island, ASN20940 (AKAMAI-ASN1, EU),
Reverse DNS
Software
/
Resource Hash
18e306e93c255be3c28d6658fcc6ca8c8690bbd1d984a4edf8a16ddbcae648ba

Request headers

:method
GET
:authority
www.dailymail.co.uk
:scheme
https
:path
/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
pragma
no-cache
cache-control
no-cache
upgrade-insecure-requests
1
user-agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
accept
text/html,application/xhtml+xml,application/xml;q=0.9,image/avif,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3;q=0.9
sec-fetch-site
cross-site
sec-fetch-mode
navigate
sec-fetch-dest
document
accept-encoding
gzip, deflate, br
accept-language
en-US
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Referer
https://info.silobreaker.com/e2t/sc2/MmZ-8yjYCXrW6zj2_M6nsGYsW7JzK5Y7LnJnQVd1GcC5Dg2KFdBBbG504

Response headers

content-type
text/html;charset=UTF-8
set-cookie
x-loc=none; path=/ percent=35743;Max-Age=31536000;path=/;HttpOnly;Secure ak_bmsc=EF55FE37279386881FB71C6B0F60C2DA0210BAA4A46C0000EFAFD85F81A9A846~plEAd0N//ysSdsD8OFuHE3Ob6eyXrQ4hZGIrhMpl157jpZIDoGp5i8aEZJpntnl317jwJMZ6vbm+X+CCq75fTiBlUx2W5SCpmo/PxS/SHhG/UQCbpmh+bmdsBQdbOgVB6eTKXd1FFU2t52eHS8Mw8BwJtaiV4GeoxlNvYplSPh4vN2AtevcXtGHESQmJiGSdMhYnWBHscjervpr+jcM0izEp375ymRIOXvMLwYRJCTl8FfIPcOVwWDbBWDfM/J4kxe; expires=Tue, 15 Dec 2020 14:45:35 GMT; max-age=7200; path=/; domain=.dailymail.co.uk; HttpOnly AKA_A2=A; expires=Tue, 15-Dec-2020 13:45:35 GMT; path=/; domain=dailymail.co.uk; secure; HttpOnly
x-rs-ctime
240
vary
User-Agent Accept-Encoding
content-security-policy-report-only
block-all-mixed-content; report-uri https://mol.report-uri.io/r/default/csp/reportOnly
server-timing
origin; dur=1057 edge; dur=43 cdn-cache; desc=REVALIDATE
x-graced
false
x-mol-georesp
de
x-rs-time
Tue, 15 Dec 2020 12-45-35 GMT
x-rs-ops
varnish-web-b2-fe.hsk.mol.dmgt.net:6081
restarts
0
x-rs-ben
cljfe-b3:8181
x-storage
newarticles
x-akamai-transformed
9 424433 0 pmb=mRUM,2
content-encoding
gzip
cache-control
max-age=92
date
Tue, 15 Dec 2020 12:45:36 GMT

Redirect headers

date
Tue, 15 Dec 2020 12:45:34 GMT
location
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
cf-ray
6020432cecd1d8f1-AMS
link
<https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8>; rel="canonical"
vary
Accept-Encoding
cf-cache-status
MISS
access-control-allow-credentials
false
cf-request-id
070808500c0000d8f126338000000001
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
referrer-policy
no-referrer
x-robots-tag
none
server
cloudflare
gpt.js
www.googletagservices.com/tag/js/
54 KB
19 KB
Script
General
Full URL
https://www.googletagservices.com/tag/js/gpt.js
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:814::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
678c16283762d2d1a12c9b055cf3e4333ca3c4c6638a95741f1130084882756f
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:45:36 GMT
content-encoding
gzip
x-content-type-options
nosniff
server
sffe
etag
"724 / 345 of 1000 / last-modified: 1608034737"
vary
Accept-Encoding
content-type
text/javascript
cache-control
private, max-age=900, stale-while-revalidate=3600
timing-allow-origin
*
alt-svc
h3-29="googleads.g.doubleclick.net:443"; ma=2592000,h3-29=":443"; ma=2592000,h3-T051="googleads.g.doubleclick.net:443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic="googleads.g.doubleclick.net:443"; ma=2592000; v="46,43",quic=":443"; ma=2592000; v="46,43"
content-length
18850
x-xss-protection
0
expires
Tue, 15 Dec 2020 12:45:36 GMT
desktop.css
www.dailymail.co.uk/static/mol-fe/static/mol-fe-sync-bundle/5.9.0/
152 KB
93 KB
Stylesheet
General
Full URL
https://www.dailymail.co.uk/static/mol-fe/static/mol-fe-sync-bundle/5.9.0/desktop.css
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2a02:26f0:6c00:296::11ae , Ascension Island, ASN20940 (AKAMAI-ASN1, EU),
Reverse DNS
Software
Akamai Resource Optimizer /
Resource Hash
8f9584b90be33bd7c46ca2521386b57de0bf7094d3f2a56b5b44111fbd094c85

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:45:36 GMT
content-encoding
br
content-security-policy-report-only
block-all-mixed-content; report-uri https://mol.report-uri.io/r/default/csp/reportOnly
server-timing
cdn-cache; desc=HIT, edge; dur=1
content-length
94448
last-modified
Wed, 18 Nov 2020 15:16:49 GMT
server
Akamai Resource Optimizer
etag
"625d215ccc396c317248be2f901b6985:1605708288.604204"
vary
User-Agent
content-type
text/css
access-control-allow-origin
*
cache-control
max-age=268357
accept-ranges
bytes
timing-allow-origin
*
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept
expires
Fri, 18 Dec 2020 15:18:13 GMT
articleDefer.css
www.dailymail.co.uk/static/mol-fe/static/mol-fe-async-bundle/6.18.1/
337 KB
84 KB
Stylesheet
General
Full URL
https://www.dailymail.co.uk/static/mol-fe/static/mol-fe-async-bundle/6.18.1/articleDefer.css
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2a02:26f0:6c00:296::11ae , Ascension Island, ASN20940 (AKAMAI-ASN1, EU),
Reverse DNS
Software
Akamai Resource Optimizer /
Resource Hash
2ad40955d26fc1042906d8322388080b9d8270019faf5527b6a4771f606693e9

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:45:36 GMT
content-encoding
br
content-security-policy-report-only
block-all-mixed-content; report-uri https://mol.report-uri.io/r/default/csp/reportOnly
server-timing
cdn-cache; desc=HIT, edge; dur=1
content-length
85293
last-modified
Thu, 19 Nov 2020 11:13:34 GMT
server
Akamai Resource Optimizer
etag
"580b61c7613c627e32a5ecb1622eb576:1605783253.249572"
vary
User-Agent
content-type
text/css
access-control-allow-origin
*
cache-control
max-age=349481
accept-ranges
bytes
timing-allow-origin
*
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept
expires
Sat, 19 Dec 2020 13:50:17 GMT
all--.css
www.dailymail.co.uk/static/gunther/17.14.0/
267 KB
34 KB
Stylesheet
General
Full URL
https://www.dailymail.co.uk/static/gunther/17.14.0/all--.css
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2a02:26f0:6c00:296::11ae , Ascension Island, ASN20940 (AKAMAI-ASN1, EU),
Reverse DNS
Software
Akamai Resource Optimizer /
Resource Hash
d43ac5826a74f4e5dcd9435aabe994b89a7e2030babd441463c621e96eec0375

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:45:36 GMT
content-encoding
br
content-security-policy-report-only
block-all-mixed-content; report-uri https://mol.report-uri.io/r/default/csp/reportOnly
server-timing
cdn-cache; desc=HIT, edge; dur=12
content-length
34267
last-modified
Sun, 09 Aug 2020 02:32:46 GMT
server
Akamai Resource Optimizer
etag
"e391873d0754fa60110c5299203d6f76:1595000955.065137"
vary
User-Agent
content-type
text/css
access-control-allow-origin
*
cache-control
max-age=827178
accept-ranges
bytes
timing-allow-origin
*
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept
expires
Fri, 25 Dec 2020 02:31:54 GMT
all1--.css
www.dailymail.co.uk/static/gunther/17.14.0/
55 KB
10 KB
Stylesheet
General
Full URL
https://www.dailymail.co.uk/static/gunther/17.14.0/all1--.css
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2a02:26f0:6c00:296::11ae , Ascension Island, ASN20940 (AKAMAI-ASN1, EU),
Reverse DNS
Software
Akamai Resource Optimizer /
Resource Hash
62e5b5020499d0dbd26922152f199b559ee4922d9132b4242364edf88dc63121

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:45:36 GMT
content-encoding
br
content-security-policy-report-only
block-all-mixed-content; report-uri https://mol.report-uri.io/r/default/csp/reportOnly
server-timing
cdn-cache; desc=HIT, edge; dur=1
content-length
10119
last-modified
Wed, 07 Oct 2020 10:21:44 GMT
server
Akamai Resource Optimizer
etag
"2456679cc8c0c996054aec3c292d82d0:1595000965.438073"
vary
User-Agent
content-type
text/css
access-control-allow-origin
*
cache-control
max-age=1287599
accept-ranges
bytes
timing-allow-origin
*
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept
expires
Wed, 30 Dec 2020 10:25:35 GMT
mol-adverts.desktop.css
www.dailymail.co.uk/static/mol-adverts/demo/mol-22070/19a28e0b/
21 KB
5 KB
Stylesheet
General
Full URL
https://www.dailymail.co.uk/static/mol-adverts/demo/mol-22070/19a28e0b/mol-adverts.desktop.css
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2a02:26f0:6c00:296::11ae , Ascension Island, ASN20940 (AKAMAI-ASN1, EU),
Reverse DNS
Software
Akamai Resource Optimizer /
Resource Hash
6ffcbf498d2e35c180533fd7a7147f65d54b32d57e4f515ad6539270fe15f793

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:45:36 GMT
content-encoding
br
content-security-policy-report-only
block-all-mixed-content; report-uri https://mol.report-uri.io/r/default/csp/reportOnly
last-modified
Tue, 15 Dec 2020 10:14:10 GMT
server
Akamai Resource Optimizer
etag
"d5134761ae4c470e63d2d30514182609:1608027086.092035"
vary
User-Agent
content-type
text/css
cache-control
max-age=2582914
server-timing
cdn-cache; desc=HIT, edge; dur=1
accept-ranges
bytes
timing-allow-origin
*
content-length
4443
expires
Thu, 14 Jan 2021 10:14:10 GMT
registration--.css
www.dailymail.co.uk/static/gunther/17.13.0/
25 KB
5 KB
Stylesheet
General
Full URL
https://www.dailymail.co.uk/static/gunther/17.13.0/registration--.css
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2a02:26f0:6c00:296::11ae , Ascension Island, ASN20940 (AKAMAI-ASN1, EU),
Reverse DNS
Software
Akamai Resource Optimizer /
Resource Hash
03482ceb4519a7706406f47e5992b55e9e5974abd56c45af482a7e1a09d836e6

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:45:36 GMT
content-encoding
br
content-security-policy-report-only
block-all-mixed-content; report-uri https://mol.report-uri.io/r/default/csp/reportOnly
server-timing
cdn-cache; desc=HIT, edge; dur=1
content-length
4945
last-modified
Thu, 05 Nov 2020 20:02:24 GMT
server
Akamai Resource Optimizer
etag
"1d7a19f1f78591a33d5ec97dd91f96b4:1593164448.110325"
vary
User-Agent
content-type
text/css
access-control-allow-origin
*
cache-control
max-age=1495029
accept-ranges
bytes
timing-allow-origin
*
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept
expires
Fri, 01 Jan 2021 20:02:45 GMT
rc-main--.css
www.dailymail.co.uk/static/gunther/17.14.0/
19 KB
5 KB
Stylesheet
General
Full URL
https://www.dailymail.co.uk/static/gunther/17.14.0/rc-main--.css
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2a02:26f0:6c00:296::11ae , Ascension Island, ASN20940 (AKAMAI-ASN1, EU),
Reverse DNS
Software
Akamai Resource Optimizer /
Resource Hash
ee80e2de5c026fa3c0786f587eed85d1521d50ba1aba027c2b0714c108c351a6

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:45:36 GMT
content-encoding
br
content-security-policy-report-only
block-all-mixed-content; report-uri https://mol.report-uri.io/r/default/csp/reportOnly
server-timing
cdn-cache; desc=HIT, edge; dur=1
content-length
4321
last-modified
Mon, 09 Nov 2020 16:23:48 GMT
server
Akamai Resource Optimizer
etag
"02c739164733a3164294a8737f313c36:1595000956.467317"
vary
User-Agent
content-type
text/css
access-control-allow-origin
*
cache-control
max-age=677081
accept-ranges
bytes
timing-allow-origin
*
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept
expires
Wed, 23 Dec 2020 08:50:17 GMT
fff.css
www.dailymail.co.uk/static/mol-fe/static/mol-fe-fff/1.3.16/styles/
46 KB
8 KB
Stylesheet
General
Full URL
https://www.dailymail.co.uk/static/mol-fe/static/mol-fe-fff/1.3.16/styles/fff.css
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2a02:26f0:6c00:296::11ae , Ascension Island, ASN20940 (AKAMAI-ASN1, EU),
Reverse DNS
Software
Akamai Resource Optimizer /
Resource Hash
01ae4bee7f4b463778e1e929d83b4eedcaf598d05ae8e748030259b5b5f0b083

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:45:36 GMT
content-encoding
br
content-security-policy-report-only
block-all-mixed-content; report-uri https://mol.report-uri.io/r/default/csp/reportOnly
server-timing
cdn-cache; desc=HIT, edge; dur=1
content-length
7921
last-modified
Sat, 24 Oct 2020 12:52:26 GMT
server
Akamai Resource Optimizer
etag
"cf69bb0d655c656383a84adc6fe705c6:1560175753"
vary
User-Agent
content-type
text/css
access-control-allow-origin
*
cache-control
max-age=432665
accept-ranges
bytes
timing-allow-origin
*
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept
expires
Sun, 20 Dec 2020 12:56:41 GMT
v-0.56.min.js
www.dailymail.co.uk/rta2/
15 KB
5 KB
Script
General
Full URL
https://www.dailymail.co.uk/rta2/v-0.56.min.js
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2a02:26f0:6c00:296::11ae , Ascension Island, ASN20940 (AKAMAI-ASN1, EU),
Reverse DNS
Software
Akamai Resource Optimizer /
Resource Hash
7a08a60be43dea8a9d5999a3dac0aa2a72456c2ba1cf11e7763502ac84d99129

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:45:36 GMT
content-encoding
br
content-security-policy-report-only
block-all-mixed-content; report-uri https://mol.report-uri.io/r/default/csp/reportOnly
x-check-cacheable
YES
server
Akamai Resource Optimizer
etag
"59974d80c74b04ca65798afd2166fe6c:1604075542.494144"
vary
User-Agent
content-type
application/x-javascript
cache-control
max-age=1821728
last-modified
Mon, 09 Nov 2020 14:46:45 GMT
server-timing
cdn-cache; desc=HIT, edge; dur=1
accept-ranges
bytes
timing-allow-origin
*
content-length
5023
expires
Tue, 05 Jan 2021 14:47:44 GMT
desktop.js
www.dailymail.co.uk/static/mol-fe/static/mol-fe-sync-bundle/5.9.0/
357 KB
89 KB
Script
General
Full URL
https://www.dailymail.co.uk/static/mol-fe/static/mol-fe-sync-bundle/5.9.0/desktop.js
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2a02:26f0:6c00:296::11ae , Ascension Island, ASN20940 (AKAMAI-ASN1, EU),
Reverse DNS
Software
Akamai Resource Optimizer /
Resource Hash
38bd596c19e49a9f4ddf96fe1592220458baf48f4ecb6398c7efa237fefcb917

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:45:36 GMT
content-encoding
br
content-security-policy-report-only
block-all-mixed-content; report-uri https://mol.report-uri.io/r/default/csp/reportOnly
server-timing
cdn-cache; desc=HIT, edge; dur=1
content-length
90729
last-modified
Wed, 18 Nov 2020 15:01:29 GMT
server
Akamai Resource Optimizer
etag
"028ef1f0a228d430a58072914d37cc73:1605708286.990279"
vary
User-Agent
content-type
application/x-javascript
access-control-allow-origin
*
cache-control
max-age=267347
accept-ranges
bytes
timing-allow-origin
*
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept
expires
Fri, 18 Dec 2020 15:01:23 GMT
mol-adverts.js
www.dailymail.co.uk/static/mol-adverts/demo/mol-22070/19a28e0b/
1 MB
321 KB
Script
General
Full URL
https://www.dailymail.co.uk/static/mol-adverts/demo/mol-22070/19a28e0b/mol-adverts.js
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2a02:26f0:6c00:296::11ae , Ascension Island, ASN20940 (AKAMAI-ASN1, EU),
Reverse DNS
Software
AkamaiNetStorage /
Resource Hash
3623b3438c9edda2eb78d592ba39d5e9a62100c2d0d50df2fed3eb2c5649216f

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:45:36 GMT
content-encoding
gzip
vary
Accept-Encoding, User-Agent
last-modified
Tue, 15 Dec 2020 10:11:28 GMT
server
AkamaiNetStorage
etag
"b5814f41264682f7e322bc33e37f5c2e:1608027088.487051"
content-security-policy-report-only
block-all-mixed-content; report-uri https://mol.report-uri.io/r/default/csp/reportOnly
content-type
application/x-javascript
cache-control
max-age=161
server-timing
cdn-cache; desc=HIT, edge; dur=1
accept-ranges
bytes
timing-allow-origin
*
content-length
327643
expires
Tue, 15 Dec 2020 12:48:17 GMT
articleDefer.js
www.dailymail.co.uk/static/mol-fe/static/mol-fe-async-bundle//6.18.1/
501 KB
116 KB
Script
General
Full URL
https://www.dailymail.co.uk/static/mol-fe/static/mol-fe-async-bundle//6.18.1/articleDefer.js
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2a02:26f0:6c00:296::11ae , Ascension Island, ASN20940 (AKAMAI-ASN1, EU),
Reverse DNS
Software
Akamai Resource Optimizer /
Resource Hash
91339a18fd1dccf876d2c33a52bbf4913c9bf61c802ff5dea3d2246824d69799

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:45:36 GMT
content-encoding
br
content-security-policy-report-only
block-all-mixed-content; report-uri https://mol.report-uri.io/r/default/csp/reportOnly
server-timing
cdn-cache; desc=HIT, edge; dur=2
content-length
117700
last-modified
Thu, 19 Nov 2020 11:11:42 GMT
server
Akamai Resource Optimizer
etag
"5246a0c538708cb10b2613fba743d79c:1605783222.595748"
vary
User-Agent
content-type
application/x-javascript
access-control-allow-origin
*
cache-control
max-age=339918
accept-ranges
bytes
timing-allow-origin
*
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept
expires
Sat, 19 Dec 2020 11:10:54 GMT
async_bundle--.js
www.dailymail.co.uk/static/gunther/17.14.0/
328 KB
84 KB
Script
General
Full URL
https://www.dailymail.co.uk/static/gunther/17.14.0/async_bundle--.js
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2a02:26f0:6c00:296::11ae , Ascension Island, ASN20940 (AKAMAI-ASN1, EU),
Reverse DNS
Software
Akamai Resource Optimizer /
Resource Hash
0c7912ff68380c2a84d28cf812215fb6d230d5750f9f67b328970e01d0da5a37

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:45:36 GMT
content-encoding
br
content-security-policy-report-only
block-all-mixed-content; report-uri https://mol.report-uri.io/r/default/csp/reportOnly
server-timing
cdn-cache; desc=HIT, edge; dur=1
content-length
85559
last-modified
Fri, 18 Sep 2020 02:58:02 GMT
server
Akamai Resource Optimizer
etag
"0620d2935cb03d1451a72e524963ba2d:1595000960.633166"
vary
User-Agent
content-type
application/x-javascript
access-control-allow-origin
*
cache-control
max-age=1952233
accept-ranges
bytes
timing-allow-origin
*
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept
expires
Thu, 07 Jan 2021 03:02:49 GMT
ima3.js
imasdk.googleapis.com/js/sdkloader/
316 KB
109 KB
Script
General
Full URL
https://imasdk.googleapis.com/js/sdkloader/ima3.js
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:825::200a Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
b14abfd75835ce63eab33192177d25b5601c61cf583f5063c793d598e5500282
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:45:36 GMT
content-encoding
gzip
x-content-type-options
nosniff
server
sffe
vary
Accept-Encoding
content-type
text/javascript
cache-control
private, max-age=900, stale-while-revalidate=3600
accept-ranges
bytes
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
111414
x-xss-protection
0
expires
Tue, 15 Dec 2020 12:45:36 GMT
mol-fe-videoplayer.min.css
www.dailymail.co.uk/static/videoplayer/6.11.0-pr-503.2312/styles/
90 KB
11 KB
Stylesheet
General
Full URL
https://www.dailymail.co.uk/static/videoplayer/6.11.0-pr-503.2312/styles/mol-fe-videoplayer.min.css
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2a02:26f0:6c00:296::11ae , Ascension Island, ASN20940 (AKAMAI-ASN1, EU),
Reverse DNS
Software
Akamai Resource Optimizer /
Resource Hash
c64308e6ed3ab4dc8c78868174040d8d09546ea9e6ab19682285a675897edc98

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:45:36 GMT
content-encoding
br
content-security-policy-report-only
block-all-mixed-content; report-uri https://mol.report-uri.io/r/default/csp/reportOnly
server-timing
cdn-cache; desc=HIT, edge; dur=1
content-length
10681
last-modified
Sun, 13 Dec 2020 23:24:47 GMT
server
Akamai Resource Optimizer
etag
"62426632e135cbbb9a89d534c68e342c:1607900148.714095"
vary
User-Agent
content-type
text/css
access-control-allow-origin
*
cache-control
max-age=2457588
accept-ranges
bytes
timing-allow-origin
*
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept
expires
Tue, 12 Jan 2021 23:25:24 GMT
mol-fe-videoplayer.min.js
www.dailymail.co.uk/static/videoplayer/6.11.0-pr-503.2312/scripts/
449 KB
101 KB
Script
General
Full URL
https://www.dailymail.co.uk/static/videoplayer/6.11.0-pr-503.2312/scripts/mol-fe-videoplayer.min.js
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2a02:26f0:6c00:296::11ae , Ascension Island, ASN20940 (AKAMAI-ASN1, EU),
Reverse DNS
Software
Akamai Resource Optimizer /
Resource Hash
5a21c893e4b3515483af9b313ef5ef75526924e820e0a7e42b307b9d697a739d

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:45:36 GMT
content-encoding
br
content-security-policy-report-only
block-all-mixed-content; report-uri https://mol.report-uri.io/r/default/csp/reportOnly
server-timing
cdn-cache; desc=HIT, edge; dur=1
content-length
102455
last-modified
Sun, 13 Dec 2020 23:13:37 GMT
server
Akamai Resource Optimizer
etag
"b2b367f122790c9ffa0832b6b0088133:1607900147.197028"
vary
User-Agent
content-type
application/x-javascript
access-control-allow-origin
*
cache-control
max-age=2456918
accept-ranges
bytes
timing-allow-origin
*
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept
expires
Tue, 12 Jan 2021 23:14:14 GMT
logo_mol.gif
i.dailymail.co.uk/i/sitelogos/
4 KB
4 KB
Image
General
Full URL
https://i.dailymail.co.uk/i/sitelogos/logo_mol.gif
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2a02:26f0:6c00:288::11ae , Ascension Island, ASN20940 (AKAMAI-ASN1, EU),
Reverse DNS
Software
Apache /
Resource Hash
f17cf1cb73dc13f928ef0122375fe550926a471e46d614199bfe8ef69733437a

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:45:36 GMT
last-modified
Tue, 09 Dec 2008 12:49:57 GMT
server
Apache
etag
"258fb3209febe558120d7d564d7422b1:1228827055"
content-type
image/gif
cache-control
max-age=2592000
accept-ranges
bytes
timing-allow-origin
*
content-length
3918
expires
Thu, 14 Jan 2021 12:45:36 GMT
DailyMail.png
i.dailymail.co.uk/i/furniture/facebook/DailyMail/
5 KB
6 KB
Image
General
Full URL
https://i.dailymail.co.uk/i/furniture/facebook/DailyMail/DailyMail.png
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2a02:26f0:6c00:288::11ae , Ascension Island, ASN20940 (AKAMAI-ASN1, EU),
Reverse DNS
Software
AkamaiNetStorage /
Resource Hash
706822fd264da6a7ad6e9763da53c45c0be08913fc51b77a33bad1b4d572c939

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:45:36 GMT
last-modified
Sun, 13 Sep 2020 22:57:02 GMT
server
AkamaiNetStorage
etag
"548b0c6a06ae3744bb1f7567824037ac:1600037822.614521"
content-type
image/png
cache-control
max-age=2592000
accept-ranges
bytes
timing-allow-origin
*
content-length
5504
expires
Thu, 14 Jan 2021 12:45:36 GMT
btn_add-your-comment.png
i.dailymail.co.uk/i/furniture/comments/articles/
1 KB
2 KB
Image
General
Full URL
https://i.dailymail.co.uk/i/furniture/comments/articles/btn_add-your-comment.png
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2a02:26f0:6c00:288::11ae , Ascension Island, ASN20940 (AKAMAI-ASN1, EU),
Reverse DNS
Software
AkamaiNetStorage /
Resource Hash
b6849b99c9da8c60aec9d8fcad58817ef0aabe354e6f9194f24b7e68df71f41a

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:45:36 GMT
last-modified
Mon, 06 Nov 2017 11:57:22 GMT
server
AkamaiNetStorage
etag
"35cf287579c56cfa1b37c7d845558128:1509969442"
content-type
image/png
cache-control
max-age=2592000
accept-ranges
bytes
timing-allow-origin
*
content-length
1349
expires
Thu, 14 Jan 2021 12:45:36 GMT
icon_comments_74.png
i.dailymail.co.uk/i/furniture/comments/articles/
517 B
723 B
Image
General
Full URL
https://i.dailymail.co.uk/i/furniture/comments/articles/icon_comments_74.png
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2a02:26f0:6c00:288::11ae , Ascension Island, ASN20940 (AKAMAI-ASN1, EU),
Reverse DNS
Software
Apache /
Resource Hash
10d217fc2d14b793dd2acba83780093ff88896b4433f7eb36bfc4a220f78350f

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:45:36 GMT
last-modified
Tue, 28 Feb 2017 12:52:27 GMT
server
Apache
etag
"a85bf8e29331cd62725b2bb16387eb8d:1488286347"
content-type
image/png
cache-control
max-age=2592000
accept-ranges
bytes
timing-allow-origin
*
content-length
517
expires
Thu, 14 Jan 2021 12:45:36 GMT
index.css
scripts.dailymail.co.uk/static/mol-fe/static/mol-fe-vouchercodes/3.1.1/
12 KB
2 KB
Stylesheet
General
Full URL
https://scripts.dailymail.co.uk/static/mol-fe/static/mol-fe-vouchercodes/3.1.1/index.css
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2a02:26f0:6c00:288::11ae , Ascension Island, ASN20940 (AKAMAI-ASN1, EU),
Reverse DNS
Software
AkamaiNetStorage /
Resource Hash
100b3faacb4f5fc346251921b1eaf802e9948e497f182783af0e35f9961863bc

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:45:36 GMT
content-encoding
gzip
last-modified
Thu, 14 May 2020 08:52:39 GMT
server
AkamaiNetStorage
etag
"df0637b2a64b87b6cfd4be29c11c324f:1589446359"
vary
Accept-Encoding
content-type
text/css
access-control-allow-origin
*
cache-control
max-age=2592000
accept-ranges
bytes
timing-allow-origin
*
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept
content-length
1839
expires
Thu, 14 Jan 2021 12:45:36 GMT
pixel
ads.creative-serving.com/ul_cb/
Redirect Chain
  • https://ads.creative-serving.com/pixel?id=3140889
  • https://ads.creative-serving.com/ul_cb/pixel?id=3140889
43 B
589 B
Image
General
Full URL
https://ads.creative-serving.com/ul_cb/pixel?id=3140889
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
18.195.7.149 Frankfurt am Main, Germany, ASN16509 (AMAZON-02, US),
Reverse DNS
ec2-18-195-7-149.eu-central-1.compute.amazonaws.com
Software
/
Resource Hash
548f2d6f4d0d820c6c5ffbeffcbd7f0e73193e2932eefe542accc84762deec87

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Date
Tue, 15 Dec 2020 12:45:36 GMT
Cache-Control
no-cache, no-store, must-revalidate
Connection
keep-alive
P3P
CP="NOI DSP COR NID CURa ADMa DEVa PSAa PSDa OUR BUS COM INT OTC PUR STA"
Content-Length
43
Content-Type
image/gif

Redirect headers

Location
https://ads.creative-serving.com/ul_cb/pixel?id=3140889
Date
Tue, 15 Dec 2020 12:45:36 GMT
Cache-Control
no-cache, no-store, must-revalidate
Connection
keep-alive
Content-Length
0
P3P
CP="NOI DSP COR NID CURa ADMa DEVa PSAa PSDa OUR BUS COM INT OTC PUR STA"
wire-36666038-1607567496-261_87x84.jpg
i.dailymail.co.uk/1s/2020/12/10/02/
3 KB
4 KB
Image
General
Full URL
https://i.dailymail.co.uk/1s/2020/12/10/02/wire-36666038-1607567496-261_87x84.jpg
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2a02:26f0:6c00:288::11ae , Ascension Island, ASN20940 (AKAMAI-ASN1, EU),
Reverse DNS
Software
AmazonS3 /
Resource Hash
9ed0d9a45e3ce3a37a3a1fe1470e618951b0d23ed8336659b5be77669641d49e

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

x-amz-version-id
ZTPOwFt1PFI_XyuFbZMpT3NKCGUYLzRV
last-modified
Thu, 10 Dec 2020 02:31:38 GMT
server
AmazonS3
x-amz-request-id
BD8B74432BD57F45
etag
"47bece4065442ee10b4718f1c8a1220a"
content-type
image/jpeg
cache-control
max-age=2592000
date
Tue, 15 Dec 2020 12:45:36 GMT
x-amz-replication-status
COMPLETED
accept-ranges
bytes
timing-allow-origin
*
content-length
3439
x-amz-id-2
9Npndf74WUREeItK8LNXQXyixun+KZzJf94JrkA5lrO2COTqlZCjHaywNvWscePgftqBqrO3QyA=
expires
Thu, 14 Jan 2021 12:45:36 GMT
36828172-0-image-a-8_1607963389043.jpg
i.dailymail.co.uk/1s/2020/12/14/16/
5 KB
5 KB
Image
General
Full URL
https://i.dailymail.co.uk/1s/2020/12/14/16/36828172-0-image-a-8_1607963389043.jpg
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2a02:26f0:6c00:288::11ae , Ascension Island, ASN20940 (AKAMAI-ASN1, EU),
Reverse DNS
Software
AmazonS3 /
Resource Hash
b6c4a7a76de5efeb8579ffe542573f66295ee8f233885bc79e62b9f29b848d32

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

x-amz-version-id
xzINNqTsyAdnp4jKh0qvh0snfjfQfpPL
last-modified
Mon, 14 Dec 2020 16:29:54 GMT
server
AmazonS3
x-amz-request-id
382E610E6F94EFCE
etag
"fa7f26c2294de79dc7e16dd96682233e"
content-type
image/jpeg
cache-control
max-age=2592000
date
Tue, 15 Dec 2020 12:45:36 GMT
x-amz-replication-status
COMPLETED
accept-ranges
bytes
timing-allow-origin
*
content-length
4952
x-amz-id-2
yD4HbHGNPAcTvjs/9ttBaRyCcUlWwsJiuntEwez/T6Y583X00EGd6nemAHwH6hckeRtRoUjIr+0=
expires
Thu, 14 Jan 2021 12:45:36 GMT
36836578-0-image-a-23_1607978667726.jpg
i.dailymail.co.uk/1s/2020/12/14/20/
4 KB
4 KB
Image
General
Full URL
https://i.dailymail.co.uk/1s/2020/12/14/20/36836578-0-image-a-23_1607978667726.jpg
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2a02:26f0:6c00:288::11ae , Ascension Island, ASN20940 (AKAMAI-ASN1, EU),
Reverse DNS
Software
AmazonS3 /
Resource Hash
85a792a4e3c1db0df263a1c5bc2b80c091846cacd77dc8cb997af68760081919

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

x-amz-version-id
dvqVMx7DMwTJIzxlDQfCLtwwpcbhIxZC
last-modified
Mon, 14 Dec 2020 20:44:29 GMT
server
AmazonS3
x-amz-request-id
0D7AE6067352E289
etag
"89fc6eeb7888432d387cfe8a25f3c4df"
content-type
image/jpeg
cache-control
max-age=2592000
date
Tue, 15 Dec 2020 12:45:36 GMT
x-amz-replication-status
COMPLETED
accept-ranges
bytes
timing-allow-origin
*
content-length
4208
x-amz-id-2
C1sJSXHarO+IausYutiy5Ixx7wOwSQCozytiUaujHX8yLIXWAiwMYTecDeARTZty1/P99rh5Zgc=
expires
Thu, 14 Jan 2021 12:45:36 GMT
36837444-0-image-a-7_1607977577625.jpg
i.dailymail.co.uk/1s/2020/12/14/20/
5 KB
5 KB
Image
General
Full URL
https://i.dailymail.co.uk/1s/2020/12/14/20/36837444-0-image-a-7_1607977577625.jpg
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2a02:26f0:6c00:288::11ae , Ascension Island, ASN20940 (AKAMAI-ASN1, EU),
Reverse DNS
Software
AmazonS3 /
Resource Hash
bd05ac1e6cf11ec9d57182c0773eb218ec1983e49eba75f4fbc47a853de3006c

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

x-amz-version-id
ECtteOstVZRe3IYCW8F2e2QfWTJryMMu
last-modified
Mon, 14 Dec 2020 20:26:21 GMT
server
AmazonS3
x-amz-request-id
A22B8AB0A64D3321
etag
"66d926836ad0ba945afcc4cca573b0d2"
content-type
image/jpeg
cache-control
max-age=2592000
date
Tue, 15 Dec 2020 12:45:36 GMT
x-amz-replication-status
COMPLETED
accept-ranges
bytes
timing-allow-origin
*
content-length
4638
x-amz-id-2
4VYxIAcIypcQHeuZZT8i2JnEHLxIJOLN+E/Lko+joVejC0Q1lQ+O1S1dUGaXk+4Yg3qQQOtvZ3w=
expires
Thu, 14 Jan 2021 12:45:36 GMT
36830554-0-image-m-29_1607965874299.jpg
i.dailymail.co.uk/1s/2020/12/14/17/
3 KB
4 KB
Image
General
Full URL
https://i.dailymail.co.uk/1s/2020/12/14/17/36830554-0-image-m-29_1607965874299.jpg
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2a02:26f0:6c00:288::11ae , Ascension Island, ASN20940 (AKAMAI-ASN1, EU),
Reverse DNS
Software
AmazonS3 /
Resource Hash
cd74edb32efde8fe026b88cc510296e7d7988274d731561c3fd61caebd825e9b

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

x-amz-version-id
X5zChIBWsg.rSkYy3Mudm01ly.xdXcDB
last-modified
Mon, 14 Dec 2020 17:11:23 GMT
server
AmazonS3
x-amz-request-id
6FD2E89F01EDDBC3
etag
"ea910fb9bbb9f01970eab6c8e00218e0"
content-type
image/jpeg
cache-control
max-age=2592000
date
Tue, 15 Dec 2020 12:45:36 GMT
x-amz-replication-status
COMPLETED
accept-ranges
bytes
timing-allow-origin
*
content-length
3397
x-amz-id-2
p1lMSitFSLkosr01zo/eox9hAkY8uLIMPNUo35cHxxbL8RA4cBCcb6DBpfroXvovz4ug6PMIEeo=
expires
Thu, 14 Jan 2021 12:45:36 GMT
36831966-0-image-a-16_1607966538962.jpg
i.dailymail.co.uk/1s/2020/12/14/17/
2 KB
2 KB
Image
General
Full URL
https://i.dailymail.co.uk/1s/2020/12/14/17/36831966-0-image-a-16_1607966538962.jpg
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2a02:26f0:6c00:288::11ae , Ascension Island, ASN20940 (AKAMAI-ASN1, EU),
Reverse DNS
Software
AmazonS3 /
Resource Hash
23dd4feae622db63eacd52142fbde329e221ddc51b8f6586ba50a98bc3da64c5

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

x-amz-version-id
RoQYTbpXMhdolmpqIb1okt.Ga6nu30o.
last-modified
Mon, 14 Dec 2020 17:22:20 GMT
server
AmazonS3
x-amz-request-id
AF29C53BE9412AA6
etag
"f716c05556c5158849b774b16e67ea41"
content-type
image/jpeg
cache-control
max-age=2592000
date
Tue, 15 Dec 2020 12:45:36 GMT
x-amz-replication-status
COMPLETED
accept-ranges
bytes
timing-allow-origin
*
content-length
2085
x-amz-id-2
Dpap/13aEgBJqr1MR1z+Lj1aCf6/5z7SGPUeRU++SI0eo7vBXupPxlXqjlAXriAg7WYxgy4G4Pc=
expires
Thu, 14 Jan 2021 12:45:36 GMT
36822432-0-image-a-7_1607951289791.jpg
i.dailymail.co.uk/1s/2020/12/14/13/
3 KB
4 KB
Image
General
Full URL
https://i.dailymail.co.uk/1s/2020/12/14/13/36822432-0-image-a-7_1607951289791.jpg
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2a02:26f0:6c00:288::11ae , Ascension Island, ASN20940 (AKAMAI-ASN1, EU),
Reverse DNS
Software
AmazonS3 /
Resource Hash
e9d3f78a91e7a061e841d8df627f663327abddc894c843efca7136e670f579dc

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

x-amz-version-id
hFpJzCMF0ZljmQAIySe0Jt09Awv0MMMV
last-modified
Mon, 14 Dec 2020 13:08:10 GMT
server
AmazonS3
x-amz-request-id
EB4356398E7F98BF
etag
"c749349eec6322d882c52b5a2bec523f"
content-type
image/jpeg
cache-control
max-age=2592000
date
Tue, 15 Dec 2020 12:45:36 GMT
x-amz-replication-status
COMPLETED
accept-ranges
bytes
timing-allow-origin
*
content-length
3228
x-amz-id-2
EXxeXcdp0CmxrDGQAByidMcOwLGtHOWQRtoD/8mcPri+7fy8nn3v2Si5lTCOzwd7riglG2m764U=
expires
Thu, 14 Jan 2021 12:45:36 GMT
36830970-0-image-m-14_1607964912819.jpg
i.dailymail.co.uk/1s/2020/12/14/16/
1 KB
2 KB
Image
General
Full URL
https://i.dailymail.co.uk/1s/2020/12/14/16/36830970-0-image-m-14_1607964912819.jpg
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2a02:26f0:6c00:288::11ae , Ascension Island, ASN20940 (AKAMAI-ASN1, EU),
Reverse DNS
Software
AmazonS3 /
Resource Hash
4c3f356fde98236d17b8b57d7fd036f2f8b271380b0b55db958ebc34ef7517be

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

x-amz-version-id
mmwWwDZ1pgKtO.3S0KcosW7o2IgHDz.T
last-modified
Mon, 14 Dec 2020 16:55:18 GMT
server
AmazonS3
x-amz-request-id
C88FAE0C70F273E9
etag
"11ea6fa17b2fd187cb48a1dbd889d430"
content-type
image/jpeg
cache-control
max-age=2592000
date
Tue, 15 Dec 2020 12:45:36 GMT
x-amz-replication-status
COMPLETED
accept-ranges
bytes
timing-allow-origin
*
content-length
1355
x-amz-id-2
3cmDFLArYtXYkh/WtWHkOIhxyHD9b11WODITOugNl5qOUcrWg7+Mp+ECWSJRuuFfnWWTSo55APM=
expires
Thu, 14 Jan 2021 12:45:36 GMT
36833232-0-image-m-4_1607968512524.jpg
i.dailymail.co.uk/1s/2020/12/14/17/
3 KB
4 KB
Image
General
Full URL
https://i.dailymail.co.uk/1s/2020/12/14/17/36833232-0-image-m-4_1607968512524.jpg
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2a02:26f0:6c00:288::11ae , Ascension Island, ASN20940 (AKAMAI-ASN1, EU),
Reverse DNS
Software
AmazonS3 /
Resource Hash
255fedf22da697ef2b26db0b3ab414d109d0b9982135378e925565e69d3bfc5b

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

x-amz-version-id
Dtk0j6x9qislDZ.7VYcXxRDy8Kwf.Pkv
last-modified
Mon, 14 Dec 2020 17:55:25 GMT
server
AmazonS3
x-amz-request-id
01C0580D76E527BA
etag
"ba8c705f46322c750604d4e1187e55c8"
content-type
image/jpeg
cache-control
max-age=2592000
date
Tue, 15 Dec 2020 12:45:36 GMT
x-amz-replication-status
COMPLETED
accept-ranges
bytes
timing-allow-origin
*
content-length
3578
x-amz-id-2
iDe/DI8VH8tyGtpMpvDtkTfD2ELSiTyH9hCo+5SyFmvsrWv9RALTH3j4grjffGIREvPgjyP3wRM=
expires
Thu, 14 Jan 2021 12:45:36 GMT
36828788-0-image-m-22_1607961742756.jpg
i.dailymail.co.uk/1s/2020/12/14/16/
2 KB
2 KB
Image
General
Full URL
https://i.dailymail.co.uk/1s/2020/12/14/16/36828788-0-image-m-22_1607961742756.jpg
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2a02:26f0:6c00:288::11ae , Ascension Island, ASN20940 (AKAMAI-ASN1, EU),
Reverse DNS
Software
AmazonS3 /
Resource Hash
c503edc50146e501269d073b7bd9c28a31f20be7558c8287a6085c624993ad0a

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

x-amz-version-id
.wHFPELWUG6RWF2MpSh0e1Tdn7Pt0Kan
last-modified
Mon, 14 Dec 2020 16:02:29 GMT
server
AmazonS3
x-amz-request-id
9FB86E27FCD68660
etag
"c605f9ae56edf3dda4a0f3140f9b1dbf"
content-type
image/jpeg
cache-control
max-age=2592000
date
Tue, 15 Dec 2020 12:45:36 GMT
x-amz-replication-status
COMPLETED
accept-ranges
bytes
timing-allow-origin
*
content-length
2156
x-amz-id-2
J0BBgLcujOCUOC3rHQCthRc8as5n6zqWO1AUHVFE0e7+agRhXMcht1dHZsuk2tY29QXbExStEtY=
expires
Thu, 14 Jan 2021 12:45:36 GMT
36830310-0-image-a-9_1607964220496.jpg
i.dailymail.co.uk/1s/2020/12/14/16/
3 KB
3 KB
Image
General
Full URL
https://i.dailymail.co.uk/1s/2020/12/14/16/36830310-0-image-a-9_1607964220496.jpg
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2a02:26f0:6c00:288::11ae , Ascension Island, ASN20940 (AKAMAI-ASN1, EU),
Reverse DNS
Software
AmazonS3 /
Resource Hash
fb13088df0fc04523af2442780eec3f56cfd8e141ce62bbe36e00a893f2e1372

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

x-amz-version-id
lCo470FfGBn6PJeEJDnTYyHLtvQZTfAo
last-modified
Mon, 14 Dec 2020 16:43:41 GMT
server
AmazonS3
x-amz-request-id
8668EC768BDD88FF
etag
"08ea1d30b95d71e562f3dee374ab493f"
content-type
image/jpeg
cache-control
max-age=2592000
date
Tue, 15 Dec 2020 12:45:36 GMT
x-amz-replication-status
COMPLETED
accept-ranges
bytes
timing-allow-origin
*
content-length
2699
x-amz-id-2
LgrdMuxCXu2iu1DuueZl7qA1GzjiC6sEHf2puU+P4JXUft8WSSGys5rBQuy85y02ASrgri0lZw0=
expires
Thu, 14 Jan 2021 12:45:36 GMT
36820590-0-image-m-9_1607949226305.jpg
i.dailymail.co.uk/1s/2020/12/14/12/
7 KB
7 KB
Image
General
Full URL
https://i.dailymail.co.uk/1s/2020/12/14/12/36820590-0-image-m-9_1607949226305.jpg
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2a02:26f0:6c00:288::11ae , Ascension Island, ASN20940 (AKAMAI-ASN1, EU),
Reverse DNS
Software
AmazonS3 /
Resource Hash
196bd5161ac3b53b38293d9c18cae0ab1841bc58efe96a1ee28f1d559bed6b89

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

x-amz-version-id
dxWQDDS0uPoTAFopQnZ3qDAHgHmXj_JN
last-modified
Mon, 14 Dec 2020 12:34:00 GMT
server
AmazonS3
x-amz-request-id
1DC0F24F47613B09
etag
"3318823d5ed0ee279e0d2bc715cea61f"
content-type
image/jpeg
cache-control
max-age=2592000
date
Tue, 15 Dec 2020 12:45:36 GMT
x-amz-replication-status
COMPLETED
accept-ranges
bytes
timing-allow-origin
*
content-length
6865
x-amz-id-2
0gxGiFIoExHiOMKQ8NmJnn9AucNsyBwLZk7s5WwBF7pwM7W/0B+kRMVZOmL7XF3Zoi2YJA1K9RU=
expires
Thu, 14 Jan 2021 12:45:36 GMT
33571772-0-There_was_more_activity_in_the_brains_of_newborn_babies_in_react-m-14_1607953109922.jpg
i.dailymail.co.uk/1s/2020/12/14/13/
3 KB
3 KB
Image
General
Full URL
https://i.dailymail.co.uk/1s/2020/12/14/13/33571772-0-There_was_more_activity_in_the_brains_of_newborn_babies_in_react-m-14_1607953109922.jpg
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2a02:26f0:6c00:288::11ae , Ascension Island, ASN20940 (AKAMAI-ASN1, EU),
Reverse DNS
Software
AmazonS3 /
Resource Hash
cfe608e6487da8145e7e48a975cb6f5ebb858b05d5f96f3ffcf499bfba3a7ee9

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

x-amz-version-id
EG8U7bz25K5azOVw53OtVqBAndEid4CQ
last-modified
Mon, 14 Dec 2020 13:38:42 GMT
server
AmazonS3
x-amz-request-id
32183099A36BD7A7
etag
"f8a9b170f697b2dbaeac42b696f4030f"
content-type
image/jpeg
cache-control
max-age=2592000
date
Tue, 15 Dec 2020 12:45:36 GMT
x-amz-replication-status
COMPLETED
accept-ranges
bytes
timing-allow-origin
*
content-length
2767
x-amz-id-2
jgkenUhIVCcIiFhuyPHnRJIK45NP3PChsKHAXE40Q5SmVL80rwq6Jv/dQJKzqJk8U3px38tta2w=
expires
Thu, 14 Jan 2021 12:45:36 GMT
36820434-0-image-m-15_1607947303994.jpg
i.dailymail.co.uk/1s/2020/12/14/12/
2 KB
3 KB
Image
General
Full URL
https://i.dailymail.co.uk/1s/2020/12/14/12/36820434-0-image-m-15_1607947303994.jpg
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2a02:26f0:6c00:288::11ae , Ascension Island, ASN20940 (AKAMAI-ASN1, EU),
Reverse DNS
Software
AmazonS3 /
Resource Hash
5232b69e435e6251aa60156bf9c0ec5b223005ad3f19265fdbc426decae2344c

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

x-amz-version-id
x.5g1HGYuzqz8TAGFr00TrBfZqq9O.Fk
last-modified
Mon, 14 Dec 2020 12:01:53 GMT
server
AmazonS3
x-amz-request-id
F747A17DC4A987F9
etag
"41b0f0d3e19cf4af12f8b25683d4e7bd"
content-type
image/jpeg
cache-control
max-age=2592000
date
Tue, 15 Dec 2020 12:45:36 GMT
x-amz-replication-status
COMPLETED
accept-ranges
bytes
timing-allow-origin
*
content-length
2439
x-amz-id-2
/vxpW16B9uX19jdwr7J3Xjhh64n4vzWlSdrjf5KcXuiovEitEdXXbmuMOY2yMTv4rFSrcgTCPjM=
expires
Thu, 14 Jan 2021 12:45:36 GMT
36817660-0-image-m-5_1607942891119.jpg
i.dailymail.co.uk/1s/2020/12/14/10/
2 KB
3 KB
Image
General
Full URL
https://i.dailymail.co.uk/1s/2020/12/14/10/36817660-0-image-m-5_1607942891119.jpg
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2a02:26f0:6c00:288::11ae , Ascension Island, ASN20940 (AKAMAI-ASN1, EU),
Reverse DNS
Software
AmazonS3 /
Resource Hash
be9bd032888981008418da966f5f6dd986a9b491a54506dd1a7a308c3eaceaed

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

x-amz-version-id
8LBIxNn6avhYU1TmTkCY0FmnU3RkyAwP
last-modified
Mon, 14 Dec 2020 10:48:17 GMT
server
AmazonS3
x-amz-request-id
D264CE7B22D5A034
etag
"15b81fb0232e88f606f8802374d84d29"
content-type
image/jpeg
cache-control
max-age=2592000
date
Tue, 15 Dec 2020 12:45:36 GMT
x-amz-replication-status
COMPLETED
accept-ranges
bytes
timing-allow-origin
*
content-length
2404
x-amz-id-2
Q8wVkh2sOohDu0M6bD7SKS+rok52R5J7h7JLLP33RCN2H8AGLN8NZTvumS8LnWHhHGBfILCGrK0=
expires
Thu, 14 Jan 2021 12:45:36 GMT
iphone_ad_308x111.jpg
i.dailymail.co.uk/i/pix/promoboxes/
18 KB
18 KB
Image
General
Full URL
https://i.dailymail.co.uk/i/pix/promoboxes/iphone_ad_308x111.jpg
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2a02:26f0:6c00:288::11ae , Ascension Island, ASN20940 (AKAMAI-ASN1, EU),
Reverse DNS
Software
AkamaiNetStorage /
Resource Hash
f744634b59058c2fa455853051f7d7cbea03c40a79a2c822e25a22cba5d82316

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:45:36 GMT
last-modified
Tue, 20 Dec 2011 15:43:09 GMT
server
AkamaiNetStorage
etag
"d0cc3541816686ffa19219c42f0bf076:1324395789"
content-type
image/jpeg
cache-control
max-age=2592000
accept-ranges
bytes
timing-allow-origin
*
content-length
18253
expires
Thu, 14 Jan 2021 12:45:36 GMT
ebayUSandGermany_308x111.jpg
i.dailymail.co.uk/i/pix/ebay/
18 KB
18 KB
Image
General
Full URL
https://i.dailymail.co.uk/i/pix/ebay/ebayUSandGermany_308x111.jpg
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2a02:26f0:6c00:288::11ae , Ascension Island, ASN20940 (AKAMAI-ASN1, EU),
Reverse DNS
Software
AkamaiNetStorage /
Resource Hash
19ee7648c66c9ee28c12dda0bf54e77586ca87c7e056d91d17cb7f45f4e11fd5

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:45:36 GMT
last-modified
Tue, 21 Aug 2012 06:55:37 GMT
server
AkamaiNetStorage
etag
"c58f0f4aacc46b045e1aacd3dcbfd38e:1345532137"
content-type
image/jpeg
cache-control
max-age=2592000
accept-ranges
bytes
timing-allow-origin
*
content-length
18143
expires
Thu, 14 Jan 2021 12:45:36 GMT
bn_michaelhanlon_308x76.jpg
i.dailymail.co.uk/i/pix/blogs/
14 KB
14 KB
Image
General
Full URL
https://i.dailymail.co.uk/i/pix/blogs/bn_michaelhanlon_308x76.jpg
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2a02:26f0:6c00:288::11ae , Ascension Island, ASN20940 (AKAMAI-ASN1, EU),
Reverse DNS
Software
Apache /
Resource Hash
aa42e91b61ad52d2fe90951063eb3926346fb39f42fcfd9722c44a0f076995a4

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:45:36 GMT
last-modified
Tue, 15 Feb 2011 16:40:11 GMT
server
Apache
etag
"1f65f9cb53bdf8c92f6261d0c841b26f:1297788011"
content-type
image/jpeg
cache-control
max-age=2592000
accept-ranges
bytes
timing-allow-origin
*
content-length
14387
expires
Thu, 14 Jan 2021 12:45:36 GMT
argos_9.png
d3tsytm1wtjqo2.cloudfront.net/180x/images/a/
3 KB
4 KB
Image
General
Full URL
https://d3tsytm1wtjqo2.cloudfront.net/180x/images/a/argos_9.png
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2600:9000:2156:4200:1:91d6:b080:21 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
nginx/1.12.1 /
Resource Hash
a4d997cd946ba1053d2915c8d762ad2a650705d2b92c7ca4ddfc51337052cc24

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Mon, 14 Dec 2020 16:41:49 GMT
via
1.1 d627b75d0c1aedd3691390ac8498d3b0.cloudfront.net (CloudFront)
server
nginx/1.12.1
age
72227
etag
"1d8a85982ac6f5d4058f8157b37565897502b868"
vary
Accept
x-cache
Hit from cloudfront
content-type
image/webp
cache-control
max-age=86400,public
x-amz-cf-pop
FRA50-C1
content-length
3342
x-amz-cf-id
LtsKqO-38Mb4fZhpxhv1L4LyeFQ0JbKou6iNPU9Bht-eZtCtK6atKA==
expires
Tue, 15 Dec 2020 16:41:49 GMT
AO_9.png
d3tsytm1wtjqo2.cloudfront.net/images/media/72/a/
2 KB
2 KB
Image
General
Full URL
https://d3tsytm1wtjqo2.cloudfront.net/images/media/72/a/AO_9.png
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2600:9000:2156:4200:1:91d6:b080:21 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
nginx/1.12.1 /
Resource Hash
466597f6c1aceaf97413759997defb334bf5ed7f70244ee967e5c9868ceee094

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 06:42:01 GMT
via
1.1 d627b75d0c1aedd3691390ac8498d3b0.cloudfront.net (CloudFront)
server
nginx/1.12.1
age
21815
etag
"d8c63d90b548f625706c2d42e013fdfdef7749c1"
vary
Accept
x-cache
Hit from cloudfront
content-type
image/webp
cache-control
max-age=86400,public
x-amz-cf-pop
FRA50-C1
content-length
1662
x-amz-cf-id
xoSLLWBa9UfPVtuXn5RDHzL9hb6dRg_XtJ5iPvUJebGDUcLexN84Gg==
expires
Wed, 16 Dec 2020 06:42:01 GMT
bq-discount-code_9.png
d3tsytm1wtjqo2.cloudfront.net/150x/images/b/
1 KB
2 KB
Image
General
Full URL
https://d3tsytm1wtjqo2.cloudfront.net/150x/images/b/bq-discount-code_9.png
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2600:9000:2156:4200:1:91d6:b080:21 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
nginx/1.12.1 /
Resource Hash
f99c74752a26095daefffa7a738fc2b0de872c1bc7d302bd43bd208e30123be3

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 08:39:51 GMT
via
1.1 d627b75d0c1aedd3691390ac8498d3b0.cloudfront.net (CloudFront)
server
nginx/1.12.1
age
14745
etag
"95906087f2aea3576c071b3539d7445f0c4eab15"
vary
Accept
x-cache
Hit from cloudfront
content-type
image/webp
cache-control
max-age=86400,public
x-amz-cf-pop
FRA50-C1
content-length
1226
x-amz-cf-id
_XF2szZZnM8Nr_ZaEJiNeAYA3IqCf95iOigF4x5nZzEPZmpMD13dhQ==
expires
Wed, 16 Dec 2020 08:39:51 GMT
ebayJAN2020logo_9.png
d3tsytm1wtjqo2.cloudfront.net/180x/images/e/
2 KB
2 KB
Image
General
Full URL
https://d3tsytm1wtjqo2.cloudfront.net/180x/images/e/ebayJAN2020logo_9.png
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2600:9000:2156:4200:1:91d6:b080:21 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
nginx/1.12.1 /
Resource Hash
b1f18ada6ab967638a22a5311419ef4418ea1e9e18c848fa0aee688825dc49fa

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 08:39:51 GMT
via
1.1 d627b75d0c1aedd3691390ac8498d3b0.cloudfront.net (CloudFront)
server
nginx/1.12.1
age
14745
etag
"12234a02a53d66bb7be0279ea5c69c26160f2d6c"
vary
Accept
x-cache
Hit from cloudfront
content-type
image/webp
cache-control
max-age=86400,public
x-amz-cf-pop
FRA50-C1
content-length
2138
x-amz-cf-id
NFx1jG2Ssvab7umEBGfAb1XTQnckbdeHXfNKfUslYVnw2XWVKwQh8A==
expires
Wed, 16 Dec 2020 08:39:51 GMT
verylogo_9.png
d3tsytm1wtjqo2.cloudfront.net/150x/images/v/
1 KB
2 KB
Image
General
Full URL
https://d3tsytm1wtjqo2.cloudfront.net/150x/images/v/verylogo_9.png
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2600:9000:2156:4200:1:91d6:b080:21 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
nginx/1.12.1 /
Resource Hash
0c757241644e8278b2e3643da1277e023aa3189172cde6d36516fe5729247f5e

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 04:43:30 GMT
via
1.1 d627b75d0c1aedd3691390ac8498d3b0.cloudfront.net (CloudFront)
server
nginx/1.12.1
age
28926
etag
"3c689fc65fdfb66a4397f98c184c7d09f621656b"
vary
Accept
x-cache
Hit from cloudfront
content-type
image/webp
cache-control
max-age=86400,public
x-amz-cf-pop
FRA50-C1
content-length
1412
x-amz-cf-id
Fe6ggBYwK-6O4Hmuc5gAen09JZWn2gsMoiyRLb6NcHh6vP0mIKH89Q==
expires
Wed, 16 Dec 2020 04:43:30 GMT
wayfair-discount-code_9.png
d3tsytm1wtjqo2.cloudfront.net/180x/images/w/
2 KB
3 KB
Image
General
Full URL
https://d3tsytm1wtjqo2.cloudfront.net/180x/images/w/wayfair-discount-code_9.png
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2600:9000:2156:4200:1:91d6:b080:21 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
nginx/1.12.1 /
Resource Hash
f657f517ee764727ecc6e8d119035bb3e750a9680aaf7a533a33f2525cb0284c

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Mon, 14 Dec 2020 22:46:05 GMT
via
1.1 d627b75d0c1aedd3691390ac8498d3b0.cloudfront.net (CloudFront)
server
nginx/1.12.1
age
50371
etag
"e2fe3865901182a19a0e804b803c15c5b0fff81f"
vary
Accept
x-cache
Hit from cloudfront
content-type
image/webp
cache-control
max-age=86400,public
x-amz-cf-pop
FRA50-C1
content-length
2452
x-amz-cf-id
rIF4iutjhdI-GBD-jDO-eRqOY5QXecQnNOjWeRUbYcfmTav_3T-WZw==
expires
Tue, 15 Dec 2020 22:46:05 GMT
36801520-0-image-m-47_1607901989700.jpg
i.dailymail.co.uk/1s/2020/12/13/23/
5 KB
5 KB
Image
General
Full URL
https://i.dailymail.co.uk/1s/2020/12/13/23/36801520-0-image-m-47_1607901989700.jpg
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2a02:26f0:6c00:288::11ae , Ascension Island, ASN20940 (AKAMAI-ASN1, EU),
Reverse DNS
Software
AmazonS3 /
Resource Hash
7f8d5f84ab7ccf51fcc7b37e0a719ea5bfba9f537b76954dc6c675ce701367c3

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

x-amz-version-id
RUwlDQioz8hXUX8JHM9.HhFpA_lQrxmb
last-modified
Sun, 13 Dec 2020 23:27:26 GMT
server
AmazonS3
x-amz-request-id
229587DFF6004005
etag
"3f77c323ea9bc82401859812f367f0b7"
content-type
image/jpeg
cache-control
max-age=2592000
date
Tue, 15 Dec 2020 12:45:36 GMT
x-amz-replication-status
COMPLETED
accept-ranges
bytes
timing-allow-origin
*
content-length
4853
x-amz-id-2
S57XFGytFUtD0mqMC9yAZkWp0yWLWUW+GyduH61Kytklfg5QKgSD4yyMVW/uQ1gssr475AJGNRk=
expires
Thu, 14 Jan 2021 12:45:36 GMT
fff.js
www.dailymail.co.uk/static/mol-fe/static/mol-fe-fff/1.3.16/scripts/
119 KB
35 KB
Script
General
Full URL
https://www.dailymail.co.uk/static/mol-fe/static/mol-fe-fff/1.3.16/scripts/fff.js
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2a02:26f0:6c00:296::11ae , Ascension Island, ASN20940 (AKAMAI-ASN1, EU),
Reverse DNS
Software
Akamai Resource Optimizer /
Resource Hash
835f1dfc4109c578b77ba1b24a70cf3c07e73440aa65a94c329c29f763423bc5

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:45:36 GMT
content-encoding
br
content-security-policy-report-only
block-all-mixed-content; report-uri https://mol.report-uri.io/r/default/csp/reportOnly
server-timing
cdn-cache; desc=HIT, edge; dur=1
content-length
35222
last-modified
Mon, 26 Oct 2020 00:49:53 GMT
server
Akamai Resource Optimizer
etag
"eea372bce8ac8e188267c4751ef1d05a:1560175752"
vary
User-Agent
content-type
application/x-javascript
access-control-allow-origin
*
cache-control
max-age=561984
accept-ranges
bytes
timing-allow-origin
*
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept
expires
Tue, 22 Dec 2020 00:52:00 GMT
logo_cookie_reg.png
i.dailymail.co.uk/i/furniture/misc/
189 B
394 B
Image
General
Full URL
https://i.dailymail.co.uk/i/furniture/misc/logo_cookie_reg.png
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2a02:26f0:6c00:288::11ae , Ascension Island, ASN20940 (AKAMAI-ASN1, EU),
Reverse DNS
Software
Apache /
Resource Hash
2f59ac8dad7d832c75edc7cf917c512a3788d03ce0862b38c1bfccc54eb01d10

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:45:36 GMT
last-modified
Mon, 06 Nov 2017 11:54:00 GMT
server
Apache
etag
"2c776973168421488cd8ba0f131ef7f4:1509969240"
content-type
image/png
cache-control
max-age=2592000
accept-ranges
bytes
timing-allow-origin
*
content-length
189
expires
Thu, 14 Jan 2021 12:45:36 GMT
door.js
uk-script.dotmetrics.net/
7 KB
3 KB
Script
General
Full URL
https://uk-script.dotmetrics.net/door.js?d=www.dailymail.co.uk&t=sciencetech
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
65.9.68.128 Seattle, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
Kestrel /
Resource Hash
18c1aa64fce13d9853ebe39604d37bf9f916895375375331db69bf18f835f26a

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:45:36 GMT
content-encoding
br
server
Kestrel
x-amz-cf-pop
FRA56-C1
etag
".www.dailymail.co.uk.sciencetech.175.2020121512"
vary
Accept-Encoding
x-cache
Miss from cloudfront
p3p
policyref="https://uk-script.dotmetrics.net/w3c/p3p.xml", CP="NOI DSP LAW CURa ADMa DEVa PSAa HISa OUR IND STA"
via
1.1 9570c3a1725c20e6faed117bbb74223b.cloudfront.net (CloudFront)
cache-control
private
content-type
application/javascript
x-amz-cf-id
307c9VkWmT-w9qGx9uH8StJIMP5bzygRzQyh8CF4BYPUIGSvKER-Xw==
sa
ted.dailymail.co.uk/s/
229 B
776 B
XHR
General
Full URL
https://ted.dailymail.co.uk/s/sa
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/rta2/v-0.56.min.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
2a02:26f0:6c00:2be::16c2 , Ascension Island, ASN20940 (AKAMAI-ASN1, EU),
Reverse DNS
Software
/
Resource Hash
945ea3d2f198055ba4358797510aab0d9130b66bb682820ffbcc72e60a6b6608

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type
text/plain;charset=UTF-8

Response headers

date
Tue, 15 Dec 2020 12:45:36 GMT
content-type
application/json
access-control-allow-origin
https://www.dailymail.co.uk
expires
Tue, 15 Dec 2020 12:45:36 GMT
cache-control
private, no-cache, proxy-revalidate
access-control-allow-credentials
true
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, documentReferer
content-length
229
x-rs-ops
rta2-rufus-a2-fe.hsk.mol.dmgt.net:8180
sa
t.dailymail.co.uk/s/
232 B
774 B
XHR
General
Full URL
https://t.dailymail.co.uk/s/sa
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/rta2/v-0.56.min.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
2a02:26f0:6c00:2be::16c2 , Ascension Island, ASN20940 (AKAMAI-ASN1, EU),
Reverse DNS
Software
/
Resource Hash
5ecbc86937c3e89bac2b4d9197ac95e65c70ca585360806775a2e5063a1c7fbe

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type
text/plain;charset=UTF-8

Response headers

date
Tue, 15 Dec 2020 12:45:36 GMT
content-type
application/json
access-control-allow-origin
https://www.dailymail.co.uk
expires
Tue, 15 Dec 2020 12:45:36 GMT
cache-control
private, no-cache, proxy-revalidate
access-control-allow-credentials
true
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, documentReferer
content-length
232
x-rs-ops
rta2-rufus-c1-fe.rdg.mol.dmgt.net:8180
r2
sb.scorecardresearch.com/
Redirect Chain
  • https://swa.and.co.uk/b/ss/anddailymailprod/1/JS-2.9.0/s23780526227545?AQB=1&ndh=1&pf=1&t=15%2F11%2F2020%2013%3A45%3A36%202%20-60&fid=22FC5A865EEA46B9-24230C8B867AAA46&ce=iso-8859-1&ns=associatedno...
  • https://swa.and.co.uk/b/ss/anddailymailprod/1/JS-2.9.0/s23780526227545?AQB=1&pccr=true&vidn=2FEC57F80515EB81-60000ACAE7ED7EC5&ndh=1&pf=1&t=15%2F11%2F2020%2013%3A45%3A36%202%20-60&fid=22FC5A865EEA46...
  • https://sb.scorecardresearch.com/r?c2=6034964&d.c=gif&d.o=anddailymailprod&d.x=3020351672&d.t=page&d.u=https%3A%2F%2Fwww.dailymail.co.uk%2Fsciencetech%2Farticle-9050821%2FRemdesivir-beneficial-pati...
  • https://sb.scorecardresearch.com/r2?c2=6034964&d.c=gif&d.o=anddailymailprod&d.x=3020351672&d.t=page&d.u=https%3A%2F%2Fwww.dailymail.co.uk%2Fsciencetech%2Farticle-9050821%2FRemdesivir-beneficial-pat...
43 B
589 B
Image
General
Full URL
https://sb.scorecardresearch.com/r2?c2=6034964&d.c=gif&d.o=anddailymailprod&d.x=3020351672&d.t=page&d.u=https%3A%2F%2Fwww.dailymail.co.uk%2Fsciencetech%2Farticle-9050821%2FRemdesivir-beneficial-patients-doctors-reveal.html%3F_hsmi%3D88974744%26_hsenc%3Dp2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8&cs_ak_ss=1
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_256_GCM
Server
104.111.238.139 , Netherlands, ASN16625 (AKAMAI-AS, US),
Reverse DNS
a104-111-238-139.deploy.static.akamaitechnologies.com
Software
/
Resource Hash
24e480e4659fbae818853a38f8a3036f529f539024dc3e772c0b594ce02ea9db

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Pragma
no-cache
Date
Tue, 15 Dec 2020 12:45:37 GMT
Cache-Control
private, no-cache, no-cache=Set-Cookie, no-store, proxy-revalidate
Connection
keep-alive
Content-Type
image/gif
Content-Length
43
Expires
Mon, 01 Jan 1990 00:00:00 GMT

Redirect headers

Location
https://sb.scorecardresearch.com/r2?c2=6034964&d.c=gif&d.o=anddailymailprod&d.x=3020351672&d.t=page&d.u=https%3A%2F%2Fwww.dailymail.co.uk%2Fsciencetech%2Farticle-9050821%2FRemdesivir-beneficial-patients-doctors-reveal.html%3F_hsmi%3D88974744%26_hsenc%3Dp2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8&cs_ak_ss=1
Pragma
no-cache
Date
Tue, 15 Dec 2020 12:45:37 GMT
Cache-Control
private, no-cache, no-cache=Set-Cookie, no-store, proxy-revalidate
Connection
keep-alive
Content-Length
0
Expires
Mon, 01 Jan 1990 00:00:00 GMT
register.js
hulkprod.anm.co.uk/api/web-push-notification/v1/static/latest/mol-fe-web-push-browser-register/
55 KB
12 KB
Script
General
Full URL
https://hulkprod.anm.co.uk/api/web-push-notification/v1/static/latest/mol-fe-web-push-browser-register/register.js
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/static/mol-fe/static/mol-fe-sync-bundle/5.9.0/desktop.js
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2a02:26f0:6c00::210:bb21 , Ascension Island, ASN20940 (AKAMAI-ASN1, EU),
Reverse DNS
Software
/
Resource Hash
0b2cc81f0d413537e2d91883bd3389eb3b6055954cbd6b9b69a71706e7ed6f47

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

x-rs-ops
mol-fe-web-push-notification-a3-fe:8080
date
Tue, 15 Dec 2020 12:45:36 GMT
content-encoding
gzip
vary
Accept-Encoding
access-control-allow-methods
GET, POST, OPTIONS, DELETE, PATCH
content-type
application/javascript; charset=UTF-8
access-control-allow-origin
*
cache-control
private, no-cache
accept-ranges
bytes
access-control-allow-headers
X-Requested-With, X-HTTP-Method-Override, Content-Type, Accept, Authorization
content-length
11443
service-worker-allowed
/
expires
Tue, 15 Dec 2020 12:45:36 GMT
sync
sync.sxp.smartclip.net/
Redirect Chain
  • https://sync.sxp.smartclip.net/sync?type=red&dsp=10
  • https://sync.sxp.smartclip.net/sync?type=red&dsp=10&ang_testid=1
42 B
377 B
XHR
General
Full URL
https://sync.sxp.smartclip.net/sync?type=red&dsp=10&ang_testid=1
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
34.250.60.119 Dublin, Ireland, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
nginx/1.17.6 /
Resource Hash
ef1955ae757c8b966c83248350331bd3a30f658ced11f387f8ebf05ab3368629

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Date
Tue, 15 Dec 2020 12:45:36 GMT
Server
nginx/1.17.6
P3P
CP="CURa ADMa DEVa PSAo PSDo OUR BUS UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
Access-Control-Allow-Origin
https://www.dailymail.co.uk
Access-Control-Allow-Credentials
true
Connection
keep-alive
Content-Type
image/gif
Content-Length
42

Redirect headers

Date
Tue, 15 Dec 2020 12:45:36 GMT
Server
nginx/1.17.6
Location
https://sync.sxp.smartclip.net/sync?type=red&dsp=10&ang_testid=1
P3P
CP="CURa ADMa DEVa PSAo PSDo OUR BUS UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
Access-Control-Allow-Origin
https://www.dailymail.co.uk
Access-Control-Allow-Credentials
true
Connection
keep-alive
Content-Length
0
edgedata.html
www.dailymail.co.uk/geo/
785 B
1 KB
Fetch
General
Full URL
https://www.dailymail.co.uk/geo/edgedata.html
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/static/mol-adverts/demo/mol-22070/19a28e0b/mol-adverts.js
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2a02:26f0:6c00:296::11ae , Ascension Island, ASN20940 (AKAMAI-ASN1, EU),
Reverse DNS
Software
/
Resource Hash
dfb749c8597c2c8686580548520a1575a8026ed3efda320792bc9f5bc8cd246a

Request headers

pragma
no-cache
cache-control
no-cache
Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:45:36 GMT
vary
User-Agent
content-security-policy-report-only
block-all-mixed-content; report-uri https://mol.report-uri.io/r/default/csp/reportOnly
content-type
text/html
cache-control
max-age=774
server-timing
edge; dur=1, cdn-cache; desc=HIT
content-length
785
x-akamai-transformed
9 785 0 pmb=mRUM,2
launcher.js
sak.userreport.com/mol/
46 KB
15 KB
Script
General
Full URL
https://sak.userreport.com/mol/launcher.js
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/static/mol-adverts/demo/mol-22070/19a28e0b/mol-adverts.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
99.84.89.98 Seattle, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-99-84-89-98.muc50.r.cloudfront.net
Software
AmazonS3 /
Resource Hash
2a2d04bb04d52ca53c1aaf2f8de8574e929f1136e08c828f36bfe0b03d588835

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

x-amz-version-id
I0zZ8fJjlbBdpU31WSxSwsQh_njKJ8CZ
content-encoding
gzip
last-modified
Mon, 16 Nov 2020 11:54:59 GMT
server
AmazonS3
age
6
etag
"6d509bc807890482e7742fa12a3fdc85"
vary
Accept-Encoding
x-cache
Hit from cloudfront
content-type
application/javascript
via
1.1 39ed76664123c3090231ff0882467152.cloudfront.net (CloudFront)
cache-control
max-age=7200, s-maxage=60
date
Tue, 15 Dec 2020 12:45:32 GMT
x-amz-cf-pop
MUC50-C1
x-amz-cf-id
nPe6efo0xQtnXwWuIJFED9bK6Qe5eIhFpLsPkSZyx59xw1fBEO3qzw==
pubcid.min.js
www.dailymail.co.uk/static/mol-adverts/demo/mol-21682/dist/
57 KB
16 KB
Script
General
Full URL
https://www.dailymail.co.uk/static/mol-adverts/demo/mol-21682/dist/pubcid.min.js
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/static/mol-adverts/demo/mol-22070/19a28e0b/mol-adverts.js
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2a02:26f0:6c00:296::11ae , Ascension Island, ASN20940 (AKAMAI-ASN1, EU),
Reverse DNS
Software
Akamai Resource Optimizer /
Resource Hash
afd2447f77118df6fd4b8710c2b23e7bb4edb557795c643e3d8a7c12df4e6586

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:45:36 GMT
content-encoding
br
content-security-policy-report-only
block-all-mixed-content; report-uri https://mol.report-uri.io/r/default/csp/reportOnly
last-modified
Mon, 26 Oct 2020 15:57:10 GMT
server
Akamai Resource Optimizer
etag
"c74b87c9a8cadd3463a338a08b3f2cf6:1603291730.298429"
vary
User-Agent
content-type
application/x-javascript
cache-control
max-age=616492
server-timing
cdn-cache; desc=HIT, edge; dur=1
accept-ranges
bytes
timing-allow-origin
*
content-length
16091
expires
Tue, 22 Dec 2020 16:00:28 GMT
apstag.js
c.amazon-adsystem.com/aax2/
116 KB
30 KB
Script
General
Full URL
https://c.amazon-adsystem.com/aax2/apstag.js
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/static/mol-adverts/demo/mol-22070/19a28e0b/mol-adverts.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
99.84.88.20 Seattle, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-99-84-88-20.muc50.r.cloudfront.net
Software
Server /
Resource Hash
dde5dcb02f349d5cd1f36d6afe709ddfd5713b27129dbae727f456cde6582883

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:34:11 GMT
content-encoding
gzip
server
Server
age
684
etag
089c185b065ebe3e9c21625b16dea242
x-cache
Hit from cloudfront
content-type
application/javascript
via
1.1 fe36c7f30c8ef2853edecc43f320092c.cloudfront.net (CloudFront)
cache-control
public, max-age=900
x-amz-cf-pop
MUC50-C1
accept-ranges
bytes
timing-allow-origin
*
x-amz-version-id
dMDl4v7Re.7jmw9HDy.5O8xRCx.Enz0f
x-amz-cf-id
lc6mgcvJT3MZdk7yLp02AakhCcdGM6NadTuANHovZ2lBoZYYEJff9g==
tfa.js
cdn.taboola.com/libtrc/unip/1125455/
62 KB
21 KB
Script
General
Full URL
https://cdn.taboola.com/libtrc/unip/1125455/tfa.js
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/static/mol-adverts/demo/mol-22070/19a28e0b/mol-adverts.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
151.101.13.44 Frankfurt am Main, Germany, ASN54113 (FASTLY, US),
Reverse DNS
Software
AmazonS3 /
Resource Hash
f3b197cbaeccc165326cbcbcafdd7c9b6cbfd9a6e4b491f7e15005d5ae1bc54f

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

x-amz-version-id
CWn2XVqOOPHV7d9ufmX_sO4trqOMW86V
content-encoding
gzip
etag
"f307857c217d76ef1a20ffe52928f705"
age
85
x-cache
HIT
x-amz-replication-status
PENDING
content-length
21416
x-amz-id-2
oM0wVJZ/zN+Ec48FN1mHYtugK2s/dviMKyu7xhpO0+9G2RDFQgC/25NySitaoNBEc9iur6l1gGA=
x-served-by
cache-fra19144-FRA
last-modified
Mon, 23 Nov 2020 22:28:02 GMT
server
AmazonS3
x-timer
S1608036337.838278,VS0,VE1
date
Tue, 15 Dec 2020 12:45:36 GMT
vary
Accept-Encoding
x-amz-request-id
9484206517740AAC
via
1.1 varnish
cache-control
private,max-age=14401
accept-ranges
bytes
content-type
application/javascript; charset=utf-8
abp
22
x-cache-hits
4
directsdk.js
aka.spotxcdn.com/integration/directsdk/v1/
Redirect Chain
  • https://js.spotx.tv/directsdk/v1/234272.js
  • https://aka.spotxcdn.com/integration/directsdk/v1/directsdk.js
418 KB
155 KB
Script
General
Full URL
https://aka.spotxcdn.com/integration/directsdk/v1/directsdk.js
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
2.21.36.138 , France, ASN20940 (AKAMAI-ASN1, EU),
Reverse DNS
a2-21-36-138.deploy.static.akamaitechnologies.com
Software
nginx /
Resource Hash
d6fa7c39b1d5e288c739c3a225a90d0698798485d5b17c1350dc17925942b841

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Date
Tue, 15 Dec 2020 12:45:37 GMT
Content-Encoding
gzip
Last-Modified
Thu, 10 Sep 2020 19:35:03 UTC
Server
nginx
Access-Control-Allow-Headers
ETag
7112a693437c5fad3aa28033ed1f53f1
Vary
Accept-Encoding
Access-Control-Allow-Methods
POST, GET, PATCH, DELETE, OPTIONS
Content-Type
text/javascript;charset=UTF-8
Access-Control-Allow-Origin
*
Cache-Control
max-age=183
Connection
keep-alive
Timing-Allow-Origin
*
X-SpotX-Build-Version
1.31.0-20200910.1910
Content-Length
157844

Redirect headers

Pragma
no-cache
Date
Tue, 15 Dec 2020 12:45:36 GMT
Last-Modified
Tue, 15 Dec 2020 12:45:36 UTC
Server
nginx
Location
//aka.spotxcdn.com/integration/directsdk/v1/directsdk.js
Access-Control-Allow-Methods
GET, POST, OPTIONS
Content-Type
text/plain
Access-Control-Allow-Origin
*
Cache-Control
post-check=0, pre-check=0, no-store, no-cache, must-revalidate, proxy-revalidate, max-age=0
Access-Control-Allow-Credentials
false
X-fe
122
Connection
keep-alive
Timing-Allow-Origin
*
Content-Length
0
Expires
Thu, 01 Jan 1970 00:00:00 GMT
iris-context.min.js
ovp.iris.tv/libs/context/
13 KB
5 KB
Script
General
Full URL
https://ovp.iris.tv/libs/context/iris-context.min.js
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/static/mol-adverts/demo/mol-22070/19a28e0b/mol-adverts.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2600:9000:20eb:b000:15:d134:4e40:93a1 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
AmazonS3 /
Resource Hash
9710dab6bb3447842cba847209148bd89fb928f55865b045105fa3aefa4fb51f

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

x-amz-version-id
5ZdiiNwZl43A.GuGAotRXH1LFI541fXN
content-encoding
gzip
last-modified
Thu, 18 Jun 2020 14:14:19 GMT
server
AmazonS3
age
68963
etag
"1f6dcd0526f7505c7eb84fec71d5e468"
vary
Accept-Encoding
x-cache
Hit from cloudfront
content-type
application/javascript
via
1.1 2bbba694ff55d664208103e9c25dce14.cloudfront.net (CloudFront)
date
Mon, 14 Dec 2020 17:36:14 GMT
x-amz-cf-pop
FRA2-C1
x-amz-cf-id
ZjjRRreAW0sswFw6_CxL_j4N1hpEiNG9WnO8cUvO0ALzYNiseZadMg==
topVideos.json
secured.dailymail.co.uk/feeds/commercial/
137 KB
40 KB
XHR
General
Full URL
https://secured.dailymail.co.uk/feeds/commercial/topVideos.json
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/static/mol-adverts/demo/mol-22070/19a28e0b/mol-adverts.js
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_256_GCM
Server
2a02:26f0:6c00:288::11ae , Ascension Island, ASN20940 (AKAMAI-ASN1, EU),
Reverse DNS
Software
/
Resource Hash
68e40a49db6a4484c50767f856fca0c2633633193cab2d6a8987adbd5cca2ba4

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Date
Tue, 15 Dec 2020 12:45:36 GMT
Content-Encoding
gzip
Vary
Accept-Encoding
Connection
keep-alive
Content-Length
40695
X-rs-ops
varnish-web-b2-fe.hsk.mol.dmgt.net:6081
Access-Control-Allow-Headers
X-Requested-With, X-HTTP-Method-Override, Content-Type, Accept, Authorization
x-graced
false
x-rs-time
Tue, 15 Dec 2020 12-44-30 GMT
restarts
0
Access-Control-Allow-Methods
GET, POST, PUT, PATCH, DELETE, OPTIONS
Content-Type
application/json; charset=utf-8
Access-Control-Allow-Origin
*
Cache-Control
private, max-age=1800
Accept-Ranges
bytes
x-rs-ben
video-feed-a1.hsk.mol.dmgt.net:3000
x-storage
other
Expires
Tue, 15 Dec 2020 13:15:36 GMT
i.gif
mfad.inskinad.com/udb/9874/pool/set/
Redirect Chain
  • https://e.serverbid.com/udb/9969/match?redir=https%3A%2F%2Fmfad.inskinad.com%2Fudb%2F9874%2Fpool%2Fset%2Fi.gif%3FpoolId%3D9969%26poolKey%3D
  • https://mfad.inskinad.com/udb/9874/pool/set/i.gif?poolId=9969&poolKey=ue1-sb1-a0c4a30f-dc3f-4275-8d75-8332c4c8fa99
43 B
875 B
Image
General
Full URL
https://mfad.inskinad.com/udb/9874/pool/set/i.gif?poolId=9969&poolKey=ue1-sb1-a0c4a30f-dc3f-4275-8d75-8332c4c8fa99
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
54.225.161.250 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
Software
nginx/1.16.1 / adzerk bifrost/
Resource Hash
a065920df8cc4016d67c3a464be90099c9d28ffe7c9e6ee3a18f257efc58cbd7

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Pragma
no-cache
Date
Tue, 15 Dec 2020 12:45:37 GMT
ETag
W/"2b-6KwiS6nul+h2cO1vOi8BKLevn+Q"
Server
nginx/1.16.1
x-powered-by
adzerk bifrost/
Access-Control-Allow-Methods
GET, PUT, POST, DELETE, OPTIONS
Content-Type
image/gif
Access-Control-Allow-Origin
undefined
Expires
0
Cache-Control
no-cache, no-store, must-revalidate
Access-Control-Allow-Credentials
true
Connection
keep-alive
Access-Control-Allow-Headers
Accept, Origin, Content-Type, Content-Length, X-Adzerk-Explain, X-Adzerk-Sdk-Version
Content-Length
43
x-served-by
engine-production-i-0dfb6fcc03ed232ba

Redirect headers

location
https://mfad.inskinad.com/udb/9874/pool/set/i.gif?poolId=9969&poolKey=ue1-sb1-a0c4a30f-dc3f-4275-8d75-8332c4c8fa99
date
Tue, 15 Dec 2020 12:45:36 GMT
content-length
0
latest.json
cdn.jsdelivr.net/gh/prebid/currency-file@1/
1 KB
939 B
XHR
General
Full URL
https://cdn.jsdelivr.net/gh/prebid/currency-file@1/latest.json
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/static/mol-adverts/demo/mol-22070/19a28e0b/mol-adverts.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
2a04:4e42:1b::621 , Ascension Island, ASN54113 (FASTLY, US),
Reverse DNS
Software
/
Resource Hash
3cfa4702961c26f4b82c3fa3a80a6de1faa60dc6eee544bf7fd1eb97b81cb655
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains; preload
X-Content-Type-Options nosniff

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type
text/plain

Response headers

strict-transport-security
max-age=31536000; includeSubDomains; preload
content-encoding
gzip
x-content-type-options
nosniff
age
37029
x-cache
HIT, HIT
cross-origin-resource-policy
cross-origin
content-length
755
etag
W/"53d-3hAsEjuqSPx7l6Hxt7WLqG3cLVY"
x-served-by
cache-fra19142-FRA, cache-hhn4052-HHN
date
Tue, 15 Dec 2020 12:45:36 GMT
vary
Accept-Encoding
content-type
application/json; charset=utf-8
access-control-allow-origin
*
access-control-expose-headers
*
cache-control
public, max-age=604800, s-maxage=43200
accept-ranges
bytes
timing-allow-origin
*
cookie_sync
prebid.adnxs.com/pbs/v1/
579 B
736 B
XHR
General
Full URL
https://prebid.adnxs.com/pbs/v1/cookie_sync
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/static/mol-adverts/demo/mol-22070/19a28e0b/mol-adverts.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
37.252.161.190 , Ascension Island, ASN29990 (ASN-APPNEX, US),
Reverse DNS
prebid.ams1.adnexus.net
Software
nginx/1.19.0 /
Resource Hash
ed46c6ec566f2365d4957732515715a333ea0c15be47f992a94e5e4ac2d6007f

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type
text/plain

Response headers

Pragma
no-cache
Date
Tue, 15 Dec 2020 12:45:36 GMT
Content-Encoding
gzip
Server
nginx/1.19.0
Vary
Accept-Encoding, Origin
Content-Type
application/json; charset=utf-8
Access-Control-Allow-Origin
https://www.dailymail.co.uk
Cache-Control
no-cache, no-store, must-revalidate
Access-Control-Allow-Credentials
true
Connection
keep-alive
Transfer-Encoding
chunked
Expires
0
auction
prebid.adnxs.com/pbs/v1/openrtb2/
166 B
515 B
XHR
General
Full URL
https://prebid.adnxs.com/pbs/v1/openrtb2/auction
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/static/mol-adverts/demo/mol-22070/19a28e0b/mol-adverts.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
37.252.161.190 , Ascension Island, ASN29990 (ASN-APPNEX, US),
Reverse DNS
prebid.ams1.adnexus.net
Software
nginx/1.19.0 /
Resource Hash
ce6fce74dcee7e32fbd4457f09b5c27addfbcd54a5afb8794049c084420581c0

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type
text/plain

Response headers

Pragma
no-cache
Date
Tue, 15 Dec 2020 12:45:36 GMT
Server
nginx/1.19.0
Vary
Origin
Content-Type
application/json
Access-Control-Allow-Origin
https://www.dailymail.co.uk
Cache-Control
no-cache, no-store, must-revalidate
Access-Control-Allow-Credentials
true
Connection
keep-alive
Content-Length
166
Expires
0
xhr
pre.ads.justpremium.com/v/2.0/t/
43 B
254 B
XHR
General
Full URL
https://pre.ads.justpremium.com/v/2.0/t/xhr?i=1608036336679
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/static/mol-adverts/demo/mol-22070/19a28e0b/mol-adverts.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
52.59.91.38 Frankfurt am Main, Germany, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
/
Resource Hash
d34e8a1a381b203e3d1f7c6ed4f077038e91782ea254c7a7e4785462147a385a

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type
text/plain

Response headers

access-control-allow-origin
https://www.dailymail.co.uk
date
Tue, 15 Dec 2020 12:45:36 GMT
cache-control
public, no-cache, no-store, must-revalidate
access-control-allow-credentials
true
content-encoding
gzip
content-type
application/json
v2
mfad.inskinad.com/api/
92 B
745 B
XHR
General
Full URL
https://mfad.inskinad.com/api/v2
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/static/mol-adverts/demo/mol-22070/19a28e0b/mol-adverts.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
54.225.161.250 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
Software
nginx/1.16.1 / adzerk bifrost/
Resource Hash
a5c5c40db65bb1862024791026dc9776e310602618183d9d6c44778ff59ac3c2

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type
text/plain

Response headers

Pragma
no-cache
Date
Tue, 15 Dec 2020 12:45:37 GMT
ETag
W/"5c-e9ojkpaeHH0cxS9alqrQihM8SMI"
Server
nginx/1.16.1
x-powered-by
adzerk bifrost/
Access-Control-Allow-Methods
GET, PUT, POST, DELETE, OPTIONS
Content-Type
application/json; charset=utf-8
Access-Control-Allow-Origin
https://www.dailymail.co.uk
Expires
0
Cache-Control
no-cache, no-store, must-revalidate
Access-Control-Allow-Credentials
true
Connection
keep-alive
Access-Control-Allow-Headers
Accept, Origin, Content-Type, Content-Length, X-Adzerk-Explain, X-Adzerk-Sdk-Version
Content-Length
92
x-served-by
engine-production-i-0f538d28fa8a79cf3
arj
mailonline-uk-d.openx.net/w/1.0/
173 B
564 B
XHR
General
Full URL
https://mailonline-uk-d.openx.net/w/1.0/arj?ju=https%3A%2F%2Fwww.dailymail.co.uk%2Fsciencetech%2Farticle-9050821%2FRemdesivir-beneficial-patients-doctors-reveal.html%3F_hsmi%3D88974744%26_hsenc%3Dp2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8&ch=UTF-8&res=1600x1200x24&ifr=false&tz=-60&tws=1600x1200&be=1&bc=hb_pb_3.0.3&dddid=63c819de-d24a-44d8-9179-6e13d72adc81%2Cc8b34ba0-6eb5-4644-a1eb-0dcfc5a00af0%2C930e0fe9-df86-420a-9d67-1e2f1dda4acb%2C7ab2196a-8063-4c7f-948b-3ff6643623d1%2Ca36d4625-55a2-49e5-852c-b23cfc8cdb48%2C4cc4f764-a8cf-4bfa-a738-4e7c44a9bae2%2C627decdc-16d8-455b-832d-5cf11180dfb6%2C401e35b8-b0d3-41ae-a04f-04fe85c9ae4d%2Cf0832d77-be58-4187-bc02-59c98c159c66%2C5746f04b-430c-43af-8965-44ac52ad40f5%2C350e3b5e-1da6-462c-8cc8-c9017dc50620&nocache=1608036336681&pubcid=84f1103b-a980-4860-8c6e-1866bcc8525c&aus=728x90%7C300x250%7C300x250%7C300x250%7C300x250%7C160x600%2C120x600%7C160x600%2C120x600%7C160x600%2C120x600%7C160x600%2C120x600%7C300x250%7C300x250&divIds=leader_wide%2Cmpu_left%2Cmpu_middle%2Cmpu_puff_20%2Cmpu_puff_45%2Csky_left_bottom%2Csky_right_bottom%2Csky_left_top%2Csky_right_top%2Cmpu_mobile_top%2Cmpu_top&auid=540437664%2C537316799%2C538767661%2C538767664%2C538767666%2C539384356%2C539384357%2C538767667%2C538767668%2C538767673%2C539384359
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/static/mol-adverts/demo/mol-22070/19a28e0b/mol-adverts.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
35.244.159.8 Mountain View, United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
OXGW/16.199.0 /
Resource Hash
056228b909f31d1ed7aa0d03cf50a52a8df7d3ce8867437acb86ca614c22deb7

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type
text/plain

Response headers

pragma
no-cache
date
Tue, 15 Dec 2020 12:45:36 GMT
content-encoding
gzip
server
OXGW/16.199.0
vary
Accept, Accept-Encoding
p3p
CP="CUR ADM OUR NOR STA NID"
access-control-allow-origin
https://www.dailymail.co.uk
cache-control
private, max-age=0, no-cache
access-control-allow-credentials
true
content-type
application/json
alt-svc
clear
content-length
165
via
1.1 google
expires
Mon, 26 Jul 1997 05:00:00 GMT
cygnus
htlb.casalemedia.com/
25 B
375 B
XHR
General
Full URL
https://htlb.casalemedia.com/cygnus?s=193651&v=7.2&r=%7B%22id%22%3A%2239be842197efd71%22%2C%22imp%22%3A%5B%7B%22id%22%3A%22406bb04e9ad82c6%22%2C%22ext%22%3A%7B%22siteID%22%3A%22193651%22%2C%22sid%22%3A%22728x90%22%7D%2C%22banner%22%3A%7B%22w%22%3A728%2C%22h%22%3A90%2C%22topframe%22%3A1%7D%7D%2C%7B%22id%22%3A%22419ca8529338ae3%22%2C%22ext%22%3A%7B%22siteID%22%3A%22193651%22%2C%22sid%22%3A%22900x250%22%7D%2C%22banner%22%3A%7B%22w%22%3A900%2C%22h%22%3A250%2C%22topframe%22%3A1%7D%7D%2C%7B%22id%22%3A%2242c5b5c4655b478%22%2C%22ext%22%3A%7B%22siteID%22%3A%22193651%22%2C%22sid%22%3A%22970x250%22%7D%2C%22banner%22%3A%7B%22w%22%3A970%2C%22h%22%3A250%2C%22topframe%22%3A1%7D%7D%2C%7B%22id%22%3A%22436d77a468d43c4%22%2C%22ext%22%3A%7B%22siteID%22%3A%22503169%22%2C%22sid%22%3A%22300x250%22%7D%2C%22banner%22%3A%7B%22w%22%3A300%2C%22h%22%3A250%2C%22topframe%22%3A1%7D%7D%2C%7B%22id%22%3A%2244dfece0ee5da93%22%2C%22ext%22%3A%7B%22siteID%22%3A%22193657%22%2C%22sid%22%3A%22300x250%22%7D%2C%22banner%22%3A%7B%22w%22%3A300%2C%22h%22%3A250%2C%22topframe%22%3A1%7D%7D%2C%7B%22id%22%3A%224581c3f466b1d33%22%2C%22ext%22%3A%7B%22siteID%22%3A%22193661%22%2C%22sid%22%3A%22300x250%22%7D%2C%22banner%22%3A%7B%22w%22%3A300%2C%22h%22%3A250%2C%22topframe%22%3A1%7D%7D%2C%7B%22id%22%3A%2246a603d7f059d89%22%2C%22ext%22%3A%7B%22siteID%22%3A%22193661%22%2C%22sid%22%3A%22300x600%22%7D%2C%22banner%22%3A%7B%22w%22%3A300%2C%22h%22%3A600%2C%22topframe%22%3A1%7D%7D%2C%7B%22id%22%3A%224773ed58a85ad1e%22%2C%22ext%22%3A%7B%22siteID%22%3A%22193665%22%2C%22sid%22%3A%22300x250%22%7D%2C%22banner%22%3A%7B%22w%22%3A300%2C%22h%22%3A250%2C%22topframe%22%3A1%7D%7D%2C%7B%22id%22%3A%2248abc7a6fc52869%22%2C%22ext%22%3A%7B%22siteID%22%3A%22193667%22%2C%22sid%22%3A%22300x250%22%7D%2C%22banner%22%3A%7B%22w%22%3A300%2C%22h%22%3A250%2C%22topframe%22%3A1%7D%7D%2C%7B%22id%22%3A%2249285f97e0ea0b1%22%2C%22ext%22%3A%7B%22siteID%22%3A%22193673%22%2C%22sid%22%3A%22300x600%22%7D%2C%22banner%22%3A%7B%22w%22%3A300%2C%22h%22%3A600%2C%22topframe%22%3A1%7D%7D%2C%7B%22id%22%3A%2250a07cb247c9853%22%2C%22ext%22%3A%7B%22siteID%22%3A%22193673%22%2C%22sid%22%3A%22300x250%22%7D%2C%22banner%22%3A%7B%22w%22%3A300%2C%22h%22%3A250%2C%22topframe%22%3A1%7D%7D%2C%7B%22id%22%3A%2251399657636a6df%22%2C%22ext%22%3A%7B%22siteID%22%3A%22217825%22%2C%22sid%22%3A%22160x600%22%7D%2C%22banner%22%3A%7B%22w%22%3A160%2C%22h%22%3A600%2C%22topframe%22%3A1%7D%7D%2C%7B%22id%22%3A%2252c21b60b7e392d%22%2C%22ext%22%3A%7B%22siteID%22%3A%22217825%22%2C%22sid%22%3A%22120x600%22%7D%2C%22banner%22%3A%7B%22w%22%3A120%2C%22h%22%3A600%2C%22topframe%22%3A1%7D%7D%2C%7B%22id%22%3A%22537e2b110b4cb65%22%2C%22ext%22%3A%7B%22siteID%22%3A%22217826%22%2C%22sid%22%3A%22160x600%22%7D%2C%22banner%22%3A%7B%22w%22%3A160%2C%22h%22%3A600%2C%22topframe%22%3A1%7D%7D%2C%7B%22id%22%3A%22543791b117433d5%22%2C%22ext%22%3A%7B%22siteID%22%3A%22217826%22%2C%22sid%22%3A%22120x600%22%7D%2C%22banner%22%3A%7B%22w%22%3A120%2C%22h%22%3A600%2C%22topframe%22%3A1%7D%7D%2C%7B%22id%22%3A%225569618441b6011%22%2C%22ext%22%3A%7B%22siteID%22%3A%22193648%22%2C%22sid%22%3A%22970x250%22%7D%2C%22banner%22%3A%7B%22w%22%3A970%2C%22h%22%3A250%2C%22topframe%22%3A1%7D%7D%2C%7B%22id%22%3A%22568404f9b5e9c7%22%2C%22ext%22%3A%7B%22siteID%22%3A%22193648%22%2C%22sid%22%3A%22900x250%22%7D%2C%22banner%22%3A%7B%22w%22%3A900%2C%22h%22%3A250%2C%22topframe%22%3A1%7D%7D%2C%7B%22id%22%3A%2257b8946eabe2cb9%22%2C%22ext%22%3A%7B%22siteID%22%3A%22193648%22%2C%22sid%22%3A%22728x90%22%7D%2C%22banner%22%3A%7B%22w%22%3A728%2C%22h%22%3A90%2C%22topframe%22%3A1%7D%7D%2C%7B%22id%22%3A%225841f69cfacc2b%22%2C%22ext%22%3A%7B%22siteID%22%3A%22193670%22%2C%22sid%22%3A%22160x600%22%7D%2C%22banner%22%3A%7B%22w%22%3A160%2C%22h%22%3A600%2C%22topframe%22%3A1%7D%7D%2C%7B%22id%22%3A%22596b0c1124dd3fa%22%2C%22ext%22%3A%7B%22siteID%22%3A%22193670%22%2C%22sid%22%3A%22120x600%22%7D%2C%22banner%22%3A%7B%22w%22%3A120%2C%22h%22%3A600%2C%22topframe%22%3A1%7D%7D%2C%7B%22id%22%3A%22607c863eacf94c2%22%2C%22ext%22%3A%7B%22siteID%22%3A%22193671%22%2C%22sid%22%3A%22160x600%22%7D%2C%22banner%22%3A%7B%22w%22%3A160%2C%22h%22%3A600%2C%22topframe%22%3A1%7D%7D%2C%7B%22id%22%3A%22617663cec3d3d52%22%2C%22ext%22%3A%7B%22siteID%22%3A%22193671%22%2C%22sid%22%3A%22120x600%22%7D%2C%22banner%22%3A%7B%22w%22%3A120%2C%22h%22%3A600%2C%22topframe%22%3A1%7D%7D%5D%2C%22site%22%3A%7B%22page%22%3A%22https%3A%2F%2Fwww.dailymail.co.uk%2Fsciencetech%2Farticle-9050821%2FRemdesivir-beneficial-patients-doctors-reveal.html%3F_hsmi%3D88974744%26_hsenc%3Dp2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8%22%7D%2C%22ext%22%3A%7B%22source%22%3A%22prebid%22%7D%7D&ac=j&sd=1
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/static/mol-adverts/demo/mol-22070/19a28e0b/mol-adverts.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
104.111.215.135 , Netherlands, ASN16625 (AKAMAI-AS, US),
Reverse DNS
a104-111-215-135.deploy.static.akamaitechnologies.com
Software
Apache /
Resource Hash
39a6a8b217ea932933d2b53a1e93dfcecac308a7b2d2a376fd51c190c8dee619

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type
text/plain

Response headers

pragma
no-cache
date
Tue, 15 Dec 2020 12:45:36 GMT
content-encoding
gzip
x-ak-initial-geo
CC:[NL], RC:[], CN:[EU], CIP:[185.212.171.67], XFF:[]
server
Apache
vary
Is-Traffic-Invalid,Accept-Encoding
content-type
application/json
access-control-allow-origin
https://www.dailymail.co.uk
x-cs-client-geo
12
cache-control
max-age=0, no-cache, no-store
access-control-allow-credentials
true
content-length
45
x-ak-client-geo
12
expires
Tue, 15 Dec 2020 12:45:36 GMT
bid-request
a.teads.tv/hb/
16 B
301 B
XHR
General
Full URL
https://a.teads.tv/hb/bid-request
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/static/mol-adverts/demo/mol-22070/19a28e0b/mol-adverts.js
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2.18.232.7 , Ascension Island, ASN16625 (AKAMAI-AS, US),
Reverse DNS
a2-18-232-7.deploy.static.akamaitechnologies.com
Software
/
Resource Hash
6a7b0c8bf87b2bd5ca31557f25cf2a6c80f93af72bf68a6085e9b55a87fe908c

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type
text/plain

Response headers

pragma
no-cache
date
Tue, 15 Dec 2020 12:45:36 GMT
content-encoding
gzip
vary
Accept-Encoding
content-type
application/json
access-control-allow-origin
https://www.dailymail.co.uk
cache-control
max-age=0, no-cache, no-store
access-control-allow-credentials
true
content-length
42
expires
Tue, 15 Dec 2020 12:45:36 GMT
cdb
bidder.criteo.com/
0
149 B
XHR
General
Full URL
https://bidder.criteo.com/cdb?profileId=207&av=32&wv=4.13.0-mol-1&cb=4218472034
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/static/mol-adverts/demo/mol-22070/19a28e0b/mol-adverts.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
178.250.0.165 , France, ASN44788 (ASN-CRITEO-EUROPE, FR),
Reverse DNS
bidder.par.vip.prod.criteo.com
Software
Finatra /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type
text/plain

Response headers

access-control-allow-origin
https://www.dailymail.co.uk
date
Tue, 15 Dec 2020 12:45:36 GMT
access-control-allow-credentials
true
server
Finatra
timing-allow-origin
*
vary
Origin
fastlane.json
fastlane.rubiconproject.com/a/api/
1 KB
11 KB
XHR
General
Full URL
https://fastlane.rubiconproject.com/a/api/fastlane.json?account_id=8625&site_id=124374&zone_id=587732%3B587734%3B1102954%3B1694086%3B587746%3B587754%3B587764%3B587782%3B724806%3B587784&size_id=2%3B2%3B2%3B15%3B15%3B15%3B15%3B15%3B15%3B9&alt_size_ids=57%3B57%3B%3B%3B%3B10%3B%3B%3B10%3B8%2C10&p_pos=atf%3B%3B%3B%3B%3Batf%3B%3B%3Batf%3Batf&eid_pubcid.org=84f1103b-a980-4860-8c6e-1866bcc8525c%5E1&rf=https%3A%2F%2Fwww.dailymail.co.uk%2Fsciencetech%2Farticle-9050821%2FRemdesivir-beneficial-patients-doctors-reveal.html%3F_hsmi%3D88974744%26_hsenc%3Dp2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8&tg_i.area=sciencetech&tk_flint=pbjs_lite_v4.13.0-mol-1&x_source.tid=4710bc1a-7288-4e85-a7e2-f07fd9ae7de5%3B187d59dd-ffbb-48c4-8610-95a8cc3ce49d%3B63c819de-d24a-44d8-9179-6e13d72adc81%3Bc8b34ba0-6eb5-4644-a1eb-0dcfc5a00af0%3B930e0fe9-df86-420a-9d67-1e2f1dda4acb%3Bcfd1ffb7-49fe-4a43-ae90-2064d9c99cba%3B7ab2196a-8063-4c7f-948b-3ff6643623d1%3Ba36d4625-55a2-49e5-852c-b23cfc8cdb48%3Bec268b93-f495-42f7-a026-d840b395c672%3B4a8652e3-2a32-4edb-8fb1-e405442a3eb0&p_screen_res=1600x1200&rp_floor=0.01&rp_secure=1&slots=10&rand=0.9551853934404106
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/static/mol-adverts/demo/mol-22070/19a28e0b/mol-adverts.js
Protocol
HTTP/1.1
Security
TLS 1.2, RSA, AES_128_GCM
Server
213.19.162.31 , United Kingdom, ASN3356 (LEVEL3, US),
Reverse DNS
Software
nginx/1.16.0 /
Resource Hash
9b08f975fe2fe9c779ab2870d57ff2f98b910ac5121e8684f6fafb868b06b082

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type
text/plain

Response headers

Pragma
no-cache
Date
Tue, 15 Dec 2020 12:45:36 GMT
Content-Encoding
gzip
Server
nginx/1.16.0
Vary
Accept-Encoding
P3P
CP="NOI CURa ADMa DEVa TAIa OUR BUS IND UNI COM NAV INT"
Access-Control-Allow-Origin
https://www.dailymail.co.uk
Cache-Control
no-cache, no-store, max-age=0, must-revalidate
Access-Control-Allow-Credentials
true
Connection
keep-alive
Content-Type
application/json
Keep-Alive
timeout=5
Content-Length
416
Expires
Wed, 17 Sep 1975 21:32:10 GMT
fastlane.json
fastlane.rubiconproject.com/a/api/
490 B
4 KB
XHR
General
Full URL
https://fastlane.rubiconproject.com/a/api/fastlane.json?account_id=8625&site_id=124374&zone_id=724800%3B587786%3B724804&size_id=9&alt_size_ids=8%2C10&p_pos=%3Batf%3B&eid_pubcid.org=84f1103b-a980-4860-8c6e-1866bcc8525c%5E1&rf=https%3A%2F%2Fwww.dailymail.co.uk%2Fsciencetech%2Farticle-9050821%2FRemdesivir-beneficial-patients-doctors-reveal.html%3F_hsmi%3D88974744%26_hsenc%3Dp2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8&tg_i.area=sciencetech&tk_flint=pbjs_lite_v4.13.0-mol-1&x_source.tid=c6674ceb-d6e4-4f95-b13e-19a3853903c3%3Bf00ae8bb-14de-4331-927c-a3bfcec42614%3Bf041cf7c-d025-4b16-8a29-2733ce1e4daf&p_screen_res=1600x1200&rp_floor=0.01&rp_secure=1&slots=3&rand=0.22296843276048905
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/static/mol-adverts/demo/mol-22070/19a28e0b/mol-adverts.js
Protocol
HTTP/1.1
Security
TLS 1.2, RSA, AES_128_GCM
Server
213.19.162.31 , United Kingdom, ASN3356 (LEVEL3, US),
Reverse DNS
Software
nginx/1.16.0 /
Resource Hash
3143cf3ecf6f554e612339e1cd3c6f965ca942bf794ebce6fc6b6a16e7e5f66f

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type
text/plain

Response headers

Pragma
no-cache
Date
Tue, 15 Dec 2020 12:45:36 GMT
Server
nginx/1.16.0
Vary
Accept-Encoding
P3P
CP="NOI CURa ADMa DEVa TAIa OUR BUS IND UNI COM NAV INT"
Access-Control-Allow-Origin
https://www.dailymail.co.uk
Cache-Control
no-cache, no-store, max-age=0, must-revalidate
Access-Control-Allow-Credentials
true
Connection
keep-alive
Content-Type
application/json
Keep-Alive
timeout=5
Content-Length
490
Expires
Wed, 17 Sep 1975 21:32:10 GMT
auction
tlx.3lift.com/header/
19 B
395 B
XHR
General
Full URL
https://tlx.3lift.com/header/auction?lib=prebid&v=4.13.0-mol-1&referrer=https%3A%2F%2Fwww.dailymail.co.uk%2Fsciencetech%2Farticle-9050821%2FRemdesivir-beneficial-patients-doctors-reveal.html%3F_hsmi%3D88974744%26_hsenc%3Dp2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8&tmax=3000
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/static/mol-adverts/demo/mol-22070/19a28e0b/mol-adverts.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
18.195.225.18 Frankfurt am Main, Germany, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
/
Resource Hash
0535c3bb3a17e4ac0fb7d29214d2181275662129dc2bdd2a89c35934e9fc5ba5
Security Headers
Name Value
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type
text/plain

Response headers

pragma
no-cache
date
Tue, 15 Dec 2020 12:45:36 GMT
x-auction-status
12, 12, 12, 12, 12, 12, 12, 12
content-type
application/json; charset=utf-8
access-control-allow-origin
https://www.dailymail.co.uk
cache-control
no-cache, no-store, must-revalidate
access-control-allow-credentials
true
content-length
19
x-xss-protection
0
expires
Thu, 15 Oct 1992 20:10:00 GMT
bidRequest
c2shb.ssp.yahoo.com/
62 B
390 B
XHR
General
Full URL
https://c2shb.ssp.yahoo.com/bidRequest?dcn=8a9691510171713aaede3c85d0ab0026&pos=desktop_billboard&cmd=bid&secure=1
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/static/mol-adverts/demo/mol-22070/19a28e0b/mol-adverts.js
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_256_GCM
Server
35.157.246.167 Frankfurt am Main, Germany, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
ATS/7.1.2.128 /
Resource Hash
e4d5a6c986c57d39e01905fc85c9c8a4c22c782b75998bc23092c0b1a61628cb

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type
text/plain

Response headers

Date
Tue, 15 Dec 2020 12:45:36 GMT
Server
ATS/7.1.2.128
Age
0
Access-Control-Allow-Methods
POST,GET,HEAD,OPTIONS
Content-Type
application/json;charset=utf-8
Access-Control-Allow-Origin
https://www.dailymail.co.uk
Access-Control-Allow-Credentials
true
Connection
keep-alive
Content-Length
62
bidRequest
c2shb.ssp.yahoo.com/
62 B
390 B
XHR
General
Full URL
https://c2shb.ssp.yahoo.com/bidRequest?dcn=8a9691510171713aaede3c85d0ab0026&pos=desktop_mpu_left&cmd=bid&secure=1
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/static/mol-adverts/demo/mol-22070/19a28e0b/mol-adverts.js
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_256_GCM
Server
35.157.246.167 Frankfurt am Main, Germany, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
ATS/7.1.2.128 /
Resource Hash
a263d76fe47c015103b3c2e09e08ac21b0e339df40db41fe51bcea5a595122dc

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type
text/plain

Response headers

Date
Tue, 15 Dec 2020 12:45:36 GMT
Server
ATS/7.1.2.128
Age
0
Access-Control-Allow-Methods
POST,GET,HEAD,OPTIONS
Content-Type
application/json;charset=utf-8
Access-Control-Allow-Origin
https://www.dailymail.co.uk
Access-Control-Allow-Credentials
true
Connection
keep-alive
Content-Length
62
bidRequest
c2shb.ssp.yahoo.com/
62 B
390 B
XHR
General
Full URL
https://c2shb.ssp.yahoo.com/bidRequest?dcn=8a9691510171713aaede3c85d0ab0026&pos=desktop_mpu_puff_20&cmd=bid&secure=1
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/static/mol-adverts/demo/mol-22070/19a28e0b/mol-adverts.js
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_256_GCM
Server
35.157.246.167 Frankfurt am Main, Germany, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
ATS/7.1.2.128 /
Resource Hash
384978ad17e81b9a11e44674315f9bca6bfbc3f70e3de4ea1f83f7c946b86bbd

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type
text/plain

Response headers

Date
Tue, 15 Dec 2020 12:45:36 GMT
Server
ATS/7.1.2.128
Age
0
Access-Control-Allow-Methods
POST,GET,HEAD,OPTIONS
Content-Type
application/json;charset=utf-8
Access-Control-Allow-Origin
https://www.dailymail.co.uk
Access-Control-Allow-Credentials
true
Connection
keep-alive
Content-Length
62
bidRequest
c2shb.ssp.yahoo.com/
62 B
390 B
XHR
General
Full URL
https://c2shb.ssp.yahoo.com/bidRequest?dcn=8a9691510171713aaede3c85d0ab0026&pos=desktop_mpu_puff_45&cmd=bid&secure=1
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/static/mol-adverts/demo/mol-22070/19a28e0b/mol-adverts.js
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_256_GCM
Server
35.157.246.167 Frankfurt am Main, Germany, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
ATS/7.1.2.128 /
Resource Hash
56e605cdc611df1e6c1114a58e320dff92a05c8eec2b47cf5756cde0e95637dc

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type
text/plain

Response headers

Date
Tue, 15 Dec 2020 12:45:36 GMT
Server
ATS/7.1.2.128
Age
0
Access-Control-Allow-Methods
POST,GET,HEAD,OPTIONS
Content-Type
application/json;charset=utf-8
Access-Control-Allow-Origin
https://www.dailymail.co.uk
Access-Control-Allow-Credentials
true
Connection
keep-alive
Content-Length
62
bidRequest
c2shb.ssp.yahoo.com/
62 B
390 B
XHR
General
Full URL
https://c2shb.ssp.yahoo.com/bidRequest?dcn=8a9691510171713aaede3c85d0ab0026&pos=desktop_mpu_top&cmd=bid&secure=1
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/static/mol-adverts/demo/mol-22070/19a28e0b/mol-adverts.js
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_256_GCM
Server
35.157.246.167 Frankfurt am Main, Germany, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
ATS/7.1.2.128 /
Resource Hash
56c9d88c9bf78500ae1d4be7b62b7e14f66bd3df52e27f47d172f3f9f73c89c7

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type
text/plain

Response headers

Date
Tue, 15 Dec 2020 12:45:36 GMT
Server
ATS/7.1.2.128
Age
0
Access-Control-Allow-Methods
POST,GET,HEAD,OPTIONS
Content-Type
application/json;charset=utf-8
Access-Control-Allow-Origin
https://www.dailymail.co.uk
Access-Control-Allow-Credentials
true
Connection
keep-alive
Content-Length
62
bidRequest
c2shb.ssp.yahoo.com/
62 B
390 B
XHR
General
Full URL
https://c2shb.ssp.yahoo.com/bidRequest?dcn=8a9691510171713aaede3c85d0ab0026&pos=desktop_leader_very_bottom&cmd=bid&secure=1
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/static/mol-adverts/demo/mol-22070/19a28e0b/mol-adverts.js
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_256_GCM
Server
35.157.246.167 Frankfurt am Main, Germany, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
ATS/7.1.2.128 /
Resource Hash
21abc1ab07e67647eb4a4e0747f2a394ff4ecefba7b67ecc617f0a305cc2fbc0

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type
text/plain

Response headers

Date
Tue, 15 Dec 2020 12:45:36 GMT
Server
ATS/7.1.2.128
Age
0
Access-Control-Allow-Methods
POST,GET,HEAD,OPTIONS
Content-Type
application/json;charset=utf-8
Access-Control-Allow-Origin
https://www.dailymail.co.uk
Access-Control-Allow-Credentials
true
Connection
keep-alive
Content-Length
62
bidRequest
c2shb.ssp.yahoo.com/
62 B
390 B
XHR
General
Full URL
https://c2shb.ssp.yahoo.com/bidRequest?dcn=8a9691510171713aaede3c85d0ab0026&pos=desktop_sky_left_bottom&cmd=bid&secure=1
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/static/mol-adverts/demo/mol-22070/19a28e0b/mol-adverts.js
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_256_GCM
Server
35.157.246.167 Frankfurt am Main, Germany, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
ATS/7.1.2.128 /
Resource Hash
3fff1c63a93c6debcc085807546473d406e3b08a6da822c9d10f6868358cede9

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type
text/plain

Response headers

Date
Tue, 15 Dec 2020 12:45:36 GMT
Server
ATS/7.1.2.128
Age
0
Access-Control-Allow-Methods
POST,GET,HEAD,OPTIONS
Content-Type
application/json;charset=utf-8
Access-Control-Allow-Origin
https://www.dailymail.co.uk
Access-Control-Allow-Credentials
true
Connection
keep-alive
Content-Length
62
bidRequest
c2shb.ssp.yahoo.com/
62 B
390 B
XHR
General
Full URL
https://c2shb.ssp.yahoo.com/bidRequest?dcn=8a9691510171713aaede3c85d0ab0026&pos=desktop_sky_left_top&cmd=bid&secure=1
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/static/mol-adverts/demo/mol-22070/19a28e0b/mol-adverts.js
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_256_GCM
Server
35.157.246.167 Frankfurt am Main, Germany, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
ATS/7.1.2.128 /
Resource Hash
aab1d46db71b8fec7342cfcf78e4a3ec1ea37b18dbdc5546a8c0aba1d1ac3abc

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type
text/plain

Response headers

Date
Tue, 15 Dec 2020 12:45:36 GMT
Server
ATS/7.1.2.128
Age
0
Access-Control-Allow-Methods
POST,GET,HEAD,OPTIONS
Content-Type
application/json;charset=utf-8
Access-Control-Allow-Origin
https://www.dailymail.co.uk
Access-Control-Allow-Credentials
true
Connection
keep-alive
Content-Length
62
bidRequest
c2shb.ssp.yahoo.com/
62 B
390 B
XHR
General
Full URL
https://c2shb.ssp.yahoo.com/bidRequest?dcn=8a9691510171713aaede3c85d0ab0026&pos=desktop_sky_right_bottom&cmd=bid&secure=1
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/static/mol-adverts/demo/mol-22070/19a28e0b/mol-adverts.js
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_256_GCM
Server
35.157.246.167 Frankfurt am Main, Germany, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
ATS/7.1.2.128 /
Resource Hash
fec53ab4bd5bd82b1a15ce6d4aa4ef79be462a601ccfcb2ab89f53bcd320555e

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type
text/plain

Response headers

Date
Tue, 15 Dec 2020 12:45:36 GMT
Server
ATS/7.1.2.128
Age
0
Access-Control-Allow-Methods
POST,GET,HEAD,OPTIONS
Content-Type
application/json;charset=utf-8
Access-Control-Allow-Origin
https://www.dailymail.co.uk
Access-Control-Allow-Credentials
true
Connection
keep-alive
Content-Length
62
bidRequest
c2shb.ssp.yahoo.com/
62 B
390 B
XHR
General
Full URL
https://c2shb.ssp.yahoo.com/bidRequest?dcn=8a9691510171713aaede3c85d0ab0026&pos=desktop_sky_right_top&cmd=bid&secure=1
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/static/mol-adverts/demo/mol-22070/19a28e0b/mol-adverts.js
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_256_GCM
Server
35.157.246.167 Frankfurt am Main, Germany, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
ATS/7.1.2.128 /
Resource Hash
3f96647d0486af5bae93c885bdcf4c380e66395797ffc875d2b661eec5f56f8f

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type
text/plain

Response headers

Date
Tue, 15 Dec 2020 12:45:36 GMT
Server
ATS/7.1.2.128
Age
0
Access-Control-Allow-Methods
POST,GET,HEAD,OPTIONS
Content-Type
application/json;charset=utf-8
Access-Control-Allow-Origin
https://www.dailymail.co.uk
Access-Control-Allow-Credentials
true
Connection
keep-alive
Content-Length
62
prebid
ib.adnxs.com/ut/v3/
19 B
716 B
XHR
General
Full URL
https://ib.adnxs.com/ut/v3/prebid
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/static/mol-adverts/demo/mol-22070/19a28e0b/mol-adverts.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_ECDSA, AES_128_GCM
Server
185.33.221.13 , Netherlands, ASN29990 (ASN-APPNEX, US),
Reverse DNS
729.bm-nginx-loadbalancer.mgmt.ams1.adnexus.net
Software
nginx/1.17.9 /
Resource Hash
0c09c070833c786cb25be38bc30992b30bad578f817dbc9e34beacd8b8ea44c5
Security Headers
Name Value
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type
text/plain

Response headers

Pragma
no-cache
Date
Tue, 15 Dec 2020 12:45:36 GMT
X-Proxy-Origin
185.212.171.67; 185.212.171.67; 729.bm-nginx-loadbalancer.mgmt.ams1; *.adnxs.com; 185.33.220.52:80
AN-X-Request-Uuid
896d3bf7-1027-4f85-8643-cbc9b9e29fed
Server
nginx/1.17.9
P3P
policyref="http://cdn.adnxs.com/w3c/policy/p3p.xml", CP="NOI DSP COR ADM PSAo PSDo OURo SAMo UNRo OTRo BUS COM NAV DEM STA PRE"
Access-Control-Allow-Origin
https://www.dailymail.co.uk
Cache-Control
no-store, no-cache, private
Access-Control-Allow-Credentials
true
Connection
keep-alive
Content-Type
application/json; charset=utf-8
Content-Length
19
X-XSS-Protection
0
Expires
Sat, 15 Nov 2008 16:00:00 GMT
prebid
ib.adnxs.com/ut/v3/
19 B
716 B
XHR
General
Full URL
https://ib.adnxs.com/ut/v3/prebid
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/static/mol-adverts/demo/mol-22070/19a28e0b/mol-adverts.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_ECDSA, AES_128_GCM
Server
185.33.221.13 , Netherlands, ASN29990 (ASN-APPNEX, US),
Reverse DNS
729.bm-nginx-loadbalancer.mgmt.ams1.adnexus.net
Software
nginx/1.17.9 /
Resource Hash
0c09c070833c786cb25be38bc30992b30bad578f817dbc9e34beacd8b8ea44c5
Security Headers
Name Value
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type
text/plain

Response headers

Pragma
no-cache
Date
Tue, 15 Dec 2020 12:45:36 GMT
X-Proxy-Origin
185.212.171.67; 185.212.171.67; 729.bm-nginx-loadbalancer.mgmt.ams1; *.adnxs.com; 185.33.223.40:80
AN-X-Request-Uuid
0eced33c-bb72-4363-a57d-912274a0c0cb
Server
nginx/1.17.9
P3P
policyref="http://cdn.adnxs.com/w3c/policy/p3p.xml", CP="NOI DSP COR ADM PSAo PSDo OURo SAMo UNRo OTRo BUS COM NAV DEM STA PRE"
Access-Control-Allow-Origin
https://www.dailymail.co.uk
Cache-Control
no-store, no-cache, private
Access-Control-Allow-Credentials
true
Connection
keep-alive
Content-Type
application/json; charset=utf-8
Content-Length
19
X-XSS-Protection
0
Expires
Sat, 15 Nov 2008 16:00:00 GMT
RQAJ2-Q4TGF-HEKJL-TAEAK-5V3VD
s.go-mpulse.net/boomerang/
205 KB
49 KB
Script
General
Full URL
https://s.go-mpulse.net/boomerang/RQAJ2-Q4TGF-HEKJL-TAEAK-5V3VD
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
Protocol
H2
Security
TLS 1.2, ECDHE_ECDSA, AES_256_GCM
Server
2a02:26f0:6c00:287::11a6 , Ascension Island, ASN20940 (AKAMAI-ASN1, EU),
Reverse DNS
Software
/
Resource Hash
09ebd7f407439990aac227e70da23e1a819e8e30282928e324370805f480bec4

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:45:36 GMT
content-encoding
br
last-modified
Tue, 10 Nov 2020 10:33:41 GMT
vary
Accept-Encoding
content-type
application/javascript; charset=utf-8
cache-control
max-age=604800
timing-allow-origin
*
content-length
50393
ga.js
google-analytics.com/
45 KB
17 KB
Script
General
Full URL
https://google-analytics.com/ga.js
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:81a::2004 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
Golfe2 /
Resource Hash
1259ea99bd76596239bfd3102c679eb0a5052578dc526b0452f4d42f8bcdd45f
Security Headers
Name Value
Strict-Transport-Security max-age=10886400; includeSubDomains; preload
X-Content-Type-Options nosniff

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

strict-transport-security
max-age=10886400; includeSubDomains; preload
content-encoding
gzip
x-content-type-options
nosniff
last-modified
Fri, 23 Oct 2020 03:00:57 GMT
server
Golfe2
age
5569
date
Tue, 15 Dec 2020 11:12:47 GMT
vary
Accept-Encoding
content-type
text/javascript
cache-control
public, max-age=7200
cross-origin-resource-policy
cross-origin
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
17168
expires
Tue, 15 Dec 2020 13:12:47 GMT
fbds.js
connect.facebook.net/en_US/
4 KB
2 KB
Script
General
Full URL
https://connect.facebook.net/en_US/fbds.js
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/static/mol-adverts/demo/mol-22070/19a28e0b/mol-adverts.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a03:2880:f02d:12:face:b00c:0:3 , Ireland, ASN32934 (FACEBOOK, US),
Reverse DNS
Software
/
Resource Hash
3436badfb4cde4f9fcfdebc1ddd208c49eaffb8834f46b89e991af6f4cac5cb8
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; preload; includeSubDomains
X-Content-Type-Options nosniff
X-Frame-Options DENY

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

strict-transport-security
max-age=31536000; preload; includeSubDomains
content-encoding
gzip
x-content-type-options
nosniff
content-md5
8AVZSXRDJVl6Y9J0CMHUuQ==
cross-origin-resource-policy
cross-origin
alt-svc
h3-29=":443"; ma=3600,h3-27=":443"; ma=3600
content-length
2117
etag
"8079f56753a4a94e54779cd208225068"
x-fb-debug
gCwor6dyxPKKpey1hVhmO77mLJkEa/a8mOFVdfvZPiJRLFoHSnTHNppZlIsDS6h7eZqK80YYFleMndMcyE/vRw==
x-fb-trip-id
436667874
x-fb-content-md5
1d6dcb0e254400f371a32548b5007cf9
x-frame-options
DENY
date
Tue, 15 Dec 2020 12:45:36 GMT
vary
Accept-Encoding
content-type
application/x-javascript; charset=utf-8
access-control-allow-origin
*
access-control-expose-headers
X-FB-Content-MD5
cache-control
public,max-age=1200,stale-while-revalidate=3600
timing-allow-origin
*
expires
Tue, 15 Dec 2020 12:58:32 GMT
truncated
/
37 B
0
Image
General
Full URL
data:truncated
Protocol
DATA
Server
-, , ASN (),
Reverse DNS
Software
/
Resource Hash
bb229a48bee31f5d54ca12dc9bd960c63a671f0d4be86a054c1d324a44499d96

Request headers

Referer
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Content-Type
image/gif
sci_tech_masthead.gif
i.dailymail.co.uk/i/pix/channelheaders/
22 KB
22 KB
Image
General
Full URL
https://i.dailymail.co.uk/i/pix/channelheaders/sci_tech_masthead.gif
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2a02:26f0:6c00:288::11ae , Ascension Island, ASN20940 (AKAMAI-ASN1, EU),
Reverse DNS
Software
Apache /
Resource Hash
a526255a9e1cbe99e7ac0f5822f568fc4ce2b8cc7b8e23273266f54c8669d4c0

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:45:36 GMT
last-modified
Mon, 15 Dec 2008 11:14:15 GMT
server
Apache
etag
"f45db57af9925ea9dac596bf296b1e8f:1229339655"
content-type
image/gif
cache-control
max-age=2592000
accept-ranges
bytes
timing-allow-origin
*
content-length
22399
expires
Thu, 14 Jan 2021 12:45:36 GMT
navigation_bottom.gif
www.dailymail.co.uk/i/furniture/structure/
154 B
510 B
Image
General
Full URL
https://www.dailymail.co.uk/i/furniture/structure/navigation_bottom.gif
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/static/mol-fe/static/mol-fe-sync-bundle/5.9.0/desktop.css
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2a02:26f0:6c00:296::11ae , Ascension Island, ASN20940 (AKAMAI-ASN1, EU),
Reverse DNS
Software
/
Resource Hash
4eaa63fe224cad73f3348b716855de0ace8a3169abfc0d7b2845d083172f53dd

Request headers

Referer
https://www.dailymail.co.uk/static/mol-fe/static/mol-fe-sync-bundle/5.9.0/desktop.css
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:45:36 GMT
content-security-policy-report-only
block-all-mixed-content; report-uri https://mol.report-uri.io/r/default/csp/reportOnly
last-modified
Fri, 25 Sep 2020 10:44:28 GMT
etag
W/"154-1601030668000"
x-rs-time
Mon, 05 Oct 2020 08-02-58 GMT
vary
User-Agent
content-type
image/gif
server-timing
cdn-cache; desc=HIT, edge; dur=7
accept-ranges
bytes
x-mol-georesp
de
content-length
154
x-rs-ops
molfejava-a2-fe.hsk.mol.dmgt.net:8081
spt_weather_nav.png
i.dailymail.co.uk/i/furniture/weather/
2 KB
2 KB
Image
General
Full URL
https://i.dailymail.co.uk/i/furniture/weather/spt_weather_nav.png
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/static/gunther/17.14.0/all--.css
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2a02:26f0:6c00:288::11ae , Ascension Island, ASN20940 (AKAMAI-ASN1, EU),
Reverse DNS
Software
Apache /
Resource Hash
0bf60782546bae441a6ce4783c2169777d728af37759e9805acbdaa48122cf36

Request headers

Referer
https://www.dailymail.co.uk/static/gunther/17.14.0/all--.css
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:45:36 GMT
last-modified
Wed, 23 Dec 2009 12:07:55 GMT
server
Apache
etag
"2a0a9e4a75bf8d1c816c273119256500:1261570075"
content-type
image/png
cache-control
max-age=2592000
accept-ranges
bytes
timing-allow-origin
*
content-length
2301
expires
Thu, 14 Jan 2021 12:45:36 GMT
5f42864d-a421-4f37-9478-00266f871d68-web.js
cdn.permutive.com/
811 KB
187 KB
Script
General
Full URL
https://cdn.permutive.com/5f42864d-a421-4f37-9478-00266f871d68-web.js
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/static/mol-adverts/demo/mol-22070/19a28e0b/mol-adverts.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
104.19.150.54 , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
ecbaca00d81dee47e105d71a524f5c44ae23dc2866ec1e2f8b3fc53a0342ecef

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:45:36 GMT
content-encoding
br
cf-cache-status
HIT
age
420
x-guploader-uploadid
ABg5-UwiHoSZkJ7ikphTwyj1qy2vQ8ZS45t_zjoiShEVsDbB7bI1ErLL6E87f_M5CnWgufc1FqLOm9i7HYlKHb9btZQ
x-goog-storage-class
REGIONAL
x-goog-metageneration
1
x-goog-stored-content-encoding
gzip
content-type
application/javascript
cf-request-id
0708085ce90000203be095f000000001
last-modified
Tue, 15 Dec 2020 11:38:33 GMT
server
cloudflare
etag
W/"8b58e91b87dd0cb4475fa0402716adc1"
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary
Accept-Encoding
x-goog-hash
crc32c=li8bRg==, md5=i1jpG4fdDLRHX6BAJxatwQ==
x-goog-generation
1608032313699745
cache-control
public, max-age=300
x-goog-stored-content-length
202637
cf-ray
60204341785d203b-AMS
expires
Tue, 15 Dec 2020 12:50:36 GMT
pubads_impl_2020120801.js
securepubads.g.doubleclick.net/gpt/
274 KB
97 KB
Script
General
Full URL
https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020120801.js
Requested by
Host: www.googletagservices.com
URL: https://www.googletagservices.com/tag/js/gpt.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
172.217.22.2 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
fra16s14-in-f2.1e100.net
Software
sffe /
Resource Hash
5f02981bfcab6807a15ddfea1babc7cee05cd0f1f59abe712928de44fb6c1f0d
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:45:36 GMT
content-encoding
gzip
x-content-type-options
nosniff
last-modified
Tue, 08 Dec 2020 09:42:29 GMT
server
sffe
vary
Accept-Encoding
content-type
text/javascript
cache-control
private, immutable, max-age=31536000
cross-origin-resource-policy
cross-origin
accept-ranges
bytes
timing-allow-origin
*
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
98829
x-xss-protection
0
expires
Tue, 15 Dec 2020 12:45:36 GMT
truncated
/
42 B
0
Image
General
Full URL
data:truncated
Protocol
DATA
Server
-, , ASN (),
Reverse DNS
Software
/
Resource Hash
ef1955ae757c8b966c83248350331bd3a30f658ced11f387f8ebf05ab3368629

Request headers

Referer
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Content-Type
image/gif
twitter_icon_tiny.png
i.dailymail.co.uk/i/furniture/icons/
1 KB
1 KB
Image
General
Full URL
https://i.dailymail.co.uk/i/furniture/icons/twitter_icon_tiny.png
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/static/gunther/17.14.0/all--.css
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2a02:26f0:6c00:288::11ae , Ascension Island, ASN20940 (AKAMAI-ASN1, EU),
Reverse DNS
Software
Apache /
Resource Hash
38f28716c48a39ee9a7bbaad9879c2330e1a394bbba98e83425920410342ac14

Request headers

Referer
https://www.dailymail.co.uk/static/gunther/17.14.0/all--.css
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:45:36 GMT
last-modified
Mon, 12 Jan 2015 12:09:29 GMT
server
Apache
etag
"238ff7fea119e41aea5f80988ff8c4c8:1421064569"
content-type
image/png
cache-control
max-age=2592000
accept-ranges
bytes
timing-allow-origin
*
content-length
1247
expires
Thu, 14 Jan 2021 12:45:36 GMT
spt_socialicons_40x40eachbttn9.png
i.dailymail.co.uk/i/furniture/articles/
26 KB
26 KB
Image
General
Full URL
https://i.dailymail.co.uk/i/furniture/articles/spt_socialicons_40x40eachbttn9.png
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/static/mol-fe/static/mol-fe-async-bundle/6.18.1/articleDefer.css
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2a02:26f0:6c00:288::11ae , Ascension Island, ASN20940 (AKAMAI-ASN1, EU),
Reverse DNS
Software
Apache /
Resource Hash
3381376497b5b338f301a29f4b399d81331e55a568f02df5db466149e5826f13

Request headers

Referer
https://www.dailymail.co.uk/static/mol-fe/static/mol-fe-async-bundle/6.18.1/articleDefer.css
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:45:36 GMT
last-modified
Thu, 17 May 2018 13:20:45 GMT
server
Apache
etag
"bab988d64a75ef93640c8ed16e05987b:1526563245"
content-type
image/png
cache-control
max-age=2592000
accept-ranges
bytes
timing-allow-origin
*
content-length
26818
expires
Thu, 14 Jan 2021 12:45:36 GMT
truncated
/
233 B
0
Image
General
Full URL
data:truncated
Protocol
DATA
Server
-, , ASN (),
Reverse DNS
Software
/
Resource Hash
b707cea228ebd1afe82a1840449e8c14d79bb62ec828d1ca7c3b6832a6905133

Request headers

Referer
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Content-Type
image/svg+xml
truncated
/
663 B
0
Image
General
Full URL
data:truncated
Protocol
DATA
Server
-, , ASN (),
Reverse DNS
Software
/
Resource Hash
deb959c047f364b4d81eb0b735fd60c7172cb808ddad43546948d90a38ad362e

Request headers

Referer
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Content-Type
image/svg+xml
truncated
/
44 KB
44 KB
Font
General
Full URL
data:truncated
Protocol
DATA
Server
-, , ASN (),
Reverse DNS
Software
/
Resource Hash
b0a9ac514283709cb85750e1a15f4ed549be7d0caa7711a70a3249d15538ac44

Request headers

Origin
https://www.dailymail.co.uk
Referer
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Content-Type
font/woff
truncated
/
41 KB
41 KB
Font
General
Full URL
data:truncated
Protocol
DATA
Server
-, , ASN (),
Reverse DNS
Software
/
Resource Hash
0b7e7d1bedae2fca5895468c68d7a3f06c5fa573a19fbdc1ea4da51441d59458

Request headers

Origin
https://www.dailymail.co.uk
Referer
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Content-Type
font/woff
graphik-medium.woff2
i.dailymail.co.uk/i/fonts/graphik-official/
33 KB
34 KB
Font
General
Full URL
https://i.dailymail.co.uk/i/fonts/graphik-official/graphik-medium.woff2
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/static/mol-fe/static/mol-fe-sync-bundle/5.9.0/desktop.css
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2a02:26f0:6c00:288::11ae , Ascension Island, ASN20940 (AKAMAI-ASN1, EU),
Reverse DNS
Software
Apache /
Resource Hash
a889d45fd306329c8c05ecfdd48f114b5ad8fb64a766c103b88cbe19a5c4b6bc

Request headers

Origin
https://www.dailymail.co.uk
Referer
https://www.dailymail.co.uk/static/mol-fe/static/mol-fe-sync-bundle/5.9.0/desktop.css
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:45:36 GMT
last-modified
Tue, 29 Nov 2016 11:56:15 GMT
server
Apache
etag
"199e5924b9ba81084b56514905d2215d:1480420575"
access-control-max-age
0
access-control-allow-methods
GET, POST, OPTIONS
content-type
application/x-font-woff
access-control-allow-origin
*
cache-control
max-age=2592000
accept-ranges
bytes
timing-allow-origin
*
access-control-allow-headers
Content-Type
content-length
34109
expires
Thu, 14 Jan 2021 12:45:36 GMT
34725488-8869893-image-a-42_1603399659388.jpg
i.dailymail.co.uk/1s/2020/10/22/21/
31 KB
31 KB
Image
General
Full URL
https://i.dailymail.co.uk/1s/2020/10/22/21/34725488-8869893-image-a-42_1603399659388.jpg
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2a02:26f0:6c00:288::11ae , Ascension Island, ASN20940 (AKAMAI-ASN1, EU),
Reverse DNS
Software
AmazonS3 /
Resource Hash
f136f4b3a437e9f7fdbfe4f638e92b53e5c6ee4ecd48238f7e0e78a46b12bc88

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

x-amz-version-id
UFnQBbUN.nd2h3iuoG_fO.78zbf2VYpG
last-modified
Thu, 22 Oct 2020 20:47:41 GMT
server
AmazonS3
x-amz-request-id
FK2Q1H9Y3P3N9W7M
etag
"cfd94bf2b3d471ff5275ba1fa3e3ec9c"
content-type
image/jpeg
cache-control
max-age=2592000
date
Tue, 15 Dec 2020 12:45:36 GMT
x-amz-replication-status
COMPLETED
accept-ranges
bytes
timing-allow-origin
*
content-length
31605
x-amz-id-2
E0v1LRYSgFe1CusRROtrlfZjjdL+jsWhiFdXd30jUbjzAQtDnhHNaPVawR+j5h0qCRtvT5PDFUo=
expires
Thu, 14 Jan 2021 12:45:36 GMT
setuid
ib.adnxs.com/prebid/
Redirect Chain
  • https://x.bidswitch.net/check_uuid/https%3A%2F%2Fib.adnxs.com%2Fprebid%2Fsetuid%3Fbidder%3Dgrid%26gdpr%3D0%26gdpr_consent%3D%26uid%3D%24%7BBSW_UUID%7D?gdpr=0&gdpr_consent=&us_privacy=
  • https://x.bidswitch.net/ul_cb/check_uuid/https%3A%2F%2Fib.adnxs.com%2Fprebid%2Fsetuid%3Fbidder%3Dgrid%26gdpr%3D0%26gdpr_consent%3D%26uid%3D%24%7BBSW_UUID%7D?gdpr=0&gdpr_consent=&us_privacy=
  • https://ib.adnxs.com/prebid/setuid?bidder=grid&gdpr=0&gdpr_consent=&uid=e731bccd-9047-4727-b766-9ea3c6cb3551
43 B
1 KB
Image
General
Full URL
https://ib.adnxs.com/prebid/setuid?bidder=grid&gdpr=0&gdpr_consent=&uid=e731bccd-9047-4727-b766-9ea3c6cb3551
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_ECDSA, AES_128_GCM
Server
185.33.221.13 , Netherlands, ASN29990 (ASN-APPNEX, US),
Reverse DNS
729.bm-nginx-loadbalancer.mgmt.ams1.adnexus.net
Software
nginx/1.17.9 /
Resource Hash
4b5b6b15c6255109e06720cce42a06d3aead8b7874423d9c52cb0303212c25ef
Security Headers
Name Value
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Pragma
no-cache
Date
Tue, 15 Dec 2020 12:45:37 GMT
X-Proxy-Origin
185.212.171.67; 185.212.171.67; 729.bm-nginx-loadbalancer.mgmt.ams1; *.adnxs.com; 185.33.220.42:80
AN-X-Request-Uuid
c69308fe-cb66-4c61-a498-bf7bcc0ef4de
Server
nginx/1.17.9
P3P
policyref="http://cdn.adnxs.com/w3c/policy/p3p.xml", CP="NOI DSP COR ADM PSAo PSDo OURo SAMo UNRo OTRo BUS COM NAV DEM STA PRE"
Cache-Control
no-store, no-cache, private
Connection
keep-alive
Content-Type
image/gif
Content-Length
43
X-XSS-Protection
0
Expires
Sat, 15 Nov 2008 16:00:00 GMT

Redirect headers

location
https://ib.adnxs.com/prebid/setuid?bidder=grid&gdpr=0&gdpr_consent=&uid=e731bccd-9047-4727-b766-9ea3c6cb3551
date
Tue, 15 Dec 2020 12:45:37 GMT
cache-control
no-cache, no-store, must-revalidate
content-length
0
p3p
CP="NOI DSP COR NID CURa ADMa DEVa PSAa PSDa OUR BUS COM INT OTC PUR STA"
auction
prebid.adnxs.com/pbs/v1/openrtb2/
150 B
499 B
XHR
General
Full URL
https://prebid.adnxs.com/pbs/v1/openrtb2/auction
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/static/mol-adverts/demo/mol-22070/19a28e0b/mol-adverts.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
37.252.161.190 , Ascension Island, ASN29990 (ASN-APPNEX, US),
Reverse DNS
prebid.ams1.adnexus.net
Software
nginx/1.19.0 /
Resource Hash
a1cc57bd9b65a8761f53af8cab875804fb95098001a8bcda29ce1cdcaaa1face

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type
text/plain

Response headers

Pragma
no-cache
Date
Tue, 15 Dec 2020 12:45:36 GMT
Server
nginx/1.19.0
Vary
Origin
Content-Type
application/json
Access-Control-Allow-Origin
https://www.dailymail.co.uk
Cache-Control
no-cache, no-store, must-revalidate
Access-Control-Allow-Credentials
true
Connection
keep-alive
Content-Length
150
Expires
0
arj
mailonline-uk-d.openx.net/w/1.0/
173 B
360 B
XHR
General
Full URL
https://mailonline-uk-d.openx.net/w/1.0/arj?ju=https%3A%2F%2Fwww.dailymail.co.uk%2Fsciencetech%2Farticle-9050821%2FRemdesivir-beneficial-patients-doctors-reveal.html%3F_hsmi%3D88974744%26_hsenc%3Dp2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8&ch=UTF-8&res=1600x1200x24&ifr=false&tz=-60&tws=1600x1200&be=1&bc=hb_pb_3.0.3&dddid=c40f66d5-678a-480f-85e7-5482a0fd9a5c&nocache=1608036336903&pubcid=84f1103b-a980-4860-8c6e-1866bcc8525c&aus=300x250&divIds=mpu_factbox_1&auid=541058631
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/static/mol-adverts/demo/mol-22070/19a28e0b/mol-adverts.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
35.244.159.8 Mountain View, United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
OXGW/16.199.0 /
Resource Hash
656c2683866c5bf872b78fc373e572523f85822e2ff784cafc1a47d25ffdadf4

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type
text/plain

Response headers

pragma
no-cache
date
Tue, 15 Dec 2020 12:45:36 GMT
content-encoding
gzip
server
OXGW/16.199.0
vary
Accept, Accept-Encoding
p3p
CP="CUR ADM OUR NOR STA NID"
access-control-allow-origin
https://www.dailymail.co.uk
cache-control
private, max-age=0, no-cache
access-control-allow-credentials
true
content-type
application/json
alt-svc
clear
content-length
164
via
1.1 google
expires
Mon, 26 Jul 1997 05:00:00 GMT
cygnus
htlb.casalemedia.com/
26 B
376 B
XHR
General
Full URL
https://htlb.casalemedia.com/cygnus?s=501785&v=7.2&r=%7B%22id%22%3A%22142632ffa6170e7e%22%2C%22imp%22%3A%5B%7B%22id%22%3A%2214387e851dc8fef%22%2C%22ext%22%3A%7B%22siteID%22%3A%22501785%22%2C%22sid%22%3A%22300x250%22%7D%2C%22banner%22%3A%7B%22w%22%3A300%2C%22h%22%3A250%2C%22topframe%22%3A1%7D%7D%5D%2C%22site%22%3A%7B%22page%22%3A%22https%3A%2F%2Fwww.dailymail.co.uk%2Fsciencetech%2Farticle-9050821%2FRemdesivir-beneficial-patients-doctors-reveal.html%3F_hsmi%3D88974744%26_hsenc%3Dp2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8%22%7D%2C%22ext%22%3A%7B%22source%22%3A%22prebid%22%7D%7D&ac=j&sd=1
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/static/mol-adverts/demo/mol-22070/19a28e0b/mol-adverts.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
104.111.215.135 , Netherlands, ASN16625 (AKAMAI-AS, US),
Reverse DNS
a104-111-215-135.deploy.static.akamaitechnologies.com
Software
Apache /
Resource Hash
e04d0e72547f70a915d012bfc3d7a9fd96bcc710f9aa2414519e9d925f0f5706

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type
text/plain

Response headers

pragma
no-cache
date
Tue, 15 Dec 2020 12:45:36 GMT
content-encoding
gzip
x-ak-initial-geo
CC:[NL], RC:[], CN:[EU], CIP:[185.212.171.67], XFF:[]
server
Apache
vary
Is-Traffic-Invalid,Accept-Encoding
content-type
application/json
access-control-allow-origin
https://www.dailymail.co.uk
x-cs-client-geo
12
cache-control
max-age=0, no-cache, no-store
access-control-allow-credentials
true
content-length
46
x-ak-client-geo
12
expires
Tue, 15 Dec 2020 12:45:36 GMT
cdb
bidder.criteo.com/
0
149 B
XHR
General
Full URL
https://bidder.criteo.com/cdb?profileId=207&av=32&wv=4.13.0-mol-1&cb=98483481502
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/static/mol-adverts/demo/mol-22070/19a28e0b/mol-adverts.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
178.250.0.165 , France, ASN44788 (ASN-CRITEO-EUROPE, FR),
Reverse DNS
bidder.par.vip.prod.criteo.com
Software
Finatra /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type
text/plain

Response headers

access-control-allow-origin
https://www.dailymail.co.uk
date
Tue, 15 Dec 2020 12:45:36 GMT
access-control-allow-credentials
true
server
Finatra
timing-allow-origin
*
vary
Origin
prebid
ib.adnxs.com/ut/v3/
19 B
717 B
XHR
General
Full URL
https://ib.adnxs.com/ut/v3/prebid
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/static/mol-adverts/demo/mol-22070/19a28e0b/mol-adverts.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_ECDSA, AES_128_GCM
Server
185.33.221.13 , Netherlands, ASN29990 (ASN-APPNEX, US),
Reverse DNS
729.bm-nginx-loadbalancer.mgmt.ams1.adnexus.net
Software
nginx/1.17.9 /
Resource Hash
0c09c070833c786cb25be38bc30992b30bad578f817dbc9e34beacd8b8ea44c5
Security Headers
Name Value
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type
text/plain

Response headers

Pragma
no-cache
Date
Tue, 15 Dec 2020 12:45:36 GMT
X-Proxy-Origin
185.212.171.67; 185.212.171.67; 729.bm-nginx-loadbalancer.mgmt.ams1; *.adnxs.com; 185.33.220.237:80
AN-X-Request-Uuid
092783f8-08e0-46fd-830f-fdde20ac3bdb
Server
nginx/1.17.9
P3P
policyref="http://cdn.adnxs.com/w3c/policy/p3p.xml", CP="NOI DSP COR ADM PSAo PSDo OURo SAMo UNRo OTRo BUS COM NAV DEM STA PRE"
Access-Control-Allow-Origin
https://www.dailymail.co.uk
Cache-Control
no-store, no-cache, private
Access-Control-Allow-Credentials
true
Connection
keep-alive
Content-Type
application/json; charset=utf-8
Content-Length
19
X-XSS-Protection
0
Expires
Sat, 15 Nov 2008 16:00:00 GMT
bid-request
a.teads.tv/hb/
16 B
251 B
XHR
General
Full URL
https://a.teads.tv/hb/bid-request
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/static/mol-adverts/demo/mol-22070/19a28e0b/mol-adverts.js
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2.18.232.7 , Ascension Island, ASN16625 (AKAMAI-AS, US),
Reverse DNS
a2-18-232-7.deploy.static.akamaitechnologies.com
Software
/
Resource Hash
6a7b0c8bf87b2bd5ca31557f25cf2a6c80f93af72bf68a6085e9b55a87fe908c

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type
text/plain

Response headers

pragma
no-cache
date
Tue, 15 Dec 2020 12:45:37 GMT
content-encoding
gzip
vary
Accept-Encoding
content-type
application/json
access-control-allow-origin
https://www.dailymail.co.uk
cache-control
max-age=0, no-cache, no-store
access-control-allow-credentials
true
content-length
42
expires
Tue, 15 Dec 2020 12:45:37 GMT
fastlane.json
fastlane.rubiconproject.com/a/api/
260 B
1 KB
XHR
General
Full URL
https://fastlane.rubiconproject.com/a/api/fastlane.json?account_id=8625&site_id=124374&zone_id=1635080&size_id=15&eid_pubcid.org=84f1103b-a980-4860-8c6e-1866bcc8525c%5E1&rf=https%3A%2F%2Fwww.dailymail.co.uk%2Fsciencetech%2Farticle-9050821%2FRemdesivir-beneficial-patients-doctors-reveal.html%3F_hsmi%3D88974744%26_hsenc%3Dp2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8&tg_i.area=sciencetech&tk_flint=pbjs_lite_v4.13.0-mol-1&x_source.tid=c40f66d5-678a-480f-85e7-5482a0fd9a5c&p_screen_res=1600x1200&rp_floor=0.01&rp_secure=1&slots=1&rand=0.36556744366948335
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/static/mol-adverts/demo/mol-22070/19a28e0b/mol-adverts.js
Protocol
HTTP/1.1
Security
TLS 1.2, RSA, AES_128_GCM
Server
213.19.162.31 , United Kingdom, ASN3356 (LEVEL3, US),
Reverse DNS
Software
nginx/1.16.0 /
Resource Hash
af68c71bd7094c96b373bdeee7134f836355e0336c147ebdd221dbc540620726

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type
text/plain

Response headers

Pragma
no-cache
Date
Tue, 15 Dec 2020 12:45:36 GMT
Server
nginx/1.16.0
Vary
Accept-Encoding
P3P
CP="NOI CURa ADMa DEVa TAIa OUR BUS IND UNI COM NAV INT"
Access-Control-Allow-Origin
https://www.dailymail.co.uk
Cache-Control
no-cache, no-store, max-age=0, must-revalidate
Access-Control-Allow-Credentials
true
Connection
keep-alive
Content-Type
application/json
Keep-Alive
timeout=5
Content-Length
260
Expires
Wed, 17 Sep 1975 21:32:10 GMT
truncated
/
715 B
0
Image
General
Full URL
data:truncated
Protocol
DATA
Server
-, , ASN (),
Reverse DNS
Software
/
Resource Hash
5a3f1dd74233f605e511f1b5b244bedf85ac88ba264caf4d6401bc7ec2017dcd

Request headers

Referer
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Content-Type
image/png
truncated
/
381 B
0
Image
General
Full URL
data:truncated
Protocol
DATA
Server
-, , ASN (),
Reverse DNS
Software
/
Resource Hash
63271dcce1a2518271ecc2b0bdcc5afc9c5f0968a8635e0f97a4c9747309eb82

Request headers

Referer
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Content-Type
image/svg+xml
auction
prebid.adnxs.com/pbs/v1/openrtb2/
150 B
499 B
XHR
General
Full URL
https://prebid.adnxs.com/pbs/v1/openrtb2/auction
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/static/mol-adverts/demo/mol-22070/19a28e0b/mol-adverts.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
37.252.161.190 , Ascension Island, ASN29990 (ASN-APPNEX, US),
Reverse DNS
prebid.ams1.adnexus.net
Software
nginx/1.19.0 /
Resource Hash
6e2a5097256ead96c0d659ce2e0f58ba5a725df5bcb60bbe98fcf5b162dfbf55

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type
text/plain

Response headers

Pragma
no-cache
Date
Tue, 15 Dec 2020 12:45:37 GMT
Server
nginx/1.19.0
Vary
Origin
Content-Type
application/json
Access-Control-Allow-Origin
https://www.dailymail.co.uk
Cache-Control
no-cache, no-store, must-revalidate
Access-Control-Allow-Credentials
true
Connection
keep-alive
Content-Length
150
Expires
0
cygnus
htlb.casalemedia.com/
26 B
376 B
XHR
General
Full URL
https://htlb.casalemedia.com/cygnus?s=501785&v=7.2&r=%7B%22id%22%3A%2215586775def6f49b%22%2C%22imp%22%3A%5B%7B%22id%22%3A%221562e2e02cb84526%22%2C%22ext%22%3A%7B%22siteID%22%3A%22501785%22%2C%22sid%22%3A%22300x250%22%7D%2C%22banner%22%3A%7B%22w%22%3A300%2C%22h%22%3A250%2C%22topframe%22%3A1%7D%7D%5D%2C%22site%22%3A%7B%22page%22%3A%22https%3A%2F%2Fwww.dailymail.co.uk%2Fsciencetech%2Farticle-9050821%2FRemdesivir-beneficial-patients-doctors-reveal.html%3F_hsmi%3D88974744%26_hsenc%3Dp2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8%22%7D%2C%22ext%22%3A%7B%22source%22%3A%22prebid%22%7D%7D&ac=j&sd=1
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/static/mol-adverts/demo/mol-22070/19a28e0b/mol-adverts.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
104.111.215.135 , Netherlands, ASN16625 (AKAMAI-AS, US),
Reverse DNS
a104-111-215-135.deploy.static.akamaitechnologies.com
Software
Apache /
Resource Hash
ddc54351655f3921ac099ca75e4b4fbc2bdf0988e38258bf5cec904756446f43

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type
text/plain

Response headers

pragma
no-cache
date
Tue, 15 Dec 2020 12:45:37 GMT
content-encoding
gzip
x-ak-initial-geo
CC:[NL], RC:[], CN:[EU], CIP:[185.212.171.67], XFF:[]
server
Apache
vary
Is-Traffic-Invalid,Accept-Encoding
content-type
application/json
access-control-allow-origin
https://www.dailymail.co.uk
x-cs-client-geo
12
cache-control
max-age=0, no-cache, no-store
access-control-allow-credentials
true
content-length
46
x-ak-client-geo
12
expires
Tue, 15 Dec 2020 12:45:37 GMT
cdb
bidder.criteo.com/
0
149 B
XHR
General
Full URL
https://bidder.criteo.com/cdb?profileId=207&av=32&wv=4.13.0-mol-1&cb=35582160945
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/static/mol-adverts/demo/mol-22070/19a28e0b/mol-adverts.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
178.250.0.165 , France, ASN44788 (ASN-CRITEO-EUROPE, FR),
Reverse DNS
bidder.par.vip.prod.criteo.com
Software
Finatra /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type
text/plain

Response headers

access-control-allow-origin
https://www.dailymail.co.uk
date
Tue, 15 Dec 2020 12:45:36 GMT
access-control-allow-credentials
true
server
Finatra
timing-allow-origin
*
vary
Origin
arj
mailonline-uk-d.openx.net/w/1.0/
172 B
359 B
XHR
General
Full URL
https://mailonline-uk-d.openx.net/w/1.0/arj?ju=https%3A%2F%2Fwww.dailymail.co.uk%2Fsciencetech%2Farticle-9050821%2FRemdesivir-beneficial-patients-doctors-reveal.html%3F_hsmi%3D88974744%26_hsenc%3Dp2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8&ch=UTF-8&res=1600x1200x24&ifr=false&tz=-60&tws=1600x1200&be=1&bc=hb_pb_3.0.3&dddid=50d2ed99-cc07-4270-b741-7ec03c17a9a2&nocache=1608036337000&pubcid=84f1103b-a980-4860-8c6e-1866bcc8525c&aus=300x250&divIds=mpu_factbox_2&auid=541058631
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/static/mol-adverts/demo/mol-22070/19a28e0b/mol-adverts.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
35.244.159.8 Mountain View, United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
OXGW/16.199.0 /
Resource Hash
33c547e1a731ac9b04cd81f552ac02e1aa0e39defb20f0bf53cbceaa514a9d6c

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type
text/plain

Response headers

pragma
no-cache
date
Tue, 15 Dec 2020 12:45:37 GMT
content-encoding
gzip
server
OXGW/16.199.0
vary
Accept, Accept-Encoding
p3p
CP="CUR ADM OUR NOR STA NID"
access-control-allow-origin
https://www.dailymail.co.uk
cache-control
private, max-age=0, no-cache
access-control-allow-credentials
true
content-type
application/json
alt-svc
clear
content-length
163
via
1.1 google
expires
Mon, 26 Jul 1997 05:00:00 GMT
prebid
ib.adnxs.com/ut/v3/
19 B
716 B
XHR
General
Full URL
https://ib.adnxs.com/ut/v3/prebid
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/static/mol-adverts/demo/mol-22070/19a28e0b/mol-adverts.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_ECDSA, AES_128_GCM
Server
185.33.221.13 , Netherlands, ASN29990 (ASN-APPNEX, US),
Reverse DNS
729.bm-nginx-loadbalancer.mgmt.ams1.adnexus.net
Software
nginx/1.17.9 /
Resource Hash
0c09c070833c786cb25be38bc30992b30bad578f817dbc9e34beacd8b8ea44c5
Security Headers
Name Value
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type
text/plain

Response headers

Pragma
no-cache
Date
Tue, 15 Dec 2020 12:45:37 GMT
X-Proxy-Origin
185.212.171.67; 185.212.171.67; 729.bm-nginx-loadbalancer.mgmt.ams1; *.adnxs.com; 185.33.220.82:80
AN-X-Request-Uuid
176314c9-5a83-40d3-9b51-8d009c8dbcbb
Server
nginx/1.17.9
P3P
policyref="http://cdn.adnxs.com/w3c/policy/p3p.xml", CP="NOI DSP COR ADM PSAo PSDo OURo SAMo UNRo OTRo BUS COM NAV DEM STA PRE"
Access-Control-Allow-Origin
https://www.dailymail.co.uk
Cache-Control
no-store, no-cache, private
Access-Control-Allow-Credentials
true
Connection
keep-alive
Content-Type
application/json; charset=utf-8
Content-Length
19
X-XSS-Protection
0
Expires
Sat, 15 Nov 2008 16:00:00 GMT
bid-request
a.teads.tv/hb/
16 B
251 B
XHR
General
Full URL
https://a.teads.tv/hb/bid-request
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/static/mol-adverts/demo/mol-22070/19a28e0b/mol-adverts.js
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2.18.232.7 , Ascension Island, ASN16625 (AKAMAI-AS, US),
Reverse DNS
a2-18-232-7.deploy.static.akamaitechnologies.com
Software
/
Resource Hash
6a7b0c8bf87b2bd5ca31557f25cf2a6c80f93af72bf68a6085e9b55a87fe908c

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type
text/plain

Response headers

pragma
no-cache
date
Tue, 15 Dec 2020 12:45:37 GMT
content-encoding
gzip
vary
Accept-Encoding
content-type
application/json
access-control-allow-origin
https://www.dailymail.co.uk
cache-control
max-age=0, no-cache, no-store
access-control-allow-credentials
true
content-length
42
expires
Tue, 15 Dec 2020 12:45:37 GMT
fastlane.json
fastlane.rubiconproject.com/a/api/
260 B
1 KB
XHR
General
Full URL
https://fastlane.rubiconproject.com/a/api/fastlane.json?account_id=8625&site_id=124374&zone_id=1635080&size_id=15&eid_pubcid.org=84f1103b-a980-4860-8c6e-1866bcc8525c%5E1&rf=https%3A%2F%2Fwww.dailymail.co.uk%2Fsciencetech%2Farticle-9050821%2FRemdesivir-beneficial-patients-doctors-reveal.html%3F_hsmi%3D88974744%26_hsenc%3Dp2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8&tg_i.area=sciencetech&tk_flint=pbjs_lite_v4.13.0-mol-1&x_source.tid=50d2ed99-cc07-4270-b741-7ec03c17a9a2&p_screen_res=1600x1200&rp_floor=0.01&rp_secure=1&slots=1&rand=0.4263514239455577
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/static/mol-adverts/demo/mol-22070/19a28e0b/mol-adverts.js
Protocol
HTTP/1.1
Security
TLS 1.2, RSA, AES_128_GCM
Server
213.19.162.31 , United Kingdom, ASN3356 (LEVEL3, US),
Reverse DNS
Software
nginx/1.16.0 /
Resource Hash
c857617c36702de303952b9268f1fa903fe3762a467f0227fa6862ac0b68d068

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type
text/plain

Response headers

Pragma
no-cache
Date
Tue, 15 Dec 2020 12:45:37 GMT
Server
nginx/1.16.0
Vary
Accept-Encoding
P3P
CP="NOI CURa ADMa DEVa TAIa OUR BUS IND UNI COM NAV INT"
Access-Control-Allow-Origin
https://www.dailymail.co.uk
Cache-Control
no-cache, no-store, max-age=0, must-revalidate
Access-Control-Allow-Credentials
true
Connection
keep-alive
Content-Type
application/json
Keep-Alive
timeout=5
Content-Length
260
Expires
Wed, 17 Sep 1975 21:32:10 GMT
truncated
/
547 B
0
Image
General
Full URL
data:truncated
Protocol
DATA
Server
-, , ASN (),
Reverse DNS
Software
/
Resource Hash
eb14baeac955bb11e33cd7fd3fd2f698cf20db1b450325f45ea843b6cdc82366

Request headers

Referer
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Content-Type
image/svg+xml
truncated
/
552 B
0
Image
General
Full URL
data:truncated
Protocol
DATA
Server
-, , ASN (),
Reverse DNS
Software
/
Resource Hash
62f3f809487194fcc55a3ebd88811a604ae496027bb425d4ebd15d9ae1921945

Request headers

Referer
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Content-Type
image/svg+xml
truncated
/
178 B
0
Image
General
Full URL
data:truncated
Protocol
DATA
Server
-, , ASN (),
Reverse DNS
Software
/
Resource Hash
3ee0806e69f2ae70a2267a58ac5fc5d52b5aa7aca6f3c0c08adad605fd8fbc16

Request headers

Referer
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Content-Type
image/svg+xml
truncated
/
352 B
0
Image
General
Full URL
data:truncated
Protocol
DATA
Server
-, , ASN (),
Reverse DNS
Software
/
Resource Hash
5f3592a8b8037ea064764a2815799612063c6722d314d1d66d3a9391c3c16d66

Request headers

Referer
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Content-Type
image/svg+xml
truncated
/
243 B
0
Image
General
Full URL
data:truncated
Protocol
DATA
Server
-, , ASN (),
Reverse DNS
Software
/
Resource Hash
9d2d8043c302d3a9da9277374a53e2285c471d5dc8397885b4931b82771d5cae

Request headers

Referer
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Content-Type
image/svg+xml
loader.js
cdn.taboola.com/libtrc/dailymail-row/
253 KB
33 KB
Script
General
Full URL
https://cdn.taboola.com/libtrc/dailymail-row/loader.js
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/static/mol-adverts/demo/mol-22070/19a28e0b/mol-adverts.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
151.101.13.44 Frankfurt am Main, Germany, ASN54113 (FASTLY, US),
Reverse DNS
Software
AmazonS3 /
Resource Hash
00e885d1932c734d6dca1b0ff4b175fb1729c4173dde2bf0321b49058b4216f4

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

x-amz-version-id
cNo9WZ36Mx.68LJAL2pG7w7TW8P_p_1c
content-encoding
gzip
etag
"dc806877dc6b156c4201a91e6ff7756d"
age
5
x-cache
HIT
content-length
33891
x-amz-id-2
fe9LgsIA+YycFdqLFMbz1XwX5WPZS8M9f2cDlQ/hgXTswDnpTh7E6O3JXQN4FBATwUtu5bDunpA=
x-served-by
cache-fra19144-FRA
last-modified
Mon, 14 Dec 2020 12:06:40 GMT
server
AmazonS3
x-timer
S1608036337.078424,VS0,VE0
date
Tue, 15 Dec 2020 12:45:37 GMT
vary
Accept-Encoding
x-amz-request-id
74C49AAD9CD52C5F
via
1.1 varnish
cache-control
private,max-age=14401
accept-ranges
bytes
content-type
application/javascript; charset=utf-8
abp
24
x-cache-hits
2
collect
stats.g.doubleclick.net/r/
Redirect Chain
  • https://ssl.google-analytics.com/r/__utm.gif?utmwv=5.7.2&utms=1&utmn=745871990&utmhn=www.dailymail.co.uk&utmcs=UTF-8&utmsr=1600x1200&utmvp=1600x1200&utmsc=24-bit&utmul=en-us&utmje=0&utmfl=-&utmdt=R...
  • https://stats.g.doubleclick.net/r/collect?v=1&aip=1&t=dc&_r=3&tid=UA-3639451-1&cid=254203172.1608036337&jid=596898861&_v=5.7.2&z=745871990
35 B
113 B
Image
General
Full URL
https://stats.g.doubleclick.net/r/collect?v=1&aip=1&t=dc&_r=3&tid=UA-3639451-1&cid=254203172.1608036337&jid=596898861&_v=5.7.2&z=745871990
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:400c:c0c::9b Brussels, Belgium, ASN15169 (GOOGLE, US),
Reverse DNS
Software
Golfe2 /
Resource Hash
8337212354871836e6763a41e615916c89bac5b3f1f0adf60ba43c7c806e1015
Security Headers
Name Value
Strict-Transport-Security max-age=10886400; includeSubDomains; preload
X-Content-Type-Options nosniff

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

pragma
no-cache
strict-transport-security
max-age=10886400; includeSubDomains; preload
x-content-type-options
nosniff
last-modified
Sun, 17 May 1998 03:00:00 GMT
server
Golfe2
date
Tue, 15 Dec 2020 12:45:37 GMT
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cross-origin-resource-policy
cross-origin
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
35
expires
Fri, 01 Jan 1990 00:00:00 GMT

Redirect headers

pragma
no-cache
date
Tue, 15 Dec 2020 12:45:37 GMT
last-modified
Sun, 17 May 1998 03:00:00 GMT
server
Golfe2
location
https://stats.g.doubleclick.net/r/collect?v=1&aip=1&t=dc&_r=3&tid=UA-3639451-1&cid=254203172.1608036337&jid=596898861&_v=5.7.2&z=745871990
content-type
text/html; charset=UTF-8
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cross-origin-resource-policy
cross-origin
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
367
expires
Fri, 01 Jan 1990 00:00:00 GMT
hit.gif
uk-script.dotmetrics.net/
43 B
1 KB
Image
General
Full URL
https://uk-script.dotmetrics.net/hit.gif?id=4626&url=https%3A%2F%2Fwww.dailymail.co.uk%2Fsciencetech%2Farticle-9050821%2FRemdesivir-beneficial-patients-doctors-reveal.html%3F_hsmi%3D88974744%26_hsenc%3Dp2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8&dom=www.dailymail.co.uk&r=1608036337103&pvs=1&pvid=kipzbemnro8tssjpr1n&c=true
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
65.9.68.128 Seattle, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
Kestrel /
Resource Hash
dcecab1355b5c2b9ecef281322bf265ac5840b4688748586e9632b473a5fe56b

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:45:37 GMT
dotmetrics-hit-status
01 OK
server
Kestrel
x-amz-cf-pop
FRA56-C1
x-cache
Miss from cloudfront
p3p
policyref="https://uk-script.dotmetrics.net/w3c/p3p.xml", CP="NOI DSP LAW CURa ADMa DEVa PSAa HISa OUR IND STA"
via
1.1 9570c3a1725c20e6faed117bbb74223b.cloudfront.net (CloudFront)
cache-control
no-cache
content-type
image/gif
x-amz-cf-id
h7vFeKViIhmSFu2MRcxS2Q5MXB_CoWQRCz0RJfj8an8sfRgq58vkeA==
json
trc.taboola.com/1125455/trc/3/
834 B
787 B
Script
General
Full URL
https://trc.taboola.com/1125455/trc/3/json?tim=1608036337117&data=%7B%22id%22%3A900%2C%22ii%22%3A%22%2Fsciencetech%2Farticle-9050821%2Fremdesivir-beneficial-patients-doctors-reveal.html%22%2C%22it%22%3A%22text%22%2C%22sd%22%3Anull%2C%22ui%22%3Anull%2C%22vi%22%3A1608036337111%2C%22cv%22%3A%2220201123-29-RELEASE%22%2C%22uiv%22%3A%22default%22%2C%22u%22%3A%22https%3A%2F%2Fwww.dailymail.co.uk%2Fsciencetech%2Farticle-9050821%2FRemdesivir-beneficial-patients-doctors-reveal.html%22%2C%22e%22%3Anull%2C%22cb%22%3A%22TFASC.trkCallback%22%2C%22qs%22%3A%22%3F_hsmi%3D88974744%26_hsenc%3Dp2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8%22%2C%22r%22%3A%5B%7B%22li%22%3A%22rbox-tracking%22%2C%22s%22%3A0%2C%22uim%22%3A%22rbox-tracking%3Apub%3Dmailonline-sc%3Aabp%3D0%22%2C%22uip%22%3A%22rbox-tracking%22%2C%22orig_uip%22%3A%22rbox-tracking%22%7D%5D%2C%22mpv%22%3Atrue%2C%22supv%22%3Atrue%2C%22mpvd%22%3A%7B%22en%22%3A%22page_view%22%2C%22tim%22%3A1608036337116%2C%22ref%22%3Anull%2C%22item-url%22%3A%22https%3A%2F%2Fwww.dailymail.co.uk%2Fsciencetech%2Farticle-9050821%2FRemdesivir-beneficial-patients-doctors-reveal.html%3F_hsmi%3D88974744%26_hsenc%3Dp2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8%22%2C%22supv%22%3Atrue%7D%7D&pubit=i
Requested by
Host: cdn.taboola.com
URL: https://cdn.taboola.com/libtrc/unip/1125455/tfa.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
151.101.13.44 Frankfurt am Main, Germany, ASN54113 (FASTLY, US),
Reverse DNS
Software
nginx /
Resource Hash
b7188fcb720d2d221db8faff67f3979c3f0fb979760b226861fd346299712915

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

x-vcl-time-ms
15
date
Tue, 15 Dec 2020 12:45:37 GMT
content-encoding
gzip
server
nginx
x-timer
S1608036337.134732,VS0,VE15
x-served-by
cache-fra19144-FRA
vary
Accept-Encoding
x-cache
MISS
p3p
policyref="http://trc.taboola.com/p3p.xml", CP="NOI DSP COR LAW NID CURa ADMa DEVa PSAa PSDa OUR BUS IND UNI COM NAV INT DEM"
access-control-allow-origin
*
access-control-allow-credentials
true
accept-ranges
bytes
content-type
application/javascript; charset=utf-8
via
1.1 varnish
x-cache-hits
0
aps_csm.js
c.amazon-adsystem.com/bao-csm/aps-comm/
6 KB
3 KB
XHR
General
Full URL
https://c.amazon-adsystem.com/bao-csm/aps-comm/aps_csm.js
Requested by
Host: c.amazon-adsystem.com
URL: https://c.amazon-adsystem.com/aax2/apstag.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
99.84.88.20 Seattle, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-99-84-88-20.muc50.r.cloudfront.net
Software
AmazonS3 /
Resource Hash
06b99248a163333e36980a6cfb756f1a7de60fa49517162b87b1a44d5d48f844

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

x-amz-version-id
null
content-encoding
gzip
etag
"a4d296427fc806b21335359e398c025c"
age
78206
x-cache
Hit from cloudfront
access-control-max-age
3000
access-control-allow-origin
*
last-modified
Sat, 05 Dec 2020 02:12:39 GMT
server
AmazonS3
date
Mon, 14 Dec 2020 15:02:12 GMT
vary
Origin
access-control-allow-methods
GET
content-type
application/javascript
via
1.1 a1e8102a85e1e5a1d6e04d628d5dc181.cloudfront.net (CloudFront)
cache-control
public, max-age=86400
x-amz-cf-pop
MUC50-C1
x-amz-cf-id
2vxFPBV1ZDy3EqhSSMQii_I-zZ_47_2fakCIUin23Df9AdSJiFWaEw==
/
www.facebook.com/tr/
44 B
258 B
Image
General
Full URL
https://www.facebook.com/tr/?id=1401367413466420&ev=PixelInitialized&dl=https%3A%2F%2Fwww.dailymail.co.uk%2Fsciencetech%2Farticle-9050821%2FRemdesivir-beneficial-patients-doctors-reveal.html%3F_hsmi%3D88974744%26_hsenc%3Dp2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8&rl=&if=false&ts=1608036337199
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a03:2880:f12d:83:face:b00c:0:25de , Ireland, ASN32934 (FACEBOOK, US),
Reverse DNS
Software
proxygen-bolt /
Resource Hash
10d8d42d73a02ddb877101e72fbfa15a0ec820224d97cedee4cf92d571be5caa
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:45:37 GMT
last-modified
Fri, 21 Dec 2012 00:00:01 GMT
server
proxygen-bolt
strict-transport-security
max-age=31536000; includeSubDomains
content-type
image/gif
cache-control
no-cache, must-revalidate, max-age=0
alt-svc
h3-29=":443"; ma=3600,h3-27=":443"; ma=3600
content-length
44
expires
Tue, 15 Dec 2020 12:45:37 GMT
5f42864d-a421-4f37-9478-00266f871d68-models.bin
cdn.permutive.com/models/
20 KB
21 KB
XHR
General
Full URL
https://cdn.permutive.com/models/5f42864d-a421-4f37-9478-00266f871d68-models.bin
Requested by
Host: cdn.permutive.com
URL: https://cdn.permutive.com/5f42864d-a421-4f37-9478-00266f871d68-web.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
104.19.150.54 , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
4c45cd70d2ed7d0949de5f5d8f7570e1d5a3e8ac60f5e83421f79ff32b71f14e

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:45:37 GMT
cf-cache-status
HIT
age
3490
x-guploader-uploadid
ABg5-UxILulDle9pme_8tLTb0jc8L_VzfsK3EZXEhbH21gy9pBM7G_twpraYqCNxYwL6JRFJkSWh7GFFXkp8yn16Rw
x-goog-storage-class
REGIONAL
x-goog-metageneration
1
x-goog-stored-content-encoding
gzip
content-type
application/x-binary
cf-request-id
0708085e740000bdc8f5292000000001
last-modified
Tue, 15 Dec 2020 05:25:37 GMT
server
cloudflare
etag
W/"ac8f35721a5b6a1246ee9c95067ddb4d"
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary
Accept-Encoding
x-goog-hash
crc32c=1H0qnA==, md5=rI81chpbahJG7pyVBn3bTQ==
x-goog-generation
1608009937921506
access-control-allow-origin
*
access-control-expose-headers
Content-Length, Date, Server, Transfer-Encoding, X-GUploader-UploadID, X-Google-Trace
cache-control
public, max-age=300
x-goog-stored-content-length
20390
cf-ray
60204343e9e2bdc8-AMS
expires
Tue, 15 Dec 2020 12:50:37 GMT
getuidj
ib.adnxs.com/
11 B
708 B
XHR
General
Full URL
https://ib.adnxs.com/getuidj
Requested by
Host: cdn.permutive.com
URL: https://cdn.permutive.com/5f42864d-a421-4f37-9478-00266f871d68-web.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_ECDSA, AES_128_GCM
Server
185.33.221.13 , Netherlands, ASN29990 (ASN-APPNEX, US),
Reverse DNS
729.bm-nginx-loadbalancer.mgmt.ams1.adnexus.net
Software
nginx/1.17.9 /
Resource Hash
31b45c462302ac175bfa43f9e5591491db780ca094f6ecdd2907f25ad578448d
Security Headers
Name Value
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Pragma
no-cache
Date
Tue, 15 Dec 2020 12:45:37 GMT
X-Proxy-Origin
185.212.171.67; 185.212.171.67; 729.bm-nginx-loadbalancer.mgmt.ams1; *.adnxs.com; 185.33.220.44:80
AN-X-Request-Uuid
16362950-8c5d-42f2-937b-02027e0e3fcb
Server
nginx/1.17.9
P3P
policyref="http://cdn.adnxs.com/w3c/policy/p3p.xml", CP="NOI DSP COR ADM PSAo PSDo OURo SAMo UNRo OTRo BUS COM NAV DEM STA PRE"
Access-Control-Allow-Origin
https://www.dailymail.co.uk
Cache-Control
no-store, no-cache, private
Access-Control-Allow-Credentials
true
Connection
keep-alive
Content-Type
application/json; charset=utf-8
Content-Length
11
X-XSS-Protection
0
Expires
Sat, 15 Nov 2008 16:00:00 GMT
bid
c.amazon-adsystem.com/e/dtb/
23 B
372 B
XHR
General
Full URL
https://c.amazon-adsystem.com/e/dtb/bid?src=3065&u=https%3A%2F%2Fwww.dailymail.co.uk%2Fsciencetech%2Farticle-9050821%2FRemdesivir-beneficial-patients-doctors-reveal.html%3F_hsmi%3D88974744%26_hsenc%3Dp2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8&pid=qkqBHoBAnjHbV&cb=0&ws=1600x1200&v=7.58.01&t=2000&slots=%5B%7B%22sd%22%3A%22billBoard%22%2C%22s%22%3A%5B%222000x1200%22%2C%22970x250%22%2C%22900x250%22%2C%22728x90%22%5D%2C%22kv%22%3A%7B%22pubcid%22%3A%223093664108%22%7D%7D%5D&gdprl=%7B%22status%22%3A%22no-cmp%22%7D
Requested by
Host: c.amazon-adsystem.com
URL: https://c.amazon-adsystem.com/aax2/apstag.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
99.84.88.20 Seattle, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-99-84-88-20.muc50.r.cloudfront.net
Software
Server /
Resource Hash
745a085b52b8371ec6705413fca70a28c6d8bff0db480e6b124bd08c54e95ef8

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:45:37 GMT
via
1.1 fe36c7f30c8ef2853edecc43f320092c.cloudfront.net (CloudFront)
server
Server
x-amz-cf-pop
MUC50-C1
vary
User-Agent
x-cache
Miss from cloudfront
content-type
text/javascript;charset=UTF-8
access-control-allow-origin
https://www.dailymail.co.uk
access-control-allow-credentials
true
timing-allow-origin
*
content-length
23
x-amz-cf-id
D_f0mZniWBbgy5OV2EbA1oZARjk5G-91turTFwd4iMD2WeZVuK2sTg==
bid
c.amazon-adsystem.com/e/dtb/
23 B
374 B
XHR
General
Full URL
https://c.amazon-adsystem.com/e/dtb/bid?src=3065&u=https%3A%2F%2Fwww.dailymail.co.uk%2Fsciencetech%2Farticle-9050821%2FRemdesivir-beneficial-patients-doctors-reveal.html%3F_hsmi%3D88974744%26_hsenc%3Dp2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8&pid=qkqBHoBAnjHbV&cb=1&ws=1600x1200&v=7.58.01&t=2000&slots=%5B%7B%22sd%22%3A%22mpu_factbox_1%22%2C%22s%22%3A%5B%22300x250%22%5D%2C%22kv%22%3A%7B%22pubcid%22%3A%223093664108%22%7D%7D%5D&gdprl=%7B%22status%22%3A%22no-cmp%22%7D
Requested by
Host: c.amazon-adsystem.com
URL: https://c.amazon-adsystem.com/aax2/apstag.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
99.84.88.20 Seattle, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-99-84-88-20.muc50.r.cloudfront.net
Software
Server /
Resource Hash
89b4aa9e9bf8516c2ab7b5134f65d47b02071637259a14c9f60dccc207e05ce4

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:45:37 GMT
via
1.1 fe36c7f30c8ef2853edecc43f320092c.cloudfront.net (CloudFront)
server
Server
x-amz-cf-pop
MUC50-C1
vary
User-Agent
x-cache
Miss from cloudfront
content-type
text/javascript;charset=UTF-8
access-control-allow-origin
https://www.dailymail.co.uk
access-control-allow-credentials
true
timing-allow-origin
*
content-length
23
x-amz-cf-id
qQYaD3MysEd-cXlGkrFp90SSfKkojqwPBXrJZHsFDiChaYxjOAPv2g==
bid
c.amazon-adsystem.com/e/dtb/
23 B
373 B
XHR
General
Full URL
https://c.amazon-adsystem.com/e/dtb/bid?src=3065&u=https%3A%2F%2Fwww.dailymail.co.uk%2Fsciencetech%2Farticle-9050821%2FRemdesivir-beneficial-patients-doctors-reveal.html%3F_hsmi%3D88974744%26_hsenc%3Dp2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8&pid=qkqBHoBAnjHbV&cb=2&ws=1600x1200&v=7.58.01&t=2000&slots=%5B%7B%22sd%22%3A%22inread_player_top%22%2C%22s%22%3A%5B%22480x270%22%2C%22636x1%22%2C%22480x1%22%5D%2C%22kv%22%3A%7B%22pubcid%22%3A%223093664108%22%7D%7D%5D&gdprl=%7B%22status%22%3A%22no-cmp%22%7D
Requested by
Host: c.amazon-adsystem.com
URL: https://c.amazon-adsystem.com/aax2/apstag.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
99.84.88.20 Seattle, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-99-84-88-20.muc50.r.cloudfront.net
Software
Server /
Resource Hash
5d7c7d25a0da74c0dd466120c3c09bd94cb982fc66ebc4a78675339f37323bf5

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:45:37 GMT
via
1.1 fe36c7f30c8ef2853edecc43f320092c.cloudfront.net (CloudFront)
server
Server
x-amz-cf-pop
MUC50-C1
vary
User-Agent
x-cache
Miss from cloudfront
content-type
text/javascript;charset=UTF-8
access-control-allow-origin
https://www.dailymail.co.uk
access-control-allow-credentials
true
timing-allow-origin
*
content-length
23
x-amz-cf-id
wY4EI3oVsbVKrU4eN_AyDsZ1vb9h6L_mtSsnJWLIZ0XTZeGRFiSoKg==
bid
c.amazon-adsystem.com/e/dtb/
23 B
373 B
XHR
General
Full URL
https://c.amazon-adsystem.com/e/dtb/bid?src=3065&u=https%3A%2F%2Fwww.dailymail.co.uk%2Fsciencetech%2Farticle-9050821%2FRemdesivir-beneficial-patients-doctors-reveal.html%3F_hsmi%3D88974744%26_hsenc%3Dp2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8&pid=qkqBHoBAnjHbV&cb=3&ws=1600x1200&v=7.58.01&t=2000&slots=%5B%7B%22sd%22%3A%22mpu_factbox_2%22%2C%22s%22%3A%5B%22300x250%22%5D%2C%22kv%22%3A%7B%22pubcid%22%3A%223093664108%22%7D%7D%5D&gdprl=%7B%22status%22%3A%22no-cmp%22%7D
Requested by
Host: c.amazon-adsystem.com
URL: https://c.amazon-adsystem.com/aax2/apstag.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
99.84.88.20 Seattle, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-99-84-88-20.muc50.r.cloudfront.net
Software
Server /
Resource Hash
1c4777fe3a673a05492e27d08032cc91c23ac5389897c9235b09b8b0f5a74db3

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:45:37 GMT
via
1.1 fe36c7f30c8ef2853edecc43f320092c.cloudfront.net (CloudFront)
server
Server
x-amz-cf-pop
MUC50-C1
vary
User-Agent
x-cache
Miss from cloudfront
content-type
text/javascript;charset=UTF-8
access-control-allow-origin
https://www.dailymail.co.uk
access-control-allow-credentials
true
timing-allow-origin
*
content-length
23
x-amz-cf-id
CepFYqrmKFVsA-6C0z9T7UiC_NR1O4adN-_T4XG8Kg6cshUvTO5-Ww==
button_bg.gif
i.dailymail.co.uk/i/furniture/articles/
450 B
662 B
Image
General
Full URL
https://i.dailymail.co.uk/i/furniture/articles/button_bg.gif
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/static/gunther/17.14.0/all--.css
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2a02:26f0:6c00:288::11ae , Ascension Island, ASN20940 (AKAMAI-ASN1, EU),
Reverse DNS
Software
AkamaiNetStorage /
Resource Hash
6b0a9a3f89a5a9633f8b55cefc8e8c937e742f77e16a7f517e245bdec940913d

Request headers

Referer
https://www.dailymail.co.uk/static/gunther/17.14.0/all--.css
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:45:37 GMT
last-modified
Sun, 28 Sep 2008 03:10:39 GMT
server
AkamaiNetStorage
etag
"660ebcf51de684aabd5640c5400a2a17:1222571440"
content-type
image/gif
cache-control
max-age=2592000
accept-ranges
bytes
timing-allow-origin
*
content-length
450
expires
Thu, 14 Jan 2021 12:45:37 GMT
spt_previewlinks_5.gif
i.dailymail.co.uk/i/furniture/
3 KB
3 KB
Image
General
Full URL
https://i.dailymail.co.uk/i/furniture/spt_previewlinks_5.gif
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/static/gunther/17.14.0/rc-main--.css
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2a02:26f0:6c00:288::11ae , Ascension Island, ASN20940 (AKAMAI-ASN1, EU),
Reverse DNS
Software
Apache /
Resource Hash
23f72af4e882a0195f05a66774f002805a01ee4c3812d480e51aeeefbae092b3

Request headers

Referer
https://www.dailymail.co.uk/static/gunther/17.14.0/rc-main--.css
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:45:37 GMT
last-modified
Tue, 28 Feb 2017 12:31:27 GMT
server
Apache
etag
"6dc31044422de3f1f57a962c4036655e:1488285087"
content-type
image/gif
cache-control
max-age=2592000
accept-ranges
bytes
timing-allow-origin
*
content-length
2587
expires
Thu, 14 Jan 2021 12:45:37 GMT
comment_ticker.png
i.dailymail.co.uk/i/furniture/comments/articles/
85 B
290 B
Image
General
Full URL
https://i.dailymail.co.uk/i/furniture/comments/articles/comment_ticker.png
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/static/gunther/17.14.0/rc-main--.css
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2a02:26f0:6c00:288::11ae , Ascension Island, ASN20940 (AKAMAI-ASN1, EU),
Reverse DNS
Software
Apache /
Resource Hash
541c63ae81fe7799a19523dc8f2500646043eaa70d36985c3f2fc86264e4e71e

Request headers

Referer
https://www.dailymail.co.uk/static/gunther/17.14.0/rc-main--.css
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:45:37 GMT
last-modified
Tue, 28 Feb 2017 12:52:42 GMT
server
Apache
etag
"18d36c5e83cfde23a9f5103f33f6ad32:1488286362"
content-type
image/png
cache-control
max-age=2592000
accept-ranges
bytes
timing-allow-origin
*
content-length
85
expires
Thu, 14 Jan 2021 12:45:37 GMT
spt_socialicons_40x40eachbttn8.png
i.dailymail.co.uk/i/furniture/articles/
9 KB
9 KB
Image
General
Full URL
https://i.dailymail.co.uk/i/furniture/articles/spt_socialicons_40x40eachbttn8.png
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/static/mol-fe/static/mol-fe-async-bundle/6.18.1/articleDefer.css
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2a02:26f0:6c00:288::11ae , Ascension Island, ASN20940 (AKAMAI-ASN1, EU),
Reverse DNS
Software
Apache /
Resource Hash
1d188cadb253c70a5a87ebdcea65f7407044606b5c4cf2ca9891970161aa9232

Request headers

Referer
https://www.dailymail.co.uk/static/mol-fe/static/mol-fe-async-bundle/6.18.1/articleDefer.css
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:45:37 GMT
last-modified
Mon, 06 Nov 2017 11:53:19 GMT
server
Apache
etag
"d5fb4ae159a29d51d27aaf551c71298a:1509969199"
content-type
image/png
cache-control
max-age=2592000
accept-ranges
bytes
timing-allow-origin
*
content-length
8735
expires
Thu, 14 Jan 2021 12:45:37 GMT
truncated
/
1 KB
0
Image
General
Full URL
data:truncated
Protocol
DATA
Server
-, , ASN (),
Reverse DNS
Software
/
Resource Hash
5887b03f44a197fcdc5400caec10de1c69f29619c1fdc868d4d461130e0f9efc

Request headers

Referer
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Content-Type
image/png
spt_rndcorner_4.png
i.dailymail.co.uk/i/furniture/corners/
3 KB
3 KB
Image
General
Full URL
https://i.dailymail.co.uk/i/furniture/corners/spt_rndcorner_4.png
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/static/gunther/17.14.0/all--.css
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2a02:26f0:6c00:288::11ae , Ascension Island, ASN20940 (AKAMAI-ASN1, EU),
Reverse DNS
Software
Apache /
Resource Hash
be6aaae29a207bdea28a1e545c6f5652abcd30845290ec990892805c895d78f6

Request headers

Referer
https://www.dailymail.co.uk/static/gunther/17.14.0/all--.css
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:45:37 GMT
last-modified
Mon, 06 Nov 2017 11:54:17 GMT
server
Apache
etag
"8709d0e0c6ea65aa87db0884a31b5355:1509969257"
content-type
image/png
cache-control
max-age=2592000
accept-ranges
bytes
timing-allow-origin
*
content-length
2998
expires
Thu, 14 Jan 2021 12:45:37 GMT
userreport.js
cdn.userreport.com/
241 KB
72 KB
Script
General
Full URL
https://cdn.userreport.com/userreport.js
Requested by
Host: sak.userreport.com
URL: https://sak.userreport.com/mol/launcher.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2600:9000:21f3:8200:19:d208:7940:93a1 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
AmazonS3 /
Resource Hash
5a678a064b3f5f09f5013253c5cdf3f5df2d891c91ff4c1a967b6a0a7d342e24

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

x-amz-version-id
mdUZv96Md1dlaUizZhqdBDLDgPlccOik
content-encoding
gzip
last-modified
Mon, 16 Nov 2020 11:36:20 GMT
server
AmazonS3
age
2187
etag
"4d30966c7f3304e37c730f73ba404918"
x-cache
Hit from cloudfront
content-type
application/x-javascript
via
1.1 2b2e2811e641703aebf776da39317b9c.cloudfront.net (CloudFront)
cache-control
max-age=3600
date
Tue, 15 Dec 2020 12:09:10 GMT
x-amz-cf-pop
FRA2-C2
accept-ranges
bytes
content-length
73144
x-amz-cf-id
iWggA5jLmCVgjT16e1ubmejUHc_7EazAiV6X98Si9exSHi1qnDZMxg==
hit
visitanalytics.userreport.com/
43 B
678 B
Image
General
Full URL
https://visitanalytics.userreport.com/hit?t=MOLm-YY4kURA16Uq4pnEr5N0VXg&rnd=363und2wpp&dsu=1.20830ade642fb79c.808ec78b-2de3-47c8-848b-d558b73536cf.1.714.f5c3d815d3687b09&med=https%3A%2F%2Fwww.dailymail.co.uk%2Fsciencetech%2Farticle-9050821%2FRemdesivir-beneficial-patients-doctors-reveal.html%3F_hsmi%3D88974744%26_hsenc%3Dp2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_128_GCM
Server
65.9.73.48 Seattle, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
AmazonS3 /
Resource Hash
cf4724b2f736ed1a0ae6bc28f1ead963d9cd2c1fd87b6ef32e7799fc1c5c8bda

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Date
Mon, 14 Dec 2020 18:13:36 GMT
Via
1.1 83bc0649a33d85c1cf516bf48779a390.cloudfront.net (CloudFront)
Age
66722
x-amz-meta-cb-modifiedtime
Tue, 14 Apr 2015 11:43:27 GMT
X-Cache
Hit from cloudfront
Connection
keep-alive
Content-Length
43
Last-Modified
Thu, 04 Jun 2020 12:03:06 GMT
Server
AmazonS3
ETag
"ad4b0f606e0f8465bc4c4c170b37e1a3"
x-amz-version-id
vrBc0EhGKa8dl_tujGhI9Fe7xKDJ.7QF
Cache-Control
no-cache, no-store, must-revalidate
X-Amz-Cf-Pop
AMS1-C1
Accept-Ranges
bytes
Content-Type
image/gif
X-Amz-Cf-Id
c4qZFpyO6YVz4jdmpQNiq8sL4HNcN6bu5JswscGzrOjjDtE2B6XwxA==
Expires
0
setuid
ib.adnxs.com/prebid/
Redirect Chain
  • https://pr-bh.ybp.yahoo.com/sync/appnexusprebidserver/?gdpr=0&euconsent=&us_privacy=&url=https%3A%2F%2Fib.adnxs.com%2Fprebid%2Fsetuid%3Fbidder%3Dbrightroll%26gdpr%3D0%26gdpr_consent%3D%26uid%3D%24UID
  • https://ib.adnxs.com/prebid/setuid?bidder=brightroll&gdpr=0&gdpr_consent=&uid=y-zYSbPG51lxZ8GZIEMBNwFdHG_IIemOnrddBxfhs6QVhBDVr0ygVXLYA-
43 B
1 KB
Image
General
Full URL
https://ib.adnxs.com/prebid/setuid?bidder=brightroll&gdpr=0&gdpr_consent=&uid=y-zYSbPG51lxZ8GZIEMBNwFdHG_IIemOnrddBxfhs6QVhBDVr0ygVXLYA-
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_ECDSA, AES_128_GCM
Server
185.33.221.13 , Netherlands, ASN29990 (ASN-APPNEX, US),
Reverse DNS
729.bm-nginx-loadbalancer.mgmt.ams1.adnexus.net
Software
nginx/1.17.9 /
Resource Hash
4b5b6b15c6255109e06720cce42a06d3aead8b7874423d9c52cb0303212c25ef
Security Headers
Name Value
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Pragma
no-cache
Date
Tue, 15 Dec 2020 12:45:37 GMT
X-Proxy-Origin
185.212.171.67; 185.212.171.67; 729.bm-nginx-loadbalancer.mgmt.ams1; *.adnxs.com; 185.33.220.71:80
AN-X-Request-Uuid
160efa70-de88-4428-aa8e-a4c23c8153c5
Server
nginx/1.17.9
P3P
policyref="http://cdn.adnxs.com/w3c/policy/p3p.xml", CP="NOI DSP COR ADM PSAo PSDo OURo SAMo UNRo OTRo BUS COM NAV DEM STA PRE"
Cache-Control
no-store, no-cache, private
Connection
keep-alive
Content-Type
image/gif
Content-Length
43
X-XSS-Protection
0
Expires
Sat, 15 Nov 2008 16:00:00 GMT

Redirect headers

date
Tue, 15 Dec 2020 12:45:37 GMT
referrer-policy
strict-origin-when-cross-origin
server
ATS
age
0
expect-ct
max-age=31536000, report-uri="http://csp.yahoo.com/beacon/csp?src=yahoocom-expect-ct-report-only"
strict-transport-security
max-age=31536000
location
https://ib.adnxs.com/prebid/setuid?bidder=brightroll&gdpr=0&gdpr_consent=&uid=y-zYSbPG51lxZ8GZIEMBNwFdHG_IIemOnrddBxfhs6QVhBDVr0ygVXLYA-
x-xss-protection
1; mode=block
content-length
0
x-content-type-options
nosniff
expires
Thu, 01 Jan 1970 00:00:00 GMT
bid
c.amazon-adsystem.com/e/dtb/
23 B
372 B
XHR
General
Full URL
https://c.amazon-adsystem.com/e/dtb/bid?src=3065&u=https%3A%2F%2Fwww.dailymail.co.uk%2Fsciencetech%2Farticle-9050821%2FRemdesivir-beneficial-patients-doctors-reveal.html%3F_hsmi%3D88974744%26_hsenc%3Dp2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8&pid=qkqBHoBAnjHbV&cb=4&ws=1600x1200&v=7.58.01&t=2000&slots=%5B%7B%22sd%22%3A%22mpu_top%22%2C%22s%22%3A%5B%22300x600%22%2C%22300x250%22%5D%2C%22kv%22%3A%7B%22pubcid%22%3A%223093664108%22%7D%7D%5D&gdprl=%7B%22status%22%3A%22no-cmp%22%7D
Requested by
Host: c.amazon-adsystem.com
URL: https://c.amazon-adsystem.com/aax2/apstag.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
99.84.88.20 Seattle, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-99-84-88-20.muc50.r.cloudfront.net
Software
Server /
Resource Hash
6139dddd3b6b6b847bccd476918dc8fb4f4f5a10908e5707c704f155e0918e84

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:45:37 GMT
via
1.1 fe36c7f30c8ef2853edecc43f320092c.cloudfront.net (CloudFront)
server
Server
x-amz-cf-pop
MUC50-C1
vary
User-Agent
x-cache
Miss from cloudfront
content-type
text/javascript;charset=UTF-8
access-control-allow-origin
https://www.dailymail.co.uk
access-control-allow-credentials
true
timing-allow-origin
*
content-length
23
x-amz-cf-id
hX_ylnNvagpdfNNRPUYc0g3bmtMaa-qAV-S1-FIaCoZuw2iIKikpMA==
impl.20201214-6-RELEASE.js
cdn.taboola.com/libtrc/
450 KB
104 KB
Script
General
Full URL
https://cdn.taboola.com/libtrc/impl.20201214-6-RELEASE.js
Requested by
Host: cdn.taboola.com
URL: https://cdn.taboola.com/libtrc/dailymail-row/loader.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
151.101.13.44 Frankfurt am Main, Germany, ASN54113 (FASTLY, US),
Reverse DNS
Software
AmazonS3-br /
Resource Hash
3d46904b944d38dac0fe78cc6c3aad567ac826a9079ce9522147ef1c7feb158b

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

x-amz-version-id
2sVTA33cfaRgn0Prw5U.XCwVzohq6ybg
content-encoding
br
etag
"10bdb5807bdff4c42c4587c2d03bb5d3"
age
4423
x-cache
HIT
content-length
106007
x-amz-id-2
27Bxf87SsWW7Z9R2qIVMcSYoU0fVZAPqLVzYq0lJPpRmTgRaLODbtW20Sr2c9AfJpfGjJ+b9K5M=
x-served-by
cache-fra19144-FRA
last-modified
Mon, 14 Dec 2020 11:30:09 GMT
server
AmazonS3-br
x-timer
S1608036337.321712,VS0,VE0
date
Tue, 15 Dec 2020 12:45:37 GMT
vary
Accept-Encoding
x-amz-request-id
51DADEDDBF5F4FEB
via
1.1 varnish
cache-control
private,max-age=31536000
accept-ranges
bytes
content-type
application/javascript
abp
22
x-cache-hits
24828
bid
c.amazon-adsystem.com/e/dtb/
23 B
373 B
XHR
General
Full URL
https://c.amazon-adsystem.com/e/dtb/bid?src=3065&u=https%3A%2F%2Fwww.dailymail.co.uk%2Fsciencetech%2Farticle-9050821%2FRemdesivir-beneficial-patients-doctors-reveal.html%3F_hsmi%3D88974744%26_hsenc%3Dp2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8&pid=qkqBHoBAnjHbV&cb=5&ws=1600x1200&v=7.58.01&t=2000&slots=%5B%7B%22sd%22%3A%22half_mpu_top%22%2C%22s%22%3A%5B%22300x150%22%5D%2C%22kv%22%3A%7B%22pubcid%22%3A%223093664108%22%7D%7D%5D&gdprl=%7B%22status%22%3A%22no-cmp%22%7D
Requested by
Host: c.amazon-adsystem.com
URL: https://c.amazon-adsystem.com/aax2/apstag.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
99.84.88.20 Seattle, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-99-84-88-20.muc50.r.cloudfront.net
Software
Server /
Resource Hash
111041158b9290ae7cc0c6da69d7c4f5600e8a73b4c7399d675df7f15ba7b063

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:45:37 GMT
via
1.1 fe36c7f30c8ef2853edecc43f320092c.cloudfront.net (CloudFront)
server
Server
x-amz-cf-pop
MUC50-C1
vary
User-Agent
x-cache
Miss from cloudfront
content-type
text/javascript;charset=UTF-8
access-control-allow-origin
https://www.dailymail.co.uk
access-control-allow-credentials
true
timing-allow-origin
*
content-length
23
x-amz-cf-id
D-Ebe4qQI8ZMCdSGTRNWo9P2xsyV22Te0b7RA8vye8G9qCEIW738ow==
truncated
/
504 B
0
Image
General
Full URL
data:truncated
Protocol
DATA
Server
-, , ASN (),
Reverse DNS
Software
/
Resource Hash
7a745591034534431b4e5e32815599cef3101631f9e6a9052a687d96dac1a3ea

Request headers

Referer
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Content-Type
image/svg+xml
truncated
/
2 KB
0
Image
General
Full URL
data:truncated
Protocol
DATA
Server
-, , ASN (),
Reverse DNS
Software
/
Resource Hash
62675c01ca7a9e7af102c699f55fa970eee7f0106984839722e018e733744c03

Request headers

Referer
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Content-Type
image/svg+xml
truncated
/
996 B
0
Image
General
Full URL
data:truncated
Protocol
DATA
Server
-, , ASN (),
Reverse DNS
Software
/
Resource Hash
f650676047609c72f3c893b13a7148916bb0a9a5ff1f6ca9c531d07038ba31ae

Request headers

Referer
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Content-Type
image/svg+xml
truncated
/
868 B
0
Image
General
Full URL
data:truncated
Protocol
DATA
Server
-, , ASN (),
Reverse DNS
Software
/
Resource Hash
4717410c1ef684a572d4662c8bc6860a753e6ea7e9640d699c4f2a0e4d08c9e2

Request headers

Referer
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Content-Type
image/svg+xml
truncated
/
2 KB
0
Image
General
Full URL
data:truncated
Protocol
DATA
Server
-, , ASN (),
Reverse DNS
Software
/
Resource Hash
b27cc2654c00d737f49cb68b74ba7893c151612b1ad52543f4691f67db0cdf97

Request headers

Referer
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Content-Type
image/svg+xml
truncated
/
390 B
0
Image
General
Full URL
data:truncated
Protocol
DATA
Server
-, , ASN (),
Reverse DNS
Software
/
Resource Hash
285e1fb1c37c145d2372d6c64bb188b4cc6e82855b1c4d4d6bfcbcdb6f4543fa

Request headers

Referer
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Content-Type
image/png
bid
c.amazon-adsystem.com/e/dtb/
23 B
373 B
XHR
General
Full URL
https://c.amazon-adsystem.com/e/dtb/bid?src=3065&u=https%3A%2F%2Fwww.dailymail.co.uk%2Fsciencetech%2Farticle-9050821%2FRemdesivir-beneficial-patients-doctors-reveal.html%3F_hsmi%3D88974744%26_hsenc%3Dp2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8&pid=qkqBHoBAnjHbV&cb=6&ws=1600x1200&v=7.58.01&t=2000&slots=%5B%7B%22sd%22%3A%22mpu_puff_20%22%2C%22s%22%3A%5B%22300x600%22%2C%22300x250%22%5D%2C%22kv%22%3A%7B%22pubcid%22%3A%223093664108%22%7D%7D%5D&gdprl=%7B%22status%22%3A%22no-cmp%22%7D
Requested by
Host: c.amazon-adsystem.com
URL: https://c.amazon-adsystem.com/aax2/apstag.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
99.84.88.20 Seattle, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-99-84-88-20.muc50.r.cloudfront.net
Software
Server /
Resource Hash
0cff03129f16a73a8ff89d06578b0b1a1127bddb582fd05f0ab62f8ccc6b62f7

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:45:37 GMT
via
1.1 fe36c7f30c8ef2853edecc43f320092c.cloudfront.net (CloudFront)
server
Server
x-amz-cf-pop
MUC50-C1
vary
User-Agent
x-cache
Miss from cloudfront
content-type
text/javascript;charset=UTF-8
access-control-allow-origin
https://www.dailymail.co.uk
access-control-allow-credentials
true
timing-allow-origin
*
content-length
23
x-amz-cf-id
nF7e-tIN7J__4bHH7hdwvuRrVpjQ-6N-CWlT8pJ3YLvOC_Dbq81Nqg==
bid
c.amazon-adsystem.com/e/dtb/
23 B
373 B
XHR
General
Full URL
https://c.amazon-adsystem.com/e/dtb/bid?src=3065&u=https%3A%2F%2Fwww.dailymail.co.uk%2Fsciencetech%2Farticle-9050821%2FRemdesivir-beneficial-patients-doctors-reveal.html%3F_hsmi%3D88974744%26_hsenc%3Dp2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8&pid=qkqBHoBAnjHbV&cb=7&ws=1600x1200&v=7.58.01&t=2000&slots=%5B%7B%22sd%22%3A%22mpu_puff_45%22%2C%22s%22%3A%5B%22300x600%22%2C%22300x250%22%5D%2C%22kv%22%3A%7B%22pubcid%22%3A%223093664108%22%7D%7D%5D&gdprl=%7B%22status%22%3A%22no-cmp%22%7D
Requested by
Host: c.amazon-adsystem.com
URL: https://c.amazon-adsystem.com/aax2/apstag.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
99.84.88.20 Seattle, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-99-84-88-20.muc50.r.cloudfront.net
Software
Server /
Resource Hash
8ec3cdfcdc79223ee04ed060812314854cb3b3d9d1914390c755934366fc3693

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:45:37 GMT
via
1.1 fe36c7f30c8ef2853edecc43f320092c.cloudfront.net (CloudFront)
server
Server
x-amz-cf-pop
MUC50-C1
vary
User-Agent
x-cache
Miss from cloudfront
content-type
text/javascript;charset=UTF-8
access-control-allow-origin
https://www.dailymail.co.uk
access-control-allow-credentials
true
timing-allow-origin
*
content-length
23
x-amz-cf-id
xzOJkwsMbSjxulJ9uSGBlsmBcIuWb-ZA-cH7MFgY6JcCtUpPKpLtwA==
b4d55025-1e08-410b-808e-d478b54d8ef6
https://www.dailymail.co.uk/
473 KB
0
Other
General
Full URL
blob:https://www.dailymail.co.uk/b4d55025-1e08-410b-808e-d478b54d8ef6
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
Protocol
BLOB
Server
-, , ASN (),
Reverse DNS
Software
/
Resource Hash
6eca6b453d53f500b779a87493d7079d7119d8715f999c1f5fb6aeee18b7cbb9

Request headers

Referer
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Content-Length
484070
Content-Type
application/javascript
graphql
api.permutive.com/
698 B
699 B
XHR
General
Full URL
https://api.permutive.com/graphql?k=ed45e86d-a09e-4d2b-85c0-fbbd6857373e
Requested by
Host: cdn.permutive.com
URL: https://cdn.permutive.com/5f42864d-a421-4f37-9478-00266f871d68-web.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
34.107.254.252 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
Permutive /
Resource Hash
daeaf50749b44060c5784213067a5819ac625592e31232acbe0b529f61ce5155

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type
text/plain

Response headers

date
Tue, 15 Dec 2020 12:45:37 GMT
content-encoding
gzip
server
Permutive
vary
Origin,Access-Control-Request-Method
access-control-allow-methods
POST
content-type
application/json
access-control-allow-origin
https://www.dailymail.co.uk
access-control-expose-headers
*
access-control-allow-credentials
true
access-control-max-age
86400
alt-svc
clear
content-length
439
via
1.1 google
2
www.dailymail.co.uk/abe/a9/price/
4 B
702 B
XHR
General
Full URL
https://www.dailymail.co.uk/abe/a9/price/2
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/static/mol-adverts/demo/mol-22070/19a28e0b/mol-adverts.js
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2a02:26f0:6c00:296::11ae , Ascension Island, ASN20940 (AKAMAI-ASN1, EU),
Reverse DNS
Software
AmazonS3 /
Resource Hash
561b2814d3c09e62a92442c946307918f7f63f833c84876c08bd4c406767e53b

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

x-amz-version-id
wDnvhJJXpo3tPt4.QtsManRqQALbFlHY
content-security-policy-report-only
block-all-mixed-content; report-uri https://mol.report-uri.io/r/default/csp/reportOnly
last-modified
Thu, 26 Jul 2018 09:55:16 GMT
server
AmazonS3
x-amz-request-id
2Z4KDQ1N7H5GAG6P
etag
"f7ddd489ab0a82567b241b05971cbdb3"
vary
User-Agent
content-type
text/plain
cache-control
public, max-age=1146256
date
Tue, 15 Dec 2020 12:45:37 GMT
x-amz-replication-status
COMPLETED
server-timing
cdn-cache; desc=HIT, edge; dur=1
accept-ranges
bytes
content-length
4
x-amz-id-2
TQa+V4AfiJ7Bmz5eGVXtXeerNKKqRrPt9yBoXYXtX5TNMag04HicxY48/1EyJyZRcnVJVxDSTyI=
2
www.dailymail.co.uk/abe/a9/price/
4 B
702 B
XHR
General
Full URL
https://www.dailymail.co.uk/abe/a9/price/2
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/static/mol-adverts/demo/mol-22070/19a28e0b/mol-adverts.js
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2a02:26f0:6c00:296::11ae , Ascension Island, ASN20940 (AKAMAI-ASN1, EU),
Reverse DNS
Software
AmazonS3 /
Resource Hash
561b2814d3c09e62a92442c946307918f7f63f833c84876c08bd4c406767e53b

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

x-amz-version-id
wDnvhJJXpo3tPt4.QtsManRqQALbFlHY
content-security-policy-report-only
block-all-mixed-content; report-uri https://mol.report-uri.io/r/default/csp/reportOnly
last-modified
Thu, 26 Jul 2018 09:55:16 GMT
server
AmazonS3
x-amz-request-id
2Z4KDQ1N7H5GAG6P
etag
"f7ddd489ab0a82567b241b05971cbdb3"
vary
User-Agent
content-type
text/plain
cache-control
public, max-age=1146256
date
Tue, 15 Dec 2020 12:45:37 GMT
x-amz-replication-status
COMPLETED
server-timing
cdn-cache; desc=HIT, edge; dur=1
accept-ranges
bytes
content-length
4
x-amz-id-2
TQa+V4AfiJ7Bmz5eGVXtXeerNKKqRrPt9yBoXYXtX5TNMag04HicxY48/1EyJyZRcnVJVxDSTyI=
2
www.dailymail.co.uk/abe/a9/price/
4 B
702 B
XHR
General
Full URL
https://www.dailymail.co.uk/abe/a9/price/2
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/static/mol-adverts/demo/mol-22070/19a28e0b/mol-adverts.js
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2a02:26f0:6c00:296::11ae , Ascension Island, ASN20940 (AKAMAI-ASN1, EU),
Reverse DNS
Software
AmazonS3 /
Resource Hash
561b2814d3c09e62a92442c946307918f7f63f833c84876c08bd4c406767e53b

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

x-amz-version-id
wDnvhJJXpo3tPt4.QtsManRqQALbFlHY
content-security-policy-report-only
block-all-mixed-content; report-uri https://mol.report-uri.io/r/default/csp/reportOnly
last-modified
Thu, 26 Jul 2018 09:55:16 GMT
server
AmazonS3
x-amz-request-id
2Z4KDQ1N7H5GAG6P
etag
"f7ddd489ab0a82567b241b05971cbdb3"
vary
User-Agent
content-type
text/plain
cache-control
public, max-age=1146256
date
Tue, 15 Dec 2020 12:45:37 GMT
x-amz-replication-status
COMPLETED
server-timing
cdn-cache; desc=HIT, edge; dur=1
accept-ranges
bytes
content-length
4
x-amz-id-2
TQa+V4AfiJ7Bmz5eGVXtXeerNKKqRrPt9yBoXYXtX5TNMag04HicxY48/1EyJyZRcnVJVxDSTyI=
2
www.dailymail.co.uk/abe/a9/price/
4 B
699 B
XHR
General
Full URL
https://www.dailymail.co.uk/abe/a9/price/2
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/static/mol-adverts/demo/mol-22070/19a28e0b/mol-adverts.js
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2a02:26f0:6c00:296::11ae , Ascension Island, ASN20940 (AKAMAI-ASN1, EU),
Reverse DNS
Software
AmazonS3 /
Resource Hash
561b2814d3c09e62a92442c946307918f7f63f833c84876c08bd4c406767e53b

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

x-amz-version-id
wDnvhJJXpo3tPt4.QtsManRqQALbFlHY
content-security-policy-report-only
block-all-mixed-content; report-uri https://mol.report-uri.io/r/default/csp/reportOnly
last-modified
Thu, 26 Jul 2018 09:55:16 GMT
server
AmazonS3
x-amz-request-id
2Z4KDQ1N7H5GAG6P
etag
"f7ddd489ab0a82567b241b05971cbdb3"
vary
User-Agent
content-type
text/plain
cache-control
public, max-age=1146256
date
Tue, 15 Dec 2020 12:45:37 GMT
x-amz-replication-status
COMPLETED
server-timing
cdn-cache; desc=HIT, edge; dur=1
accept-ranges
bytes
content-length
4
x-amz-id-2
TQa+V4AfiJ7Bmz5eGVXtXeerNKKqRrPt9yBoXYXtX5TNMag04HicxY48/1EyJyZRcnVJVxDSTyI=
2
www.dailymail.co.uk/abe/a9/price/
4 B
701 B
XHR
General
Full URL
https://www.dailymail.co.uk/abe/a9/price/2
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/static/mol-adverts/demo/mol-22070/19a28e0b/mol-adverts.js
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2a02:26f0:6c00:296::11ae , Ascension Island, ASN20940 (AKAMAI-ASN1, EU),
Reverse DNS
Software
AmazonS3 /
Resource Hash
561b2814d3c09e62a92442c946307918f7f63f833c84876c08bd4c406767e53b

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

x-amz-version-id
wDnvhJJXpo3tPt4.QtsManRqQALbFlHY
content-security-policy-report-only
block-all-mixed-content; report-uri https://mol.report-uri.io/r/default/csp/reportOnly
last-modified
Thu, 26 Jul 2018 09:55:16 GMT
server
AmazonS3
x-amz-request-id
2Z4KDQ1N7H5GAG6P
etag
"f7ddd489ab0a82567b241b05971cbdb3"
vary
User-Agent
content-type
text/plain
cache-control
public, max-age=1146256
date
Tue, 15 Dec 2020 12:45:37 GMT
x-amz-replication-status
COMPLETED
server-timing
cdn-cache; desc=HIT, edge; dur=1
accept-ranges
bytes
content-length
4
x-amz-id-2
TQa+V4AfiJ7Bmz5eGVXtXeerNKKqRrPt9yBoXYXtX5TNMag04HicxY48/1EyJyZRcnVJVxDSTyI=
2
www.dailymail.co.uk/abe/a9/price/
4 B
703 B
XHR
General
Full URL
https://www.dailymail.co.uk/abe/a9/price/2
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/static/mol-adverts/demo/mol-22070/19a28e0b/mol-adverts.js
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2a02:26f0:6c00:296::11ae , Ascension Island, ASN20940 (AKAMAI-ASN1, EU),
Reverse DNS
Software
AmazonS3 /
Resource Hash
561b2814d3c09e62a92442c946307918f7f63f833c84876c08bd4c406767e53b

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

x-amz-version-id
wDnvhJJXpo3tPt4.QtsManRqQALbFlHY
content-security-policy-report-only
block-all-mixed-content; report-uri https://mol.report-uri.io/r/default/csp/reportOnly
last-modified
Thu, 26 Jul 2018 09:55:16 GMT
server
AmazonS3
x-amz-request-id
2Z4KDQ1N7H5GAG6P
etag
"f7ddd489ab0a82567b241b05971cbdb3"
vary
User-Agent
content-type
text/plain
cache-control
public, max-age=1146256
date
Tue, 15 Dec 2020 12:45:37 GMT
x-amz-replication-status
COMPLETED
server-timing
cdn-cache; desc=HIT, edge; dur=1
accept-ranges
bytes
content-length
4
x-amz-id-2
TQa+V4AfiJ7Bmz5eGVXtXeerNKKqRrPt9yBoXYXtX5TNMag04HicxY48/1EyJyZRcnVJVxDSTyI=
json
trc.taboola.com/dailymail-row/trc/3/
41 KB
13 KB
XHR
General
Full URL
https://trc.taboola.com/dailymail-row/trc/3/json?tim=13%3A45%3A37.585&lti=deflated&data=%7B%22id%22%3A708%2C%22ii%22%3A%22%2Fsciencetech%2Farticle-9050821%2Fremdesivir-beneficial-patients-doctors-reveal.html%22%2C%22it%22%3A%22text%22%2C%22sd%22%3Anull%2C%22ui%22%3A%2281242381-ab73-4352-8bed-9e7099c82ee1-tuct6d23571%22%2C%22uifp%22%3Anull%2C%22lbt%22%3A1607947590030%2C%22vi%22%3A1608036337111%2C%22cv%22%3A%2220201214-6-RELEASE%22%2C%22uiv%22%3A%22default%22%2C%22u%22%3A%22https%3A%2F%2Fwww.dailymail.co.uk%2Fsciencetech%2Farticle-9050821%2FRemdesivir-beneficial-patients-doctors-reveal.html%22%2C%22bv%22%3A%220%22%2C%22ul%22%3A%5B%22en-US%22%5D%2C%22btv%22%3A%220%22%2C%22cos%22%3A%224g%22%2C%22bad%22%3A-1%2C%22sw%22%3A1600%2C%22sh%22%3A1200%2C%22bw%22%3A1600%2C%22sde%22%3A%221.000%22%2C%22bh%22%3A1200%2C%22dw%22%3A1600%2C%22dh%22%3A13813%2C%22qs%22%3A%22%3F_hsmi%3D88974744%26_hsenc%3Dp2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8%22%2C%22r%22%3A%5B%7B%22li%22%3A%22rbox-t2v%22%2C%22s%22%3A15%2C%22uim%22%3A%22autosized-generated-text-under-1r-row%3Aabp%3D0%22%2C%22uip%22%3A%22desktop-Desktop-Wide%22%2C%22orig_uip%22%3A%22Desktop-Wide%22%2C%22cd%22%3A5810.75%2C%22mw%22%3A632%7D%2C%7B%22li%22%3A%22rbox-t2m%22%2C%22s%22%3A3%2C%22uim%22%3A%22thumbnails-b%3Aabp%3D0%22%2C%22uip%22%3A%22Below%20Article%20Thumbnails%202nd%22%2C%22orig_uip%22%3A%22Below%20Article%20Thumbnails%202nd%22%2C%22cd%22%3A5838.75%2C%22mw%22%3A636%7D%5D%2C%22cacheKey%22%3A%22text%3D%2Fsciencetech%2Farticle-9050821%2Fremdesivir-beneficial-patients-doctors-reveal.html%2CBelow%20Article%20Thumbnails%202nd%3Dthumbnails-b%3Aabp%3D0%2C%2Cdesktop-Desktop-Wide%3Dautosized-generated-text-under-1r-row%3Aabp%3D0%22%2C%22cb%22%3A%22TRC.callbacks.recommendations_1%22%2C%22lt%22%3A%22deflated%22%7D
Requested by
Host: cdn.taboola.com
URL: https://cdn.taboola.com/libtrc/impl.20201214-6-RELEASE.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
151.101.13.44 Frankfurt am Main, Germany, ASN54113 (FASTLY, US),
Reverse DNS
Software
nginx /
Resource Hash
5b3a487b828eab3316e9ba624615309fab23cc1a434536ba41660d8a1b43ed70

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type
text/plain

Response headers

x-vcl-time-ms
741
date
Tue, 15 Dec 2020 12:45:38 GMT
content-encoding
gzip
server
nginx
x-timer
S1608036338.598199,VS0,VE741
x-served-by
cache-fra19144-FRA
vary
Accept-Encoding
x-cache
MISS
p3p
policyref="http://trc.taboola.com/p3p.xml", CP="NOI DSP COR LAW NID CURa ADMa DEVa PSAa PSDa OUR BUS IND UNI COM NAV INT DEM"
access-control-allow-origin
https://www.dailymail.co.uk
access-control-allow-credentials
true
accept-ranges
bytes
content-type
application/javascript; charset=utf-8
via
1.1 varnish
x-cache-hits
0
integrator.js
adservice.google.de/adsid/
109 B
169 B
Script
General
Full URL
https://adservice.google.de/adsid/integrator.js?domain=www.dailymail.co.uk
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020120801.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:81f::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
0482a98d09daebc18a0d2e1ed8f748da5b0179e61223ed541101df1f4699f073
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

timing-allow-origin
*
date
Tue, 15 Dec 2020 12:45:37 GMT
content-encoding
gzip
x-content-type-options
nosniff
server
cafe
p3p
CP="This is not a P3P policy! See http://support.google.com/accounts/answer/151657 for more info."
cache-control
private, no-cache, no-store
cross-origin-resource-policy
cross-origin
content-disposition
attachment; filename="f.txt"
content-type
application/javascript; charset=UTF-8
alt-svc
h3-29="googleads.g.doubleclick.net:443"; ma=2592000,h3-29=":443"; ma=2592000,h3-T051="googleads.g.doubleclick.net:443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic="googleads.g.doubleclick.net:443"; ma=2592000; v="46,43",quic=":443"; ma=2592000; v="46,43"
content-length
104
x-xss-protection
0
integrator.js
adservice.google.com/adsid/
109 B
169 B
Script
General
Full URL
https://adservice.google.com/adsid/integrator.js?domain=www.dailymail.co.uk
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020120801.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:814::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
0482a98d09daebc18a0d2e1ed8f748da5b0179e61223ed541101df1f4699f073
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

timing-allow-origin
*
date
Tue, 15 Dec 2020 12:45:37 GMT
content-encoding
gzip
x-content-type-options
nosniff
server
cafe
p3p
CP="This is not a P3P policy! See http://support.google.com/accounts/answer/151657 for more info."
cache-control
private, no-cache, no-store
cross-origin-resource-policy
cross-origin
content-disposition
attachment; filename="f.txt"
content-type
application/javascript; charset=UTF-8
alt-svc
h3-29="googleads.g.doubleclick.net:443"; ma=2592000,h3-29=":443"; ma=2592000,h3-T051="googleads.g.doubleclick.net:443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic="googleads.g.doubleclick.net:443"; ma=2592000; v="46,43",quic=":443"; ma=2592000; v="46,43"
content-length
104
x-xss-protection
0
ads
securepubads.g.doubleclick.net/gampad/
51 KB
11 KB
XHR
General
Full URL
https://securepubads.g.doubleclick.net/gampad/ads?gdfp_req=1&pvsid=2639827676159032&correlator=2455119041695441&output=ldjh&impl=fif&eid=21069142&vrg=2020120801&guci=1.2.0.0.2.2.0.0&sc=1&sfv=1-0-37&ecs=20201215&iu_parts=5765%2Cdailymail.uk%2Cdm_dmsciencetech_sciencetechart%2Cbillboard&enc_prev_ius=%2F0%2F1%2F2%2F3&prev_iu_szs=2000x1200%7C970x250%7C900x250%7C728x90&prev_scp=pos%3Dbillboard%26amznbid%3D2%26amznp%3D2%26adx_channel%3D14%26nobids%3Dfalse%26refreshCount%3D0%26amznsz%3D0x0&eri=4&cust_params=page%3Dart%26article%3D9050821%26area%3Dsciencetech%26subarea%3Dsciencetech%26environment%3Dproduction%26country%3Dde%26abv%3Dmol-22070%252F19a28e0b%26bot%3Dfalse%26random%3D9ceebda3-1911-4085-b4cd-4ef660466486%26impid%3Dc0338c30-9d3e-46d6-8db6-95c14a8ccbca%26browserResolution%3Dmin_1244px%26device%3Dother%26device_features%3D%26articlewithvideo%3Dtrue%26style%3Dwide%26session%3D1%26session_page_ID%3Dnone%26utm_source%3Dnone%26watershed%3Dfalse%26location%3Ddailymail_co_uk%26id5%3Dtrue%26permutive%3D%26puid%3Db77f6280-fced-4776-aef9-89e90021e68b%26ptime%3D1608036337226&cookie_enabled=1&cdm=www.dailymail.co.uk&bc=31&abxe=1&dt=1608036337630&dlt=1608036336099&idt=1063&frm=20&biw=1600&bih=1200&oid=3&adxs=315&adys=-278&adks=1878184308&ucis=1&ifi=1&u_tz=60&u_his=2&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_sd=1&flash=0&url=www.dailymail.co.uk%2Fsciencetech%2Farticle-9050821%2FRemdesivir-beneficial-patients-doctors-reveal.html&loc=https%3A%2F%2Fwww.dailymail.co.uk%2Fsciencetech%2Farticle-9050821%2FRemdesivir-beneficial-patients-doctors-reveal.html%3F_hsmi%3D88974744%26_hsenc%3Dp2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8&vis=1&dmc=8&scr_x=0&scr_y=0&psz=964x250&msz=967x250&ga_vid=254203172.1608036337&ga_sid=1608036337&ga_hid=881620343&ga_fc=true&fws=4&ohw=967&btvi=0&tt_state=W3siaXNzdWVyT3JpZ2luIjoiaHR0cHM6Ly9hZHNlcnZpY2UuZ29vZ2xlLmNvbSIsInN0YXRlIjowfSx7Imlzc3Vlck9yaWdpbiI6Imh0dHBzOi8vYXR0ZXN0YXRpb24uYW5kcm9pZC5jb20iLCJzdGF0ZSI6MH1d
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020120801.js
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
172.217.22.2 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
fra16s14-in-f2.1e100.net
Software
cafe /
Resource Hash
c58b4357b4d4121e76fe81bd0fa5d9c7482692fd932b65a2799487fac11b9490
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:45:39 GMT
content-encoding
br
x-content-type-options
nosniff
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
cross-origin-resource-policy
cross-origin
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
11593
x-xss-protection
0
google-lineitem-id
-1
pragma
no-cache
server
cafe
google-creative-id
-1
content-type
text/plain; charset=UTF-8
access-control-allow-origin
https://www.dailymail.co.uk
access-control-expose-headers
x-google-amp-ad-validated-version
cache-control
no-cache, must-revalidate
access-control-allow-credentials
true
timing-allow-origin
*
expires
Fri, 01 Jan 1990 00:00:00 GMT
container.html
b1c90d68092b57f74adceeec8a58c68a.safeframe.googlesyndication.com/safeframe/1-0-37/html/
0
0
Other
General
Full URL
https://b1c90d68092b57f74adceeec8a58c68a.safeframe.googlesyndication.com/safeframe/1-0-37/html/container.html
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020120801.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:801::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
/
Resource Hash

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

container.html
tpc.googlesyndication.com/safeframe/1-0-37/html/
0
0
Other
General
Full URL
https://tpc.googlesyndication.com/safeframe/1-0-37/html/container.html
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020120801.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:81d::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
/
Resource Hash

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

ads
securepubads.g.doubleclick.net/gampad/
484 B
300 B
XHR
General
Full URL
https://securepubads.g.doubleclick.net/gampad/ads?gdfp_req=1&pvsid=2639827676159032&correlator=2455119041695441&output=ldjh&impl=fif&eid=21069142&vrg=2020120801&guci=1.2.0.0.2.2.0.0&sc=1&sfv=1-0-37&ecs=20201215&iu_parts=5765%2Cdailymail.uk%2Cdm_dmsciencetech_sciencetechart%2Cbillboard&enc_prev_ius=%2F0%2F1%2F2%2F3&prev_iu_szs=1x1&ists=1&prev_scp=pos%3Dbillboard%26adx_channel%3D14%26nobids%3Dfalse%26refreshCount%3D0%26amznbid%3D2%26amznsz%3D0x0%26amznp%3D2&eri=4&cust_params=page%3Dart%26article%3D9050821%26area%3Dsciencetech%26subarea%3Dsciencetech%26environment%3Dproduction%26country%3Dde%26abv%3Dmol-22070%252F19a28e0b%26bot%3Dfalse%26random%3D9ceebda3-1911-4085-b4cd-4ef660466486%26impid%3Dc0338c30-9d3e-46d6-8db6-95c14a8ccbca%26browserResolution%3Dmin_1244px%26device%3Dother%26device_features%3D%26articlewithvideo%3Dtrue%26style%3Dwide%26session%3D1%26session_page_ID%3Dnone%26utm_source%3Dnone%26watershed%3Dfalse%26location%3Ddailymail_co_uk%26id5%3Dtrue%26permutive%3D%26puid%3Db77f6280-fced-4776-aef9-89e90021e68b%26ptime%3D1608036337226&cookie_enabled=1&cdm=www.dailymail.co.uk&bc=31&abxe=1&dt=1608036337640&dlt=1608036336099&idt=1063&frm=20&biw=1600&bih=1200&oid=3&adxs=-12245933&adys=-12245933&adks=2298815886&ucis=2&ifi=2&u_tz=60&u_his=2&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_sd=1&flash=0&url=www.dailymail.co.uk%2Fsciencetech%2Farticle-9050821%2FRemdesivir-beneficial-patients-doctors-reveal.html&loc=https%3A%2F%2Fwww.dailymail.co.uk%2Fsciencetech%2Farticle-9050821%2FRemdesivir-beneficial-patients-doctors-reveal.html%3F_hsmi%3D88974744%26_hsenc%3Dp2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8&vis=1&dmc=8&scr_x=0&scr_y=0&psz=964x250&msz=1x1&ga_vid=254203172.1608036337&ga_sid=1608036337&ga_hid=881620343&ga_fc=true&fws=132&ohw=1600&tt_state=W3siaXNzdWVyT3JpZ2luIjoiaHR0cHM6Ly9hZHNlcnZpY2UuZ29vZ2xlLmNvbSIsInN0YXRlIjowfSx7Imlzc3Vlck9yaWdpbiI6Imh0dHBzOi8vYXR0ZXN0YXRpb24uYW5kcm9pZC5jb20iLCJzdGF0ZSI6MH1d
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020120801.js
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
172.217.22.2 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
fra16s14-in-f2.1e100.net
Software
cafe /
Resource Hash
a096b6dd62fb0b2004e8d480da110fc846fe61bc1d1555876d11f71f293aee88
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:45:38 GMT
content-encoding
br
x-content-type-options
nosniff
google-mediationgroup-id
-2
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
cross-origin-resource-policy
cross-origin
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
257
x-xss-protection
0
google-lineitem-id
-2
pragma
no-cache
server
cafe
google-mediationtag-id
-2
google-creative-id
-2
content-type
text/plain; charset=UTF-8
access-control-allow-origin
https://www.dailymail.co.uk
cache-control
no-cache, must-revalidate
access-control-allow-credentials
true
timing-allow-origin
*
expires
Fri, 01 Jan 1990 00:00:00 GMT
ads
securepubads.g.doubleclick.net/gampad/
42 KB
11 KB
XHR
General
Full URL
https://securepubads.g.doubleclick.net/gampad/ads?gdfp_req=1&pvsid=2639827676159032&correlator=2455119041695441&output=ldjh&impl=fif&eid=21069142&vrg=2020120801&guci=1.2.0.0.2.2.0.0&sc=1&sfv=1-0-37&ecs=20201215&iu_parts=5765%2Cdailymail.uk%2Cdm_dmsciencetech_sciencetechart%2Cmpu_factbox_1&enc_prev_ius=%2F0%2F1%2F2%2F3&prev_iu_szs=300x250&prev_scp=pos%3Dmpu_factbox%26puff_offset%3D1%26adx_channel%3D18%26nobids%3Dtrue%26amznbid%3D2%26amznsz%3D0x0%26amznp%3D2&eri=4&cust_params=page%3Dart%26article%3D9050821%26area%3Dsciencetech%26subarea%3Dsciencetech%26environment%3Dproduction%26country%3Dde%26abv%3Dmol-22070%252F19a28e0b%26bot%3Dfalse%26random%3D9ceebda3-1911-4085-b4cd-4ef660466486%26impid%3Dc0338c30-9d3e-46d6-8db6-95c14a8ccbca%26browserResolution%3Dmin_1244px%26device%3Dother%26device_features%3D%26articlewithvideo%3Dtrue%26style%3Dwide%26session%3D1%26session_page_ID%3Dnone%26utm_source%3Dnone%26watershed%3Dfalse%26location%3Ddailymail_co_uk%26id5%3Dtrue%26permutive%3D%26puid%3Db77f6280-fced-4776-aef9-89e90021e68b%26ptime%3D1608036337226&cookie_enabled=1&cdm=www.dailymail.co.uk&bc=31&abxe=1&dt=1608036337645&dlt=1608036336099&idt=1063&frm=20&biw=1600&bih=1200&oid=3&adxs=650&adys=3409&adks=406235259&ucis=3&ifi=3&u_tz=60&u_his=2&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_sd=1&flash=0&url=www.dailymail.co.uk%2Fsciencetech%2Farticle-9050821%2FRemdesivir-beneficial-patients-doctors-reveal.html&loc=https%3A%2F%2Fwww.dailymail.co.uk%2Fsciencetech%2Farticle-9050821%2FRemdesivir-beneficial-patients-doctors-reveal.html%3F_hsmi%3D88974744%26_hsenc%3Dp2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8&vis=1&dmc=8&scr_x=0&scr_y=0&psz=276x250&msz=300x250&ga_vid=254203172.1608036337&ga_sid=1608036337&ga_hid=881620343&ga_fc=true&fws=4&ohw=1600&btvi=1&tt_state=W3siaXNzdWVyT3JpZ2luIjoiaHR0cHM6Ly9hZHNlcnZpY2UuZ29vZ2xlLmNvbSIsInN0YXRlIjowfSx7Imlzc3Vlck9yaWdpbiI6Imh0dHBzOi8vYXR0ZXN0YXRpb24uYW5kcm9pZC5jb20iLCJzdGF0ZSI6MH1d
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020120801.js
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
172.217.22.2 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
fra16s14-in-f2.1e100.net
Software
cafe /
Resource Hash
bd86303c666e0f37884b82d13d03bbc5ccf35d53cca02d42ce5fd54ee5022778
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:45:38 GMT
content-encoding
br
x-content-type-options
nosniff
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
cross-origin-resource-policy
cross-origin
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
10868
x-xss-protection
0
google-lineitem-id
-1
pragma
no-cache
server
cafe
google-creative-id
-1
content-type
text/plain; charset=UTF-8
access-control-allow-origin
https://www.dailymail.co.uk
access-control-expose-headers
x-google-amp-ad-validated-version
cache-control
no-cache, must-revalidate
access-control-allow-credentials
true
timing-allow-origin
*
expires
Fri, 01 Jan 1990 00:00:00 GMT
ads
securepubads.g.doubleclick.net/gampad/
6 KB
4 KB
XHR
General
Full URL
https://securepubads.g.doubleclick.net/gampad/ads?gdfp_req=1&pvsid=2639827676159032&correlator=2455119041695441&output=ldjh&impl=fif&eid=21069142&vrg=2020120801&guci=1.2.0.0.2.2.0.0&sc=1&sfv=1-0-37&ecs=20201215&iu_parts=5765%2Cdailymail.uk%2Cdm_dmsciencetech_sciencetechart%2Cinread_player_top&enc_prev_ius=%2F0%2F1%2F2%2F3&prev_iu_szs=480x270%7C636x1%7C480x1&prev_scp=pos%3Dinread_player_top%26amznbid%3D2%26amznp%3D2%26adx_channel%3D1%26nobids%3Dfalse%26refreshCount%3D0%26amznsz%3D0x0&eri=4&cust_params=page%3Dart%26article%3D9050821%26area%3Dsciencetech%26subarea%3Dsciencetech%26environment%3Dproduction%26country%3Dde%26abv%3Dmol-22070%252F19a28e0b%26bot%3Dfalse%26random%3D9ceebda3-1911-4085-b4cd-4ef660466486%26impid%3Dc0338c30-9d3e-46d6-8db6-95c14a8ccbca%26browserResolution%3Dmin_1244px%26device%3Dother%26device_features%3D%26articlewithvideo%3Dtrue%26style%3Dwide%26session%3D1%26session_page_ID%3Dnone%26utm_source%3Dnone%26watershed%3Dfalse%26location%3Ddailymail_co_uk%26id5%3Dtrue%26permutive%3D%26puid%3Db77f6280-fced-4776-aef9-89e90021e68b%26ptime%3D1608036337226&cookie_enabled=1&cdm=www.dailymail.co.uk&bc=31&abxe=1&dt=1608036337649&dlt=1608036336099&idt=1063&frm=20&biw=1600&bih=1200&oid=3&adxs=396&adys=1173&adks=26236092&ucis=4&ifi=4&u_tz=60&u_his=2&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_sd=1&flash=0&url=www.dailymail.co.uk%2Fsciencetech%2Farticle-9050821%2FRemdesivir-beneficial-patients-doctors-reveal.html&loc=https%3A%2F%2Fwww.dailymail.co.uk%2Fsciencetech%2Farticle-9050821%2FRemdesivir-beneficial-patients-doctors-reveal.html%3F_hsmi%3D88974744%26_hsenc%3Dp2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8&vis=1&dmc=8&scr_x=0&scr_y=0&psz=636x5187&msz=636x270&ga_vid=254203172.1608036337&ga_sid=1608036337&ga_hid=881620343&ga_fc=true&fws=4&ohw=1600&btvi=0&tt_state=W3siaXNzdWVyT3JpZ2luIjoiaHR0cHM6Ly9hZHNlcnZpY2UuZ29vZ2xlLmNvbSIsInN0YXRlIjowfSx7Imlzc3Vlck9yaWdpbiI6Imh0dHBzOi8vYXR0ZXN0YXRpb24uYW5kcm9pZC5jb20iLCJzdGF0ZSI6MH1d
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020120801.js
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
172.217.22.2 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
fra16s14-in-f2.1e100.net
Software
cafe /
Resource Hash
e3c31f1348222e09da1a3dc84ad4055d71ded62c10397de753b77c399a30da6d
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:45:37 GMT
content-encoding
br
x-content-type-options
nosniff
google-mediationgroup-id
-2
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
cross-origin-resource-policy
cross-origin
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
2982
x-xss-protection
0
google-lineitem-id
5343416350
pragma
no-cache
server
cafe
google-mediationtag-id
-2
google-creative-id
138308123804
content-type
text/plain; charset=UTF-8
access-control-allow-origin
https://www.dailymail.co.uk
cache-control
no-cache, must-revalidate
access-control-allow-credentials
true
timing-allow-origin
*
expires
Fri, 01 Jan 1990 00:00:00 GMT
ads
securepubads.g.doubleclick.net/gampad/
50 KB
11 KB
XHR
General
Full URL
https://securepubads.g.doubleclick.net/gampad/ads?gdfp_req=1&pvsid=2639827676159032&correlator=2455119041695441&output=ldjh&impl=fif&eid=21069142&vrg=2020120801&guci=1.2.0.0.2.2.0.0&sc=1&sfv=1-0-37&ecs=20201215&iu_parts=5765%2Cdailymail.uk%2Cdm_dmsciencetech_sciencetechart%2Cmpu_factbox_2&enc_prev_ius=%2F0%2F1%2F2%2F3&prev_iu_szs=300x250&prev_scp=pos%3Dmpu_factbox%26puff_offset%3D2%26adx_channel%3D11%26nobids%3Dtrue%26amznbid%3D2%26amznsz%3D0x0%26amznp%3D2&eri=4&cust_params=page%3Dart%26article%3D9050821%26area%3Dsciencetech%26subarea%3Dsciencetech%26environment%3Dproduction%26country%3Dde%26abv%3Dmol-22070%252F19a28e0b%26bot%3Dfalse%26random%3D9ceebda3-1911-4085-b4cd-4ef660466486%26impid%3Dc0338c30-9d3e-46d6-8db6-95c14a8ccbca%26browserResolution%3Dmin_1244px%26device%3Dother%26device_features%3D%26articlewithvideo%3Dtrue%26style%3Dwide%26session%3D1%26session_page_ID%3Dnone%26utm_source%3Dnone%26watershed%3Dfalse%26location%3Ddailymail_co_uk%26id5%3Dtrue%26permutive%3D%26puid%3Db77f6280-fced-4776-aef9-89e90021e68b%26ptime%3D1608036337226&cookie_enabled=1&cdm=www.dailymail.co.uk&bc=31&abxe=1&dt=1608036337652&dlt=1608036336099&idt=1063&frm=20&biw=1600&bih=1200&oid=3&adxs=650&adys=5753&adks=3738025968&ucis=5&ifi=5&u_tz=60&u_his=2&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_sd=1&flash=0&url=www.dailymail.co.uk%2Fsciencetech%2Farticle-9050821%2FRemdesivir-beneficial-patients-doctors-reveal.html&loc=https%3A%2F%2Fwww.dailymail.co.uk%2Fsciencetech%2Farticle-9050821%2FRemdesivir-beneficial-patients-doctors-reveal.html%3F_hsmi%3D88974744%26_hsenc%3Dp2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8&vis=1&dmc=8&scr_x=0&scr_y=0&psz=276x250&msz=300x250&ga_vid=254203172.1608036337&ga_sid=1608036337&ga_hid=881620343&ga_fc=true&fws=4&ohw=1600&btvi=2&tt_state=W3siaXNzdWVyT3JpZ2luIjoiaHR0cHM6Ly9hZHNlcnZpY2UuZ29vZ2xlLmNvbSIsInN0YXRlIjowfSx7Imlzc3Vlck9yaWdpbiI6Imh0dHBzOi8vYXR0ZXN0YXRpb24uYW5kcm9pZC5jb20iLCJzdGF0ZSI6MH1d
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020120801.js
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
172.217.22.2 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
fra16s14-in-f2.1e100.net
Software
cafe /
Resource Hash
de63221c463e9820898b669a0f0b118f0a82e743947feccd44686426ba166bc2
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:45:38 GMT
content-encoding
br
x-content-type-options
nosniff
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
cross-origin-resource-policy
cross-origin
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
11492
x-xss-protection
0
google-lineitem-id
-1
pragma
no-cache
server
cafe
google-creative-id
-1
content-type
text/plain; charset=UTF-8
access-control-allow-origin
https://www.dailymail.co.uk
access-control-expose-headers
x-google-amp-ad-validated-version
cache-control
no-cache, must-revalidate
access-control-allow-credentials
true
timing-allow-origin
*
expires
Fri, 01 Jan 1990 00:00:00 GMT
2
www.dailymail.co.uk/abe/a9/price/
4 B
701 B
XHR
General
Full URL
https://www.dailymail.co.uk/abe/a9/price/2
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/static/mol-adverts/demo/mol-22070/19a28e0b/mol-adverts.js
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2a02:26f0:6c00:296::11ae , Ascension Island, ASN20940 (AKAMAI-ASN1, EU),
Reverse DNS
Software
AmazonS3 /
Resource Hash
561b2814d3c09e62a92442c946307918f7f63f833c84876c08bd4c406767e53b

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

x-amz-version-id
wDnvhJJXpo3tPt4.QtsManRqQALbFlHY
content-security-policy-report-only
block-all-mixed-content; report-uri https://mol.report-uri.io/r/default/csp/reportOnly
last-modified
Thu, 26 Jul 2018 09:55:16 GMT
server
AmazonS3
x-amz-request-id
2Z4KDQ1N7H5GAG6P
etag
"f7ddd489ab0a82567b241b05971cbdb3"
vary
User-Agent
content-type
text/plain
cache-control
public, max-age=1146256
date
Tue, 15 Dec 2020 12:45:37 GMT
x-amz-replication-status
COMPLETED
server-timing
cdn-cache; desc=HIT, edge; dur=1
accept-ranges
bytes
content-length
4
x-amz-id-2
TQa+V4AfiJ7Bmz5eGVXtXeerNKKqRrPt9yBoXYXtX5TNMag04HicxY48/1EyJyZRcnVJVxDSTyI=
2
www.dailymail.co.uk/abe/a9/price/
4 B
700 B
XHR
General
Full URL
https://www.dailymail.co.uk/abe/a9/price/2
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/static/mol-adverts/demo/mol-22070/19a28e0b/mol-adverts.js
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2a02:26f0:6c00:296::11ae , Ascension Island, ASN20940 (AKAMAI-ASN1, EU),
Reverse DNS
Software
AmazonS3 /
Resource Hash
561b2814d3c09e62a92442c946307918f7f63f833c84876c08bd4c406767e53b

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

x-amz-version-id
wDnvhJJXpo3tPt4.QtsManRqQALbFlHY
content-security-policy-report-only
block-all-mixed-content; report-uri https://mol.report-uri.io/r/default/csp/reportOnly
last-modified
Thu, 26 Jul 2018 09:55:16 GMT
server
AmazonS3
x-amz-request-id
2Z4KDQ1N7H5GAG6P
etag
"f7ddd489ab0a82567b241b05971cbdb3"
vary
User-Agent
content-type
text/plain
cache-control
public, max-age=1146256
date
Tue, 15 Dec 2020 12:45:37 GMT
x-amz-replication-status
COMPLETED
server-timing
cdn-cache; desc=HIT, edge; dur=1
accept-ranges
bytes
content-length
4
x-amz-id-2
TQa+V4AfiJ7Bmz5eGVXtXeerNKKqRrPt9yBoXYXtX5TNMag04HicxY48/1EyJyZRcnVJVxDSTyI=
/
crta.dailymail.co.uk/
8 B
449 B
Other
General
Full URL
https://crta.dailymail.co.uk/
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/static/mol-adverts/demo/mol-22070/19a28e0b/mol-adverts.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
2a02:26f0:6c00:2be::16c2 , Ascension Island, ASN20940 (AKAMAI-ASN1, EU),
Reverse DNS
Software
http-to-kafka/0.8.10 /
Resource Hash
a00fb0c50741f81bb51d35b4475a4357f8039aabd896a21036bc516839401595

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type
text/plain

Response headers

pragma
no-cache
date
Tue, 15 Dec 2020 12:45:37 GMT
server
http-to-kafka/0.8.10
etag
W/"8-YaBXLEiT7zQxEyDYTILfiL6oPhE"
content-type
text/plain; charset=utf-8
access-control-allow-origin
*
cache-control
max-age=0, no-cache, no-store
access-control-allow-credentials
true
content-length
8
expires
Tue, 15 Dec 2020 12:45:37 GMT
ads
securepubads.g.doubleclick.net/gampad/
82 KB
25 KB
XHR
General
Full URL
https://securepubads.g.doubleclick.net/gampad/ads?gdfp_req=1&pvsid=2639827676159032&correlator=2455119041695441&output=ldjh&impl=fif&eid=21069142&vrg=2020120801&guci=1.2.0.0.2.2.0.0&sc=1&sfv=1-0-37&ecs=20201215&iu_parts=5765%2Cdailymail.uk%2Cdm_dmsciencetech_sciencetechart%2Cmpu_top&enc_prev_ius=%2F0%2F1%2F2%2F3&prev_iu_szs=300x600%7C300x250&prev_scp=pos%3Dmpu_top%26amznbid%3D2%26amznp%3D2%26adx_channel%3D3%26nobids%3Dfalse%26refreshCount%3D0%26amznsz%3D0x0&eri=4&cust_params=page%3Dart%26article%3D9050821%26area%3Dsciencetech%26subarea%3Dsciencetech%26environment%3Dproduction%26country%3Dde%26abv%3Dmol-22070%252F19a28e0b%26bot%3Dfalse%26random%3D9ceebda3-1911-4085-b4cd-4ef660466486%26impid%3Dc0338c30-9d3e-46d6-8db6-95c14a8ccbca%26browserResolution%3Dmin_1244px%26device%3Dother%26device_features%3D%26articlewithvideo%3Dtrue%26style%3Dwide%26session%3D1%26session_page_ID%3Dnone%26utm_source%3Dnone%26watershed%3Dfalse%26location%3Ddailymail_co_uk%26id5%3Dtrue%26permutive%3D%26puid%3Db77f6280-fced-4776-aef9-89e90021e68b%26ptime%3D1608036337226&cookie_enabled=1&cdm=www.dailymail.co.uk&bc=31&abxe=1&dt=1608036337737&dlt=1608036336099&idt=1063&frm=20&biw=1600&bih=1200&oid=3&adxs=978&adys=553&adks=1173142669&ucis=6&ifi=6&u_tz=60&u_his=2&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_sd=1&flash=0&url=www.dailymail.co.uk%2Fsciencetech%2Farticle-9050821%2FRemdesivir-beneficial-patients-doctors-reveal.html&loc=https%3A%2F%2Fwww.dailymail.co.uk%2Fsciencetech%2Farticle-9050821%2FRemdesivir-beneficial-patients-doctors-reveal.html%3F_hsmi%3D88974744%26_hsenc%3Dp2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8&vis=1&dmc=8&scr_x=0&scr_y=0&psz=308x627&msz=308x627&ga_vid=254203172.1608036337&ga_sid=1608036337&ga_hid=881620343&ga_fc=true&fws=4&ohw=1600&btvi=0&tt_state=W3siaXNzdWVyT3JpZ2luIjoiaHR0cHM6Ly9hZHNlcnZpY2UuZ29vZ2xlLmNvbSIsInN0YXRlIjowfSx7Imlzc3Vlck9yaWdpbiI6Imh0dHBzOi8vYXR0ZXN0YXRpb24uYW5kcm9pZC5jb20iLCJzdGF0ZSI6MH1d
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020120801.js
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
172.217.22.2 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
fra16s14-in-f2.1e100.net
Software
cafe /
Resource Hash
6d5e67c68b006e1c9eec26922a825431a6d8d0b5d7961fb04350ecc0900b8868
Security Headers
Name Value
Content-Security-Policy child-src 'unsafe-inline' cm.g.doubleclick.net googleads.g.doubleclick.net www.google.com accounts.google.com pagead2.googlesyndication.com/pagead/s/cookie_push.html gmsg: https://tpc.googlesyndication.com/sadbundle/$csp%3Der3$/15297336090616240942/index.html;frame-src 'unsafe-inline' cm.g.doubleclick.net googleads.g.doubleclick.net www.google.com accounts.google.com pagead2.googlesyndication.com/pagead/s/cookie_push.html gmsg: https://tpc.googlesyndication.com/sadbundle/$csp%3Der3$/15297336090616240942/index.html;report-uri https://pagead2.googlesyndication.com/pagead/gen_csp?id=adbundle&qqi=CKSho5aC0O0CFRgL4AodKUYEyg&gqi=&layout=/sadbundle/%24csp%253Der3%24/15297336090616240942/index.html
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

content-security-policy
child-src 'unsafe-inline' cm.g.doubleclick.net googleads.g.doubleclick.net www.google.com accounts.google.com pagead2.googlesyndication.com/pagead/s/cookie_push.html gmsg: https://tpc.googlesyndication.com/sadbundle/$csp%3Der3$/15297336090616240942/index.html;frame-src 'unsafe-inline' cm.g.doubleclick.net googleads.g.doubleclick.net www.google.com accounts.google.com pagead2.googlesyndication.com/pagead/s/cookie_push.html gmsg: https://tpc.googlesyndication.com/sadbundle/$csp%3Der3$/15297336090616240942/index.html;report-uri https://pagead2.googlesyndication.com/pagead/gen_csp?id=adbundle&qqi=CKSho5aC0O0CFRgL4AodKUYEyg&gqi=&layout=/sadbundle/%24csp%253Der3%24/15297336090616240942/index.html
content-encoding
br
x-content-type-options
nosniff
google-creative-id
-1
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
cross-origin-resource-policy
cross-origin
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
25242
x-xss-protection
0
google-lineitem-id
-1
pragma
no-cache
server
cafe
date
Tue, 15 Dec 2020 12:45:39 GMT
content-type
text/plain; charset=UTF-8
access-control-allow-origin
https://www.dailymail.co.uk
cache-control
no-cache, must-revalidate
access-control-allow-credentials
true
timing-allow-origin
*
expires
Fri, 01 Jan 1990 00:00:00 GMT
ads
securepubads.g.doubleclick.net/gampad/
490 B
301 B
XHR
General
Full URL
https://securepubads.g.doubleclick.net/gampad/ads?gdfp_req=1&pvsid=2639827676159032&correlator=2455119041695441&output=ldjh&impl=fif&eid=21069142&vrg=2020120801&guci=1.2.0.0.2.2.0.0&sc=1&sfv=1-0-37&ecs=20201215&iu_parts=5765%2Cdailymail.uk%2Cdm_dmsciencetech_sciencetechart%2Chalf_mpu_top&enc_prev_ius=%2F0%2F1%2F2%2F3&prev_iu_szs=300x150&prev_scp=pos%3Dhalf_mpu_top%26amznbid%3D2%26amznp%3D2%26adx_channel%3D13%26nobids%3Dfalse%26refreshCount%3D0%26amznsz%3D0x0&eri=4&cust_params=page%3Dart%26article%3D9050821%26area%3Dsciencetech%26subarea%3Dsciencetech%26environment%3Dproduction%26country%3Dde%26abv%3Dmol-22070%252F19a28e0b%26bot%3Dfalse%26random%3D9ceebda3-1911-4085-b4cd-4ef660466486%26impid%3Dc0338c30-9d3e-46d6-8db6-95c14a8ccbca%26browserResolution%3Dmin_1244px%26device%3Dother%26device_features%3D%26articlewithvideo%3Dtrue%26style%3Dwide%26session%3D1%26session_page_ID%3Dnone%26utm_source%3Dnone%26watershed%3Dfalse%26location%3Ddailymail_co_uk%26id5%3Dtrue%26permutive%3D%26puid%3Db77f6280-fced-4776-aef9-89e90021e68b%26ptime%3D1608036337226&cookie_enabled=1&cdm=www.dailymail.co.uk&bc=31&abxe=1&dt=1608036337740&dlt=1608036336099&idt=1063&frm=20&biw=1600&bih=1200&oid=3&adxs=974&adys=1309&adks=3278541271&ucis=7&ifi=7&u_tz=60&u_his=2&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_sd=1&flash=0&url=www.dailymail.co.uk%2Fsciencetech%2Farticle-9050821%2FRemdesivir-beneficial-patients-doctors-reveal.html&loc=https%3A%2F%2Fwww.dailymail.co.uk%2Fsciencetech%2Farticle-9050821%2FRemdesivir-beneficial-patients-doctors-reveal.html%3F_hsmi%3D88974744%26_hsenc%3Dp2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8&vis=1&dmc=8&scr_x=0&scr_y=0&psz=308x15371&msz=308x150&ga_vid=254203172.1608036337&ga_sid=1608036337&ga_hid=881620343&ga_fc=true&fws=4&ohw=1600&btvi=3&tt_state=W3siaXNzdWVyT3JpZ2luIjoiaHR0cHM6Ly9hZHNlcnZpY2UuZ29vZ2xlLmNvbSIsInN0YXRlIjowfSx7Imlzc3Vlck9yaWdpbiI6Imh0dHBzOi8vYXR0ZXN0YXRpb24uYW5kcm9pZC5jb20iLCJzdGF0ZSI6MH1d
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020120801.js
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
172.217.22.2 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
fra16s14-in-f2.1e100.net
Software
cafe /
Resource Hash
5f5643623de017dbdc1d7badecac04d5ed9b6d7b773af5e15d981e767bdad3a2
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:45:39 GMT
content-encoding
br
x-content-type-options
nosniff
google-mediationgroup-id
-2
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
cross-origin-resource-policy
cross-origin
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
266
x-xss-protection
0
google-lineitem-id
-2
pragma
no-cache
server
cafe
google-mediationtag-id
-2
google-creative-id
-2
content-type
text/plain; charset=UTF-8
access-control-allow-origin
https://www.dailymail.co.uk
cache-control
no-cache, must-revalidate
access-control-allow-credentials
true
timing-allow-origin
*
expires
Fri, 01 Jan 1990 00:00:00 GMT
settings.js
cdn.userreport.com/w_51248e61-3510-4ae9-b8a6-712be4dd155e/
5 KB
2 KB
Script
General
Full URL
https://cdn.userreport.com/w_51248e61-3510-4ae9-b8a6-712be4dd155e/settings.js
Requested by
Host: cdn.userreport.com
URL: https://cdn.userreport.com/userreport.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2600:9000:21f3:8200:19:d208:7940:93a1 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
AmazonS3 /
Resource Hash
eae5fa416343a7c9494925c49cc48570b457c562a25a388a9fbfa39e405d57d8

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

x-amz-version-id
oKKUtr9VrqsV2HkWDM2dVmdvbyg0.yq4
content-encoding
gzip
last-modified
Thu, 14 May 2020 09:32:50 GMT
server
AmazonS3
x-amz-cf-pop
FRA2-C2
etag
"4eb5cc0a9ea3469c133043e9f20606fe"
x-cache
RefreshHit from cloudfront
content-type
text/javascript
via
1.1 2b2e2811e641703aebf776da39317b9c.cloudfront.net (CloudFront)
cache-control
max-age=0
date
Tue, 15 Dec 2020 12:45:38 GMT
accept-ranges
bytes
content-length
1737
x-amz-cf-id
HCkbLQbzpIxvmsnglU7Yed7VPqNYHv10hH_uGmxERdRt-MQPAZ2JwA==
bid
c.amazon-adsystem.com/e/dtb/
23 B
373 B
XHR
General
Full URL
https://c.amazon-adsystem.com/e/dtb/bid?src=3065&u=https%3A%2F%2Fwww.dailymail.co.uk%2Fsciencetech%2Farticle-9050821%2FRemdesivir-beneficial-patients-doctors-reveal.html%3F_hsmi%3D88974744%26_hsenc%3Dp2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8&pid=qkqBHoBAnjHbV&cb=8&ws=1600x1200&v=7.58.01&t=2000&slots=%5B%7B%22sd%22%3A%22mpu_middle%22%2C%22s%22%3A%5B%22300x600%22%2C%22300x250%22%5D%2C%22kv%22%3A%7B%22pubcid%22%3A%223093664108%22%7D%7D%5D&gdprl=%7B%22status%22%3A%22no-cmp%22%7D
Requested by
Host: c.amazon-adsystem.com
URL: https://c.amazon-adsystem.com/aax2/apstag.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
99.84.88.20 Seattle, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-99-84-88-20.muc50.r.cloudfront.net
Software
Server /
Resource Hash
c905a799c91593b68a840f7aae0bd411b7f0d2d475c8f5f5a780d54018fb61b8

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:45:37 GMT
via
1.1 fe36c7f30c8ef2853edecc43f320092c.cloudfront.net (CloudFront)
server
Server
x-amz-cf-pop
MUC50-C1
vary
User-Agent
x-cache
Miss from cloudfront
content-type
text/javascript;charset=UTF-8
access-control-allow-origin
https://www.dailymail.co.uk
access-control-allow-credentials
true
timing-allow-origin
*
content-length
23
x-amz-cf-id
afbb-yZs8p0h98ZzGRVMqjCiJntY83n8bj2jwSZGIkxzz3A7eVT1Ew==
5714758-0-image-a-6_1541433836539.jpg
i.dailymail.co.uk/1s/2018/11/05/16/
6 KB
7 KB
Image
General
Full URL
https://i.dailymail.co.uk/1s/2018/11/05/16/5714758-0-image-a-6_1541433836539.jpg
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2a02:26f0:6c00:288::11ae , Ascension Island, ASN20940 (AKAMAI-ASN1, EU),
Reverse DNS
Software
AmazonS3 /
Resource Hash
ae3e170e857bed9e494a304a2eecf39a59568cdff6d2bf09c3cee6890e0bcacd

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

x-amz-version-id
8udGaw_.zf9v4BX7M8p2K6tfHwqSkMnb
last-modified
Mon, 05 Nov 2018 16:03:57 GMT
server
AmazonS3
x-amz-request-id
E7A0692A85D80106
etag
"ace7b561b8f0eb5f29cd074a93e1ee06"
content-type
image/jpeg
cache-control
max-age=2592000
date
Tue, 15 Dec 2020 12:45:37 GMT
x-amz-replication-status
COMPLETED
accept-ranges
bytes
timing-allow-origin
*
content-length
6366
x-amz-id-2
G2eCKACtmNsPMKzCKDzdBzGqRM+YrKPWZpCC2laNFFcXh3oB4xPpdxkYEdd3/bpnCYlD8ZSi3IA=
expires
Thu, 14 Jan 2021 12:45:37 GMT
spt_previewlinks_11.png
i.dailymail.co.uk/i/furniture/
4 KB
4 KB
Image
General
Full URL
https://i.dailymail.co.uk/i/furniture/spt_previewlinks_11.png
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/static/mol-fe/static/mol-fe-sync-bundle/5.9.0/desktop.css
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2a02:26f0:6c00:288::11ae , Ascension Island, ASN20940 (AKAMAI-ASN1, EU),
Reverse DNS
Software
AkamaiNetStorage /
Resource Hash
2de827c9500598749eea66b8b160381c4d3f879c83b9566ddefff4f4835709ef

Request headers

Referer
https://www.dailymail.co.uk/static/mol-fe/static/mol-fe-sync-bundle/5.9.0/desktop.css
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:45:37 GMT
last-modified
Mon, 31 Mar 2014 16:12:17 GMT
server
AkamaiNetStorage
etag
"9397e448905fdab93b871a5fb55e462f:1396282337"
content-type
image/png
cache-control
max-age=2592000
accept-ranges
bytes
timing-allow-origin
*
content-length
4126
expires
Thu, 14 Jan 2021 12:45:37 GMT
5412846-0-image-a-8_1540488021535.jpg
i.dailymail.co.uk/1s/2018/10/25/18/
3 KB
3 KB
Image
General
Full URL
https://i.dailymail.co.uk/1s/2018/10/25/18/5412846-0-image-a-8_1540488021535.jpg
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2a02:26f0:6c00:288::11ae , Ascension Island, ASN20940 (AKAMAI-ASN1, EU),
Reverse DNS
Software
AmazonS3 /
Resource Hash
362d6daba2e9b6130e3fe509a9f735607e5966e8aaf6138ac6b95e14c67eb07d

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

x-amz-version-id
VWsy3jgni4v9i6MG0ucvSZkA0iese3vX
last-modified
Thu, 25 Oct 2018 17:20:23 GMT
server
AmazonS3
x-amz-request-id
3D7BAA4960483DA8
etag
"f18ad24d9e3dd72b45c31f6503f72cd1"
content-type
image/jpeg
cache-control
max-age=2592000
date
Tue, 15 Dec 2020 12:45:37 GMT
x-amz-replication-status
COMPLETED
accept-ranges
bytes
timing-allow-origin
*
content-length
3041
x-amz-id-2
ZDIU7AMgY6GtSK/+aop6Z55v7CGcoUPEv+2SZHzUcFLkoitCXgk4AvBy7RH5D52+Qtz8d97r9W0=
expires
Thu, 14 Jan 2021 12:45:37 GMT
5331710-0-image-m-8_1540317153365.jpg
i.dailymail.co.uk/1s/2018/10/23/18/
3 KB
3 KB
Image
General
Full URL
https://i.dailymail.co.uk/1s/2018/10/23/18/5331710-0-image-m-8_1540317153365.jpg
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2a02:26f0:6c00:288::11ae , Ascension Island, ASN20940 (AKAMAI-ASN1, EU),
Reverse DNS
Software
AmazonS3 /
Resource Hash
262eabf7f738e525ef65ad6ba22f1595014f904547f4ee8a4e40e51cbf7f951b

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

x-amz-version-id
lCiHpzJhyh7dfbvC3ZUYFIY.jEGfeLbl
last-modified
Tue, 23 Oct 2018 17:52:39 GMT
server
AmazonS3
x-amz-request-id
B25B72521DAF46FE
etag
"d88d0d9e743da6df855ba49b3616006a"
content-type
image/jpeg
cache-control
max-age=2592000
date
Tue, 15 Dec 2020 12:45:37 GMT
x-amz-replication-status
COMPLETED
accept-ranges
bytes
timing-allow-origin
*
content-length
3147
x-amz-id-2
uKqsxHcuL+SdWEXAk+UoSmFd+0pZ1rOvAxO65pitt/Pcc+A1AccZms7aqomI1UphF5vhZf6xCIU=
expires
Thu, 14 Jan 2021 12:45:37 GMT
5215280-0-image-m-52_1539982417591.jpg
i.dailymail.co.uk/1s/2018/10/19/21/
4 KB
4 KB
Image
General
Full URL
https://i.dailymail.co.uk/1s/2018/10/19/21/5215280-0-image-m-52_1539982417591.jpg
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2a02:26f0:6c00:288::11ae , Ascension Island, ASN20940 (AKAMAI-ASN1, EU),
Reverse DNS
Software
AmazonS3 /
Resource Hash
d86145e800b2edf1e5eb56d69b8d4b032e3fe80d188b214b2d96a1f2bf4b4489

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

x-amz-version-id
wvBKzifmNudP.Ud9eG49QPa2Njfq7qCY
last-modified
Fri, 19 Oct 2018 20:53:50 GMT
server
AmazonS3
x-amz-request-id
744361A841DB8ECA
etag
"cad5372398912247eec9726be5c76b02"
content-type
image/jpeg
cache-control
max-age=2592000
date
Tue, 15 Dec 2020 12:45:37 GMT
x-amz-replication-status
COMPLETED
accept-ranges
bytes
timing-allow-origin
*
content-length
4013
x-amz-id-2
fO1bNdsbqd9r0PagUHZ6Ui5DN9oOP7VzisMWyqLH+EsVXzO/nHRG0miyu6KQrxyI0PgCBXqGSR8=
expires
Thu, 14 Jan 2021 12:45:37 GMT
50187CA400000578-0-image-m-6_1537221081247.jpg
i.dailymail.co.uk/i/newpix/2018/09/17/22/
9 KB
9 KB
Image
General
Full URL
https://i.dailymail.co.uk/i/newpix/2018/09/17/22/50187CA400000578-0-image-m-6_1537221081247.jpg
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2a02:26f0:6c00:288::11ae , Ascension Island, ASN20940 (AKAMAI-ASN1, EU),
Reverse DNS
Software
AmazonS3 /
Resource Hash
7715a959ab7727da10cf349d186ac930deee63caa1da57b6a06f593169120463

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

x-amz-version-id
69XQkAdVBDtAZqQwrQNlsWb9zFfn0i8C
content-type
image/jpeg
x-amz-request-id
34DD6D4F13345678
x-amz-meta-mode
33188
x-amz-replication-status
COMPLETED
content-length
9027
x-amz-id-2
7Q1+M2+9yby3W7+PVq6+sjCv9KcDIRHyOTL4tMELxmQvevD+1E+8x97DfXzbJEmNBLoYoaFi/hk=
last-modified
Mon, 17 Sep 2018 21:51:50 GMT
server
AmazonS3
etag
"66be7a043c74435e66d39c6e56d5b080"
x-amz-meta-uid
1001
x-amz-meta-gid
1001
expires
Thu, 14 Jan 2021 12:45:37 GMT
cache-control
max-age=2592000
accept-ranges
bytes
timing-allow-origin
*
date
Tue, 15 Dec 2020 12:45:37 GMT
x-amz-meta-mtime
1537221109
5103536-0-image-a-19_1539725071750.jpg
i.dailymail.co.uk/1s/2018/10/16/22/
2 KB
3 KB
Image
General
Full URL
https://i.dailymail.co.uk/1s/2018/10/16/22/5103536-0-image-a-19_1539725071750.jpg
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2a02:26f0:6c00:288::11ae , Ascension Island, ASN20940 (AKAMAI-ASN1, EU),
Reverse DNS
Software
AmazonS3 /
Resource Hash
0beaf04aa3ffe6710f5c82bcabc2abe511e502e0a6efb67d3c0f6f0a16e1ecaf

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

x-amz-version-id
THriLqeUHwahvD58RwbYcp4aNG2c1ppO
last-modified
Tue, 16 Oct 2018 21:24:33 GMT
server
AmazonS3
x-amz-request-id
55C607FE5E420A8D
etag
"d07a1976ac9cc106db68ffdc9b413903"
content-type
image/jpeg
cache-control
max-age=2592000
date
Tue, 15 Dec 2020 12:45:37 GMT
x-amz-replication-status
COMPLETED
accept-ranges
bytes
timing-allow-origin
*
content-length
2457
x-amz-id-2
CpvSA1FMvjJ2LWtOS9k71tdARmmCEWPKfrph246dtxx73wpVOkAfLi0/2VmYA6XN+ndc5TB5bsI=
expires
Thu, 14 Jan 2021 12:45:37 GMT
5018D69B00000578-0-image-m-25_1537206890240.jpg
i.dailymail.co.uk/i/newpix/2018/09/17/18/
4 KB
4 KB
Image
General
Full URL
https://i.dailymail.co.uk/i/newpix/2018/09/17/18/5018D69B00000578-0-image-m-25_1537206890240.jpg
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2a02:26f0:6c00:288::11ae , Ascension Island, ASN20940 (AKAMAI-ASN1, EU),
Reverse DNS
Software
AmazonS3 /
Resource Hash
762b7e0a62a387d1c30959378b78a1d3ba353af55627d535008eed4d40cb2304

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

x-amz-version-id
TgpbUsNqviYpWo4sBOS3jj.EbD1xHQqV
content-type
image/jpeg
x-amz-request-id
AB45D2C875F31C61
x-amz-meta-mode
33188
x-amz-replication-status
COMPLETED
content-length
3670
x-amz-id-2
g/1X7iIUAVCnVdNTSYphsRiHimeMd8BfA+u/CgCISnZMY460LXScRtDFlhqdsVIkwPdqGUrujXA=
last-modified
Mon, 17 Sep 2018 17:55:01 GMT
server
AmazonS3
etag
"01fdc609cc6cf31cbefa585ed3f7e0c6"
x-amz-meta-uid
1001
x-amz-meta-gid
1006
expires
Thu, 14 Jan 2021 12:45:37 GMT
cache-control
max-age=2592000
accept-ranges
bytes
timing-allow-origin
*
date
Tue, 15 Dec 2020 12:45:37 GMT
x-amz-meta-mtime
1537206900
47A0BC8600000578-0-image-m-9_1514842576590.jpg
i.dailymail.co.uk/i/pix/2018/01/01/21/
3 KB
3 KB
Image
General
Full URL
https://i.dailymail.co.uk/i/pix/2018/01/01/21/47A0BC8600000578-0-image-m-9_1514842576590.jpg
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2a02:26f0:6c00:288::11ae , Ascension Island, ASN20940 (AKAMAI-ASN1, EU),
Reverse DNS
Software
Apache /
Resource Hash
f9379aa18d07b23638150a9dd541fc3b1b067b630deeeb82acce091bb0c804bc

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:45:37 GMT
last-modified
Mon, 01 Jan 2018 21:36:33 GMT
server
Apache
etag
"8ffaaa4e9a4498b9a4cc2fc0138126e9:1514842593"
content-type
image/jpeg
cache-control
max-age=2592000
accept-ranges
bytes
timing-allow-origin
*
content-length
3351
expires
Thu, 14 Jan 2021 12:45:37 GMT
30E0B9C900000578-0-image-m-23_1454693647723.jpg
i.dailymail.co.uk/i/pix/2016/02/05/17/
3 KB
3 KB
Image
General
Full URL
https://i.dailymail.co.uk/i/pix/2016/02/05/17/30E0B9C900000578-0-image-m-23_1454693647723.jpg
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2a02:26f0:6c00:288::11ae , Ascension Island, ASN20940 (AKAMAI-ASN1, EU),
Reverse DNS
Software
AkamaiNetStorage /
Resource Hash
e9de05ef39f54d3d1e517f917de4391be1ce2082481b776d224e1d0109ea082e

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:45:37 GMT
last-modified
Fri, 05 Feb 2016 17:34:16 GMT
server
AkamaiNetStorage
etag
"3cb57b1741b4544e2644221548784472:1454693656"
content-type
image/jpeg
cache-control
max-age=2592000
accept-ranges
bytes
timing-allow-origin
*
content-length
2912
expires
Thu, 14 Jan 2021 12:45:37 GMT
3158355B00000578-0-image-m-5_1455807123483.jpg
i.dailymail.co.uk/i/pix/2016/02/18/14/
4 KB
4 KB
Image
General
Full URL
https://i.dailymail.co.uk/i/pix/2016/02/18/14/3158355B00000578-0-image-m-5_1455807123483.jpg
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2a02:26f0:6c00:288::11ae , Ascension Island, ASN20940 (AKAMAI-ASN1, EU),
Reverse DNS
Software
Apache /
Resource Hash
c80e4716674a9b307269ad181a8985f1b97cdfd4065e7384dfcadbbd5e657520

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:45:37 GMT
last-modified
Thu, 18 Feb 2016 14:52:13 GMT
server
Apache
etag
"b49c58d2f5207cf6b67c42a54240c5d5:1455807133"
content-type
image/jpeg
cache-control
max-age=2592000
accept-ranges
bytes
timing-allow-origin
*
content-length
3705
expires
Thu, 14 Jan 2021 12:45:37 GMT
294F489500000578-0-image-m-22_1433292308497.jpg
i.dailymail.co.uk/i/pix/2015/06/03/01/
3 KB
3 KB
Image
General
Full URL
https://i.dailymail.co.uk/i/pix/2015/06/03/01/294F489500000578-0-image-m-22_1433292308497.jpg
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2a02:26f0:6c00:288::11ae , Ascension Island, ASN20940 (AKAMAI-ASN1, EU),
Reverse DNS
Software
AkamaiNetStorage /
Resource Hash
db1bdd24b8e6603a6c27576228d57eb0db7518a781a33a614ff63a28b005f841

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:45:37 GMT
last-modified
Wed, 03 Jun 2015 00:45:32 GMT
server
AkamaiNetStorage
etag
"b81aaa0b69e4389fea9c60a44d84695a:1433292332"
content-type
image/jpeg
cache-control
max-age=2592000
accept-ranges
bytes
timing-allow-origin
*
content-length
3061
expires
Thu, 14 Jan 2021 12:45:37 GMT
2
www.dailymail.co.uk/abe/a9/price/
4 B
826 B
XHR
General
Full URL
https://www.dailymail.co.uk/abe/a9/price/2
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/static/mol-adverts/demo/mol-22070/19a28e0b/mol-adverts.js
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2a02:26f0:6c00:296::11ae , Ascension Island, ASN20940 (AKAMAI-ASN1, EU),
Reverse DNS
Software
AmazonS3 /
Resource Hash
561b2814d3c09e62a92442c946307918f7f63f833c84876c08bd4c406767e53b

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

x-amz-version-id
wDnvhJJXpo3tPt4.QtsManRqQALbFlHY
content-security-policy-report-only
block-all-mixed-content; report-uri https://mol.report-uri.io/r/default/csp/reportOnly
last-modified
Thu, 26 Jul 2018 09:55:16 GMT
server
AmazonS3
x-amz-request-id
2Z4KDQ1N7H5GAG6P
etag
"f7ddd489ab0a82567b241b05971cbdb3"
vary
User-Agent
content-type
text/plain
cache-control
public, max-age=1146256
date
Tue, 15 Dec 2020 12:45:37 GMT
x-amz-replication-status
COMPLETED
server-timing
cdn-cache; desc=HIT, edge; dur=1
accept-ranges
bytes
content-length
4
x-amz-id-2
TQa+V4AfiJ7Bmz5eGVXtXeerNKKqRrPt9yBoXYXtX5TNMag04HicxY48/1EyJyZRcnVJVxDSTyI=
spt_previewlinks_12.png
i.dailymail.co.uk/i/furniture/
777 B
983 B
Image
General
Full URL
https://i.dailymail.co.uk/i/furniture/spt_previewlinks_12.png
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/static/gunther/17.14.0/all--.css
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2a02:26f0:6c00:288::11ae , Ascension Island, ASN20940 (AKAMAI-ASN1, EU),
Reverse DNS
Software
Apache /
Resource Hash
570e1f285b390e0f3d884194a0ff4dfa733fec75c306f437b7a6b8e30ba31034

Request headers

Referer
https://www.dailymail.co.uk/static/gunther/17.14.0/all--.css
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:45:37 GMT
last-modified
Mon, 06 Nov 2017 11:51:20 GMT
server
Apache
etag
"89d33ecb32c726c50934f04d4af5876b:1509969080"
content-type
image/png
cache-control
max-age=2592000
accept-ranges
bytes
timing-allow-origin
*
content-length
777
expires
Thu, 14 Jan 2021 12:45:37 GMT
bid
c.amazon-adsystem.com/e/dtb/
23 B
373 B
XHR
General
Full URL
https://c.amazon-adsystem.com/e/dtb/bid?src=3065&u=https%3A%2F%2Fwww.dailymail.co.uk%2Fsciencetech%2Farticle-9050821%2FRemdesivir-beneficial-patients-doctors-reveal.html%3F_hsmi%3D88974744%26_hsenc%3Dp2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8&pid=qkqBHoBAnjHbV&cb=9&ws=1600x1200&v=7.58.01&t=2000&slots=%5B%7B%22sd%22%3A%22sky-left%22%2C%22s%22%3A%5B%22300x600%22%2C%22160x600%22%2C%22120x600%22%2C%22300x250%22%5D%2C%22kv%22%3A%7B%22pubcid%22%3A%223093664108%22%7D%7D%5D&gdprl=%7B%22status%22%3A%22no-cmp%22%7D
Requested by
Host: c.amazon-adsystem.com
URL: https://c.amazon-adsystem.com/aax2/apstag.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
99.84.88.20 Seattle, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-99-84-88-20.muc50.r.cloudfront.net
Software
Server /
Resource Hash
4b8f230af668f20a7b50021f1edb1fac1c96cab1aa576933a2064e5d7807179b

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:45:37 GMT
via
1.1 fe36c7f30c8ef2853edecc43f320092c.cloudfront.net (CloudFront)
server
Server
x-amz-cf-pop
MUC50-C1
vary
User-Agent
x-cache
Miss from cloudfront
content-type
text/javascript;charset=UTF-8
access-control-allow-origin
https://www.dailymail.co.uk
access-control-allow-credentials
true
timing-allow-origin
*
content-length
23
x-amz-cf-id
G7EFgvXNWTudQGbQo2uHtiYopILr_mVJzQbnbMSukCgY4OkU48zScA==
bid
c.amazon-adsystem.com/e/dtb/
24 B
374 B
XHR
General
Full URL
https://c.amazon-adsystem.com/e/dtb/bid?src=3065&u=https%3A%2F%2Fwww.dailymail.co.uk%2Fsciencetech%2Farticle-9050821%2FRemdesivir-beneficial-patients-doctors-reveal.html%3F_hsmi%3D88974744%26_hsenc%3Dp2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8&pid=qkqBHoBAnjHbV&cb=10&ws=1600x1200&v=7.58.01&t=2000&slots=%5B%7B%22sd%22%3A%22sky-right%22%2C%22s%22%3A%5B%22300x600%22%2C%22160x600%22%2C%22120x600%22%2C%22300x250%22%5D%2C%22kv%22%3A%7B%22pubcid%22%3A%223093664108%22%7D%7D%5D&gdprl=%7B%22status%22%3A%22no-cmp%22%7D
Requested by
Host: c.amazon-adsystem.com
URL: https://c.amazon-adsystem.com/aax2/apstag.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
99.84.88.20 Seattle, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-99-84-88-20.muc50.r.cloudfront.net
Software
Server /
Resource Hash
b84677c9d507861ede2db86349957b3fff926d3857fb11595ab96d8866314798

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:45:38 GMT
via
1.1 fe36c7f30c8ef2853edecc43f320092c.cloudfront.net (CloudFront)
server
Server
x-amz-cf-pop
MUC50-C1
vary
User-Agent
x-cache
Miss from cloudfront
content-type
text/javascript;charset=UTF-8
access-control-allow-origin
https://www.dailymail.co.uk
access-control-allow-credentials
true
timing-allow-origin
*
content-length
24
x-amz-cf-id
JsJS12q1XfcDckmSOMKU-Q34N0t56mPzs3vHUY3F5LGFlJXeMhFhdQ==
bid
c.amazon-adsystem.com/e/dtb/
24 B
374 B
XHR
General
Full URL
https://c.amazon-adsystem.com/e/dtb/bid?src=3065&u=https%3A%2F%2Fwww.dailymail.co.uk%2Fsciencetech%2Farticle-9050821%2FRemdesivir-beneficial-patients-doctors-reveal.html%3F_hsmi%3D88974744%26_hsenc%3Dp2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8&pid=qkqBHoBAnjHbV&cb=11&ws=1600x1200&v=7.58.01&t=2000&slots=%5B%7B%22sd%22%3A%22sky_left_bottom%22%2C%22s%22%3A%5B%22300x600%22%2C%22160x600%22%2C%22120x600%22%5D%2C%22kv%22%3A%7B%22pubcid%22%3A%223093664108%22%7D%7D%5D&gdprl=%7B%22status%22%3A%22no-cmp%22%7D
Requested by
Host: c.amazon-adsystem.com
URL: https://c.amazon-adsystem.com/aax2/apstag.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
99.84.88.20 Seattle, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-99-84-88-20.muc50.r.cloudfront.net
Software
Server /
Resource Hash
843ca27aa5a55f23f36493f7a6c93bd16bae165e07e4be441ea45723b586eae2

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:45:38 GMT
via
1.1 fe36c7f30c8ef2853edecc43f320092c.cloudfront.net (CloudFront)
server
Server
x-amz-cf-pop
MUC50-C1
vary
User-Agent
x-cache
Miss from cloudfront
content-type
text/javascript;charset=UTF-8
access-control-allow-origin
https://www.dailymail.co.uk
access-control-allow-credentials
true
timing-allow-origin
*
content-length
24
x-amz-cf-id
3gBwXnzbYlz-cwtY48J6Iz863v6DCVkSmqngGJQiQ_DKEtiKfTrmtw==
bid
c.amazon-adsystem.com/e/dtb/
24 B
373 B
XHR
General
Full URL
https://c.amazon-adsystem.com/e/dtb/bid?src=3065&u=https%3A%2F%2Fwww.dailymail.co.uk%2Fsciencetech%2Farticle-9050821%2FRemdesivir-beneficial-patients-doctors-reveal.html%3F_hsmi%3D88974744%26_hsenc%3Dp2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8&pid=qkqBHoBAnjHbV&cb=12&ws=1600x1200&v=7.58.01&t=2000&slots=%5B%7B%22sd%22%3A%22sky_right_bottom%22%2C%22s%22%3A%5B%22300x600%22%2C%22160x600%22%2C%22120x600%22%5D%2C%22kv%22%3A%7B%22pubcid%22%3A%223093664108%22%7D%7D%5D&gdprl=%7B%22status%22%3A%22no-cmp%22%7D
Requested by
Host: c.amazon-adsystem.com
URL: https://c.amazon-adsystem.com/aax2/apstag.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
99.84.88.20 Seattle, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-99-84-88-20.muc50.r.cloudfront.net
Software
Server /
Resource Hash
63c3f35eed8f9fae951373f4f0642d09521b1b86c8d3a6d679047bc5440790fb

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:45:38 GMT
via
1.1 fe36c7f30c8ef2853edecc43f320092c.cloudfront.net (CloudFront)
server
Server
x-amz-cf-pop
MUC50-C1
vary
User-Agent
x-cache
Miss from cloudfront
content-type
text/javascript;charset=UTF-8
access-control-allow-origin
https://www.dailymail.co.uk
access-control-allow-credentials
true
timing-allow-origin
*
content-length
24
x-amz-cf-id
QTcBb9FTz2C2PPzvhKEMy6t4_7t4V60Mtd1TJkwBcu0oUzptnia8LQ==
preload-inline.gif
i.dailymail.co.uk/i/furniture/fff/
3 KB
3 KB
Image
General
Full URL
https://i.dailymail.co.uk/i/furniture/fff/preload-inline.gif
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2a02:26f0:6c00:288::11ae , Ascension Island, ASN20940 (AKAMAI-ASN1, EU),
Reverse DNS
Software
Apache /
Resource Hash
aebc793d0064383ee6b1625bf3bb32532ec30a5c12bf9117066107d412119123

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:45:38 GMT
last-modified
Tue, 02 Jul 2013 10:22:29 GMT
server
Apache
etag
"a51c5608d01acf32df728f299767f82b:1372760549"
content-type
image/gif
cache-control
max-age=2592000
accept-ranges
bytes
timing-allow-origin
*
content-length
3208
expires
Thu, 14 Jan 2021 12:45:38 GMT
icon_camera_90x68.png
i.dailymail.co.uk/i/furniture/mobile/
876 B
1 KB
Image
General
Full URL
https://i.dailymail.co.uk/i/furniture/mobile/icon_camera_90x68.png
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/static/mol-fe/static/mol-fe-async-bundle/6.18.1/articleDefer.css
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2a02:26f0:6c00:288::11ae , Ascension Island, ASN20940 (AKAMAI-ASN1, EU),
Reverse DNS
Software
Apache /
Resource Hash
be5c85bf40c3790d8bb01cbf334c014a920ad644d8ea3b61a3b8ed755b73a114

Request headers

Referer
https://www.dailymail.co.uk/static/mol-fe/static/mol-fe-async-bundle/6.18.1/articleDefer.css
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:45:38 GMT
last-modified
Tue, 28 Feb 2017 12:53:16 GMT
server
Apache
etag
"8d29fb626b73132ae1d4b6540c126c58:1488286396"
content-type
image/png
cache-control
max-age=2592000
accept-ranges
bytes
timing-allow-origin
*
content-length
876
expires
Thu, 14 Jan 2021 12:45:38 GMT
currencyExchangeRate
fff.dailymail.co.uk/
19 B
166 B
XHR
General
Full URL
https://fff.dailymail.co.uk/currencyExchangeRate
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/static/mol-fe/static/mol-fe-fff/1.3.16/scripts/fff.js
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2a02:26f0:6c00:288::11ae , Ascension Island, ASN20940 (AKAMAI-ASN1, EU),
Reverse DNS
Software
/
Resource Hash
f4be37ae6f3da730d311ea6ff931acc51d1ae189ec3c2d28869cb00e536605cd

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

access-control-allow-origin
*
x-rs-ops
fff2-fe:8180
date
Tue, 15 Dec 2020 12:45:38 GMT
cache-control
max-age=48369
content-length
19
access-control-allow-methods
GET
content-type
application/json; charset=utf-8
1.0.1
fff.dailymail.co.uk/templates/
9 KB
2 KB
XHR
General
Full URL
https://fff.dailymail.co.uk/templates/1.0.1
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/static/mol-fe/static/mol-fe-fff/1.3.16/scripts/fff.js
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2a02:26f0:6c00:288::11ae , Ascension Island, ASN20940 (AKAMAI-ASN1, EU),
Reverse DNS
Software
/
Resource Hash
6b8474a0f9c6b3c69e02409f7eeb8faa908b8b18e64fdf7cc88a9129585fc7c3

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:45:38 GMT
content-encoding
gzip
vary
Accept-Encoding
access-control-allow-methods
GET
content-type
application/json; charset=utf-8
access-control-allow-origin
*
cache-control
max-age=512054
content-length
1941
x-rs-ops
fff1-fe:8180
55199X1584066.skimlinks.js
s.skimresources.com/js/
58 KB
22 KB
Script
General
Full URL
https://s.skimresources.com/js/55199X1584066.skimlinks.js
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/static/mol-adverts/demo/mol-22070/19a28e0b/mol-adverts.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
151.139.128.11 Dallas, United States, ASN20446 (HIGHWINDS3, US),
Reverse DNS
Software
AmazonS3 /
Resource Hash
d15d47ae173596cea02055037e0583eee0b1c9fce6179a4fbcb5faf296fea2f2

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:45:38 GMT
content-encoding
gzip
last-modified
Mon, 30 Nov 2020 17:56:03 GMT
server
AmazonS3
x-amz-request-id
5W4HASEZCJ6K3GAM
etag
"7f46ae8cd859199c8b62c24129e50c89"
x-hw
1608036338.cds040.lo4.hc,1608036338.cds062.lo4.c
content-type
application/octet-stream
cache-control
max-age=3600
accept-ranges
bytes
content-length
21929
x-amz-id-2
N/TA2eZj3rlSeAwKiT7xHsFpOs3Qk6xPwvuKwoHSQQBGob9UhrW51cDpzhhHQ51Mom7zrH+XTLQ=
truncated
/
174 B
0
Image
General
Full URL
data:truncated
Protocol
DATA
Server
-, , ASN (),
Reverse DNS
Software
/
Resource Hash
52efd6959ae8fb441d9b7bce3624bcbda0b601316751028b16b31484124019c5

Request headers

Referer
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Content-Type
image/svg+xml
truncated
/
685 B
0
Image
General
Full URL
data:truncated
Protocol
DATA
Server
-, , ASN (),
Reverse DNS
Software
/
Resource Hash
fce704a574001e626087c28db6ba29c8c6bce20f156a7fc3a321b505326be3b5

Request headers

Referer
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Content-Type
image/svg+xml
35301122-0-image-a-72_1604597135950.jpg
i.dailymail.co.uk/1s/2020/11/05/17/
39 KB
39 KB
Image
General
Full URL
https://i.dailymail.co.uk/1s/2020/11/05/17/35301122-0-image-a-72_1604597135950.jpg
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2a02:26f0:6c00:288::11ae , Ascension Island, ASN20940 (AKAMAI-ASN1, EU),
Reverse DNS
Software
AmazonS3 /
Resource Hash
97cdff8479a3f6226825bdfce4a1b3321e9ed6a8dbd421ce7fe0938fceff6b36

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

x-amz-version-id
yp7jOty6Pityry1xyBlnwow665j9.BNt
last-modified
Thu, 05 Nov 2020 17:25:37 GMT
server
AmazonS3
x-amz-request-id
F11CC7ECC78A2F15
etag
"567f119af5c2cf8c56a640be41f0d247"
content-type
image/jpeg
cache-control
max-age=2592000
date
Tue, 15 Dec 2020 12:45:38 GMT
x-amz-replication-status
COMPLETED
accept-ranges
bytes
timing-allow-origin
*
content-length
39446
x-amz-id-2
SittGBFE+HRht6X/BaHNWvcxyuDU2gT1ffxTK5Y9b8c8FK/3Ehwv2l4gUuaudyMUInxx0DDCo4M=
expires
Thu, 14 Jan 2021 12:45:38 GMT
mol-video.woff
www.dailymail.co.uk/static/videoplayer/6.11.0-pr-503.2312/font/
3 KB
4 KB
Font
General
Full URL
https://www.dailymail.co.uk/static/videoplayer/6.11.0-pr-503.2312/font/mol-video.woff
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/static/videoplayer/6.11.0-pr-503.2312/styles/mol-fe-videoplayer.min.css
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2a02:26f0:6c00:296::11ae , Ascension Island, ASN20940 (AKAMAI-ASN1, EU),
Reverse DNS
Software
AkamaiNetStorage /
Resource Hash
4e89866ffba8b06a31d366ea9f6f5331f87fe29877bfce5381b78a46ddb7fd19

Request headers

Origin
https://www.dailymail.co.uk
Referer
https://www.dailymail.co.uk/static/videoplayer/6.11.0-pr-503.2312/styles/mol-fe-videoplayer.min.css
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:45:38 GMT
content-security-policy-report-only
block-all-mixed-content; report-uri https://mol.report-uri.io/r/default/csp/reportOnly
last-modified
Sun, 13 Dec 2020 22:55:47 GMT
server
AkamaiNetStorage
etag
"485a02e860743f3a21195c18ca687a40:1607900147.982203"
vary
User-Agent
content-type
font/woff
access-control-allow-origin
*
cache-control
max-age=2514664
server-timing
cdn-cache; desc=HIT, edge; dur=3
accept-ranges
bytes
timing-allow-origin
*
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept
content-length
3376
expires
Wed, 13 Jan 2021 15:16:42 GMT
bridge3.431.1_en.html
imasdk.googleapis.com/js/core/ Frame A6D9
0
0
Document
General
Full URL
https://imasdk.googleapis.com/js/core/bridge3.431.1_en.html
Requested by
Host: imasdk.googleapis.com
URL: https://imasdk.googleapis.com/js/sdkloader/ima3.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:825::200a Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

:method
GET
:authority
imasdk.googleapis.com
:scheme
https
:path
/js/core/bridge3.431.1_en.html
pragma
no-cache
cache-control
no-cache
upgrade-insecure-requests
1
user-agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
accept
text/html,application/xhtml+xml,application/xml;q=0.9,image/avif,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3;q=0.9
sec-fetch-site
cross-site
sec-fetch-mode
navigate
sec-fetch-dest
iframe
referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
accept-encoding
gzip, deflate, br
accept-language
en-US
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8

Response headers

accept-ranges
bytes
vary
Accept-Encoding
content-encoding
gzip
content-type
text/html
cross-origin-resource-policy
cross-origin
content-length
192077
date
Tue, 15 Dec 2020 11:15:04 GMT
expires
Wed, 15 Dec 2021 11:15:04 GMT
last-modified
Mon, 14 Dec 2020 09:10:26 GMT
x-content-type-options
nosniff
server
sffe
x-xss-protection
0
cache-control
public, max-age=31536000
age
5434
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
client.js
s0.2mdn.net/instream/video/
26 KB
11 KB
Script
General
Full URL
https://s0.2mdn.net/instream/video/client.js
Requested by
Host: imasdk.googleapis.com
URL: https://imasdk.googleapis.com/js/sdkloader/ima3.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:81b::2006 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
62f2eeec7851ae0d5e322062cf40092478236d4a4fc5a2cfd87b257739104147
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:45:38 GMT
content-encoding
gzip
x-content-type-options
nosniff
server
sffe
vary
Accept-Encoding
content-type
text/javascript
cache-control
private, max-age=900
cross-origin-resource-policy
cross-origin
accept-ranges
bytes
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
10523
x-xss-protection
0
expires
Tue, 15 Dec 2020 12:45:38 GMT
video-sources.json
www.dailymail.co.uk/api/player/8132733030895302559/
1 KB
1 KB
Fetch
General
Full URL
https://www.dailymail.co.uk/api/player/8132733030895302559/video-sources.json?geo=DE
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/static/videoplayer/6.11.0-pr-503.2312/scripts/mol-fe-videoplayer.min.js
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2a02:26f0:6c00:296::11ae , Ascension Island, ASN20940 (AKAMAI-ASN1, EU),
Reverse DNS
Software
/
Resource Hash
12e37e027ca2c71961fa9bb81688795414a682fea3f110e747b075763742be6c

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:45:38 GMT
content-encoding
gzip
vary
Accept-Encoding, User-Agent
content-security-policy-report-only
block-all-mixed-content; report-uri https://mol.report-uri.io/r/default/csp/reportOnly
server-timing
cdn-cache; desc=REVALIDATE, edge; dur=7, origin; dur=19
content-length
329
x-rs-ops
varnish-web-a1-fe.hsk.mol.dmgt.net:6081
x-graced
false
x-rs-time
Tue, 15 Dec 2020 12-45-02 GMT
restarts
0
access-control-allow-methods
GET
content-type
application/json; charset=utf-8
access-control-allow-origin
*
x-rs-ben
cljfe-b1:8181
accept-ranges
bytes
x-mol-georesp
de
access-control-allow-headers
*
x-storage
api
chromeless_closer.png
i.dailymail.co.uk/video/
372 B
584 B
Image
General
Full URL
https://i.dailymail.co.uk/video/chromeless_closer.png
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2a02:26f0:6c00:288::11ae , Ascension Island, ASN20940 (AKAMAI-ASN1, EU),
Reverse DNS
Software
AkamaiNetStorage /
Resource Hash
9dff2251abbde2c57b87b8e340e8cc695637fa72f8ff311c61c37b97ec5810c1

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:45:38 GMT
last-modified
Mon, 01 Jul 2019 16:55:07 GMT
server
AkamaiNetStorage
etag
"8de2a98adb80767b95658b4b19f1342c:1562000107"
content-type
image/png
cache-control
max-age=2592000
accept-ranges
bytes
timing-allow-origin
*
content-length
372
expires
Thu, 14 Jan 2021 12:45:38 GMT
bid
c.amazon-adsystem.com/e/dtb/
24 B
374 B
XHR
General
Full URL
https://c.amazon-adsystem.com/e/dtb/bid?src=3065&u=https%3A%2F%2Fwww.dailymail.co.uk%2Fsciencetech%2Farticle-9050821%2FRemdesivir-beneficial-patients-doctors-reveal.html%3F_hsmi%3D88974744%26_hsenc%3Dp2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8&pid=qkqBHoBAnjHbV&cb=13&ws=1600x1200&v=7.58.01&t=2000&slots=%5B%7B%22id%22%3A%22ctp_video_desktop%22%2C%22mt%22%3A%22v%22%2C%22kv%22%3A%7B%22pubcid%22%3A%223093664108%22%7D%7D%5D&gdprl=%7B%22status%22%3A%22no-cmp%22%7D
Requested by
Host: c.amazon-adsystem.com
URL: https://c.amazon-adsystem.com/aax2/apstag.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
99.84.88.20 Seattle, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-99-84-88-20.muc50.r.cloudfront.net
Software
Server /
Resource Hash
af058bc0a949d80a2234f297e983e6fb3438a7f360daf4cdecd3d717ce047ea7

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:45:38 GMT
via
1.1 fe36c7f30c8ef2853edecc43f320092c.cloudfront.net (CloudFront)
server
Server
x-amz-cf-pop
MUC50-C1
vary
User-Agent
x-cache
Miss from cloudfront
content-type
text/javascript;charset=UTF-8
access-control-allow-origin
https://www.dailymail.co.uk
access-control-allow-credentials
true
timing-allow-origin
*
content-length
24
x-amz-cf-id
cXhMNYh2ZPaDx0quiIMWkYCdUPDbplaEvrpcvXBZaQwUuDwiege9Ng==
partner
sync.search.spotxchange.com/
Redirect Chain
  • https://sync.search.spotxchange.com/partner?source=dados
  • https://sync.search.spotxchange.com/partner?source=dados&__user_check__=1&sync_id=6ec57fba-3ed3-11eb-be73-1e1d47873f06
0
588 B
Image
General
Full URL
https://sync.search.spotxchange.com/partner?source=dados&__user_check__=1&sync_id=6ec57fba-3ed3-11eb-be73-1e1d47873f06
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
185.94.180.126 , Netherlands, ASN35220 (SPOTX-AMS, NL),
Reverse DNS
Software
nginx /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

x-spotx-halt-type
Audience Dsp sync Priority Sync endpoint Source ID is not on enabled source whitelist
Date
Tue, 15 Dec 2020 12:45:38 GMT
Server
nginx
Access-Control-Allow-Methods
GET, POST, OPTIONS
Content-Type
text/plain
Access-Control-Allow-Origin
*
Cache-Control
no-store, no-cache, must-revalidate, proxy-revalidate, max-age=0
Access-Control-Allow-Credentials
false
X-fe
54
Connection
keep-alive
Content-Length
0

Redirect headers

Date
Tue, 15 Dec 2020 12:45:38 GMT
Server
nginx
Location
/partner?source=dados&__user_check__=1&sync_id=6ec57fba-3ed3-11eb-be73-1e1d47873f06
Access-Control-Allow-Methods
GET, POST, OPTIONS
Content-Type
text/plain
Access-Control-Allow-Origin
*
Cache-Control
no-store, no-cache, must-revalidate, proxy-revalidate, max-age=0
Access-Control-Allow-Credentials
false
X-fe
104
Connection
keep-alive
Content-Length
0
bid
c.amazon-adsystem.com/e/dtb/
24 B
373 B
XHR
General
Full URL
https://c.amazon-adsystem.com/e/dtb/bid?src=3065&u=https%3A%2F%2Fwww.dailymail.co.uk%2Fsciencetech%2Farticle-9050821%2FRemdesivir-beneficial-patients-doctors-reveal.html%3F_hsmi%3D88974744%26_hsenc%3Dp2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8&pid=qkqBHoBAnjHbV&cb=14&ws=1600x1200&v=7.58.01&t=2000&slots=%5B%7B%22id%22%3A%22jw_video_desktop%22%2C%22mt%22%3A%22v%22%2C%22kv%22%3A%7B%22pubcid%22%3A%223093664108%22%7D%7D%5D&gdprl=%7B%22status%22%3A%22no-cmp%22%7D
Requested by
Host: c.amazon-adsystem.com
URL: https://c.amazon-adsystem.com/aax2/apstag.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
99.84.88.20 Seattle, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-99-84-88-20.muc50.r.cloudfront.net
Software
Server /
Resource Hash
36a74661dfb652c289dd3bdccf3c31dc9ba453a328a4318aa72a34f1454f0842

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:45:38 GMT
via
1.1 fe36c7f30c8ef2853edecc43f320092c.cloudfront.net (CloudFront)
server
Server
x-amz-cf-pop
MUC50-C1
vary
User-Agent
x-cache
Miss from cloudfront
content-type
text/javascript;charset=UTF-8
access-control-allow-origin
https://www.dailymail.co.uk
access-control-allow-credentials
true
timing-allow-origin
*
content-length
24
x-amz-cf-id
XpPwYiU7Oa4K7SgwlyoVWfCriAlorieeIS95_6CXuugmg_ejQkUU5g==
auction
prebid.adnxs.com/pbs/v1/openrtb2/
150 B
499 B
XHR
General
Full URL
https://prebid.adnxs.com/pbs/v1/openrtb2/auction
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/static/mol-adverts/demo/mol-22070/19a28e0b/mol-adverts.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
37.252.161.190 , Ascension Island, ASN29990 (ASN-APPNEX, US),
Reverse DNS
prebid.ams1.adnexus.net
Software
nginx/1.19.0 /
Resource Hash
9e31284889265e25ce2ba8b574c9bb1437160ec494db82e7b134b41880966b97

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type
text/plain

Response headers

Pragma
no-cache
Date
Tue, 15 Dec 2020 12:45:38 GMT
Server
nginx/1.19.0
Vary
Origin
Content-Type
application/json
Access-Control-Allow-Origin
https://www.dailymail.co.uk
Cache-Control
no-cache, no-store, must-revalidate
Access-Control-Allow-Credentials
true
Connection
keep-alive
Content-Length
150
Expires
0
cygnus
htlb.casalemedia.com/
26 B
376 B
XHR
General
Full URL
https://htlb.casalemedia.com/cygnus?s=293355&v=8.1&r=%7B%22id%22%3A%22170eff22965284fa%22%2C%22imp%22%3A%5B%7B%22id%22%3A%221712a0521d8a0588%22%2C%22ext%22%3A%7B%22siteID%22%3A%22293355%22%2C%22sid%22%3A%22636x358%22%7D%2C%22video%22%3A%7B%22startdelay%22%3A0%2C%22mimes%22%3A%5B%22video%2Fmp4%22%2C%22video%2Fwebm%22%2C%22application%2Fjavascript%22%5D%2C%22minduration%22%3A0%2C%22maxduration%22%3A30%2C%22protocols%22%3A%5B1%2C2%2C3%2C4%2C5%2C6%5D%2C%22api%22%3A%5B1%2C2%5D%2C%22w%22%3A636%2C%22h%22%3A358%2C%22placement%22%3A1%7D%7D%5D%2C%22site%22%3A%7B%22page%22%3A%22https%3A%2F%2Fwww.dailymail.co.uk%2Fsciencetech%2Farticle-9050821%2FRemdesivir-beneficial-patients-doctors-reveal.html%3F_hsmi%3D88974744%26_hsenc%3Dp2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8%22%7D%2C%22ext%22%3A%7B%22source%22%3A%22prebid%22%7D%7D&ac=j&sd=1&nf=1
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/static/mol-adverts/demo/mol-22070/19a28e0b/mol-adverts.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
104.111.215.135 , Netherlands, ASN16625 (AKAMAI-AS, US),
Reverse DNS
a104-111-215-135.deploy.static.akamaitechnologies.com
Software
Apache /
Resource Hash
6a4c6cdbf01fd49c79c912a4888748f4bdf962cf6c1b651c8cc6d413c1b69a3f

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type
text/plain

Response headers

pragma
no-cache
date
Tue, 15 Dec 2020 12:45:38 GMT
content-encoding
gzip
x-ak-initial-geo
CC:[NL], RC:[], CN:[EU], CIP:[185.212.171.67], XFF:[]
server
Apache
vary
Is-Traffic-Invalid,Accept-Encoding
content-type
application/json
access-control-allow-origin
https://www.dailymail.co.uk
x-cs-client-geo
12
cache-control
max-age=0, no-cache, no-store
access-control-allow-credentials
true
content-length
46
x-ak-client-geo
12
expires
Tue, 15 Dec 2020 12:45:38 GMT
openrtb
ads.adaptv.advertising.com/rtb/
0
220 B
XHR
General
Full URL
https://ads.adaptv.advertising.com/rtb/openrtb?ext_id=MailOnline
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/static/mol-adverts/demo/mol-22070/19a28e0b/mol-adverts.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
52.59.160.25 Frankfurt am Main, Germany, ASN16509 (AMAZON-02, US),
Reverse DNS
ec2-52-59-160-25.eu-central-1.compute.amazonaws.com
Software
adaptv/1.0 /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type
text/plain

Response headers

access-control-allow-origin
https://www.dailymail.co.uk
access-control-allow-credentials
true
server
adaptv/1.0
Connection
keep-alive
content-length
0
content-type
application/json
avjp
mailonline-uk-d.openx.net/v/1.0/
92 B
285 B
XHR
General
Full URL
https://mailonline-uk-d.openx.net/v/1.0/avjp?ju=https%3A%2F%2Fwww.dailymail.co.uk%2Fsciencetech%2Farticle-9050821%2FRemdesivir-beneficial-patients-doctors-reveal.html%3F_hsmi%3D88974744%26_hsenc%3Dp2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8&ch=UTF-8&res=1600x1200x24&ifr=false&tz=-60&tws=1600x1200&be=1&bc=hb_pb_3.0.3&dddid=4f752cab-aaab-4a45-9912-8969b2e44de6&nocache=1608036338190&pubcid=84f1103b-a980-4860-8c6e-1866bcc8525c&auid=540675380&vwd=636&vht=358
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/static/mol-adverts/demo/mol-22070/19a28e0b/mol-adverts.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
35.244.159.8 Mountain View, United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
OXGW/16.199.0 /
Resource Hash
004e5faf0bf890f61697daeede9f21826affd1137fb2cb58eaf4719937a04a14

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type
text/plain

Response headers

pragma
no-cache
date
Tue, 15 Dec 2020 12:45:38 GMT
via
1.1 google
server
OXGW/16.199.0
p3p
CP="CUR ADM OUR NOR STA NID"
access-control-allow-origin
https://www.dailymail.co.uk
cache-control
private, max-age=0, no-cache
access-control-allow-credentials
true
content-type
application/json
alt-svc
clear
content-length
92
expires
Mon, 26 Jul 1997 05:00:00 GMT
auction
prebid.adnxs.com/pbs/v1/openrtb2/
150 B
499 B
XHR
General
Full URL
https://prebid.adnxs.com/pbs/v1/openrtb2/auction
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/static/mol-adverts/demo/mol-22070/19a28e0b/mol-adverts.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
37.252.161.190 , Ascension Island, ASN29990 (ASN-APPNEX, US),
Reverse DNS
prebid.ams1.adnexus.net
Software
nginx/1.19.0 /
Resource Hash
25d42ec3678b462a9db75766720b97599230d20efde34aa83a21f0a5ea11c567

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type
text/plain

Response headers

Pragma
no-cache
Date
Tue, 15 Dec 2020 12:45:38 GMT
Server
nginx/1.19.0
Vary
Origin
Content-Type
application/json
Access-Control-Allow-Origin
https://www.dailymail.co.uk
Cache-Control
no-cache, no-store, must-revalidate
Access-Control-Allow-Credentials
true
Connection
keep-alive
Content-Length
150
Expires
0
avjp
mailonline-uk-d.openx.net/v/1.0/
92 B
282 B
XHR
General
Full URL
https://mailonline-uk-d.openx.net/v/1.0/avjp?ju=https%3A%2F%2Fwww.dailymail.co.uk%2Fsciencetech%2Farticle-9050821%2FRemdesivir-beneficial-patients-doctors-reveal.html%3F_hsmi%3D88974744%26_hsenc%3Dp2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8&ch=UTF-8&res=1600x1200x24&ifr=false&tz=-60&tws=1600x1200&be=1&bc=hb_pb_3.0.3&dddid=37030f62-b83c-4070-8d60-71d3279fdf6d&nocache=1608036338198&pubcid=84f1103b-a980-4860-8c6e-1866bcc8525c&auid=540675388&vwd=401&vht=225
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/static/mol-adverts/demo/mol-22070/19a28e0b/mol-adverts.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
35.244.159.8 Mountain View, United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
OXGW/16.199.0 /
Resource Hash
004e5faf0bf890f61697daeede9f21826affd1137fb2cb58eaf4719937a04a14

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type
text/plain

Response headers

pragma
no-cache
date
Tue, 15 Dec 2020 12:45:38 GMT
via
1.1 google
server
OXGW/16.199.0
p3p
CP="CUR ADM OUR NOR STA NID"
access-control-allow-origin
https://www.dailymail.co.uk
cache-control
private, max-age=0, no-cache
access-control-allow-credentials
true
content-type
application/json
alt-svc
clear
content-length
92
expires
Mon, 26 Jul 1997 05:00:00 GMT
prebid
ib.adnxs.com/ut/v3/
19 B
716 B
XHR
General
Full URL
https://ib.adnxs.com/ut/v3/prebid
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/static/mol-adverts/demo/mol-22070/19a28e0b/mol-adverts.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_ECDSA, AES_128_GCM
Server
185.33.221.13 , Netherlands, ASN29990 (ASN-APPNEX, US),
Reverse DNS
729.bm-nginx-loadbalancer.mgmt.ams1.adnexus.net
Software
nginx/1.17.9 /
Resource Hash
0c09c070833c786cb25be38bc30992b30bad578f817dbc9e34beacd8b8ea44c5
Security Headers
Name Value
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type
text/plain

Response headers

Pragma
no-cache
Date
Tue, 15 Dec 2020 12:45:38 GMT
X-Proxy-Origin
185.212.171.67; 185.212.171.67; 729.bm-nginx-loadbalancer.mgmt.ams1; *.adnxs.com; 185.33.220.84:80
AN-X-Request-Uuid
c81e52fa-9dc3-490b-a2f1-a44ee56409f6
Server
nginx/1.17.9
P3P
policyref="http://cdn.adnxs.com/w3c/policy/p3p.xml", CP="NOI DSP COR ADM PSAo PSDo OURo SAMo UNRo OTRo BUS COM NAV DEM STA PRE"
Access-Control-Allow-Origin
https://www.dailymail.co.uk
Cache-Control
no-store, no-cache, private
Access-Control-Allow-Credentials
true
Connection
keep-alive
Content-Type
application/json; charset=utf-8
Content-Length
19
X-XSS-Protection
0
Expires
Sat, 15 Nov 2008 16:00:00 GMT
cygnus
htlb.casalemedia.com/
26 B
376 B
XHR
General
Full URL
https://htlb.casalemedia.com/cygnus?s=293354&v=8.1&r=%7B%22id%22%3A%22183c1d937ae1fb61%22%2C%22imp%22%3A%5B%7B%22id%22%3A%22184d0f24c6fb3ef5%22%2C%22ext%22%3A%7B%22siteID%22%3A%22293354%22%2C%22sid%22%3A%22401x225%22%7D%2C%22video%22%3A%7B%22startdelay%22%3A0%2C%22mimes%22%3A%5B%22video%2Fmp4%22%2C%22video%2Fwebm%22%2C%22application%2Fjavascript%22%5D%2C%22minduration%22%3A0%2C%22maxduration%22%3A30%2C%22protocols%22%3A%5B1%2C2%2C3%2C4%2C5%2C6%5D%2C%22api%22%3A%5B1%2C2%5D%2C%22w%22%3A401%2C%22h%22%3A225%2C%22placement%22%3A1%7D%7D%5D%2C%22site%22%3A%7B%22page%22%3A%22https%3A%2F%2Fwww.dailymail.co.uk%2Fsciencetech%2Farticle-9050821%2FRemdesivir-beneficial-patients-doctors-reveal.html%3F_hsmi%3D88974744%26_hsenc%3Dp2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8%22%7D%2C%22ext%22%3A%7B%22source%22%3A%22prebid%22%7D%7D&ac=j&sd=1&nf=1
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/static/mol-adverts/demo/mol-22070/19a28e0b/mol-adverts.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
104.111.215.135 , Netherlands, ASN16625 (AKAMAI-AS, US),
Reverse DNS
a104-111-215-135.deploy.static.akamaitechnologies.com
Software
Apache /
Resource Hash
3db46fd29dcf70f998939eb2852c06841d54a0373afd94dae454a79dc69492d0

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type
text/plain

Response headers

pragma
no-cache
date
Tue, 15 Dec 2020 12:45:38 GMT
content-encoding
gzip
x-ak-initial-geo
CC:[NL], RC:[], CN:[EU], CIP:[185.212.171.67], XFF:[]
server
Apache
vary
Is-Traffic-Invalid,Accept-Encoding
content-type
application/json
access-control-allow-origin
https://www.dailymail.co.uk
x-cs-client-geo
12
cache-control
max-age=0, no-cache, no-store
access-control-allow-credentials
true
content-length
46
x-ak-client-geo
12
expires
Tue, 15 Dec 2020 12:45:38 GMT
openrtb
ads.adaptv.advertising.com/rtb/
0
220 B
XHR
General
Full URL
https://ads.adaptv.advertising.com/rtb/openrtb?ext_id=MailOnline
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/static/mol-adverts/demo/mol-22070/19a28e0b/mol-adverts.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
52.59.160.25 Frankfurt am Main, Germany, ASN16509 (AMAZON-02, US),
Reverse DNS
ec2-52-59-160-25.eu-central-1.compute.amazonaws.com
Software
adaptv/1.0 /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type
text/plain

Response headers

access-control-allow-origin
https://www.dailymail.co.uk
access-control-allow-credentials
true
server
adaptv/1.0
Connection
keep-alive
content-length
0
content-type
application/json
usermatch
ssum-sec.casalemedia.com/ Frame D1BB
Redirect Chain
  • https://ssum-sec.casalemedia.com/usermatch?s=184665&cb=https%3A%2F%2Fmfad.inskinad.com%2Fudb%2F9874%2Fsync%2Fi.gif%3FpartnerId%3D1%26userId%3D
  • https://ssum-sec.casalemedia.com/usermatch?s=184665&cb=https%3A%2F%2Fmfad.inskinad.com%2Fudb%2F9874%2Fsync%2Fi.gif%3FpartnerId%3D1%26userId%3D&C=1
0
0
Document
General
Full URL
https://ssum-sec.casalemedia.com/usermatch?s=184665&cb=https%3A%2F%2Fmfad.inskinad.com%2Fudb%2F9874%2Fsync%2Fi.gif%3FpartnerId%3D1%26userId%3D&C=1
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/static/mol-adverts/demo/mol-22070/19a28e0b/mol-adverts.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
104.111.215.135 , Netherlands, ASN16625 (AKAMAI-AS, US),
Reverse DNS
a104-111-215-135.deploy.static.akamaitechnologies.com
Software
Apache /
Resource Hash

Request headers

:method
GET
:authority
ssum-sec.casalemedia.com
:scheme
https
:path
/usermatch?s=184665&cb=https%3A%2F%2Fmfad.inskinad.com%2Fudb%2F9874%2Fsync%2Fi.gif%3FpartnerId%3D1%26userId%3D&C=1
pragma
no-cache
cache-control
no-cache
upgrade-insecure-requests
1
user-agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
accept
text/html,application/xhtml+xml,application/xml;q=0.9,image/avif,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3;q=0.9
sec-fetch-site
cross-site
sec-fetch-mode
navigate
sec-fetch-dest
iframe
referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
accept-encoding
gzip, deflate, br
accept-language
en-US
cookie
CMID=X9iv8oE1aeK2FeDJu3VAdAAA; CMPS=3164
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8

Response headers

server
Apache
content-type
text/html
p3p
policyref="/w3c/p3p.xml", CP="NOI DSP COR DEVa TAIa OUR BUS UNI"
vary
Is-Traffic-Usersync
content-length
1788
expires
Tue, 15 Dec 2020 12:45:38 GMT
cache-control
max-age=0, no-cache, no-store
pragma
no-cache
date
Tue, 15 Dec 2020 12:45:38 GMT
set-cookie
CMID=X9iv8oE1aeK2FeDJu3VAdAAA;domain=casalemedia.com;path=/;sameSite=None;Secure;expires=Wed, 15 Dec 2021 12:45:38 GMT CMPS=3164;domain=casalemedia.com;path=/;sameSite=None;Secure;expires=Mon, 15 Mar 2021 12:45:38 GMT CMPRO=1142;domain=casalemedia.com;path=/;sameSite=None;Secure;expires=Mon, 15 Mar 2021 12:45:38 GMT CMRUM3=035fd8aff205a0&2d5fd8aff205a0&e65fd8aff227600&825fd8aff2a8c0&be5fd8aff205a0&275fd8aff20b40&1f5fd8aff205a00&f15fd8aff205a00;domain=casalemedia.com;path=/;sameSite=None;Secure;expires=Wed, 15 Dec 2021 12:45:38 GMT CMST=X9iv8l-Yr-IA;domain=casalemedia.com;path=/;sameSite=None;Secure;expires=Wed, 16 Dec 2020 12:45:38 GMT

Redirect headers

server
Apache
content-length
338
content-type
text/html; charset=iso-8859-1
location
https://ssum-sec.casalemedia.com/usermatch?s=184665&cb=https%3A%2F%2Fmfad.inskinad.com%2Fudb%2F9874%2Fsync%2Fi.gif%3FpartnerId%3D1%26userId%3D&C=1
p3p
policyref="/w3c/p3p.xml", CP="NOI DSP COR DEVa TAIa OUR BUS UNI"
expires
Tue, 15 Dec 2020 12:45:38 GMT
cache-control
max-age=0, no-cache, no-store
pragma
no-cache
date
Tue, 15 Dec 2020 12:45:38 GMT
set-cookie
CMID=X9iv8oE1aeK2FeDJu3VAdAAA;domain=casalemedia.com;path=/;sameSite=None;Secure;expires=Wed, 15 Dec 2021 12:45:38 GMT CMPS=3164;domain=casalemedia.com;path=/;sameSite=None;Secure;expires=Mon, 15 Mar 2021 12:45:38 GMT
pixel
cm.g.doubleclick.net/
Redirect Chain
  • https://id5-sync.com/i/167/9.gif?gdpr=&gdpr_consent=
  • https://id5-sync.com/c/167/0/9/1.gif?gdpr=1&gdpr_consent=
  • https://ice.360yield.com/match?publisher_dsp_id=79&dsp_callback=1&external_user_id=ID5-ZHMOqMhJTrldgGJIBsru2iINA62VBTrOOYCHIcZtjg&r=https%3A%2F%2Fid5-sync.com%2Fcq%2F167%2F124%2F8%2F2.gif%3Fpuid%3D...
  • https://ice.360yield.com/ul_cb/match?publisher_dsp_id=79&dsp_callback=1&external_user_id=ID5-ZHMOqMhJTrldgGJIBsru2iINA62VBTrOOYCHIcZtjg&r=https%3A%2F%2Fid5-sync.com%2Fcq%2F167%2F124%2F8%2F2.gif%3Fp...
  • https://id5-sync.com/cq/167/124/8/2.gif?puid=c8e333de-0161-44b0-a13a-a10c76c6062d&gdpr=1&gdpr_consent=&gdpr=1&gdpr_consent=
  • https://sync.crwdcntrl.net/map/c=13953/tp=IDFI/gdpr=1/gdpr_consent=?https://id5-sync.com/c/167/19/7/3.gif?puid=${profile_id}&gdpr=1&gdpr_consent=
  • https://id5-sync.com/c/167/19/7/3.gif?puid=960aa2c2273f6b492958f96d36bf6304&gdpr=1&gdpr_consent=
  • https://ads.creative-serving.com/id5_cm?callback=https%3A%2F%2Fid5-sync.com%2Fc%2F167%2F101%2F6%2F4.gif%3Fpuid%3D%5BUID%5D%26gdpr%3D1%26gdpr_consent%3D
  • https://ads.creative-serving.com/ul_cb/id5_cm?callback=https%3A%2F%2Fid5-sync.com%2Fc%2F167%2F101%2F6%2F4.gif%3Fpuid%3D%5BUID%5D%26gdpr%3D1%26gdpr_consent%3D
  • https://id5-sync.com/c/167/101/6/4.gif?puid=dfec055f-0cbe-4353-bc57-bb4ed58dc033&gdpr=1&gdpr_consent=
  • https://pixel.tapad.com/idsync/ex/push?partner_id=2922&partner_url=https%3A%2F%2Fid5-sync.com%2Fc%2F167%2F108%2F5%2F5.gif%3Fpuid%3D%24%7BTA_DEVICE_ID%7D%26gdpr%3D1%26gdpr_consent%3D&gdpr=1&gdpr_con...
  • https://pixel.tapad.com/idsync/ex/push/check?partner_id=2922&partner_url=https%3A%2F%2Fid5-sync.com%2Fc%2F167%2F108%2F5%2F5.gif%3Fpuid%3D%24%7BTA_DEVICE_ID%7D%26gdpr%3D1%26gdpr_consent%3D&gdpr=1&gd...
  • https://id5-sync.com/c/167/108/5/5.gif?puid=6fb9c801-3ed3-11eb-b7db-6e8555c96cc6&gdpr=1&gdpr_consent=
  • https://uipglob.semasio.net/id5/1/get?gdpr=1&gdpr_consent=&_url=https%3A%2F%2Fid5-sync.com%2Fc%2F167%2F112%2F4%2F6.gif%3Fpuid%3D%24%7BUIPID%7D%26gdpr%3D1%26gdpr_consent%3D
  • https://uipglob.semasio.net/id5/1/get2?gdpr=1&gdpr_consent=&_url=https%3A%2F%2Fid5-sync.com%2Fc%2F167%2F112%2F4%2F6.gif%3Fpuid%3D%24%7BUIPID%7D%26gdpr%3D1%26gdpr_consent%3D
  • https://id5-sync.com/c/167/112/4/6.gif?puid=BF51C9F9126D1D3E&gdpr=1&gdpr_consent=
  • https://ads.avocet.io/getuid?url=https%3A%2F%2Fid5-sync.com%2Fc%2F167%2F146%2F3%2F7.gif%3Fpuid%3D%7B%7BUUID%7D%7D%26gdpr%3D1%26gdpr_consent%3D
  • https://ads.avct.cloud/getuid?r=1&url=https%3A%2F%2Fid5-sync.com%2Fc%2F167%2F146%2F3%2F7.gif%3Fpuid%3D%7B%7BUUID%7D%7D%26gdpr%3D1%26gdpr_consent%3D
  • https://id5-sync.com/c/167/146/3/7.gif?puid=11f3923d-c6d0-4798-93e0-b14556a89c0a&gdpr=1&gdpr_consent=
  • https://sync.crwdcntrl.net/map/c=2831/tp=GDMP?https://cm.g.doubleclick.net/pixel?google_nid=lotame_dmp&google_hm=${base64_profileid}&google_redir=https%3A%2F%2Fid5-sync.com%2Fc%2F167%2F398%2F2%2F8....
  • https://cm.g.doubleclick.net/pixel?google_nid=lotame_dmp&google_hm=OTYwYWEyYzIyNzNmNmI0OTI5NThmOTZkMzZiZjYzMDQ&google_redir=https://id5-sync.com/c/167/398/2/8.gif?puid=OTYwYWEyYzIyNzNmNmI0OTI5NThmO...
0
0

top-videos.jpg
creative.dailymail.co.uk/videos/
111 KB
111 KB
Image
General
Full URL
https://creative.dailymail.co.uk/videos/top-videos.jpg
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2a02:26f0:6c00:288::11ae , Ascension Island, ASN20940 (AKAMAI-ASN1, EU),
Reverse DNS
Software
AkamaiNetStorage /
Resource Hash
6924aeec6e6de01dfd439327c170d8adc2f9dd8415e9903e3b24f2c3b6506389

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:45:38 GMT
last-modified
Wed, 01 May 2019 13:28:47 GMT
server
AkamaiNetStorage
accept-ranges
bytes
etag
"41c301b2aac4a100430b42c8cf52583e:1556717327"
content-length
113532
content-type
image/jpeg
black-preload.gif
i.dailymail.co.uk/i/furniture/fff/hub/
3 KB
3 KB
Image
General
Full URL
https://i.dailymail.co.uk/i/furniture/fff/hub/black-preload.gif
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2a02:26f0:6c00:288::11ae , Ascension Island, ASN20940 (AKAMAI-ASN1, EU),
Reverse DNS
Software
Apache /
Resource Hash
babed8ddf22ed2e66590a4f75773661304242a4f4167d52e165652fee492933e

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:45:38 GMT
last-modified
Tue, 19 Nov 2013 14:19:15 GMT
server
Apache
etag
"37e24e0370847870c1c43ea9ce19b1f4:1384870755"
content-type
image/gif
cache-control
max-age=2592000
accept-ranges
bytes
timing-allow-origin
*
content-length
3208
expires
Thu, 14 Jan 2021 12:45:38 GMT
script.js
uk-script.dotmetrics.net/Scripts/
76 KB
34 KB
Script
General
Full URL
https://uk-script.dotmetrics.net/Scripts/script.js?v=175
Requested by
Host: uk-script.dotmetrics.net
URL: https://uk-script.dotmetrics.net/door.js?d=www.dailymail.co.uk&t=sciencetech
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
65.9.68.128 Seattle, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
Kestrel /
Resource Hash
baefc8e2d17efa61e19c14031bc6e61cd89718a052276151bd4c7fdfac723598

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:45:38 GMT
content-encoding
br
last-modified
Mon, 30 Nov 2020 14:50:31 GMT
server
Kestrel
x-amz-cf-pop
FRA56-C1
etag
"1d6c728265824d3"
vary
Accept-Encoding
x-cache
Miss from cloudfront
content-type
application/javascript
via
1.1 9570c3a1725c20e6faed117bbb74223b.cloudfront.net (CloudFront)
accept-ranges
bytes
x-amz-cf-id
lbLi9W4zw8NCBnaTEoxiuWZAKlOTneIL6lZRby25Uj8LQ1rvhuofRQ==
ads
securepubads.g.doubleclick.net/gampad/
50 KB
11 KB
XHR
General
Full URL
https://securepubads.g.doubleclick.net/gampad/ads?gdfp_req=1&pvsid=2639827676159032&correlator=2455119041695441&output=ldjh&impl=fif&eid=21069142&vrg=2020120801&guci=1.2.0.0.2.2.0.0&sc=1&sfv=1-0-37&ecs=20201215&iu_parts=5765%2Cdailymail.uk%2Cdm_dmsciencetech_sciencetechart%2Cmpu_puff_20&enc_prev_ius=%2F0%2F1%2F2%2F3&prev_iu_szs=300x600%7C300x250&prev_scp=pos%3Dmpu_puff_20%26amznbid%3D2%26amznp%3D2%26adx_channel%3D4%26nobids%3Dfalse%26refreshCount%3D0%26amznsz%3D0x0&eri=4&cust_params=page%3Dart%26article%3D9050821%26area%3Dsciencetech%26subarea%3Dsciencetech%26environment%3Dproduction%26country%3Dde%26abv%3Dmol-22070%252F19a28e0b%26bot%3Dfalse%26random%3D9ceebda3-1911-4085-b4cd-4ef660466486%26impid%3Dc0338c30-9d3e-46d6-8db6-95c14a8ccbca%26browserResolution%3Dmin_1244px%26device%3Dother%26device_features%3D%26articlewithvideo%3Dtrue%26style%3Dwide%26session%3D1%26session_page_ID%3Dnone%26utm_source%3Dnone%26watershed%3Dfalse%26location%3Ddailymail_co_uk%26id5%3Dtrue%26permutive%3D%26puid%3Db77f6280-fced-4776-aef9-89e90021e68b%26ptime%3D1608036337226&cookie_enabled=1&cdm=www.dailymail.co.uk&bc=31&abxe=1&dt=1608036338262&dlt=1608036336099&idt=1063&frm=20&biw=1600&bih=1200&oid=3&adxs=978&adys=4915&adks=34998414&ucis=8&ifi=8&u_tz=60&u_his=2&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_sd=1&flash=0&url=www.dailymail.co.uk%2Fsciencetech%2Farticle-9050821%2FRemdesivir-beneficial-patients-doctors-reveal.html&loc=https%3A%2F%2Fwww.dailymail.co.uk%2Fsciencetech%2Farticle-9050821%2FRemdesivir-beneficial-patients-doctors-reveal.html%3F_hsmi%3D88974744%26_hsenc%3Dp2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8&vis=1&dmc=8&scr_x=0&scr_y=0&psz=308x627&msz=308x627&ga_vid=254203172.1608036337&ga_sid=1608036337&ga_hid=881620343&fws=4&ohw=1600&btvi=4&tt_state=W3siaXNzdWVyT3JpZ2luIjoiaHR0cHM6Ly9hZHNlcnZpY2UuZ29vZ2xlLmNvbSIsInN0YXRlIjowfSx7Imlzc3Vlck9yaWdpbiI6Imh0dHBzOi8vYXR0ZXN0YXRpb24uYW5kcm9pZC5jb20iLCJzdGF0ZSI6MH1d
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020120801.js
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
172.217.22.2 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
fra16s14-in-f2.1e100.net
Software
cafe /
Resource Hash
a35802fd36fee10ecd11fd4d5207a82005d10f04872e37d3d28c6ac9eeb4ba25
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:45:40 GMT
content-encoding
br
x-content-type-options
nosniff
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
cross-origin-resource-policy
cross-origin
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
11247
x-xss-protection
0
google-lineitem-id
-1
pragma
no-cache
server
cafe
google-creative-id
-1
content-type
text/plain; charset=UTF-8
access-control-allow-origin
https://www.dailymail.co.uk
access-control-expose-headers
x-google-amp-ad-validated-version
cache-control
no-cache, must-revalidate
access-control-allow-credentials
true
timing-allow-origin
*
expires
Fri, 01 Jan 1990 00:00:00 GMT
ads
securepubads.g.doubleclick.net/gampad/
40 KB
12 KB
XHR
General
Full URL
https://securepubads.g.doubleclick.net/gampad/ads?gdfp_req=1&pvsid=2639827676159032&correlator=2455119041695441&output=ldjh&impl=fif&eid=21069142&vrg=2020120801&guci=1.2.0.0.2.2.0.0&sc=1&sfv=1-0-37&ecs=20201215&iu_parts=5765%2Cdailymail.uk%2Cdm_dmsciencetech_sciencetechart%2Cmpu_puff_45&enc_prev_ius=%2F0%2F1%2F2%2F3&prev_iu_szs=300x600%7C300x250&prev_scp=pos%3Dmpu_puff_45%26amznbid%3D2%26amznp%3D2%26adx_channel%3D8%26nobids%3Dfalse%26refreshCount%3D0%26amznsz%3D0x0&eri=4&cust_params=page%3Dart%26article%3D9050821%26area%3Dsciencetech%26subarea%3Dsciencetech%26environment%3Dproduction%26country%3Dde%26abv%3Dmol-22070%252F19a28e0b%26bot%3Dfalse%26random%3D9ceebda3-1911-4085-b4cd-4ef660466486%26impid%3Dc0338c30-9d3e-46d6-8db6-95c14a8ccbca%26browserResolution%3Dmin_1244px%26device%3Dother%26device_features%3D%26articlewithvideo%3Dtrue%26style%3Dwide%26session%3D1%26session_page_ID%3Dnone%26utm_source%3Dnone%26watershed%3Dfalse%26location%3Ddailymail_co_uk%26id5%3Dtrue%26permutive%3D%26puid%3Db77f6280-fced-4776-aef9-89e90021e68b%26ptime%3D1608036337226&cookie_enabled=1&cdm=www.dailymail.co.uk&bc=31&abxe=1&dt=1608036338266&dlt=1608036336099&idt=1063&frm=20&biw=1600&bih=1200&oid=3&adxs=978&adys=8683&adks=3500948802&ucis=9&ifi=9&u_tz=60&u_his=2&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_sd=1&flash=0&url=www.dailymail.co.uk%2Fsciencetech%2Farticle-9050821%2FRemdesivir-beneficial-patients-doctors-reveal.html&loc=https%3A%2F%2Fwww.dailymail.co.uk%2Fsciencetech%2Farticle-9050821%2FRemdesivir-beneficial-patients-doctors-reveal.html%3F_hsmi%3D88974744%26_hsenc%3Dp2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8&vis=1&dmc=8&scr_x=0&scr_y=0&psz=308x627&msz=308x627&ga_vid=254203172.1608036337&ga_sid=1608036337&ga_hid=881620343&fws=4&ohw=1600&btvi=5&tt_state=W3siaXNzdWVyT3JpZ2luIjoiaHR0cHM6Ly9hZHNlcnZpY2UuZ29vZ2xlLmNvbSIsInN0YXRlIjowfSx7Imlzc3Vlck9yaWdpbiI6Imh0dHBzOi8vYXR0ZXN0YXRpb24uYW5kcm9pZC5jb20iLCJzdGF0ZSI6MH1d
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020120801.js
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
172.217.22.2 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
fra16s14-in-f2.1e100.net
Software
cafe /
Resource Hash
3d572de379cc50e7565a0e38ca74babce4a28e71d1e162c8b9c816a05eddddaa
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:45:39 GMT
content-encoding
br
x-content-type-options
nosniff
google-mediationgroup-id
-2
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
cross-origin-resource-policy
cross-origin
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
11872
x-xss-protection
0
google-lineitem-id
5290996269
pragma
no-cache
server
cafe
google-mediationtag-id
-2
google-creative-id
138334241998
content-type
text/plain; charset=UTF-8
access-control-allow-origin
https://www.dailymail.co.uk
cache-control
no-cache, must-revalidate
access-control-allow-credentials
true
timing-allow-origin
*
expires
Fri, 01 Jan 1990 00:00:00 GMT
sync
googlesync.permutive.com/v2.0/px/
Redirect Chain
  • https://cm.g.doubleclick.net/pixel?google_nid=permutive_dmp&google_cm&type=ddp&k=ed45e86d-a09e-4d2b-85c0-fbbd6857373e&u=b77f6280-fced-4776-aef9-89e90021e68b
  • https://googlesync.permutive.com/v2.0/px/sync?alias=CAESECdjrni2f179vc2nxVGfA8A&error=&type=ddp&k=ed45e86d-a09e-4d2b-85c0-fbbd6857373e&u=b77f6280-fced-4776-aef9-89e90021e68b&google_cver=1
35 B
107 B
Image
General
Full URL
https://googlesync.permutive.com/v2.0/px/sync?alias=CAESECdjrni2f179vc2nxVGfA8A&error=&type=ddp&k=ed45e86d-a09e-4d2b-85c0-fbbd6857373e&u=b77f6280-fced-4776-aef9-89e90021e68b&google_cver=1
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
34.107.254.252 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
Permutive /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:45:38 GMT
via
1.1 google
server
Permutive
alt-svc
clear
content-length
35
content-type
image/gif

Redirect headers

pragma
no-cache
date
Tue, 15 Dec 2020 12:45:38 GMT
server
HTTP server (unknown)
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
location
https://googlesync.permutive.com/v2.0/px/sync?alias=CAESECdjrni2f179vc2nxVGfA8A&error=&type=ddp&k=ed45e86d-a09e-4d2b-85c0-fbbd6857373e&u=b77f6280-fced-4776-aef9-89e90021e68b&google_cver=1
cache-control
no-cache, must-revalidate
cross-origin-resource-policy
cross-origin
content-type
text/html; charset=UTF-8
alt-svc
h3-29="googleads.g.doubleclick.net:443"; ma=2592000,h3-29=":443"; ma=2592000,h3-T051="googleads.g.doubleclick.net:443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic="googleads.g.doubleclick.net:443"; ma=2592000; v="46,43",quic=":443"; ma=2592000; v="46,43"
content-length
404
x-xss-protection
0
expires
Fri, 01 Jan 1990 00:00:00 GMT
view
securepubads.g.doubleclick.net/pcs/ Frame 16BB
0
0
Fetch
General
Full URL
https://securepubads.g.doubleclick.net/pcs/view?xai=AKAOjsuOF91WtR8sfrCFlA2CK7UDL8IKdxK_9rse_wWBoYK7ETgHLQa0Gb7C1W8Opri9F8GPBoZkpMI9RnE1cjS-XneZZGivVGSn-ti4iJ2Gz3PKmDTqo1po5yvPdT0Mb_UlRwTPtUCCKNGxgrq_NTJurJJxYHC56k1JGISR2b3X3G9bhM_3p1NguNP3At0aotp9hND2xA8t7WHRwLJilVyHrdI4Mf14GfIa2jtH2PtJBPVtpIPmoWCQj5udAcgx8pvle7nyW4fbMEtBUhWHOCxOh5w1C7bpJRMq3MhBjsMP9VzbiNTFnwvqoU7tu3_g19CssItVWpDLxRils5pa&sai=AMfl-YTHVsLX0MINW0WnfPGHaHf4rtqN9oAVnvKBq1il0Qu6gDuT1mdnMXaFfhOYp43SOQhRpHd5N65KDbFktFxk-CfQ1w368X6cmI0EsnfDMF3lDrEtXmN8ZHY8IYxhU20&sig=Cg0ArKJSzKKfNRSKUbu3EAE&urlfix=1&adurl=
Requested by
Host: info.silobreaker.com
URL: https://info.silobreaker.com/e2t/sc2/MmZ-8yjYCXrW6zj2_M6nsGYsW7JzK5Y7LnJnQVd1GcC5Dg2KFdBBbG504
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
172.217.22.2 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
fra16s14-in-f2.1e100.net
Software
cafe /
Resource Hash
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

timing-allow-origin
*
date
Tue, 15 Dec 2020 12:45:38 GMT
x-content-type-options
nosniff
server
cafe
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
access-control-allow-origin
*
cache-control
private
cross-origin-resource-policy
cross-origin
content-type
image/gif
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
0
x-xss-protection
0
expires
Tue, 15 Dec 2020 12:45:38 GMT
dailymail.co.uk_mix.js
play.selectmedia.asia/58fcbed1073ef420086c9d08/5e84b6a4f3500a68ee259b56/ Frame 16BB
11 KB
5 KB
Script
General
Full URL
https://play.selectmedia.asia/58fcbed1073ef420086c9d08/5e84b6a4f3500a68ee259b56/dailymail.co.uk_mix.js
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020120801.js
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_256_GCM
Server
2a02:26f0:eb::214:bece , Ascension Island, ASN20940 (AKAMAI-ASN1, EU),
Reverse DNS
Software
UploadServer /
Resource Hash
0e6f013f6485ea79d57880c3ef0b5279c8883af65ec13705d2ef91b882053d48

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Date
Tue, 15 Dec 2020 12:45:38 GMT
Content-Encoding
gzip
X-GUploader-UploadID
ABg5-UxQ01dKlAffC2fXbUAAgVfaaDuY77rDLdxEV-Yi2Af5NZjDIdd3Z_LD9aJGhkZhFdqwZ13jL7sCfA6ngWzPg2Dzx1tR0A
x-goog-storage-class
MULTI_REGIONAL
x-goog-metageneration
1
x-goog-stored-content-encoding
identity
Connection
keep-alive
Content-Length
4075
Last-Modified
Mon, 19 Oct 2020 10:29:47 GMT
Server
UploadServer
ETag
"cb8a878188fb8134ee6a133228b58381"
Vary
Accept-Encoding
x-goog-hash
crc32c=knlHQA==
x-goog-generation
1603103387919090
Access-Control-Allow-Origin
*
Access-Control-Expose-Headers
Content-Type
Cache-Control
public, max-age=1800
x-goog-stored-content-length
10861
Accept-Ranges
bytes
Content-Type
text/javascript
Expires
Tue, 15 Dec 2020 13:15:38 GMT
osd_listener.js
www.googletagservices.com/activeview/js/current/ Frame 16BB
76 KB
29 KB
Script
General
Full URL
https://www.googletagservices.com/activeview/js/current/osd_listener.js?cache=r20110914
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020120801.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:814::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
07a3eb8be1687dc1ee377d85bffd51891d0fd539258b63ab4031b012bd77f5fc
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:45:38 GMT
content-encoding
gzip
x-content-type-options
nosniff
server
sffe
etag
"1607690616793149"
vary
Accept-Encoding
content-type
text/javascript
cache-control
private, max-age=3000
accept-ranges
bytes
alt-svc
h3-29="googleads.g.doubleclick.net:443"; ma=2592000,h3-29=":443"; ma=2592000,h3-T051="googleads.g.doubleclick.net:443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic="googleads.g.doubleclick.net:443"; ma=2592000; v="46,43",quic=":443"; ma=2592000; v="46,43"
content-length
29432
x-xss-protection
0
expires
Tue, 15 Dec 2020 12:45:38 GMT
osd.js
www.googletagservices.com/activeview/js/current/
74 KB
28 KB
Script
General
Full URL
https://www.googletagservices.com/activeview/js/current/osd.js?cb=%2Fr20100101
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020120801.js
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:816::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
c1c9310eb6a56101c2133db372cfbe9cefb5ff6b90a02ded916984c975b813b2
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:45:38 GMT
content-encoding
gzip
x-content-type-options
nosniff
server
sffe
etag
"1607690616793149"
vary
Accept-Encoding
content-type
text/javascript
cache-control
private, max-age=3000
accept-ranges
bytes
alt-svc
h3-29="googleads.g.doubleclick.net:443"; ma=2592000,h3-29=":443"; ma=2592000,h3-T051="googleads.g.doubleclick.net:443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic="googleads.g.doubleclick.net:443"; ma=2592000; v="46,43",quic=":443"; ma=2592000; v="46,43"
content-length
28334
x-xss-protection
0
expires
Tue, 15 Dec 2020 12:45:38 GMT
2
www.dailymail.co.uk/abe/a9/price/
4 B
702 B
XHR
General
Full URL
https://www.dailymail.co.uk/abe/a9/price/2
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/static/mol-adverts/demo/mol-22070/19a28e0b/mol-adverts.js
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2a02:26f0:6c00:296::11ae , Ascension Island, ASN20940 (AKAMAI-ASN1, EU),
Reverse DNS
Software
AmazonS3 /
Resource Hash
561b2814d3c09e62a92442c946307918f7f63f833c84876c08bd4c406767e53b

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

x-amz-version-id
wDnvhJJXpo3tPt4.QtsManRqQALbFlHY
content-security-policy-report-only
block-all-mixed-content; report-uri https://mol.report-uri.io/r/default/csp/reportOnly
last-modified
Thu, 26 Jul 2018 09:55:16 GMT
server
AmazonS3
x-amz-request-id
2Z4KDQ1N7H5GAG6P
etag
"f7ddd489ab0a82567b241b05971cbdb3"
vary
User-Agent
content-type
text/plain
cache-control
public, max-age=1146255
date
Tue, 15 Dec 2020 12:45:38 GMT
x-amz-replication-status
COMPLETED
server-timing
cdn-cache; desc=HIT, edge; dur=1
accept-ranges
bytes
content-length
4
x-amz-id-2
TQa+V4AfiJ7Bmz5eGVXtXeerNKKqRrPt9yBoXYXtX5TNMag04HicxY48/1EyJyZRcnVJVxDSTyI=
2
www.dailymail.co.uk/abe/a9/price/
4 B
704 B
XHR
General
Full URL
https://www.dailymail.co.uk/abe/a9/price/2
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/static/mol-adverts/demo/mol-22070/19a28e0b/mol-adverts.js
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2a02:26f0:6c00:296::11ae , Ascension Island, ASN20940 (AKAMAI-ASN1, EU),
Reverse DNS
Software
AmazonS3 /
Resource Hash
561b2814d3c09e62a92442c946307918f7f63f833c84876c08bd4c406767e53b

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

x-amz-version-id
wDnvhJJXpo3tPt4.QtsManRqQALbFlHY
content-security-policy-report-only
block-all-mixed-content; report-uri https://mol.report-uri.io/r/default/csp/reportOnly
last-modified
Thu, 26 Jul 2018 09:55:16 GMT
server
AmazonS3
x-amz-request-id
2Z4KDQ1N7H5GAG6P
etag
"f7ddd489ab0a82567b241b05971cbdb3"
vary
User-Agent
content-type
text/plain
cache-control
public, max-age=1146255
date
Tue, 15 Dec 2020 12:45:38 GMT
x-amz-replication-status
COMPLETED
server-timing
cdn-cache; desc=HIT, edge; dur=1
accept-ranges
bytes
content-length
4
x-amz-id-2
TQa+V4AfiJ7Bmz5eGVXtXeerNKKqRrPt9yBoXYXtX5TNMag04HicxY48/1EyJyZRcnVJVxDSTyI=
2
www.dailymail.co.uk/abe/a9/price/
4 B
702 B
XHR
General
Full URL
https://www.dailymail.co.uk/abe/a9/price/2
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/static/mol-adverts/demo/mol-22070/19a28e0b/mol-adverts.js
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2a02:26f0:6c00:296::11ae , Ascension Island, ASN20940 (AKAMAI-ASN1, EU),
Reverse DNS
Software
AmazonS3 /
Resource Hash
561b2814d3c09e62a92442c946307918f7f63f833c84876c08bd4c406767e53b

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

x-amz-version-id
wDnvhJJXpo3tPt4.QtsManRqQALbFlHY
content-security-policy-report-only
block-all-mixed-content; report-uri https://mol.report-uri.io/r/default/csp/reportOnly
last-modified
Thu, 26 Jul 2018 09:55:16 GMT
server
AmazonS3
x-amz-request-id
2Z4KDQ1N7H5GAG6P
etag
"f7ddd489ab0a82567b241b05971cbdb3"
vary
User-Agent
content-type
text/plain
cache-control
public, max-age=1146255
date
Tue, 15 Dec 2020 12:45:38 GMT
x-amz-replication-status
COMPLETED
server-timing
cdn-cache; desc=HIT, edge; dur=1
accept-ranges
bytes
content-length
4
x-amz-id-2
TQa+V4AfiJ7Bmz5eGVXtXeerNKKqRrPt9yBoXYXtX5TNMag04HicxY48/1EyJyZRcnVJVxDSTyI=
2
www.dailymail.co.uk/abe/a9/price/
4 B
701 B
XHR
General
Full URL
https://www.dailymail.co.uk/abe/a9/price/2
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/static/mol-adverts/demo/mol-22070/19a28e0b/mol-adverts.js
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2a02:26f0:6c00:296::11ae , Ascension Island, ASN20940 (AKAMAI-ASN1, EU),
Reverse DNS
Software
AmazonS3 /
Resource Hash
561b2814d3c09e62a92442c946307918f7f63f833c84876c08bd4c406767e53b

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

x-amz-version-id
wDnvhJJXpo3tPt4.QtsManRqQALbFlHY
content-security-policy-report-only
block-all-mixed-content; report-uri https://mol.report-uri.io/r/default/csp/reportOnly
last-modified
Thu, 26 Jul 2018 09:55:16 GMT
server
AmazonS3
x-amz-request-id
2Z4KDQ1N7H5GAG6P
etag
"f7ddd489ab0a82567b241b05971cbdb3"
vary
User-Agent
content-type
text/plain
cache-control
public, max-age=1146255
date
Tue, 15 Dec 2020 12:45:38 GMT
x-amz-replication-status
COMPLETED
server-timing
cdn-cache; desc=HIT, edge; dur=1
accept-ranges
bytes
content-length
4
x-amz-id-2
TQa+V4AfiJ7Bmz5eGVXtXeerNKKqRrPt9yBoXYXtX5TNMag04HicxY48/1EyJyZRcnVJVxDSTyI=
products
fff.dailymail.co.uk/
2 B
135 B
XHR
General
Full URL
https://fff.dailymail.co.uk/products?articleId=9050821&geo=gb
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/static/mol-fe/static/mol-fe-fff/1.3.16/scripts/fff.js
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2a02:26f0:6c00:288::11ae , Ascension Island, ASN20940 (AKAMAI-ASN1, EU),
Reverse DNS
Software
/
Resource Hash
4f53cda18c2baa0c0354bb5f9a3ecbe5ed12ab4d8e11ba873c2f11161202b945

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

access-control-allow-origin
*
x-rs-ops
fff1-fe:8180
date
Tue, 15 Dec 2020 12:45:38 GMT
content-length
2
access-control-allow-methods
GET
content-type
application/json; charset=utf-8
config.json
c.go-mpulse.net/api/
5 KB
2 KB
XHR
General
Full URL
https://c.go-mpulse.net/api/config.json?key=RQAJ2-Q4TGF-HEKJL-TAEAK-5V3VD&d=www.dailymail.co.uk&t=5360121&v=1.720.0&sl=0&si=f37fefe4-59ee-447f-b8fa-299c2039f8f5-qldsry&plugins=AK,ConfigOverride,Continuity,PageParams,IFrameDelay,AutoXHR,SPA,History,Angular,Backbone,Ember,RT,CrossDomain,BW,PaintTiming,NavigationTiming,ResourceTiming,Memory,CACHE_RELOAD,Errors,TPAnalytics,UserTiming,Akamai,Early,EventTiming,LOGN&acao=&ak.ai=145913
Requested by
Host: s.go-mpulse.net
URL: https://s.go-mpulse.net/boomerang/RQAJ2-Q4TGF-HEKJL-TAEAK-5V3VD
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_ECDSA, AES_256_GCM
Server
2a02:26f0:6c00:191::11a6 , Ascension Island, ASN20940 (AKAMAI-ASN1, EU),
Reverse DNS
Software
/
Resource Hash
dccdb07318248be82b78c3b3de2d98f2449b50d14904232163cc5cefcdd90230

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Date
Tue, 15 Dec 2020 12:45:38 GMT
Content-Encoding
gzip
Vary
Accept-Encoding
Content-Type
application/json
Access-Control-Allow-Origin
*
Cache-Control
private, max-age=300, stale-while-revalidate=60, stale-if-error=120
Connection
keep-alive
Timing-Allow-Origin
*
Content-Length
1341
amp4ads-v0.mjs
cdn.ampproject.org/rtv/012010270040000/ Frame 63F6
180 KB
50 KB
Script
General
Full URL
https://cdn.ampproject.org/rtv/012010270040000/amp4ads-v0.mjs
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020120801.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:81f::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
b2ab9ac436910017b9a2ca7db0e981bad3638db97f576d713eaa9b302e06c094
Security Headers
Name Value
Content-Security-Policy default-src * blob: data:; script-src blob: https://cdn.ampproject.org/esm/ https://cdn.ampproject.org/lts/ https://cdn.ampproject.org/mp/ https://cdn.ampproject.org/rtv/ https://cdn.ampproject.org/sp/ https://cdn.ampproject.org/sw/ https://cdn.ampproject.org/v0.js https://cdn.ampproject.org/v0.mjs https://cdn.ampproject.org/v0/ https://cdn.ampproject.org/viewer/; object-src 'none'; style-src 'unsafe-inline' https://cdn.ampproject.org/rtv/ https://cdn.materialdesignicons.com https://cloud.typography.com https://fast.fonts.net https://fonts.googleapis.com https://maxcdn.bootstrapcdn.com https://p.typekit.net https://pro.fontawesome.com https://use.fontawesome.com https://use.typekit.net; report-uri https://csp.withgoogle.com/csp/amp
Strict-Transport-Security max-age=31536000; includeSubDomains; preload
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

content-security-policy
default-src * blob: data:; script-src blob: https://cdn.ampproject.org/esm/ https://cdn.ampproject.org/lts/ https://cdn.ampproject.org/mp/ https://cdn.ampproject.org/rtv/ https://cdn.ampproject.org/sp/ https://cdn.ampproject.org/sw/ https://cdn.ampproject.org/v0.js https://cdn.ampproject.org/v0.mjs https://cdn.ampproject.org/v0/ https://cdn.ampproject.org/viewer/; object-src 'none'; style-src 'unsafe-inline' https://cdn.ampproject.org/rtv/ https://cdn.materialdesignicons.com https://cloud.typography.com https://fast.fonts.net https://fonts.googleapis.com https://maxcdn.bootstrapcdn.com https://p.typekit.net https://pro.fontawesome.com https://use.fontawesome.com https://use.typekit.net; report-uri https://csp.withgoogle.com/csp/amp
content-encoding
br
x-content-type-options
nosniff
age
397955
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
51478
x-xss-protection
0
server
sffe
date
Thu, 10 Dec 2020 22:13:03 GMT
strict-transport-security
max-age=31536000; includeSubDomains; preload
content-type
text/javascript
access-control-allow-origin
*
vary
Accept-Encoding
cache-control
public, max-age=31536000
etag
"0305d7d21a7fe4a1"
accept-ranges
bytes
timing-allow-origin
*
expires
Fri, 10 Dec 2021 22:13:03 GMT
amp-ad-exit-0.1.mjs
cdn.ampproject.org/rtv/012010270040000/v0/ Frame 63F6
13 KB
5 KB
Script
General
Full URL
https://cdn.ampproject.org/rtv/012010270040000/v0/amp-ad-exit-0.1.mjs
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020120801.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:81f::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
ebab910fdc7c7e9e079caa9f7321177b135b2e1542f86ce36937ceb41865086d
Security Headers
Name Value
Content-Security-Policy default-src * blob: data:; script-src blob: https://cdn.ampproject.org/esm/ https://cdn.ampproject.org/lts/ https://cdn.ampproject.org/mp/ https://cdn.ampproject.org/rtv/ https://cdn.ampproject.org/sp/ https://cdn.ampproject.org/sw/ https://cdn.ampproject.org/v0.js https://cdn.ampproject.org/v0.mjs https://cdn.ampproject.org/v0/ https://cdn.ampproject.org/viewer/; object-src 'none'; style-src 'unsafe-inline' https://cdn.ampproject.org/rtv/ https://cdn.materialdesignicons.com https://cloud.typography.com https://fast.fonts.net https://fonts.googleapis.com https://maxcdn.bootstrapcdn.com https://p.typekit.net https://pro.fontawesome.com https://use.fontawesome.com https://use.typekit.net; report-uri https://csp.withgoogle.com/csp/amp
Strict-Transport-Security max-age=31536000; includeSubDomains; preload
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

content-security-policy
default-src * blob: data:; script-src blob: https://cdn.ampproject.org/esm/ https://cdn.ampproject.org/lts/ https://cdn.ampproject.org/mp/ https://cdn.ampproject.org/rtv/ https://cdn.ampproject.org/sp/ https://cdn.ampproject.org/sw/ https://cdn.ampproject.org/v0.js https://cdn.ampproject.org/v0.mjs https://cdn.ampproject.org/v0/ https://cdn.ampproject.org/viewer/; object-src 'none'; style-src 'unsafe-inline' https://cdn.ampproject.org/rtv/ https://cdn.materialdesignicons.com https://cloud.typography.com https://fast.fonts.net https://fonts.googleapis.com https://maxcdn.bootstrapcdn.com https://p.typekit.net https://pro.fontawesome.com https://use.fontawesome.com https://use.typekit.net; report-uri https://csp.withgoogle.com/csp/amp
content-encoding
br
x-content-type-options
nosniff
age
285466
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
4850
x-xss-protection
0
server
sffe
date
Sat, 12 Dec 2020 05:27:52 GMT
strict-transport-security
max-age=31536000; includeSubDomains; preload
content-type
text/javascript
access-control-allow-origin
*
vary
Accept-Encoding
cache-control
public, max-age=31536000
etag
"77bd676d834aaa8d"
accept-ranges
bytes
timing-allow-origin
*
expires
Sun, 12 Dec 2021 05:27:52 GMT
amp-analytics-0.1.mjs
cdn.ampproject.org/rtv/012010270040000/v0/ Frame 63F6
90 KB
28 KB
Script
General
Full URL
https://cdn.ampproject.org/rtv/012010270040000/v0/amp-analytics-0.1.mjs
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020120801.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:81f::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
477549a4d5fb644cda6bf64af01631b8411022d88e608bbd8e5a06e327b391cb
Security Headers
Name Value
Content-Security-Policy default-src * blob: data:; script-src blob: https://cdn.ampproject.org/esm/ https://cdn.ampproject.org/lts/ https://cdn.ampproject.org/mp/ https://cdn.ampproject.org/rtv/ https://cdn.ampproject.org/sp/ https://cdn.ampproject.org/sw/ https://cdn.ampproject.org/v0.js https://cdn.ampproject.org/v0.mjs https://cdn.ampproject.org/v0/ https://cdn.ampproject.org/viewer/; object-src 'none'; style-src 'unsafe-inline' https://cdn.ampproject.org/rtv/ https://cdn.materialdesignicons.com https://cloud.typography.com https://fast.fonts.net https://fonts.googleapis.com https://maxcdn.bootstrapcdn.com https://p.typekit.net https://pro.fontawesome.com https://use.fontawesome.com https://use.typekit.net; report-uri https://csp.withgoogle.com/csp/amp
Strict-Transport-Security max-age=31536000; includeSubDomains; preload
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

content-security-policy
default-src * blob: data:; script-src blob: https://cdn.ampproject.org/esm/ https://cdn.ampproject.org/lts/ https://cdn.ampproject.org/mp/ https://cdn.ampproject.org/rtv/ https://cdn.ampproject.org/sp/ https://cdn.ampproject.org/sw/ https://cdn.ampproject.org/v0.js https://cdn.ampproject.org/v0.mjs https://cdn.ampproject.org/v0/ https://cdn.ampproject.org/viewer/; object-src 'none'; style-src 'unsafe-inline' https://cdn.ampproject.org/rtv/ https://cdn.materialdesignicons.com https://cloud.typography.com https://fast.fonts.net https://fonts.googleapis.com https://maxcdn.bootstrapcdn.com https://p.typekit.net https://pro.fontawesome.com https://use.fontawesome.com https://use.typekit.net; report-uri https://csp.withgoogle.com/csp/amp
content-encoding
br
x-content-type-options
nosniff
age
475636
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
27668
x-xss-protection
0
server
sffe
date
Thu, 10 Dec 2020 00:38:22 GMT
strict-transport-security
max-age=31536000; includeSubDomains; preload
content-type
text/javascript
access-control-allow-origin
*
vary
Accept-Encoding
cache-control
public, max-age=31536000
etag
"1304c1c0caf7ca3c"
accept-ranges
bytes
timing-allow-origin
*
expires
Fri, 10 Dec 2021 00:38:22 GMT
amp-fit-text-0.1.mjs
cdn.ampproject.org/rtv/012010270040000/v0/ Frame 63F6
3 KB
1 KB
Script
General
Full URL
https://cdn.ampproject.org/rtv/012010270040000/v0/amp-fit-text-0.1.mjs
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020120801.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:81f::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
a86753d4effe5e607d4eaf03fe37eccb8cac743a528f874f736f4d7f35e094b1
Security Headers
Name Value
Content-Security-Policy default-src * blob: data:; script-src blob: https://cdn.ampproject.org/esm/ https://cdn.ampproject.org/lts/ https://cdn.ampproject.org/mp/ https://cdn.ampproject.org/rtv/ https://cdn.ampproject.org/sp/ https://cdn.ampproject.org/sw/ https://cdn.ampproject.org/v0.js https://cdn.ampproject.org/v0.mjs https://cdn.ampproject.org/v0/ https://cdn.ampproject.org/viewer/; object-src 'none'; style-src 'unsafe-inline' https://cdn.ampproject.org/rtv/ https://cdn.materialdesignicons.com https://cloud.typography.com https://fast.fonts.net https://fonts.googleapis.com https://maxcdn.bootstrapcdn.com https://p.typekit.net https://pro.fontawesome.com https://use.fontawesome.com https://use.typekit.net; report-uri https://csp.withgoogle.com/csp/amp
Strict-Transport-Security max-age=31536000; includeSubDomains; preload
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

content-security-policy
default-src * blob: data:; script-src blob: https://cdn.ampproject.org/esm/ https://cdn.ampproject.org/lts/ https://cdn.ampproject.org/mp/ https://cdn.ampproject.org/rtv/ https://cdn.ampproject.org/sp/ https://cdn.ampproject.org/sw/ https://cdn.ampproject.org/v0.js https://cdn.ampproject.org/v0.mjs https://cdn.ampproject.org/v0/ https://cdn.ampproject.org/viewer/; object-src 'none'; style-src 'unsafe-inline' https://cdn.ampproject.org/rtv/ https://cdn.materialdesignicons.com https://cloud.typography.com https://fast.fonts.net https://fonts.googleapis.com https://maxcdn.bootstrapcdn.com https://p.typekit.net https://pro.fontawesome.com https://use.fontawesome.com https://use.typekit.net; report-uri https://csp.withgoogle.com/csp/amp
content-encoding
br
x-content-type-options
nosniff
age
355558
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
1350
x-xss-protection
0
server
sffe
date
Fri, 11 Dec 2020 09:59:40 GMT
strict-transport-security
max-age=31536000; includeSubDomains; preload
content-type
text/javascript
access-control-allow-origin
*
vary
Accept-Encoding
cache-control
public, max-age=31536000
etag
"12c034eb739190af"
accept-ranges
bytes
timing-allow-origin
*
expires
Sat, 11 Dec 2021 09:59:40 GMT
amp-form-0.1.mjs
cdn.ampproject.org/rtv/012010270040000/v0/ Frame 63F6
41 KB
13 KB
Script
General
Full URL
https://cdn.ampproject.org/rtv/012010270040000/v0/amp-form-0.1.mjs
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020120801.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:81f::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
b61eb57ae77f31b91b04781da33023ecd897fda21f6c817e6c27623204046f42
Security Headers
Name Value
Content-Security-Policy default-src * blob: data:; script-src blob: https://cdn.ampproject.org/esm/ https://cdn.ampproject.org/lts/ https://cdn.ampproject.org/mp/ https://cdn.ampproject.org/rtv/ https://cdn.ampproject.org/sp/ https://cdn.ampproject.org/sw/ https://cdn.ampproject.org/v0.js https://cdn.ampproject.org/v0.mjs https://cdn.ampproject.org/v0/ https://cdn.ampproject.org/viewer/; object-src 'none'; style-src 'unsafe-inline' https://cdn.ampproject.org/rtv/ https://cdn.materialdesignicons.com https://cloud.typography.com https://fast.fonts.net https://fonts.googleapis.com https://maxcdn.bootstrapcdn.com https://p.typekit.net https://pro.fontawesome.com https://use.fontawesome.com https://use.typekit.net; report-uri https://csp.withgoogle.com/csp/amp
Strict-Transport-Security max-age=31536000; includeSubDomains; preload
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

content-security-policy
default-src * blob: data:; script-src blob: https://cdn.ampproject.org/esm/ https://cdn.ampproject.org/lts/ https://cdn.ampproject.org/mp/ https://cdn.ampproject.org/rtv/ https://cdn.ampproject.org/sp/ https://cdn.ampproject.org/sw/ https://cdn.ampproject.org/v0.js https://cdn.ampproject.org/v0.mjs https://cdn.ampproject.org/v0/ https://cdn.ampproject.org/viewer/; object-src 'none'; style-src 'unsafe-inline' https://cdn.ampproject.org/rtv/ https://cdn.materialdesignicons.com https://cloud.typography.com https://fast.fonts.net https://fonts.googleapis.com https://maxcdn.bootstrapcdn.com https://p.typekit.net https://pro.fontawesome.com https://use.fontawesome.com https://use.typekit.net; report-uri https://csp.withgoogle.com/csp/amp
content-encoding
br
x-content-type-options
nosniff
age
353670
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
13075
x-xss-protection
0
server
sffe
date
Fri, 11 Dec 2020 10:31:08 GMT
strict-transport-security
max-age=31536000; includeSubDomains; preload
content-type
text/javascript
access-control-allow-origin
*
vary
Accept-Encoding
cache-control
public, max-age=31536000
etag
"1e8a1dae72af56cd"
accept-ranges
bytes
timing-allow-origin
*
expires
Sat, 11 Dec 2021 10:31:08 GMT
truncated
/ Frame 63F6
217 B
0
Image
General
Full URL
data:truncated
Protocol
DATA
Server
-, , ASN (),
Reverse DNS
Software
/
Resource Hash
769f8b8e2cc7f6c53c7817cd116e53c23d6a0a86bff13d9add76e47c5ec2aec2

Request headers

Referer
https://www.dailymail.co.uk/
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Content-Type
image/png
3331366516218933350
tpc.googlesyndication.com/simgad/ Frame 63F6
28 KB
28 KB
Image
General
Full URL
https://tpc.googlesyndication.com/simgad/3331366516218933350?sqp=4sqPyQQ7QjkqNxABHQAAtEIgASgBMAk4A0DwkwlYAWBfcAKAAQGIAQGdAQAAgD-oAQGwAYCt4gS4AV_FAS2ynT4&rs=AOga4qmYDCb36CzpN-IY8nY25ACpqDrq9A
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:81d::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
f1665d05085b2ed9ee80a1c0a7f585f2bce8bf6c25a80ec9301c4bbfb572b3f5
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Mon, 14 Dec 2020 22:09:57 GMT
x-content-type-options
nosniff
last-modified
Tue, 27 Oct 2020 22:34:36 GMT
server
sffe
age
52541
content-type
image/png
access-control-allow-origin
*
cache-control
public, max-age=31536000
cross-origin-resource-policy
cross-origin
accept-ranges
bytes
timing-allow-origin
*
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
28993
x-xss-protection
0
expires
Tue, 14 Dec 2021 22:09:57 GMT
en.png
tpc.googlesyndication.com/pagead/images/adchoices/ Frame 63F6
2 KB
3 KB
Image
General
Full URL
https://tpc.googlesyndication.com/pagead/images/adchoices/en.png
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:81d::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
36133ca07927c88a7cc578fddbaed3c668ab75087834d0ca13dca5de4ec856c1
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

timing-allow-origin
*
date
Mon, 14 Dec 2020 23:34:27 GMT
x-content-type-options
nosniff
server
cafe
age
47471
etag
14819457070020093239
vary
Accept-Encoding
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
cache-control
public, max-age=86400
cross-origin-resource-policy
cross-origin
content-type
image/png
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
2502
x-xss-protection
0
expires
Tue, 15 Dec 2020 23:34:27 GMT
icon.png
tpc.googlesyndication.com/pagead/images/adchoices/ Frame 63F6
295 B
399 B
Image
General
Full URL
https://tpc.googlesyndication.com/pagead/images/adchoices/icon.png
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:81d::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
7fd59024b6ca83f11f7a3448ec148309a13b705725716df134f699e60a96eb1b
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

timing-allow-origin
*
date
Mon, 14 Dec 2020 21:53:21 GMT
x-content-type-options
nosniff
server
cafe
age
53537
etag
426692510519060060
vary
Accept-Encoding
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
cache-control
public, max-age=86400
cross-origin-resource-policy
cross-origin
content-type
image/png
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
295
x-xss-protection
0
expires
Tue, 15 Dec 2020 21:53:21 GMT
adview
securepubads.g.doubleclick.net/pagead/ Frame 63F6
0
0
Image
General
Full URL
https://securepubads.g.doubleclick.net/pagead/adview?ai=Ci0zZ8a_YX9KEONDKgAfqupaIAsDKpctfg_vuyfAM5L6R-dEIEAEgrNm4ImCRhJOF_BegAeze4_QDyAEC4AIAqAMByAMIqgS_Ak_QLpXB4LK9BlBDk558MZm8IUIoSLexO3GCyxG_eXv19VE8ond5tbkaBRFJko2U7OCY6MHKZkXGM8MPPALUr0NNtBaSxBnIBprmImJChZs4dWZrlSVmMT8CVS5gev3V-zwY8MW0YHY0HLPZ1pRjMhJ6fvxhrlrLdvp0l8nnQ6gqW3D1gNVJ92I0zbDNrSitSKNd4WTt-RQJUaHDJHdU-AYqzLSThdkNfG9Pobqg5Mds3IaPOC0bvLXj8asu3X9f2NMwbWQ7W1yRV46hlzKpWqJ1_mY78L0XblriJe0mPkHEv_kUNDbJBEOrLPgmUsWCiX_7el__LAEDbjW3EUkqo1KFl92-svI4D3cjHCdmk6fxGv3xklzvg7teLhX6FSnXmh9WZ22Bp31FvsQV1yunyY3ZnIpYwiKoKBHIL-BPkVvABJPm55SbAeAEAZIFBAgEGAGSBQQIBRgEkgUECAUYGJIFBQgFGKgBoAYCgAf8oJwLqAfVyRuoB_DZG6gH8tkbqAeUmLECqAel3xuoB47OG6gHk9gbqAe6BqgH7paxAqgHpr4bqAfs1RvYBwHyBwQQoIgH0ggJCIDhgFAQARgdgAoDyAsB2BMMshcaChgIARIUcHViLTQxODA4MzU2OTQxNjYyNTU&sigh=AJknp-QA4cA&tpd=AGWhJmtz2UJ96DG3sK-hYoimEKu7UvWUqXABLCvOhFPlR2eOEw
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
172.217.22.2 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
fra16s14-in-f2.1e100.net
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
https://www.dailymail.co.uk/
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

ads
securepubads.g.doubleclick.net/gampad/
40 KB
12 KB
XHR
General
Full URL
https://securepubads.g.doubleclick.net/gampad/ads?gdfp_req=1&pvsid=2639827676159032&correlator=2455119041695441&output=ldjh&impl=fif&adsid=NT&eid=21069142&vrg=2020120801&guci=1.2.0.0.2.2.0.0&sc=1&sfv=1-0-37&ecs=20201215&iu_parts=5765%2Cdailymail.uk%2Cdm_dmsciencetech_sciencetechart%2Cmpu_middle&enc_prev_ius=%2F0%2F1%2F2%2F3&prev_iu_szs=300x600%7C300x250&prev_scp=pos%3Dmpu_middle%26amznbid%3D2%26amznp%3D2%26adx_channel%3D9%26nobids%3Dfalse%26refreshCount%3D0%26amznsz%3D0x0&eri=4&cust_params=page%3Dart%26article%3D9050821%26area%3Dsciencetech%26subarea%3Dsciencetech%26environment%3Dproduction%26country%3Dde%26abv%3Dmol-22070%252F19a28e0b%26bot%3Dfalse%26random%3D9ceebda3-1911-4085-b4cd-4ef660466486%26impid%3Dc0338c30-9d3e-46d6-8db6-95c14a8ccbca%26browserResolution%3Dmin_1244px%26device%3Dother%26device_features%3D%26articlewithvideo%3Dtrue%26style%3Dwide%26session%3D1%26session_page_ID%3Dnone%26utm_source%3Dnone%26watershed%3Dfalse%26location%3Ddailymail_co_uk%26id5%3Dtrue%26permutive%3Drts%26puid%3Db77f6280-fced-4776-aef9-89e90021e68b%26ptime%3D1608036337226&cookie=ID%3Daac5ef6e1b7c2a1b-2253aafe66b900a9%3AT%3D1608036337%3AS%3DALNI_MY3_sO7DT2mLATMEHjKQNbU8J6E8g&cdm=www.dailymail.co.uk&bc=31&abxe=1&dt=1608036338484&dlt=1608036336099&idt=1063&frm=20&biw=1600&bih=1200&oid=3&adxs=978&adys=32260&adks=3722470808&ucis=a&ifi=10&u_tz=60&u_his=2&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_sd=1&flash=0&url=www.dailymail.co.uk%2Fsciencetech%2Farticle-9050821%2FRemdesivir-beneficial-patients-doctors-reveal.html&loc=https%3A%2F%2Fwww.dailymail.co.uk%2Fsciencetech%2Farticle-9050821%2FRemdesivir-beneficial-patients-doctors-reveal.html%3F_hsmi%3D88974744%26_hsenc%3Dp2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8&vis=1&dmc=8&scr_x=0&scr_y=0&psz=308x627&msz=308x627&psts=AGkb-H8Ea__ROWP6iCtuJnTikfDqFvgEhdFS__bGkDqK7myRJiYdigEmc1U3zmUA-HbB_-yknenOJN1ffIdLQkho7xCYGVETkh6MjNNcBQB1GThq&ga_vid=254203172.1608036337&ga_sid=1608036337&ga_hid=881620343&fws=4&ohw=1600&btvi=6&tt_state=W3siaXNzdWVyT3JpZ2luIjoiaHR0cHM6Ly9hZHNlcnZpY2UuZ29vZ2xlLmNvbSIsInN0YXRlIjowfSx7Imlzc3Vlck9yaWdpbiI6Imh0dHBzOi8vYXR0ZXN0YXRpb24uYW5kcm9pZC5jb20iLCJzdGF0ZSI6MH1d
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020120801.js
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
172.217.22.2 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
fra16s14-in-f2.1e100.net
Software
cafe /
Resource Hash
d34ed788d30bd4233d17b8f981dfef56be734e8aa86386e66c619b65873b08f0
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:45:40 GMT
content-encoding
br
x-content-type-options
nosniff
google-mediationgroup-id
-2
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
cross-origin-resource-policy
cross-origin
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
11715
x-xss-protection
0
google-lineitem-id
5290996269
pragma
no-cache
server
cafe
google-mediationtag-id
-2
google-creative-id
138333866013
content-type
text/plain; charset=UTF-8
access-control-allow-origin
https://www.dailymail.co.uk
cache-control
no-cache, must-revalidate
access-control-allow-credentials
true
timing-allow-origin
*
expires
Fri, 01 Jan 1990 00:00:00 GMT
cta-branding.js
cdn.taboola.com/demand-formats/cta-branding/
8 KB
3 KB
Script
General
Full URL
https://cdn.taboola.com/demand-formats/cta-branding/cta-branding.js
Requested by
Host: cdn.taboola.com
URL: https://cdn.taboola.com/libtrc/impl.20201214-6-RELEASE.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
151.101.13.44 Frankfurt am Main, Germany, ASN54113 (FASTLY, US),
Reverse DNS
Software
AmazonS3 /
Resource Hash
0c56a21524db6a9ae3e1969698a146013f95b2fab9ac4ed167048d7e5d3c0830

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

x-amz-version-id
zMWJo1PVj_h5BEu57MrR0ouiGawOeH2Y
content-encoding
gzip
etag
"2f4d244e58c3b6e32e449819d4fe0da1"
age
9839
x-cache
HIT
x-amz-replication-status
PENDING
content-length
2983
x-amz-id-2
UrqGF85PdXRhKnUzExvGW2WYb6SeGntEowKtDacaaZ9nc/UoQj+MisXht2ltBkCE5LBTYqqc2BY=
x-served-by
cache-fra19144-FRA
last-modified
Sun, 13 Dec 2020 10:01:26 GMT
server
AmazonS3
x-timer
S1608036339.512893,VS0,VE0
date
Tue, 15 Dec 2020 12:45:38 GMT
vary
Accept-Encoding
x-amz-request-id
3EE68CC59824B1CF
via
1.1 varnish
cache-control
private,max-age=14400
accept-ranges
bytes
content-type
application/javascript
abp
94
x-cache-hits
92235
cta-branding.css
cdn.taboola.com/demand-formats/cta-branding/
3 KB
1020 B
Stylesheet
General
Full URL
https://cdn.taboola.com/demand-formats/cta-branding/cta-branding.css
Requested by
Host: cdn.taboola.com
URL: https://cdn.taboola.com/libtrc/impl.20201214-6-RELEASE.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
151.101.13.44 Frankfurt am Main, Germany, ASN54113 (FASTLY, US),
Reverse DNS
Software
AmazonS3 /
Resource Hash
b2cb57515497d75f4345929ae896c87c21f27d609aed94fb83f857e5b96f9835

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

x-amz-version-id
tcahAQL7SM5vHmChLog9xryayd2KNhUu
content-encoding
gzip
etag
"9e155136143a96e23a99757df9aa3cc8"
age
12275
x-cache
HIT
x-amz-replication-status
PENDING
content-length
728
x-amz-id-2
f65xj6iuxogMKrz0V0PcFaMwZec2VDREXRA0jdjbf3aLNlkxtn2vhTmCXQ21535SK5HpYLHFJGI=
x-served-by
cache-fra19144-FRA
last-modified
Sun, 15 Nov 2020 09:20:35 GMT
server
AmazonS3
x-timer
S1608036339.512744,VS0,VE0
date
Tue, 15 Dec 2020 12:45:38 GMT
vary
Accept-Encoding
x-amz-request-id
414C1B5C7AA1A893
via
1.1 varnish
cache-control
private,max-age=14400
accept-ranges
bytes
content-type
text/css
abp
94
x-cache-hits
110854
tb
15.taboola.com/
29 KB
9 KB
Script
General
Full URL
https://15.taboola.com/tb?oid=15&pubnm=dailymail-row&unitType=226&tbloc=&pageType=text&pstn=Below%20Article%20Thumbnails%202nd&uuip=&cisrf=&cirf=https%3A%2F%2Fwww.dailymail.co.uk%2Fsciencetech%2Farticle-9050821%2FRemdesivir-beneficial-patients-doctors-reveal.html&encoded=1&uid=81242381-ab73-4352-8bed-9e7099c82ee1-tuct6d23571&variant=-100|421&callback=TRC.videoTagCallbacks.videoCallback1&cb=1608036338524&tagid=&cntry=NL&platform=1&sesid=dd4d66c38ae1b97cdc5b7b1dc3632300&itemid=/sciencetech/article-9050821/remdesivir-beneficial-patients-doctors-reveal.html&viewid=1608036337111&geolat=&geoing=&deviceifa=&appid=&sd=v2_dd4d66c38ae1b97cdc5b7b1dc3632300_81242381-ab73-4352-8bed-9e7099c82ee1-tuct6d23571_1608036337_1608036337_CNawjgYQ-4w9GNeLvbPmLiABKAQwoQE4l-oLQJWXEEj-0toDUP___________wFYAGAAaOKmqpGyrZficA&ri=20dccde5e5f66e09052b97b4a9fd6921&appname=&cdb=&gdprApplies=true&rid=&sii=3375619910924715558&oee=true&tpubid=1001083&uis=4&fagg=1&ccpaDns=false&ccpaPrivacy=&region=GE&hasGDPRConsent=true&tcfVersion=&cmpStatus=&tnetid=1001079
Requested by
Host: cdn.taboola.com
URL: https://cdn.taboola.com/libtrc/impl.20201214-6-RELEASE.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
151.101.13.44 Frankfurt am Main, Germany, ASN54113 (FASTLY, US),
Reverse DNS
Software
nginx /
Resource Hash
295a62b514a142df37c32e9fb50102fbe0fec8958012d5bc0de1d0d7e87ea50f

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:45:38 GMT
content-encoding
gzip
machineid
1418
x-cache
MISS
x-cache-hits
0
x-served-by
cache-fra19144-FRA
pragma
no-cache
server
nginx
x-timer
S1608036339.537499,VS0,VE21
vary
Accept-Encoding
content-type
text/html;charset=ISO-8859-1
via
1.1 varnish
cache-control
no-cache,must-revalidate,no-store,max-age=0,s-maxage=0
accept-ranges
bytes
link
<https://am-wf.taboola.com>; rel=preconnect
expires
Sat, 26 Jul 1997 05:00:00 GMT
userx.20201214-6-RELEASE.es6.js
cdn.taboola.com/libtrc/
23 KB
8 KB
Script
General
Full URL
https://cdn.taboola.com/libtrc/userx.20201214-6-RELEASE.es6.js
Requested by
Host: cdn.taboola.com
URL: https://cdn.taboola.com/libtrc/dailymail-row/loader.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
151.101.13.44 Frankfurt am Main, Germany, ASN54113 (FASTLY, US),
Reverse DNS
Software
AmazonS3 /
Resource Hash
727885a70a1364d1fb91147b801bdc8f7dede4774fd1c9ae833850ed71fc29ce

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

x-amz-version-id
Y0ss_Jafd96z_HkO2cF.Em0G3eY1Is9S
content-encoding
gzip
etag
"cfd0cc9c6be211947cf31df27de14f76"
age
16015
x-cache
HIT
x-amz-replication-status
PENDING
content-length
7879
x-amz-id-2
XLrx3K8fe/oa6Kfi/rG4gcK23ZBpn2W29w3g+mGMz+j61ELj8e81BP4fZw913s0CuASzBtUTGIo=
x-served-by
cache-fra19144-FRA
last-modified
Tue, 15 Dec 2020 08:18:39 GMT
server
AmazonS3
x-timer
S1608036339.536593,VS0,VE0
date
Tue, 15 Dec 2020 12:45:38 GMT
vary
Accept-Encoding
x-amz-request-id
2ABC199CCE0964B5
via
1.1 varnish
cache-control
private,max-age=14400
accept-ranges
bytes
content-type
application/javascript; charset=utf-8
abp
94
x-cache-hits
43810
tb
15.taboola.com/
33 KB
10 KB
Script
General
Full URL
https://15.taboola.com/tb?oid=15&pubnm=dailymail-row&unitType=244&tbloc=&pageType=text&pstn=Desktop-Wide&uuip=Feed%20-%20desktop-Desktop-Wide&cisrf=&cirf=https%3A%2F%2Fwww.dailymail.co.uk%2Fsciencetech%2Farticle-9050821%2FRemdesivir-beneficial-patients-doctors-reveal.html&encoded=1&uid=81242381-ab73-4352-8bed-9e7099c82ee1-tuct6d23571&variant=-100|421&callback=TRC.videoTagCallbacks.videoCallback2&cb=1608036338527&tagid=&cntry=NL&platform=1&sesid=dd4d66c38ae1b97cdc5b7b1dc3632300&itemid=/sciencetech/article-9050821/remdesivir-beneficial-patients-doctors-reveal.html&viewid=1608036337111&geolat=&geoing=&deviceifa=&appid=&sd=v2_dd4d66c38ae1b97cdc5b7b1dc3632300_81242381-ab73-4352-8bed-9e7099c82ee1-tuct6d23571_1608036337_1608036337_CNawjgYQ-4w9GNeLvbPmLiABKAQwoQE4l-oLQJWXEEj-0toDUP___________wFYAGAAaOKmqpGyrZficA&ri=03d7569ca8414d2f01c3c52c09537213&appname=&cdb=&gdprApplies=true&rid=&sii=3375619910924715558&oee=true&tpubid=1001083&uis=4&fagg=1&ccpaDns=false&ccpaPrivacy=&region=GE&hasGDPRConsent=true&tcfVersion=&cmpStatus=&tnetid=1001079
Requested by
Host: cdn.taboola.com
URL: https://cdn.taboola.com/libtrc/impl.20201214-6-RELEASE.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
151.101.13.44 Frankfurt am Main, Germany, ASN54113 (FASTLY, US),
Reverse DNS
Software
nginx /
Resource Hash
7a8371b96212a9a14da3da7ddab11d6c2ec8f56f8497f78eda8f88cbbe66dbbe

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:45:38 GMT
content-encoding
gzip
machineid
1451
x-cache
MISS
x-cache-hits
0
x-served-by
cache-fra19144-FRA
pragma
no-cache
server
nginx
x-timer
S1608036339.538687,VS0,VE21
vary
Accept-Encoding
content-type
text/html;charset=ISO-8859-1
via
1.1 varnish
cache-control
no-cache,must-revalidate,no-store,max-age=0,s-maxage=0
accept-ranges
bytes
link
<https://am-wf.taboola.com>; rel=preconnect
expires
Sat, 26 Jul 1997 05:00:00 GMT
feed-card-placeholder.20201214-6-RELEASE.es6.js
cdn.taboola.com/libtrc/
5 KB
2 KB
Script
General
Full URL
https://cdn.taboola.com/libtrc/feed-card-placeholder.20201214-6-RELEASE.es6.js
Requested by
Host: cdn.taboola.com
URL: https://cdn.taboola.com/libtrc/dailymail-row/loader.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
151.101.13.44 Frankfurt am Main, Germany, ASN54113 (FASTLY, US),
Reverse DNS
Software
AmazonS3 /
Resource Hash
0db846dc61339c357dd05512f87a0c17edff73892a40cfdc9cc99e9a6a87c2de

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

x-amz-version-id
1N_QgF8B43Ufhx3IGB4dyPFi6gyUlKhG
content-encoding
gzip
etag
"46667327073dd22e72d64173fcceee57"
age
15981
x-cache
HIT
x-amz-replication-status
PENDING
content-length
1269
x-amz-id-2
iDORd5mP3ruvGTFfTBUVv9TqGW+N8KDLWpS1YSX8aK0QXBSWT8MZSgzysEPqGnmkenwTsTAsMBQ=
x-served-by
cache-fra19144-FRA
last-modified
Tue, 15 Dec 2020 08:19:15 GMT
server
AmazonS3
x-timer
S1608036339.545283,VS0,VE0
date
Tue, 15 Dec 2020 12:45:38 GMT
vary
Accept-Encoding
x-amz-request-id
0AE60F5492B9C1F0
via
1.1 varnish
cache-control
private,max-age=14400
accept-ranges
bytes
content-type
application/javascript; charset=utf-8
abp
94
x-cache-hits
77015
f89e1763-220d-4e09-ba69-9e040548fb7a.svg
cdn.taboola.com/static/f8/
4 KB
2 KB
Image
General
Full URL
https://cdn.taboola.com/static/f8/f89e1763-220d-4e09-ba69-9e040548fb7a.svg
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
151.101.13.44 Frankfurt am Main, Germany, ASN54113 (FASTLY, US),
Reverse DNS
Software
AmazonS3 /
Resource Hash
39b076e4bb4fab9b8a142499cf6155f8c128464974691a04de7e764f71b72618

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

x-amz-version-id
cMrDKn.emLmm9kiiOOF64ulDT4DRy6LK
content-encoding
gzip
etag
"b8b410e4b18d45aa2f3d9bc09cd335fb"
age
32
via
1.1 varnish
x-cache
HIT
x-amz-replication-status
COMPLETED
content-length
1758
x-amz-id-2
GFFBZiYr8EfRQVO22BVguu3tcQoWriDU4+e/Shm9C5asLqbab74JOY1R9fsMhrMMqRCBiYUSNQQ=
x-served-by
cache-fra19144-FRA
last-modified
Wed, 07 Feb 2018 11:15:52 GMT
server
AmazonS3
x-timer
S1608036339.548255,VS0,VE0
date
Tue, 15 Dec 2020 12:45:38 GMT
vary
Accept-Encoding
access-control-allow-methods
GET
x-amz-request-id
7V6J8M4G7K4P5VER
access-control-allow-origin
*
cache-control
private,max-age=31536000
accept-ranges
bytes
content-type
image/svg+xml
access-control-allow-headers
*
abp
94
x-cache-hits
75
c5ef96bc-30ab-456a-b3d5-a84f367c6a46.svg
cdn.taboola.com/static/c5/
3 KB
2 KB
Image
General
Full URL
https://cdn.taboola.com/static/c5/c5ef96bc-30ab-456a-b3d5-a84f367c6a46.svg
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
151.101.13.44 Frankfurt am Main, Germany, ASN54113 (FASTLY, US),
Reverse DNS
Software
AmazonS3 /
Resource Hash
1d89405054b0eccfd66baa763bf4781b8dff83824636284b79800ecdc25579f1

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

x-amz-version-id
3GoWmPpnzFDs5CP3.ebHbCmhALWQMuvH
content-encoding
gzip
etag
"11d8569a7da0739259e3ac0b0d666e94"
age
38
via
1.1 varnish
x-cache
HIT
x-amz-replication-status
COMPLETED
content-length
1502
x-amz-id-2
LwAbM/TqYBcy8MmWt42d3nIT8MVIJbcor/NMIveZB5jhLN35dP/PtcEOLo4NPissi5fqZFiAxoA=
x-served-by
cache-fra19144-FRA
last-modified
Sun, 10 Jun 2018 13:23:55 GMT
server
AmazonS3
x-timer
S1608036339.559776,VS0,VE0
date
Tue, 15 Dec 2020 12:45:38 GMT
vary
Accept-Encoding
access-control-allow-methods
GET
x-amz-request-id
B4390413E103EA3C
access-control-allow-origin
*
cache-control
private,max-age=31536000
accept-ranges
bytes
content-type
image/svg+xml
access-control-allow-headers
*
abp
94
x-cache-hits
44
tpid=81242381-ab73-4352-8bed-9e7099c82ee1-tuct6d23571
sync.crwdcntrl.net/map/ct=y/c=10924/tp=OOLA/ Frame DECF
Redirect Chain
  • https://sync.crwdcntrl.net/map/c=10924/tp=OOLA/tpid=81242381-ab73-4352-8bed-9e7099c82ee1-tuct6d23571
  • https://sync.crwdcntrl.net/map/ct=y/c=10924/tp=OOLA/tpid=81242381-ab73-4352-8bed-9e7099c82ee1-tuct6d23571
49 B
713 B
Image
General
Full URL
https://sync.crwdcntrl.net/map/ct=y/c=10924/tp=OOLA/tpid=81242381-ab73-4352-8bed-9e7099c82ee1-tuct6d23571
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
52.30.234.204 Dublin, Ireland, ASN16509 (AMAZON-02, US),
Reverse DNS
ec2-52-30-234-204.eu-west-1.compute.amazonaws.com
Software
/
Resource Hash
2f561b02a49376e3679acd5975e3790abdff09ecbadfa1e1858c7ba26e3ffcef

Request headers

Referer
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

pragma
no-cache
date
Tue, 15 Dec 2020 12:45:38 GMT
p3p
CP=NOI DSP COR NID PSAa PSDa OUR UNI COM NAV
access-control-allow-origin
*
cache-control
no-cache
x-server
10.45.0.119
content-type
image/gif
content-length
49
expires
0

Redirect headers

pragma
no-cache
date
Tue, 15 Dec 2020 12:45:38 GMT
p3p
CP=NOI DSP COR NID PSAa PSDa OUR UNI COM NAV
location
https://sync.crwdcntrl.net/map/ct=y/c=10924/tp=OOLA/tpid=81242381-ab73-4352-8bed-9e7099c82ee1-tuct6d23571
cache-control
no-cache
x-server
10.45.14.175
content-length
0
expires
0
rtb-h
match.taboola.com/sg/mediaforcebidder-network/1/ Frame DECF
Redirect Chain
  • https://rtb.mfadsrvr.com/sync?ssp=taboola
  • https://rtb.mfadsrvr.com/ul_cb/sync?ssp=taboola
  • https://sync.taboola.com/sg/mediaforcebidder-network/1/rtb-h?taboola_hm=36f9d606-76a8-4afa-b7e5-6e7d149d5651
  • https://match.taboola.com/sg/mediaforcebidder-network/1/rtb-h?taboola_hm=36f9d606-76a8-4afa-b7e5-6e7d149d5651&tbid=81242381-ab73-4352-8bed-9e7099c82ee1-tuct6d23571&query=taboola_hm%3D36f9d606-76a8-...
0
63 B
Image
General
Full URL
https://match.taboola.com/sg/mediaforcebidder-network/1/rtb-h?taboola_hm=36f9d606-76a8-4afa-b7e5-6e7d149d5651&tbid=81242381-ab73-4352-8bed-9e7099c82ee1-tuct6d23571&query=taboola_hm%3D36f9d606-76a8-4afa-b7e5-6e7d149d5651&isDirect=0
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
151.101.13.44 Frankfurt am Main, Germany, ASN54113 (FASTLY, US),
Reverse DNS
Software
nginx /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:45:39 GMT
via
1.1 varnish
server
nginx
x-timer
S1608036339.348488,VS0,VE11
x-cache
MISS
x-cache-hits
0
accept-ranges
bytes
content-length
0
x-served-by
cache-fra19144-FRA

Redirect headers

location
https://match.taboola.com/sg/mediaforcebidder-network/1/rtb-h?taboola_hm=36f9d606-76a8-4afa-b7e5-6e7d149d5651&tbid=81242381-ab73-4352-8bed-9e7099c82ee1-tuct6d23571&query=taboola_hm%3D36f9d606-76a8-4afa-b7e5-6e7d149d5651&isDirect=0
tbl-x-upstream
10.40.0.111:10213
date
Tue, 15 Dec 2020 12:45:39 GMT
server
nginx
x-fastly-to-nlb-rtt
2006
sync.php
pixel.rubiconproject.com/exchange/ Frame DECF
0
239 B
Image
General
Full URL
https://pixel.rubiconproject.com/exchange/sync.php?p=16698
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
Protocol
HTTP/1.1
Security
TLS 1.2, RSA, AES_256_GCM
Server
69.173.144.139 Frankfurt am Main, Germany, ASN26667 (RUBICONPROJECT, US),
Reverse DNS
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Pragma
no-cache
Expires
0
Cache-Control
no-cache,no-store,must-revalidate
P3P
CP="NOI CURa ADMa DEVa TAIa OUR BUS IND UNI COM NAV INT"
X-RPHost
4cdacfaa68e4ab216fffbcc107c5b898
Content-Type
image/gif
/
sync.taboola.com/sg/pulsepointrtb-network/1/rtb-h/ Frame DECF
Redirect Chain
  • https://bh.contextweb.com/bh/rtset?pid=562107&ev=1&rurl=https%3A%2F%2Fsync.taboola.com/sg/pulsepointrtb-network/1/rtb-h/?taboola_hm=%%VGUID%%&orig=trc
  • https://sync.taboola.com/sg/pulsepointrtb-network/1/rtb-h/?taboola_hm=qY3WWD6Xbl1F&ev=1&orig=trc&pid=562107
0
216 B
Image
General
Full URL
https://sync.taboola.com/sg/pulsepointrtb-network/1/rtb-h/?taboola_hm=qY3WWD6Xbl1F&ev=1&orig=trc&pid=562107
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
Protocol
H2
Security
TLS 1.2, ECDHE_ECDSA, AES_128_GCM
Server
141.226.228.48 , Netherlands, ASN200478 (TABOOLA-AS, IL),
Reverse DNS
Software
nginx /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

tbl-x-upstream
10.40.20.9:10213
date
Tue, 15 Dec 2020 12:45:39 GMT
server
nginx
x-fastly-to-nlb-rtt
2006

Redirect headers

strict-transport-security
max-age=15768000
server
Jetty(9.4.14.v20181114)
p3p
policyref="/bh/w3c/p3p.xml", CP="NOI DSP COR NID CURa DEVa PSAa OUR BUS COM NAV INT"
content-language
en-US
location
https://sync.taboola.com/sg/pulsepointrtb-network/1/rtb-h/?taboola_hm=qY3WWD6Xbl1F&ev=1&orig=trc&pid=562107
cache-control
private, max-age=0, no-cache, no-store
cw-server
bh-deployment-659d447f4f-wq9dw
expires
-1
35702
tags.bluekai.com/site/ Frame DECF
62 B
329 B
Image
General
Full URL
https://tags.bluekai.com/site/35702?id=81242381-ab73-4352-8bed-9e7099c82ee1-tuct6d23571
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_256_GCM
Server
104.111.246.202 , Netherlands, ASN16625 (AKAMAI-AS, US),
Reverse DNS
a104-111-246-202.deploy.static.akamaitechnologies.com
Software
/
Resource Hash
0af3aae90b7de9fdceee2ab421378ea2f54c74be81ef43fc6c1790a032755d80

Request headers

Referer
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Date
Tue, 15 Dec 2020 12:45:39 GMT
X-N
S
Connection
keep-alive
P3P
CP="NOI DSP COR CUR ADMo DEVo PSAo PSDo OUR SAMo BUS UNI NAV", policyref="http://tags.bluekai.com/w3c/p3p.xml"
Content-Length
62
BK-Server
7c80
Content-Type
image/gif
mw
mwzeom.zeotap.com/ Frame DECF
95 B
574 B
Image
General
Full URL
https://mwzeom.zeotap.com/mw?zpartnerid=1367&env=mWeb&cid=81242381-ab73-4352-8bed-9e7099c82ee1-tuct6d23571&gdpr=$0&gdpr_consent=$
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:10::6816:1857 , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
3eb10792d1f0c7e07e7248273540f1952d9a5a2996f4b5df70ab026cd9f05517

Request headers

Referer
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:45:38 GMT
via
1.1 google
cf-cache-status
DYNAMIC
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
content-type
image/png
access-control-allow-origin
*
access-control-allow-credentials
true
cf-ray
6020434cbafa16f2-FRA
access-control-allow-headers
*
content-length
95
cf-request-id
07080863f2000016f2c295e000000001
sync
odr.mookie1.com/t/v2/ Frame DECF
43 B
324 B
Image
General
Full URL
https://odr.mookie1.com/t/v2/sync?tagid=V2_866925&src.visitorId=81242381-ab73-4352-8bed-9e7099c82ee1-tuct6d23571&gdpr=0&gdpr_consent=
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
34.98.67.61 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
61.67.98.34.bc.googleusercontent.com
Software
Apache /
Resource Hash
a065920df8cc4016d67c3a464be90099c9d28ffe7c9e6ee3a18f257efc58cbd7

Request headers

Referer
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

pragma
no-cache
date
Tue, 15 Dec 2020 12:45:41 GMT
via
1.1 google
server
Apache
p3p
CP="NON DSP COR NID CURa PSAa PSDa OUR STP UNI COM NAV STA LOC OTC",policyref="/w3c/p3p.xml"
cache-control
no-cache, no-store, must-revalidate
content-type
image/gif;charset=UTF-8
alt-svc
clear
content-length
43
x-application-context
application
expires
Thu, 01 Jan 1970 00:00:00 GMT
cm
trc.taboola.com/sg/neustar/1/ Frame DECF
Redirect Chain
  • https://aa.agkn.com/adscores/g.pixel?sid=9212237748&puid=81242381-ab73-4352-8bed-9e7099c82ee1-tuct6d23571
  • https://trc.taboola.com/sg/neustar/1/cm?taboola_hm=164950303636000649678
0
71 B
Image
General
Full URL
https://trc.taboola.com/sg/neustar/1/cm?taboola_hm=164950303636000649678
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
151.101.13.44 Frankfurt am Main, Germany, ASN54113 (FASTLY, US),
Reverse DNS
Software
nginx /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

x-vcl-time-ms
9
pragma
no-cache
date
Tue, 15 Dec 2020 12:45:39 GMT
via
1.1 varnish
server
nginx
x-timer
S1608036340.773183,VS0,VE9
x-served-by
cache-fra19144-FRA
x-cache
MISS
cache-control
no-cache, no-store
accept-ranges
bytes
content-length
0
x-cache-hits
0

Redirect headers

pragma
no-cache
date
Tue, 15 Dec 2020 12:45:39 GMT
server
AAWebServer
p3p
policyref="https://www.agkn.com/p3p/p3p.xml",CP="NOI NID"
location
https://trc.taboola.com/sg/neustar/1/cm?taboola_hm=164950303636000649678
cache-control
no-cache, no-store, must-revalidate
content-length
0
expires
0
32441
i6.liadm.com/s/ Frame DECF
Redirect Chain
  • https://i.liadm.com/s/32441?bidder_id=88068&bidder_uuid=81242381-ab73-4352-8bed-9e7099c82ee1-tuct6d23571
  • https://i.liadm.com/s/32441?bidder_id=88068&bidder_uuid=81242381-ab73-4352-8bed-9e7099c82ee1-tuct6d23571&_li_chk=true&previous_uuid=8626b73be29245099a3365d61c54f4a0
  • https://i6.liadm.com/s/32441?bidder_id=88068&bidder_uuid=81242381-ab73-4352-8bed-9e7099c82ee1-tuct6d23571
43 B
419 B
Image
General
Full URL
https://i6.liadm.com/s/32441?bidder_id=88068&bidder_uuid=81242381-ab73-4352-8bed-9e7099c82ee1-tuct6d23571
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
2600:1f18:444a:4680:1ed9:60e9:aafd:7d9f Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
Software
/
Resource Hash
caa849b179befa2645a8e2c474d2e82a76777a3305315ece911013e8ee9a916c
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains

Request headers

Referer
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Date
Tue, 15 Dec 2020 12:45:39 GMT
Cache-Control
no-store
Connection
keep-alive
Content-Length
43
Strict-Transport-Security
max-age=31536000; includeSubDomains
Content-Type
image/gif

Redirect headers

Location
https://i6.liadm.com/s/32441?bidder_id=88068&bidder_uuid=81242381-ab73-4352-8bed-9e7099c82ee1-tuct6d23571
Date
Tue, 15 Dec 2020 12:45:39 GMT
Connection
keep-alive
Content-Length
0
Strict-Transport-Security
max-age=31536000; includeSubDomains
/
pixel.onaudience.com/ Frame DECF
Redirect Chain
  • https://pixel.onaudience.com/?partner=137085097&mapped=81242381-ab73-4352-8bed-9e7099c82ee1-tuct6d23571
  • https://loada.exelator.com/load/?p=1164&g=1&j=r&ru=https%3A%2F%2Fpixel.onaudience.com%2F%3Fpartner%3D161%26icm%26mapped%3D%25%25UID%25%25
  • https://loada.exelator.com/load/?p=1164&g=1&j=r&ru=https%3A%2F%2Fpixel.onaudience.com%2F%3Fpartner%3D161%26icm%26mapped%3D%25%25UID%25%25&xl8blockcheck=1
  • https://pixel.onaudience.com/?partner=161&icm&mapped=9dc42152e8dc6248e072f0d3a3218ac8
35 B
248 B
Image
General
Full URL
https://pixel.onaudience.com/?partner=161&icm&mapped=9dc42152e8dc6248e072f0d3a3218ac8
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_128_GCM
Server
51.210.112.63 , France, ASN16276 (OVH, FR),
Reverse DNS
ns3174889.ip-51-210-112.eu
Software
/
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Referer
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

content-length
35
content-type
image/gif

Redirect headers

date
Tue, 15 Dec 2020 12:45:49 GMT
server
nginx
x-powered-by
Undertow/1
p3p
policyref=/w3c/p3p.xml, CP=NOI DSP COR NID CURa ADMa DEVa PSAa PSDa OUR BUS COM INT OTC PUR STA, policyref=/w3c/p3p.xml, CP=NOI DSP COR NID CURa ADMa DEVa PSAa PSDa OUR BUS COM INT OTC PUR STA
location
https://pixel.onaudience.com/?partner=161&icm&mapped=9dc42152e8dc6248e072f0d3a3218ac8
cache-control
no-cache
access-control-allow-credentials
true
content-type
text/html
content-length
0
getuidnb
ib.adnxs.com/ Frame DECF
43 B
693 B
Image
General
Full URL
https://ib.adnxs.com/getuidnb?https://sync.taboola.com/sg/appnexus-network/1/rtb-h/?taboola_hm=$UID&orig=trc
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_ECDSA, AES_128_GCM
Server
185.33.221.13 , Netherlands, ASN29990 (ASN-APPNEX, US),
Reverse DNS
729.bm-nginx-loadbalancer.mgmt.ams1.adnexus.net
Software
nginx/1.17.9 /
Resource Hash
4b5b6b15c6255109e06720cce42a06d3aead8b7874423d9c52cb0303212c25ef
Security Headers
Name Value
X-Xss-Protection 0

Request headers

Referer
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Pragma
no-cache
Date
Tue, 15 Dec 2020 12:45:38 GMT
X-Proxy-Origin
185.212.171.67; 185.212.171.67; 729.bm-nginx-loadbalancer.mgmt.ams1; *.adnxs.com; 185.33.222.236:80
AN-X-Request-Uuid
4a3e8594-bc41-487c-967c-68755b7dce8a
Server
nginx/1.17.9
P3P
policyref="http://cdn.adnxs.com/w3c/policy/p3p.xml", CP="NOI DSP COR ADM PSAo PSDo OURo SAMo UNRo OTRo BUS COM NAV DEM STA PRE"
Access-Control-Allow-Origin
*
Cache-Control
no-store, no-cache, private
Access-Control-Allow-Credentials
true
Connection
keep-alive
Content-Type
image/gif
Content-Length
43
X-XSS-Protection
0
Expires
Sat, 15 Nov 2008 16:00:00 GMT
/
trc.taboola.com/sg/google-network/1/rtb-h/ Frame DECF
Redirect Chain
  • https://cm.g.doubleclick.net/pixel?google_nid=taboola_dbm&google_cm&google_sc
  • https://trc.taboola.com/sg/google-network/1/rtb-h/?taboola_hm=CAESEOcJWVLnpHsl-ZO-woQlv5Y&google_cver=1
0
196 B
Image
General
Full URL
https://trc.taboola.com/sg/google-network/1/rtb-h/?taboola_hm=CAESEOcJWVLnpHsl-ZO-woQlv5Y&google_cver=1
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
151.101.13.44 Frankfurt am Main, Germany, ASN54113 (FASTLY, US),
Reverse DNS
Software
nginx /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

x-vcl-time-ms
9
date
Tue, 15 Dec 2020 12:45:38 GMT
via
1.1 varnish
server
nginx
x-timer
S1608036339.731373,VS0,VE9
x-cache
MISS
x-cache-hits
0
accept-ranges
bytes
content-length
0
x-served-by
cache-fra19144-FRA

Redirect headers

pragma
no-cache
date
Tue, 15 Dec 2020 12:45:38 GMT
server
HTTP server (unknown)
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
location
https://trc.taboola.com/sg/google-network/1/rtb-h/?taboola_hm=CAESEOcJWVLnpHsl-ZO-woQlv5Y&google_cver=1
cache-control
no-cache, must-revalidate
cross-origin-resource-policy
cross-origin
content-type
text/html; charset=UTF-8
alt-svc
h3-29="googleads.g.doubleclick.net:443"; ma=2592000,h3-29=":443"; ma=2592000,h3-T051="googleads.g.doubleclick.net:443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic="googleads.g.doubleclick.net:443"; ma=2592000; v="46,43",quic=":443"; ma=2592000; v="46,43"
content-length
304
x-xss-protection
0
expires
Fri, 01 Jan 1990 00:00:00 GMT
Pug
simage2.pubmatic.com/AdServer/ Frame DECF
42 B
1009 B
Image
General
Full URL
https://simage2.pubmatic.com/AdServer/Pug?vcode=bz0yJnR5cGU9MSZjb2RlPTM0MjcmdGw9MTI5NjAw&piggybackCookie=81242381-ab73-4352-8bed-9e7099c82ee1-tuct6d23571:$UID
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
185.64.190.80 , United Kingdom, ASN62713 (AS-PUBMATIC, US),
Reverse DNS
Software
Apache/2.2.24 (Unix) mod_ssl/2.2.24 OpenSSL/1.0.0-fips mod_fastcgi/2.4.6 /
Resource Hash
ef1955ae757c8b966c83248350331bd3a30f658ced11f387f8ebf05ab3368629

Request headers

Referer
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

X-Cnection
close
Pragma
no-cache
Date
Tue, 15 Dec 2020 12:45:38 GMT
X-lat
Pug23003:0:327
Server
Apache/2.2.24 (Unix) mod_ssl/2.2.24 OpenSSL/1.0.0-fips mod_fastcgi/2.4.6
P3P
CP="NOI DSP COR LAW CUR ADMo DEVo TAIo PSAo PSDo IVAo IVDo HISo OTPo OUR SAMo BUS UNI COM NAV INT DEM CNT STA PRE LOC", CP="NOI DSP COR LAW CUR ADMo DEVo TAIo PSAo PSDo IVAo IVDo HISo OTPo OUR SAMo BUS UNI COM NAV INT DEM CNT STA PRE LOC"
Cache-Control
no-store, no-cache, private
Content-Type
image/gif; charset=utf-8
Content-Length
42
csync.ashx
ml314.com/ Frame DECF
Redirect Chain
  • https://ml314.com/utsync.ashx?eid=50077&et=0&fp=81242381-ab73-4352-8bed-9e7099c82ee1-tuct6d23571&return=https%3a%2f%2fidsync.rlcdn.com%2f395886.gif%3fpartner_uid%3d%5bPersonID%5d
  • https://idsync.rlcdn.com/395886.gif?partner_uid=3615253808165159036
  • https://idsync.rlcdn.com/1000.gif?memo=CO6UGBIeChoIARCuXxoTMzYxNTI1MzgwODE2NTE1OTAzNhAAGg0I9t_i_gUSBQjoBxAAQgBKAA
  • https://ml314.com/csync.ashx?fp=1b141d853f9d3b173ea13075c620addcccb1639f6e0b7c9655daab11fda649fff4cb09cee1a4f8eb&person_id=3615253808165159036&eid=50082
43 B
312 B
Image
General
Full URL
https://ml314.com/csync.ashx?fp=1b141d853f9d3b173ea13075c620addcccb1639f6e0b7c9655daab11fda649fff4cb09cee1a4f8eb&person_id=3615253808165159036&eid=50082
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
34.251.167.52 Dublin, Ireland, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
Microsoft-IIS/10.0 / ASP.NET
Resource Hash
b1442e85b03bdcaf66dc58c7abb98745dd2687d86350be9a298a1d9382ac849b

Request headers

Referer
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Date
Tue, 15 Dec 2020 12:45:43 GMT
Server
Microsoft-IIS/10.0
X-AspNet-Version
4.0.30319
X-Powered-By
ASP.NET
Content-Type
image/gif
Cache-Control
private
Connection
keep-alive
Content-Length
43
Expires
Wed, 16 Dec 2020 07:45:44 GMT

Redirect headers

date
Tue, 15 Dec 2020 12:45:42 GMT
via
1.1 google
p3p
CP="NOI DSP COR NID CURa ADMa DEVa PSAa PSDa OUR BUS COM INT OTC PUR STA"
location
https://ml314.com/csync.ashx?fp=1b141d853f9d3b173ea13075c620addcccb1639f6e0b7c9655daab11fda649fff4cb09cee1a4f8eb&person_id=3615253808165159036&eid=50082
cache-control
no-cache, no-store
timing-allow-origin
*
alt-svc
clear
content-length
0
pixel
cm.g.doubleclick.net/ Frame DECF
Redirect Chain
  • https://sync.taboola.com/sg/google-network/1/rtb?redir=https%3A%2F%2Fcm.g.doubleclick.net%2Fpixel%3Fgoogle_nid%3Dtaboola_dbm%26google_sc%26gdpr%3D0%26gdpr_consent%3D&orig=trc
  • https://cm.g.doubleclick.net/pixel?google_nid=taboola_dbm&google_sc&gdpr=0&gdpr_consent=&google_hm=81242381-ab73-4352-8bed-9e7099c82ee1-tuct6d23571
170 B
201 B
Image
General
Full URL
https://cm.g.doubleclick.net/pixel?google_nid=taboola_dbm&google_sc&gdpr=0&gdpr_consent=&google_hm=81242381-ab73-4352-8bed-9e7099c82ee1-tuct6d23571
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:816::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
HTTP server (unknown) /
Resource Hash
0b8a20373c6dd04e091902226d922b3688143a8938afb9d283d889de7b55ceb5
Security Headers
Name Value
X-Xss-Protection 0

Request headers

Referer
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

pragma
no-cache
date
Tue, 15 Dec 2020 12:45:39 GMT
server
HTTP server (unknown)
content-type
image/png
cache-control
no-cache, must-revalidate
cross-origin-resource-policy
cross-origin
alt-svc
h3-29="googleads.g.doubleclick.net:443"; ma=2592000,h3-29=":443"; ma=2592000,h3-T051="googleads.g.doubleclick.net:443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic="googleads.g.doubleclick.net:443"; ma=2592000; v="46,43",quic=":443"; ma=2592000; v="46,43"
content-length
170
x-xss-protection
0
expires
Fri, 01 Jan 1990 00:00:00 GMT

Redirect headers

location
https://cm.g.doubleclick.net/pixel?google_nid=taboola_dbm&google_sc&gdpr=0&gdpr_consent=&google_hm=81242381-ab73-4352-8bed-9e7099c82ee1-tuct6d23571
tbl-x-upstream
10.40.20.14:10213
date
Tue, 15 Dec 2020 12:45:39 GMT
server
nginx
x-fastly-to-nlb-rtt
2006
/
trc.taboola.com/sg/thetradedesk-network/1/rtb-h/ Frame DECF
Redirect Chain
  • https://match.adsrvr.org/track/cmf/generic?ttd_pid=054f32o&ttd_tpi=1
  • https://match.adsrvr.org/track/cmb/generic?ttd_pid=054f32o&ttd_tpi=1
  • https://trc.taboola.com/sg/thetradedesk-network/1/rtb-h/?taboola_hm=c1befdb7-5c1a-4d0f-b053-b3ef508e7ce4
0
201 B
Image
General
Full URL
https://trc.taboola.com/sg/thetradedesk-network/1/rtb-h/?taboola_hm=c1befdb7-5c1a-4d0f-b053-b3ef508e7ce4
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
151.101.13.44 Frankfurt am Main, Germany, ASN54113 (FASTLY, US),
Reverse DNS
Software
nginx /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

x-vcl-time-ms
9
date
Tue, 15 Dec 2020 12:45:39 GMT
via
1.1 varnish
server
nginx
x-timer
S1608036339.154637,VS0,VE9
x-cache
MISS
x-cache-hits
0
accept-ranges
bytes
content-length
0
x-served-by
cache-fra19144-FRA

Redirect headers

pragma
no-cache
date
Tue, 15 Dec 2020 12:45:38 GMT
x-aspnet-version
4.0.30319
p3p
CP="NOI DSP COR CUR ADMo DEVo PSAo PSDo OUR SAMo BUS UNI NAV"
location
https://trc.taboola.com/sg/thetradedesk-network/1/rtb-h/?taboola_hm=c1befdb7-5c1a-4d0f-b053-b3ef508e7ce4
cache-control
private,no-cache, must-revalidate
content-type
text/html
content-length
239
merge
ce.lijit.com/ Frame DECF
Redirect Chain
  • https://ce.lijit.com/merge?pid=42&3pid=81242381-ab73-4352-8bed-9e7099c82ee1-tuct6d23571&us_privacy=&gdpr=0&gdpr_consent=
  • https://ce.lijit.com/merge?pid=42&3pid=81242381-ab73-4352-8bed-9e7099c82ee1-tuct6d23571&us_privacy=&gdpr=0&gdpr_consent=&dnr=1
0
433 B
Image
General
Full URL
https://ce.lijit.com/merge?pid=42&3pid=81242381-ab73-4352-8bed-9e7099c82ee1-tuct6d23571&us_privacy=&gdpr=0&gdpr_consent=&dnr=1
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_256_GCM
Server
72.251.249.14 Amsterdam, Netherlands, ASN29791 (VOXEL-DOT-NET, US),
Reverse DNS
Software
nginx / raptor
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Pragma
no-cache
Date
Tue, 15 Dec 2020 12:45:39 GMT
Server
nginx
X-Powered-By
raptor
P3P
CP="CUR ADM OUR NOR STA NID"
Cache-Control
private, no-cache, no-store, must-revalidate, proxy-revalidate, max-age=0, s-maxage=0
X-Sovrn-Pod
ad_ap1ams1
Expires
Fri, 20 Mar 2009 00:00:00 GMT

Redirect headers

Pragma
no-cache
Date
Tue, 15 Dec 2020 12:45:39 GMT
Server
nginx
X-Powered-By
raptor
P3P
CP="CUR ADM OUR NOR STA NID"
Location
https://ce.lijit.com/merge?pid=42&3pid=81242381-ab73-4352-8bed-9e7099c82ee1-tuct6d23571&us_privacy=&gdpr=0&gdpr_consent=&dnr=1
Cache-Control
private, no-cache, no-store, must-revalidate, proxy-revalidate, max-age=0, s-maxage=0
X-Sovrn-Pod
ad_ap1ams1
Content-Length
0
Expires
Fri, 20 Mar 2009 00:00:00 GMT
rtset
bh.contextweb.com/bh/ Frame DECF
49 B
333 B
Image
General
Full URL
https://bh.contextweb.com/bh/rtset?do=add&pid=553204&ev=81242381-ab73-4352-8bed-9e7099c82ee1-tuct6d23571
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
198.148.27.140 New York, United States, ASN19189 (PULSEPOINT, US),
Reverse DNS
Software
Jetty(9.4.14.v20181114) /
Resource Hash
d0409a1b73dab4e29dc40f92fb431fa9133baa23b4a1ffae4897f39068110e32
Security Headers
Name Value
Strict-Transport-Security max-age=15768000

Request headers

Referer
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

strict-transport-security
max-age=15768000
server
Jetty(9.4.14.v20181114)
content-language
en-US
p3p
policyref="/bh/w3c/p3p.xml", CP="NOI DSP COR NID CURa DEVa PSAa OUR BUS COM NAV INT"
cache-control
private, max-age=0, no-cache, no-store
content-type
image/gif;charset=iso-8859-1
cw-server
bh-deployment-659d447f4f-wq9dw
expires
-1
rtb-h
sync.taboola.com/sg/storygize-network/1/ Frame DECF
Redirect Chain
  • https://www.storygize.net/ccm/4b560cdd-91f9-422b-adb7-e9dff26bc3ad?u=81242381-ab73-4352-8bed-9e7099c82ee1-tuct6d23571
  • https://sync.taboola.com/sg/storygize-network/1/rtb-h?taboola_hm=37cf273d-6031-4a9e-b4c2-17b86d952301
0
226 B
Image
General
Full URL
https://sync.taboola.com/sg/storygize-network/1/rtb-h?taboola_hm=37cf273d-6031-4a9e-b4c2-17b86d952301
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
Protocol
H2
Security
TLS 1.2, ECDHE_ECDSA, AES_128_GCM
Server
141.226.228.48 , Netherlands, ASN200478 (TABOOLA-AS, IL),
Reverse DNS
Software
nginx /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

tbl-x-upstream
10.40.0.117:10213
date
Tue, 15 Dec 2020 12:45:43 GMT
server
nginx
x-fastly-to-nlb-rtt
1890

Redirect headers

Location
https://sync.taboola.com/sg/storygize-network/1/rtb-h?taboola_hm=37cf273d-6031-4a9e-b4c2-17b86d952301
Pragma
no-cache
cache-control
no-cache, no-store, must-revalidate
Connection
keep-alive
P3P
CP ALL ADM DEV PSAi COM OUR OTRo STP IND ONL
Content-Length
0
expires
0
/
rtb-csync.smartadserver.com/redir/ Frame DECF
43 B
697 B
Image
General
Full URL
https://rtb-csync.smartadserver.com/redir/?partnerid=107&partneruserid=81242381-ab73-4352-8bed-9e7099c82ee1-tuct6d23571&gdpr=0&gdpr_consent=
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_256_GCM
Server
185.86.139.89 , France, ASN201081 (SMARTADSERVER, FR),
Reverse DNS
Software
/
Resource Hash
89fe0ee6020314794fc2cfeacf3d10c31050cfe56f8ebddf1ed0a33fbe941fa7

Request headers

Referer
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

pragma
no-cache
date
Tue, 15 Dec 2020 12:45:39 GMT
cache-control
no-cache,no-store
content-type
image/gif
transfer-encoding
chunked
p3p
CP="BUS CUR CONo FIN IVDo ONL OUR PHY SAMo TELo"
sync
dsp.adkernel.com/ Frame DECF
42 B
233 B
Image
General
Full URL
https://dsp.adkernel.com/sync?exchange=281&r=%2F%2Fsync.taboola.com%2Fsg%2Fadkernelrtb-network%2F1%2Frtb-h%3Ftaboola_hm%3D%7BUID%7D
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
174.137.133.49 Garden City, United States, ASN27257 (WEBAIR-INTERNET, US),
Reverse DNS
Software
nginx /
Resource Hash
ef1955ae757c8b966c83248350331bd3a30f658ced11f387f8ebf05ab3368629

Request headers

Referer
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Pragma
no-cache
Date
Tue, 15 Dec 2020 12:45:39 GMT
Server
nginx
Age
0
Content-Type
image/gif
Cache-Control
no-store
Connection
keep-alive
Content-Length
42
put
e1.emxdgt.com/ Frame DECF
43 B
124 B
Image
General
Full URL
https://e1.emxdgt.com/put?d=d41&uid=81242381-ab73-4352-8bed-9e7099c82ee1-tuct6d23571
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
18.195.155.181 Frankfurt am Main, Germany, ASN16509 (AMAZON-02, US),
Reverse DNS
ec2-18-195-155-181.eu-central-1.compute.amazonaws.com
Software
/
Resource Hash
b1442e85b03bdcaf66dc58c7abb98745dd2687d86350be9a298a1d9382ac849b

Request headers

Referer
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:45:49 GMT
content-length
43
x-nosync
emp
content-type
image/gif
pixel.gif
sync.1dmp.io/ Frame DECF
Redirect Chain
  • https://sync.1dmp.io/pixel.gif?cid=bbd655c2-4912-4064-9036-7e0aec8fb8f2&brid=1ad3958e-57cd-4f58-80a2-9c478e047fdd&pid=w&uid=81242381-ab73-4352-8bed-9e7099c82ee1-tuct6d23571
  • https://sync.1dmp.io/pixel.gif?cid=bbd655c2-4912-4064-9036-7e0aec8fb8f2&brid=1ad3958e-57cd-4f58-80a2-9c478e047fdd&pid=w&uid=81242381-ab73-4352-8bed-9e7099c82ee1-tuct6d23571&cs=1
35 B
378 B
Image
General
Full URL
https://sync.1dmp.io/pixel.gif?cid=bbd655c2-4912-4064-9036-7e0aec8fb8f2&brid=1ad3958e-57cd-4f58-80a2-9c478e047fdd&pid=w&uid=81242381-ab73-4352-8bed-9e7099c82ee1-tuct6d23571&cs=1
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
88.99.214.77 Ludwigshafen am Rhein, Germany, ASN24940 (HETZNER-AS, DE),
Reverse DNS
Software
nginx /
Resource Hash
8337212354871836e6763a41e615916c89bac5b3f1f0adf60ba43c7c806e1015

Request headers

Referer
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:45:39 GMT
cache-control
private, no-cache, no-store, no-cache=Set-Cookie, proxy-revalidate
server
nginx
content-type
image/gif
content-length
35
expires
0

Redirect headers

location
/pixel.gif?cid=bbd655c2-4912-4064-9036-7e0aec8fb8f2&brid=1ad3958e-57cd-4f58-80a2-9c478e047fdd&pid=w&uid=81242381-ab73-4352-8bed-9e7099c82ee1-tuct6d23571&cs=1
date
Tue, 15 Dec 2020 12:45:39 GMT
cache-control
private, no-cache, no-store, no-cache=Set-Cookie, proxy-revalidate
server
nginx
content-length
0
expires
0
/
loadm.exelator.com/load/ Frame DECF
Redirect Chain
  • https://loadm.exelator.com/load/?p=204&g=1270&j=0&BUID=81242381-ab73-4352-8bed-9e7099c82ee1-tuct6d23571
  • https://loadm.exelator.com/load/?p=204&g=1270&j=0&BUID=81242381-ab73-4352-8bed-9e7099c82ee1-tuct6d23571&xl8blockcheck=1
0
755 B
Image
General
Full URL
https://loadm.exelator.com/load/?p=204&g=1270&j=0&BUID=81242381-ab73-4352-8bed-9e7099c82ee1-tuct6d23571&xl8blockcheck=1
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
147.75.102.200 Central, Hong Kong, ASN54825 (PACKET, US),
Reverse DNS
Software
nginx / Undertow/1
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:45:42 GMT
cache-control
no-cache
access-control-allow-credentials
true
server
nginx
x-powered-by
Undertow/1
p3p
policyref=/w3c/p3p.xml, CP=NOI DSP COR NID CURa ADMa DEVa PSAa PSDa OUR BUS COM INT OTC PUR STA, policyref=/w3c/p3p.xml, CP=NOI DSP COR NID CURa ADMa DEVa PSAa PSDa OUR BUS COM INT OTC PUR STA

Redirect headers

date
Tue, 15 Dec 2020 12:45:42 GMT
server
nginx
x-powered-by
Undertow/1
p3p
policyref=/w3c/p3p.xml, CP=NOI DSP COR NID CURa ADMa DEVa PSAa PSDa OUR BUS COM INT OTC PUR STA, policyref=/w3c/p3p.xml, CP=NOI DSP COR NID CURa ADMa DEVa PSAa PSDa OUR BUS COM INT OTC PUR STA
location
https://loadm.exelator.com/load/?p=204&g=1270&j=0&BUID=81242381-ab73-4352-8bed-9e7099c82ee1-tuct6d23571&xl8blockcheck=1
cache-control
no-cache
access-control-allow-credentials
true
content-type
image/gif
content-length
0
/
sync-t1.taboola.com/sg/criteortb-network/1/rtb-h/ Frame DECF
Redirect Chain
  • https://dis.criteo.com/dis/usersync.aspx?r=29&p=282&cp=taboolaortb&cu=1&url=https%3A%2F%2Fsync-t1.taboola.com%2Fsg%2Fcriteortb-network%2F1%2Frtb-h%2F%3Ftaboola_hm%3D%40%40CRITEO_USERID%40%40
  • https://sync-t1.taboola.com/sg/criteortb-network/1/rtb-h/?taboola_hm=c851c1a0-a35b-4d6a-ada8-ff9a540db409
0
225 B
Image
General
Full URL
https://sync-t1.taboola.com/sg/criteortb-network/1/rtb-h/?taboola_hm=c851c1a0-a35b-4d6a-ada8-ff9a540db409
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
Protocol
H2
Security
TLS 1.2, ECDHE_ECDSA, AES_128_GCM
Server
141.226.228.48 , Netherlands, ASN200478 (TABOOLA-AS, IL),
Reverse DNS
Software
nginx /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

tbl-x-upstream
10.40.20.11:10213
date
Tue, 15 Dec 2020 12:45:40 GMT
server
nginx
x-fastly-to-nlb-rtt
1919

Redirect headers

pragma
no-cache
x-errorlevel
0
date
Tue, 15 Dec 2020 12:45:40 GMT
p3p
CP="NON DSP COR CURa PSA PSD OUR BUS NAV STA"
location
https://sync-t1.taboola.com/sg/criteortb-network/1/rtb-h/?taboola_hm=c851c1a0-a35b-4d6a-ada8-ff9a540db409
cache-control
no-cache
server-processing-duration-in-ticks
1853
content-type
text/html; charset=utf-8
content-length
222
expires
Tue, 15 Dec 2020 00:00:00 GMT
mw
mwzeom.zeotap.com/ Frame DECF
95 B
306 B
Image
General
Full URL
https://mwzeom.zeotap.com/mw?zpartnerid=1412&env=mWeb&cid=995820094a5c1a48944f0d15e93202719fb4c27c370e6294c695d9967efe84d9&gdpr=$0&gdpr_consent=$
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:10::6816:1857 , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
3eb10792d1f0c7e07e7248273540f1952d9a5a2996f4b5df70ab026cd9f05517

Request headers

Referer
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:45:40 GMT
via
1.1 google
cf-cache-status
DYNAMIC
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
content-type
image/png
access-control-allow-origin
*
access-control-allow-credentials
true
cf-ray
60204353097a16f2-FRA
access-control-allow-headers
*
content-length
95
cf-request-id
07080867e9000016f2f33cd000000001
tap.php
pixel.rubiconproject.com/ Frame DECF
Redirect Chain
  • https://id5-sync.com/s/464/9.gif?puid=81242381-ab73-4352-8bed-9e7099c82ee1-tuct6d23571&gdpr=0&gdpr_consent=&callback=https%3A%2F%2Fsync.taboola.com%2Fsg%2Fid5-network%2F1%2Frtb-h%2F%3Ftaboola_hm%3D...
  • https://pixel.tapad.com/idsync/ex/push?partner_id=2922&partner_url=https%3A%2F%2Fid5-sync.com%2Fc%2F464%2F108%2F6%2F2.gif%3Fpuid%3D%24%7BTA_DEVICE_ID%7D%26gdpr%3D1%26gdpr_consent%3D&gdpr=1&gdpr_con...
  • https://id5-sync.com/c/464/108/6/2.gif?puid=6fb9c801-3ed3-11eb-b7db-6e8555c96cc6&gdpr=1&gdpr_consent=
  • https://uipglob.semasio.net/id5/1/get?gdpr=1&gdpr_consent=&_url=https%3A%2F%2Fid5-sync.com%2Fc%2F464%2F112%2F5%2F3.gif%3Fpuid%3D%24%7BUIPID%7D%26gdpr%3D1%26gdpr_consent%3D
  • https://uipglob.semasio.net/id5/1/get2?gdpr=1&gdpr_consent=&_url=https%3A%2F%2Fid5-sync.com%2Fc%2F464%2F112%2F5%2F3.gif%3Fpuid%3D%24%7BUIPID%7D%26gdpr%3D1%26gdpr_consent%3D
  • https://id5-sync.com/c/464/112/5/3.gif?puid=620A8F54E31F2C38&gdpr=1&gdpr_consent=
  • https://ads.avocet.io/getuid?url=https%3A%2F%2Fid5-sync.com%2Fc%2F464%2F146%2F4%2F4.gif%3Fpuid%3D%7B%7BUUID%7D%7D%26gdpr%3D1%26gdpr_consent%3D
  • https://ads.avct.cloud/getuid?r=1&url=https%3A%2F%2Fid5-sync.com%2Fc%2F464%2F146%2F4%2F4.gif%3Fpuid%3D%7B%7BUUID%7D%7D%26gdpr%3D1%26gdpr_consent%3D
  • https://id5-sync.com/c/464/146/4/4.gif?puid=11f3923d-c6d0-4798-93e0-b14556a89c0a&gdpr=1&gdpr_consent=
  • https://sync.crwdcntrl.net/map/c=2831/tp=GDMP?https://cm.g.doubleclick.net/pixel?google_nid=lotame_dmp&google_hm=${base64_profileid}&google_redir=https%3A%2F%2Fid5-sync.com%2Fc%2F464%2F398%2F3%2F5....
  • https://cm.g.doubleclick.net/pixel?google_nid=lotame_dmp&google_hm=OTYwYWEyYzIyNzNmNmI0OTI5NThmOTZkMzZiZjYzMDQ&google_redir=https://id5-sync.com/c/464/398/3/5.gif?puid=OTYwYWEyYzIyNzNmNmI0OTI5NThmO...
  • https://id5-sync.com/c/464/398/3/5.gif?puid=OTYwYWEyYzIyNzNmNmI0OTI5NThmOTZkMzZiZjYzMDQ&gdpr=1&gdpr_consent=
  • https://rtb.gumgum.com/getuid/id5?r=https%3A%2F%2Fid5-sync.com%2Fc%2F464%2F441%2F2%2F6.gif%3Fpuid%3D%5BUID%5D%26gdpr%3D1%26gdpr_consent%3D&gdpr=1&gdpr_consent=
  • https://id5-sync.com/c/464/441/2/6.gif?puid=e_ff9d8ba4-bd30-4ba3-976b-aa6278778f22&gdpr=1&gdpr_consent=
  • https://dpm.demdex.net/ibs:dpid=121998&dpuuid=960aa2c2273f6b492958f96d36bf6304&redir=https%3A%2F%2Fid5-sync.com%2Fc%2F464%2F485%2F1%2F7.gif%3Fpuid%3D%24%7BDD_UUID%7D%26gdpr%3D1%26gdpr_consent%3D&gd...
  • https://id5-sync.com/c/464/485/1/7.gif?puid=02429134991296611824265187627393430398&gdpr=1&gdpr_consent=
  • https://pixel.rubiconproject.com/tap.php?v=16829&nid=2820&put=ID5-ZHMOqMhJTrldgGJIBsru2iINA62VBTrOOYCHIcZtjg
0
239 B
Image
General
Full URL
https://pixel.rubiconproject.com/tap.php?v=16829&nid=2820&put=ID5-ZHMOqMhJTrldgGJIBsru2iINA62VBTrOOYCHIcZtjg
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
Protocol
HTTP/1.1
Security
TLS 1.2, RSA, AES_256_GCM
Server
69.173.144.139 Frankfurt am Main, Germany, ASN26667 (RUBICONPROJECT, US),
Reverse DNS
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Pragma
no-cache
Expires
0
Cache-Control
no-cache,no-store,must-revalidate
P3P
CP="NOI CURa ADMa DEVa TAIa OUR BUS IND UNI COM NAV INT"
X-RPHost
4cdacfaa68e4ab216fffbcc107c5b898
Content-Type
image/gif

Redirect headers

Location
https://pixel.rubiconproject.com/tap.php?v=16829&nid=2820&put=ID5-ZHMOqMhJTrldgGJIBsru2iINA62VBTrOOYCHIcZtjg
Date
Tue, 15 Dec 2020 12:45:48 GMT
Transfer-Encoding
chunked
Strict-Transport-Security
max-age=63072000; includeSubDomains; preload
P3P
CP="CAO PSA OUR"
rtb-h
sync.taboola.com/sg/appierrtb-network/1/ Frame DECF
Redirect Chain
  • https://s.c.appier.net/taboola
  • https://sync.taboola.com/sg/appierrtb-network/1/rtb-h?taboola_hm=zKys0U2RDk6MekcJ9K_YXw
0
216 B
Image
General
Full URL
https://sync.taboola.com/sg/appierrtb-network/1/rtb-h?taboola_hm=zKys0U2RDk6MekcJ9K_YXw
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
Protocol
H2
Security
TLS 1.2, ECDHE_ECDSA, AES_128_GCM
Server
141.226.228.48 , Netherlands, ASN200478 (TABOOLA-AS, IL),
Reverse DNS
Software
nginx /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

tbl-x-upstream
10.40.0.117:10213
date
Tue, 15 Dec 2020 12:45:41 GMT
server
nginx
x-fastly-to-nlb-rtt
1909

Redirect headers

location
https://sync.taboola.com/sg/appierrtb-network/1/rtb-h?taboola_hm=zKys0U2RDk6MekcJ9K_YXw
date
Tue, 15 Dec 2020 12:45:40 GMT
cache-control
no-store
server
nginx
content-type
text/html; charset=utf-8
content-length
110
p3p
CP="CUR ADM DEV TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
sync
ups.analytics.yahoo.com/ups/55973/ Frame DECF
Redirect Chain
  • https://pixel.advertising.com/ups/55973/sync?uid=81242381-ab73-4352-8bed-9e7099c82ee1-tuct6d23571&_origin=1
  • https://pixel.advertising.com/ups/55973/sync?uid=81242381-ab73-4352-8bed-9e7099c82ee1-tuct6d23571&_origin=1&verify=true
  • https://ups.analytics.yahoo.com/ups/55973/sync?uid=81242381-ab73-4352-8bed-9e7099c82ee1-tuct6d23571&_origin=1&apid=UP706d39db-3ed3-11eb-92c6-02d43f703412
0
964 B
Image
General
Full URL
https://ups.analytics.yahoo.com/ups/55973/sync?uid=81242381-ab73-4352-8bed-9e7099c82ee1-tuct6d23571&_origin=1&apid=UP706d39db-3ed3-11eb-92c6-02d43f703412
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_256_GCM
Server
18.156.0.31 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
ec2-18-156-0-31.eu-central-1.compute.amazonaws.com
Software
ATS/7.1.2.128 /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
Strict-Transport-Security max-age=31536000

Request headers

Referer
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Date
Tue, 15 Dec 2020 12:45:43 GMT
Server
ATS/7.1.2.128
Connection
keep-alive
Age
0
Strict-Transport-Security
max-age=31536000
P3P
CP=NOI DSP COR LAW CURa DEVa TAIa PSAa PSDa OUR BUS UNI COM NAV

Redirect headers

location
https://ups.analytics.yahoo.com/ups/55973/sync?uid=81242381-ab73-4352-8bed-9e7099c82ee1-tuct6d23571&_origin=1&apid=UP706d39db-3ed3-11eb-92c6-02d43f703412
date
Tue, 15 Dec 2020 12:45:41 GMT
content-length
0
strict-transport-security
max-age=31536000
p3p
CP=NOI DSP COR LAW CURa DEVa TAIa PSAa PSDa OUR BUS UNI COM NAV
cookiesync
bttrack.com/pixel/ Frame DECF
35 B
380 B
Image
General
Full URL
https://bttrack.com/pixel/cookiesync?source=14b8c562-d12b-418b-b680-ad517d5839ec
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
Protocol
HTTP/1.1
Security
TLS 1.2, RSA, AES_256_GCM
Server
192.132.33.46 , United States, ASN18568 (BIDTELLECT, US),
Reverse DNS
46.bidtellect.com
Software
Microsoft-IIS/8.5 /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Referer
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

X-ServerName
Track001-dc3
Pragma
no-cache
Date
Tue, 15 Dec 2020 12:45:41 GMT
X-AspNetMvc-Version
5.2
Server
Microsoft-IIS/8.5
X-AspNet-Version
4.0.30319
P3P
CP="CAO DSP COR ADMo DEVo PSAo PSDo HISo IVAo IVDo OUR IND OTC"
Cache-Control
private,no-cache
Content-Type
image/gif
Content-Length
35
Expires
-1
/
cds.taboola.com/ Frame DECF
0
155 B
Image
General
Full URL
https://cds.taboola.com/?uid=81242381-ab73-4352-8bed-9e7099c82ee1-tuct6d23571&_r=4436347
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_ECDSA, AES_128_GCM
Server
141.226.224.32 , United States, ASN200478 (TABOOLA-AS, IL),
Reverse DNS
Software
nginx /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Access-Control-Allow-Origin
*
Date
Tue, 15 Dec 2020 12:45:43 GMT
Cache-Control
no-store
Server
nginx
Connection
close
rtb-h
sync-t1.taboola.com/sg/bidswitch-network/1/ Frame DECF
Redirect Chain
  • https://x.bidswitch.net/sync?ssp=taboola&gdpr=0&gdpr_consent=
  • https://ads.betweendigital.com/match?bidder_id=43092&callback_url=https%3A%2F%2Fx.bidswitch.net%2Fsync%3Fdsp_id%3D429%26user_id%3D%24%7BUSER_ID%7D%26ssp%3Dtaboola%26expires%3D30%26user_group%3D%24%...
  • https://ads.betweendigital.com/match?bidder_id=43092&callback_url=https%3A%2F%2Fx.bidswitch.net%2Fsync%3Fdsp_id%3D429%26user_id%3D%24%7BUSER_ID%7D%26ssp%3Dtaboola%26expires%3D30%26user_group%3D%24%...
  • https://x.bidswitch.net/sync?dsp_id=429&user_id=1c93d881-2f55-525e-9eb7-0aafc16fa558&ssp=taboola&expires=30&user_group=1
  • https://sync-t1.taboola.com/sg/bidswitch-network/1/rtb-h?taboola_hm=c374b576-af0f-4001-86dd-ddc2d8f91de1
0
226 B
Image
General
Full URL
https://sync-t1.taboola.com/sg/bidswitch-network/1/rtb-h?taboola_hm=c374b576-af0f-4001-86dd-ddc2d8f91de1
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
Protocol
H2
Security
TLS 1.2, ECDHE_ECDSA, AES_128_GCM
Server
141.226.228.48 , Netherlands, ASN200478 (TABOOLA-AS, IL),
Reverse DNS
Software
nginx /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

tbl-x-upstream
10.40.20.14:10213
date
Tue, 15 Dec 2020 12:45:43 GMT
server
nginx
x-fastly-to-nlb-rtt
1868

Redirect headers

location
//sync-t1.taboola.com/sg/bidswitch-network/1/rtb-h?taboola_hm=c374b576-af0f-4001-86dd-ddc2d8f91de1
date
Tue, 15 Dec 2020 12:45:43 GMT
cache-control
no-cache, no-store, must-revalidate
content-length
0
p3p
CP="NOI DSP COR NID CURa ADMa DEVa PSAa PSDa OUR BUS COM INT OTC PUR STA"
abtests
trc.taboola.com/dailymail-row/log/3/
0
241 B
Image
General
Full URL
https://trc.taboola.com/dailymail-row/log/3/abtests?route=AM:AM:V&lti=deflated&ri=20dccde5e5f66e09052b97b4a9fd6921&sd=v2_dd4d66c38ae1b97cdc5b7b1dc3632300_81242381-ab73-4352-8bed-9e7099c82ee1-tuct6d23571_1608036337_1608036337_CNawjgYQ-4w9GNeLvbPmLiABKAQwoQE4l-oLQJWXEEj-0toDUP___________wFYAGAAaOKmqpGyrZficA&ui=81242381-ab73-4352-8bed-9e7099c82ee1-tuct6d23571&pi=/sciencetech/article-9050821/remdesivir-beneficial-patients-doctors-reveal.html&wi=3375619910924715558&pt=text&vi=1608036337111&d=%7B%22abTestsEventType%22%3A%22simple%22%2C%22name%22%3A%22DEDUP_DEBUG%22%2C%22type%22%3A%22true%22%2C%22eventTime%22%3A1608036338533%7D&tim=13%3A45%3A38.534&id=3656&llvl=1&cv=20201214-6-RELEASE&
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
151.101.13.44 Frankfurt am Main, Germany, ASN54113 (FASTLY, US),
Reverse DNS
Software
nginx /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

x-vcl-time-ms
9
pragma
no-cache
date
Tue, 15 Dec 2020 12:45:43 GMT
via
1.1 varnish
server
nginx
x-timer
S1608036343.082211,VS0,VE9
x-served-by
cache-fra19144-FRA
x-cache
MISS
p3p
policyref="http://trc.taboola.com/p3p.xml", CP="NOI DSP COR LAW NID CURa ADMa DEVa PSAa PSDa OUR BUS IND UNI COM NAV INT DEM"
access-control-allow-origin
*
cache-control
no-cache
access-control-allow-credentials
true
accept-ranges
bytes
content-type
image/gif
x-cache-hits
0
debug
trc-events.taboola.com/dailymail-row/log/2/
0
275 B
Image
General
Full URL
https://trc-events.taboola.com/dailymail-row/log/2/debug?tim=13%3A45%3A38.534&type=warn&msg=Duplicated%20items%20monitoring%20enabled&id=688&cv=20201214-6-RELEASE&lt=deflated&pcs=%5Bdata-feed-main-container-id%3D%22taboola-below-article-thumbnails%22%5D&vi=1608036337111
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
Protocol
H2
Security
TLS 1.2, ECDHE_ECDSA, AES_128_GCM
Server
141.226.228.48 , Netherlands, ASN200478 (TABOOLA-AS, IL),
Reverse DNS
Software
nginx /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

pragma
no-cache
date
Tue, 15 Dec 2020 12:45:43 GMT
server
nginx
x-fastly-to-nlb-rtt
1881
p3p
policyref="http://trc.taboola.com/p3p.xml", CP="NOI DSP COR LAW NID CURa ADMa DEVa PSAa PSDa OUR BUS IND UNI COM NAV INT DEM"
access-control-allow-origin
*
cache-control
no-cache
access-control-allow-credentials
true
tbl-x-upstream
10.41.30.18:10213
24015022-35ce-4454-8c00-dfee1989ffa1.png
cdn.taboola.com/static/24/
2 KB
2 KB
Image
General
Full URL
https://cdn.taboola.com/static/24/24015022-35ce-4454-8c00-dfee1989ffa1.png
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
151.101.13.44 Frankfurt am Main, Germany, ASN54113 (FASTLY, US),
Reverse DNS
Software
AmazonS3 /
Resource Hash
53eeac6afb74c6a3b1aca65c7ec44883268d44023b4565eccdd8ee5a68db4e63

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

x-amz-version-id
UbzmkdKVxR2hexvCtEoBTeEkUjPghW4t
via
1.1 varnish
etag
"ebe314a8ee4abde6826bbe25039672bb"
age
7254
x-cache
HIT
x-amz-replication-status
COMPLETED
content-length
1644
x-amz-id-2
nli5miVdAU6/Vl/efztVyviOjBTkFyTokNBiHIbc2pn+UJkcc+SDt2wi8hG+goplrv20hLxC7MY=
x-served-by
cache-fra19144-FRA
last-modified
Sun, 18 Mar 2018 11:55:49 GMT
server
AmazonS3
x-timer
S1608036343.113599,VS0,VE0
date
Tue, 15 Dec 2020 12:45:43 GMT
x-amz-request-id
5879D2F0DF068D76
cache-control
private,max-age=31536000
accept-ranges
bytes
content-type
image/png
abp
94
x-cache-hits
74
debug
trc-events.taboola.com/dailymail-row/log/2/
0
275 B
Image
General
Full URL
https://trc-events.taboola.com/dailymail-row/log/2/debug?tim=13%3A45%3A38.595&type=info&msg=Load%20publisher%20card%3A%20most%20watched%20videos%20on%20Card%3A%209%20with%20the%20anchor%20element%20selector%3A%20%23most-watched-videos-lazy-container%20succeed&id=6814&cv=20201214-6-RELEASE&lt=deflated&idx=pc&pc=most%20watched%20videos&st=1
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
Protocol
H2
Security
TLS 1.2, ECDHE_ECDSA, AES_128_GCM
Server
141.226.228.48 , Netherlands, ASN200478 (TABOOLA-AS, IL),
Reverse DNS
Software
nginx /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

pragma
no-cache
date
Tue, 15 Dec 2020 12:45:43 GMT
server
nginx
x-fastly-to-nlb-rtt
1871
p3p
policyref="http://trc.taboola.com/p3p.xml", CP="NOI DSP COR LAW NID CURa ADMa DEVa PSAa PSDa OUR BUS IND UNI COM NAV INT DEM"
access-control-allow-origin
*
cache-control
no-cache
access-control-allow-credentials
true
tbl-x-upstream
10.41.24.10:10213
d65c91689ac388ce4d81a754ce7bb1d7.jpeg
images.taboola.com/taboola/image/fetch/f_jpg%2Cq_auto%2Ch_217%2Cw_260%2Cc_fill%2Cg_faces:auto%2Ce_sharpen/http%3A//cdn.taboola.com/libtrc/static/thumbnails/
7 KB
7 KB
Image
General
Full URL
https://images.taboola.com/taboola/image/fetch/f_jpg%2Cq_auto%2Ch_217%2Cw_260%2Cc_fill%2Cg_faces:auto%2Ce_sharpen/http%3A//cdn.taboola.com/libtrc/static/thumbnails/d65c91689ac388ce4d81a754ce7bb1d7.jpeg
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
151.101.13.44 Frankfurt am Main, Germany, ASN54113 (FASTLY, US),
Reverse DNS
Software
cloudinary /
Resource Hash
3fe39aed0eba0e7239c3c403500ea8ef630d600a32e1af36fc893685e2f4e686

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

x-vcl-time-ms
1
date
Tue, 15 Dec 2020 12:45:43 GMT
via
1.1 varnish, 1.1 varnish, 1.1 varnish
age
502461
edge-cache-tag
473893535715853526307896963127861640653,534554604223319601008643105194670925976,29ecf9b93bbf306179626feeda1fab70
expiration
expiry-date="Mon, 21 Dec 2020 00:00:00 GMT", rule-id="delete fetch for taboola after 30 days"
x-cache
MISS, HIT, HIT
x-debug
/taboola/image/fetch/f_jpg%2Cq_auto%2Ch_217%2Cw_260%2Cc_fill%2Cg_faces:auto%2Ce_sharpen/http%3A//cdn.taboola.com/libtrc/static/thumbnails/d65c91689ac388ce4d81a754ce7bb1d7.jpeg
content-length
6955
x-served-by
cache-dca17729-DCA, cache-dca17733-DCA, cache-fra19144-FRA
last-modified
Fri, 20 Nov 2020 00:30:59 GMT
server
cloudinary
x-timer
S1608036343.136210,VS0,VE1
etag
"ed9474eec27ef8a14d39ffabecfbb44f"
content-type
image/jpeg
access-control-allow-origin
*
cache-control
public, max-age=7776000
accept-ranges
bytes
timing-allow-origin
*
access-control-allow-headers
X-Requested-With
x-cache-hits
0, 1, 1
5fef3c3f720f1d7e70a7d84d75c0cc1f.jpg
images.taboola.com/taboola/image/fetch/f_jpg%2Cq_auto%2Ch_217%2Cw_260%2Cc_fill%2Cg_faces:auto%2Ce_sharpen/http%3A//cdn.taboola.com/libtrc/static/thumbnails/
26 KB
26 KB
Image
General
Full URL
https://images.taboola.com/taboola/image/fetch/f_jpg%2Cq_auto%2Ch_217%2Cw_260%2Cc_fill%2Cg_faces:auto%2Ce_sharpen/http%3A//cdn.taboola.com/libtrc/static/thumbnails/5fef3c3f720f1d7e70a7d84d75c0cc1f.jpg
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
151.101.13.44 Frankfurt am Main, Germany, ASN54113 (FASTLY, US),
Reverse DNS
Software
cloudinary /
Resource Hash
73820201feaab591b2bf1dd253c703b3683fbd93a242de9428ef9298bd7c214e

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

x-vcl-time-ms
1
date
Tue, 15 Dec 2020 12:45:43 GMT
via
1.1 varnish, 1.1 varnish, 1.1 varnish
age
425410
edge-cache-tag
525204815285266847788106457305215901031,534554604223319601008643105194670925976,29ecf9b93bbf306179626feeda1fab70
expiration
expiry-date="Wed, 06 Jan 2021 00:00:00 GMT", rule-id="delete fetch for taboola after 30 days"
x-cache
MISS, HIT, HIT
x-debug
/taboola/image/fetch/f_jpg%2Cq_auto%2Ch_217%2Cw_260%2Cc_fill%2Cg_faces:auto%2Ce_sharpen/http%3A//cdn.taboola.com/libtrc/static/thumbnails/5fef3c3f720f1d7e70a7d84d75c0cc1f.jpg
content-length
26394
x-served-by
cache-dca17762-DCA, cache-dca17767-DCA, cache-fra19144-FRA
last-modified
Sun, 06 Dec 2020 10:34:12 GMT
server
cloudinary
x-timer
S1608036343.136399,VS0,VE1
etag
"5a76944542d0447e0c9468ad7379952f"
content-type
image/jpeg
access-control-allow-origin
*
cache-control
public, max-age=7776000
accept-ranges
bytes
timing-allow-origin
*
access-control-allow-headers
X-Requested-With
x-cache-hits
0, 1, 1
7ebfcf635f049fdd1e2db17716b4545f.jpg
images.taboola.com/taboola/image/fetch/f_jpg%2Cq_auto%2Ch_217%2Cw_260%2Cc_fill%2Cg_faces:auto%2Ce_sharpen/http%3A//cdn.taboola.com/libtrc/static/thumbnails/
9 KB
9 KB
Image
General
Full URL
https://images.taboola.com/taboola/image/fetch/f_jpg%2Cq_auto%2Ch_217%2Cw_260%2Cc_fill%2Cg_faces:auto%2Ce_sharpen/http%3A//cdn.taboola.com/libtrc/static/thumbnails/7ebfcf635f049fdd1e2db17716b4545f.jpg
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
151.101.13.44 Frankfurt am Main, Germany, ASN54113 (FASTLY, US),
Reverse DNS
Software
cloudinary /
Resource Hash
8a6e83bad97f771cd82dd5701f3431bc6af9fc3588f08468587cb1c74136d4d7

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

x-vcl-time-ms
1
date
Tue, 15 Dec 2020 12:45:43 GMT
via
1.1 varnish, 1.1 varnish, 1.1 varnish
age
2262091
edge-cache-tag
331711549794897893656263709331011895765,534554604223319601008643105194670925976,29ecf9b93bbf306179626feeda1fab70
expiration
expiry-date="Sun, 22 Nov 2020 00:00:00 GMT", rule-id="delete fetch for taboola after 30 days"
x-cache
MISS, HIT, HIT
x-debug
/taboola/image/fetch/f_jpg%2Cq_auto%2Ch_217%2Cw_260%2Cc_fill%2Cg_faces:auto%2Ce_sharpen/http%3A//cdn.taboola.com/libtrc/static/thumbnails/7ebfcf635f049fdd1e2db17716b4545f.jpg
content-length
8721
x-served-by
cache-dca17753-DCA, cache-dca17764-DCA, cache-fra19144-FRA
last-modified
Thu, 22 Oct 2020 12:51:58 GMT
server
cloudinary
x-timer
S1608036343.159869,VS0,VE1
etag
"e7c6ea3197bfb5934c70c42dd5fcb8a7"
content-type
image/jpeg
access-control-allow-origin
*
cache-control
public, max-age=7776000
accept-ranges
bytes
timing-allow-origin
*
access-control-allow-headers
X-Requested-With
x-cache-hits
0, 1, 1
tbp
15.taboola.com/
7 KB
3 KB
Script
General
Full URL
https://15.taboola.com/tbp?oid=15&pubid=166277&tagid=948107&pstn=[pstn]&cb=[cb]&callback=TRC.pVideoCallbacks.videoCallback1
Requested by
Host: cdn.taboola.com
URL: https://cdn.taboola.com/libtrc/impl.20201214-6-RELEASE.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
151.101.13.44 Frankfurt am Main, Germany, ASN54113 (FASTLY, US),
Reverse DNS
Software
nginx /
Resource Hash
9bbed73028ae543c1ac09f3da15317426bcb62904c6b467c1753e9eaae349bc4

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

pragma
no-cache
date
Tue, 15 Dec 2020 12:45:43 GMT
content-encoding
gzip
server
nginx
x-timer
S1608036343.160713,VS0,VE26
machineid
1417
vary
Accept-Encoding
x-cache
MISS
content-type
text/html;charset=ISO-8859-1
via
1.1 varnish
expires
Sat, 26 Jul 1997 05:00:00 GMT
cache-control
no-cache,must-revalidate,no-store,max-age=0,s-maxage=0
x-cache-hits
0
accept-ranges
bytes
x-served-by
cache-fra19144-FRA
6b68fbc8ae3631ec48f097384495ad59.jpg
images.taboola.com/taboola/image/fetch/f_jpg%2Cq_auto%2Ch_380%2Cw_760%2Cc_fill%2Cg_faces:auto%2Ce_sharpen/http%3A//cdn.taboola.com/libtrc/static/thumbnails/
64 KB
65 KB
Image
General
Full URL
https://images.taboola.com/taboola/image/fetch/f_jpg%2Cq_auto%2Ch_380%2Cw_760%2Cc_fill%2Cg_faces:auto%2Ce_sharpen/http%3A//cdn.taboola.com/libtrc/static/thumbnails/6b68fbc8ae3631ec48f097384495ad59.jpg
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
151.101.13.44 Frankfurt am Main, Germany, ASN54113 (FASTLY, US),
Reverse DNS
Software
cloudinary /
Resource Hash
f2de579375a03b06357be7d5b1d80a41010e84e6f38f7922b32dacb3a22edcc8

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

x-vcl-time-ms
0
date
Tue, 15 Dec 2020 12:45:43 GMT
via
1.1 varnish, 1.1 varnish, 1.1 varnish
age
821589
edge-cache-tag
327488782157785223649913794111829872760,575325974753229111106645491868203992126,29ecf9b93bbf306179626feeda1fab70
expiration
expiry-date="Sun, 13 Dec 2020 00:00:00 GMT", rule-id="delete fetch for taboola after 30 days"
x-cache
MISS, HIT, HIT
x-debug
/taboola/image/fetch/f_jpg%2Cq_auto%2Ch_380%2Cw_760%2Cc_fill%2Cg_faces:auto%2Ce_sharpen/http%3A//cdn.taboola.com/libtrc/static/thumbnails/6b68fbc8ae3631ec48f097384495ad59.jpg
content-length
65800
x-served-by
cache-dca17724-DCA, cache-dca17723-DCA, cache-fra19144-FRA
last-modified
Thu, 12 Nov 2020 08:43:19 GMT
server
cloudinary
x-timer
S1608036343.183241,VS0,VE0
etag
"a9380099bebb90a302552bc1aac9ba13"
content-type
image/jpeg
access-control-allow-origin
*
cache-control
public, max-age=7776000
accept-ranges
bytes
timing-allow-origin
*
access-control-allow-headers
X-Requested-With
x-cache-hits
0, 1, 3
36866806-0-image-a-292_1608034324849.jpg
images.taboola.com/taboola/image/fetch/f_jpg%2Cq_auto%2Ch_380%2Cw_760%2Cc_fill%2Cg_faces:auto%2Ce_sharpen/https%3A//i.dailymail.co.uk/1s/2020/12/15/12/
57 KB
57 KB
Image
General
Full URL
https://images.taboola.com/taboola/image/fetch/f_jpg%2Cq_auto%2Ch_380%2Cw_760%2Cc_fill%2Cg_faces:auto%2Ce_sharpen/https%3A//i.dailymail.co.uk/1s/2020/12/15/12/36866806-0-image-a-292_1608034324849.jpg
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
151.101.13.44 Frankfurt am Main, Germany, ASN54113 (FASTLY, US),
Reverse DNS
Software
cloudinary /
Resource Hash
4f29914531077cccaa55422908568bcf6cda2f7d2655add593da49ca19b2431e

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

x-vcl-time-ms
0
date
Tue, 15 Dec 2020 12:45:43 GMT
via
1.1 varnish, 1.1 varnish, 1.1 varnish
age
1455
edge-cache-tag
471156675145263339484691092196459889108,575325974753229111106645491868203992126,29ecf9b93bbf306179626feeda1fab70
status
200 OK
x-cache
MISS, HIT, HIT
x-debug
/taboola/image/fetch/f_jpg%2Cq_auto%2Ch_380%2Cw_760%2Cc_fill%2Cg_faces:auto%2Ce_sharpen/https%3A//i.dailymail.co.uk/1s/2020/12/15/12/36866806-0-image-a-292_1608034324849.jpg
content-length
58122
x-request-id
604b5cea9dc11cae5b603109d208cfa0
x-served-by
cache-dca17753-DCA, cache-dca17753-DCA, cache-fra19144-FRA
last-modified
Tue, 15 Dec 2020 12:17:37 GMT
server
cloudinary
x-timer
S1608036343.210789,VS0,VE0
etag
"7f51afeeb57bd8a5b9cded52b803a4b8"
content-type
image/jpeg
access-control-allow-origin
*
cache-control
public, max-age=7776000
accept-ranges
bytes
timing-allow-origin
*
access-control-allow-headers
X-Requested-With
x-cache-hits
0, 23, 4
d65c91689ac388ce4d81a754ce7bb1d7.jpeg
images.taboola.com/taboola/image/fetch/f_jpg%2Cq_auto%2Ch_380%2Cw_760%2Cc_fill%2Cg_faces:auto%2Ce_sharpen/http%3A//cdn.taboola.com/libtrc/static/thumbnails/
23 KB
23 KB
Image
General
Full URL
https://images.taboola.com/taboola/image/fetch/f_jpg%2Cq_auto%2Ch_380%2Cw_760%2Cc_fill%2Cg_faces:auto%2Ce_sharpen/http%3A//cdn.taboola.com/libtrc/static/thumbnails/d65c91689ac388ce4d81a754ce7bb1d7.jpeg
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
151.101.13.44 Frankfurt am Main, Germany, ASN54113 (FASTLY, US),
Reverse DNS
Software
cloudinary /
Resource Hash
d80f64c5e943f7453a3091adb6606ed92e6b4787a85a6333622d6808e3627ec7

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

x-vcl-time-ms
1
date
Tue, 15 Dec 2020 12:45:43 GMT
via
1.1 varnish, 1.1 varnish, 1.1 varnish
age
2292430
edge-cache-tag
473893535715853526307896963127861640653,575325974753229111106645491868203992126,29ecf9b93bbf306179626feeda1fab70
expiration
expiry-date="Fri, 20 Nov 2020 00:00:00 GMT", rule-id="delete fetch for taboola after 30 days"
x-cache
MISS, HIT, HIT
x-debug
/taboola/image/fetch/f_jpg%2Cq_auto%2Ch_380%2Cw_760%2Cc_fill%2Cg_faces:auto%2Ce_sharpen/http%3A//cdn.taboola.com/libtrc/static/thumbnails/d65c91689ac388ce4d81a754ce7bb1d7.jpeg
content-length
23153
x-served-by
cache-dca17730-DCA, cache-dca17770-DCA, cache-fra19144-FRA
last-modified
Tue, 20 Oct 2020 09:20:21 GMT
server
cloudinary
x-timer
S1608036343.210790,VS0,VE1
etag
"25f3d893f85b648ab74ab56c418ed4f6"
content-type
image/jpeg
access-control-allow-origin
*
cache-control
public, max-age=7776000
accept-ranges
bytes
timing-allow-origin
*
access-control-allow-headers
X-Requested-With
x-cache-hits
0, 1, 1
3ed74a55daa05f7de4783c3f403f42f0.png
images.taboola.com/taboola/image/fetch/f_jpg%2Cq_auto%2Ch_212%2Cw_380%2Cc_fill%2Cg_faces:auto%2Ce_sharpen/http%3A//cdn.taboola.com/libtrc/static/thumbnails/
23 KB
24 KB
Image
General
Full URL
https://images.taboola.com/taboola/image/fetch/f_jpg%2Cq_auto%2Ch_212%2Cw_380%2Cc_fill%2Cg_faces:auto%2Ce_sharpen/http%3A//cdn.taboola.com/libtrc/static/thumbnails/3ed74a55daa05f7de4783c3f403f42f0.png
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
151.101.13.44 Frankfurt am Main, Germany, ASN54113 (FASTLY, US),
Reverse DNS
Software
cloudinary /
Resource Hash
3050d9d4b0c33d17535cd29649d2f58eff4de3229a952bdbd725ec08d41c47a8

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

x-vcl-time-ms
1
date
Tue, 15 Dec 2020 12:45:43 GMT
via
1.1 varnish, 1.1 varnish, 1.1 varnish
age
2228490
edge-cache-tag
325532585709847690419228286438930093412,309727233042263395173288000816347086757,29ecf9b93bbf306179626feeda1fab70
expiration
expiry-date="Thu, 19 Nov 2020 00:00:00 GMT", rule-id="delete fetch for taboola after 30 days"
x-cache
MISS, HIT, HIT
x-debug
/taboola/image/fetch/f_jpg%2Cq_auto%2Ch_212%2Cw_380%2Cc_fill%2Cg_faces:auto%2Ce_sharpen/http%3A//cdn.taboola.com/libtrc/static/thumbnails/3ed74a55daa05f7de4783c3f403f42f0.png
content-length
23795
x-served-by
cache-dca17741-DCA, cache-dca17750-DCA, cache-fra19144-FRA
last-modified
Mon, 19 Oct 2020 13:18:07 GMT
server
cloudinary
x-timer
S1608036343.234339,VS0,VE1
etag
"5ef7fc71d1aeeea558be900e45c1dabb"
content-type
image/jpeg
access-control-allow-origin
*
cache-control
public, max-age=7776000
accept-ranges
bytes
timing-allow-origin
*
access-control-allow-headers
X-Requested-With
x-cache-hits
0, 1, 1
65366e56ae09d517ee7534a073d32f71.jpg
images.taboola.com/taboola/image/fetch/h_212,w_380,c_fill,g_xy_center,x_576,y_278/http%3A//cdn.taboola.com/libtrc/static/thumbnails/
34 KB
34 KB
Image
General
Full URL
https://images.taboola.com/taboola/image/fetch/h_212,w_380,c_fill,g_xy_center,x_576,y_278/http%3A//cdn.taboola.com/libtrc/static/thumbnails/65366e56ae09d517ee7534a073d32f71.jpg
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
151.101.13.44 Frankfurt am Main, Germany, ASN54113 (FASTLY, US),
Reverse DNS
Software
cloudinary /
Resource Hash
b2ef707d57dd6c57a59c3ff413b5a89ebee04a4f81cb7fc19e1d4aa6d10c32b3

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

x-vcl-time-ms
1
date
Tue, 15 Dec 2020 12:45:43 GMT
via
1.1 varnish, 1.1 varnish, 1.1 varnish
age
1140568
edge-cache-tag
440699737744025692704583927288507989066,472130260006013933123693797555284241246,29ecf9b93bbf306179626feeda1fab70
expiration
expiry-date="Mon, 21 Dec 2020 00:00:00 GMT", rule-id="delete fetch for taboola after 30 days"
x-cache
MISS, HIT, HIT
x-debug
/taboola/image/fetch/h_212,w_380,c_fill,g_xy_center,x_576,y_278/http%3A//cdn.taboola.com/libtrc/static/thumbnails/65366e56ae09d517ee7534a073d32f71.jpg
content-length
34481
x-served-by
cache-dca17770-DCA, cache-dca17762-DCA, cache-fra19144-FRA
last-modified
Fri, 20 Nov 2020 15:24:51 GMT
server
cloudinary
x-timer
S1608036343.236943,VS0,VE1
etag
"1a9594e80b1860ccc1627f37f14b6a17"
content-type
image/jpeg
access-control-allow-origin
*
cache-control
public, max-age=7776000
accept-ranges
bytes
timing-allow-origin
*
access-control-allow-headers
X-Requested-With
x-cache-hits
0, 1, 1
5fef3c3f720f1d7e70a7d84d75c0cc1f.jpg
images.taboola.com/taboola/image/fetch/f_jpg%2Cq_auto%2Ch_380%2Cw_760%2Cc_fill%2Cg_faces:auto%2Ce_sharpen/http%3A//cdn.taboola.com/libtrc/static/thumbnails/
56 KB
57 KB
Image
General
Full URL
https://images.taboola.com/taboola/image/fetch/f_jpg%2Cq_auto%2Ch_380%2Cw_760%2Cc_fill%2Cg_faces:auto%2Ce_sharpen/http%3A//cdn.taboola.com/libtrc/static/thumbnails/5fef3c3f720f1d7e70a7d84d75c0cc1f.jpg
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
151.101.13.44 Frankfurt am Main, Germany, ASN54113 (FASTLY, US),
Reverse DNS
Software
cloudinary /
Resource Hash
7a49c00ad45423b29aaaadc6824d2008e59cca4c7f3fb21f5b9cdfcb84b5248c

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

x-vcl-time-ms
2
date
Tue, 15 Dec 2020 12:45:43 GMT
via
1.1 varnish, 1.1 varnish, 1.1 varnish
age
780117
edge-cache-tag
525204815285266847788106457305215901031,575325974753229111106645491868203992126,29ecf9b93bbf306179626feeda1fab70
status
200 OK
x-cache
MISS, HIT, HIT
x-debug
/taboola/image/fetch/f_jpg%2Cq_auto%2Ch_380%2Cw_760%2Cc_fill%2Cg_faces:auto%2Ce_sharpen/http%3A//cdn.taboola.com/libtrc/static/thumbnails/5fef3c3f720f1d7e70a7d84d75c0cc1f.jpg
content-length
57580
x-request-id
6172668f9e8c10d559a5888b5978525c
x-served-by
cache-dca17775-DCA, cache-dca17749-DCA, cache-fra19144-FRA
last-modified
Fri, 04 Dec 2020 14:31:44 GMT
server
cloudinary
x-timer
S1608036343.238606,VS0,VE2
etag
"afc7fc1fd808242bf9607927ad44ab5d"
content-type
image/jpeg
access-control-allow-origin
*
cache-control
public, max-age=7776000
accept-ranges
bytes
timing-allow-origin
*
access-control-allow-headers
X-Requested-With
x-cache-hits
0, 1, 1
36865672-0-image-a-68_1608032781212.jpg
images.taboola.com/taboola/image/fetch/f_jpg%2Cq_auto%2Ch_380%2Cw_760%2Cc_fill%2Cg_faces:auto%2Ce_sharpen/https%3A//i.dailymail.co.uk/1s/2020/12/15/11/
98 KB
98 KB
Image
General
Full URL
https://images.taboola.com/taboola/image/fetch/f_jpg%2Cq_auto%2Ch_380%2Cw_760%2Cc_fill%2Cg_faces:auto%2Ce_sharpen/https%3A//i.dailymail.co.uk/1s/2020/12/15/11/36865672-0-image-a-68_1608032781212.jpg
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
151.101.13.44 Frankfurt am Main, Germany, ASN54113 (FASTLY, US),
Reverse DNS
Software
cloudinary /
Resource Hash
c869307f75755a9c0887460682de79cfb7ae30e0a06f545bbd70bd7fb223cb13

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

x-vcl-time-ms
0
date
Tue, 15 Dec 2020 12:45:43 GMT
via
1.1 varnish, 1.1 varnish, 1.1 varnish
age
1345
edge-cache-tag
447619348299548752358516709160847393483,575325974753229111106645491868203992126,29ecf9b93bbf306179626feeda1fab70
status
200 OK
x-cache
MISS, HIT, HIT
x-debug
/taboola/image/fetch/f_jpg%2Cq_auto%2Ch_380%2Cw_760%2Cc_fill%2Cg_faces:auto%2Ce_sharpen/https%3A//i.dailymail.co.uk/1s/2020/12/15/11/36865672-0-image-a-68_1608032781212.jpg
content-length
100104
x-request-id
ba42e1eccee6253fd4c451e0832f473a
x-served-by
cache-dca17766-DCA, cache-dca17776-DCA, cache-fra19144-FRA
last-modified
Tue, 15 Dec 2020 12:17:37 GMT
server
cloudinary
x-timer
S1608036343.258564,VS0,VE0
etag
"0068a2c5a920b6006b324fc1fb1364e6"
content-type
image/jpeg
access-control-allow-origin
*
cache-control
public, max-age=7776000
accept-ranges
bytes
timing-allow-origin
*
access-control-allow-headers
X-Requested-With
x-cache-hits
0, 2, 3
truncated
/
120 B
0
Image
General
Full URL
data:truncated
Protocol
DATA
Server
-, , ASN (),
Reverse DNS
Software
/
Resource Hash
902899b8dd3a6b30f6bc1be0f39f48ce72d0c41357d8bf521cd86f58bb633b7e

Request headers

Referer
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Content-Type
image/png
bridge3.431.1_en.html
imasdk.googleapis.com/js/core/ Frame DF76
0
0
Document
General
Full URL
https://imasdk.googleapis.com/js/core/bridge3.431.1_en.html
Requested by
Host: imasdk.googleapis.com
URL: https://imasdk.googleapis.com/js/sdkloader/ima3.js
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:825::200a Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

:method
GET
:authority
imasdk.googleapis.com
:scheme
https
:path
/js/core/bridge3.431.1_en.html
pragma
no-cache
cache-control
no-cache
upgrade-insecure-requests
1
user-agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
accept
text/html,application/xhtml+xml,application/xml;q=0.9,image/avif,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3;q=0.9
sec-fetch-site
cross-site
sec-fetch-mode
navigate
sec-fetch-dest
iframe
referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
accept-encoding
gzip, deflate, br
accept-language
en-US
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8

Response headers

accept-ranges
bytes
vary
Accept-Encoding
content-encoding
gzip
content-type
text/html
cross-origin-resource-policy
cross-origin
content-length
192077
date
Tue, 15 Dec 2020 11:15:04 GMT
expires
Wed, 15 Dec 2021 11:15:04 GMT
last-modified
Mon, 14 Dec 2020 09:10:26 GMT
x-content-type-options
nosniff
server
sffe
x-xss-protection
0
cache-control
public, max-age=31536000
age
5434
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
7ebfcf635f049fdd1e2db17716b4545f.jpg
images.taboola.com/taboola/image/fetch/f_jpg%2Cq_auto%2Ch_380%2Cw_760%2Cc_fill%2Cg_faces:auto%2Ce_sharpen/http%3A//cdn.taboola.com/libtrc/static/thumbnails/
28 KB
29 KB
Image
General
Full URL
https://images.taboola.com/taboola/image/fetch/f_jpg%2Cq_auto%2Ch_380%2Cw_760%2Cc_fill%2Cg_faces:auto%2Ce_sharpen/http%3A//cdn.taboola.com/libtrc/static/thumbnails/7ebfcf635f049fdd1e2db17716b4545f.jpg
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
151.101.13.44 Frankfurt am Main, Germany, ASN54113 (FASTLY, US),
Reverse DNS
Software
cloudinary /
Resource Hash
fd0fe346ff347de3a0c6f46cba315878fffc473abb7f1e11cc287b4a0fd86970

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

x-vcl-time-ms
1
date
Tue, 15 Dec 2020 12:45:43 GMT
via
1.1 varnish, 1.1 varnish, 1.1 varnish
age
4666003
edge-cache-tag
331711549794897893656263709331011895765,575325974753229111106645491868203992126,29ecf9b93bbf306179626feeda1fab70
status
200 OK
x-cache
MISS, HIT, HIT
x-debug
/taboola/image/fetch/f_jpg%2Cq_auto%2Ch_380%2Cw_760%2Cc_fill%2Cg_faces:auto%2Ce_sharpen/http%3A//cdn.taboola.com/libtrc/static/thumbnails/7ebfcf635f049fdd1e2db17716b4545f.jpg
content-length
29170
x-request-id
eac09d88c2a5810b4b41c56af2535a89
x-served-by
cache-dca17731-DCA, cache-dca17730-DCA, cache-fra19144-FRA
last-modified
Tue, 06 Oct 2020 14:23:34 GMT
server
cloudinary
x-timer
S1608036343.262564,VS0,VE1
etag
"3b88a5986ed4b0716688dff51c9b180c"
content-type
image/jpeg
access-control-allow-origin
*
cache-control
public, max-age=7776000
accept-ranges
bytes
timing-allow-origin
*
access-control-allow-headers
X-Requested-With
x-cache-hits
0, 1, 1
36866470-0-image-a-38_1608033834974.jpg
images.taboola.com/taboola/image/fetch/f_jpg%2Cq_auto%2Ch_390%2Cw_780%2Cc_fill%2Cg_faces:auto%2Ce_sharpen/https%3A//i.dailymail.co.uk/1s/2020/12/15/12/
72 KB
72 KB
Image
General
Full URL
https://images.taboola.com/taboola/image/fetch/f_jpg%2Cq_auto%2Ch_390%2Cw_780%2Cc_fill%2Cg_faces:auto%2Ce_sharpen/https%3A//i.dailymail.co.uk/1s/2020/12/15/12/36866470-0-image-a-38_1608033834974.jpg
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
151.101.13.44 Frankfurt am Main, Germany, ASN54113 (FASTLY, US),
Reverse DNS
Software
cloudinary /
Resource Hash
38f96c995e52296532c346153796e97fd49d9b4916e6e3c1b1d35aeffc3c3a65

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

x-vcl-time-ms
0
date
Tue, 15 Dec 2020 12:45:43 GMT
via
1.1 varnish, 1.1 varnish, 1.1 varnish
age
2226
edge-cache-tag
458960278857726732369933916300258899735,356737923103245843458775926512817796149,29ecf9b93bbf306179626feeda1fab70
status
200 OK
x-cache
MISS, HIT, HIT
x-debug
/taboola/image/fetch/f_jpg%2Cq_auto%2Ch_390%2Cw_780%2Cc_fill%2Cg_faces:auto%2Ce_sharpen/https%3A//i.dailymail.co.uk/1s/2020/12/15/12/36866470-0-image-a-38_1608033834974.jpg
content-length
73468
x-request-id
fe7d1db284e6ed2697fb0c2b40d05159
x-served-by
cache-dca17769-DCA, cache-dca17736-DCA, cache-fra19144-FRA
last-modified
Tue, 15 Dec 2020 12:07:12 GMT
server
cloudinary
x-timer
S1608036343.267003,VS0,VE0
etag
"03d38c59b2392a94b4f40862036160c3"
content-type
image/jpeg
access-control-allow-origin
*
cache-control
public, max-age=7776000
accept-ranges
bytes
timing-allow-origin
*
access-control-allow-headers
X-Requested-With
x-cache-hits
0, 3, 4
unip
trc-events.taboola.com/1125455/log/3/
0
294 B
XHR
General
Full URL
https://trc-events.taboola.com/1125455/log/3/unip?en=pre_d_eng_tb&tos=1664&scd=20&ssd=1&est=1608036337115&ver=27&isls=true&src=i&invt=1500&tim=1608036338779&vi=1608036337111&ri=b6dc80672a17aca292567a573e6453e2&sd=v2_15bf3ddba6eb6e007097014d6bd5af7c_81242381-ab73-4352-8bed-9e7099c82ee1-tuct6d23571_1608036337_1608036337_CNawjgYQz9hEGNeLvbPmLiABKAEwoQE4l-oLQJWXEEj-0toDUP___________wFYAWAAaOKmqpGyrZficA&ui=81242381-ab73-4352-8bed-9e7099c82ee1-tuct6d23571&ref=null&cv=20201123-29-RELEASE
Requested by
Host: cdn.taboola.com
URL: https://cdn.taboola.com/libtrc/unip/1125455/tfa.js
Protocol
H2
Security
TLS 1.2, ECDHE_ECDSA, AES_128_GCM
Server
141.226.228.48 , Netherlands, ASN200478 (TABOOLA-AS, IL),
Reverse DNS
Software
nginx /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

pragma
no-cache
date
Tue, 15 Dec 2020 12:45:41 GMT
server
nginx
x-fastly-to-nlb-rtt
1903
p3p
policyref="http://trc.taboola.com/p3p.xml", CP="NOI DSP COR LAW NID CURa ADMa DEVa PSAa PSDa OUR BUS IND UNI COM NAV INT DEM"
access-control-allow-origin
https://www.dailymail.co.uk
cache-control
no-cache
access-control-allow-credentials
true
tbl-x-upstream
10.40.0.111:10213
5fabfda63aa0d0b6e906d6c165b49757.png
images.taboola.com/taboola/image/fetch/f_jpg%2Cq_auto%2Ch_390%2Cw_780%2Cc_fill%2Cg_faces:auto%2Ce_sharpen/http%3A//cdn.taboola.com/libtrc/static/thumbnails/
126 KB
127 KB
Image
General
Full URL
https://images.taboola.com/taboola/image/fetch/f_jpg%2Cq_auto%2Ch_390%2Cw_780%2Cc_fill%2Cg_faces:auto%2Ce_sharpen/http%3A//cdn.taboola.com/libtrc/static/thumbnails/5fabfda63aa0d0b6e906d6c165b49757.png
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
151.101.13.44 Frankfurt am Main, Germany, ASN54113 (FASTLY, US),
Reverse DNS
Software
cloudinary /
Resource Hash
d605679bd780f46c94f3caaee3f3b7336adde866184adf2b1f0b5f3b4e9dcbcf

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

x-vcl-time-ms
2
date
Tue, 15 Dec 2020 12:45:43 GMT
via
1.1 varnish, 1.1 varnish, 1.1 varnish
age
438317
edge-cache-tag
584769432920862690395953953336111213417,356737923103245843458775926512817796149,29ecf9b93bbf306179626feeda1fab70
expiration
expiry-date="Mon, 28 Dec 2020 00:00:00 GMT", rule-id="delete fetch for taboola after 30 days"
x-cache
MISS, MISS, HIT
x-debug
/taboola/image/fetch/f_jpg%2Cq_auto%2Ch_390%2Cw_780%2Cc_fill%2Cg_faces:auto%2Ce_sharpen/http%3A//cdn.taboola.com/libtrc/static/thumbnails/5fabfda63aa0d0b6e906d6c165b49757.png
content-length
129525
x-served-by
cache-dca17746-DCA, cache-dca17752-DCA, cache-fra19144-FRA
last-modified
Fri, 27 Nov 2020 15:12:06 GMT
server
cloudinary
x-timer
S1608036343.290125,VS0,VE2
etag
"e68f836cc7f0f04ee7fd6a373c031ae2"
content-type
image/jpeg
access-control-allow-origin
*
cache-control
public, max-age=7776000
accept-ranges
bytes
timing-allow-origin
*
access-control-allow-headers
X-Requested-With
x-cache-hits
0, 0, 1
36865214-0-image-a-59_1608032110424.jpg
images.taboola.com/taboola/image/fetch/f_jpg%2Cq_auto%2Ch_390%2Cw_780%2Cc_fill%2Cg_faces:auto%2Ce_sharpen/https%3A//i.dailymail.co.uk/1s/2020/12/15/11/
65 KB
65 KB
Image
General
Full URL
https://images.taboola.com/taboola/image/fetch/f_jpg%2Cq_auto%2Ch_390%2Cw_780%2Cc_fill%2Cg_faces:auto%2Ce_sharpen/https%3A//i.dailymail.co.uk/1s/2020/12/15/11/36865214-0-image-a-59_1608032110424.jpg
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
151.101.13.44 Frankfurt am Main, Germany, ASN54113 (FASTLY, US),
Reverse DNS
Software
cloudinary /
Resource Hash
657f02de8feb7db46cabba09d1d3331217a0998480dcae1307fdc9ea5ca191de

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

x-vcl-time-ms
0
date
Tue, 15 Dec 2020 12:45:43 GMT
via
1.1 varnish, 1.1 varnish, 1.1 varnish
age
2227
edge-cache-tag
321081848014597378324677131140158710597,356737923103245843458775926512817796149,29ecf9b93bbf306179626feeda1fab70
status
200 OK
x-cache
MISS, HIT, HIT
x-debug
/taboola/image/fetch/f_jpg%2Cq_auto%2Ch_390%2Cw_780%2Cc_fill%2Cg_faces:auto%2Ce_sharpen/https%3A//i.dailymail.co.uk/1s/2020/12/15/11/36865214-0-image-a-59_1608032110424.jpg
content-length
66507
x-request-id
1c84ac6949527225aa42f047bf379804
x-served-by
cache-dca17726-DCA, cache-dca17780-DCA, cache-fra19144-FRA
last-modified
Tue, 15 Dec 2020 12:05:33 GMT
server
cloudinary
x-timer
S1608036343.290115,VS0,VE0
etag
"8dda8da6f59225cdf72e7b76a8eca09f"
content-type
image/jpeg
access-control-allow-origin
*
cache-control
public, max-age=7776000
accept-ranges
bytes
timing-allow-origin
*
access-control-allow-headers
X-Requested-With
x-cache-hits
0, 1, 3
36866090-0-image-a-15_1608033592065.jpg
images.taboola.com/taboola/image/fetch/f_jpg%2Cq_auto%2Ch_190%2Cw_380%2Cc_fill%2Cg_faces:auto%2Ce_sharpen/https%3A//i.dailymail.co.uk/1s/2020/12/15/11/
39 KB
40 KB
Image
General
Full URL
https://images.taboola.com/taboola/image/fetch/f_jpg%2Cq_auto%2Ch_190%2Cw_380%2Cc_fill%2Cg_faces:auto%2Ce_sharpen/https%3A//i.dailymail.co.uk/1s/2020/12/15/11/36866090-0-image-a-15_1608033592065.jpg
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
151.101.13.44 Frankfurt am Main, Germany, ASN54113 (FASTLY, US),
Reverse DNS
Software
cloudinary /
Resource Hash
4cccf3e963eabc5beeb779c26b99f3a1590f7f7217c86edd8b37c372f882a0e5

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

x-vcl-time-ms
0
date
Tue, 15 Dec 2020 12:45:43 GMT
via
1.1 varnish, 1.1 varnish, 1.1 varnish
age
2244
edge-cache-tag
503524947950434534467249514469503244592,586447576921672440320975332630694222884,29ecf9b93bbf306179626feeda1fab70
status
200 OK
x-cache
MISS, HIT, HIT
x-debug
/taboola/image/fetch/f_jpg%2Cq_auto%2Ch_190%2Cw_380%2Cc_fill%2Cg_faces:auto%2Ce_sharpen/https%3A//i.dailymail.co.uk/1s/2020/12/15/11/36866090-0-image-a-15_1608033592065.jpg
content-length
39925
x-request-id
462467097ad282578c2d8290361beb75
x-served-by
cache-dca17760-DCA, cache-dca17738-DCA, cache-fra19144-FRA
last-modified
Tue, 15 Dec 2020 12:07:12 GMT
server
cloudinary
x-timer
S1608036343.294877,VS0,VE0
etag
"2acc279597c7ce9371a89f0625617167"
content-type
image/jpeg
access-control-allow-origin
*
cache-control
public, max-age=7776000
accept-ranges
bytes
timing-allow-origin
*
access-control-allow-headers
X-Requested-With
x-cache-hits
0, 1, 5
36865902-0-image-a-160_1608033449986.jpg
images.taboola.com/taboola/image/fetch/f_jpg%2Cq_auto%2Ch_190%2Cw_380%2Cc_fill%2Cg_faces:auto%2Ce_sharpen/https%3A//i.dailymail.co.uk/1s/2020/12/15/11/
21 KB
21 KB
Image
General
Full URL
https://images.taboola.com/taboola/image/fetch/f_jpg%2Cq_auto%2Ch_190%2Cw_380%2Cc_fill%2Cg_faces:auto%2Ce_sharpen/https%3A//i.dailymail.co.uk/1s/2020/12/15/11/36865902-0-image-a-160_1608033449986.jpg
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
151.101.13.44 Frankfurt am Main, Germany, ASN54113 (FASTLY, US),
Reverse DNS
Software
cloudinary /
Resource Hash
782b7b3f13d098fa008cefcaa856e0f3ad5690fb44fd53a293110887788e6099

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

x-vcl-time-ms
0
date
Tue, 15 Dec 2020 12:45:43 GMT
via
1.1 varnish, 1.1 varnish, 1.1 varnish
age
2245
edge-cache-tag
574009631333024523014856743102117262217,586447576921672440320975332630694222884,29ecf9b93bbf306179626feeda1fab70
status
200 OK
x-cache
MISS, HIT, HIT
x-debug
/taboola/image/fetch/f_jpg%2Cq_auto%2Ch_190%2Cw_380%2Cc_fill%2Cg_faces:auto%2Ce_sharpen/https%3A//i.dailymail.co.uk/1s/2020/12/15/11/36865902-0-image-a-160_1608033449986.jpg
content-length
21584
x-request-id
8d518785279654f77243d7a5c02f41d5
x-served-by
cache-dca17732-DCA, cache-dca17758-DCA, cache-fra19144-FRA
last-modified
Tue, 15 Dec 2020 12:07:12 GMT
server
cloudinary
x-timer
S1608036343.306055,VS0,VE0
etag
"460071f7592cbe4b6378455c3e1544a6"
content-type
image/jpeg
access-control-allow-origin
*
cache-control
public, max-age=7776000
accept-ranges
bytes
timing-allow-origin
*
access-control-allow-headers
X-Requested-With
x-cache-hits
0, 1, 3
f4872ba27de0ccc014a4a3e1c422ea6e.png
images.taboola.com/taboola/image/fetch/f_jpg%2Cq_auto%2Ch_390%2Cw_780%2Cc_fill%2Cg_faces:auto%2Ce_sharpen/http%3A//cdn.taboola.com/libtrc/static/thumbnails/
112 KB
112 KB
Image
General
Full URL
https://images.taboola.com/taboola/image/fetch/f_jpg%2Cq_auto%2Ch_390%2Cw_780%2Cc_fill%2Cg_faces:auto%2Ce_sharpen/http%3A//cdn.taboola.com/libtrc/static/thumbnails/f4872ba27de0ccc014a4a3e1c422ea6e.png
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
151.101.13.44 Frankfurt am Main, Germany, ASN54113 (FASTLY, US),
Reverse DNS
Software
cloudinary /
Resource Hash
6978471cdfa3b22cae51f140d515531aaf99513117481d386ef7ad9666f1de50

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

x-vcl-time-ms
2
date
Tue, 15 Dec 2020 12:45:43 GMT
via
1.1 varnish, 1.1 varnish, 1.1 varnish
age
1287772
edge-cache-tag
490387720893396366024038026432307319363,356737923103245843458775926512817796149,29ecf9b93bbf306179626feeda1fab70
expiration
expiry-date="Fri, 25 Dec 2020 00:00:00 GMT", rule-id="delete fetch for taboola after 30 days"
x-cache
MISS, HIT, HIT
x-debug
/taboola/image/fetch/f_jpg%2Cq_auto%2Ch_390%2Cw_780%2Cc_fill%2Cg_faces:auto%2Ce_sharpen/http%3A//cdn.taboola.com/libtrc/static/thumbnails/f4872ba27de0ccc014a4a3e1c422ea6e.png
content-length
114436
x-served-by
cache-dca17725-DCA, cache-dca17751-DCA, cache-fra19144-FRA
last-modified
Tue, 24 Nov 2020 13:23:16 GMT
server
cloudinary
x-timer
S1608036343.318020,VS0,VE2
etag
"2299973611fd12e72747c80cc0efe674"
content-type
image/jpeg
access-control-allow-origin
*
cache-control
public, max-age=7776000
accept-ranges
bytes
timing-allow-origin
*
access-control-allow-headers
X-Requested-With
x-cache-hits
0, 1, 1
36865858-0-image-a-71_1608033476010.jpg
images.taboola.com/taboola/image/fetch/f_jpg%2Cq_auto%2Ch_390%2Cw_780%2Cc_fill%2Cg_faces:auto%2Ce_sharpen/https%3A//i.dailymail.co.uk/1s/2020/12/15/11/
75 KB
75 KB
Image
General
Full URL
https://images.taboola.com/taboola/image/fetch/f_jpg%2Cq_auto%2Ch_390%2Cw_780%2Cc_fill%2Cg_faces:auto%2Ce_sharpen/https%3A//i.dailymail.co.uk/1s/2020/12/15/11/36865858-0-image-a-71_1608033476010.jpg
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
151.101.13.44 Frankfurt am Main, Germany, ASN54113 (FASTLY, US),
Reverse DNS
Software
cloudinary /
Resource Hash
4a72d3566471808c315b53b76321554053f20a3636be6db84e52cc507aa8ca46

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

x-vcl-time-ms
0
date
Tue, 15 Dec 2020 12:45:43 GMT
via
1.1 varnish, 1.1 varnish, 1.1 varnish
age
2227
edge-cache-tag
512760620906177600963045384975075300316,356737923103245843458775926512817796149,29ecf9b93bbf306179626feeda1fab70
status
200 OK
x-cache
MISS, HIT, HIT
x-debug
/taboola/image/fetch/f_jpg%2Cq_auto%2Ch_390%2Cw_780%2Cc_fill%2Cg_faces:auto%2Ce_sharpen/https%3A//i.dailymail.co.uk/1s/2020/12/15/11/36865858-0-image-a-71_1608033476010.jpg
content-length
76752
x-request-id
53ee35f01eba6d056be9d9d73f48a223
x-served-by
cache-dca17723-DCA, cache-dca17730-DCA, cache-fra19144-FRA
last-modified
Tue, 15 Dec 2020 12:07:12 GMT
server
cloudinary
x-timer
S1608036343.322128,VS0,VE0
etag
"4aff9cc27c79f922b6b814c5f42c0fed"
content-type
image/jpeg
access-control-allow-origin
*
cache-control
public, max-age=7776000
accept-ranges
bytes
timing-allow-origin
*
access-control-allow-headers
X-Requested-With
x-cache-hits
0, 1, 4
2213fde5ce7269cfbdb05a49b7d3086e.png
images.taboola.com/taboola/image/fetch/f_jpg%2Cq_auto%2Ch_212%2Cw_380%2Cc_fill%2Cg_faces:auto%2Ce_sharpen/http%3A//cdn.taboola.com/libtrc/static/thumbnails/
23 KB
23 KB
Image
General
Full URL
https://images.taboola.com/taboola/image/fetch/f_jpg%2Cq_auto%2Ch_212%2Cw_380%2Cc_fill%2Cg_faces:auto%2Ce_sharpen/http%3A//cdn.taboola.com/libtrc/static/thumbnails/2213fde5ce7269cfbdb05a49b7d3086e.png
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
151.101.13.44 Frankfurt am Main, Germany, ASN54113 (FASTLY, US),
Reverse DNS
Software
cloudinary /
Resource Hash
71bb19b7f43fea28ba94e116ea754e2718b4faee019c8bc0c169c5d5596a37ff

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

x-vcl-time-ms
1
date
Tue, 15 Dec 2020 12:45:43 GMT
via
1.1 varnish, 1.1 varnish, 1.1 varnish
age
1103478
edge-cache-tag
462804302167753405916766856028784611199,309727233042263395173288000816347086757,29ecf9b93bbf306179626feeda1fab70
expiration
expiry-date="Fri, 25 Dec 2020 00:00:00 GMT", rule-id="delete fetch for taboola after 30 days"
x-cache
MISS, MISS, HIT
x-debug
/taboola/image/fetch/f_jpg%2Cq_auto%2Ch_212%2Cw_380%2Cc_fill%2Cg_faces:auto%2Ce_sharpen/http%3A//cdn.taboola.com/libtrc/static/thumbnails/2213fde5ce7269cfbdb05a49b7d3086e.png
content-length
23123
x-served-by
cache-dca17778-DCA, cache-dca17759-DCA, cache-fra19144-FRA
last-modified
Tue, 24 Nov 2020 22:36:18 GMT
server
cloudinary
x-timer
S1608036343.324292,VS0,VE1
etag
"2650cd629dd81773b55e143c5e7278f0"
content-type
image/jpeg
access-control-allow-origin
*
cache-control
public, max-age=7776000
accept-ranges
bytes
timing-allow-origin
*
access-control-allow-headers
X-Requested-With
x-cache-hits
0, 0, 1
32737cb5643ee764096e10d08de4527f.jpg
images.taboola.com/taboola/image/fetch/f_jpg%2Cq_auto%2Ch_212%2Cw_380%2Cc_fill%2Cg_faces:auto%2Ce_sharpen/http%3A//cdn.taboola.com/libtrc/static/thumbnails/
50 KB
51 KB
Image
General
Full URL
https://images.taboola.com/taboola/image/fetch/f_jpg%2Cq_auto%2Ch_212%2Cw_380%2Cc_fill%2Cg_faces:auto%2Ce_sharpen/http%3A//cdn.taboola.com/libtrc/static/thumbnails/32737cb5643ee764096e10d08de4527f.jpg
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
151.101.13.44 Frankfurt am Main, Germany, ASN54113 (FASTLY, US),
Reverse DNS
Software
cloudinary /
Resource Hash
4acb48334c754a1338fd02f28999cc6d423b448f409b27c4feb17c21abe79766

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

x-vcl-time-ms
1
date
Tue, 15 Dec 2020 12:45:43 GMT
via
1.1 varnish, 1.1 varnish, 1.1 varnish
age
4922605
edge-cache-tag
378983111563217681801611365415903147439,309727233042263395173288000816347086757,29ecf9b93bbf306179626feeda1fab70
expiration
expiry-date="Fri, 30 Oct 2020 00:00:00 GMT", rule-id="delete fetch for taboola after 30 days"
x-cache
MISS, HIT, HIT
x-debug
/taboola/image/fetch/f_jpg%2Cq_auto%2Ch_212%2Cw_380%2Cc_fill%2Cg_faces:auto%2Ce_sharpen/http%3A//cdn.taboola.com/libtrc/static/thumbnails/32737cb5643ee764096e10d08de4527f.jpg
content-length
51451
x-served-by
cache-dca17733-DCA, cache-dca17749-DCA, cache-fra19144-FRA
last-modified
Tue, 29 Sep 2020 20:34:41 GMT
server
cloudinary
x-timer
S1608036343.332200,VS0,VE1
etag
"34866b5ed4e27d25c594ed5fe72a94f2"
content-type
image/jpeg
access-control-allow-origin
*
cache-control
public, max-age=7776000
accept-ranges
bytes
timing-allow-origin
*
access-control-allow-headers
X-Requested-With
x-cache-hits
0, 1, 1
225114
search.spotxchange.com/openrtb/2.3/dados/ Frame
0
0
Other
General
Full URL
https://search.spotxchange.com/openrtb/2.3/dados/225114
Protocol
HTTP/1.1
Server
185.94.180.124 , Netherlands, ASN35220 (SPOTX-AMS, NL),
Reverse DNS
Software
nginx /
Resource Hash

Request headers

Accept
*/*
Access-Control-Request-Method
POST
Access-Control-Request-Headers
content-type,x-openrtb-version
Origin
https://www.dailymail.co.uk
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Sec-Fetch-Mode
cors

Response headers

Server
nginx
Date
Tue, 15 Dec 2020 12:45:39 GMT
Content-Type
text/plain;charset=UTF-8
Content-Length
0
Connection
keep-alive
Expires
Thu, 01 Jan 1970 00:00:00 GMT
Last-Modified
Tue, 15 Dec 2020 12:45:39 GMT
Cache-Control
no-cache, must-revalidate post-check=0, pre-check=0
Pragma
no-cache
Access-Control-Allow-Origin
https://www.dailymail.co.uk
Access-Control-Allow-Methods
POST, GET, PATCH, DELETE, OPTIONS
Access-Control-Allow-Headers
content-type,x-openrtb-version
Access-Control-Allow-Credentials
true
Access-Control-Max-Age
2592000
225114
search.spotxchange.com/openrtb/2.3/dados/
0
1 KB
XHR
General
Full URL
https://search.spotxchange.com/openrtb/2.3/dados/225114
Requested by
Host: js.spotx.tv
URL: https://js.spotx.tv/directsdk/v1/234272.js
Protocol
HTTP/1.1
Security
TLS 1.2, RSA, AES_256_GCM
Server
185.94.180.124 , Netherlands, ASN35220 (SPOTX-AMS, NL),
Reverse DNS
Software
nginx /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
x-openrtb-version
2.3
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type
application/json

Response headers

Date
Tue, 15 Dec 2020 12:45:39 GMT
X-SpotX-Timing-Transform
0.000665
X-SpotX-Timing-SpotMarket
0.014057
X-SpotX-Timing-Page-Mux
0.001297
X-SpotX-Timing-Page-Require
0.000465
X-fe
013
Connection
keep-alive
X-SpotX-Timing-Page-Cookie
0.000036
X-SpotX-Timing-Page
0.019769
Pragma
no-cache
X-SpotX-Timing-Page-Context
0.000450
Last-Modified
Tue, 15 Dec 2020 12:45:39 GMT
Server
nginx
Cache-Control
no-cache, must-revalidate, post-check=0, pre-check=0
X-SpotX-Timing-SpotMarket-Primary
0.014057
Access-Control-Allow-Methods
POST, GET, PATCH, DELETE, OPTIONS
Content-Type
application/json
Access-Control-Allow-Origin
https://www.dailymail.co.uk
X-SpotX-Timing-Page-Misc
0.002783
X-SpotX-Timing-Page-Exception
0.000001
X-SpotX-Timing-SpotMarket-Secondary
0.000000
X-SpotX-Timing-Page-URI
0.000016
Access-Control-Allow-Credentials
true
Access-Control-Allow-Headers
Expires
Thu, 01 Jan 1970 00:00:00 GMT
SystemSettings.js
cdn.userreport.com/
894 B
843 B
Script
General
Full URL
https://cdn.userreport.com/SystemSettings.js
Requested by
Host: cdn.userreport.com
URL: https://cdn.userreport.com/userreport.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2600:9000:21f3:8200:19:d208:7940:93a1 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
AmazonS3 /
Resource Hash
9464552e64337889ef3a9dc120396d91f87b2015ad60a8bc0b61d846839f28af

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

x-amz-version-id
6kJ.oVpG3emizYDtxaJznkN1t118DNMr
content-encoding
gzip
last-modified
Thu, 26 Nov 2020 08:23:54 GMT
server
AmazonS3
x-amz-cf-pop
FRA2-C2
etag
"fbcd727c30fa10bc139aca4aec81f8e3"
x-cache
RefreshHit from cloudfront
content-type
text/javascript
via
1.1 2b2e2811e641703aebf776da39317b9c.cloudfront.net (CloudFront)
cache-control
max-age=0
date
Tue, 15 Dec 2020 12:45:44 GMT
accept-ranges
bytes
content-length
442
x-amz-cf-id
d_-zQD9xAuW_xJVBFV_T_XhaKH3g6CRL0UUH_VxyAs8S0M9UOrkhBA==
ads
securepubads.g.doubleclick.net/gampad/
49 KB
11 KB
XHR
General
Full URL
https://securepubads.g.doubleclick.net/gampad/ads?gdfp_req=1&pvsid=2639827676159032&correlator=2455119041695441&output=ldjh&impl=fif&adsid=NT&eid=21069142&vrg=2020120801&guci=1.2.0.0.2.2.0.0&sc=1&sfv=1-0-37&ecs=20201215&iu_parts=5765%2Cdailymail.uk%2Cdm_dmsciencetech_sciencetechart%2Csky_left_top&enc_prev_ius=%2F0%2F1%2F2%2F3&prev_iu_szs=300x600%7C160x600%7C120x600%7C300x250&prev_scp=pos%3Dsky_left_top%26amznbid%3D2%26amznp%3D2%26adx_channel%3D12%26nobids%3Dfalse%26refreshCount%3D0%26amznsz%3D0x0&eri=4&cust_params=page%3Dart%26article%3D9050821%26area%3Dsciencetech%26subarea%3Dsciencetech%26environment%3Dproduction%26country%3Dde%26abv%3Dmol-22070%252F19a28e0b%26bot%3Dfalse%26random%3D9ceebda3-1911-4085-b4cd-4ef660466486%26impid%3Dc0338c30-9d3e-46d6-8db6-95c14a8ccbca%26browserResolution%3Dmin_1244px%26device%3Dother%26device_features%3D%26articlewithvideo%3Dtrue%26style%3Dwide%26session%3D1%26session_page_ID%3Dnone%26utm_source%3Dnone%26watershed%3Dfalse%26location%3Ddailymail_co_uk%26id5%3Dtrue%26permutive%3Drts%26puid%3Db77f6280-fced-4776-aef9-89e90021e68b%26ptime%3D1608036337226&cookie=ID%3D9f90493bd6767b5e-22bf810d66b9004c%3AT%3D1608036337%3AS%3DALNI_MbYxhsI0vi4dzG4Cco_wkD8_fL04A&cdm=www.dailymail.co.uk&bc=31&abxe=1&dt=1608036338802&dlt=1608036336099&idt=1063&frm=20&biw=1600&bih=1200&oid=3&adxs=3&adys=20&adks=1681991210&ucis=b&ifi=11&u_tz=60&u_his=2&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_sd=1&flash=0&url=www.dailymail.co.uk%2Fsciencetech%2Farticle-9050821%2FRemdesivir-beneficial-patients-doctors-reveal.html&loc=https%3A%2F%2Fwww.dailymail.co.uk%2Fsciencetech%2Farticle-9050821%2FRemdesivir-beneficial-patients-doctors-reveal.html%3F_hsmi%3D88974744%26_hsenc%3Dp2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8&vis=1&dmc=8&scr_x=0&scr_y=0&psz=300x620&msz=300x600&psts=AGkb-H9awlplzm3R5rYar7qljqzk%2CAGkb-H8Ea__ROWP6iCtuJnTikfDqFvgEhdFS__bGkDqK7myRJiYdigEmc1U3zmUA-HbB_-yknenOJN1ffIdLQkho7xCYGVETkh6MjNNcBQB1GThq&ga_vid=254203172.1608036337&ga_sid=1608036337&ga_hid=881620343&fws=4&ohw=1600&btvi=0&tt_state=W3siaXNzdWVyT3JpZ2luIjoiaHR0cHM6Ly9hZHNlcnZpY2UuZ29vZ2xlLmNvbSIsInN0YXRlIjowfSx7Imlzc3Vlck9yaWdpbiI6Imh0dHBzOi8vYXR0ZXN0YXRpb24uYW5kcm9pZC5jb20iLCJzdGF0ZSI6MH1d
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020120801.js
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
172.217.22.2 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
fra16s14-in-f2.1e100.net
Software
cafe /
Resource Hash
6dddb7267e4d5591b2b31abac79c524bf3e0987e6f18b2c7f5b85343e861d360
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:45:40 GMT
content-encoding
br
x-content-type-options
nosniff
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
cross-origin-resource-policy
cross-origin
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
11169
x-xss-protection
0
google-lineitem-id
-1
pragma
no-cache
server
cafe
google-creative-id
-1
content-type
text/plain; charset=UTF-8
access-control-allow-origin
https://www.dailymail.co.uk
access-control-expose-headers
x-google-amp-ad-validated-version
cache-control
no-cache, must-revalidate
access-control-allow-credentials
true
timing-allow-origin
*
expires
Fri, 01 Jan 1990 00:00:00 GMT
ads
securepubads.g.doubleclick.net/gampad/
42 KB
11 KB
XHR
General
Full URL
https://securepubads.g.doubleclick.net/gampad/ads?gdfp_req=1&pvsid=2639827676159032&correlator=2455119041695441&output=ldjh&impl=fif&adsid=NT&eid=21069142&vrg=2020120801&guci=1.2.0.0.2.2.0.0&sc=1&sfv=1-0-37&ecs=20201215&iu_parts=5765%2Cdailymail.uk%2Cdm_dmsciencetech_sciencetechart%2Csky_right_top&enc_prev_ius=%2F0%2F1%2F2%2F3&prev_iu_szs=300x600%7C160x600%7C120x600%7C300x250&prev_scp=pos%3Dsky_right_top%26amznbid%3D2%26amznp%3D2%26adx_channel%3D7%26nobids%3Dfalse%26refreshCount%3D0%26amznsz%3D0x0&eri=4&cust_params=page%3Dart%26article%3D9050821%26area%3Dsciencetech%26subarea%3Dsciencetech%26environment%3Dproduction%26country%3Dde%26abv%3Dmol-22070%252F19a28e0b%26bot%3Dfalse%26random%3D9ceebda3-1911-4085-b4cd-4ef660466486%26impid%3Dc0338c30-9d3e-46d6-8db6-95c14a8ccbca%26browserResolution%3Dmin_1244px%26device%3Dother%26device_features%3D%26articlewithvideo%3Dtrue%26style%3Dwide%26session%3D1%26session_page_ID%3Dnone%26utm_source%3Dnone%26watershed%3Dfalse%26location%3Ddailymail_co_uk%26id5%3Dtrue%26permutive%3Drts%26puid%3Db77f6280-fced-4776-aef9-89e90021e68b%26ptime%3D1608036337226&cookie=ID%3D9f90493bd6767b5e-22bf810d66b9004c%3AT%3D1608036337%3AS%3DALNI_MbYxhsI0vi4dzG4Cco_wkD8_fL04A&cdm=www.dailymail.co.uk&bc=31&abxe=1&dt=1608036338804&dlt=1608036336099&idt=1063&frm=20&biw=1600&bih=1200&oid=3&adxs=1297&adys=20&adks=3607738367&ucis=c&ifi=12&u_tz=60&u_his=2&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_sd=1&flash=0&url=www.dailymail.co.uk%2Fsciencetech%2Farticle-9050821%2FRemdesivir-beneficial-patients-doctors-reveal.html&loc=https%3A%2F%2Fwww.dailymail.co.uk%2Fsciencetech%2Farticle-9050821%2FRemdesivir-beneficial-patients-doctors-reveal.html%3F_hsmi%3D88974744%26_hsenc%3Dp2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8&vis=1&dmc=8&scr_x=0&scr_y=0&psz=300x620&msz=300x600&psts=AGkb-H9awlplzm3R5rYar7qljqzk%2CAGkb-H8Ea__ROWP6iCtuJnTikfDqFvgEhdFS__bGkDqK7myRJiYdigEmc1U3zmUA-HbB_-yknenOJN1ffIdLQkho7xCYGVETkh6MjNNcBQB1GThq&ga_vid=254203172.1608036337&ga_sid=1608036337&ga_hid=881620343&fws=4&ohw=1600&btvi=0&tt_state=W3siaXNzdWVyT3JpZ2luIjoiaHR0cHM6Ly9hZHNlcnZpY2UuZ29vZ2xlLmNvbSIsInN0YXRlIjowfSx7Imlzc3Vlck9yaWdpbiI6Imh0dHBzOi8vYXR0ZXN0YXRpb24uYW5kcm9pZC5jb20iLCJzdGF0ZSI6MH1d
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020120801.js
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
172.217.22.2 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
fra16s14-in-f2.1e100.net
Software
cafe /
Resource Hash
76e2a5500bf554f8efff7cf280b0f0fc4705b53036eed2e9a13c055f6f0306c6
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:45:41 GMT
content-encoding
br
x-content-type-options
nosniff
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
cross-origin-resource-policy
cross-origin
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
10725
x-xss-protection
0
google-lineitem-id
-1
pragma
no-cache
server
cafe
google-creative-id
-1
content-type
text/plain; charset=UTF-8
access-control-allow-origin
https://www.dailymail.co.uk
access-control-expose-headers
x-google-amp-ad-validated-version
cache-control
no-cache, must-revalidate
access-control-allow-credentials
true
timing-allow-origin
*
expires
Fri, 01 Jan 1990 00:00:00 GMT
ads
securepubads.g.doubleclick.net/gampad/
40 KB
12 KB
XHR
General
Full URL
https://securepubads.g.doubleclick.net/gampad/ads?gdfp_req=1&pvsid=2639827676159032&correlator=2455119041695441&output=ldjh&impl=fif&adsid=NT&eid=21069142&vrg=2020120801&guci=1.2.0.0.2.2.0.0&sc=1&sfv=1-0-37&ecs=20201215&iu_parts=5765%2Cdailymail.uk%2Cdm_dmsciencetech_sciencetechart%2Csky_left_bottom&enc_prev_ius=%2F0%2F1%2F2%2F3&prev_iu_szs=300x600%7C160x600%7C120x600&prev_scp=pos%3Dsky_left_bottom%26amznbid%3D2%26amznp%3D2%26adx_channel%3D15%26nobids%3Dfalse%26refreshCount%3D0%26amznsz%3D0x0&eri=4&cust_params=page%3Dart%26article%3D9050821%26area%3Dsciencetech%26subarea%3Dsciencetech%26environment%3Dproduction%26country%3Dde%26abv%3Dmol-22070%252F19a28e0b%26bot%3Dfalse%26random%3D9ceebda3-1911-4085-b4cd-4ef660466486%26impid%3Dc0338c30-9d3e-46d6-8db6-95c14a8ccbca%26browserResolution%3Dmin_1244px%26device%3Dother%26device_features%3D%26articlewithvideo%3Dtrue%26style%3Dwide%26session%3D1%26session_page_ID%3Dnone%26utm_source%3Dnone%26watershed%3Dfalse%26location%3Ddailymail_co_uk%26id5%3Dtrue%26permutive%3Drts%26puid%3Db77f6280-fced-4776-aef9-89e90021e68b%26ptime%3D1608036337226&cookie=ID%3D9f90493bd6767b5e-22bf810d66b9004c%3AT%3D1608036337%3AS%3DALNI_MbYxhsI0vi4dzG4Cco_wkD8_fL04A&cdm=www.dailymail.co.uk&bc=31&abxe=1&dt=1608036338808&dlt=1608036336099&idt=1063&frm=20&biw=1600&bih=1200&oid=3&adxs=3&adys=34725&adks=1756589617&ucis=d&ifi=13&u_tz=60&u_his=2&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_sd=1&flash=0&url=www.dailymail.co.uk%2Fsciencetech%2Farticle-9050821%2FRemdesivir-beneficial-patients-doctors-reveal.html&loc=https%3A%2F%2Fwww.dailymail.co.uk%2Fsciencetech%2Farticle-9050821%2FRemdesivir-beneficial-patients-doctors-reveal.html%3F_hsmi%3D88974744%26_hsenc%3Dp2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8&vis=1&dmc=8&scr_x=0&scr_y=0&psz=964x35324&msz=300x600&psts=AGkb-H9awlplzm3R5rYar7qljqzk%2CAGkb-H8Ea__ROWP6iCtuJnTikfDqFvgEhdFS__bGkDqK7myRJiYdigEmc1U3zmUA-HbB_-yknenOJN1ffIdLQkho7xCYGVETkh6MjNNcBQB1GThq&ga_vid=254203172.1608036337&ga_sid=1608036337&ga_hid=881620343&fws=4&ohw=1600&btvi=7&tt_state=W3siaXNzdWVyT3JpZ2luIjoiaHR0cHM6Ly9hZHNlcnZpY2UuZ29vZ2xlLmNvbSIsInN0YXRlIjowfSx7Imlzc3Vlck9yaWdpbiI6Imh0dHBzOi8vYXR0ZXN0YXRpb24uYW5kcm9pZC5jb20iLCJzdGF0ZSI6MH1d
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020120801.js
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
172.217.22.2 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
fra16s14-in-f2.1e100.net
Software
cafe /
Resource Hash
e26b64bd31bbd3a9b33ba74560187f11eb1209523a3106d42878d1604a5adacc
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:45:40 GMT
content-encoding
br
x-content-type-options
nosniff
google-mediationgroup-id
-2
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
cross-origin-resource-policy
cross-origin
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
11771
x-xss-protection
0
google-lineitem-id
4444921622
pragma
no-cache
server
cafe
google-mediationtag-id
-2
google-creative-id
138236649600
content-type
text/plain; charset=UTF-8
access-control-allow-origin
https://www.dailymail.co.uk
cache-control
no-cache, must-revalidate
access-control-allow-credentials
true
timing-allow-origin
*
expires
Fri, 01 Jan 1990 00:00:00 GMT
ads
securepubads.g.doubleclick.net/gampad/
40 KB
12 KB
XHR
General
Full URL
https://securepubads.g.doubleclick.net/gampad/ads?gdfp_req=1&pvsid=2639827676159032&correlator=2455119041695441&output=ldjh&impl=fif&adsid=NT&eid=21069142&vrg=2020120801&guci=1.2.0.0.2.2.0.0&sc=1&sfv=1-0-37&ecs=20201215&iu_parts=5765%2Cdailymail.uk%2Cdm_dmsciencetech_sciencetechart%2Csky_right_bottom&enc_prev_ius=%2F0%2F1%2F2%2F3&prev_iu_szs=300x600%7C160x600%7C120x600&prev_scp=pos%3Dsky_right_bottom%26amznbid%3D2%26amznp%3D2%26adx_channel%3D6%26nobids%3Dfalse%26refreshCount%3D0%26amznsz%3D0x0&eri=4&cust_params=page%3Dart%26article%3D9050821%26area%3Dsciencetech%26subarea%3Dsciencetech%26environment%3Dproduction%26country%3Dde%26abv%3Dmol-22070%252F19a28e0b%26bot%3Dfalse%26random%3D9ceebda3-1911-4085-b4cd-4ef660466486%26impid%3Dc0338c30-9d3e-46d6-8db6-95c14a8ccbca%26browserResolution%3Dmin_1244px%26device%3Dother%26device_features%3D%26articlewithvideo%3Dtrue%26style%3Dwide%26session%3D1%26session_page_ID%3Dnone%26utm_source%3Dnone%26watershed%3Dfalse%26location%3Ddailymail_co_uk%26id5%3Dtrue%26permutive%3Drts%26puid%3Db77f6280-fced-4776-aef9-89e90021e68b%26ptime%3D1608036337226&cookie=ID%3D9f90493bd6767b5e-22bf810d66b9004c%3AT%3D1608036337%3AS%3DALNI_MbYxhsI0vi4dzG4Cco_wkD8_fL04A&cdm=www.dailymail.co.uk&bc=31&abxe=1&dt=1608036338810&dlt=1608036336099&idt=1063&frm=20&biw=1600&bih=1200&oid=3&adxs=1297&adys=34725&adks=118847816&ucis=e&ifi=14&u_tz=60&u_his=2&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_sd=1&flash=0&url=www.dailymail.co.uk%2Fsciencetech%2Farticle-9050821%2FRemdesivir-beneficial-patients-doctors-reveal.html&loc=https%3A%2F%2Fwww.dailymail.co.uk%2Fsciencetech%2Farticle-9050821%2FRemdesivir-beneficial-patients-doctors-reveal.html%3F_hsmi%3D88974744%26_hsenc%3Dp2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8&vis=1&dmc=8&scr_x=0&scr_y=0&psz=964x35324&msz=300x600&psts=AGkb-H9awlplzm3R5rYar7qljqzk%2CAGkb-H8Ea__ROWP6iCtuJnTikfDqFvgEhdFS__bGkDqK7myRJiYdigEmc1U3zmUA-HbB_-yknenOJN1ffIdLQkho7xCYGVETkh6MjNNcBQB1GThq&ga_vid=254203172.1608036337&ga_sid=1608036337&ga_hid=881620343&fws=4&ohw=1600&btvi=8&tt_state=W3siaXNzdWVyT3JpZ2luIjoiaHR0cHM6Ly9hZHNlcnZpY2UuZ29vZ2xlLmNvbSIsInN0YXRlIjowfSx7Imlzc3Vlck9yaWdpbiI6Imh0dHBzOi8vYXR0ZXN0YXRpb24uYW5kcm9pZC5jb20iLCJzdGF0ZSI6MH1d
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020120801.js
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
172.217.22.2 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
fra16s14-in-f2.1e100.net
Software
cafe /
Resource Hash
36e9b0def25ae2570f511ecc6c09edb407a19b125e9963b75d85738f35bd5db7
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:45:41 GMT
content-encoding
br
x-content-type-options
nosniff
google-mediationgroup-id
-2
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
cross-origin-resource-policy
cross-origin
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
11757
x-xss-protection
0
google-lineitem-id
4444921622
pragma
no-cache
server
cafe
google-mediationtag-id
-2
google-creative-id
138236649597
content-type
text/plain; charset=UTF-8
access-control-allow-origin
https://www.dailymail.co.uk
cache-control
no-cache, must-revalidate
access-control-allow-credentials
true
timing-allow-origin
*
expires
Fri, 01 Jan 1990 00:00:00 GMT
robots.txt
t.skimresources.com/api/v2/ Frame C69F
0
61 B
Image
General
Full URL
https://t.skimresources.com/api/v2/robots.txt?__skimjs_preflight__please_ignore__=true&rnd=0.20716357540113406
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
35.201.67.47 , Ascension Island, ASN15169 (GOOGLE, US),
Reverse DNS
Software
Python/3.7 aiohttp/3.5.4 /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:45:43 GMT
via
1.1 google
server
Python/3.7 aiohttp/3.5.4
alt-svc
clear
content-length
0
content-type
text/plain charset=UTF-8
px.gif
p.skimresources.com/
43 B
102 B
Image
General
Full URL
https://p.skimresources.com/px.gif?ch=1&rn=5.116892206991256
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
35.190.91.160 Mountain View, United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
Skimlinks Pixel 1.0 /
Resource Hash
dcecab1355b5c2b9ecef281322bf265ac5840b4688748586e9632b473a5fe56b

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:45:43 GMT
via
1.1 google
server
Skimlinks Pixel 1.0
p3p
policyref="http://skimlinks.com/w3c/p3p.xml", CP="NOI DSP COR CURa ADMa DEVa TAIa OUR BUS IND UNI COM NAV INT"
alt-svc
clear
content-length
43
content-type
image/gif
px.gif
p.skimresources.com/
43 B
102 B
Image
General
Full URL
https://p.skimresources.com/px.gif?ch=2&rn=5.116892206991256
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
35.190.91.160 Mountain View, United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
Skimlinks Pixel 1.0 /
Resource Hash
dcecab1355b5c2b9ecef281322bf265ac5840b4688748586e9632b473a5fe56b

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:45:43 GMT
via
1.1 google
server
Skimlinks Pixel 1.0
p3p
policyref="http://skimlinks.com/w3c/p3p.xml", CP="NOI DSP COR CURa ADMa DEVa TAIa OUR BUS IND UNI COM NAV INT"
alt-svc
clear
content-length
43
content-type
image/gif
truncated
/ Frame 16BB
210 B
0
Image
General
Full URL
data:truncated
Protocol
DATA
Server
-, , ASN (),
Reverse DNS
Software
/
Resource Hash
acd93a31875051305e7c9a9c28db62d0233fd78751d28bee44ffa44949595ce4

Request headers

Referer
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Content-Type
image/png
Artemis
aud.pubmatic.com/AdServer/
Redirect Chain
  • https://image2.pubmatic.com/AdServer/UCookieSetPug?rd=https%3A%2F%2Faud.pubmatic.com%2FAdServer%2FArtemis%3Fdpid%3D267%26segid%3D10277
  • https://aud.pubmatic.com/AdServer/Artemis?dpid=267&segid=10277
7 B
147 B
Image
General
Full URL
https://aud.pubmatic.com/AdServer/Artemis?dpid=267&segid=10277
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
185.64.190.106 , United Kingdom, ASN62713 (AS-PUBMATIC, US),
Reverse DNS
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Date
Tue, 15 Dec 2020 12:45:45 GMT
Connection
keep-alive
Content-Length
7
Content-Type
text/plain; charset=utf-8

Redirect headers

Location
https://aud.pubmatic.com/AdServer/Artemis?dpid=267&segid=10277
Date
Tue, 15 Dec 2020 12:45:43 GMT
X-Cnection
close
Server
Apache/2.2.24 (Unix) mod_ssl/2.2.24 OpenSSL/1.0.1e-fips mod_fastcgi/2.4.6
Content-Length
386
Content-Type
text/html; charset=iso-8859-1
player.js
player.aniview.com/script/6.1/
24 KB
9 KB
Script
General
Full URL
https://player.aniview.com/script/6.1/player.js
Requested by
Host: play.selectmedia.asia
URL: https://play.selectmedia.asia/58fcbed1073ef420086c9d08/5e84b6a4f3500a68ee259b56/dailymail.co.uk_mix.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
2a02:26f0:10c:48b::2c79 , Ascension Island, ASN20940 (AKAMAI-ASN1, EU),
Reverse DNS
Software
UploadServer /
Resource Hash
e48b41194e160d21995423b168df29c00140d84105e6907bba5d4522150e3213

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:45:43 GMT
content-encoding
gzip
x-guploader-uploadid
ABg5-UzBu-vRrdVAbR9K-CGSbHVSshqTSn3SwaUerAcRu1YD1lAtcBwliYp4dywzGUvbwWTObHXJILRPw2jZI-J2h9v1DAvB1w
x-goog-storage-class
MULTI_REGIONAL
x-goog-metageneration
2
x-goog-stored-content-encoding
gzip
content-length
8944
last-modified
Wed, 18 Nov 2020 12:57:23 GMT
server
UploadServer
etag
"e3bddd782aa5424c55e550284384b173"
vary
Accept-Encoding
x-goog-hash
crc32c=IW+Krg==, md5=473deCqlQkxV5VAoQ4Sxcw==
content-language
en
access-control-allow-origin
*
x-goog-generation
1605704243561772
access-control-expose-headers
Content-Type
cache-control
public, max-age=300
x-goog-stored-content-length
8944
accept-ranges
bytes
content-type
application/javascript
expires
Tue, 15 Dec 2020 12:50:43 GMT
track
track1.aniview.com/ Frame 16BB
0
71 B
Image
General
Full URL
https://track1.aniview.com/track?pid=5e3a966128a06134f417790e&cid=5e3a987528a0611c3444f80c&e=playerLoaded&cb=1608036338909
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
34.197.221.162 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:45:46 GMT
cache-control
max-age=0, no-cache, no-store
content-length
0
server.html
tag.userreport.com/ Frame 0680
0
0
Document
General
Full URL
https://tag.userreport.com/server.html
Requested by
Host: cdn.userreport.com
URL: https://cdn.userreport.com/userreport.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2600:9000:2156:2800:11:af01:b40:93a1 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
nginx/1.12.2 /
Resource Hash

Request headers

:method
GET
:authority
tag.userreport.com
:scheme
https
:path
/server.html
pragma
no-cache
cache-control
no-cache
upgrade-insecure-requests
1
user-agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
accept
text/html,application/xhtml+xml,application/xml;q=0.9,image/avif,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3;q=0.9
sec-fetch-site
cross-site
sec-fetch-mode
navigate
sec-fetch-dest
iframe
referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
accept-encoding
gzip, deflate, br
accept-language
en-US
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8

Response headers

content-type
text/html
server
nginx/1.12.2
last-modified
Mon, 26 Oct 2020 12:54:03 GMT
p3p
CP="IDC DSP COR ADM DEVi TAIi PSA PSD IVAi IVDi CONi HIS OUR IND CNT"
content-encoding
gzip
date
Tue, 15 Dec 2020 12:09:40 GMT
etag
"5f96c6eb-9d35"
cache-control
max-age=3600
vary
Accept-Encoding
x-cache
Hit from cloudfront
via
1.1 6b4954a8411e7b2a232537f8000c5c9d.cloudfront.net (CloudFront)
x-amz-cf-pop
FRA50-C1
x-amz-cf-id
7Pipeyn0R6q_YHbURBt-2RdcyvIyPrbYmaNxK4zLbFweaRLHpk3P6Q==
age
2158
amp4ads-v0.mjs
cdn.ampproject.org/rtv/012010270040000/ Frame A2A2
180 KB
51 KB
Script
General
Full URL
https://cdn.ampproject.org/rtv/012010270040000/amp4ads-v0.mjs
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020120801.js
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:81f::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
b2ab9ac436910017b9a2ca7db0e981bad3638db97f576d713eaa9b302e06c094
Security Headers
Name Value
Content-Security-Policy default-src * blob: data:; script-src blob: https://cdn.ampproject.org/esm/ https://cdn.ampproject.org/lts/ https://cdn.ampproject.org/mp/ https://cdn.ampproject.org/rtv/ https://cdn.ampproject.org/sp/ https://cdn.ampproject.org/sw/ https://cdn.ampproject.org/v0.js https://cdn.ampproject.org/v0.mjs https://cdn.ampproject.org/v0/ https://cdn.ampproject.org/viewer/; object-src 'none'; style-src 'unsafe-inline' https://cdn.ampproject.org/rtv/ https://cdn.materialdesignicons.com https://cloud.typography.com https://fast.fonts.net https://fonts.googleapis.com https://maxcdn.bootstrapcdn.com https://p.typekit.net https://pro.fontawesome.com https://use.fontawesome.com https://use.typekit.net; report-uri https://csp.withgoogle.com/csp/amp
Strict-Transport-Security max-age=31536000; includeSubDomains; preload
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

content-security-policy
default-src * blob: data:; script-src blob: https://cdn.ampproject.org/esm/ https://cdn.ampproject.org/lts/ https://cdn.ampproject.org/mp/ https://cdn.ampproject.org/rtv/ https://cdn.ampproject.org/sp/ https://cdn.ampproject.org/sw/ https://cdn.ampproject.org/v0.js https://cdn.ampproject.org/v0.mjs https://cdn.ampproject.org/v0/ https://cdn.ampproject.org/viewer/; object-src 'none'; style-src 'unsafe-inline' https://cdn.ampproject.org/rtv/ https://cdn.materialdesignicons.com https://cloud.typography.com https://fast.fonts.net https://fonts.googleapis.com https://maxcdn.bootstrapcdn.com https://p.typekit.net https://pro.fontawesome.com https://use.fontawesome.com https://use.typekit.net; report-uri https://csp.withgoogle.com/csp/amp
content-encoding
br
x-content-type-options
nosniff
age
397955
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
51478
x-xss-protection
0
server
sffe
date
Thu, 10 Dec 2020 22:13:03 GMT
strict-transport-security
max-age=31536000; includeSubDomains; preload
content-type
text/javascript
access-control-allow-origin
*
vary
Accept-Encoding
cache-control
public, max-age=31536000
etag
"0305d7d21a7fe4a1"
accept-ranges
bytes
timing-allow-origin
*
expires
Fri, 10 Dec 2021 22:13:03 GMT
amp-ad-exit-0.1.mjs
cdn.ampproject.org/rtv/012010270040000/v0/ Frame A2A2
13 KB
5 KB
Script
General
Full URL
https://cdn.ampproject.org/rtv/012010270040000/v0/amp-ad-exit-0.1.mjs
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020120801.js
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:81f::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
ebab910fdc7c7e9e079caa9f7321177b135b2e1542f86ce36937ceb41865086d
Security Headers
Name Value
Content-Security-Policy default-src * blob: data:; script-src blob: https://cdn.ampproject.org/esm/ https://cdn.ampproject.org/lts/ https://cdn.ampproject.org/mp/ https://cdn.ampproject.org/rtv/ https://cdn.ampproject.org/sp/ https://cdn.ampproject.org/sw/ https://cdn.ampproject.org/v0.js https://cdn.ampproject.org/v0.mjs https://cdn.ampproject.org/v0/ https://cdn.ampproject.org/viewer/; object-src 'none'; style-src 'unsafe-inline' https://cdn.ampproject.org/rtv/ https://cdn.materialdesignicons.com https://cloud.typography.com https://fast.fonts.net https://fonts.googleapis.com https://maxcdn.bootstrapcdn.com https://p.typekit.net https://pro.fontawesome.com https://use.fontawesome.com https://use.typekit.net; report-uri https://csp.withgoogle.com/csp/amp
Strict-Transport-Security max-age=31536000; includeSubDomains; preload
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

content-security-policy
default-src * blob: data:; script-src blob: https://cdn.ampproject.org/esm/ https://cdn.ampproject.org/lts/ https://cdn.ampproject.org/mp/ https://cdn.ampproject.org/rtv/ https://cdn.ampproject.org/sp/ https://cdn.ampproject.org/sw/ https://cdn.ampproject.org/v0.js https://cdn.ampproject.org/v0.mjs https://cdn.ampproject.org/v0/ https://cdn.ampproject.org/viewer/; object-src 'none'; style-src 'unsafe-inline' https://cdn.ampproject.org/rtv/ https://cdn.materialdesignicons.com https://cloud.typography.com https://fast.fonts.net https://fonts.googleapis.com https://maxcdn.bootstrapcdn.com https://p.typekit.net https://pro.fontawesome.com https://use.fontawesome.com https://use.typekit.net; report-uri https://csp.withgoogle.com/csp/amp
content-encoding
br
x-content-type-options
nosniff
age
285466
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
4850
x-xss-protection
0
server
sffe
date
Sat, 12 Dec 2020 05:27:52 GMT
strict-transport-security
max-age=31536000; includeSubDomains; preload
content-type
text/javascript
access-control-allow-origin
*
vary
Accept-Encoding
cache-control
public, max-age=31536000
etag
"77bd676d834aaa8d"
accept-ranges
bytes
timing-allow-origin
*
expires
Sun, 12 Dec 2021 05:27:52 GMT
amp-analytics-0.1.mjs
cdn.ampproject.org/rtv/012010270040000/v0/ Frame A2A2
90 KB
27 KB
Script
General
Full URL
https://cdn.ampproject.org/rtv/012010270040000/v0/amp-analytics-0.1.mjs
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020120801.js
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:81f::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
477549a4d5fb644cda6bf64af01631b8411022d88e608bbd8e5a06e327b391cb
Security Headers
Name Value
Content-Security-Policy default-src * blob: data:; script-src blob: https://cdn.ampproject.org/esm/ https://cdn.ampproject.org/lts/ https://cdn.ampproject.org/mp/ https://cdn.ampproject.org/rtv/ https://cdn.ampproject.org/sp/ https://cdn.ampproject.org/sw/ https://cdn.ampproject.org/v0.js https://cdn.ampproject.org/v0.mjs https://cdn.ampproject.org/v0/ https://cdn.ampproject.org/viewer/; object-src 'none'; style-src 'unsafe-inline' https://cdn.ampproject.org/rtv/ https://cdn.materialdesignicons.com https://cloud.typography.com https://fast.fonts.net https://fonts.googleapis.com https://maxcdn.bootstrapcdn.com https://p.typekit.net https://pro.fontawesome.com https://use.fontawesome.com https://use.typekit.net; report-uri https://csp.withgoogle.com/csp/amp
Strict-Transport-Security max-age=31536000; includeSubDomains; preload
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

content-security-policy
default-src * blob: data:; script-src blob: https://cdn.ampproject.org/esm/ https://cdn.ampproject.org/lts/ https://cdn.ampproject.org/mp/ https://cdn.ampproject.org/rtv/ https://cdn.ampproject.org/sp/ https://cdn.ampproject.org/sw/ https://cdn.ampproject.org/v0.js https://cdn.ampproject.org/v0.mjs https://cdn.ampproject.org/v0/ https://cdn.ampproject.org/viewer/; object-src 'none'; style-src 'unsafe-inline' https://cdn.ampproject.org/rtv/ https://cdn.materialdesignicons.com https://cloud.typography.com https://fast.fonts.net https://fonts.googleapis.com https://maxcdn.bootstrapcdn.com https://p.typekit.net https://pro.fontawesome.com https://use.fontawesome.com https://use.typekit.net; report-uri https://csp.withgoogle.com/csp/amp
content-encoding
br
x-content-type-options
nosniff
age
475636
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
27668
x-xss-protection
0
server
sffe
date
Thu, 10 Dec 2020 00:38:22 GMT
strict-transport-security
max-age=31536000; includeSubDomains; preload
content-type
text/javascript
access-control-allow-origin
*
vary
Accept-Encoding
cache-control
public, max-age=31536000
etag
"1304c1c0caf7ca3c"
accept-ranges
bytes
timing-allow-origin
*
expires
Fri, 10 Dec 2021 00:38:22 GMT
amp-fit-text-0.1.mjs
cdn.ampproject.org/rtv/012010270040000/v0/ Frame A2A2
3 KB
1 KB
Script
General
Full URL
https://cdn.ampproject.org/rtv/012010270040000/v0/amp-fit-text-0.1.mjs
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020120801.js
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:81f::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
a86753d4effe5e607d4eaf03fe37eccb8cac743a528f874f736f4d7f35e094b1
Security Headers
Name Value
Content-Security-Policy default-src * blob: data:; script-src blob: https://cdn.ampproject.org/esm/ https://cdn.ampproject.org/lts/ https://cdn.ampproject.org/mp/ https://cdn.ampproject.org/rtv/ https://cdn.ampproject.org/sp/ https://cdn.ampproject.org/sw/ https://cdn.ampproject.org/v0.js https://cdn.ampproject.org/v0.mjs https://cdn.ampproject.org/v0/ https://cdn.ampproject.org/viewer/; object-src 'none'; style-src 'unsafe-inline' https://cdn.ampproject.org/rtv/ https://cdn.materialdesignicons.com https://cloud.typography.com https://fast.fonts.net https://fonts.googleapis.com https://maxcdn.bootstrapcdn.com https://p.typekit.net https://pro.fontawesome.com https://use.fontawesome.com https://use.typekit.net; report-uri https://csp.withgoogle.com/csp/amp
Strict-Transport-Security max-age=31536000; includeSubDomains; preload
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

content-security-policy
default-src * blob: data:; script-src blob: https://cdn.ampproject.org/esm/ https://cdn.ampproject.org/lts/ https://cdn.ampproject.org/mp/ https://cdn.ampproject.org/rtv/ https://cdn.ampproject.org/sp/ https://cdn.ampproject.org/sw/ https://cdn.ampproject.org/v0.js https://cdn.ampproject.org/v0.mjs https://cdn.ampproject.org/v0/ https://cdn.ampproject.org/viewer/; object-src 'none'; style-src 'unsafe-inline' https://cdn.ampproject.org/rtv/ https://cdn.materialdesignicons.com https://cloud.typography.com https://fast.fonts.net https://fonts.googleapis.com https://maxcdn.bootstrapcdn.com https://p.typekit.net https://pro.fontawesome.com https://use.fontawesome.com https://use.typekit.net; report-uri https://csp.withgoogle.com/csp/amp
content-encoding
br
x-content-type-options
nosniff
age
355558
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
1350
x-xss-protection
0
server
sffe
date
Fri, 11 Dec 2020 09:59:40 GMT
strict-transport-security
max-age=31536000; includeSubDomains; preload
content-type
text/javascript
access-control-allow-origin
*
vary
Accept-Encoding
cache-control
public, max-age=31536000
etag
"12c034eb739190af"
accept-ranges
bytes
timing-allow-origin
*
expires
Sat, 11 Dec 2021 09:59:40 GMT
amp-form-0.1.mjs
cdn.ampproject.org/rtv/012010270040000/v0/ Frame A2A2
41 KB
13 KB
Script
General
Full URL
https://cdn.ampproject.org/rtv/012010270040000/v0/amp-form-0.1.mjs
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020120801.js
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:81f::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
b61eb57ae77f31b91b04781da33023ecd897fda21f6c817e6c27623204046f42
Security Headers
Name Value
Content-Security-Policy default-src * blob: data:; script-src blob: https://cdn.ampproject.org/esm/ https://cdn.ampproject.org/lts/ https://cdn.ampproject.org/mp/ https://cdn.ampproject.org/rtv/ https://cdn.ampproject.org/sp/ https://cdn.ampproject.org/sw/ https://cdn.ampproject.org/v0.js https://cdn.ampproject.org/v0.mjs https://cdn.ampproject.org/v0/ https://cdn.ampproject.org/viewer/; object-src 'none'; style-src 'unsafe-inline' https://cdn.ampproject.org/rtv/ https://cdn.materialdesignicons.com https://cloud.typography.com https://fast.fonts.net https://fonts.googleapis.com https://maxcdn.bootstrapcdn.com https://p.typekit.net https://pro.fontawesome.com https://use.fontawesome.com https://use.typekit.net; report-uri https://csp.withgoogle.com/csp/amp
Strict-Transport-Security max-age=31536000; includeSubDomains; preload
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

content-security-policy
default-src * blob: data:; script-src blob: https://cdn.ampproject.org/esm/ https://cdn.ampproject.org/lts/ https://cdn.ampproject.org/mp/ https://cdn.ampproject.org/rtv/ https://cdn.ampproject.org/sp/ https://cdn.ampproject.org/sw/ https://cdn.ampproject.org/v0.js https://cdn.ampproject.org/v0.mjs https://cdn.ampproject.org/v0/ https://cdn.ampproject.org/viewer/; object-src 'none'; style-src 'unsafe-inline' https://cdn.ampproject.org/rtv/ https://cdn.materialdesignicons.com https://cloud.typography.com https://fast.fonts.net https://fonts.googleapis.com https://maxcdn.bootstrapcdn.com https://p.typekit.net https://pro.fontawesome.com https://use.fontawesome.com https://use.typekit.net; report-uri https://csp.withgoogle.com/csp/amp
content-encoding
br
x-content-type-options
nosniff
age
353670
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
13075
x-xss-protection
0
server
sffe
date
Fri, 11 Dec 2020 10:31:08 GMT
strict-transport-security
max-age=31536000; includeSubDomains; preload
content-type
text/javascript
access-control-allow-origin
*
vary
Accept-Encoding
cache-control
public, max-age=31536000
etag
"1e8a1dae72af56cd"
accept-ranges
bytes
timing-allow-origin
*
expires
Sat, 11 Dec 2021 10:31:08 GMT
css
fonts.googleapis.com/ Frame A2A2
4 KB
725 B
Stylesheet
General
Full URL
https://fonts.googleapis.com/css?family=Roboto:400,500&lang=en
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020120801.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:824::200a Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
ESF /
Resource Hash
2190c16423c2557bcb20ccba2edc176fbeb16e6a3de2b2af297f650aae85a43e
Security Headers
Name Value
Strict-Transport-Security max-age=31536000
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

strict-transport-security
max-age=31536000
content-encoding
gzip
x-content-type-options
nosniff
cross-origin-resource-policy
cross-origin
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
x-xss-protection
0
last-modified
Tue, 15 Dec 2020 12:29:11 GMT
server
ESF
date
Tue, 15 Dec 2020 12:45:38 GMT
x-frame-options
SAMEORIGIN
content-type
text/css; charset=utf-8
access-control-allow-origin
*
cache-control
private, max-age=86400, stale-while-revalidate=604800
timing-allow-origin
*
link
<https://fonts.gstatic.com>; rel=preconnect; crossorigin
expires
Tue, 15 Dec 2020 12:45:38 GMT
css
fonts.googleapis.com/ Frame A2A2
4 KB
702 B
Stylesheet
General
Full URL
https://fonts.googleapis.com/css?family=Roboto:400,500&text=
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020120801.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:824::200a Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
ESF /
Resource Hash
2190c16423c2557bcb20ccba2edc176fbeb16e6a3de2b2af297f650aae85a43e
Security Headers
Name Value
Strict-Transport-Security max-age=31536000
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

strict-transport-security
max-age=31536000
content-encoding
gzip
x-content-type-options
nosniff
cross-origin-resource-policy
cross-origin
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
x-xss-protection
0
last-modified
Tue, 15 Dec 2020 11:02:31 GMT
server
ESF
date
Tue, 15 Dec 2020 12:45:38 GMT
x-frame-options
SAMEORIGIN
content-type
text/css; charset=utf-8
access-control-allow-origin
*
cache-control
private, max-age=86400, stale-while-revalidate=604800
timing-allow-origin
*
link
<https://fonts.gstatic.com>; rel=preconnect; crossorigin
expires
Tue, 15 Dec 2020 12:45:38 GMT
en.png
tpc.googlesyndication.com/pagead/images/adchoices/ Frame A2A2
2 KB
3 KB
Image
General
Full URL
https://tpc.googlesyndication.com/pagead/images/adchoices/en.png
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020120801.js
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:81d::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
36133ca07927c88a7cc578fddbaed3c668ab75087834d0ca13dca5de4ec856c1
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

timing-allow-origin
*
date
Mon, 14 Dec 2020 23:34:27 GMT
x-content-type-options
nosniff
server
cafe
age
47471
etag
14819457070020093239
vary
Accept-Encoding
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
cache-control
public, max-age=86400
cross-origin-resource-policy
cross-origin
content-type
image/png
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
2502
x-xss-protection
0
expires
Tue, 15 Dec 2020 23:34:27 GMT
icon.png
tpc.googlesyndication.com/pagead/images/adchoices/ Frame A2A2
295 B
748 B
Image
General
Full URL
https://tpc.googlesyndication.com/pagead/images/adchoices/icon.png
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020120801.js
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:81d::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
7fd59024b6ca83f11f7a3448ec148309a13b705725716df134f699e60a96eb1b
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

timing-allow-origin
*
date
Mon, 14 Dec 2020 21:53:21 GMT
x-content-type-options
nosniff
server
cafe
age
53537
etag
426692510519060060
vary
Accept-Encoding
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
cache-control
public, max-age=86400
cross-origin-resource-policy
cross-origin
content-type
image/png
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
295
x-xss-protection
0
expires
Tue, 15 Dec 2020 21:53:21 GMT
truncated
/ Frame A2A2
213 B
0
Image
General
Full URL
data:truncated
Protocol
DATA
Server
-, , ASN (),
Reverse DNS
Software
/
Resource Hash
07dac6654661fe0f1983d9259c95440f9696f88a9ee49d81f8d0d7134ebced55

Request headers

Referer
https://www.dailymail.co.uk/
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Content-Type
image/png
downsize_200k_v1
tpc.googlesyndication.com/simgad/17164485721341996091/ Frame A2A2
10 KB
10 KB
Image
General
Full URL
https://tpc.googlesyndication.com/simgad/17164485721341996091/downsize_200k_v1?sqp=4sqPyQR5QncIABIUDc3MzD4VAAAAQB0AAAAAJQAAAAAYACIKDQAAgD8VAACAPypPCFoQAR0AALRCIAEoATAGOANAgMLXL0gAUABYAGBacAJ4AIABAIgBAJABAJ0BAACAP6ABAKgBALABgK3iBLgB____________AcUBLbKdPg&rs=AOga4qmdAEK_wKLTh6AcGoc62-8fB7Kg_w
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:81d::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
cbc831a5ed376dbc1096bbf510ebc16df330aca5b5c3599441dbfde46256da3b
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Thu, 10 Dec 2020 18:22:38 GMT
x-content-type-options
nosniff
last-modified
Fri, 30 Oct 2020 14:02:45 GMT
server
sffe
age
411780
content-type
image/jpeg
access-control-allow-origin
*
cache-control
public, max-age=31536000
cross-origin-resource-policy
cross-origin
accept-ranges
bytes
timing-allow-origin
*
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
10254
x-xss-protection
0
expires
Fri, 10 Dec 2021 18:22:38 GMT
downsize_200k_v1
tpc.googlesyndication.com/simgad/14124411546386148791/ Frame A2A2
26 KB
26 KB
Image
General
Full URL
https://tpc.googlesyndication.com/simgad/14124411546386148791/downsize_200k_v1?sqp=4sqPyQSWAUKTAQgAEhQNzczMPhUAAABAHQAAAAAlAAAAABgAIgoNAACAPxUAAIA_Kk8IWhABHQAAtEIgASgBMAY4A0CAwtcvSABQAFgAYFpwAngAgAEAiAEAkAEAnQEAAIA_oAEAqAEAsAGAreIEuAH___________8BxQEtsp0-MhoIrAIQnQEYASABLQAAAD8wrAI4nQFFAACAPw&rs=AOga4qkb-hQ6UfLba2r_MkDqsXbphhqTBg
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:81d::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
12d5e62263fb358f28d10e32316fdfbd3dd2a94acce63607a929d8ea8317bbbb
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Thu, 10 Dec 2020 22:02:38 GMT
x-content-type-options
nosniff
last-modified
Wed, 02 Sep 2020 12:34:42 GMT
server
sffe
age
398580
content-type
image/jpeg
access-control-allow-origin
*
cache-control
public, max-age=31536000
cross-origin-resource-policy
cross-origin
accept-ranges
bytes
timing-allow-origin
*
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
26623
x-xss-protection
0
expires
Fri, 10 Dec 2021 22:02:38 GMT
adview
securepubads.g.doubleclick.net/pagead/ Frame A2A2
0
0
Image
General
Full URL
https://securepubads.g.doubleclick.net/pagead/adview?ai=CKO968q_YX4KFFYiWgAft74PwCffgj7Ng3byt84sMsJAfEAEgrNm4ImCRhJOF_BegAdWetf4DyAEG4AIAqAMByAMKqgTAAk_Qui1z5uUluYhuPhlTdCFtbxzcRO-EMQAd9Xi_7MnudYrbuJ-oW4D93PyHqdxAh83ADd1Qq2DdwDKcTjGS_h3Y0eTwDu8UdcYk9KvhUrddFujJj9IqfmIAJRb7AOTMuiqu5GAQfHNj1y7uMG0CA3ivkr4OXuOJ6sPNubQhy631lOgOTlZycv5nmHsl-DBiJv8PSXepXYqKeQtG7Kpf6kZiUJFccgxyytBNOGBPo9X1LtqyMLcczYHvk07lYCG7y28Fo63em0Z8OsMKbo1f0BkVxKQnyNIB5oU5V5EFTljtwqzXxR8nXj_3nBGiPet0YHbzmbcYImVCVuBIjBX9ftaPpXQ7avpc92pv0UEFWOAmpJBP-EFjhVT2Bzmn38yVEJ-snXF-kfhlayXB3cmJ4HqRSeSr0tXLGwIMTyR0XI6LwASXvOmGhQPgBAGSBQQIBBgBkgUECAUYBJIFBAgFGBiSBQUIBRioAaAGN4AHk-HKAagH1ckbqAfw2RuoB_LZG6gHlJixAqgHpd8bqAeOzhuoB5PYG6gHugaoB-6WsQKoB6a-G6gH7NUb2AcB8gcEEPjoBdIICQiA4YBQEAEYHYAKA8gLAdgTDYgUA7IXGgoYCAESFHB1Yi00MTgwODM1Njk0MTY2MjU1&sigh=u3nqHFRiGzE&template_id=492&tpd=AGWhJmukCKwiPq6W2j3rV6KlAJjiuawSxSrepZuWvaO_XyZVUA
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
172.217.22.2 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
fra16s14-in-f2.1e100.net
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
https://www.dailymail.co.uk/
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

l
www.google.com/ads/measurement/ Frame A2A2
0
0
Image
General
Full URL
https://www.google.com/ads/measurement/l?ebcid=ALh7CaRjfhvwZAXZaPXigSo1C_PhZF4jc2eogJQSlcJ2197MR2-ZcQAR42WNjS8vMo8B3raM_ydg
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:817::2004 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
https://www.dailymail.co.uk/
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

/
r.skimresources.com/api/
Redirect Chain
  • https://r.skimresources.com/api/
  • https://r.skimresources.com/api/?xguid=01ESK6YKBYW08DGF8S3WVHJBE8&persistence=1&checksum=27c6d66aa694d3eaccf7a3dabbb5d985e927fafe719bffac488183a8754b2408
208 B
510 B
XHR
General
Full URL
https://r.skimresources.com/api/?xguid=01ESK6YKBYW08DGF8S3WVHJBE8&persistence=1&checksum=27c6d66aa694d3eaccf7a3dabbb5d985e927fafe719bffac488183a8754b2408
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
35.190.59.101 Mountain View, United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
openresty/1.11.2.5 /
Resource Hash
431a79898690124fc63918440e4a9fc5d8441d2312b3b4cba004ace0f6565d44
Security Headers
Name Value
Strict-Transport-Security max-age=31536000
X-Content-Type-Options nosniff

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:45:39 GMT
content-encoding
gzip
x-content-type-options
nosniff
server
openresty/1.11.2.5
strict-transport-security
max-age=31536000
p3p
CP="IDC DSP COR ADM DEVi TAIi PSA PSD IVAi IVDi CONi HIS OUR IND CNT"
access-control-allow-origin
https://www.dailymail.co.uk
vary
Accept-Encoding
access-control-allow-credentials
true
content-type
application/json
alt-svc
clear
via
1.1 google

Redirect headers

date
Tue, 15 Dec 2020 12:45:39 GMT
via
1.1 google
server
openresty/1.11.2.5
access-control-allow-origin
https://www.dailymail.co.uk
strict-transport-security
max-age=31536000
p3p
CP="IDC DSP COR ADM DEVi TAIi PSA PSD IVAi IVDi CONi HIS OUR IND CNT"
location
https://r.skimresources.com/api/?xguid=01ESK6YKBYW08DGF8S3WVHJBE8&persistence=1&checksum=27c6d66aa694d3eaccf7a3dabbb5d985e927fafe719bffac488183a8754b2408
access-control-allow-credentials
true
content-type
text/html
alt-svc
clear
content-length
193
f539211219b796ffbb49949997c764f0.png
cdn.taboola.com/libtrc/static/thumbnails/
254 B
726 B
Image
General
Full URL
https://cdn.taboola.com/libtrc/static/thumbnails/f539211219b796ffbb49949997c764f0.png
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
151.101.13.44 Frankfurt am Main, Germany, ASN54113 (FASTLY, US),
Reverse DNS
Software
AmazonS3 /
Resource Hash
f68019eb4b4e5933301d4ee75969e0cb94ed8333bf514630fa749eb9c3e483c9

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

x-amz-version-id
hL.cyLD7Q4TL5ceY.7JQwF9m5IYI8mkC
via
1.1 varnish
etag
"dfa7b52c86e56bd67fa4002f6ed19854"
age
2933
x-cache
HIT
x-amz-replication-status
COMPLETED
content-length
254
x-amz-id-2
Vjnfq2okxpLEG/cBVxSfv3DOOCGN7KTpixt29L7DwUhoZL6eRlgDSODZqhfatrYL58q01gaLKf4=
x-served-by
cache-fra19144-FRA
last-modified
Wed, 24 Jun 2015 07:14:11 GMT
server
AmazonS3
x-amz-meta-s3cmd-attrs
uid:0/gname:root/uname:root/gid:0/mode:33188/mtime:1377415166/atime:1435052450/md5:dfa7b52c86e56bd67fa4002f6ed19854/ctime:1422381567
x-timer
S1608036344.752912,VS0,VE0
date
Tue, 15 Dec 2020 12:45:43 GMT
x-amz-request-id
F6D91014AAA6CDC4
cache-control
private,max-age=31536000
accept-ranges
bytes
content-type
image/png
abp
94
x-cache-hits
5351
UnitWidgetItemDesktop.min.js
vidstat.taboola.com/lite-unit/2.4.6/
89 KB
26 KB
Script
General
Full URL
https://vidstat.taboola.com/lite-unit/2.4.6/UnitWidgetItemDesktop.min.js
Requested by
Host: cdn.taboola.com
URL: https://cdn.taboola.com/libtrc/impl.20201214-6-RELEASE.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
151.101.13.44 Frankfurt am Main, Germany, ASN54113 (FASTLY, US),
Reverse DNS
Software
AmazonS3 /
Resource Hash
1326ea711c56158154751b7c597f07f1dd4ab7ce180aa5f39693d83b2a5662fd

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:45:43 GMT
via
1.1 a56d6b55603697d6c44b19d4f907baaa.cloudfront.net (CloudFront), 1.1 varnish
age
614816
x-cache
Hit from cloudfront, HIT
content-encoding
gzip
content-length
25989
x-served-by
cache-fra19144-FRA
last-modified
Mon, 07 Dec 2020 16:23:05 GMT
server
AmazonS3
x-timer
S1608036344.753929,VS0,VE0
etag
"365143735d44746a7fb7a87ce519c4ed"
vary
Accept-Encoding
access-control-allow-methods
GET, OPTIONS, HEAD
content-type
application/javascript
access-control-allow-origin
*
cache-control
public, max-age=2592000
x-amz-cf-pop
FRA6-C1
accept-ranges
bytes
access-control-allow-headers
*
x-amz-cf-id
PqgasNAZU92N40YBTKGXZQivMw1Dmn9mJR5Tw6qa1QlvdAmxmTD1rg==
x-cache-hits
107662
UnitFeedManagerDesktop.min.js
vidstat.taboola.com/lite-unit/2.4.6/
89 KB
26 KB
Script
General
Full URL
https://vidstat.taboola.com/lite-unit/2.4.6/UnitFeedManagerDesktop.min.js
Requested by
Host: cdn.taboola.com
URL: https://cdn.taboola.com/libtrc/impl.20201214-6-RELEASE.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
151.101.13.44 Frankfurt am Main, Germany, ASN54113 (FASTLY, US),
Reverse DNS
Software
AmazonS3 /
Resource Hash
48857dcfba3940d2477a3402b30975809d401a6ec2f10ba3fc93b3dee833151b

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:45:43 GMT
via
1.1 d07eabeb1ed60c06da1457f35fb5c8c5.cloudfront.net (CloudFront), 1.1 varnish
age
614815
x-cache
Hit from cloudfront, HIT
content-encoding
gzip
content-length
26200
x-served-by
cache-fra19144-FRA
last-modified
Mon, 07 Dec 2020 16:23:05 GMT
server
AmazonS3
x-timer
S1608036344.757402,VS0,VE0
etag
"079a63ee7debd7b5ba6f8cae9d86fb21"
vary
Accept-Encoding
access-control-allow-methods
GET, OPTIONS, HEAD
content-type
application/javascript
access-control-allow-origin
*
cache-control
public, max-age=2592000
x-amz-cf-pop
FRA6-C1
accept-ranges
bytes
access-control-allow-headers
*
x-amz-cf-id
9DUb79uesyaUyWXAQ4QumQRoXvveypDz3PbzJJRUUcZl-qPXX_tXBA==
x-cache-hits
188422
225114
search.spotxchange.com/openrtb/2.3/dados/ Frame
0
0
Other
General
Full URL
https://search.spotxchange.com/openrtb/2.3/dados/225114
Protocol
HTTP/1.1
Server
185.94.180.124 , Netherlands, ASN35220 (SPOTX-AMS, NL),
Reverse DNS
Software
nginx /
Resource Hash

Request headers

Accept
*/*
Access-Control-Request-Method
POST
Access-Control-Request-Headers
content-type,x-openrtb-version
Origin
https://www.dailymail.co.uk
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Sec-Fetch-Mode
cors

Response headers

Server
nginx
Date
Tue, 15 Dec 2020 12:45:39 GMT
Content-Type
text/plain;charset=UTF-8
Content-Length
0
Connection
keep-alive
Expires
Thu, 01 Jan 1970 00:00:00 GMT
Last-Modified
Tue, 15 Dec 2020 12:45:39 GMT
Cache-Control
no-cache, must-revalidate post-check=0, pre-check=0
Pragma
no-cache
Access-Control-Allow-Origin
https://www.dailymail.co.uk
Access-Control-Allow-Methods
POST, GET, PATCH, DELETE, OPTIONS
Access-Control-Allow-Headers
content-type,x-openrtb-version
Access-Control-Allow-Credentials
true
Access-Control-Max-Age
2592000
225114
search.spotxchange.com/openrtb/2.3/dados/
0
1 KB
XHR
General
Full URL
https://search.spotxchange.com/openrtb/2.3/dados/225114
Requested by
Host: js.spotx.tv
URL: https://js.spotx.tv/directsdk/v1/234272.js
Protocol
HTTP/1.1
Security
TLS 1.2, RSA, AES_256_GCM
Server
185.94.180.124 , Netherlands, ASN35220 (SPOTX-AMS, NL),
Reverse DNS
Software
nginx /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
x-openrtb-version
2.3
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type
application/json

Response headers

Date
Tue, 15 Dec 2020 12:45:39 GMT
X-SpotX-Timing-Transform
0.002009
X-SpotX-Timing-SpotMarket
0.012835
X-SpotX-Timing-Page-Mux
0.001276
X-SpotX-Timing-Page-Require
0.000422
X-fe
029
Connection
keep-alive
X-SpotX-Timing-Page-Cookie
0.000026
X-SpotX-Timing-Page
0.019348
Pragma
no-cache
X-SpotX-Timing-Page-Context
0.000366
Last-Modified
Tue, 15 Dec 2020 12:45:39 GMT
Server
nginx
Cache-Control
no-cache, must-revalidate, post-check=0, pre-check=0
X-SpotX-Timing-SpotMarket-Primary
0.012835
Access-Control-Allow-Methods
POST, GET, PATCH, DELETE, OPTIONS
Content-Type
application/json
Access-Control-Allow-Origin
https://www.dailymail.co.uk
X-SpotX-Timing-Page-Misc
0.002398
X-SpotX-Timing-Page-Exception
0.000000
X-SpotX-Timing-SpotMarket-Secondary
0.000000
X-SpotX-Timing-Page-URI
0.000016
Access-Control-Allow-Credentials
true
Access-Control-Allow-Headers
Expires
Thu, 01 Jan 1970 00:00:00 GMT
SiteEvent.dotmetrics
uk-script.dotmetrics.net/
316 B
1 KB
Script
General
Full URL
https://uk-script.dotmetrics.net/SiteEvent.dotmetrics?v=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%3D%3D&r=1608036339190
Requested by
Host: uk-script.dotmetrics.net
URL: https://uk-script.dotmetrics.net/Scripts/script.js?v=175
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
65.9.68.128 Seattle, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
Kestrel /
Resource Hash
d200a26b9067b59b0090129d1e634df45df67a66efcc6f9bf006b84e7b047543

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:45:43 GMT
content-encoding
br
server
Kestrel
x-amz-cf-pop
FRA56-C1
vary
Accept-Encoding
x-cache
Miss from cloudfront
p3p
policyref="https://uk-script.dotmetrics.net/w3c/p3p.xml", CP="NOI DSP LAW CURa ADMa DEVa PSAa HISa OUR IND STA"
via
1.1 9570c3a1725c20e6faed117bbb74223b.cloudfront.net (CloudFront)
cache-control
no-cache
content-type
application/javascript
x-amz-cf-id
hQ0cQNiOkfyFad5gpZOlYPDflg9xCCqpRz9f9m3N2yOp8ZfIfbTwdQ==
KFOmCnqEu92Fr1Mu4mxKKTU1Kg.woff2
fonts.gstatic.com/s/roboto/v20/ Frame A2A2
11 KB
11 KB
Font
General
Full URL
https://fonts.gstatic.com/s/roboto/v20/KFOmCnqEu92Fr1Mu4mxKKTU1Kg.woff2
Requested by
Host: fonts.googleapis.com
URL: https://fonts.googleapis.com/css?family=Roboto:400,500&lang=en
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:809::2003 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
5d1bc9b443f3f81fa4b4ad4634c1bb9702194c1898e3a9de0ab5e2cdc0e9f479
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Origin
https://www.dailymail.co.uk
Referer
https://fonts.googleapis.com/css?family=Roboto:400,500&lang=en
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 08 Dec 2020 17:20:25 GMT
x-content-type-options
nosniff
last-modified
Wed, 24 Jul 2019 01:18:50 GMT
server
sffe
age
588314
content-type
font/woff2
access-control-allow-origin
*
cache-control
public, max-age=31536000
accept-ranges
bytes
timing-allow-origin
*
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
11016
x-xss-protection
0
expires
Wed, 08 Dec 2021 17:20:25 GMT
KFOlCnqEu92Fr1MmEU9fBBc4AMP6lQ.woff2
fonts.gstatic.com/s/roboto/v20/ Frame A2A2
11 KB
11 KB
Font
General
Full URL
https://fonts.gstatic.com/s/roboto/v20/KFOlCnqEu92Fr1MmEU9fBBc4AMP6lQ.woff2
Requested by
Host: fonts.googleapis.com
URL: https://fonts.googleapis.com/css?family=Roboto:400,500&lang=en
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:809::2003 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
ce897833ac6e362df7c91ac8223fe511c6defcf33964928a81004600a2dd4c2e
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Origin
https://www.dailymail.co.uk
Referer
https://fonts.googleapis.com/css?family=Roboto:400,500&lang=en
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Mon, 14 Dec 2020 22:21:20 GMT
x-content-type-options
nosniff
last-modified
Wed, 24 Jul 2019 01:18:48 GMT
server
sffe
age
51859
content-type
font/woff2
access-control-allow-origin
*
cache-control
public, max-age=31536000
accept-ranges
bytes
timing-allow-origin
*
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
11056
x-xss-protection
0
expires
Tue, 14 Dec 2021 22:21:20 GMT
amp4ads-v0.mjs
cdn.ampproject.org/rtv/012010270040000/ Frame C794
180 KB
50 KB
Script
General
Full URL
https://cdn.ampproject.org/rtv/012010270040000/amp4ads-v0.mjs
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020120801.js
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:81f::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
b2ab9ac436910017b9a2ca7db0e981bad3638db97f576d713eaa9b302e06c094
Security Headers
Name Value
Content-Security-Policy default-src * blob: data:; script-src blob: https://cdn.ampproject.org/esm/ https://cdn.ampproject.org/lts/ https://cdn.ampproject.org/mp/ https://cdn.ampproject.org/rtv/ https://cdn.ampproject.org/sp/ https://cdn.ampproject.org/sw/ https://cdn.ampproject.org/v0.js https://cdn.ampproject.org/v0.mjs https://cdn.ampproject.org/v0/ https://cdn.ampproject.org/viewer/; object-src 'none'; style-src 'unsafe-inline' https://cdn.ampproject.org/rtv/ https://cdn.materialdesignicons.com https://cloud.typography.com https://fast.fonts.net https://fonts.googleapis.com https://maxcdn.bootstrapcdn.com https://p.typekit.net https://pro.fontawesome.com https://use.fontawesome.com https://use.typekit.net; report-uri https://csp.withgoogle.com/csp/amp
Strict-Transport-Security max-age=31536000; includeSubDomains; preload
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

content-security-policy
default-src * blob: data:; script-src blob: https://cdn.ampproject.org/esm/ https://cdn.ampproject.org/lts/ https://cdn.ampproject.org/mp/ https://cdn.ampproject.org/rtv/ https://cdn.ampproject.org/sp/ https://cdn.ampproject.org/sw/ https://cdn.ampproject.org/v0.js https://cdn.ampproject.org/v0.mjs https://cdn.ampproject.org/v0/ https://cdn.ampproject.org/viewer/; object-src 'none'; style-src 'unsafe-inline' https://cdn.ampproject.org/rtv/ https://cdn.materialdesignicons.com https://cloud.typography.com https://fast.fonts.net https://fonts.googleapis.com https://maxcdn.bootstrapcdn.com https://p.typekit.net https://pro.fontawesome.com https://use.fontawesome.com https://use.typekit.net; report-uri https://csp.withgoogle.com/csp/amp
content-encoding
br
x-content-type-options
nosniff
age
397956
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
51478
x-xss-protection
0
server
sffe
date
Thu, 10 Dec 2020 22:13:03 GMT
strict-transport-security
max-age=31536000; includeSubDomains; preload
content-type
text/javascript
access-control-allow-origin
*
vary
Accept-Encoding
cache-control
public, max-age=31536000
etag
"0305d7d21a7fe4a1"
accept-ranges
bytes
timing-allow-origin
*
expires
Fri, 10 Dec 2021 22:13:03 GMT
amp-ad-exit-0.1.mjs
cdn.ampproject.org/rtv/012010270040000/v0/ Frame C794
13 KB
5 KB
Script
General
Full URL
https://cdn.ampproject.org/rtv/012010270040000/v0/amp-ad-exit-0.1.mjs
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020120801.js
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:81f::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
ebab910fdc7c7e9e079caa9f7321177b135b2e1542f86ce36937ceb41865086d
Security Headers
Name Value
Content-Security-Policy default-src * blob: data:; script-src blob: https://cdn.ampproject.org/esm/ https://cdn.ampproject.org/lts/ https://cdn.ampproject.org/mp/ https://cdn.ampproject.org/rtv/ https://cdn.ampproject.org/sp/ https://cdn.ampproject.org/sw/ https://cdn.ampproject.org/v0.js https://cdn.ampproject.org/v0.mjs https://cdn.ampproject.org/v0/ https://cdn.ampproject.org/viewer/; object-src 'none'; style-src 'unsafe-inline' https://cdn.ampproject.org/rtv/ https://cdn.materialdesignicons.com https://cloud.typography.com https://fast.fonts.net https://fonts.googleapis.com https://maxcdn.bootstrapcdn.com https://p.typekit.net https://pro.fontawesome.com https://use.fontawesome.com https://use.typekit.net; report-uri https://csp.withgoogle.com/csp/amp
Strict-Transport-Security max-age=31536000; includeSubDomains; preload
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

content-security-policy
default-src * blob: data:; script-src blob: https://cdn.ampproject.org/esm/ https://cdn.ampproject.org/lts/ https://cdn.ampproject.org/mp/ https://cdn.ampproject.org/rtv/ https://cdn.ampproject.org/sp/ https://cdn.ampproject.org/sw/ https://cdn.ampproject.org/v0.js https://cdn.ampproject.org/v0.mjs https://cdn.ampproject.org/v0/ https://cdn.ampproject.org/viewer/; object-src 'none'; style-src 'unsafe-inline' https://cdn.ampproject.org/rtv/ https://cdn.materialdesignicons.com https://cloud.typography.com https://fast.fonts.net https://fonts.googleapis.com https://maxcdn.bootstrapcdn.com https://p.typekit.net https://pro.fontawesome.com https://use.fontawesome.com https://use.typekit.net; report-uri https://csp.withgoogle.com/csp/amp
content-encoding
br
x-content-type-options
nosniff
age
285467
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
4850
x-xss-protection
0
server
sffe
date
Sat, 12 Dec 2020 05:27:52 GMT
strict-transport-security
max-age=31536000; includeSubDomains; preload
content-type
text/javascript
access-control-allow-origin
*
vary
Accept-Encoding
cache-control
public, max-age=31536000
etag
"77bd676d834aaa8d"
accept-ranges
bytes
timing-allow-origin
*
expires
Sun, 12 Dec 2021 05:27:52 GMT
amp-analytics-0.1.mjs
cdn.ampproject.org/rtv/012010270040000/v0/ Frame C794
90 KB
27 KB
Script
General
Full URL
https://cdn.ampproject.org/rtv/012010270040000/v0/amp-analytics-0.1.mjs
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020120801.js
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:81f::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
477549a4d5fb644cda6bf64af01631b8411022d88e608bbd8e5a06e327b391cb
Security Headers
Name Value
Content-Security-Policy default-src * blob: data:; script-src blob: https://cdn.ampproject.org/esm/ https://cdn.ampproject.org/lts/ https://cdn.ampproject.org/mp/ https://cdn.ampproject.org/rtv/ https://cdn.ampproject.org/sp/ https://cdn.ampproject.org/sw/ https://cdn.ampproject.org/v0.js https://cdn.ampproject.org/v0.mjs https://cdn.ampproject.org/v0/ https://cdn.ampproject.org/viewer/; object-src 'none'; style-src 'unsafe-inline' https://cdn.ampproject.org/rtv/ https://cdn.materialdesignicons.com https://cloud.typography.com https://fast.fonts.net https://fonts.googleapis.com https://maxcdn.bootstrapcdn.com https://p.typekit.net https://pro.fontawesome.com https://use.fontawesome.com https://use.typekit.net; report-uri https://csp.withgoogle.com/csp/amp
Strict-Transport-Security max-age=31536000; includeSubDomains; preload
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

content-security-policy
default-src * blob: data:; script-src blob: https://cdn.ampproject.org/esm/ https://cdn.ampproject.org/lts/ https://cdn.ampproject.org/mp/ https://cdn.ampproject.org/rtv/ https://cdn.ampproject.org/sp/ https://cdn.ampproject.org/sw/ https://cdn.ampproject.org/v0.js https://cdn.ampproject.org/v0.mjs https://cdn.ampproject.org/v0/ https://cdn.ampproject.org/viewer/; object-src 'none'; style-src 'unsafe-inline' https://cdn.ampproject.org/rtv/ https://cdn.materialdesignicons.com https://cloud.typography.com https://fast.fonts.net https://fonts.googleapis.com https://maxcdn.bootstrapcdn.com https://p.typekit.net https://pro.fontawesome.com https://use.fontawesome.com https://use.typekit.net; report-uri https://csp.withgoogle.com/csp/amp
content-encoding
br
x-content-type-options
nosniff
age
475637
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
27668
x-xss-protection
0
server
sffe
date
Thu, 10 Dec 2020 00:38:22 GMT
strict-transport-security
max-age=31536000; includeSubDomains; preload
content-type
text/javascript
access-control-allow-origin
*
vary
Accept-Encoding
cache-control
public, max-age=31536000
etag
"1304c1c0caf7ca3c"
accept-ranges
bytes
timing-allow-origin
*
expires
Fri, 10 Dec 2021 00:38:22 GMT
amp-fit-text-0.1.mjs
cdn.ampproject.org/rtv/012010270040000/v0/ Frame C794
3 KB
1 KB
Script
General
Full URL
https://cdn.ampproject.org/rtv/012010270040000/v0/amp-fit-text-0.1.mjs
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020120801.js
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:81f::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
a86753d4effe5e607d4eaf03fe37eccb8cac743a528f874f736f4d7f35e094b1
Security Headers
Name Value
Content-Security-Policy default-src * blob: data:; script-src blob: https://cdn.ampproject.org/esm/ https://cdn.ampproject.org/lts/ https://cdn.ampproject.org/mp/ https://cdn.ampproject.org/rtv/ https://cdn.ampproject.org/sp/ https://cdn.ampproject.org/sw/ https://cdn.ampproject.org/v0.js https://cdn.ampproject.org/v0.mjs https://cdn.ampproject.org/v0/ https://cdn.ampproject.org/viewer/; object-src 'none'; style-src 'unsafe-inline' https://cdn.ampproject.org/rtv/ https://cdn.materialdesignicons.com https://cloud.typography.com https://fast.fonts.net https://fonts.googleapis.com https://maxcdn.bootstrapcdn.com https://p.typekit.net https://pro.fontawesome.com https://use.fontawesome.com https://use.typekit.net; report-uri https://csp.withgoogle.com/csp/amp
Strict-Transport-Security max-age=31536000; includeSubDomains; preload
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

content-security-policy
default-src * blob: data:; script-src blob: https://cdn.ampproject.org/esm/ https://cdn.ampproject.org/lts/ https://cdn.ampproject.org/mp/ https://cdn.ampproject.org/rtv/ https://cdn.ampproject.org/sp/ https://cdn.ampproject.org/sw/ https://cdn.ampproject.org/v0.js https://cdn.ampproject.org/v0.mjs https://cdn.ampproject.org/v0/ https://cdn.ampproject.org/viewer/; object-src 'none'; style-src 'unsafe-inline' https://cdn.ampproject.org/rtv/ https://cdn.materialdesignicons.com https://cloud.typography.com https://fast.fonts.net https://fonts.googleapis.com https://maxcdn.bootstrapcdn.com https://p.typekit.net https://pro.fontawesome.com https://use.fontawesome.com https://use.typekit.net; report-uri https://csp.withgoogle.com/csp/amp
content-encoding
br
x-content-type-options
nosniff
age
355559
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
1350
x-xss-protection
0
server
sffe
date
Fri, 11 Dec 2020 09:59:40 GMT
strict-transport-security
max-age=31536000; includeSubDomains; preload
content-type
text/javascript
access-control-allow-origin
*
vary
Accept-Encoding
cache-control
public, max-age=31536000
etag
"12c034eb739190af"
accept-ranges
bytes
timing-allow-origin
*
expires
Sat, 11 Dec 2021 09:59:40 GMT
amp-form-0.1.mjs
cdn.ampproject.org/rtv/012010270040000/v0/ Frame C794
41 KB
13 KB
Script
General
Full URL
https://cdn.ampproject.org/rtv/012010270040000/v0/amp-form-0.1.mjs
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020120801.js
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:81f::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
b61eb57ae77f31b91b04781da33023ecd897fda21f6c817e6c27623204046f42
Security Headers
Name Value
Content-Security-Policy default-src * blob: data:; script-src blob: https://cdn.ampproject.org/esm/ https://cdn.ampproject.org/lts/ https://cdn.ampproject.org/mp/ https://cdn.ampproject.org/rtv/ https://cdn.ampproject.org/sp/ https://cdn.ampproject.org/sw/ https://cdn.ampproject.org/v0.js https://cdn.ampproject.org/v0.mjs https://cdn.ampproject.org/v0/ https://cdn.ampproject.org/viewer/; object-src 'none'; style-src 'unsafe-inline' https://cdn.ampproject.org/rtv/ https://cdn.materialdesignicons.com https://cloud.typography.com https://fast.fonts.net https://fonts.googleapis.com https://maxcdn.bootstrapcdn.com https://p.typekit.net https://pro.fontawesome.com https://use.fontawesome.com https://use.typekit.net; report-uri https://csp.withgoogle.com/csp/amp
Strict-Transport-Security max-age=31536000; includeSubDomains; preload
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

content-security-policy
default-src * blob: data:; script-src blob: https://cdn.ampproject.org/esm/ https://cdn.ampproject.org/lts/ https://cdn.ampproject.org/mp/ https://cdn.ampproject.org/rtv/ https://cdn.ampproject.org/sp/ https://cdn.ampproject.org/sw/ https://cdn.ampproject.org/v0.js https://cdn.ampproject.org/v0.mjs https://cdn.ampproject.org/v0/ https://cdn.ampproject.org/viewer/; object-src 'none'; style-src 'unsafe-inline' https://cdn.ampproject.org/rtv/ https://cdn.materialdesignicons.com https://cloud.typography.com https://fast.fonts.net https://fonts.googleapis.com https://maxcdn.bootstrapcdn.com https://p.typekit.net https://pro.fontawesome.com https://use.fontawesome.com https://use.typekit.net; report-uri https://csp.withgoogle.com/csp/amp
content-encoding
br
x-content-type-options
nosniff
age
353671
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
13075
x-xss-protection
0
server
sffe
date
Fri, 11 Dec 2020 10:31:08 GMT
strict-transport-security
max-age=31536000; includeSubDomains; preload
content-type
text/javascript
access-control-allow-origin
*
vary
Accept-Encoding
cache-control
public, max-age=31536000
etag
"1e8a1dae72af56cd"
accept-ranges
bytes
timing-allow-origin
*
expires
Sat, 11 Dec 2021 10:31:08 GMT
css
fonts.googleapis.com/ Frame C794
6 KB
701 B
Stylesheet
General
Full URL
https://fonts.googleapis.com/css?family=Roboto:300|Roboto:400,500&lang=nl
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020120801.js
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:802::200a Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
ESF /
Resource Hash
56e4953af5c01ed820d5e5dc430e77234a87e8d019c38fda46f9f3593cd05e0f
Security Headers
Name Value
Strict-Transport-Security max-age=31536000
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

strict-transport-security
max-age=31536000
content-encoding
gzip
x-content-type-options
nosniff
cross-origin-resource-policy
cross-origin
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
x-xss-protection
0
last-modified
Tue, 15 Dec 2020 11:34:38 GMT
server
ESF
date
Tue, 15 Dec 2020 12:45:39 GMT
x-frame-options
SAMEORIGIN
content-type
text/css; charset=utf-8
access-control-allow-origin
*
cache-control
private, max-age=86400, stale-while-revalidate=604800
timing-allow-origin
*
link
<https://fonts.gstatic.com>; rel=preconnect; crossorigin
expires
Tue, 15 Dec 2020 12:45:39 GMT
css
fonts.googleapis.com/ Frame C794
4 KB
1 KB
Stylesheet
General
Full URL
https://fonts.googleapis.com/css?family=Roboto:400,500&text=
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020120801.js
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:802::200a Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
ESF /
Resource Hash
2190c16423c2557bcb20ccba2edc176fbeb16e6a3de2b2af297f650aae85a43e
Security Headers
Name Value
Strict-Transport-Security max-age=31536000
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

strict-transport-security
max-age=31536000
content-encoding
gzip
x-content-type-options
nosniff
cross-origin-resource-policy
cross-origin
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
x-xss-protection
0
last-modified
Tue, 15 Dec 2020 11:56:33 GMT
server
ESF
date
Tue, 15 Dec 2020 12:45:39 GMT
x-frame-options
SAMEORIGIN
content-type
text/css; charset=utf-8
access-control-allow-origin
*
cache-control
private, max-age=86400, stale-while-revalidate=604800
timing-allow-origin
*
link
<https://fonts.gstatic.com>; rel=preconnect; crossorigin
expires
Tue, 15 Dec 2020 12:45:39 GMT
en.png
tpc.googlesyndication.com/pagead/images/adchoices/ Frame C794
2 KB
2 KB
Image
General
Full URL
https://tpc.googlesyndication.com/pagead/images/adchoices/en.png
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020120801.js
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:81d::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
36133ca07927c88a7cc578fddbaed3c668ab75087834d0ca13dca5de4ec856c1
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

timing-allow-origin
*
date
Mon, 14 Dec 2020 23:34:27 GMT
x-content-type-options
nosniff
server
cafe
age
47472
etag
14819457070020093239
vary
Accept-Encoding
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
cache-control
public, max-age=86400
cross-origin-resource-policy
cross-origin
content-type
image/png
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
2502
x-xss-protection
0
expires
Tue, 15 Dec 2020 23:34:27 GMT
icon.png
tpc.googlesyndication.com/pagead/images/adchoices/ Frame C794
295 B
325 B
Image
General
Full URL
https://tpc.googlesyndication.com/pagead/images/adchoices/icon.png
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020120801.js
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:81d::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
7fd59024b6ca83f11f7a3448ec148309a13b705725716df134f699e60a96eb1b
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

timing-allow-origin
*
date
Mon, 14 Dec 2020 21:53:21 GMT
x-content-type-options
nosniff
server
cafe
age
53538
etag
426692510519060060
vary
Accept-Encoding
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
cache-control
public, max-age=86400
cross-origin-resource-policy
cross-origin
content-type
image/png
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
295
x-xss-protection
0
expires
Tue, 15 Dec 2020 21:53:21 GMT
truncated
/ Frame C794
216 B
0
Image
General
Full URL
data:truncated
Protocol
DATA
Server
-, , ASN (),
Reverse DNS
Software
/
Resource Hash
bd5d490c8584f656521647c9547ca8310bf83d08dff27f73a7295a8b9407e682

Request headers

Referer
https://www.dailymail.co.uk/
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Content-Type
image/png
downsize_200k_v1
tpc.googlesyndication.com/simgad/11860752003366304664/ Frame C794
8 KB
8 KB
Image
General
Full URL
https://tpc.googlesyndication.com/simgad/11860752003366304664/downsize_200k_v1?sqp=4sqPyQSWAUKTAQgAEhQNzczMPhUAAABAHQAAAAAlAAAAABgAIgoNAACAPxUAAIA_Kk8IWhABHQAAtEIgASgBMAY4A0CAwtcvSABQAFgAYFpwAngAgAEAiAEAkAEAnQEAAIA_oAEAqAEAsAGAreIEuAH___________8BxQEtsp0-MhoImQMQ1gEYASABLQAAAD8wmgM41gFFAACAPw&rs=AOga4qnnKWwwc2DFk-3F4ud_FPuRBcZ61A
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:81d::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
23e464e3d5c25100784cb720208b6e3d0c052a37953f1f0d901ab3b1ad5ca564
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:45:39 GMT
x-content-type-options
nosniff
last-modified
Wed, 11 Nov 2020 14:52:30 GMT
server
sffe
content-type
image/jpeg
access-control-allow-origin
*
cache-control
public, max-age=31536000
cross-origin-resource-policy
cross-origin
accept-ranges
bytes
timing-allow-origin
*
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
8051
x-xss-protection
0
expires
Wed, 15 Dec 2021 12:45:39 GMT
downsize_200k_v1
tpc.googlesyndication.com/simgad/12301430751875938281/ Frame C794
15 KB
16 KB
Image
General
Full URL
https://tpc.googlesyndication.com/simgad/12301430751875938281/downsize_200k_v1?sqp=4sqPyQR5QncIABIUDc3MzD4VAAAAQB0AAAAAJQAAAAAYACIKDQAAgD8VAACAPypPCFoQAR0AALRCIAEoATAGOANAgMLXL0gAUABYAGBacAJ4AIABAIgBAJABAJ0BAACAP6ABAKgBALABgK3iBLgB____________AcUBLbKdPg&rs=AOga4qmpAJ2aOi-parO2BsA0xfAB-F2E-A
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:81d::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
e274ee0cc1158eba5e5eac24da735b4f5bd0f12fbcc9c744dfadacaf687bfd6c
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 08:43:49 GMT
x-content-type-options
nosniff
last-modified
Wed, 11 Nov 2020 14:52:30 GMT
server
sffe
age
14510
content-type
image/jpeg
access-control-allow-origin
*
cache-control
public, max-age=31536000
cross-origin-resource-policy
cross-origin
accept-ranges
bytes
timing-allow-origin
*
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
15850
x-xss-protection
0
expires
Wed, 15 Dec 2021 08:43:49 GMT
adview
securepubads.g.doubleclick.net/pagead/ Frame C794
0
0
Image
General
Full URL
https://securepubads.g.doubleclick.net/pagead/adview?ai=C7HlK8q_YX5eXMIOC-gbo0ZewCLCS2r9g9Kjp6bcM2NiVmEMQASCs2bgiYJGEk4X8F6ABs6O34wPIAQapAr8-RoZnYbQ-4AIAqAMByAMKqgTFAk_Qz9FgDJCjWQJIZNiFnI677Na3onsEcEh04Kj2aaNk7tFam2r1tzGVM7_vaTHX4XiVWaTo63fojgi3Mz9bpn-hjW-9NoQAM4VU-2YSRfgFUqubzZqSP30QFGkh8n6yTfZ6ZFQz6btDhCzyOD3Ru5PiLpOSGfQgUetDHm4eDcQ3eBxxjmQ5toGL1DXMRr0XCjc3Tll_IhPdTj8vMMk1Dcz9f8BZ_mSw3WN3MoOKLnFsktDJFhcyFxYVoATs9JY3SgTrUNCmyQw_f31RHlkr7xvk-21sCKmTid-hH-NBFTqNuzeUd1E2HfheAFyGo2qmDAT9OQDGBQXei-voWWMNVDInZN9rtz90Bhr6uUl7egqvsYo-lINpa6NpS5yxpaAM_vhipZ5D1ZYoOwh8n_Sgm3JvGygeljdmc76RVrLZNNt912KgH03ABJD_iPC-A-AEAZIFBAgEGAGSBQQIBRgEoAY3gAe13MgcqAfVyRuoB_DZG6gH8tkbqAeUmLECqAel3xuoB47OG6gHk9gbqAe6BqgH7paxAqgHpr4bqAfs1RvYBwHyBwQQ-YgY0ggJCIDhgFAQARgdgAoDyAsB2BMNiBQCshcaChgIARIUcHViLTQxODA4MzU2OTQxNjYyNTU&sigh=wFRTWVNpCdU&template_id=492&tpd=AGWhJmu0pvKy52L8whWuV65WsSPNq74vqEIXXDdoB81aRzBjXw
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
172.217.22.2 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
fra16s14-in-f2.1e100.net
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
https://www.dailymail.co.uk/
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

bid
c.amazon-adsystem.com/e/dtb/
24 B
374 B
XHR
General
Full URL
https://c.amazon-adsystem.com/e/dtb/bid?src=3065&u=https%3A%2F%2Fwww.dailymail.co.uk%2Fsciencetech%2Farticle-9050821%2FRemdesivir-beneficial-patients-doctors-reveal.html%3F_hsmi%3D88974744%26_hsenc%3Dp2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8&pid=qkqBHoBAnjHbV&cb=15&ws=1600x1200&v=7.58.01&t=2000&slots=%5B%7B%22sd%22%3A%22mpu_left%22%2C%22s%22%3A%5B%22300x250%22%5D%2C%22kv%22%3A%7B%22pubcid%22%3A%223093664108%22%7D%7D%5D&gdprl=%7B%22status%22%3A%22no-cmp%22%7D
Requested by
Host: c.amazon-adsystem.com
URL: https://c.amazon-adsystem.com/aax2/apstag.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
99.84.88.20 Seattle, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-99-84-88-20.muc50.r.cloudfront.net
Software
Server /
Resource Hash
08ec332c446e727696ff53c4c9ee2f3f5f605ce5672021e9691f89bd12c02f43

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:45:39 GMT
via
1.1 fe36c7f30c8ef2853edecc43f320092c.cloudfront.net (CloudFront)
server
Server
x-amz-cf-pop
MUC50-C1
vary
User-Agent
x-cache
Miss from cloudfront
content-type
text/javascript;charset=UTF-8
access-control-allow-origin
https://www.dailymail.co.uk
access-control-allow-credentials
true
timing-allow-origin
*
content-length
24
x-amz-cf-id
0d6RJgCaPlNpycPKMsmXAZYR8oB6NcS2OZnYtAxe8jNVRbM-c-mLrg==
si
googleads.g.doubleclick.net/pagead/drt/ Frame 63F6
Redirect Chain
  • https://www.google.com/pagead/drt/ui
  • https://googleads.g.doubleclick.net/pagead/drt/si
0
0
Image
General
Full URL
https://googleads.g.doubleclick.net/pagead/drt/si
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:816::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Redirect headers

date
Tue, 15 Dec 2020 12:45:43 GMT
x-content-type-options
nosniff
server
safe
content-type
text/html; charset=UTF-8
location
https://googleads.g.doubleclick.net/pagead/drt/si
cache-control
private
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
246
x-xss-protection
0
video_info
context.iris.tv/
191 B
524 B
XHR
General
Full URL
https://context.iris.tv/video_info?access_token=1d9f05c8b00daddfbffcf5afa8a0691bf6370c0cd9dfc8bc6fb38e13c4474dab&global=GlobalIrisPlayer&client_token=W491AUI45FTTFWD&platform_id=105387676350826941
Requested by
Host: ovp.iris.tv
URL: https://ovp.iris.tv/libs/context/iris-context.min.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
65.9.73.71 Seattle, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
Zer01ne /
Resource Hash
32ca65da0fd8419f8c29c5974dba7d902eed28732c475d6d2690e7c81b01313f

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:42:07 GMT
via
1.1 3ffec0ecfde687fb371812ad42f5cfc2.cloudfront.net (CloudFront)
server
Zer01ne
age
212
x-cache
Hit from cloudfront
content-type
application/json
access-control-allow-origin
*
cache-control
max-age=3600, stale-while-revalidate=600, stale-if-error=600
x-amz-cf-pop
AMS1-C1
x-robots-tag
noindex, follow
x-amz-cf-id
fc6d2QmxxMlN2fpBHzxwWBNqzX5QXVwj1OncYV3E-G-7WKL3QYRAiQ==
video_info
context.iris.tv/
191 B
525 B
XHR
General
Full URL
https://context.iris.tv/video_info?access_token=1d9f05c8b00daddfbffcf5afa8a0691bf6370c0cd9dfc8bc6fb38e13c4474dab&global=GlobalIrisPlayer&client_token=W491AUI45FTTFWD&platform_id=105387676350826941
Requested by
Host: ovp.iris.tv
URL: https://ovp.iris.tv/libs/context/iris-context.min.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
65.9.73.71 Seattle, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
Zer01ne /
Resource Hash
32ca65da0fd8419f8c29c5974dba7d902eed28732c475d6d2690e7c81b01313f

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 11:41:46 GMT
via
1.1 3ffec0ecfde687fb371812ad42f5cfc2.cloudfront.net (CloudFront)
server
Zer01ne
age
2795
x-cache
Miss from cloudfront
content-type
application/json
access-control-allow-origin
*
cache-control
max-age=3600, stale-while-revalidate=600, stale-if-error=600
x-amz-cf-pop
AMS1-C1
x-robots-tag
noindex, follow
x-amz-cf-id
fYKjHsYRzpC9j2cBte3xwNoH_GUJT0JK1-JutavtozSL-5LnquY6gQ==
partner
sync.search.spotxchange.com/
0
588 B
Image
General
Full URL
https://sync.search.spotxchange.com/partner?source=dados
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
185.94.180.126 , Netherlands, ASN35220 (SPOTX-AMS, NL),
Reverse DNS
Software
nginx /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

x-spotx-halt-type
Audience Dsp sync Priority Sync endpoint Source ID is not on enabled source whitelist
Date
Tue, 15 Dec 2020 12:45:43 GMT
Server
nginx
Access-Control-Allow-Methods
GET, POST, OPTIONS
Content-Type
text/plain
Access-Control-Allow-Origin
*
Cache-Control
no-store, no-cache, must-revalidate, proxy-revalidate, max-age=0
Access-Control-Allow-Credentials
false
X-fe
88
Connection
keep-alive
Content-Length
0
bid
c.amazon-adsystem.com/e/dtb/
24 B
372 B
XHR
General
Full URL
https://c.amazon-adsystem.com/e/dtb/bid?src=3065&u=https%3A%2F%2Fwww.dailymail.co.uk%2Fsciencetech%2Farticle-9050821%2FRemdesivir-beneficial-patients-doctors-reveal.html%3F_hsmi%3D88974744%26_hsenc%3Dp2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8&pid=qkqBHoBAnjHbV&cb=16&ws=1600x1200&v=7.58.01&t=2000&slots=%5B%7B%22id%22%3A%22jw_video_desktop%22%2C%22mt%22%3A%22v%22%2C%22kv%22%3A%7B%22pubcid%22%3A%223093664108%22%7D%7D%5D&gdprl=%7B%22status%22%3A%22no-cmp%22%7D
Requested by
Host: c.amazon-adsystem.com
URL: https://c.amazon-adsystem.com/aax2/apstag.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
99.84.88.20 Seattle, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-99-84-88-20.muc50.r.cloudfront.net
Software
Server /
Resource Hash
134f4a39b11972e436ad81464caa48cf07310f1d14e4397a763c4b30782ea3bf

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:45:39 GMT
via
1.1 fe36c7f30c8ef2853edecc43f320092c.cloudfront.net (CloudFront)
server
Server
x-amz-cf-pop
MUC50-C1
vary
User-Agent
x-cache
Miss from cloudfront
content-type
text/javascript;charset=UTF-8
access-control-allow-origin
https://www.dailymail.co.uk
access-control-allow-credentials
true
timing-allow-origin
*
content-length
24
x-amz-cf-id
62lpkoT0hdGUWehoD2mbInlo1ib5ZivkmdTkdSwhzEBeIR90hbsi8Q==
auction
prebid.adnxs.com/pbs/v1/openrtb2/
150 B
499 B
XHR
General
Full URL
https://prebid.adnxs.com/pbs/v1/openrtb2/auction
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/static/mol-adverts/demo/mol-22070/19a28e0b/mol-adverts.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
37.252.161.190 , Ascension Island, ASN29990 (ASN-APPNEX, US),
Reverse DNS
prebid.ams1.adnexus.net
Software
nginx/1.19.0 /
Resource Hash
4674214087eb1d9b29f2815e55933612f7809ccb14197e813a489cb7a05775e7

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type
text/plain

Response headers

Pragma
no-cache
Date
Tue, 15 Dec 2020 12:45:39 GMT
Server
nginx/1.19.0
Vary
Origin
Content-Type
application/json
Access-Control-Allow-Origin
https://www.dailymail.co.uk
Cache-Control
no-cache, no-store, must-revalidate
Access-Control-Allow-Credentials
true
Connection
keep-alive
Content-Length
150
Expires
0
prebid
ib.adnxs.com/ut/v3/
19 B
716 B
XHR
General
Full URL
https://ib.adnxs.com/ut/v3/prebid
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/static/mol-adverts/demo/mol-22070/19a28e0b/mol-adverts.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_ECDSA, AES_128_GCM
Server
185.33.221.13 , Netherlands, ASN29990 (ASN-APPNEX, US),
Reverse DNS
729.bm-nginx-loadbalancer.mgmt.ams1.adnexus.net
Software
nginx/1.17.9 /
Resource Hash
0c09c070833c786cb25be38bc30992b30bad578f817dbc9e34beacd8b8ea44c5
Security Headers
Name Value
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type
text/plain

Response headers

Pragma
no-cache
Date
Tue, 15 Dec 2020 12:45:39 GMT
X-Proxy-Origin
185.212.171.67; 185.212.171.67; 729.bm-nginx-loadbalancer.mgmt.ams1; *.adnxs.com; 185.33.223.48:80
AN-X-Request-Uuid
21af4dab-4850-4bbb-b88b-e8b77845b8ae
Server
nginx/1.17.9
P3P
policyref="http://cdn.adnxs.com/w3c/policy/p3p.xml", CP="NOI DSP COR ADM PSAo PSDo OURo SAMo UNRo OTRo BUS COM NAV DEM STA PRE"
Access-Control-Allow-Origin
https://www.dailymail.co.uk
Cache-Control
no-store, no-cache, private
Access-Control-Allow-Credentials
true
Connection
keep-alive
Content-Type
application/json; charset=utf-8
Content-Length
19
X-XSS-Protection
0
Expires
Sat, 15 Nov 2008 16:00:00 GMT
cygnus
htlb.casalemedia.com/
26 B
376 B
XHR
General
Full URL
https://htlb.casalemedia.com/cygnus?s=293354&v=8.1&r=%7B%22id%22%3A%22192ca02b1b438723%22%2C%22imp%22%3A%5B%7B%22id%22%3A%22193e23b4ac0d0f5f%22%2C%22ext%22%3A%7B%22siteID%22%3A%22293354%22%2C%22sid%22%3A%22401x225%22%7D%2C%22video%22%3A%7B%22startdelay%22%3A0%2C%22mimes%22%3A%5B%22video%2Fmp4%22%2C%22video%2Fwebm%22%2C%22application%2Fjavascript%22%5D%2C%22minduration%22%3A0%2C%22maxduration%22%3A30%2C%22protocols%22%3A%5B1%2C2%2C3%2C4%2C5%2C6%5D%2C%22api%22%3A%5B1%2C2%5D%2C%22w%22%3A401%2C%22h%22%3A225%2C%22placement%22%3A1%7D%7D%5D%2C%22site%22%3A%7B%22page%22%3A%22https%3A%2F%2Fwww.dailymail.co.uk%2Fsciencetech%2Farticle-9050821%2FRemdesivir-beneficial-patients-doctors-reveal.html%3F_hsmi%3D88974744%26_hsenc%3Dp2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8%22%7D%2C%22ext%22%3A%7B%22source%22%3A%22prebid%22%7D%7D&ac=j&sd=1&nf=1
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/static/mol-adverts/demo/mol-22070/19a28e0b/mol-adverts.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
104.111.215.135 , Netherlands, ASN16625 (AKAMAI-AS, US),
Reverse DNS
a104-111-215-135.deploy.static.akamaitechnologies.com
Software
Apache /
Resource Hash
7a3a8db6fd06370e8be5037e3bde99fdb9e557d660ae7ee212b37e6af7e63e38

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type
text/plain

Response headers

pragma
no-cache
date
Tue, 15 Dec 2020 12:45:39 GMT
content-encoding
gzip
x-ak-initial-geo
CC:[NL], RC:[], CN:[EU], CIP:[185.212.171.67], XFF:[]
server
Apache
vary
Is-Traffic-Invalid,Accept-Encoding
content-type
application/json
access-control-allow-origin
https://www.dailymail.co.uk
x-cs-client-geo
12
cache-control
max-age=0, no-cache, no-store
access-control-allow-credentials
true
content-length
46
x-ak-client-geo
12
expires
Tue, 15 Dec 2020 12:45:39 GMT
avjp
mailonline-uk-d.openx.net/v/1.0/
92 B
282 B
XHR
General
Full URL
https://mailonline-uk-d.openx.net/v/1.0/avjp?ju=https%3A%2F%2Fwww.dailymail.co.uk%2Fsciencetech%2Farticle-9050821%2FRemdesivir-beneficial-patients-doctors-reveal.html%3F_hsmi%3D88974744%26_hsenc%3Dp2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8&ch=UTF-8&res=1600x1200x24&ifr=false&tz=-60&tws=1600x1200&be=1&bc=hb_pb_3.0.3&dddid=b453048d-75a3-4fef-a410-0665ec96f9c2&nocache=1608036339280&pubcid=84f1103b-a980-4860-8c6e-1866bcc8525c&auid=540675388&vwd=401&vht=225
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/static/mol-adverts/demo/mol-22070/19a28e0b/mol-adverts.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
35.244.159.8 Mountain View, United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
OXGW/16.199.0 /
Resource Hash
004e5faf0bf890f61697daeede9f21826affd1137fb2cb58eaf4719937a04a14

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type
text/plain

Response headers

pragma
no-cache
date
Tue, 15 Dec 2020 12:45:39 GMT
via
1.1 google
server
OXGW/16.199.0
p3p
CP="CUR ADM OUR NOR STA NID"
access-control-allow-origin
https://www.dailymail.co.uk
cache-control
private, max-age=0, no-cache
access-control-allow-credentials
true
content-type
application/json
alt-svc
clear
content-length
92
expires
Mon, 26 Jul 1997 05:00:00 GMT
openrtb
ads.adaptv.advertising.com/rtb/
0
220 B
XHR
General
Full URL
https://ads.adaptv.advertising.com/rtb/openrtb?ext_id=MailOnline
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/static/mol-adverts/demo/mol-22070/19a28e0b/mol-adverts.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
52.59.160.25 Frankfurt am Main, Germany, ASN16509 (AMAZON-02, US),
Reverse DNS
ec2-52-59-160-25.eu-central-1.compute.amazonaws.com
Software
adaptv/1.0 /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type
text/plain

Response headers

access-control-allow-origin
https://www.dailymail.co.uk
access-control-allow-credentials
true
server
adaptv/1.0
Connection
keep-alive
content-length
0
content-type
application/json
3331366516218933350
tpc.googlesyndication.com/simgad/ Frame 63F6
28 KB
28 KB
Image
General
Full URL
https://tpc.googlesyndication.com/simgad/3331366516218933350?sqp=4sqPyQQ7QjkqNxABHQAAtEIgASgBMAk4A0DwkwlYAWBfcAKAAQGIAQGdAQAAgD-oAQGwAYCt4gS4AV_FAS2ynT4&rs=AOga4qmYDCb36CzpN-IY8nY25ACpqDrq9A
Requested by
Host: cdn.ampproject.org
URL: https://cdn.ampproject.org/rtv/012010270040000/amp4ads-v0.mjs
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:81d::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
f1665d05085b2ed9ee80a1c0a7f585f2bce8bf6c25a80ec9301c4bbfb572b3f5
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Mon, 14 Dec 2020 22:09:57 GMT
x-content-type-options
nosniff
last-modified
Tue, 27 Oct 2020 22:34:36 GMT
server
sffe
age
52542
content-type
image/png
access-control-allow-origin
*
cache-control
public, max-age=31536000
cross-origin-resource-policy
cross-origin
accept-ranges
bytes
timing-allow-origin
*
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
28993
x-xss-protection
0
expires
Tue, 14 Dec 2021 22:09:57 GMT
en.png
tpc.googlesyndication.com/pagead/images/adchoices/ Frame 63F6
2 KB
2 KB
Image
General
Full URL
https://tpc.googlesyndication.com/pagead/images/adchoices/en.png
Requested by
Host: cdn.ampproject.org
URL: https://cdn.ampproject.org/rtv/012010270040000/amp4ads-v0.mjs
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:81d::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
36133ca07927c88a7cc578fddbaed3c668ab75087834d0ca13dca5de4ec856c1
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

timing-allow-origin
*
date
Mon, 14 Dec 2020 23:34:27 GMT
x-content-type-options
nosniff
server
cafe
age
47472
etag
14819457070020093239
vary
Accept-Encoding
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
cache-control
public, max-age=86400
cross-origin-resource-policy
cross-origin
content-type
image/png
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
2502
x-xss-protection
0
expires
Tue, 15 Dec 2020 23:34:27 GMT
icon.png
tpc.googlesyndication.com/pagead/images/adchoices/ Frame 63F6
295 B
320 B
Image
General
Full URL
https://tpc.googlesyndication.com/pagead/images/adchoices/icon.png
Requested by
Host: cdn.ampproject.org
URL: https://cdn.ampproject.org/rtv/012010270040000/amp4ads-v0.mjs
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:81d::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
7fd59024b6ca83f11f7a3448ec148309a13b705725716df134f699e60a96eb1b
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

timing-allow-origin
*
date
Mon, 14 Dec 2020 21:53:21 GMT
x-content-type-options
nosniff
server
cafe
age
53538
etag
426692510519060060
vary
Accept-Encoding
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
cache-control
public, max-age=86400
cross-origin-resource-policy
cross-origin
content-type
image/png
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
295
x-xss-protection
0
expires
Tue, 15 Dec 2020 21:53:21 GMT
2
www.dailymail.co.uk/abe/a9/price/
4 B
703 B
XHR
General
Full URL
https://www.dailymail.co.uk/abe/a9/price/2
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/static/mol-adverts/demo/mol-22070/19a28e0b/mol-adverts.js
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2a02:26f0:6c00:296::11ae , Ascension Island, ASN20940 (AKAMAI-ASN1, EU),
Reverse DNS
Software
AmazonS3 /
Resource Hash
561b2814d3c09e62a92442c946307918f7f63f833c84876c08bd4c406767e53b

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

x-amz-version-id
wDnvhJJXpo3tPt4.QtsManRqQALbFlHY
content-security-policy-report-only
block-all-mixed-content; report-uri https://mol.report-uri.io/r/default/csp/reportOnly
last-modified
Thu, 26 Jul 2018 09:55:16 GMT
server
AmazonS3
x-amz-request-id
2Z4KDQ1N7H5GAG6P
etag
"f7ddd489ab0a82567b241b05971cbdb3"
vary
User-Agent
content-type
text/plain
cache-control
public, max-age=1146254
date
Tue, 15 Dec 2020 12:45:39 GMT
x-amz-replication-status
COMPLETED
server-timing
cdn-cache; desc=HIT, edge; dur=1
accept-ranges
bytes
content-length
4
x-amz-id-2
TQa+V4AfiJ7Bmz5eGVXtXeerNKKqRrPt9yBoXYXtX5TNMag04HicxY48/1EyJyZRcnVJVxDSTyI=
KFOlCnqEu92Fr1MmEU9fBBc4AMP6lQ.woff2
fonts.gstatic.com/s/roboto/v20/ Frame C794
11 KB
11 KB
Font
General
Full URL
https://fonts.gstatic.com/s/roboto/v20/KFOlCnqEu92Fr1MmEU9fBBc4AMP6lQ.woff2
Requested by
Host: fonts.googleapis.com
URL: https://fonts.googleapis.com/css?family=Roboto:300|Roboto:400,500&lang=nl
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:825::2003 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
ce897833ac6e362df7c91ac8223fe511c6defcf33964928a81004600a2dd4c2e
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Origin
https://www.dailymail.co.uk
Referer
https://fonts.googleapis.com/css?family=Roboto:300|Roboto:400,500&lang=nl
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Mon, 14 Dec 2020 22:21:20 GMT
x-content-type-options
nosniff
last-modified
Wed, 24 Jul 2019 01:18:48 GMT
server
sffe
age
51859
content-type
font/woff2
access-control-allow-origin
*
cache-control
public, max-age=31536000
accept-ranges
bytes
timing-allow-origin
*
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
11056
x-xss-protection
0
expires
Tue, 14 Dec 2021 22:21:20 GMT
KFOmCnqEu92Fr1Mu4mxKKTU1Kg.woff2
fonts.gstatic.com/s/roboto/v20/ Frame C794
11 KB
11 KB
Font
General
Full URL
https://fonts.gstatic.com/s/roboto/v20/KFOmCnqEu92Fr1Mu4mxKKTU1Kg.woff2
Requested by
Host: fonts.googleapis.com
URL: https://fonts.googleapis.com/css?family=Roboto:300|Roboto:400,500&lang=nl
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:825::2003 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
5d1bc9b443f3f81fa4b4ad4634c1bb9702194c1898e3a9de0ab5e2cdc0e9f479
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Origin
https://www.dailymail.co.uk
Referer
https://fonts.googleapis.com/css?family=Roboto:300|Roboto:400,500&lang=nl
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 08 Dec 2020 17:20:25 GMT
x-content-type-options
nosniff
last-modified
Wed, 24 Jul 2019 01:18:50 GMT
server
sffe
age
588314
content-type
font/woff2
access-control-allow-origin
*
cache-control
public, max-age=31536000
accept-ranges
bytes
timing-allow-origin
*
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
11016
x-xss-protection
0
expires
Wed, 08 Dec 2021 17:20:25 GMT
si
googleads.g.doubleclick.net/pagead/drt/ Frame A2A2
Redirect Chain
  • https://www.google.com/pagead/drt/ui
  • https://googleads.g.doubleclick.net/pagead/drt/si
0
0
Image
General
Full URL
https://googleads.g.doubleclick.net/pagead/drt/si
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:816::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Redirect headers

date
Tue, 15 Dec 2020 12:45:43 GMT
x-content-type-options
nosniff
server
safe
content-type
text/html; charset=UTF-8
location
https://googleads.g.doubleclick.net/pagead/drt/si
cache-control
private
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
246
x-xss-protection
0
iab
api.skimlinks.mgr.consensu.org/
772 B
944 B
XHR
General
Full URL
https://api.skimlinks.mgr.consensu.org/iab?nocache=1608036339422
Requested by
Host: s.skimresources.com
URL: https://s.skimresources.com/js/55199X1584066.skimlinks.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
35.190.40.172 Mountain View, United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
gunicorn/20.0.4 /
Resource Hash
3af1040f40683c251264df004d2ff25d93970cb1300258008256db650dd106fa

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:45:39 GMT
via
1.1 google
server
gunicorn/20.0.4
vary
Origin
content-type
text/html; charset=utf-8
access-control-allow-origin
https://www.dailymail.co.uk
access-control-allow-credentials
true
alt-svc
clear
content-length
772
link
t.skimresources.com/api/v2/
22 B
88 B
XHR
General
Full URL
https://t.skimresources.com/api/v2/link
Requested by
Host: s.skimresources.com
URL: https://s.skimresources.com/js/55199X1584066.skimlinks.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
35.201.67.47 , Ascension Island, ASN15169 (GOOGLE, US),
Reverse DNS
Software
Python/3.7 aiohttp/3.5.4 /
Resource Hash
fcc83a5b6aef86420c1ad553167106df96bd0ff4192ffe52b1647599948edbcf
Security Headers
Name Value
X-Content-Type-Options nosniff

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-type
text/plain

Response headers

pragma
no-cache
date
Tue, 15 Dec 2020 12:45:39 GMT
via
1.1 google
x-content-type-options
nosniff
server
Python/3.7 aiohttp/3.5.4
access-control-allow-headers
Origin, Accept, Content-Type, X-Requested-With, X-CSRF-Token
access-control-allow-methods
GET, POST, OPTIONS
content-type
text/plain; charset=utf-8, application/javascript
access-control-allow-origin
https://www.dailymail.co.uk
cache-control
no-store, no-cache, must-revalidate
access-control-allow-credentials
true
alt-svc
clear
content-length
22
ads
securepubads.g.doubleclick.net/gampad/
80 KB
26 KB
XHR
General
Full URL
https://securepubads.g.doubleclick.net/gampad/ads?gdfp_req=1&pvsid=2639827676159032&correlator=2455119041695441&output=ldjh&impl=fif&adsid=NT&eid=21069142&vrg=2020120801&guci=1.2.0.0.2.2.0.0&sc=1&sfv=1-0-37&ecs=20201215&iu_parts=5765%2Cdailymail.uk%2Cdm_dmsciencetech_sciencetechart%2Cmpu_left&enc_prev_ius=%2F0%2F1%2F2%2F3&prev_iu_szs=300x250&prev_scp=pos%3Dmpu_left%26adx_channel%3D20%26nobids%3Dfalse%26refreshCount%3D0%26amznbid%3D2%26amznsz%3D0x0%26amznp%3D2&eri=4&cust_params=page%3Dart%26article%3D9050821%26area%3Dsciencetech%26subarea%3Dsciencetech%26environment%3Dproduction%26country%3Dde%26abv%3Dmol-22070%252F19a28e0b%26bot%3Dfalse%26random%3D9ceebda3-1911-4085-b4cd-4ef660466486%26impid%3Dc0338c30-9d3e-46d6-8db6-95c14a8ccbca%26browserResolution%3Dmin_1244px%26device%3Dother%26device_features%3D%26articlewithvideo%3Dtrue%26style%3Dwide%26session%3D1%26session_page_ID%3Dnone%26utm_source%3Dnone%26watershed%3Dfalse%26location%3Ddailymail_co_uk%26id5%3Dtrue%26permutive%3D10277%252C31736%252Crts%26puid%3Db77f6280-fced-4776-aef9-89e90021e68b%26ptime%3D1608036337226&cookie=ID%3Dc89640a04ff12e60-2224152f66b90021%3AT%3D1608036337%3AS%3DALNI_MbVsEq-tT8SfQxgcA0onjF82FljWA&cdm=www.dailymail.co.uk&bc=31&abxe=1&dt=1608036339592&dlt=1608036336099&idt=1063&frm=20&biw=1600&bih=1200&oid=3&adxs=3&adys=670&adks=565397896&ucis=f&ifi=15&u_tz=60&u_his=2&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_sd=1&flash=0&url=www.dailymail.co.uk%2Fsciencetech%2Farticle-9050821%2FRemdesivir-beneficial-patients-doctors-reveal.html&loc=https%3A%2F%2Fwww.dailymail.co.uk%2Fsciencetech%2Farticle-9050821%2FRemdesivir-beneficial-patients-doctors-reveal.html%3F_hsmi%3D88974744%26_hsenc%3Dp2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8&vis=1&dmc=8&scr_x=0&scr_y=0&psz=300x620&msz=300x-1&psts=AGkb-H9awlplzm3R5rYar7qljqzk%2CAGkb-H9awlplzm3R5rYar7qljqzk%2CAGkb-H8Ea__ROWP6iCtuJnTikfDqFvgEhdFS__bGkDqK7myRJiYdigEmc1U3zmUA-HbB_-yknenOJN1ffIdLQkho7xCYGVETkh6MjNNcBQB1GThq&ga_vid=254203172.1608036337&ga_sid=1608036337&ga_hid=881620343&fws=516&ohw=1600&btvi=0&tt_state=W3siaXNzdWVyT3JpZ2luIjoiaHR0cHM6Ly9hZHNlcnZpY2UuZ29vZ2xlLmNvbSIsInN0YXRlIjowfSx7Imlzc3Vlck9yaWdpbiI6Imh0dHBzOi8vYXR0ZXN0YXRpb24uYW5kcm9pZC5jb20iLCJzdGF0ZSI6MH1d
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020120801.js
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
172.217.22.2 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
fra16s14-in-f2.1e100.net
Software
cafe /
Resource Hash
fe42de15c68a2f8a658120ad943ba8b826d030c0cb9dc03d55da9ce7831169e9
Security Headers
Name Value
Content-Security-Policy child-src 'unsafe-inline' cm.g.doubleclick.net googleads.g.doubleclick.net www.google.com accounts.google.com pagead2.googlesyndication.com/pagead/s/cookie_push.html gmsg: https://tpc.googlesyndication.com/sadbundle/$csp%3Der3$/12752319330752913096/Hi-Fi-300x250px-nl/Hi-Fi-300x250px-nl.html;frame-src 'unsafe-inline' cm.g.doubleclick.net googleads.g.doubleclick.net www.google.com accounts.google.com pagead2.googlesyndication.com/pagead/s/cookie_push.html gmsg: https://tpc.googlesyndication.com/sadbundle/$csp%3Der3$/12752319330752913096/Hi-Fi-300x250px-nl/Hi-Fi-300x250px-nl.html;report-uri https://pagead2.googlesyndication.com/pagead/gen_csp?id=adbundle&qqi=COOynZeC0O0CFZEU4AodEsEEkQ&gqi=&layout=/sadbundle/%24csp%253Der3%24/12752319330752913096/Hi-Fi-300x250px-nl/Hi-Fi-300x250px-nl.html
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

content-security-policy
child-src 'unsafe-inline' cm.g.doubleclick.net googleads.g.doubleclick.net www.google.com accounts.google.com pagead2.googlesyndication.com/pagead/s/cookie_push.html gmsg: https://tpc.googlesyndication.com/sadbundle/$csp%3Der3$/12752319330752913096/Hi-Fi-300x250px-nl/Hi-Fi-300x250px-nl.html;frame-src 'unsafe-inline' cm.g.doubleclick.net googleads.g.doubleclick.net www.google.com accounts.google.com pagead2.googlesyndication.com/pagead/s/cookie_push.html gmsg: https://tpc.googlesyndication.com/sadbundle/$csp%3Der3$/12752319330752913096/Hi-Fi-300x250px-nl/Hi-Fi-300x250px-nl.html;report-uri https://pagead2.googlesyndication.com/pagead/gen_csp?id=adbundle&qqi=COOynZeC0O0CFZEU4AodEsEEkQ&gqi=&layout=/sadbundle/%24csp%253Der3%24/12752319330752913096/Hi-Fi-300x250px-nl/Hi-Fi-300x250px-nl.html
content-encoding
br
x-content-type-options
nosniff
google-creative-id
-1
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
cross-origin-resource-policy
cross-origin
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
26130
x-xss-protection
0
google-lineitem-id
-1
pragma
no-cache
server
cafe
date
Tue, 15 Dec 2020 12:45:41 GMT
content-type
text/plain; charset=UTF-8
access-control-allow-origin
https://www.dailymail.co.uk
cache-control
no-cache, must-revalidate
access-control-allow-credentials
true
timing-allow-origin
*
expires
Fri, 01 Jan 1990 00:00:00 GMT
events
api.permutive.com/v2.0/batch/
701 B
324 B
XHR
General
Full URL
https://api.permutive.com/v2.0/batch/events?enrich=false&k=ed45e86d-a09e-4d2b-85c0-fbbd6857373e
Requested by
Host: cdn.permutive.com
URL: https://cdn.permutive.com/5f42864d-a421-4f37-9478-00266f871d68-web.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
34.107.254.252 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
Permutive /
Resource Hash
917c8f3b49403e71ac44f298bbd1a77e3bd3654870ae58eb2c846c20964e3261

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type
text/plain

Response headers

date
Tue, 15 Dec 2020 12:45:42 GMT
content-encoding
gzip
server
Permutive
vary
Origin,Access-Control-Request-Method
access-control-allow-methods
POST
content-type
application/json
access-control-allow-origin
https://www.dailymail.co.uk
access-control-expose-headers
*
access-control-allow-credentials
true
access-control-max-age
86400
alt-svc
clear
content-length
255
via
1.1 google
si
googleads.g.doubleclick.net/pagead/drt/ Frame C794
Redirect Chain
  • https://www.google.com/pagead/drt/ui
  • https://googleads.g.doubleclick.net/pagead/drt/si
0
0
Image
General
Full URL
https://googleads.g.doubleclick.net/pagead/drt/si
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:816::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Redirect headers

date
Tue, 15 Dec 2020 12:45:43 GMT
x-content-type-options
nosniff
server
safe
content-type
text/html; charset=UTF-8
location
https://googleads.g.doubleclick.net/pagead/drt/si
cache-control
private
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
246
x-xss-protection
0
/
loadeu.exelator.com/load/ Frame C69F
Redirect Chain
  • https://x.skimresources.com/?provider=exelate&gdpr=1&gdpr_consent=
  • https://loadeu.exelator.com/load/?p=787&g=001&j=0&gdpr=1
0
755 B
Image
General
Full URL
https://loadeu.exelator.com/load/?p=787&g=001&j=0&gdpr=1
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
147.75.102.200 Central, Hong Kong, ASN54825 (PACKET, US),
Reverse DNS
Software
nginx / Undertow/1
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:45:43 GMT
cache-control
no-cache
access-control-allow-credentials
true
server
nginx
x-powered-by
Undertow/1
p3p
policyref=/w3c/p3p.xml, CP=NOI DSP COR NID CURa ADMa DEVa PSAa PSDa OUR BUS COM INT OTC PUR STA, policyref=/w3c/p3p.xml, CP=NOI DSP COR NID CURa ADMa DEVa PSAa PSDa OUR BUS COM INT OTC PUR STA

Redirect headers

date
Tue, 15 Dec 2020 12:45:43 GMT
via
1.1 google
server
nginx/1.16.1
p3p
CP="IDC DSP COR ADM DEVi TAIi PSA PSD IVAi IVDi CONi HIS OUR IND CNT"
location
https://loadeu.exelator.com/load/?p=787&g=001&j=0&gdpr=1
content-type
text/html; charset=UTF-8
alt-svc
clear
content-length
0
page
t.skimresources.com/api/v2/
22 B
384 B
XHR
General
Full URL
https://t.skimresources.com/api/v2/page
Requested by
Host: s.skimresources.com
URL: https://s.skimresources.com/js/55199X1584066.skimlinks.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
35.201.67.47 , Ascension Island, ASN15169 (GOOGLE, US),
Reverse DNS
Software
Python/3.7 aiohttp/3.5.4 /
Resource Hash
fcc83a5b6aef86420c1ad553167106df96bd0ff4192ffe52b1647599948edbcf
Security Headers
Name Value
X-Content-Type-Options nosniff

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-type
text/plain

Response headers

pragma
no-cache
date
Tue, 15 Dec 2020 12:45:39 GMT
via
1.1 google
x-content-type-options
nosniff
server
Python/3.7 aiohttp/3.5.4
access-control-allow-headers
Origin, Accept, Content-Type, X-Requested-With, X-CSRF-Token
access-control-allow-methods
GET, POST, OPTIONS
content-type
text/plain; charset=utf-8, application/javascript
access-control-allow-origin
https://www.dailymail.co.uk
cache-control
no-store, no-cache, must-revalidate
access-control-allow-credentials
true
alt-svc
clear
content-length
22
container.html
b1c90d68092b57f74adceeec8a58c68a.safeframe.googlesyndication.com/safeframe/1-0-37/html/ Frame B8B0
0
0
Document
General
Full URL
https://b1c90d68092b57f74adceeec8a58c68a.safeframe.googlesyndication.com/safeframe/1-0-37/html/container.html
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020120801.js
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:801::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

:method
GET
:authority
b1c90d68092b57f74adceeec8a58c68a.safeframe.googlesyndication.com
:scheme
https
:path
/safeframe/1-0-37/html/container.html
pragma
no-cache
cache-control
no-cache
upgrade-insecure-requests
1
user-agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
accept
text/html,application/xhtml+xml,application/xml;q=0.9,image/avif,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3;q=0.9
sec-fetch-site
cross-site
sec-fetch-mode
navigate
sec-fetch-dest
iframe
referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
accept-encoding
gzip, deflate, br
accept-language
en-US
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8

Response headers

accept-ranges
bytes
vary
Accept-Encoding
content-encoding
gzip
content-type
text/html
cross-origin-resource-policy
cross-origin
timing-allow-origin
*
content-length
2973
date
Tue, 15 Dec 2020 12:45:37 GMT
expires
Wed, 15 Dec 2021 12:45:37 GMT
last-modified
Thu, 21 Nov 2019 16:01:11 GMT
x-content-type-options
nosniff
server
sffe
x-xss-protection
0
cache-control
public, immutable, max-age=31536000
age
2
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
downsize_200k_v1
tpc.googlesyndication.com/simgad/11860752003366304664/ Frame C794
8 KB
8 KB
Image
General
Full URL
https://tpc.googlesyndication.com/simgad/11860752003366304664/downsize_200k_v1?sqp=4sqPyQSWAUKTAQgAEhQNzczMPhUAAABAHQAAAAAlAAAAABgAIgoNAACAPxUAAIA_Kk8IWhABHQAAtEIgASgBMAY4A0CAwtcvSABQAFgAYFpwAngAgAEAiAEAkAEAnQEAAIA_oAEAqAEAsAGAreIEuAH___________8BxQEtsp0-MhoImQMQ1gEYASABLQAAAD8wmgM41gFFAACAPw&rs=AOga4qnnKWwwc2DFk-3F4ud_FPuRBcZ61A
Requested by
Host: cdn.ampproject.org
URL: https://cdn.ampproject.org/rtv/012010270040000/amp4ads-v0.mjs
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:81d::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
23e464e3d5c25100784cb720208b6e3d0c052a37953f1f0d901ab3b1ad5ca564
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:45:39 GMT
x-content-type-options
nosniff
last-modified
Wed, 11 Nov 2020 14:52:30 GMT
server
sffe
age
0
content-type
image/jpeg
access-control-allow-origin
*
cache-control
public, max-age=31536000
cross-origin-resource-policy
cross-origin
accept-ranges
bytes
timing-allow-origin
*
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
8051
x-xss-protection
0
expires
Wed, 15 Dec 2021 12:45:39 GMT
downsize_200k_v1
tpc.googlesyndication.com/simgad/12301430751875938281/ Frame C794
15 KB
16 KB
Image
General
Full URL
https://tpc.googlesyndication.com/simgad/12301430751875938281/downsize_200k_v1?sqp=4sqPyQR5QncIABIUDc3MzD4VAAAAQB0AAAAAJQAAAAAYACIKDQAAgD8VAACAPypPCFoQAR0AALRCIAEoATAGOANAgMLXL0gAUABYAGBacAJ4AIABAIgBAJABAJ0BAACAP6ABAKgBALABgK3iBLgB____________AcUBLbKdPg&rs=AOga4qmpAJ2aOi-parO2BsA0xfAB-F2E-A
Requested by
Host: cdn.ampproject.org
URL: https://cdn.ampproject.org/rtv/012010270040000/amp4ads-v0.mjs
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:81d::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
e274ee0cc1158eba5e5eac24da735b4f5bd0f12fbcc9c744dfadacaf687bfd6c
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 08:43:49 GMT
x-content-type-options
nosniff
last-modified
Wed, 11 Nov 2020 14:52:30 GMT
server
sffe
age
14510
content-type
image/jpeg
access-control-allow-origin
*
cache-control
public, max-age=31536000
cross-origin-resource-policy
cross-origin
accept-ranges
bytes
timing-allow-origin
*
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
15850
x-xss-protection
0
expires
Wed, 15 Dec 2021 08:43:49 GMT
en.png
tpc.googlesyndication.com/pagead/images/adchoices/ Frame C794
2 KB
2 KB
Image
General
Full URL
https://tpc.googlesyndication.com/pagead/images/adchoices/en.png
Requested by
Host: cdn.ampproject.org
URL: https://cdn.ampproject.org/rtv/012010270040000/amp4ads-v0.mjs
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:81d::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
36133ca07927c88a7cc578fddbaed3c668ab75087834d0ca13dca5de4ec856c1
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

timing-allow-origin
*
date
Mon, 14 Dec 2020 23:34:27 GMT
x-content-type-options
nosniff
server
cafe
age
47472
etag
14819457070020093239
vary
Accept-Encoding
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
cache-control
public, max-age=86400
cross-origin-resource-policy
cross-origin
content-type
image/png
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
2502
x-xss-protection
0
expires
Tue, 15 Dec 2020 23:34:27 GMT
icon.png
tpc.googlesyndication.com/pagead/images/adchoices/ Frame C794
295 B
320 B
Image
General
Full URL
https://tpc.googlesyndication.com/pagead/images/adchoices/icon.png
Requested by
Host: cdn.ampproject.org
URL: https://cdn.ampproject.org/rtv/012010270040000/amp4ads-v0.mjs
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:81d::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
7fd59024b6ca83f11f7a3448ec148309a13b705725716df134f699e60a96eb1b
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

timing-allow-origin
*
date
Mon, 14 Dec 2020 21:53:21 GMT
x-content-type-options
nosniff
server
cafe
age
53538
etag
426692510519060060
vary
Accept-Encoding
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
cache-control
public, max-age=86400
cross-origin-resource-policy
cross-origin
content-type
image/png
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
295
x-xss-protection
0
expires
Tue, 15 Dec 2020 21:53:21 GMT
publishertag.prebid.js
static.criteo.net/js/ld/
77 KB
25 KB
Script
General
Full URL
https://static.criteo.net/js/ld/publishertag.prebid.js
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/static/mol-adverts/demo/mol-22070/19a28e0b/mol-adverts.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a02:2638:1::3 , France, ASN44788 (ASN-CRITEO-EUROPE, FR),
Reverse DNS
Software
nginx /
Resource Hash
6d8ffd84868d7c4232e88167eb1adc0a83d4c1f5efb41d78eb1a03127dcdb625

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:45:43 GMT
content-encoding
gzip
last-modified
Tue, 17 Nov 2020 07:57:58 GMT
server
nginx
etag
W/"5fb38286-13244"
content-type
text/javascript
access-control-allow-origin
*
cache-control
max-age=86400, public
timing-allow-origin
*
expires
Wed, 16 Dec 2020 12:45:43 GMT
bulk
trc.taboola.com/dailymail-row/log/3/
0
244 B
XHR
General
Full URL
https://trc.taboola.com/dailymail-row/log/3/bulk?route=AM%3AAM%3AV&lti=deflated&bulkSize=15
Requested by
Host: cdn.taboola.com
URL: https://cdn.taboola.com/libtrc/impl.20201214-6-RELEASE.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
151.101.13.44 Frankfurt am Main, Germany, ASN54113 (FASTLY, US),
Reverse DNS
Software
nginx /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type
application/x-www-form-urlencoded

Response headers

x-vcl-time-ms
42
pragma
no-cache
date
Tue, 15 Dec 2020 12:45:39 GMT
via
1.1 varnish
server
nginx
x-timer
S1608036340.737635,VS0,VE42
x-served-by
cache-fra19144-FRA
x-cache
MISS
p3p
policyref="http://trc.taboola.com/p3p.xml", CP="NOI DSP COR LAW NID CURa ADMa DEVa PSAa PSDa OUR BUS IND UNI COM NAV INT DEM"
access-control-allow-origin
https://www.dailymail.co.uk
cache-control
no-cache
access-control-allow-credentials
true
accept-ranges
bytes
content-type
image/gif
x-cache-hits
0
225114
search.spotxchange.com/openrtb/2.3/dados/ Frame
0
0
Other
General
Full URL
https://search.spotxchange.com/openrtb/2.3/dados/225114
Protocol
HTTP/1.1
Server
185.94.180.124 , Netherlands, ASN35220 (SPOTX-AMS, NL),
Reverse DNS
Software
nginx /
Resource Hash

Request headers

Accept
*/*
Access-Control-Request-Method
POST
Access-Control-Request-Headers
content-type,x-openrtb-version
Origin
https://www.dailymail.co.uk
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Sec-Fetch-Mode
cors

Response headers

Server
nginx
Date
Tue, 15 Dec 2020 12:45:39 GMT
Content-Type
text/plain;charset=UTF-8
Content-Length
0
Connection
keep-alive
Expires
Thu, 01 Jan 1970 00:00:00 GMT
Last-Modified
Tue, 15 Dec 2020 12:45:39 GMT
Cache-Control
no-cache, must-revalidate post-check=0, pre-check=0
Pragma
no-cache
Access-Control-Allow-Origin
https://www.dailymail.co.uk
Access-Control-Allow-Methods
POST, GET, PATCH, DELETE, OPTIONS
Access-Control-Allow-Headers
content-type,x-openrtb-version
Access-Control-Allow-Credentials
true
Access-Control-Max-Age
2592000
225114
search.spotxchange.com/openrtb/2.3/dados/
0
1 KB
XHR
General
Full URL
https://search.spotxchange.com/openrtb/2.3/dados/225114
Requested by
Host: js.spotx.tv
URL: https://js.spotx.tv/directsdk/v1/234272.js
Protocol
HTTP/1.1
Security
TLS 1.2, RSA, AES_256_GCM
Server
185.94.180.124 , Netherlands, ASN35220 (SPOTX-AMS, NL),
Reverse DNS
Software
nginx /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
x-openrtb-version
2.3
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type
application/json

Response headers

Date
Tue, 15 Dec 2020 12:45:39 GMT
X-SpotX-Timing-Transform
0.000284
X-SpotX-Timing-SpotMarket
0.009902
X-SpotX-Timing-Page-Mux
0.001012
X-SpotX-Timing-Page-Require
0.000318
X-fe
087
Connection
keep-alive
X-SpotX-Timing-Page-Cookie
0.000024
X-SpotX-Timing-Page
0.014088
Pragma
no-cache
X-SpotX-Timing-Page-Context
0.000266
Last-Modified
Tue, 15 Dec 2020 12:45:39 GMT
Server
nginx
Cache-Control
no-cache, must-revalidate, post-check=0, pre-check=0
X-SpotX-Timing-SpotMarket-Primary
0.009902
Access-Control-Allow-Methods
POST, GET, PATCH, DELETE, OPTIONS
Content-Type
application/json
Access-Control-Allow-Origin
https://www.dailymail.co.uk
X-SpotX-Timing-Page-Misc
0.002269
X-SpotX-Timing-Page-Exception
0.000001
X-SpotX-Timing-SpotMarket-Secondary
0.000000
X-SpotX-Timing-Page-URI
0.000012
Access-Control-Allow-Credentials
true
Access-Control-Allow-Headers
Expires
Thu, 01 Jan 1970 00:00:00 GMT
view
securepubads.g.doubleclick.net/pcs/ Frame 93CD
0
0
Fetch
General
Full URL
https://securepubads.g.doubleclick.net/pcs/view?xai=AKAOjsszLyA3nhQCxPE1gbKsOri1yFpZiXy-A3ho839kvzUti71jvPcJCNBEA8UUGCRejAqCSVITkO5LYBQTcV3pV7H0dZ2s-5_6-xNgWfVo-Q3e82iG5fnj0L4T7Qn4GM1x7bU_8OlZ3ZiyxV1g23r01xaFUK32ibtn9Ei3Ytk9SWhQ5LA95hikE6CKLDiMINXCWzl_cmKDFQBZBUageF-g-EENtBDi3pL3cWt1N1mXUchS3UBKc_VgaPVKTwyJueFIuMEkej8jup7H8rPjdn3NfAn0gTOoMNMr6AcjAUGPWHqZ4YjOeP0AX1X75C_DnpLipRJM8cg&sig=Cg0ArKJSzFJ4OM58SnqyEAE&adurl=
Requested by
Host: info.silobreaker.com
URL: https://info.silobreaker.com/e2t/sc2/MmZ-8yjYCXrW6zj2_M6nsGYsW7JzK5Y7LnJnQVd1GcC5Dg2KFdBBbG504
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
172.217.22.2 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
fra16s14-in-f2.1e100.net
Software
cafe /
Resource Hash
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

timing-allow-origin
*
date
Tue, 15 Dec 2020 12:45:39 GMT
x-content-type-options
nosniff
server
cafe
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
access-control-allow-origin
*
cache-control
private
cross-origin-resource-policy
cross-origin
content-type
image/gif
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
0
x-xss-protection
0
abg_lite_fy2019.js
tpc.googlesyndication.com/pagead/js/r20201203/r20110914/ Frame 93CD
18 KB
7 KB
Script
General
Full URL
https://tpc.googlesyndication.com/pagead/js/r20201203/r20110914/abg_lite_fy2019.js
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020120801.js
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:81d::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
631c6a3617e2f5860eaa62155f5200b6ca156c00438445f9862089ef785e4542
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Mon, 14 Dec 2020 15:46:12 GMT
content-encoding
gzip
x-content-type-options
nosniff
age
75567
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
cross-origin-resource-policy
cross-origin
content-disposition
attachment; filename="f.txt"
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
7483
x-xss-protection
0
server
cafe
etag
7789600959769866771
vary
Accept-Encoding, Origin
content-type
text/javascript; charset=UTF-8
cache-control
public, max-age=1209600
timing-allow-origin
*
expires
Mon, 28 Dec 2020 15:46:12 GMT
window_focus_fy2019.js
tpc.googlesyndication.com/pagead/js/r20201203/r20110914/client/ Frame 93CD
3 KB
1 KB
Script
General
Full URL
https://tpc.googlesyndication.com/pagead/js/r20201203/r20110914/client/window_focus_fy2019.js
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020120801.js
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:81d::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
f8f96b0cc81405b2a95c412dbf43aebae111f11e98ad743b8fff74b2d5c793a2
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 03:27:47 GMT
content-encoding
gzip
x-content-type-options
nosniff
age
33472
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
cross-origin-resource-policy
cross-origin
content-disposition
attachment; filename="f.txt"
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
1494
x-xss-protection
0
server
cafe
etag
5335486849732140232
vary
Accept-Encoding, Origin
content-type
text/javascript; charset=UTF-8
cache-control
public, max-age=1209600
timing-allow-origin
*
expires
Tue, 29 Dec 2020 03:27:47 GMT
osd_listener.js
www.googletagservices.com/activeview/js/current/ Frame 93CD
76 KB
29 KB
Script
General
Full URL
https://www.googletagservices.com/activeview/js/current/osd_listener.js?cache=r20110914
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020120801.js
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:816::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
07a3eb8be1687dc1ee377d85bffd51891d0fd539258b63ab4031b012bd77f5fc
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:45:39 GMT
content-encoding
gzip
x-content-type-options
nosniff
server
sffe
etag
"1607690616793149"
vary
Accept-Encoding
content-type
text/javascript
cache-control
private, max-age=3000
accept-ranges
bytes
alt-svc
h3-29="googleads.g.doubleclick.net:443"; ma=2592000,h3-29=":443"; ma=2592000,h3-T051="googleads.g.doubleclick.net:443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic="googleads.g.doubleclick.net:443"; ma=2592000; v="46,43",quic=":443"; ma=2592000; v="46,43"
content-length
29432
x-xss-protection
0
expires
Tue, 15 Dec 2020 12:45:39 GMT
l
www.google.com/ads/measurement/ Frame 93CD
0
0
Image
General
Full URL
https://www.google.com/ads/measurement/l?ebcid=ALh7CaTfO9pkD6cMDubyYLZy6Y15moU4xm7SbKUVE6n4yiUHDFZzrp7Z7zcEthfx6NJ7-6RFZRypFka0qkTr4OigNmuv-ofNqw
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020120801.js
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:817::2004 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

3791481572381204646
tpc.googlesyndication.com/simgad/ Frame 93CD
23 KB
24 KB
Image
General
Full URL
https://tpc.googlesyndication.com/simgad/3791481572381204646
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020120801.js
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:81d::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
9d0058bf5606d26f341c810071e00b9feb946dfea23c258f3d60392c02767ed3
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Mon, 14 Dec 2020 17:51:34 GMT
x-content-type-options
nosniff
age
68045
x-dns-prefetch-control
off
cross-origin-resource-policy
cross-origin
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
23957
x-xss-protection
0
last-modified
Fri, 11 Dec 2020 14:11:18 GMT
server
sffe
content-type
image/png
access-control-allow-origin
*
cache-control
public, max-age=31536000
accept-ranges
bytes
timing-allow-origin
*
expires
Tue, 14 Dec 2021 17:51:34 GMT
DOUBLE-MPU-1.jpg
i.dailymail.co.uk/i/pix/2016/03/23/
12 KB
12 KB
Image
General
Full URL
https://i.dailymail.co.uk/i/pix/2016/03/23/DOUBLE-MPU-1.jpg
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/static/mol-adverts/demo/mol-22070/19a28e0b/mol-adverts.desktop.css
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2a02:26f0:6c00:288::11ae , Ascension Island, ASN20940 (AKAMAI-ASN1, EU),
Reverse DNS
Software
Apache /
Resource Hash
981793c8e58a9ebc2fa825db3f2e1de282a682d2158238d497cca1af74844116

Request headers

Referer
https://www.dailymail.co.uk/static/mol-adverts/demo/mol-22070/19a28e0b/mol-adverts.desktop.css
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:45:43 GMT
last-modified
Tue, 24 Apr 2018 08:44:48 GMT
server
Apache
etag
"80b954e5f874a18861095c8c9da27bb0:1524559488"
content-type
image/jpeg
cache-control
max-age=2592000
accept-ranges
bytes
timing-allow-origin
*
content-length
12558
expires
Thu, 14 Jan 2021 12:45:43 GMT
view
securepubads.g.doubleclick.net/pcs/ Frame 93CD
0
22 B
Image
General
Full URL
https://securepubads.g.doubleclick.net/pcs/view?xai=AKAOjstqR75FD92wLyIHrnfvh4BlSHKTWkauaX5tsXNcZjd8kFyRJ3tTTdlq62g9az7GQToOf3LjlGlPgcwzMaCTkCqZsWRSSfGotewrrM6PovHQ-oIPUfIjr_Vvid3843PAG6YEbZRzWLRT9LFEDuhckvzB_ndz7dwEIA06J8EF2QEC2y7Js1HAZLfJJag5H76u6wlGRrkqnv6WUouXOt6r7h9aC3Qh42VCGMZxKeAIwfAJUPta24CgX0atq6ktWVoONY3qVnmyPvwDiHQdaDwiAdpYaha7AzdmWVVk36yp97FYIuJbQDSnKTp9Z4L1cybr3E7U5_STnQ&sig=Cg0ArKJSzCWTNrjP2JLjEAE&adurl=
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
172.217.22.2 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
fra16s14-in-f2.1e100.net
Software
cafe /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

timing-allow-origin
*
date
Tue, 15 Dec 2020 12:45:39 GMT
x-content-type-options
nosniff
server
cafe
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
access-control-allow-origin
*
cache-control
private
cross-origin-resource-policy
cross-origin
content-type
image/gif
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
0
x-xss-protection
0
truncated
/ Frame 93CD
207 B
0
Image
General
Full URL
data:truncated
Protocol
DATA
Server
-, , ASN (),
Reverse DNS
Software
/
Resource Hash
a948ba209c3130845fc6c203f8f95266a6e94d524179c465b405e57af55b7cd4

Request headers

Referer
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Content-Type
image/png
167.json
id5-sync.com/g/v2/
346 B
895 B
XHR
General
Full URL
https://id5-sync.com/g/v2/167.json?gdpr_consent=&gdpr=0
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/static/mol-adverts/demo/mol-22070/19a28e0b/mol-adverts.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
51.89.7.198 , Germany, ASN16276 (OVH, FR),
Reverse DNS
Software
/
Resource Hash
d9bdee37e2fa837ec0d36497fc4abdb746f021df4ab369d36074409b443aeeca
Security Headers
Name Value
Strict-Transport-Security max-age=63072000; includeSubDomains; preload

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type
text/plain

Response headers

Date
Tue, 15 Dec 2020 12:45:39 GMT
Vary
Origin
P3P
CP="CAO PSA OUR"
Access-Control-Allow-Origin
https://www.dailymail.co.uk
Access-Control-Allow-Credentials
true
Strict-Transport-Security
max-age=63072000; includeSubDomains; preload
Content-Type
application/json;charset=UTF-8
Transfer-Encoding
chunked
rid
match.adsrvr.org/track/
108 B
652 B
XHR
General
Full URL
https://match.adsrvr.org/track/rid?ttd_pid=a8r0pns&fmt=json
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/static/mol-adverts/demo/mol-22070/19a28e0b/mol-adverts.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
54.171.98.69 Dublin, Ireland, ASN16509 (AMAZON-02, US),
Reverse DNS
ec2-54-171-98-69.eu-west-1.compute.amazonaws.com
Software
/
Resource Hash
f7ddae218d24069bc760eba3db0e406087f8543474b9c05f8155d27fb75a6ff9

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type
text/plain

Response headers

date
Tue, 15 Dec 2020 12:45:40 GMT
x-aspnet-version
4.0.30319
vary
Origin
content-type
application/json; charset=utf-8
access-control-allow-origin
https://www.dailymail.co.uk
cache-control
private
access-control-allow-credentials
true
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Content-Length, Content-Encoding, Vary, Cache-Control, Accept
content-length
108
expires
Thu, 14 Jan 2021 12:45:40 GMT
async_usersync.html
acdn.adnxs.com/dmp/ Frame 7EA7
0
0
Document
General
Full URL
https://acdn.adnxs.com/dmp/async_usersync.html
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/static/mol-adverts/demo/mol-22070/19a28e0b/mol-adverts.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
151.101.113.108 Frankfurt am Main, Germany, ASN54113 (FASTLY, US),
Reverse DNS
Software
nginx/1.13.10 /
Resource Hash

Request headers

Host
acdn.adnxs.com
Connection
keep-alive
Pragma
no-cache
Cache-Control
no-cache
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Accept
text/html,application/xhtml+xml,application/xml;q=0.9,image/avif,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3;q=0.9
Sec-Fetch-Site
cross-site
Sec-Fetch-Mode
navigate
Sec-Fetch-Dest
iframe
Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
Accept-Encoding
gzip, deflate, br
Accept-Language
en-US
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8

Response headers

Connection
keep-alive
Content-Length
17053
Server
nginx/1.13.10
Content-Type
text/html
Last-Modified
Wed, 02 Dec 2020 20:56:47 GMT
ETag
W/"5fc7ff8f-cf34"
Expires
Thu, 03 Dec 2020 21:09:36 GMT
Cache-Control
max-age=86402
Access-Control-Allow-Origin
*
Content-Encoding
gzip
Via
1.1 varnish, 1.1 varnish
Accept-Ranges
bytes
Date
Tue, 15 Dec 2020 12:45:40 GMT
Age
56141
X-Served-By
cache-lga21951-LGA, cache-hhn4043-HHN
X-Cache
HIT, HIT
X-Cache-Hits
5, 522326
X-Timer
S1608036340.180264,VS0,VE0
Vary
Accept-Encoding
async_usersync.html
acdn.adnxs.com/dmp/ Frame F380
0
0
Document
General
Full URL
https://acdn.adnxs.com/dmp/async_usersync.html
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/static/mol-adverts/demo/mol-22070/19a28e0b/mol-adverts.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
151.101.113.108 Frankfurt am Main, Germany, ASN54113 (FASTLY, US),
Reverse DNS
Software
nginx/1.13.10 /
Resource Hash

Request headers

Host
acdn.adnxs.com
Connection
keep-alive
Pragma
no-cache
Cache-Control
no-cache
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Accept
text/html,application/xhtml+xml,application/xml;q=0.9,image/avif,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3;q=0.9
Sec-Fetch-Site
cross-site
Sec-Fetch-Mode
navigate
Sec-Fetch-Dest
iframe
Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
Accept-Encoding
gzip, deflate, br
Accept-Language
en-US
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8

Response headers

Connection
keep-alive
Content-Length
17053
Server
nginx/1.13.10
Content-Type
text/html
Last-Modified
Wed, 02 Dec 2020 20:56:47 GMT
ETag
W/"5fc7ff8f-cf34"
Expires
Thu, 03 Dec 2020 21:09:36 GMT
Cache-Control
max-age=86402
Access-Control-Allow-Origin
*
Content-Encoding
gzip
Via
1.1 varnish, 1.1 varnish
Accept-Ranges
bytes
Date
Tue, 15 Dec 2020 12:45:40 GMT
Age
56141
X-Served-By
cache-lga21951-LGA, cache-hhn4043-HHN
X-Cache
HIT, HIT
X-Cache-Hits
5, 522330
X-Timer
S1608036340.288704,VS0,VE0
Vary
Accept-Encoding
usermatch
ssum-sec.casalemedia.com/ Frame F434
0
0
Document
General
Full URL
https://ssum-sec.casalemedia.com/usermatch?s=184665&cb=https%3A%2F%2Fmfad.inskinad.com%2Fudb%2F9874%2Fsync%2Fi.gif%3FpartnerId%3D1%26userId%3D
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/static/mol-adverts/demo/mol-22070/19a28e0b/mol-adverts.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
104.111.215.135 , Netherlands, ASN16625 (AKAMAI-AS, US),
Reverse DNS
a104-111-215-135.deploy.static.akamaitechnologies.com
Software
Apache /
Resource Hash

Request headers

:method
GET
:authority
ssum-sec.casalemedia.com
:scheme
https
:path
/usermatch?s=184665&cb=https%3A%2F%2Fmfad.inskinad.com%2Fudb%2F9874%2Fsync%2Fi.gif%3FpartnerId%3D1%26userId%3D
pragma
no-cache
cache-control
no-cache
upgrade-insecure-requests
1
user-agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
accept
text/html,application/xhtml+xml,application/xml;q=0.9,image/avif,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3;q=0.9
sec-fetch-site
cross-site
sec-fetch-mode
navigate
sec-fetch-dest
iframe
referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
accept-encoding
gzip, deflate, br
accept-language
en-US
cookie
CMID=X9iv8oE1aeK2FeDJu3VAdAAA; CMPS=3164; CMPRO=1142; CMST=X9iv8l-Yr-IA; CMRUM3=f15fd8aff205a00&1f5fd8aff205a00&275fd8aff20b40&be5fd8aff205a0&825fd8aff22760AAIoPE6_sWAAAA_9W0UXnA&e65fd8aff227600&2d5fd8aff205a0&035fd8aff205a0
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8

Response headers

server
Apache
content-type
text/html
p3p
policyref="/w3c/p3p.xml", CP="NOI DSP COR DEVa TAIa OUR BUS UNI"
vary
Is-Traffic-Usersync
content-length
1377
expires
Tue, 15 Dec 2020 12:45:40 GMT
cache-control
max-age=0, no-cache, no-store
pragma
no-cache
date
Tue, 15 Dec 2020 12:45:40 GMT
set-cookie
CMID=X9iv8oE1aeK2FeDJu3VAdAAA;domain=casalemedia.com;path=/;sameSite=None;Secure;expires=Wed, 15 Dec 2021 12:45:40 GMT CMPS=3164;domain=casalemedia.com;path=/;sameSite=None;Secure;expires=Mon, 15 Mar 2021 12:45:40 GMT CMPRO=1142;domain=casalemedia.com;path=/;sameSite=None;Secure;expires=Mon, 15 Mar 2021 12:45:40 GMT CMRUM3=b05fd8aff405a00&275fd8aff20b40&1f5fd8aff205a00&295fd8aff405a00&825fd8aff2a8c0&585fd8aff405a0&2d5fd8aff205a0&e65fd8aff227600&495fd8aff405a00&f15fd8aff205a00&2e5fd8aff405a0&be5fd8aff205a0&035fd8aff205a0&6f5fd8aff405a0&045fd8aff405a0&395fd8aff405a00;domain=casalemedia.com;path=/;sameSite=None;Secure;expires=Wed, 15 Dec 2021 12:45:40 GMT CMST=X9iv8l-Yr-QA;domain=casalemedia.com;path=/;sameSite=None;Secure;expires=Wed, 16 Dec 2020 12:45:40 GMT
ixmatch.html
js-sec.indexww.com/um/ Frame B866
0
0
Document
General
Full URL
https://js-sec.indexww.com/um/ixmatch.html
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/static/mol-adverts/demo/mol-22070/19a28e0b/mol-adverts.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
104.111.215.135 , Netherlands, ASN16625 (AKAMAI-AS, US),
Reverse DNS
a104-111-215-135.deploy.static.akamaitechnologies.com
Software
Apache /
Resource Hash

Request headers

:method
GET
:authority
js-sec.indexww.com
:scheme
https
:path
/um/ixmatch.html
pragma
no-cache
cache-control
no-cache
upgrade-insecure-requests
1
user-agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
accept
text/html,application/xhtml+xml,application/xml;q=0.9,image/avif,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3;q=0.9
sec-fetch-site
cross-site
sec-fetch-mode
navigate
sec-fetch-dest
iframe
referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
accept-encoding
gzip, deflate, br
accept-language
en-US
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8

Response headers

server
Apache
last-modified
Tue, 06 Oct 2020 14:04:48 GMT
etag
"e20015-8f4-5b10114f2003a"
accept-ranges
bytes
p3p
policyref="/w3c/p3p.xml", CP="NOI DSP COR DEVa TAIa OUR BUS UNI"
content-type
text/html; charset=UTF-8
vary
Accept-Encoding
content-encoding
gzip
content-length
1136
date
Tue, 15 Dec 2020 12:45:40 GMT
async_usersync.html
acdn.adnxs.com/dmp/ Frame AF2A
0
0
Document
General
Full URL
https://acdn.adnxs.com/dmp/async_usersync.html
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/static/mol-adverts/demo/mol-22070/19a28e0b/mol-adverts.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
151.101.113.108 Frankfurt am Main, Germany, ASN54113 (FASTLY, US),
Reverse DNS
Software
nginx/1.13.10 /
Resource Hash

Request headers

Host
acdn.adnxs.com
Connection
keep-alive
Pragma
no-cache
Cache-Control
no-cache
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Accept
text/html,application/xhtml+xml,application/xml;q=0.9,image/avif,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3;q=0.9
Sec-Fetch-Site
cross-site
Sec-Fetch-Mode
navigate
Sec-Fetch-Dest
iframe
Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
Accept-Encoding
gzip, deflate, br
Accept-Language
en-US
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8

Response headers

Connection
keep-alive
Content-Length
17053
Server
nginx/1.13.10
Content-Type
text/html
Last-Modified
Wed, 02 Dec 2020 20:56:47 GMT
ETag
W/"5fc7ff8f-cf34"
Expires
Thu, 03 Dec 2020 21:09:36 GMT
Cache-Control
max-age=86402
Access-Control-Allow-Origin
*
Content-Encoding
gzip
Via
1.1 varnish, 1.1 varnish
Accept-Ranges
bytes
Date
Tue, 15 Dec 2020 12:45:40 GMT
Age
56141
X-Served-By
cache-lga21951-LGA, cache-hhn4069-HHN
X-Cache
HIT, HIT
X-Cache-Hits
5, 523023
X-Timer
S1608036340.291454,VS0,VE0
Vary
Accept-Encoding
sync
pre.ads.justpremium.com/v/1.0/t/ Frame 66FA
0
0
Document
General
Full URL
https://pre.ads.justpremium.com/v/1.0/t/sync?_c=ak70n1608036336967
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/static/mol-adverts/demo/mol-22070/19a28e0b/mol-adverts.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
52.59.91.38 Frankfurt am Main, Germany, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
/
Resource Hash

Request headers

:method
GET
:authority
pre.ads.justpremium.com
:scheme
https
:path
/v/1.0/t/sync?_c=ak70n1608036336967
pragma
no-cache
cache-control
no-cache
upgrade-insecure-requests
1
user-agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
accept
text/html,application/xhtml+xml,application/xml;q=0.9,image/avif,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3;q=0.9
sec-fetch-site
cross-site
sec-fetch-mode
navigate
sec-fetch-dest
iframe
referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
accept-encoding
gzip, deflate, br
accept-language
en-US
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8

Response headers

date
Tue, 15 Dec 2020 12:45:40 GMT
content-type
text/html; charset=utf-8
cache-control
public, no-cache, no-store, must-revalidate
pd
eu-u.openx.net/w/1.0/ Frame C6E2
0
0
Document
General
Full URL
https://eu-u.openx.net/w/1.0/pd?plm=6&ph=36664cef-3484-4aa7-9d01-fa4f6f6b2d4e&gdpr=1
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/static/mol-adverts/demo/mol-22070/19a28e0b/mol-adverts.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
35.244.159.8 Mountain View, United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
OXGW/16.199.0 /
Resource Hash

Request headers

:method
GET
:authority
eu-u.openx.net
:scheme
https
:path
/w/1.0/pd?plm=6&ph=36664cef-3484-4aa7-9d01-fa4f6f6b2d4e&gdpr=1
pragma
no-cache
cache-control
no-cache
upgrade-insecure-requests
1
user-agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
accept
text/html,application/xhtml+xml,application/xml;q=0.9,image/avif,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3;q=0.9
sec-fetch-site
cross-site
sec-fetch-mode
navigate
sec-fetch-dest
iframe
referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
accept-encoding
gzip, deflate, br
accept-language
en-US
cookie
i=84f1103b-a980-4860-8c6e-1866bcc8525c|1608036338
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8

Response headers

vary
Accept, Accept-Encoding
set-cookie
i=84f1103b-a980-4860-8c6e-1866bcc8525c|1608036338; Version=1; Expires=Wed, 15-Dec-2021 12:45:40 GMT; Max-Age=31536000; Secure; Domain=.openx.net; Path=/; SameSite=None pd=v2|1608036340|gekin0vNiygu; Version=1; Expires=Wed, 30-Dec-2020 12:45:40 GMT; Max-Age=1296000; Secure; Domain=.openx.net; Path=/; SameSite=None
server
OXGW/16.199.0
p3p
CP="CUR ADM OUR NOR STA NID"
date
Tue, 15 Dec 2020 12:45:40 GMT
content-type
text/html
content-length
417
content-encoding
gzip
via
1.1 google
alt-svc
clear
pd
u.openx.net/w/1.0/ Frame 1526
0
0
Document
General
Full URL
https://u.openx.net/w/1.0/pd
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/static/mol-adverts/demo/mol-22070/19a28e0b/mol-adverts.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
35.244.159.8 Mountain View, United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
OXGW/16.199.0 /
Resource Hash

Request headers

:method
GET
:authority
u.openx.net
:scheme
https
:path
/w/1.0/pd
pragma
no-cache
cache-control
no-cache
upgrade-insecure-requests
1
user-agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
accept
text/html,application/xhtml+xml,application/xml;q=0.9,image/avif,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3;q=0.9
sec-fetch-site
cross-site
sec-fetch-mode
navigate
sec-fetch-dest
iframe
referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
accept-encoding
gzip, deflate, br
accept-language
en-US
cookie
i=84f1103b-a980-4860-8c6e-1866bcc8525c|1608036338
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8

Response headers

vary
Accept, Accept-Encoding
set-cookie
i=84f1103b-a980-4860-8c6e-1866bcc8525c|1608036338; Version=1; Expires=Wed, 15-Dec-2021 12:45:40 GMT; Max-Age=31536000; Secure; Domain=.openx.net; Path=/; SameSite=None pd=v2|1608036340|gekin0vNiygu; Version=1; Expires=Wed, 30-Dec-2020 12:45:40 GMT; Max-Age=1296000; Secure; Domain=.openx.net; Path=/; SameSite=None
server
OXGW/16.199.0
p3p
CP="CUR ADM OUR NOR STA NID"
date
Tue, 15 Dec 2020 12:45:40 GMT
content-type
text/html
content-length
417
content-encoding
gzip
via
1.1 google
alt-svc
clear
ixmatch.html
js-sec.indexww.com/um/ Frame B98B
0
0
Document
General
Full URL
https://js-sec.indexww.com/um/ixmatch.html
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/static/mol-adverts/demo/mol-22070/19a28e0b/mol-adverts.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
104.111.215.135 , Netherlands, ASN16625 (AKAMAI-AS, US),
Reverse DNS
a104-111-215-135.deploy.static.akamaitechnologies.com
Software
Apache /
Resource Hash

Request headers

:method
GET
:authority
js-sec.indexww.com
:scheme
https
:path
/um/ixmatch.html
pragma
no-cache
cache-control
no-cache
upgrade-insecure-requests
1
user-agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
accept
text/html,application/xhtml+xml,application/xml;q=0.9,image/avif,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3;q=0.9
sec-fetch-site
cross-site
sec-fetch-mode
navigate
sec-fetch-dest
iframe
referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
accept-encoding
gzip, deflate, br
accept-language
en-US
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8

Response headers

server
Apache
last-modified
Tue, 06 Oct 2020 14:04:48 GMT
etag
"e20015-8f4-5b10114f2003a"
accept-ranges
bytes
p3p
policyref="/w3c/p3p.xml", CP="NOI DSP COR DEVa TAIa OUR BUS UNI"
content-type
text/html; charset=UTF-8
vary
Accept-Encoding
content-encoding
gzip
content-length
1136
date
Tue, 15 Dec 2020 12:45:40 GMT
ixmatch.html
js-sec.indexww.com/um/ Frame 78CE
0
0
Document
General
Full URL
https://js-sec.indexww.com/um/ixmatch.html
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/static/mol-adverts/demo/mol-22070/19a28e0b/mol-adverts.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
104.111.215.135 , Netherlands, ASN16625 (AKAMAI-AS, US),
Reverse DNS
a104-111-215-135.deploy.static.akamaitechnologies.com
Software
Apache /
Resource Hash

Request headers

:method
GET
:authority
js-sec.indexww.com
:scheme
https
:path
/um/ixmatch.html
pragma
no-cache
cache-control
no-cache
upgrade-insecure-requests
1
user-agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
accept
text/html,application/xhtml+xml,application/xml;q=0.9,image/avif,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3;q=0.9
sec-fetch-site
cross-site
sec-fetch-mode
navigate
sec-fetch-dest
iframe
referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
accept-encoding
gzip, deflate, br
accept-language
en-US
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8

Response headers

server
Apache
last-modified
Tue, 06 Oct 2020 14:04:48 GMT
etag
"e20015-8f4-5b10114f2003a"
accept-ranges
bytes
p3p
policyref="/w3c/p3p.xml", CP="NOI DSP COR DEVa TAIa OUR BUS UNI"
content-type
text/html; charset=UTF-8
vary
Accept-Encoding
content-encoding
gzip
content-length
1136
date
Tue, 15 Dec 2020 12:45:40 GMT
pd
u.openx.net/w/1.0/ Frame 3687
0
0
Document
General
Full URL
https://u.openx.net/w/1.0/pd
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/static/mol-adverts/demo/mol-22070/19a28e0b/mol-adverts.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
35.244.159.8 Mountain View, United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
OXGW/16.199.0 /
Resource Hash

Request headers

:method
GET
:authority
u.openx.net
:scheme
https
:path
/w/1.0/pd
pragma
no-cache
cache-control
no-cache
upgrade-insecure-requests
1
user-agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
accept
text/html,application/xhtml+xml,application/xml;q=0.9,image/avif,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3;q=0.9
sec-fetch-site
cross-site
sec-fetch-mode
navigate
sec-fetch-dest
iframe
referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
accept-encoding
gzip, deflate, br
accept-language
en-US
cookie
i=84f1103b-a980-4860-8c6e-1866bcc8525c|1608036338
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8

Response headers

vary
Accept, Accept-Encoding
set-cookie
i=84f1103b-a980-4860-8c6e-1866bcc8525c|1608036338; Version=1; Expires=Wed, 15-Dec-2021 12:45:40 GMT; Max-Age=31536000; Secure; Domain=.openx.net; Path=/; SameSite=None pd=v2|1608036340|gekin0vNiygu; Version=1; Expires=Wed, 30-Dec-2020 12:45:40 GMT; Max-Age=1296000; Secure; Domain=.openx.net; Path=/; SameSite=None
server
OXGW/16.199.0
p3p
CP="CUR ADM OUR NOR STA NID"
date
Tue, 15 Dec 2020 12:45:40 GMT
content-type
text/html
content-length
417
content-encoding
gzip
via
1.1 google
alt-svc
clear
usync.html
eus.rubiconproject.com/ Frame 4A93
0
0
Document
General
Full URL
https://eus.rubiconproject.com/usync.html
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/static/mol-adverts/demo/mol-22070/19a28e0b/mol-adverts.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
104.108.50.124 , Netherlands, ASN16625 (AKAMAI-AS, US),
Reverse DNS
a104-108-50-124.deploy.static.akamaitechnologies.com
Software
Apache/2.2.15 (CentOS) /
Resource Hash

Request headers

Host
eus.rubiconproject.com
Connection
keep-alive
Pragma
no-cache
Cache-Control
no-cache
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Accept
text/html,application/xhtml+xml,application/xml;q=0.9,image/avif,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3;q=0.9
Sec-Fetch-Site
cross-site
Sec-Fetch-Mode
navigate
Sec-Fetch-Dest
iframe
Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
Accept-Encoding
gzip, deflate, br
Accept-Language
en-US
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8

Response headers

Server
Apache/2.2.15 (CentOS)
Last-Modified
Mon, 28 Sep 2020 17:02:39 GMT
ETag
"4000c-123-5b062a240e9c0"
Accept-Ranges
bytes
Content-Encoding
gzip
Content-Length
238
Content-Type
text/html; charset=UTF-8
Date
Tue, 15 Dec 2020 12:45:43 GMT
Connection
keep-alive
Vary
Accept-Encoding
ixmatch.html
js-sec.indexww.com/um/ Frame 0AB3
0
0
Document
General
Full URL
https://js-sec.indexww.com/um/ixmatch.html
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/static/mol-adverts/demo/mol-22070/19a28e0b/mol-adverts.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
104.111.215.135 , Netherlands, ASN16625 (AKAMAI-AS, US),
Reverse DNS
a104-111-215-135.deploy.static.akamaitechnologies.com
Software
Apache /
Resource Hash

Request headers

:method
GET
:authority
js-sec.indexww.com
:scheme
https
:path
/um/ixmatch.html
pragma
no-cache
cache-control
no-cache
upgrade-insecure-requests
1
user-agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
accept
text/html,application/xhtml+xml,application/xml;q=0.9,image/avif,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3;q=0.9
sec-fetch-site
cross-site
sec-fetch-mode
navigate
sec-fetch-dest
iframe
referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
accept-encoding
gzip, deflate, br
accept-language
en-US
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8

Response headers

server
Apache
last-modified
Tue, 06 Oct 2020 14:04:48 GMT
etag
"e20015-8f4-5b10114f2003a"
accept-ranges
bytes
p3p
policyref="/w3c/p3p.xml", CP="NOI DSP COR DEVa TAIa OUR BUS UNI"
content-type
text/html; charset=UTF-8
vary
Accept-Encoding
content-encoding
gzip
content-length
1136
date
Tue, 15 Dec 2020 12:45:40 GMT
async_usersync.html
acdn.adnxs.com/dmp/ Frame DA5D
0
0
Document
General
Full URL
https://acdn.adnxs.com/dmp/async_usersync.html
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/static/mol-adverts/demo/mol-22070/19a28e0b/mol-adverts.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
151.101.113.108 Frankfurt am Main, Germany, ASN54113 (FASTLY, US),
Reverse DNS
Software
nginx/1.13.10 /
Resource Hash

Request headers

Host
acdn.adnxs.com
Connection
keep-alive
Pragma
no-cache
Cache-Control
no-cache
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Accept
text/html,application/xhtml+xml,application/xml;q=0.9,image/avif,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3;q=0.9
Sec-Fetch-Site
cross-site
Sec-Fetch-Mode
navigate
Sec-Fetch-Dest
iframe
Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
Accept-Encoding
gzip, deflate, br
Accept-Language
en-US
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8

Response headers

Connection
keep-alive
Content-Length
17053
Server
nginx/1.13.10
Content-Type
text/html
Last-Modified
Wed, 02 Dec 2020 20:56:47 GMT
ETag
W/"5fc7ff8f-cf34"
Expires
Thu, 03 Dec 2020 21:09:36 GMT
Cache-Control
max-age=86402
Access-Control-Allow-Origin
*
Content-Encoding
gzip
Via
1.1 varnish, 1.1 varnish
Accept-Ranges
bytes
Date
Tue, 15 Dec 2020 12:45:40 GMT
Age
56141
X-Served-By
cache-lga21951-LGA, cache-hhn4043-HHN
X-Cache
HIT, HIT
X-Cache-Hits
5, 522331
X-Timer
S1608036340.391314,VS0,VE0
Vary
Accept-Encoding
pd
eu-u.openx.net/w/1.0/ Frame 5E3F
0
0
Document
General
Full URL
https://eu-u.openx.net/w/1.0/pd?plm=6&ph=36664cef-3484-4aa7-9d01-fa4f6f6b2d4e&gdpr=1
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/static/mol-adverts/demo/mol-22070/19a28e0b/mol-adverts.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
35.244.159.8 Mountain View, United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
OXGW/16.199.0 /
Resource Hash

Request headers

:method
GET
:authority
eu-u.openx.net
:scheme
https
:path
/w/1.0/pd?plm=6&ph=36664cef-3484-4aa7-9d01-fa4f6f6b2d4e&gdpr=1
pragma
no-cache
cache-control
no-cache
upgrade-insecure-requests
1
user-agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
accept
text/html,application/xhtml+xml,application/xml;q=0.9,image/avif,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3;q=0.9
sec-fetch-site
cross-site
sec-fetch-mode
navigate
sec-fetch-dest
iframe
referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
accept-encoding
gzip, deflate, br
accept-language
en-US
cookie
i=84f1103b-a980-4860-8c6e-1866bcc8525c|1608036338; pd=v2|1608036340|gekin0vNiygu
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8

Response headers

vary
Accept, Accept-Encoding
set-cookie
i=84f1103b-a980-4860-8c6e-1866bcc8525c|1608036338; Version=1; Expires=Wed, 15-Dec-2021 12:45:40 GMT; Max-Age=31536000; Secure; Domain=.openx.net; Path=/; SameSite=None pd=v2|1608036340|mWkigqiysLommOgevNgunsn0; Version=1; Expires=Wed, 30-Dec-2020 12:45:40 GMT; Max-Age=1296000; Secure; Domain=.openx.net; Path=/; SameSite=None
server
OXGW/16.199.0
p3p
CP="CUR ADM OUR NOR STA NID"
date
Tue, 15 Dec 2020 12:45:40 GMT
content-type
text/html
content-length
316
content-encoding
gzip
via
1.1 google
alt-svc
clear
async_usersync.html
acdn.adnxs.com/dmp/ Frame 1ECB
0
0
Document
General
Full URL
https://acdn.adnxs.com/dmp/async_usersync.html
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/static/mol-adverts/demo/mol-22070/19a28e0b/mol-adverts.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
151.101.113.108 Frankfurt am Main, Germany, ASN54113 (FASTLY, US),
Reverse DNS
Software
nginx/1.13.10 /
Resource Hash

Request headers

Host
acdn.adnxs.com
Connection
keep-alive
Pragma
no-cache
Cache-Control
no-cache
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Accept
text/html,application/xhtml+xml,application/xml;q=0.9,image/avif,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3;q=0.9
Sec-Fetch-Site
cross-site
Sec-Fetch-Mode
navigate
Sec-Fetch-Dest
iframe
Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
Accept-Encoding
gzip, deflate, br
Accept-Language
en-US
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8

Response headers

Connection
keep-alive
Content-Length
17053
Server
nginx/1.13.10
Content-Type
text/html
Last-Modified
Wed, 02 Dec 2020 20:56:47 GMT
ETag
W/"5fc7ff8f-cf34"
Expires
Thu, 03 Dec 2020 21:09:36 GMT
Cache-Control
max-age=86402
Access-Control-Allow-Origin
*
Content-Encoding
gzip
Via
1.1 varnish, 1.1 varnish
Accept-Ranges
bytes
Date
Tue, 15 Dec 2020 12:45:40 GMT
Age
56141
X-Served-By
cache-lga21951-LGA, cache-hhn4069-HHN
X-Cache
HIT, HIT
X-Cache-Hits
5, 523024
X-Timer
S1608036340.391369,VS0,VE0
Vary
Accept-Encoding
ixmatch.html
js-sec.indexww.com/um/ Frame 99C2
0
0
Document
General
Full URL
https://js-sec.indexww.com/um/ixmatch.html
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/static/mol-adverts/demo/mol-22070/19a28e0b/mol-adverts.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
104.111.215.135 , Netherlands, ASN16625 (AKAMAI-AS, US),
Reverse DNS
a104-111-215-135.deploy.static.akamaitechnologies.com
Software
Apache /
Resource Hash

Request headers

:method
GET
:authority
js-sec.indexww.com
:scheme
https
:path
/um/ixmatch.html
pragma
no-cache
cache-control
no-cache
upgrade-insecure-requests
1
user-agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
accept
text/html,application/xhtml+xml,application/xml;q=0.9,image/avif,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3;q=0.9
sec-fetch-site
cross-site
sec-fetch-mode
navigate
sec-fetch-dest
iframe
referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
accept-encoding
gzip, deflate, br
accept-language
en-US
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8

Response headers

server
Apache
last-modified
Tue, 06 Oct 2020 14:04:48 GMT
etag
"e20015-8f4-5b10114f2003a"
accept-ranges
bytes
p3p
policyref="/w3c/p3p.xml", CP="NOI DSP COR DEVa TAIa OUR BUS UNI"
content-type
text/html; charset=UTF-8
vary
Accept-Encoding
content-encoding
gzip
content-length
1136
date
Tue, 15 Dec 2020 12:45:40 GMT
sync
eb2.3lift.com/ Frame A1F9
Redirect Chain
  • https://eb2.3lift.com/sync?
  • https://eb2.3lift.com/sync?&ld=1
0
0
Document
General
Full URL
https://eb2.3lift.com/sync?&ld=1
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/static/mol-adverts/demo/mol-22070/19a28e0b/mol-adverts.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
52.29.22.19 Frankfurt am Main, Germany, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
/
Resource Hash

Request headers

:method
GET
:authority
eb2.3lift.com
:scheme
https
:path
/sync?&ld=1
pragma
no-cache
cache-control
no-cache
upgrade-insecure-requests
1
user-agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
accept
text/html,application/xhtml+xml,application/xml;q=0.9,image/avif,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3;q=0.9
sec-fetch-site
cross-site
sec-fetch-mode
navigate
sec-fetch-dest
iframe
referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
accept-encoding
gzip, deflate, br
accept-language
en-US
cookie
tluid=657867970647066735
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8

Response headers

date
Tue, 15 Dec 2020 12:45:41 GMT
content-type
text/html; charset=utf-8
content-length
533
set-cookie
sync=CgoIgQIQhK29s-YuCgoI4gEQhK29s-YuCgoI5gEQhK29s-YuCgoIhwIQhK29s-YuCgkIORCErb2z5i4KCQg6EIStvbPmLgoJCAsQhK29s-YuCgoIjAIQhK29s-YuCgkIXxCErb2z5i4KCQgfEIStvbPmLg==; Max-Age=7776000; Expires=Mon, 15 Mar 2021 12:45:41 GMT; Path=/sync; Domain=.3lift.com; SameSite=None; Secure tluid=657867970647066735; Max-Age=7776000; Expires=Mon, 15 Mar 2021 12:45:41 GMT; Path=/; Domain=.3lift.com; SameSite=None; Secure
content-encoding
gzip
p3p
policyref="http://cdn.3lift.com/w3c/p3p.xml", CP="NON DSP COR NID OUR DEL SAM OTR UNR COM NAV INT DEM CNT STA PRE LOC OTC"
cache-control
no-cache, no-store, must-revalidate

Redirect headers

date
Tue, 15 Dec 2020 12:45:41 GMT
content-length
0
set-cookie
tluid=657867970647066735; Max-Age=7776000; Expires=Mon, 15 Mar 2021 12:45:41 GMT; Path=/; Domain=.3lift.com; SameSite=None; Secure
location
/sync?&ld=1
cache-control
no-cache, no-store, must-revalidate
p3p
policyref="http://cdn.3lift.com/w3c/p3p.xml", CP="NON DSP COR NID OUR DEL SAM OTR UNR COM NAV INT DEM CNT STA PRE LOC OTC"
pd
eu-u.openx.net/w/1.0/ Frame 97F6
0
0
Document
General
Full URL
https://eu-u.openx.net/w/1.0/pd?plm=6&ph=36664cef-3484-4aa7-9d01-fa4f6f6b2d4e&gdpr=1
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/static/mol-adverts/demo/mol-22070/19a28e0b/mol-adverts.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
35.244.159.8 Mountain View, United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
OXGW/16.199.0 /
Resource Hash

Request headers

:method
GET
:authority
eu-u.openx.net
:scheme
https
:path
/w/1.0/pd?plm=6&ph=36664cef-3484-4aa7-9d01-fa4f6f6b2d4e&gdpr=1
pragma
no-cache
cache-control
no-cache
upgrade-insecure-requests
1
user-agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
accept
text/html,application/xhtml+xml,application/xml;q=0.9,image/avif,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3;q=0.9
sec-fetch-site
cross-site
sec-fetch-mode
navigate
sec-fetch-dest
iframe
referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
accept-encoding
gzip, deflate, br
accept-language
en-US
cookie
i=84f1103b-a980-4860-8c6e-1866bcc8525c|1608036338; pd=v2|1608036340|gekin0vNiygu
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8

Response headers

vary
Accept, Accept-Encoding
set-cookie
i=84f1103b-a980-4860-8c6e-1866bcc8525c|1608036338; Version=1; Expires=Wed, 15-Dec-2021 12:45:40 GMT; Max-Age=31536000; Secure; Domain=.openx.net; Path=/; SameSite=None pd=v2|1608036340|mWkigqiysLommOgevNgunsn0; Version=1; Expires=Wed, 30-Dec-2020 12:45:40 GMT; Max-Age=1296000; Secure; Domain=.openx.net; Path=/; SameSite=None
server
OXGW/16.199.0
p3p
CP="CUR ADM OUR NOR STA NID"
date
Tue, 15 Dec 2020 12:45:40 GMT
content-type
text/html
content-length
316
content-encoding
gzip
via
1.1 google
alt-svc
clear
i.gif
mfad.inskinad.com/udb/9874/pool/set/
Redirect Chain
  • https://e.serverbid.com/udb/9969/match?redir=https%3A%2F%2Fmfad.inskinad.com%2Fudb%2F9874%2Fpool%2Fset%2Fi.gif%3FpoolId%3D9969%26poolKey%3D
  • https://mfad.inskinad.com/udb/9874/pool/set/i.gif?poolId=9969&poolKey=ue1-sb1-50ee6297-b466-414e-be83-34869700d04b
43 B
780 B
Image
General
Full URL
https://mfad.inskinad.com/udb/9874/pool/set/i.gif?poolId=9969&poolKey=ue1-sb1-50ee6297-b466-414e-be83-34869700d04b
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
54.225.161.250 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
Software
nginx/1.16.1 / adzerk bifrost/
Resource Hash
a065920df8cc4016d67c3a464be90099c9d28ffe7c9e6ee3a18f257efc58cbd7

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Pragma
no-cache
Date
Tue, 15 Dec 2020 12:45:52 GMT
ETag
W/"2b-6KwiS6nul+h2cO1vOi8BKLevn+Q"
Server
nginx/1.16.1
x-powered-by
adzerk bifrost/
Access-Control-Allow-Methods
GET, PUT, POST, DELETE, OPTIONS
Content-Type
image/gif
Access-Control-Allow-Origin
undefined
Expires
0
Cache-Control
no-cache, no-store, must-revalidate
Access-Control-Allow-Credentials
true
Connection
keep-alive
Access-Control-Allow-Headers
Accept, Origin, Content-Type, Content-Length, X-Adzerk-Explain, X-Adzerk-Sdk-Version
Content-Length
43
x-served-by
engine-production-i-09d1782aba764ec6d

Redirect headers

location
https://mfad.inskinad.com/udb/9874/pool/set/i.gif?poolId=9969&poolKey=ue1-sb1-50ee6297-b466-414e-be83-34869700d04b
date
Tue, 15 Dec 2020 12:45:44 GMT
content-length
0
sync
ups.analytics.yahoo.com/ups/57304/
Redirect Chain
  • https://pixel.advertising.com/ups/57304/sync?gdpr=&gdpr_consent=&_origin=0&redir=true
  • https://ups.analytics.yahoo.com/ups/57304/sync?gdpr=&gdpr_consent=&_origin=0&redir=true&apid=UP706d39db-3ed3-11eb-92c6-02d43f703412
  • https://cm.g.doubleclick.net/pixel?google_nid=adaptv_dbm&google_cm&google_hm=VVA3MDZkMzlkYi0zZWQzLTExZWItOTJjNi0wMmQ0M2Y3MDM0MTI%3D
  • https://pixel.advertising.com/ups/57304/sync?uid=CAESEKvCJyDknWY1dCU0u5ddLbQ&google_cver=1
  • https://ups.analytics.yahoo.com/ups/57304/sync?uid=CAESEKvCJyDknWY1dCU0u5ddLbQ&google_cver=1&apid=UP706d39db-3ed3-11eb-92c6-02d43f703412
0
964 B
Image
General
Full URL
https://ups.analytics.yahoo.com/ups/57304/sync?uid=CAESEKvCJyDknWY1dCU0u5ddLbQ&google_cver=1&apid=UP706d39db-3ed3-11eb-92c6-02d43f703412
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_256_GCM
Server
18.156.0.31 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
ec2-18-156-0-31.eu-central-1.compute.amazonaws.com
Software
ATS/7.1.2.128 /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
Strict-Transport-Security max-age=31536000

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Date
Tue, 15 Dec 2020 12:45:44 GMT
Server
ATS/7.1.2.128
Connection
keep-alive
Age
0
Strict-Transport-Security
max-age=31536000
P3P
CP=NOI DSP COR LAW CURa DEVa TAIa PSAa PSDa OUR BUS UNI COM NAV

Redirect headers

location
https://ups.analytics.yahoo.com/ups/57304/sync?uid=CAESEKvCJyDknWY1dCU0u5ddLbQ&google_cver=1&apid=UP706d39db-3ed3-11eb-92c6-02d43f703412
date
Tue, 15 Dec 2020 12:45:44 GMT
content-length
0
strict-transport-security
max-age=31536000
p3p
CP=NOI DSP COR LAW CURa DEVa TAIa PSAa PSDa OUR BUS UNI COM NAV
sync
pixel.advertising.com/ups/55953/
Redirect Chain
  • https://match.adsrvr.org/track/cmf/generic?ttd_pid=adaptv&ttd_tpi=1
  • https://pixel.advertising.com/ups/55953/sync?uid=c1befdb7-5c1a-4d0f-b053-b3ef508e7ce4&_origin=1&gdpr=1&gdpr_consent=&piggybackCookie=c1befdb7-5c1a-4d0f-b053-b3ef508e7ce4
0
125 B
Image
General
Full URL
https://pixel.advertising.com/ups/55953/sync?uid=c1befdb7-5c1a-4d0f-b053-b3ef508e7ce4&_origin=1&gdpr=1&gdpr_consent=&piggybackCookie=c1befdb7-5c1a-4d0f-b053-b3ef508e7ce4
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
18.197.99.6 Frankfurt am Main, Germany, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
Strict-Transport-Security max-age=31536000

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:45:40 GMT
strict-transport-security
max-age=31536000
p3p
CP=NOI DSP COR LAW CURa DEVa TAIa PSAa PSDa OUR BUS UNI COM NAV

Redirect headers

pragma
no-cache
date
Tue, 15 Dec 2020 12:45:40 GMT
x-aspnet-version
4.0.30319
p3p
CP="NOI DSP COR CUR ADMo DEVo PSAo PSDo OUR SAMo BUS UNI NAV"
location
https://pixel.advertising.com/ups/55953/sync?uid=c1befdb7-5c1a-4d0f-b053-b3ef508e7ce4&_origin=1&gdpr=1&gdpr_consent=&piggybackCookie=c1befdb7-5c1a-4d0f-b053-b3ef508e7ce4
cache-control
private,no-cache, must-revalidate
content-type
text/html
content-length
369
getuids
grid.bidswitch.net/
Redirect Chain
  • https://x.bidswitch.net/sync?ssp=themediagrid
  • https://a.sportradarserving.com/sync?ssp=bidswitch&bidswitch_ssp_id=themediagrid
  • https://a.sportradarserving.com/ul_cb/sync?ssp=bidswitch&bidswitch_ssp_id=themediagrid
  • https://x.bidswitch.net/sync?dsp_id=409&expires=14&user_group=1&user_id=358dfaab-6bf8-4136-a294-2816f441f4c8&ssp=themediagrid
  • https://grid.bidswitch.net/getuids?bsw_uid=c374b576-af0f-4001-86dd-ddc2d8f91de1&ssp_custom_data=
0
260 B
Image
General
Full URL
https://grid.bidswitch.net/getuids?bsw_uid=c374b576-af0f-4001-86dd-ddc2d8f91de1&ssp_custom_data=
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
18.159.79.175 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Date
Tue, 15 Dec 2020 12:45:45 GMT
Cache-Control
no-cache, no-store, must-revalidate
Connection
keep-alive
P3P
CP="NOI DSP COR NID CURa ADMa DEVa PSAa PSDa OUR BUS COM INT OTC PUR STA"
Content-Type
text/html; charset=UTF-8

Redirect headers

location
//grid.bidswitch.net/getuids?bsw_uid=c374b576-af0f-4001-86dd-ddc2d8f91de1&ssp_custom_data=
date
Tue, 15 Dec 2020 12:45:45 GMT
cache-control
no-cache, no-store, must-revalidate
content-length
0
p3p
CP="NOI DSP COR NID CURa ADMa DEVa PSAa PSDa OUR BUS COM INT OTC PUR STA"
sync
ups.analytics.yahoo.com/ups/55986/
Redirect Chain
  • https://sync-tm.everesttech.net/upi/pid/m7y5t93k?gdpr=0&gdpr_consent=&redir=https%3A%2F%2Fpixel.advertising.com%2Fups%2F55986%2Fsync%3Fuid%3D%24%7BUSER_ID%7D%26_origin%3D0&gdpr=0&gdpr_consent=
  • https://sync-tm.everesttech.net/ct/upi/pid/m7y5t93k?gdpr=0&gdpr_consent=&redir=https%3A%2F%2Fpixel.advertising.com%2Fups%2F55986%2Fsync%3Fuid%3D%24%7BUSER_ID%7D%26_origin%3D0&gdpr=0&gdpr_consent=&_...
  • https://pixel.advertising.com/ups/55986/sync?uid=X9iv9wAAAGMUcyrK&_origin=0&gdpr=0&gdpr_consent=&_test=X9iv9wAAAGMUcyrK
  • https://ups.analytics.yahoo.com/ups/55986/sync?uid=X9iv9wAAAGMUcyrK&_origin=0&gdpr=0&gdpr_consent=&_test=X9iv9wAAAGMUcyrK&apid=UP706d39db-3ed3-11eb-92c6-02d43f703412
0
976 B
Image
General
Full URL
https://ups.analytics.yahoo.com/ups/55986/sync?uid=X9iv9wAAAGMUcyrK&_origin=0&gdpr=0&gdpr_consent=&_test=X9iv9wAAAGMUcyrK&apid=UP706d39db-3ed3-11eb-92c6-02d43f703412
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_256_GCM
Server
18.156.0.31 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
ec2-18-156-0-31.eu-central-1.compute.amazonaws.com
Software
ATS/7.1.2.128 /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
Strict-Transport-Security max-age=31536000

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Date
Tue, 15 Dec 2020 12:45:44 GMT
Server
ATS/7.1.2.128
Connection
keep-alive
Age
0
Strict-Transport-Security
max-age=31536000
P3P
CP=NOI DSP COR LAW CURa DEVa TAIa PSAa PSDa OUR BUS UNI COM NAV

Redirect headers

location
https://ups.analytics.yahoo.com/ups/55986/sync?uid=X9iv9wAAAGMUcyrK&_origin=0&gdpr=0&gdpr_consent=&_test=X9iv9wAAAGMUcyrK&apid=UP706d39db-3ed3-11eb-92c6-02d43f703412
date
Tue, 15 Dec 2020 12:45:44 GMT
content-length
0
strict-transport-security
max-age=31536000
p3p
CP=NOI DSP COR LAW CURa DEVa TAIa PSAa PSDa OUR BUS UNI COM NAV
i.gif
mfad.inskinad.com/udb/9874/sync/
Redirect Chain
  • https://ssum.casalemedia.com/usermatchredir?s=185638&cb=https%3A%2F%2Fmfad.inskinad.com%2Fudb%2F9874%2Fsync%2Fi.gif%3FpartnerId%3D1%26userId%3D
  • https://mfad.inskinad.com/udb/9874/sync/i.gif?partnerId=1&userId=X9iv8oE1aeK2FeDJu3VAdAAA%261142
43 B
780 B
Image
General
Full URL
https://mfad.inskinad.com/udb/9874/sync/i.gif?partnerId=1&userId=X9iv8oE1aeK2FeDJu3VAdAAA%261142
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
54.225.161.250 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
Software
nginx/1.16.1 / adzerk bifrost/
Resource Hash
a065920df8cc4016d67c3a464be90099c9d28ffe7c9e6ee3a18f257efc58cbd7

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Pragma
no-cache
Date
Tue, 15 Dec 2020 12:45:52 GMT
ETag
W/"2b-6KwiS6nul+h2cO1vOi8BKLevn+Q"
Server
nginx/1.16.1
x-powered-by
adzerk bifrost/
Access-Control-Allow-Methods
GET, PUT, POST, DELETE, OPTIONS
Content-Type
image/gif
Access-Control-Allow-Origin
undefined
Expires
0
Cache-Control
no-cache, no-store, must-revalidate
Access-Control-Allow-Credentials
true
Connection
keep-alive
Access-Control-Allow-Headers
Accept, Origin, Content-Type, Content-Length, X-Adzerk-Explain, X-Adzerk-Sdk-Version
Content-Length
43
x-served-by
engine-production-i-08e9e7def57c6c3eb

Redirect headers

pragma
no-cache
date
Tue, 15 Dec 2020 12:45:43 GMT
server
Apache
p3p
policyref="/w3c/p3p.xml", CP="NOI DSP COR DEVa TAIa OUR BUS UNI"
location
https://mfad.inskinad.com/udb/9874/sync/i.gif?partnerId=1&userId=X9iv8oE1aeK2FeDJu3VAdAAA%261142
cache-control
max-age=0, no-cache, no-store
content-type
text/html; charset=iso-8859-1
content-length
284
expires
Tue, 15 Dec 2020 12:45:43 GMT
amp4ads-v0.mjs
cdn.ampproject.org/rtv/012010270040000/ Frame 2DB7
180 KB
50 KB
Script
General
Full URL
https://cdn.ampproject.org/rtv/012010270040000/amp4ads-v0.mjs
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020120801.js
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:81f::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
b2ab9ac436910017b9a2ca7db0e981bad3638db97f576d713eaa9b302e06c094
Security Headers
Name Value
Content-Security-Policy default-src * blob: data:; script-src blob: https://cdn.ampproject.org/esm/ https://cdn.ampproject.org/lts/ https://cdn.ampproject.org/mp/ https://cdn.ampproject.org/rtv/ https://cdn.ampproject.org/sp/ https://cdn.ampproject.org/sw/ https://cdn.ampproject.org/v0.js https://cdn.ampproject.org/v0.mjs https://cdn.ampproject.org/v0/ https://cdn.ampproject.org/viewer/; object-src 'none'; style-src 'unsafe-inline' https://cdn.ampproject.org/rtv/ https://cdn.materialdesignicons.com https://cloud.typography.com https://fast.fonts.net https://fonts.googleapis.com https://maxcdn.bootstrapcdn.com https://p.typekit.net https://pro.fontawesome.com https://use.fontawesome.com https://use.typekit.net; report-uri https://csp.withgoogle.com/csp/amp
Strict-Transport-Security max-age=31536000; includeSubDomains; preload
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

content-security-policy
default-src * blob: data:; script-src blob: https://cdn.ampproject.org/esm/ https://cdn.ampproject.org/lts/ https://cdn.ampproject.org/mp/ https://cdn.ampproject.org/rtv/ https://cdn.ampproject.org/sp/ https://cdn.ampproject.org/sw/ https://cdn.ampproject.org/v0.js https://cdn.ampproject.org/v0.mjs https://cdn.ampproject.org/v0/ https://cdn.ampproject.org/viewer/; object-src 'none'; style-src 'unsafe-inline' https://cdn.ampproject.org/rtv/ https://cdn.materialdesignicons.com https://cloud.typography.com https://fast.fonts.net https://fonts.googleapis.com https://maxcdn.bootstrapcdn.com https://p.typekit.net https://pro.fontawesome.com https://use.fontawesome.com https://use.typekit.net; report-uri https://csp.withgoogle.com/csp/amp
content-encoding
br
x-content-type-options
nosniff
age
397957
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
51478
x-xss-protection
0
server
sffe
date
Thu, 10 Dec 2020 22:13:03 GMT
strict-transport-security
max-age=31536000; includeSubDomains; preload
content-type
text/javascript
access-control-allow-origin
*
vary
Accept-Encoding
cache-control
public, max-age=31536000
etag
"0305d7d21a7fe4a1"
accept-ranges
bytes
timing-allow-origin
*
expires
Fri, 10 Dec 2021 22:13:03 GMT
amp-ad-exit-0.1.mjs
cdn.ampproject.org/rtv/012010270040000/v0/ Frame 2DB7
13 KB
5 KB
Script
General
Full URL
https://cdn.ampproject.org/rtv/012010270040000/v0/amp-ad-exit-0.1.mjs
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020120801.js
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:81f::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
ebab910fdc7c7e9e079caa9f7321177b135b2e1542f86ce36937ceb41865086d
Security Headers
Name Value
Content-Security-Policy default-src * blob: data:; script-src blob: https://cdn.ampproject.org/esm/ https://cdn.ampproject.org/lts/ https://cdn.ampproject.org/mp/ https://cdn.ampproject.org/rtv/ https://cdn.ampproject.org/sp/ https://cdn.ampproject.org/sw/ https://cdn.ampproject.org/v0.js https://cdn.ampproject.org/v0.mjs https://cdn.ampproject.org/v0/ https://cdn.ampproject.org/viewer/; object-src 'none'; style-src 'unsafe-inline' https://cdn.ampproject.org/rtv/ https://cdn.materialdesignicons.com https://cloud.typography.com https://fast.fonts.net https://fonts.googleapis.com https://maxcdn.bootstrapcdn.com https://p.typekit.net https://pro.fontawesome.com https://use.fontawesome.com https://use.typekit.net; report-uri https://csp.withgoogle.com/csp/amp
Strict-Transport-Security max-age=31536000; includeSubDomains; preload
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

content-security-policy
default-src * blob: data:; script-src blob: https://cdn.ampproject.org/esm/ https://cdn.ampproject.org/lts/ https://cdn.ampproject.org/mp/ https://cdn.ampproject.org/rtv/ https://cdn.ampproject.org/sp/ https://cdn.ampproject.org/sw/ https://cdn.ampproject.org/v0.js https://cdn.ampproject.org/v0.mjs https://cdn.ampproject.org/v0/ https://cdn.ampproject.org/viewer/; object-src 'none'; style-src 'unsafe-inline' https://cdn.ampproject.org/rtv/ https://cdn.materialdesignicons.com https://cloud.typography.com https://fast.fonts.net https://fonts.googleapis.com https://maxcdn.bootstrapcdn.com https://p.typekit.net https://pro.fontawesome.com https://use.fontawesome.com https://use.typekit.net; report-uri https://csp.withgoogle.com/csp/amp
content-encoding
br
x-content-type-options
nosniff
age
285468
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
4850
x-xss-protection
0
server
sffe
date
Sat, 12 Dec 2020 05:27:52 GMT
strict-transport-security
max-age=31536000; includeSubDomains; preload
content-type
text/javascript
access-control-allow-origin
*
vary
Accept-Encoding
cache-control
public, max-age=31536000
etag
"77bd676d834aaa8d"
accept-ranges
bytes
timing-allow-origin
*
expires
Sun, 12 Dec 2021 05:27:52 GMT
amp-analytics-0.1.mjs
cdn.ampproject.org/rtv/012010270040000/v0/ Frame 2DB7
90 KB
27 KB
Script
General
Full URL
https://cdn.ampproject.org/rtv/012010270040000/v0/amp-analytics-0.1.mjs
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020120801.js
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:81f::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
477549a4d5fb644cda6bf64af01631b8411022d88e608bbd8e5a06e327b391cb
Security Headers
Name Value
Content-Security-Policy default-src * blob: data:; script-src blob: https://cdn.ampproject.org/esm/ https://cdn.ampproject.org/lts/ https://cdn.ampproject.org/mp/ https://cdn.ampproject.org/rtv/ https://cdn.ampproject.org/sp/ https://cdn.ampproject.org/sw/ https://cdn.ampproject.org/v0.js https://cdn.ampproject.org/v0.mjs https://cdn.ampproject.org/v0/ https://cdn.ampproject.org/viewer/; object-src 'none'; style-src 'unsafe-inline' https://cdn.ampproject.org/rtv/ https://cdn.materialdesignicons.com https://cloud.typography.com https://fast.fonts.net https://fonts.googleapis.com https://maxcdn.bootstrapcdn.com https://p.typekit.net https://pro.fontawesome.com https://use.fontawesome.com https://use.typekit.net; report-uri https://csp.withgoogle.com/csp/amp
Strict-Transport-Security max-age=31536000; includeSubDomains; preload
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

content-security-policy
default-src * blob: data:; script-src blob: https://cdn.ampproject.org/esm/ https://cdn.ampproject.org/lts/ https://cdn.ampproject.org/mp/ https://cdn.ampproject.org/rtv/ https://cdn.ampproject.org/sp/ https://cdn.ampproject.org/sw/ https://cdn.ampproject.org/v0.js https://cdn.ampproject.org/v0.mjs https://cdn.ampproject.org/v0/ https://cdn.ampproject.org/viewer/; object-src 'none'; style-src 'unsafe-inline' https://cdn.ampproject.org/rtv/ https://cdn.materialdesignicons.com https://cloud.typography.com https://fast.fonts.net https://fonts.googleapis.com https://maxcdn.bootstrapcdn.com https://p.typekit.net https://pro.fontawesome.com https://use.fontawesome.com https://use.typekit.net; report-uri https://csp.withgoogle.com/csp/amp
content-encoding
br
x-content-type-options
nosniff
age
475638
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
27668
x-xss-protection
0
server
sffe
date
Thu, 10 Dec 2020 00:38:22 GMT
strict-transport-security
max-age=31536000; includeSubDomains; preload
content-type
text/javascript
access-control-allow-origin
*
vary
Accept-Encoding
cache-control
public, max-age=31536000
etag
"1304c1c0caf7ca3c"
accept-ranges
bytes
timing-allow-origin
*
expires
Fri, 10 Dec 2021 00:38:22 GMT
amp-fit-text-0.1.mjs
cdn.ampproject.org/rtv/012010270040000/v0/ Frame 2DB7
3 KB
1 KB
Script
General
Full URL
https://cdn.ampproject.org/rtv/012010270040000/v0/amp-fit-text-0.1.mjs
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020120801.js
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:81f::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
a86753d4effe5e607d4eaf03fe37eccb8cac743a528f874f736f4d7f35e094b1
Security Headers
Name Value
Content-Security-Policy default-src * blob: data:; script-src blob: https://cdn.ampproject.org/esm/ https://cdn.ampproject.org/lts/ https://cdn.ampproject.org/mp/ https://cdn.ampproject.org/rtv/ https://cdn.ampproject.org/sp/ https://cdn.ampproject.org/sw/ https://cdn.ampproject.org/v0.js https://cdn.ampproject.org/v0.mjs https://cdn.ampproject.org/v0/ https://cdn.ampproject.org/viewer/; object-src 'none'; style-src 'unsafe-inline' https://cdn.ampproject.org/rtv/ https://cdn.materialdesignicons.com https://cloud.typography.com https://fast.fonts.net https://fonts.googleapis.com https://maxcdn.bootstrapcdn.com https://p.typekit.net https://pro.fontawesome.com https://use.fontawesome.com https://use.typekit.net; report-uri https://csp.withgoogle.com/csp/amp
Strict-Transport-Security max-age=31536000; includeSubDomains; preload
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

content-security-policy
default-src * blob: data:; script-src blob: https://cdn.ampproject.org/esm/ https://cdn.ampproject.org/lts/ https://cdn.ampproject.org/mp/ https://cdn.ampproject.org/rtv/ https://cdn.ampproject.org/sp/ https://cdn.ampproject.org/sw/ https://cdn.ampproject.org/v0.js https://cdn.ampproject.org/v0.mjs https://cdn.ampproject.org/v0/ https://cdn.ampproject.org/viewer/; object-src 'none'; style-src 'unsafe-inline' https://cdn.ampproject.org/rtv/ https://cdn.materialdesignicons.com https://cloud.typography.com https://fast.fonts.net https://fonts.googleapis.com https://maxcdn.bootstrapcdn.com https://p.typekit.net https://pro.fontawesome.com https://use.fontawesome.com https://use.typekit.net; report-uri https://csp.withgoogle.com/csp/amp
content-encoding
br
x-content-type-options
nosniff
age
355560
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
1350
x-xss-protection
0
server
sffe
date
Fri, 11 Dec 2020 09:59:40 GMT
strict-transport-security
max-age=31536000; includeSubDomains; preload
content-type
text/javascript
access-control-allow-origin
*
vary
Accept-Encoding
cache-control
public, max-age=31536000
etag
"12c034eb739190af"
accept-ranges
bytes
timing-allow-origin
*
expires
Sat, 11 Dec 2021 09:59:40 GMT
amp-form-0.1.mjs
cdn.ampproject.org/rtv/012010270040000/v0/ Frame 2DB7
41 KB
13 KB
Script
General
Full URL
https://cdn.ampproject.org/rtv/012010270040000/v0/amp-form-0.1.mjs
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020120801.js
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:81f::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
b61eb57ae77f31b91b04781da33023ecd897fda21f6c817e6c27623204046f42
Security Headers
Name Value
Content-Security-Policy default-src * blob: data:; script-src blob: https://cdn.ampproject.org/esm/ https://cdn.ampproject.org/lts/ https://cdn.ampproject.org/mp/ https://cdn.ampproject.org/rtv/ https://cdn.ampproject.org/sp/ https://cdn.ampproject.org/sw/ https://cdn.ampproject.org/v0.js https://cdn.ampproject.org/v0.mjs https://cdn.ampproject.org/v0/ https://cdn.ampproject.org/viewer/; object-src 'none'; style-src 'unsafe-inline' https://cdn.ampproject.org/rtv/ https://cdn.materialdesignicons.com https://cloud.typography.com https://fast.fonts.net https://fonts.googleapis.com https://maxcdn.bootstrapcdn.com https://p.typekit.net https://pro.fontawesome.com https://use.fontawesome.com https://use.typekit.net; report-uri https://csp.withgoogle.com/csp/amp
Strict-Transport-Security max-age=31536000; includeSubDomains; preload
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

content-security-policy
default-src * blob: data:; script-src blob: https://cdn.ampproject.org/esm/ https://cdn.ampproject.org/lts/ https://cdn.ampproject.org/mp/ https://cdn.ampproject.org/rtv/ https://cdn.ampproject.org/sp/ https://cdn.ampproject.org/sw/ https://cdn.ampproject.org/v0.js https://cdn.ampproject.org/v0.mjs https://cdn.ampproject.org/v0/ https://cdn.ampproject.org/viewer/; object-src 'none'; style-src 'unsafe-inline' https://cdn.ampproject.org/rtv/ https://cdn.materialdesignicons.com https://cloud.typography.com https://fast.fonts.net https://fonts.googleapis.com https://maxcdn.bootstrapcdn.com https://p.typekit.net https://pro.fontawesome.com https://use.fontawesome.com https://use.typekit.net; report-uri https://csp.withgoogle.com/csp/amp
content-encoding
br
x-content-type-options
nosniff
age
353672
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
13075
x-xss-protection
0
server
sffe
date
Fri, 11 Dec 2020 10:31:08 GMT
strict-transport-security
max-age=31536000; includeSubDomains; preload
content-type
text/javascript
access-control-allow-origin
*
vary
Accept-Encoding
cache-control
public, max-age=31536000
etag
"1e8a1dae72af56cd"
accept-ranges
bytes
timing-allow-origin
*
expires
Sat, 11 Dec 2021 10:31:08 GMT
css
fonts.googleapis.com/ Frame 2DB7
6 KB
747 B
Stylesheet
General
Full URL
https://fonts.googleapis.com/css?family=Roboto:300|Roboto:400,500&lang=nl
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020120801.js
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:802::200a Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
ESF /
Resource Hash
56e4953af5c01ed820d5e5dc430e77234a87e8d019c38fda46f9f3593cd05e0f
Security Headers
Name Value
Strict-Transport-Security max-age=31536000
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

strict-transport-security
max-age=31536000
content-encoding
gzip
x-content-type-options
nosniff
cross-origin-resource-policy
cross-origin
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
x-xss-protection
0
last-modified
Tue, 15 Dec 2020 11:10:46 GMT
server
ESF
date
Tue, 15 Dec 2020 12:45:40 GMT
x-frame-options
SAMEORIGIN
content-type
text/css; charset=utf-8
access-control-allow-origin
*
cache-control
private, max-age=86400, stale-while-revalidate=604800
timing-allow-origin
*
link
<https://fonts.gstatic.com>; rel=preconnect; crossorigin
expires
Tue, 15 Dec 2020 12:45:40 GMT
css
fonts.googleapis.com/ Frame 2DB7
4 KB
651 B
Stylesheet
General
Full URL
https://fonts.googleapis.com/css?family=Roboto:400,500&text=
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020120801.js
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:802::200a Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
ESF /
Resource Hash
2190c16423c2557bcb20ccba2edc176fbeb16e6a3de2b2af297f650aae85a43e
Security Headers
Name Value
Strict-Transport-Security max-age=31536000
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

strict-transport-security
max-age=31536000
content-encoding
gzip
x-content-type-options
nosniff
cross-origin-resource-policy
cross-origin
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
x-xss-protection
0
last-modified
Tue, 15 Dec 2020 11:59:32 GMT
server
ESF
date
Tue, 15 Dec 2020 12:45:40 GMT
x-frame-options
SAMEORIGIN
content-type
text/css; charset=utf-8
access-control-allow-origin
*
cache-control
private, max-age=86400, stale-while-revalidate=604800
timing-allow-origin
*
link
<https://fonts.gstatic.com>; rel=preconnect; crossorigin
expires
Tue, 15 Dec 2020 12:45:40 GMT
en.png
tpc.googlesyndication.com/pagead/images/adchoices/ Frame 2DB7
2 KB
3 KB
Image
General
Full URL
https://tpc.googlesyndication.com/pagead/images/adchoices/en.png
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020120801.js
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:81d::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
36133ca07927c88a7cc578fddbaed3c668ab75087834d0ca13dca5de4ec856c1
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

timing-allow-origin
*
date
Mon, 14 Dec 2020 23:34:27 GMT
x-content-type-options
nosniff
server
cafe
age
47473
etag
14819457070020093239
vary
Accept-Encoding
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
cache-control
public, max-age=86400
cross-origin-resource-policy
cross-origin
content-type
image/png
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
2502
x-xss-protection
0
expires
Tue, 15 Dec 2020 23:34:27 GMT
icon.png
tpc.googlesyndication.com/pagead/images/adchoices/ Frame 2DB7
295 B
406 B
Image
General
Full URL
https://tpc.googlesyndication.com/pagead/images/adchoices/icon.png
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020120801.js
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:81d::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
7fd59024b6ca83f11f7a3448ec148309a13b705725716df134f699e60a96eb1b
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

timing-allow-origin
*
date
Mon, 14 Dec 2020 21:53:21 GMT
x-content-type-options
nosniff
server
cafe
age
53539
etag
426692510519060060
vary
Accept-Encoding
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
cache-control
public, max-age=86400
cross-origin-resource-policy
cross-origin
content-type
image/png
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
295
x-xss-protection
0
expires
Tue, 15 Dec 2020 21:53:21 GMT
truncated
/ Frame 2DB7
211 B
0
Image
General
Full URL
data:truncated
Protocol
DATA
Server
-, , ASN (),
Reverse DNS
Software
/
Resource Hash
2d19fb3cd5875bdaa970e2520b62994347ee9ec634b636dbdf55659b7679bc76

Request headers

Referer
https://www.dailymail.co.uk/
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Content-Type
image/png
downsize_200k_v1
tpc.googlesyndication.com/simgad/16735864853205177106/ Frame 2DB7
22 KB
22 KB
Image
General
Full URL
https://tpc.googlesyndication.com/simgad/16735864853205177106/downsize_200k_v1?sqp=4sqPyQSLAUKIAQgAEhQNzczMPhUAAABAHQAAAAAlAAAAABgAIgoNAACAPxUAAIA_Kk8IWhABHQAAtEIgASgBMAY4A0CAwtcvSABQAFgAYFpwAngAgAEAiAEAkAEAnQEAAIA_oAEAqAEAsAGAreIEuAH___________8BxQEtsp0-Mg8I2AQQ2AQYASABLQAAAD8&rs=AOga4qlj8veMEcMgJyJ3scP2ZNcBrbNI7w
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:81d::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
1ae244e4b84167176433c6c5f10f51d0176ac0d43823bfc8202e22459b2d8df8
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 06:57:47 GMT
x-content-type-options
nosniff
last-modified
Tue, 24 Nov 2020 12:43:22 GMT
server
sffe
age
20873
content-type
image/png
access-control-allow-origin
*
cache-control
public, max-age=31536000
cross-origin-resource-policy
cross-origin
accept-ranges
bytes
timing-allow-origin
*
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
22631
x-xss-protection
0
expires
Wed, 15 Dec 2021 06:57:47 GMT
downsize_200k_v1
tpc.googlesyndication.com/simgad/15117266339955274523/ Frame 2DB7
19 KB
19 KB
Image
General
Full URL
https://tpc.googlesyndication.com/simgad/15117266339955274523/downsize_200k_v1?sqp=4sqPyQSWAUKTAQgAEhQNzczMPhUAAABAHQAAAAAlAAAAABgAIgoNAACAPxUAAIA_Kk8IWhABHQAAtEIgASgBMAY4A0CAwtcvSABQAFgAYFpwAngAgAEAiAEAkAEAnQEAAIA_oAEAqAEAsAGAreIEuAH___________8BxQEtsp0-MhoIrAIQnQEYASABLQAAAD8wrAI4nQFFAACAPw&rs=AOga4qkRD1AlAGtGafo11gB-F68ncV5H4A
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:81d::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
6e6bc59860c2fd0a17e5e84e849f0e02afd0434f1c6e395f0acf18d596c8aa29
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:45:40 GMT
x-content-type-options
nosniff
last-modified
Tue, 24 Nov 2020 12:36:40 GMT
server
sffe
content-type
image/jpeg
access-control-allow-origin
*
cache-control
public, max-age=31536000
cross-origin-resource-policy
cross-origin
accept-ranges
bytes
timing-allow-origin
*
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
19168
x-xss-protection
0
expires
Wed, 15 Dec 2021 12:45:40 GMT
adview
securepubads.g.doubleclick.net/pagead/ Frame 2DB7
0
0
Image
General
Full URL
https://securepubads.g.doubleclick.net/pagead/adview?ai=C7VxL86_YX4f0L8iBx_APuqiMwAuiqPimYMzsir6zDJiS-IezAhABIKzZuCJgkYSThfwXoAG3uLfZA8gBBqkCH9hI1d5etD7gAgCoAwHIAwqqBMQCT9BggGn8PVC3GPFBlCz4Cy0gHNKwFVw2HOlRa__YBkOyuL2MrJzV4eLxOyFGsq3xfhSGbcH9X9MVtSQmblxLKsxyfa4BT4xd3dbwypU-p7HH5L5VGxMi-EcYToDh82eecMAd08i-WSwDeXniXaEaTyvm-G_uzY87afUvmRSSMNf6HcUU0tDUQN68oYMHggAoxVkvV3AV_8A7perWd5d6SSprKi1qv8RUOTFmxYfwyij8CA_UKcCGNNcQJqJPvMDk7bIF-rvjvKZH595j1mzgVqNpnBExXTBFzklDF875Onp0xg_ej7PxAjSpELAyDj5QLK1H4cuAjVPzcnTGvhb__eep6BTWgxOv_wYB0XuFD_GXS2B4wYlzqxyfMR6QVMrQk7zNr0KRgH3FyDO1AiyiDuk5e9RfW_RLlV-kepM8vyTbauvWwASk1P-nuwPgBAGgBjeAB7HHyCaoB9XJG6gH8NkbqAfy2RuoB5SYsQKoB6XfG6gHjs4bqAeT2BuoB7oGqAfulrECqAemvhuoB-zVG9gHAfIHBBDHpwPSCAkIgOGAEBABGB2ACgPICwHYEwOIFAHQFQGAFwGyFxoKGAgBEhRwdWItNDE4MDgzNTY5NDE2NjI1NQ&sigh=4hjWCwLs670&template_id=492&tpd=AGWhJmvbTsSGs02auHfNY8HjV45DPgvW4N4ov-UZwEY7qCaLPg
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
172.217.22.2 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
fra16s14-in-f2.1e100.net
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
https://www.dailymail.co.uk/
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

/
p.skimresources.com/ Frame C69F
Redirect Chain
  • https://sync.crwdcntrl.net/map/c=7505/tp=SKIM/?https%3A%2F%2Fx.skimresources.com%2F%3Fprovider%3Dlotame%26skim_mapping%3Dtrue%26provider_id%3D%24%7Bprofile_id%7D
  • https://x.skimresources.com/?provider=lotame&skim_mapping=true&provider_id=
  • https://p.skimresources.com/?skim_mapping=true
43 B
244 B
Image
General
Full URL
https://p.skimresources.com/?skim_mapping=true
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
35.190.91.160 Mountain View, United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
Skimlinks Pixel 1.0 /
Resource Hash
dcecab1355b5c2b9ecef281322bf265ac5840b4688748586e9632b473a5fe56b

Request headers

Referer
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:45:43 GMT
via
1.1 google
server
Skimlinks Pixel 1.0
p3p
policyref="http://skimlinks.com/w3c/p3p.xml", CP="NOI DSP COR CURa ADMa DEVa TAIa OUR BUS IND UNI COM NAV INT"
alt-svc
clear
content-length
43
content-type
image/gif

Redirect headers

date
Tue, 15 Dec 2020 12:45:40 GMT
via
1.1 google
server
nginx/1.16.1
p3p
CP="IDC DSP COR ADM DEVi TAIi PSA PSD IVAi IVDi CONi HIS OUR IND CNT"
location
https://p.skimresources.com?skim_mapping=true
content-type
text/html; charset=UTF-8
alt-svc
clear
content-length
0
KFOmCnqEu92Fr1Mu4mxKKTU1Kg.woff2
fonts.gstatic.com/s/roboto/v20/ Frame 2DB7
11 KB
11 KB
Font
General
Full URL
https://fonts.gstatic.com/s/roboto/v20/KFOmCnqEu92Fr1Mu4mxKKTU1Kg.woff2
Requested by
Host: fonts.googleapis.com
URL: https://fonts.googleapis.com/css?family=Roboto:300|Roboto:400,500&lang=nl
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:825::2003 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
5d1bc9b443f3f81fa4b4ad4634c1bb9702194c1898e3a9de0ab5e2cdc0e9f479
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Origin
https://www.dailymail.co.uk
Referer
https://fonts.googleapis.com/css?family=Roboto:300|Roboto:400,500&lang=nl
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 08 Dec 2020 17:20:25 GMT
x-content-type-options
nosniff
last-modified
Wed, 24 Jul 2019 01:18:50 GMT
server
sffe
age
588315
content-type
font/woff2
access-control-allow-origin
*
cache-control
public, max-age=31536000
accept-ranges
bytes
timing-allow-origin
*
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
11016
x-xss-protection
0
expires
Wed, 08 Dec 2021 17:20:25 GMT
KFOlCnqEu92Fr1MmEU9fBBc4AMP6lQ.woff2
fonts.gstatic.com/s/roboto/v20/ Frame 2DB7
11 KB
11 KB
Font
General
Full URL
https://fonts.gstatic.com/s/roboto/v20/KFOlCnqEu92Fr1MmEU9fBBc4AMP6lQ.woff2
Requested by
Host: fonts.googleapis.com
URL: https://fonts.googleapis.com/css?family=Roboto:300|Roboto:400,500&lang=nl
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:825::2003 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
ce897833ac6e362df7c91ac8223fe511c6defcf33964928a81004600a2dd4c2e
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Origin
https://www.dailymail.co.uk
Referer
https://fonts.googleapis.com/css?family=Roboto:300|Roboto:400,500&lang=nl
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Mon, 14 Dec 2020 22:21:20 GMT
x-content-type-options
nosniff
last-modified
Wed, 24 Jul 2019 01:18:48 GMT
server
sffe
age
51860
content-type
font/woff2
access-control-allow-origin
*
cache-control
public, max-age=31536000
accept-ranges
bytes
timing-allow-origin
*
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
11056
x-xss-protection
0
expires
Tue, 14 Dec 2021 22:21:20 GMT
/
crta.dailymail.co.uk/
8 B
451 B
Other
General
Full URL
https://crta.dailymail.co.uk/
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/static/mol-adverts/demo/mol-22070/19a28e0b/mol-adverts.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
2a02:26f0:6c00:2be::16c2 , Ascension Island, ASN20940 (AKAMAI-ASN1, EU),
Reverse DNS
Software
http-to-kafka/0.8.10 /
Resource Hash
a00fb0c50741f81bb51d35b4475a4357f8039aabd896a21036bc516839401595

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type
text/plain

Response headers

pragma
no-cache
date
Tue, 15 Dec 2020 12:45:47 GMT
server
http-to-kafka/0.8.10
etag
W/"8-YaBXLEiT7zQxEyDYTILfiL6oPhE"
content-type
text/plain; charset=utf-8
access-control-allow-origin
*
cache-control
max-age=0, no-cache, no-store
access-control-allow-credentials
true
content-length
8
expires
Tue, 15 Dec 2020 12:45:47 GMT
view
securepubads.g.doubleclick.net/pcs/ Frame 636C
0
0
Fetch
General
Full URL
https://securepubads.g.doubleclick.net/pcs/view?xai=AKAOjsv0H54rRNjx_jkWNg_io5nLn9_Mw7zc-6fKaPX48YZMj_SuQ1sxdSXeM0E7L6QHZlFQDVySLpid1PrByodPilEMrmVnTkbEgh-q6g0hNZpL7kEP1hrB2EMzWNGczXLZouvM1DD0QJV2EmNWMIcVNlZ0IPq_0uIik42PU5M7gL-j9DF-Kkf4Xj-d-rHsExZbktZwWv3L-R91zFWzjeSBXPafEFlGxv1ObBkpimaF_EuK9wXItGoxdyRnH7pwniG-nBWVQGwqy51lh__R755zfdgFc25qjJALqk3iVZ83tqzzzADV5C4hLUvl0qaiKG9MpmQ15w&sig=Cg0ArKJSzHlBiPq9EAmNEAE&adurl=
Requested by
Host: info.silobreaker.com
URL: https://info.silobreaker.com/e2t/sc2/MmZ-8yjYCXrW6zj2_M6nsGYsW7JzK5Y7LnJnQVd1GcC5Dg2KFdBBbG504
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
172.217.22.2 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
fra16s14-in-f2.1e100.net
Software
cafe /
Resource Hash
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

timing-allow-origin
*
date
Tue, 15 Dec 2020 12:45:40 GMT
x-content-type-options
nosniff
server
cafe
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
access-control-allow-origin
*
cache-control
private
cross-origin-resource-policy
cross-origin
content-type
image/gif
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
0
x-xss-protection
0
3791481572381204646
tpc.googlesyndication.com/simgad/ Frame 636C
23 KB
24 KB
Image
General
Full URL
https://tpc.googlesyndication.com/simgad/3791481572381204646
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020120801.js
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:81d::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
9d0058bf5606d26f341c810071e00b9feb946dfea23c258f3d60392c02767ed3
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Mon, 14 Dec 2020 17:51:34 GMT
x-content-type-options
nosniff
age
68046
x-dns-prefetch-control
off
cross-origin-resource-policy
cross-origin
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
23957
x-xss-protection
0
last-modified
Fri, 11 Dec 2020 14:11:18 GMT
server
sffe
content-type
image/png
access-control-allow-origin
*
cache-control
public, max-age=31536000
accept-ranges
bytes
timing-allow-origin
*
expires
Tue, 14 Dec 2021 17:51:34 GMT
abg_lite_fy2019.js
tpc.googlesyndication.com/pagead/js/r20201203/r20110914/ Frame 636C
18 KB
7 KB
Script
General
Full URL
https://tpc.googlesyndication.com/pagead/js/r20201203/r20110914/abg_lite_fy2019.js
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020120801.js
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:81d::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
631c6a3617e2f5860eaa62155f5200b6ca156c00438445f9862089ef785e4542
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Mon, 14 Dec 2020 15:46:12 GMT
content-encoding
gzip
x-content-type-options
nosniff
age
75568
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
cross-origin-resource-policy
cross-origin
content-disposition
attachment; filename="f.txt"
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
7483
x-xss-protection
0
server
cafe
etag
7789600959769866771
vary
Accept-Encoding, Origin
content-type
text/javascript; charset=UTF-8
cache-control
public, max-age=1209600
timing-allow-origin
*
expires
Mon, 28 Dec 2020 15:46:12 GMT
window_focus_fy2019.js
tpc.googlesyndication.com/pagead/js/r20201203/r20110914/client/ Frame 636C
3 KB
2 KB
Script
General
Full URL
https://tpc.googlesyndication.com/pagead/js/r20201203/r20110914/client/window_focus_fy2019.js
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020120801.js
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:81d::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
f8f96b0cc81405b2a95c412dbf43aebae111f11e98ad743b8fff74b2d5c793a2
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 03:27:47 GMT
content-encoding
gzip
x-content-type-options
nosniff
age
33473
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
cross-origin-resource-policy
cross-origin
content-disposition
attachment; filename="f.txt"
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
1494
x-xss-protection
0
server
cafe
etag
5335486849732140232
vary
Accept-Encoding, Origin
content-type
text/javascript; charset=UTF-8
cache-control
public, max-age=1209600
timing-allow-origin
*
expires
Tue, 29 Dec 2020 03:27:47 GMT
rx_lidar.js
www.googletagservices.com/activeview/js/current/ Frame 636C
104 KB
32 KB
Script
General
Full URL
https://www.googletagservices.com/activeview/js/current/rx_lidar.js?cache=r20110914
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020120801.js
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:816::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
641620cb44b22d924bd94996adebcd8cf56e65629af1ba9d98a7371d07be127d
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:45:40 GMT
content-encoding
gzip
x-content-type-options
nosniff
server
sffe
etag
"1607690634902976"
vary
Accept-Encoding
content-type
text/javascript
cache-control
private, max-age=3000
accept-ranges
bytes
alt-svc
h3-29="googleads.g.doubleclick.net:443"; ma=2592000,h3-29=":443"; ma=2592000,h3-T051="googleads.g.doubleclick.net:443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic="googleads.g.doubleclick.net:443"; ma=2592000; v="46,43",quic=":443"; ma=2592000; v="46,43"
content-length
32509
x-xss-protection
0
expires
Tue, 15 Dec 2020 12:45:40 GMT
si
googleads.g.doubleclick.net/pagead/drt/ Frame 2DB7
Redirect Chain
  • https://www.google.com/pagead/drt/ui
  • https://googleads.g.doubleclick.net/pagead/drt/si
0
0
Image
General
Full URL
https://googleads.g.doubleclick.net/pagead/drt/si
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:816::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Redirect headers

date
Tue, 15 Dec 2020 12:45:40 GMT
x-content-type-options
nosniff
server
safe
content-type
text/html; charset=UTF-8
location
https://googleads.g.doubleclick.net/pagead/drt/si
cache-control
private
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
246
x-xss-protection
0
truncated
/ Frame 636C
216 B
0
Image
General
Full URL
data:truncated
Protocol
DATA
Server
-, , ASN (),
Reverse DNS
Software
/
Resource Hash
cc71b0075c466feeb1a2b80645b0380c629529628e3715b7e3627aaef2695db0

Request headers

Referer
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Content-Type
image/png
view
securepubads.g.doubleclick.net/pcs/ Frame 636C
0
0
Fetch
General
Full URL
https://securepubads.g.doubleclick.net/pcs/view?xai=AKAOjst93kLjVqbDWn1cDXGe9cGVHQLhfgiu1WN6FSzVYnV_CUuWwR7CV6isi7jAn0buoFq_wHGTHrN8dvYOsFfHnbyGy8CV9uUTtn4c56oPhdKuWviBgc_4Ejbx4shXdbP0JfgdRtYcyK9gtATK09XAUOT0SjGV_QFKzsm_FzIN1tOLlMg61kMHOaQrECPtVW8CvjArQedVmxtGN5-S0YU7KcXNCWzSWXszDQjncAaTyv70esvcHbJ_Ndfu8f1qPMMy6LpdaMShv0_41EHlnx0RoMsLgSCx0hURwboq_BY496ru_qa4JT_VWY0es921nwrYh3tNZVsH&sig=Cg0ArKJSzKiRyd_HkHqpEAE&adurl=
Requested by
Host: www.googletagservices.com
URL: https://www.googletagservices.com/activeview/js/current/rx_lidar.js?cache=r20110914
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
172.217.22.2 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
fra16s14-in-f2.1e100.net
Software
cafe /
Resource Hash
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

timing-allow-origin
*
date
Tue, 15 Dec 2020 12:45:40 GMT
x-content-type-options
nosniff
server
cafe
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
access-control-allow-origin
*
cache-control
private
cross-origin-resource-policy
cross-origin
content-type
image/gif
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
0
x-xss-protection
0
expires
Tue, 15 Dec 2020 12:45:40 GMT
amp4ads-v0.mjs
cdn.ampproject.org/rtv/052012102342000/ Frame 94F8
186 KB
52 KB
Script
General
Full URL
https://cdn.ampproject.org/rtv/052012102342000/amp4ads-v0.mjs
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020120801.js
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:81f::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
15d8f78205a26b554bd167de81e5e6c84e2be6627aef26477dd6fef8578d397d
Security Headers
Name Value
Content-Security-Policy default-src * blob: data:; script-src blob: https://cdn.ampproject.org/esm/ https://cdn.ampproject.org/lts/ https://cdn.ampproject.org/mp/ https://cdn.ampproject.org/rtv/ https://cdn.ampproject.org/sp/ https://cdn.ampproject.org/sw/ https://cdn.ampproject.org/v0.js https://cdn.ampproject.org/v0.mjs https://cdn.ampproject.org/v0/ https://cdn.ampproject.org/viewer/; object-src 'none'; style-src 'unsafe-inline' https://cdn.ampproject.org/rtv/ https://cdn.materialdesignicons.com https://cloud.typography.com https://fast.fonts.net https://fonts.googleapis.com https://maxcdn.bootstrapcdn.com https://p.typekit.net https://pro.fontawesome.com https://use.fontawesome.com https://use.typekit.net; report-uri https://csp.withgoogle.com/csp/amp
Strict-Transport-Security max-age=31536000; includeSubDomains; preload
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

content-security-policy
default-src * blob: data:; script-src blob: https://cdn.ampproject.org/esm/ https://cdn.ampproject.org/lts/ https://cdn.ampproject.org/mp/ https://cdn.ampproject.org/rtv/ https://cdn.ampproject.org/sp/ https://cdn.ampproject.org/sw/ https://cdn.ampproject.org/v0.js https://cdn.ampproject.org/v0.mjs https://cdn.ampproject.org/v0/ https://cdn.ampproject.org/viewer/; object-src 'none'; style-src 'unsafe-inline' https://cdn.ampproject.org/rtv/ https://cdn.materialdesignicons.com https://cloud.typography.com https://fast.fonts.net https://fonts.googleapis.com https://maxcdn.bootstrapcdn.com https://p.typekit.net https://pro.fontawesome.com https://use.fontawesome.com https://use.typekit.net; report-uri https://csp.withgoogle.com/csp/amp
content-encoding
br
x-content-type-options
nosniff
age
77711
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
53265
x-xss-protection
0
server
sffe
date
Mon, 14 Dec 2020 15:10:29 GMT
strict-transport-security
max-age=31536000; includeSubDomains; preload
content-type
text/javascript
access-control-allow-origin
*
vary
Accept-Encoding
cache-control
public, max-age=31536000
etag
"f72bba98081828c2"
accept-ranges
bytes
timing-allow-origin
*
expires
Tue, 14 Dec 2021 15:10:29 GMT
amp-ad-exit-0.1.mjs
cdn.ampproject.org/rtv/052012102342000/v0/ Frame 94F8
13 KB
5 KB
Script
General
Full URL
https://cdn.ampproject.org/rtv/052012102342000/v0/amp-ad-exit-0.1.mjs
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020120801.js
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:81f::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
2a65878202ba8da80194219b71ce06766b19591a9ad48884a42d99813a2287e2
Security Headers
Name Value
Content-Security-Policy default-src * blob: data:; script-src blob: https://cdn.ampproject.org/esm/ https://cdn.ampproject.org/lts/ https://cdn.ampproject.org/mp/ https://cdn.ampproject.org/rtv/ https://cdn.ampproject.org/sp/ https://cdn.ampproject.org/sw/ https://cdn.ampproject.org/v0.js https://cdn.ampproject.org/v0.mjs https://cdn.ampproject.org/v0/ https://cdn.ampproject.org/viewer/; object-src 'none'; style-src 'unsafe-inline' https://cdn.ampproject.org/rtv/ https://cdn.materialdesignicons.com https://cloud.typography.com https://fast.fonts.net https://fonts.googleapis.com https://maxcdn.bootstrapcdn.com https://p.typekit.net https://pro.fontawesome.com https://use.fontawesome.com https://use.typekit.net; report-uri https://csp.withgoogle.com/csp/amp
Strict-Transport-Security max-age=31536000; includeSubDomains; preload
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

content-security-policy
default-src * blob: data:; script-src blob: https://cdn.ampproject.org/esm/ https://cdn.ampproject.org/lts/ https://cdn.ampproject.org/mp/ https://cdn.ampproject.org/rtv/ https://cdn.ampproject.org/sp/ https://cdn.ampproject.org/sw/ https://cdn.ampproject.org/v0.js https://cdn.ampproject.org/v0.mjs https://cdn.ampproject.org/v0/ https://cdn.ampproject.org/viewer/; object-src 'none'; style-src 'unsafe-inline' https://cdn.ampproject.org/rtv/ https://cdn.materialdesignicons.com https://cloud.typography.com https://fast.fonts.net https://fonts.googleapis.com https://maxcdn.bootstrapcdn.com https://p.typekit.net https://pro.fontawesome.com https://use.fontawesome.com https://use.typekit.net; report-uri https://csp.withgoogle.com/csp/amp
content-encoding
br
x-content-type-options
nosniff
age
77711
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
4851
x-xss-protection
0
server
sffe
date
Mon, 14 Dec 2020 15:10:29 GMT
strict-transport-security
max-age=31536000; includeSubDomains; preload
content-type
text/javascript
access-control-allow-origin
*
vary
Accept-Encoding
cache-control
public, max-age=31536000
etag
"0b29bfab4c809524"
accept-ranges
bytes
timing-allow-origin
*
expires
Tue, 14 Dec 2021 15:10:29 GMT
amp-analytics-0.1.mjs
cdn.ampproject.org/rtv/052012102342000/v0/ Frame 94F8
90 KB
27 KB
Script
General
Full URL
https://cdn.ampproject.org/rtv/052012102342000/v0/amp-analytics-0.1.mjs
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020120801.js
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:81f::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
65961e007908054525e219f8572a7a4eed3797d663d1d49ad13a321af897c139
Security Headers
Name Value
Content-Security-Policy default-src * blob: data:; script-src blob: https://cdn.ampproject.org/esm/ https://cdn.ampproject.org/lts/ https://cdn.ampproject.org/mp/ https://cdn.ampproject.org/rtv/ https://cdn.ampproject.org/sp/ https://cdn.ampproject.org/sw/ https://cdn.ampproject.org/v0.js https://cdn.ampproject.org/v0.mjs https://cdn.ampproject.org/v0/ https://cdn.ampproject.org/viewer/; object-src 'none'; style-src 'unsafe-inline' https://cdn.ampproject.org/rtv/ https://cdn.materialdesignicons.com https://cloud.typography.com https://fast.fonts.net https://fonts.googleapis.com https://maxcdn.bootstrapcdn.com https://p.typekit.net https://pro.fontawesome.com https://use.fontawesome.com https://use.typekit.net; report-uri https://csp.withgoogle.com/csp/amp
Strict-Transport-Security max-age=31536000; includeSubDomains; preload
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

content-security-policy
default-src * blob: data:; script-src blob: https://cdn.ampproject.org/esm/ https://cdn.ampproject.org/lts/ https://cdn.ampproject.org/mp/ https://cdn.ampproject.org/rtv/ https://cdn.ampproject.org/sp/ https://cdn.ampproject.org/sw/ https://cdn.ampproject.org/v0.js https://cdn.ampproject.org/v0.mjs https://cdn.ampproject.org/v0/ https://cdn.ampproject.org/viewer/; object-src 'none'; style-src 'unsafe-inline' https://cdn.ampproject.org/rtv/ https://cdn.materialdesignicons.com https://cloud.typography.com https://fast.fonts.net https://fonts.googleapis.com https://maxcdn.bootstrapcdn.com https://p.typekit.net https://pro.fontawesome.com https://use.fontawesome.com https://use.typekit.net; report-uri https://csp.withgoogle.com/csp/amp
content-encoding
br
x-content-type-options
nosniff
age
77711
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
27650
x-xss-protection
0
server
sffe
date
Mon, 14 Dec 2020 15:10:29 GMT
strict-transport-security
max-age=31536000; includeSubDomains; preload
content-type
text/javascript
access-control-allow-origin
*
vary
Accept-Encoding
cache-control
public, max-age=31536000
etag
"5ee8f5c1fe9379c6"
accept-ranges
bytes
timing-allow-origin
*
expires
Tue, 14 Dec 2021 15:10:29 GMT
amp-fit-text-0.1.mjs
cdn.ampproject.org/rtv/052012102342000/v0/ Frame 94F8
3 KB
1 KB
Script
General
Full URL
https://cdn.ampproject.org/rtv/052012102342000/v0/amp-fit-text-0.1.mjs
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020120801.js
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:81f::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
e783c38d9f44263c62bb177e68ccccde5bf031316384f2e67e31715c598e274d
Security Headers
Name Value
Content-Security-Policy default-src * blob: data:; script-src blob: https://cdn.ampproject.org/esm/ https://cdn.ampproject.org/lts/ https://cdn.ampproject.org/mp/ https://cdn.ampproject.org/rtv/ https://cdn.ampproject.org/sp/ https://cdn.ampproject.org/sw/ https://cdn.ampproject.org/v0.js https://cdn.ampproject.org/v0.mjs https://cdn.ampproject.org/v0/ https://cdn.ampproject.org/viewer/; object-src 'none'; style-src 'unsafe-inline' https://cdn.ampproject.org/rtv/ https://cdn.materialdesignicons.com https://cloud.typography.com https://fast.fonts.net https://fonts.googleapis.com https://maxcdn.bootstrapcdn.com https://p.typekit.net https://pro.fontawesome.com https://use.fontawesome.com https://use.typekit.net; report-uri https://csp.withgoogle.com/csp/amp
Strict-Transport-Security max-age=31536000; includeSubDomains; preload
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

content-security-policy
default-src * blob: data:; script-src blob: https://cdn.ampproject.org/esm/ https://cdn.ampproject.org/lts/ https://cdn.ampproject.org/mp/ https://cdn.ampproject.org/rtv/ https://cdn.ampproject.org/sp/ https://cdn.ampproject.org/sw/ https://cdn.ampproject.org/v0.js https://cdn.ampproject.org/v0.mjs https://cdn.ampproject.org/v0/ https://cdn.ampproject.org/viewer/; object-src 'none'; style-src 'unsafe-inline' https://cdn.ampproject.org/rtv/ https://cdn.materialdesignicons.com https://cloud.typography.com https://fast.fonts.net https://fonts.googleapis.com https://maxcdn.bootstrapcdn.com https://p.typekit.net https://pro.fontawesome.com https://use.fontawesome.com https://use.typekit.net; report-uri https://csp.withgoogle.com/csp/amp
content-encoding
br
x-content-type-options
nosniff
age
77711
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
1364
x-xss-protection
0
server
sffe
date
Mon, 14 Dec 2020 15:10:29 GMT
strict-transport-security
max-age=31536000; includeSubDomains; preload
content-type
text/javascript
access-control-allow-origin
*
vary
Accept-Encoding
cache-control
public, max-age=31536000
etag
"18bf484c56e6e5d3"
accept-ranges
bytes
timing-allow-origin
*
expires
Tue, 14 Dec 2021 15:10:29 GMT
amp-form-0.1.mjs
cdn.ampproject.org/rtv/052012102342000/v0/ Frame 94F8
41 KB
13 KB
Script
General
Full URL
https://cdn.ampproject.org/rtv/052012102342000/v0/amp-form-0.1.mjs
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020120801.js
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:81f::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
6aefa9dfc39f7bbb1fce0f13108fbc1fa43585443961448f0f9ddd926be0e211
Security Headers
Name Value
Content-Security-Policy default-src * blob: data:; script-src blob: https://cdn.ampproject.org/esm/ https://cdn.ampproject.org/lts/ https://cdn.ampproject.org/mp/ https://cdn.ampproject.org/rtv/ https://cdn.ampproject.org/sp/ https://cdn.ampproject.org/sw/ https://cdn.ampproject.org/v0.js https://cdn.ampproject.org/v0.mjs https://cdn.ampproject.org/v0/ https://cdn.ampproject.org/viewer/; object-src 'none'; style-src 'unsafe-inline' https://cdn.ampproject.org/rtv/ https://cdn.materialdesignicons.com https://cloud.typography.com https://fast.fonts.net https://fonts.googleapis.com https://maxcdn.bootstrapcdn.com https://p.typekit.net https://pro.fontawesome.com https://use.fontawesome.com https://use.typekit.net; report-uri https://csp.withgoogle.com/csp/amp
Strict-Transport-Security max-age=31536000; includeSubDomains; preload
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

content-security-policy
default-src * blob: data:; script-src blob: https://cdn.ampproject.org/esm/ https://cdn.ampproject.org/lts/ https://cdn.ampproject.org/mp/ https://cdn.ampproject.org/rtv/ https://cdn.ampproject.org/sp/ https://cdn.ampproject.org/sw/ https://cdn.ampproject.org/v0.js https://cdn.ampproject.org/v0.mjs https://cdn.ampproject.org/v0/ https://cdn.ampproject.org/viewer/; object-src 'none'; style-src 'unsafe-inline' https://cdn.ampproject.org/rtv/ https://cdn.materialdesignicons.com https://cloud.typography.com https://fast.fonts.net https://fonts.googleapis.com https://maxcdn.bootstrapcdn.com https://p.typekit.net https://pro.fontawesome.com https://use.fontawesome.com https://use.typekit.net; report-uri https://csp.withgoogle.com/csp/amp
content-encoding
br
x-content-type-options
nosniff
age
77711
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
12915
x-xss-protection
0
server
sffe
date
Mon, 14 Dec 2020 15:10:29 GMT
strict-transport-security
max-age=31536000; includeSubDomains; preload
content-type
text/javascript
access-control-allow-origin
*
vary
Accept-Encoding
cache-control
public, max-age=31536000
etag
"14db4fe596ec13fb"
accept-ranges
bytes
timing-allow-origin
*
expires
Tue, 14 Dec 2021 15:10:29 GMT
css
fonts.googleapis.com/ Frame 94F8
6 KB
701 B
Stylesheet
General
Full URL
https://fonts.googleapis.com/css?family=Roboto:300|Roboto:400,500&lang=nl
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020120801.js
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:802::200a Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
ESF /
Resource Hash
56e4953af5c01ed820d5e5dc430e77234a87e8d019c38fda46f9f3593cd05e0f
Security Headers
Name Value
Strict-Transport-Security max-age=31536000
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

strict-transport-security
max-age=31536000
content-encoding
gzip
x-content-type-options
nosniff
cross-origin-resource-policy
cross-origin
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
x-xss-protection
0
last-modified
Tue, 15 Dec 2020 12:14:37 GMT
server
ESF
date
Tue, 15 Dec 2020 12:45:40 GMT
x-frame-options
SAMEORIGIN
content-type
text/css; charset=utf-8
access-control-allow-origin
*
cache-control
private, max-age=86400, stale-while-revalidate=604800
timing-allow-origin
*
link
<https://fonts.gstatic.com>; rel=preconnect; crossorigin
expires
Tue, 15 Dec 2020 12:45:40 GMT
css
fonts.googleapis.com/ Frame 94F8
4 KB
651 B
Stylesheet
General
Full URL
https://fonts.googleapis.com/css?family=Roboto:400,500&text=
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020120801.js
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:802::200a Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
ESF /
Resource Hash
2190c16423c2557bcb20ccba2edc176fbeb16e6a3de2b2af297f650aae85a43e
Security Headers
Name Value
Strict-Transport-Security max-age=31536000
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

strict-transport-security
max-age=31536000
content-encoding
gzip
x-content-type-options
nosniff
cross-origin-resource-policy
cross-origin
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
x-xss-protection
0
last-modified
Tue, 15 Dec 2020 12:06:13 GMT
server
ESF
date
Tue, 15 Dec 2020 12:45:40 GMT
x-frame-options
SAMEORIGIN
content-type
text/css; charset=utf-8
access-control-allow-origin
*
cache-control
private, max-age=86400, stale-while-revalidate=604800
timing-allow-origin
*
link
<https://fonts.gstatic.com>; rel=preconnect; crossorigin
expires
Tue, 15 Dec 2020 12:45:40 GMT
en.png
tpc.googlesyndication.com/pagead/images/adchoices/ Frame 94F8
2 KB
2 KB
Image
General
Full URL
https://tpc.googlesyndication.com/pagead/images/adchoices/en.png
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020120801.js
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:81d::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
36133ca07927c88a7cc578fddbaed3c668ab75087834d0ca13dca5de4ec856c1
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

timing-allow-origin
*
date
Mon, 14 Dec 2020 23:34:27 GMT
x-content-type-options
nosniff
server
cafe
age
47473
etag
14819457070020093239
vary
Accept-Encoding
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
cache-control
public, max-age=86400
cross-origin-resource-policy
cross-origin
content-type
image/png
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
2502
x-xss-protection
0
expires
Tue, 15 Dec 2020 23:34:27 GMT
icon.png
tpc.googlesyndication.com/pagead/images/adchoices/ Frame 94F8
295 B
320 B
Image
General
Full URL
https://tpc.googlesyndication.com/pagead/images/adchoices/icon.png
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020120801.js
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:81d::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
7fd59024b6ca83f11f7a3448ec148309a13b705725716df134f699e60a96eb1b
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

timing-allow-origin
*
date
Mon, 14 Dec 2020 21:53:21 GMT
x-content-type-options
nosniff
server
cafe
age
53539
etag
426692510519060060
vary
Accept-Encoding
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
cache-control
public, max-age=86400
cross-origin-resource-policy
cross-origin
content-type
image/png
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
295
x-xss-protection
0
expires
Tue, 15 Dec 2020 21:53:21 GMT
truncated
/ Frame 94F8
213 B
0
Image
General
Full URL
data:truncated
Protocol
DATA
Server
-, , ASN (),
Reverse DNS
Software
/
Resource Hash
1ca0fc6118e7ac5368bea8059f944e4b6dde9706fcada3d332549f2d619d45f0

Request headers

Referer
https://www.dailymail.co.uk/
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Content-Type
image/png
40933678460698624
tpc.googlesyndication.com/simgad/ Frame 94F8
1 KB
847 B
Image
General
Full URL
https://tpc.googlesyndication.com/simgad/40933678460698624
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:81d::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
09fba596f1ba572cf4b3ceb9c1f3962d1b75bbb4a6d6d7707f1f93e2fe889aee
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Thu, 10 Dec 2020 11:54:18 GMT
content-encoding
gzip
x-content-type-options
nosniff
age
435082
x-dns-prefetch-control
off
cross-origin-resource-policy
cross-origin
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
728
x-xss-protection
0
last-modified
Thu, 26 Oct 2017 18:18:20 GMT
server
sffe
vary
Accept-Encoding
content-type
image/svg+xml
access-control-allow-origin
*
cache-control
public, max-age=31536000
accept-ranges
bytes
timing-allow-origin
*
expires
Fri, 10 Dec 2021 11:54:18 GMT
downsize_200k_v1
tpc.googlesyndication.com/simgad/3882756974678146739/ Frame 94F8
23 KB
23 KB
Image
General
Full URL
https://tpc.googlesyndication.com/simgad/3882756974678146739/downsize_200k_v1?sqp=4sqPyQSWAUKTAQgAEhQNzczMPhUAAABAHQAAAAAlAAAAABgAIgoNAACAPxUAAIA_Kk8IWhABHQAAtEIgASgBMAY4A0CAwtcvSABQAFgAYFpwAngAgAEAiAEAkAEAnQEAAIA_oAEAqAEAsAGAreIEuAH___________8BxQEtsp0-MhoIrAIQnQEYASABLQAAAD8wrAI4nQFFAACAPw&rs=AOga4qmCZKo4y3ni5pe0KNxnpnMXd0do5Q
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:81d::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
7decc889e8e728b8fe994e7b84142c8f1631ce400234a5fa10b75aeac8011540
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Mon, 14 Dec 2020 18:52:45 GMT
x-content-type-options
nosniff
last-modified
Tue, 28 Jul 2020 11:53:25 GMT
server
sffe
age
64375
content-type
image/jpeg
access-control-allow-origin
*
cache-control
public, max-age=31536000
cross-origin-resource-policy
cross-origin
accept-ranges
bytes
timing-allow-origin
*
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
23925
x-xss-protection
0
expires
Tue, 14 Dec 2021 18:52:45 GMT
adview
securepubads.g.doubleclick.net/pagead/ Frame 94F8
0
0
Image
General
Full URL
https://securepubads.g.doubleclick.net/pagead/adview?ai=C4g5T9K_YX52gGNrpgAebhqDwCPDy19Re2b7t6I8M2tkeEAEgrNm4ImCRhJOF_BegAZm5rvwDyAEGqQK_PkaGZ2G0PuACAKgDAcgDCqoExAJP0GSMKwlb7jDhlmpFj3rP4HjldE7WkvrVEkyh79iIVWWL0hMM7rGfxn8NH2XPE6m5rqY-I0XO0obiSMw84lXzlI191Zp8Yc7nCv7EcXsFZYBTh04zGezRaWF_qu8_fn0HOMjIGrjnutE4_DgGef-ETDERv7TkgqeLnER-_DsCj6qgj3FDWD7udm0DakuMr0Z6E1xTFpol7Yrr85ui3yPW48Toh-xL8thLAkvm2r0ziNID66b_8DNKMgoglgcSG7BI5oIhhT_V78Tvk6xJrzyvt809IkqAbQUcgX7_EEnBjjgiS3HKG6GZlIvD8cpmdG68gZ_brj6Vavj9yl6p75xLUG4RTFc4n9Xowy3nZQmoDqBRsREHNVoDGrKsOxX2s-7wUoYDjItRh3z9HAE7E0gBpF5pM75FxiUqDrfEwsI8UnYdnqvABJThz5WoA-AEAaAGN4AHz8bRA6gH1ckbqAfw2RuoB_LZG6gHlJixAqgHpd8bqAeOzhuoB5PYG6gHugaoB-6WsQKoB6a-G6gH7NUb2AcB8gcEENC-CtIICQiA4YAQEAEYHYAKA8gLAdgTA7IXGgoYCAESFHB1Yi00MTgwODM1Njk0MTY2MjU1&sigh=32RZQPab57g&template_id=492&tpd=AGWhJmt0UcFlV6PKm8LqDHAU6W5iZtzJcp81U7Wc5GYCFxx8-Q
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
172.217.22.2 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
fra16s14-in-f2.1e100.net
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
https://www.dailymail.co.uk/
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

activeview
pagead2.googlesyndication.com/pcs/ Frame C794
42 B
66 B
Image
General
Full URL
https://pagead2.googlesyndication.com/pcs/activeview?xai=AKAOjstNZOUiXsY_TgyyWYBPyy325TItuvcKyXk82m6Sam-VGCVaexhH1sQGNG4uaM1fDAhxNeYGEhgXTaqHfzIlkYSbSEnX6ekK2o5xv0OBy-j3cQqicb0pYUuFalnd6g&sai=AMfl-YR0H0WpfSTVi7N-OacTQpSLgRYvgqn7SrzxU_lOiecy51p3C8p3RVVSFCQnwWMdCrYRD3QQB44UWF3kCpX1iMthon313bWWByqiwWmN4IC7vLhxbTHVcrkBoqdu7J4C&sig=Cg0ArKJSzFueB9y2cWsNEAE&cid=CAASPeRobQiJ-Cqc8yf1gtt8HEWvOo2g1aloCD86xKO-FvF92zLzh8xhUR2yVjHKmme_dPNwa04StwgTs0-WAbM&id=ampim&o=315,197&d=970,250&ss=1600,1200&bs=1600,1200&mcvt=1010&mtos=0,0,0,1010,1010&tos=0,0,0,1010,0&tfs=310&tls=1320&g=99.69072341918945&h=99.69072341918945&tt=1320&r=v&avms=ampa&adk=1878184308
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:816::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
ef1955ae757c8b966c83248350331bd3a30f658ced11f387f8ebf05ab3368629
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

pragma
no-cache
date
Tue, 15 Dec 2020 12:45:43 GMT
x-content-type-options
nosniff
server
cafe
timing-allow-origin
*
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
access-control-allow-origin
*
cache-control
no-cache, must-revalidate
cross-origin-resource-policy
cross-origin
content-type
image/gif
alt-svc
h3-29="googleads.g.doubleclick.net:443"; ma=2592000,h3-29=":443"; ma=2592000,h3-T051="googleads.g.doubleclick.net:443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic="googleads.g.doubleclick.net:443"; ma=2592000; v="46,43",quic=":443"; ma=2592000; v="46,43"
content-length
42
x-xss-protection
0
expires
Fri, 01 Jan 1990 00:00:00 GMT
KFOmCnqEu92Fr1Mu4mxKKTU1Kg.woff2
fonts.gstatic.com/s/roboto/v20/ Frame 94F8
11 KB
11 KB
Font
General
Full URL
https://fonts.gstatic.com/s/roboto/v20/KFOmCnqEu92Fr1Mu4mxKKTU1Kg.woff2
Requested by
Host: fonts.googleapis.com
URL: https://fonts.googleapis.com/css?family=Roboto:300|Roboto:400,500&lang=nl
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:825::2003 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
5d1bc9b443f3f81fa4b4ad4634c1bb9702194c1898e3a9de0ab5e2cdc0e9f479
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Origin
https://www.dailymail.co.uk
Referer
https://fonts.googleapis.com/css?family=Roboto:300|Roboto:400,500&lang=nl
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 08 Dec 2020 17:20:25 GMT
x-content-type-options
nosniff
last-modified
Wed, 24 Jul 2019 01:18:50 GMT
server
sffe
age
588315
content-type
font/woff2
access-control-allow-origin
*
cache-control
public, max-age=31536000
accept-ranges
bytes
timing-allow-origin
*
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
11016
x-xss-protection
0
expires
Wed, 08 Dec 2021 17:20:25 GMT
KFOlCnqEu92Fr1MmEU9fBBc4AMP6lQ.woff2
fonts.gstatic.com/s/roboto/v20/ Frame 94F8
11 KB
11 KB
Font
General
Full URL
https://fonts.gstatic.com/s/roboto/v20/KFOlCnqEu92Fr1MmEU9fBBc4AMP6lQ.woff2
Requested by
Host: fonts.googleapis.com
URL: https://fonts.googleapis.com/css?family=Roboto:300|Roboto:400,500&lang=nl
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:825::2003 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
ce897833ac6e362df7c91ac8223fe511c6defcf33964928a81004600a2dd4c2e
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Origin
https://www.dailymail.co.uk
Referer
https://fonts.googleapis.com/css?family=Roboto:300|Roboto:400,500&lang=nl
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Mon, 14 Dec 2020 22:21:20 GMT
x-content-type-options
nosniff
last-modified
Wed, 24 Jul 2019 01:18:48 GMT
server
sffe
age
51860
content-type
font/woff2
access-control-allow-origin
*
cache-control
public, max-age=31536000
accept-ranges
bytes
timing-allow-origin
*
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
11056
x-xss-protection
0
expires
Tue, 14 Dec 2021 22:21:20 GMT
si
googleads.g.doubleclick.net/pagead/drt/ Frame 94F8
Redirect Chain
  • https://www.google.com/pagead/drt/ui
  • https://googleads.g.doubleclick.net/pagead/drt/si
0
0
Image
General
Full URL
https://googleads.g.doubleclick.net/pagead/drt/si
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:816::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Redirect headers

date
Tue, 15 Dec 2020 12:45:40 GMT
x-content-type-options
nosniff
server
safe
content-type
text/html; charset=UTF-8
location
https://googleads.g.doubleclick.net/pagead/drt/si
cache-control
private
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
246
x-xss-protection
0
40933678460698624
tpc.googlesyndication.com/simgad/ Frame 94F8
1 KB
864 B
Image
General
Full URL
https://tpc.googlesyndication.com/simgad/40933678460698624
Requested by
Host: cdn.ampproject.org
URL: https://cdn.ampproject.org/rtv/052012102342000/amp4ads-v0.mjs
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:81d::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
09fba596f1ba572cf4b3ceb9c1f3962d1b75bbb4a6d6d7707f1f93e2fe889aee
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Thu, 10 Dec 2020 11:54:18 GMT
content-encoding
gzip
x-content-type-options
nosniff
age
435082
x-dns-prefetch-control
off
cross-origin-resource-policy
cross-origin
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
728
x-xss-protection
0
last-modified
Thu, 26 Oct 2017 18:18:20 GMT
server
sffe
vary
Accept-Encoding
content-type
image/svg+xml
access-control-allow-origin
*
cache-control
public, max-age=31536000
accept-ranges
bytes
timing-allow-origin
*
expires
Fri, 10 Dec 2021 11:54:18 GMT
downsize_200k_v1
tpc.googlesyndication.com/simgad/3882756974678146739/ Frame 94F8
23 KB
23 KB
Image
General
Full URL
https://tpc.googlesyndication.com/simgad/3882756974678146739/downsize_200k_v1?sqp=4sqPyQSWAUKTAQgAEhQNzczMPhUAAABAHQAAAAAlAAAAABgAIgoNAACAPxUAAIA_Kk8IWhABHQAAtEIgASgBMAY4A0CAwtcvSABQAFgAYFpwAngAgAEAiAEAkAEAnQEAAIA_oAEAqAEAsAGAreIEuAH___________8BxQEtsp0-MhoIrAIQnQEYASABLQAAAD8wrAI4nQFFAACAPw&rs=AOga4qmCZKo4y3ni5pe0KNxnpnMXd0do5Q
Requested by
Host: cdn.ampproject.org
URL: https://cdn.ampproject.org/rtv/052012102342000/amp4ads-v0.mjs
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:81d::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
7decc889e8e728b8fe994e7b84142c8f1631ce400234a5fa10b75aeac8011540
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Mon, 14 Dec 2020 18:52:45 GMT
x-content-type-options
nosniff
last-modified
Tue, 28 Jul 2020 11:53:25 GMT
server
sffe
age
64375
content-type
image/jpeg
access-control-allow-origin
*
cache-control
public, max-age=31536000
cross-origin-resource-policy
cross-origin
accept-ranges
bytes
timing-allow-origin
*
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
23925
x-xss-protection
0
expires
Tue, 14 Dec 2021 18:52:45 GMT
en.png
tpc.googlesyndication.com/pagead/images/adchoices/ Frame 94F8
2 KB
2 KB
Image
General
Full URL
https://tpc.googlesyndication.com/pagead/images/adchoices/en.png
Requested by
Host: cdn.ampproject.org
URL: https://cdn.ampproject.org/rtv/052012102342000/amp4ads-v0.mjs
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:81d::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
36133ca07927c88a7cc578fddbaed3c668ab75087834d0ca13dca5de4ec856c1
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

timing-allow-origin
*
date
Mon, 14 Dec 2020 23:34:27 GMT
x-content-type-options
nosniff
server
cafe
age
47473
etag
14819457070020093239
vary
Accept-Encoding
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
cache-control
public, max-age=86400
cross-origin-resource-policy
cross-origin
content-type
image/png
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
2502
x-xss-protection
0
expires
Tue, 15 Dec 2020 23:34:27 GMT
icon.png
tpc.googlesyndication.com/pagead/images/adchoices/ Frame 94F8
295 B
321 B
Image
General
Full URL
https://tpc.googlesyndication.com/pagead/images/adchoices/icon.png
Requested by
Host: cdn.ampproject.org
URL: https://cdn.ampproject.org/rtv/052012102342000/amp4ads-v0.mjs
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:81d::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
7fd59024b6ca83f11f7a3448ec148309a13b705725716df134f699e60a96eb1b
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

timing-allow-origin
*
date
Mon, 14 Dec 2020 21:53:21 GMT
x-content-type-options
nosniff
server
cafe
age
53539
etag
426692510519060060
vary
Accept-Encoding
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
cache-control
public, max-age=86400
cross-origin-resource-policy
cross-origin
content-type
image/png
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
295
x-xss-protection
0
expires
Tue, 15 Dec 2020 21:53:21 GMT
view
securepubads.g.doubleclick.net/pcs/ Frame A0A6
0
0
Fetch
General
Full URL
https://securepubads.g.doubleclick.net/pcs/view?xai=AKAOjstO1XhPo69ltIPAjLQV5iy-42iw18FNdRdU6gIcA9uYQW_zac9eRyhz102DGMXy4TxvXlHZg7TFmxtU5kKMA_Oa0ITshe_6XsIWlTamW5Mu19DpRyHRtiky8knFDPsFG14-7UMZWespdD9_9d5AJgpYjlXpnJe5ggAQTYnsMkiLbD0UWT47O4GhIh0fWUs8GPUMw2ivs6YTAtOjTrI6G1Q-mvU6bY-BHSrEvAiqF1MsTWDqzOmcSaxLjgRCpXOJug0u5p1S6PWKfz-0EBZNM0CAn1SBYKr4dhdLVhx-gtFcCJwe6V4aPAuMQKa5YIHM9-jUTR_IQg&sig=Cg0ArKJSzAOnTmqOtwjLEAE&adurl=
Requested by
Host: info.silobreaker.com
URL: https://info.silobreaker.com/e2t/sc2/MmZ-8yjYCXrW6zj2_M6nsGYsW7JzK5Y7LnJnQVd1GcC5Dg2KFdBBbG504
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
172.217.22.2 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
fra16s14-in-f2.1e100.net
Software
cafe /
Resource Hash
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

timing-allow-origin
*
date
Tue, 15 Dec 2020 12:45:40 GMT
x-content-type-options
nosniff
server
cafe
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
access-control-allow-origin
*
cache-control
private
cross-origin-resource-policy
cross-origin
content-type
image/gif
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
0
x-xss-protection
0
abg_lite_fy2019.js
tpc.googlesyndication.com/pagead/js/r20201203/r20110914/ Frame A0A6
18 KB
7 KB
Script
General
Full URL
https://tpc.googlesyndication.com/pagead/js/r20201203/r20110914/abg_lite_fy2019.js
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020120801.js
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:81d::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
631c6a3617e2f5860eaa62155f5200b6ca156c00438445f9862089ef785e4542
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Mon, 14 Dec 2020 15:46:12 GMT
content-encoding
gzip
x-content-type-options
nosniff
age
75568
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
cross-origin-resource-policy
cross-origin
content-disposition
attachment; filename="f.txt"
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
7483
x-xss-protection
0
server
cafe
etag
7789600959769866771
vary
Accept-Encoding, Origin
content-type
text/javascript; charset=UTF-8
cache-control
public, max-age=1209600
timing-allow-origin
*
expires
Mon, 28 Dec 2020 15:46:12 GMT
window_focus_fy2019.js
tpc.googlesyndication.com/pagead/js/r20201203/r20110914/client/ Frame A0A6
3 KB
1 KB
Script
General
Full URL
https://tpc.googlesyndication.com/pagead/js/r20201203/r20110914/client/window_focus_fy2019.js
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020120801.js
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:81d::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
f8f96b0cc81405b2a95c412dbf43aebae111f11e98ad743b8fff74b2d5c793a2
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 03:27:47 GMT
content-encoding
gzip
x-content-type-options
nosniff
age
33473
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
cross-origin-resource-policy
cross-origin
content-disposition
attachment; filename="f.txt"
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
1494
x-xss-protection
0
server
cafe
etag
5335486849732140232
vary
Accept-Encoding, Origin
content-type
text/javascript; charset=UTF-8
cache-control
public, max-age=1209600
timing-allow-origin
*
expires
Tue, 29 Dec 2020 03:27:47 GMT
rx_lidar.js
www.googletagservices.com/activeview/js/current/ Frame A0A6
104 KB
32 KB
Script
General
Full URL
https://www.googletagservices.com/activeview/js/current/rx_lidar.js?cache=r20110914
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020120801.js
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:816::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
641620cb44b22d924bd94996adebcd8cf56e65629af1ba9d98a7371d07be127d
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:45:40 GMT
content-encoding
gzip
x-content-type-options
nosniff
server
sffe
etag
"1607690634902976"
vary
Accept-Encoding
content-type
text/javascript
cache-control
private, max-age=3000
accept-ranges
bytes
alt-svc
h3-29="googleads.g.doubleclick.net:443"; ma=2592000,h3-29=":443"; ma=2592000,h3-T051="googleads.g.doubleclick.net:443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic="googleads.g.doubleclick.net:443"; ma=2592000; v="46,43",quic=":443"; ma=2592000; v="46,43"
content-length
32509
x-xss-protection
0
expires
Tue, 15 Dec 2020 12:45:40 GMT
2372239932193196690
tpc.googlesyndication.com/simgad/ Frame A0A6
80 KB
81 KB
Image
General
Full URL
https://tpc.googlesyndication.com/simgad/2372239932193196690
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020120801.js
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:81d::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
6edd38aac0568ccb6d5e16653372139450baf060813e25aefae4103bd6320898
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Sat, 12 Dec 2020 05:27:53 GMT
x-content-type-options
nosniff
age
285467
x-dns-prefetch-control
off
cross-origin-resource-policy
cross-origin
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
82242
x-xss-protection
0
last-modified
Wed, 20 Jun 2018 11:14:02 GMT
server
sffe
content-type
image/jpeg
access-control-allow-origin
*
cache-control
public, max-age=31536000
accept-ranges
bytes
timing-allow-origin
*
expires
Sun, 12 Dec 2021 05:27:53 GMT
truncated
/ Frame A0A6
214 B
0
Image
General
Full URL
data:truncated
Protocol
DATA
Server
-, , ASN (),
Reverse DNS
Software
/
Resource Hash
b26796851a3eab07c7ffbaa313637716efb8fe73c19ec99dc9902bfd335dbb69

Request headers

Referer
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Content-Type
image/png
sa
ted.dailymail.co.uk/s/
65 B
609 B
XHR
General
Full URL
https://ted.dailymail.co.uk/s/sa
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/rta2/v-0.56.min.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
2a02:26f0:6c00:2be::16c2 , Ascension Island, ASN20940 (AKAMAI-ASN1, EU),
Reverse DNS
Software
/
Resource Hash
826bd8a7b80fd5dea4208dc794a1bf130e57aa2bcbe2812b1fdf3b613268c6cd

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type
text/plain;charset=UTF-8

Response headers

date
Tue, 15 Dec 2020 12:45:41 GMT
content-type
application/json
access-control-allow-origin
https://www.dailymail.co.uk
expires
Tue, 15 Dec 2020 12:45:41 GMT
cache-control
private, no-cache, proxy-revalidate
access-control-allow-credentials
true
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, documentReferer
content-length
65
x-rs-ops
rta2-rufus-a3-fe.hsk.mol.dmgt.net:8180
sa
t.dailymail.co.uk/s/
65 B
609 B
XHR
General
Full URL
https://t.dailymail.co.uk/s/sa
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/rta2/v-0.56.min.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
2a02:26f0:6c00:2be::16c2 , Ascension Island, ASN20940 (AKAMAI-ASN1, EU),
Reverse DNS
Software
/
Resource Hash
05652ea60eaae2c55aa4b565ba69004d0b890129121e9c5ba5254852c260300d

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type
text/plain;charset=UTF-8

Response headers

date
Tue, 15 Dec 2020 12:45:41 GMT
content-type
application/json
access-control-allow-origin
https://www.dailymail.co.uk
expires
Tue, 15 Dec 2020 12:45:41 GMT
cache-control
private, no-cache, proxy-revalidate
access-control-allow-credentials
true
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, documentReferer
content-length
65
x-rs-ops
rta2-rufus-c3-fe.rdg.mol.dmgt.net:8180
view
securepubads.g.doubleclick.net/pcs/ Frame A0A6
0
0
Fetch
General
Full URL
https://securepubads.g.doubleclick.net/pcs/view?xai=AKAOjssRnOAqB0-EXDofcl-BrtYYt0roNlfJ-SVwRio3ObQ0U_Dbg3qKNsWgZtU5H4-s3RMsyZ41Cax6Iv2-dkoLcUWrrXndoChuXQGgHryNrpLBwS-5eFmKgLt_0_Cb_adVPfg5hj6zUz0Ve03Ih3sHSta1pEYeFdTZtxg3-9rQVVQ91cVZ88ziVnB2-TcKnMuyMCz6qSJyUkKpBT64ZyYCYWbJ0eRdmlSJU-H2ASIximyRVIaH98JwtkJTGhpK-tHkZxrStXC1EVpr5urUou3Nnr0PWZlRKZwm7zx3nUoAJMO-z-WbLQ52AxyM-QtQwcSlMDJT8PFZ58Mq&sig=Cg0ArKJSzPedUCVqlc3HEAE&adurl=
Requested by
Host: www.googletagservices.com
URL: https://www.googletagservices.com/activeview/js/current/rx_lidar.js?cache=r20110914
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
172.217.22.2 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
fra16s14-in-f2.1e100.net
Software
cafe /
Resource Hash
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

timing-allow-origin
*
date
Tue, 15 Dec 2020 12:45:40 GMT
x-content-type-options
nosniff
server
cafe
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
access-control-allow-origin
*
cache-control
private
cross-origin-resource-policy
cross-origin
content-type
image/gif
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
0
x-xss-protection
0
expires
Tue, 15 Dec 2020 12:45:40 GMT
view
securepubads.g.doubleclick.net/pcs/ Frame 0D33
0
0
Fetch
General
Full URL
https://securepubads.g.doubleclick.net/pcs/view?xai=AKAOjsvDd4GbcKKNE6MyeLtgbITanH7czj9XFpUiL9z6aI6E5JlxJ-8ebnjkfNl1eS-QbuYYR0AIU48Fbayx4tHinz3T6323dzt5oI6H10iQdEyHBd8mAX7jyRFtNY2K1RO1ExbYJ7I9zyJ6tCxTuyMf7z9hhYLtMkrpF_UGeEv7FOAe2Zgfz6LVKhEE7VU_jnst_cFJuduEjiu8uSe9bMBNJ0S8_jN1mFZ8fS8qGW5RkvEP-WOmTUzspktoR0cXLv9j-2bhxs4pmL64kA6zsdnPI-nX2E3dxrr-Einq-0EYV3aW_3stqFfEQnMVYmo3Ouok9u2G4aCWrXM&sig=Cg0ArKJSzIOKmedf4jFoEAE&adurl=
Requested by
Host: info.silobreaker.com
URL: https://info.silobreaker.com/e2t/sc2/MmZ-8yjYCXrW6zj2_M6nsGYsW7JzK5Y7LnJnQVd1GcC5Dg2KFdBBbG504
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
172.217.22.2 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
fra16s14-in-f2.1e100.net
Software
cafe /
Resource Hash
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

timing-allow-origin
*
date
Tue, 15 Dec 2020 12:45:41 GMT
x-content-type-options
nosniff
server
cafe
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
access-control-allow-origin
*
cache-control
private
cross-origin-resource-policy
cross-origin
content-type
image/gif
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
0
x-xss-protection
0
abg_lite_fy2019.js
tpc.googlesyndication.com/pagead/js/r20201203/r20110914/ Frame 0D33
18 KB
7 KB
Script
General
Full URL
https://tpc.googlesyndication.com/pagead/js/r20201203/r20110914/abg_lite_fy2019.js
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020120801.js
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:81d::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
631c6a3617e2f5860eaa62155f5200b6ca156c00438445f9862089ef785e4542
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Mon, 14 Dec 2020 15:46:12 GMT
content-encoding
gzip
x-content-type-options
nosniff
age
75569
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
cross-origin-resource-policy
cross-origin
content-disposition
attachment; filename="f.txt"
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
7483
x-xss-protection
0
server
cafe
etag
7789600959769866771
vary
Accept-Encoding, Origin
content-type
text/javascript; charset=UTF-8
cache-control
public, max-age=1209600
timing-allow-origin
*
expires
Mon, 28 Dec 2020 15:46:12 GMT
window_focus_fy2019.js
tpc.googlesyndication.com/pagead/js/r20201203/r20110914/client/ Frame 0D33
3 KB
1 KB
Script
General
Full URL
https://tpc.googlesyndication.com/pagead/js/r20201203/r20110914/client/window_focus_fy2019.js
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020120801.js
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:81d::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
f8f96b0cc81405b2a95c412dbf43aebae111f11e98ad743b8fff74b2d5c793a2
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 03:27:47 GMT
content-encoding
gzip
x-content-type-options
nosniff
age
33474
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
cross-origin-resource-policy
cross-origin
content-disposition
attachment; filename="f.txt"
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
1494
x-xss-protection
0
server
cafe
etag
5335486849732140232
vary
Accept-Encoding, Origin
content-type
text/javascript; charset=UTF-8
cache-control
public, max-age=1209600
timing-allow-origin
*
expires
Tue, 29 Dec 2020 03:27:47 GMT
rx_lidar.js
www.googletagservices.com/activeview/js/current/ Frame 0D33
104 KB
32 KB
Script
General
Full URL
https://www.googletagservices.com/activeview/js/current/rx_lidar.js?cache=r20110914
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020120801.js
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:816::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
641620cb44b22d924bd94996adebcd8cf56e65629af1ba9d98a7371d07be127d
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:45:41 GMT
content-encoding
gzip
x-content-type-options
nosniff
server
sffe
etag
"1607690634902976"
vary
Accept-Encoding
content-type
text/javascript
cache-control
private, max-age=3000
accept-ranges
bytes
alt-svc
h3-29="googleads.g.doubleclick.net:443"; ma=2592000,h3-29=":443"; ma=2592000,h3-T051="googleads.g.doubleclick.net:443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic="googleads.g.doubleclick.net:443"; ma=2592000; v="46,43",quic=":443"; ma=2592000; v="46,43"
content-length
32509
x-xss-protection
0
expires
Tue, 15 Dec 2020 12:45:41 GMT
3321723837421127684
tpc.googlesyndication.com/simgad/ Frame 0D33
83 KB
83 KB
Image
General
Full URL
https://tpc.googlesyndication.com/simgad/3321723837421127684
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020120801.js
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:81d::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
0f50fe418a9cf436fef6d337b03cd38b4e9e837f80ed8e5c600f1a2355ac9665
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Thu, 10 Dec 2020 11:57:12 GMT
x-content-type-options
nosniff
age
434909
x-dns-prefetch-control
off
cross-origin-resource-policy
cross-origin
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
84805
x-xss-protection
0
last-modified
Wed, 20 Jun 2018 11:13:56 GMT
server
sffe
content-type
image/jpeg
access-control-allow-origin
*
cache-control
public, max-age=31536000
accept-ranges
bytes
timing-allow-origin
*
expires
Fri, 10 Dec 2021 11:57:12 GMT
truncated
/ Frame 0D33
217 B
0
Image
General
Full URL
data:truncated
Protocol
DATA
Server
-, , ASN (),
Reverse DNS
Software
/
Resource Hash
14f2e0183b147001aea88a40f99ee57993740cf2f8d53eea298e0cf260a782c8

Request headers

Referer
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Content-Type
image/png
view
securepubads.g.doubleclick.net/pcs/ Frame 0D33
0
0
Fetch
General
Full URL
https://securepubads.g.doubleclick.net/pcs/view?xai=AKAOjsusKhMpf2BX-aUuXu0XbBX8uz1fEIECNWBDnc1a0VQJnnYZrGBPKa_A7dxVvDtgNBrJByfwQ4SJPtLfTgOzA697CK_WpKF-PJE6KcAHX4W2Q6ZZohpjbZIszvaPQcdnJxU30LA3IoE2SbV5-hpQOJNXC1USJYw3WQ0hiYLuQ3ytrL5vbCGQDnmJSuYj5EbvTNsiZtSRokg2sKiXWgWHFOv83AASqZ6m_6GRn1NX2QAiOX9GEReSyTY5tuHXCOcTTKqks616AF4c6U-KwsDOqfuCCbsGjcMD0u_gIry0unm5rwil96Ul8ROj_uJNxXCxHrcplQUYtMkZPg&sig=Cg0ArKJSzOIiuGBOmP5NEAE&adurl=
Requested by
Host: www.googletagservices.com
URL: https://www.googletagservices.com/activeview/js/current/rx_lidar.js?cache=r20110914
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
172.217.22.2 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
fra16s14-in-f2.1e100.net
Software
cafe /
Resource Hash
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

timing-allow-origin
*
date
Tue, 15 Dec 2020 12:45:41 GMT
x-content-type-options
nosniff
server
cafe
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
access-control-allow-origin
*
cache-control
private
cross-origin-resource-policy
cross-origin
content-type
image/gif
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
0
x-xss-protection
0
expires
Tue, 15 Dec 2020 12:45:41 GMT
480x270_MP4_105387676350826941.mp4
video.dailymail.co.uk/video/mol/2020/10/13/105387676350826941/
64 KB
0
Media
General
Full URL
https://video.dailymail.co.uk/video/mol/2020/10/13/105387676350826941/480x270_MP4_105387676350826941.mp4
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2a02:26f0:6c00:288::11ae , Ascension Island, ASN20940 (AKAMAI-ASN1, EU),
Reverse DNS
Software
AkamaiNetStorage /
Resource Hash

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
Accept-Encoding
identity;q=1, *;q=0
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Range
bytes=0-

Response headers

date
Tue, 15 Dec 2020 12:45:44 GMT
last-modified
Tue, 13 Oct 2020 13:58:50 GMT
server
AkamaiNetStorage
etag
"10d05f799add804eb49f119edc3bdb85:1602597530.421767"
content-type
video/mp4
Content-Range
bytes 0-2668555/2668556
accept-ranges
bytes
Content-Length
2668556
amp4ads-v0.mjs
cdn.ampproject.org/rtv/052012102342000/ Frame 4A6D
186 KB
53 KB
Script
General
Full URL
https://cdn.ampproject.org/rtv/052012102342000/amp4ads-v0.mjs
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020120801.js
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:81f::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
15d8f78205a26b554bd167de81e5e6c84e2be6627aef26477dd6fef8578d397d
Security Headers
Name Value
Content-Security-Policy default-src * blob: data:; script-src blob: https://cdn.ampproject.org/esm/ https://cdn.ampproject.org/lts/ https://cdn.ampproject.org/mp/ https://cdn.ampproject.org/rtv/ https://cdn.ampproject.org/sp/ https://cdn.ampproject.org/sw/ https://cdn.ampproject.org/v0.js https://cdn.ampproject.org/v0.mjs https://cdn.ampproject.org/v0/ https://cdn.ampproject.org/viewer/; object-src 'none'; style-src 'unsafe-inline' https://cdn.ampproject.org/rtv/ https://cdn.materialdesignicons.com https://cloud.typography.com https://fast.fonts.net https://fonts.googleapis.com https://maxcdn.bootstrapcdn.com https://p.typekit.net https://pro.fontawesome.com https://use.fontawesome.com https://use.typekit.net; report-uri https://csp.withgoogle.com/csp/amp
Strict-Transport-Security max-age=31536000; includeSubDomains; preload
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

content-security-policy
default-src * blob: data:; script-src blob: https://cdn.ampproject.org/esm/ https://cdn.ampproject.org/lts/ https://cdn.ampproject.org/mp/ https://cdn.ampproject.org/rtv/ https://cdn.ampproject.org/sp/ https://cdn.ampproject.org/sw/ https://cdn.ampproject.org/v0.js https://cdn.ampproject.org/v0.mjs https://cdn.ampproject.org/v0/ https://cdn.ampproject.org/viewer/; object-src 'none'; style-src 'unsafe-inline' https://cdn.ampproject.org/rtv/ https://cdn.materialdesignicons.com https://cloud.typography.com https://fast.fonts.net https://fonts.googleapis.com https://maxcdn.bootstrapcdn.com https://p.typekit.net https://pro.fontawesome.com https://use.fontawesome.com https://use.typekit.net; report-uri https://csp.withgoogle.com/csp/amp
content-encoding
br
x-content-type-options
nosniff
age
77712
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
53265
x-xss-protection
0
server
sffe
date
Mon, 14 Dec 2020 15:10:29 GMT
strict-transport-security
max-age=31536000; includeSubDomains; preload
content-type
text/javascript
access-control-allow-origin
*
vary
Accept-Encoding
cache-control
public, max-age=31536000
etag
"f72bba98081828c2"
accept-ranges
bytes
timing-allow-origin
*
expires
Tue, 14 Dec 2021 15:10:29 GMT
amp-ad-exit-0.1.mjs
cdn.ampproject.org/rtv/052012102342000/v0/ Frame 4A6D
13 KB
5 KB
Script
General
Full URL
https://cdn.ampproject.org/rtv/052012102342000/v0/amp-ad-exit-0.1.mjs
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020120801.js
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:81f::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
2a65878202ba8da80194219b71ce06766b19591a9ad48884a42d99813a2287e2
Security Headers
Name Value
Content-Security-Policy default-src * blob: data:; script-src blob: https://cdn.ampproject.org/esm/ https://cdn.ampproject.org/lts/ https://cdn.ampproject.org/mp/ https://cdn.ampproject.org/rtv/ https://cdn.ampproject.org/sp/ https://cdn.ampproject.org/sw/ https://cdn.ampproject.org/v0.js https://cdn.ampproject.org/v0.mjs https://cdn.ampproject.org/v0/ https://cdn.ampproject.org/viewer/; object-src 'none'; style-src 'unsafe-inline' https://cdn.ampproject.org/rtv/ https://cdn.materialdesignicons.com https://cloud.typography.com https://fast.fonts.net https://fonts.googleapis.com https://maxcdn.bootstrapcdn.com https://p.typekit.net https://pro.fontawesome.com https://use.fontawesome.com https://use.typekit.net; report-uri https://csp.withgoogle.com/csp/amp
Strict-Transport-Security max-age=31536000; includeSubDomains; preload
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

content-security-policy
default-src * blob: data:; script-src blob: https://cdn.ampproject.org/esm/ https://cdn.ampproject.org/lts/ https://cdn.ampproject.org/mp/ https://cdn.ampproject.org/rtv/ https://cdn.ampproject.org/sp/ https://cdn.ampproject.org/sw/ https://cdn.ampproject.org/v0.js https://cdn.ampproject.org/v0.mjs https://cdn.ampproject.org/v0/ https://cdn.ampproject.org/viewer/; object-src 'none'; style-src 'unsafe-inline' https://cdn.ampproject.org/rtv/ https://cdn.materialdesignicons.com https://cloud.typography.com https://fast.fonts.net https://fonts.googleapis.com https://maxcdn.bootstrapcdn.com https://p.typekit.net https://pro.fontawesome.com https://use.fontawesome.com https://use.typekit.net; report-uri https://csp.withgoogle.com/csp/amp
content-encoding
br
x-content-type-options
nosniff
age
77712
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
4851
x-xss-protection
0
server
sffe
date
Mon, 14 Dec 2020 15:10:29 GMT
strict-transport-security
max-age=31536000; includeSubDomains; preload
content-type
text/javascript
access-control-allow-origin
*
vary
Accept-Encoding
cache-control
public, max-age=31536000
etag
"0b29bfab4c809524"
accept-ranges
bytes
timing-allow-origin
*
expires
Tue, 14 Dec 2021 15:10:29 GMT
amp-analytics-0.1.mjs
cdn.ampproject.org/rtv/052012102342000/v0/ Frame 4A6D
90 KB
27 KB
Script
General
Full URL
https://cdn.ampproject.org/rtv/052012102342000/v0/amp-analytics-0.1.mjs
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020120801.js
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:81f::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
65961e007908054525e219f8572a7a4eed3797d663d1d49ad13a321af897c139
Security Headers
Name Value
Content-Security-Policy default-src * blob: data:; script-src blob: https://cdn.ampproject.org/esm/ https://cdn.ampproject.org/lts/ https://cdn.ampproject.org/mp/ https://cdn.ampproject.org/rtv/ https://cdn.ampproject.org/sp/ https://cdn.ampproject.org/sw/ https://cdn.ampproject.org/v0.js https://cdn.ampproject.org/v0.mjs https://cdn.ampproject.org/v0/ https://cdn.ampproject.org/viewer/; object-src 'none'; style-src 'unsafe-inline' https://cdn.ampproject.org/rtv/ https://cdn.materialdesignicons.com https://cloud.typography.com https://fast.fonts.net https://fonts.googleapis.com https://maxcdn.bootstrapcdn.com https://p.typekit.net https://pro.fontawesome.com https://use.fontawesome.com https://use.typekit.net; report-uri https://csp.withgoogle.com/csp/amp
Strict-Transport-Security max-age=31536000; includeSubDomains; preload
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

content-security-policy
default-src * blob: data:; script-src blob: https://cdn.ampproject.org/esm/ https://cdn.ampproject.org/lts/ https://cdn.ampproject.org/mp/ https://cdn.ampproject.org/rtv/ https://cdn.ampproject.org/sp/ https://cdn.ampproject.org/sw/ https://cdn.ampproject.org/v0.js https://cdn.ampproject.org/v0.mjs https://cdn.ampproject.org/v0/ https://cdn.ampproject.org/viewer/; object-src 'none'; style-src 'unsafe-inline' https://cdn.ampproject.org/rtv/ https://cdn.materialdesignicons.com https://cloud.typography.com https://fast.fonts.net https://fonts.googleapis.com https://maxcdn.bootstrapcdn.com https://p.typekit.net https://pro.fontawesome.com https://use.fontawesome.com https://use.typekit.net; report-uri https://csp.withgoogle.com/csp/amp
content-encoding
br
x-content-type-options
nosniff
age
77712
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
27650
x-xss-protection
0
server
sffe
date
Mon, 14 Dec 2020 15:10:29 GMT
strict-transport-security
max-age=31536000; includeSubDomains; preload
content-type
text/javascript
access-control-allow-origin
*
vary
Accept-Encoding
cache-control
public, max-age=31536000
etag
"5ee8f5c1fe9379c6"
accept-ranges
bytes
timing-allow-origin
*
expires
Tue, 14 Dec 2021 15:10:29 GMT
amp-fit-text-0.1.mjs
cdn.ampproject.org/rtv/052012102342000/v0/ Frame 4A6D
3 KB
1 KB
Script
General
Full URL
https://cdn.ampproject.org/rtv/052012102342000/v0/amp-fit-text-0.1.mjs
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020120801.js
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:81f::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
e783c38d9f44263c62bb177e68ccccde5bf031316384f2e67e31715c598e274d
Security Headers
Name Value
Content-Security-Policy default-src * blob: data:; script-src blob: https://cdn.ampproject.org/esm/ https://cdn.ampproject.org/lts/ https://cdn.ampproject.org/mp/ https://cdn.ampproject.org/rtv/ https://cdn.ampproject.org/sp/ https://cdn.ampproject.org/sw/ https://cdn.ampproject.org/v0.js https://cdn.ampproject.org/v0.mjs https://cdn.ampproject.org/v0/ https://cdn.ampproject.org/viewer/; object-src 'none'; style-src 'unsafe-inline' https://cdn.ampproject.org/rtv/ https://cdn.materialdesignicons.com https://cloud.typography.com https://fast.fonts.net https://fonts.googleapis.com https://maxcdn.bootstrapcdn.com https://p.typekit.net https://pro.fontawesome.com https://use.fontawesome.com https://use.typekit.net; report-uri https://csp.withgoogle.com/csp/amp
Strict-Transport-Security max-age=31536000; includeSubDomains; preload
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

content-security-policy
default-src * blob: data:; script-src blob: https://cdn.ampproject.org/esm/ https://cdn.ampproject.org/lts/ https://cdn.ampproject.org/mp/ https://cdn.ampproject.org/rtv/ https://cdn.ampproject.org/sp/ https://cdn.ampproject.org/sw/ https://cdn.ampproject.org/v0.js https://cdn.ampproject.org/v0.mjs https://cdn.ampproject.org/v0/ https://cdn.ampproject.org/viewer/; object-src 'none'; style-src 'unsafe-inline' https://cdn.ampproject.org/rtv/ https://cdn.materialdesignicons.com https://cloud.typography.com https://fast.fonts.net https://fonts.googleapis.com https://maxcdn.bootstrapcdn.com https://p.typekit.net https://pro.fontawesome.com https://use.fontawesome.com https://use.typekit.net; report-uri https://csp.withgoogle.com/csp/amp
content-encoding
br
x-content-type-options
nosniff
age
77712
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
1364
x-xss-protection
0
server
sffe
date
Mon, 14 Dec 2020 15:10:29 GMT
strict-transport-security
max-age=31536000; includeSubDomains; preload
content-type
text/javascript
access-control-allow-origin
*
vary
Accept-Encoding
cache-control
public, max-age=31536000
etag
"18bf484c56e6e5d3"
accept-ranges
bytes
timing-allow-origin
*
expires
Tue, 14 Dec 2021 15:10:29 GMT
amp-form-0.1.mjs
cdn.ampproject.org/rtv/052012102342000/v0/ Frame 4A6D
41 KB
13 KB
Script
General
Full URL
https://cdn.ampproject.org/rtv/052012102342000/v0/amp-form-0.1.mjs
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020120801.js
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:81f::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
6aefa9dfc39f7bbb1fce0f13108fbc1fa43585443961448f0f9ddd926be0e211
Security Headers
Name Value
Content-Security-Policy default-src * blob: data:; script-src blob: https://cdn.ampproject.org/esm/ https://cdn.ampproject.org/lts/ https://cdn.ampproject.org/mp/ https://cdn.ampproject.org/rtv/ https://cdn.ampproject.org/sp/ https://cdn.ampproject.org/sw/ https://cdn.ampproject.org/v0.js https://cdn.ampproject.org/v0.mjs https://cdn.ampproject.org/v0/ https://cdn.ampproject.org/viewer/; object-src 'none'; style-src 'unsafe-inline' https://cdn.ampproject.org/rtv/ https://cdn.materialdesignicons.com https://cloud.typography.com https://fast.fonts.net https://fonts.googleapis.com https://maxcdn.bootstrapcdn.com https://p.typekit.net https://pro.fontawesome.com https://use.fontawesome.com https://use.typekit.net; report-uri https://csp.withgoogle.com/csp/amp
Strict-Transport-Security max-age=31536000; includeSubDomains; preload
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

content-security-policy
default-src * blob: data:; script-src blob: https://cdn.ampproject.org/esm/ https://cdn.ampproject.org/lts/ https://cdn.ampproject.org/mp/ https://cdn.ampproject.org/rtv/ https://cdn.ampproject.org/sp/ https://cdn.ampproject.org/sw/ https://cdn.ampproject.org/v0.js https://cdn.ampproject.org/v0.mjs https://cdn.ampproject.org/v0/ https://cdn.ampproject.org/viewer/; object-src 'none'; style-src 'unsafe-inline' https://cdn.ampproject.org/rtv/ https://cdn.materialdesignicons.com https://cloud.typography.com https://fast.fonts.net https://fonts.googleapis.com https://maxcdn.bootstrapcdn.com https://p.typekit.net https://pro.fontawesome.com https://use.fontawesome.com https://use.typekit.net; report-uri https://csp.withgoogle.com/csp/amp
content-encoding
br
x-content-type-options
nosniff
age
77712
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
12915
x-xss-protection
0
server
sffe
date
Mon, 14 Dec 2020 15:10:29 GMT
strict-transport-security
max-age=31536000; includeSubDomains; preload
content-type
text/javascript
access-control-allow-origin
*
vary
Accept-Encoding
cache-control
public, max-age=31536000
etag
"14db4fe596ec13fb"
accept-ranges
bytes
timing-allow-origin
*
expires
Tue, 14 Dec 2021 15:10:29 GMT
en.png
tpc.googlesyndication.com/pagead/images/adchoices/ Frame 4A6D
2 KB
3 KB
Image
General
Full URL
https://tpc.googlesyndication.com/pagead/images/adchoices/en.png
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020120801.js
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:81d::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
36133ca07927c88a7cc578fddbaed3c668ab75087834d0ca13dca5de4ec856c1
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

timing-allow-origin
*
date
Mon, 14 Dec 2020 23:34:27 GMT
x-content-type-options
nosniff
server
cafe
age
47474
etag
14819457070020093239
vary
Accept-Encoding
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
cache-control
public, max-age=86400
cross-origin-resource-policy
cross-origin
content-type
image/png
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
2502
x-xss-protection
0
expires
Tue, 15 Dec 2020 23:34:27 GMT
icon.png
tpc.googlesyndication.com/pagead/images/adchoices/ Frame 4A6D
295 B
389 B
Image
General
Full URL
https://tpc.googlesyndication.com/pagead/images/adchoices/icon.png
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020120801.js
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:81d::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
7fd59024b6ca83f11f7a3448ec148309a13b705725716df134f699e60a96eb1b
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

timing-allow-origin
*
date
Mon, 14 Dec 2020 21:53:21 GMT
x-content-type-options
nosniff
server
cafe
age
53540
etag
426692510519060060
vary
Accept-Encoding
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
cache-control
public, max-age=86400
cross-origin-resource-policy
cross-origin
content-type
image/png
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
295
x-xss-protection
0
expires
Tue, 15 Dec 2020 21:53:21 GMT
truncated
/ Frame 4A6D
214 B
0
Image
General
Full URL
data:truncated
Protocol
DATA
Server
-, , ASN (),
Reverse DNS
Software
/
Resource Hash
761c6a7ccd8917000e7f27f04f864a916d1bf0a945a5b100b3bf8dcd68ad0a3e

Request headers

Referer
https://www.dailymail.co.uk/
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Content-Type
image/png
9686309644740860853
tpc.googlesyndication.com/simgad/ Frame 4A6D
64 KB
64 KB
Image
General
Full URL
https://tpc.googlesyndication.com/simgad/9686309644740860853?sqp=4sqPyQQ7QjkqNxABHQAAtEIgASgBMAk4A0DwkwlYAWBfcAKAAQGIAQGdAQAAgD-oAQGwAYCt4gS4AV_FAS2ynT4&rs=AOga4qmImd5nj5IFos5MNwvoxA4GdUOj1g
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:81d::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
99abaf26acda38e5bbd57aedf506b794599fcf97d46ced3814db8eb36f921802
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Sat, 12 Dec 2020 10:04:23 GMT
x-content-type-options
nosniff
last-modified
Fri, 20 Nov 2020 08:52:06 GMT
server
sffe
age
268878
content-type
image/jpeg
access-control-allow-origin
*
cache-control
public, max-age=31536000
cross-origin-resource-policy
cross-origin
accept-ranges
bytes
timing-allow-origin
*
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
65669
x-xss-protection
0
expires
Sun, 12 Dec 2021 10:04:23 GMT
l
www.google.com/ads/measurement/ Frame 4A6D
0
0
Image
General
Full URL
https://www.google.com/ads/measurement/l?ebcid=ALh7CaQOrw8BCwwRmTze29PVVdu8vdiNYk6D-UOZVvROpq_OAV0eR7Ykucg5Psf0NTBiK6TIa0K0kElRsfGP23NBcDzmKmcVmw
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:817::2004 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
https://www.dailymail.co.uk/
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

adview
securepubads.g.doubleclick.net/pagead/ Frame 4A6D
0
0
Image
General
Full URL
https://securepubads.g.doubleclick.net/pagead/adview?ai=C1oos9a_YX6UqloXuA4X-npgMlPjFnmCahKLflAza2R4QASCs2bgiYJGEk4X8F6ABwIfNjQPIAQKpAr8-RoZnYbQ-4AIAqAMByAMIqgS-Ak_Q5MdpqVliZfeutXlHZM9eZaCweRJn61uNsMQ2iRDw9VRpn2epESeXQ95toIRLJSDSzqx2eBNTBe-IXZcr20B0gu46hjDp6qYbzsYDjHl_1OfRxpROl4It1NJUST97toAKRe7dIgA0Q55dBqnj6bKhqScksScf0_AIF7gzGinhafK3vQg_CK9W_LSbhiKXiQtfq06K9MdxxW_amnfR8RKpk8464xTdLaRzlWf97AxlILGfb3PVuDBCdspb6w-Q0E5q_7aRwqMeF259MgNxnAti69aJmNANCRA0vDr3lklUls9aIccU6L9Q2nZSWBW8CClYaVwlqjBt9BxUcgEgUS3C-u34qFdJtEwQ6Hbe_rT-OHkfF5vBROeJl2i3_zE4tiX0Ljs1mbokYp4ArC9epHIF_tNGFdCNBMAJvbSCzcAEqcfYgewC4AQBkgUECAQYAZIFBAgFGASgBgKAB9bTspwBqAfVyRuoB_DZG6gH8tkbqAeUmLECqAel3xuoB47OG6gHk9gbqAe6BqgH7paxAqgHpr4bqAfs1RvYBwHyBwQQs7YI0ggJCIDhgBAQARgdgAoDyAsB2BMCshcaChgIARIUcHViLTQxODA4MzU2OTQxNjYyNTU&sigh=-k1ikEd9Mmg&tpd=AGWhJmuUfOaUMeCd-LIlzvrSiGXWrSiCCB9iYHv4nc6fHSmohg
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
172.217.22.2 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
fra16s14-in-f2.1e100.net
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
https://www.dailymail.co.uk/
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

si
googleads.g.doubleclick.net/pagead/drt/ Frame 4A6D
Redirect Chain
  • https://www.google.com/pagead/drt/ui
  • https://googleads.g.doubleclick.net/pagead/drt/si
0
0
Image
General
Full URL
https://googleads.g.doubleclick.net/pagead/drt/si
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:816::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Redirect headers

date
Tue, 15 Dec 2020 12:45:41 GMT
x-content-type-options
nosniff
server
safe
content-type
text/html; charset=UTF-8
location
https://googleads.g.doubleclick.net/pagead/drt/si
cache-control
private
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
246
x-xss-protection
0
events
api.permutive.com/v2.0/batch/
401 B
258 B
XHR
General
Full URL
https://api.permutive.com/v2.0/batch/events?enrich=false&k=ed45e86d-a09e-4d2b-85c0-fbbd6857373e
Requested by
Host: cdn.permutive.com
URL: https://cdn.permutive.com/5f42864d-a421-4f37-9478-00266f871d68-web.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
34.107.254.252 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
Permutive /
Resource Hash
2b9d51dada5a17380695a24bef8444be658c2f27594467f529abc22e2b449038

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type
text/plain

Response headers

date
Tue, 15 Dec 2020 12:45:42 GMT
content-encoding
gzip
server
Permutive
vary
Origin,Access-Control-Request-Method
access-control-allow-methods
POST
content-type
application/json
access-control-allow-origin
https://www.dailymail.co.uk
access-control-expose-headers
*
access-control-allow-credentials
true
access-control-max-age
86400
alt-svc
clear
content-length
190
via
1.1 google
container.html
b1c90d68092b57f74adceeec8a58c68a.safeframe.googlesyndication.com/safeframe/1-0-37/html/ Frame 33EB
0
0
Document
General
Full URL
https://b1c90d68092b57f74adceeec8a58c68a.safeframe.googlesyndication.com/safeframe/1-0-37/html/container.html
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020120801.js
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:801::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

:method
GET
:authority
b1c90d68092b57f74adceeec8a58c68a.safeframe.googlesyndication.com
:scheme
https
:path
/safeframe/1-0-37/html/container.html
pragma
no-cache
cache-control
no-cache
upgrade-insecure-requests
1
user-agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
accept
text/html,application/xhtml+xml,application/xml;q=0.9,image/avif,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3;q=0.9
sec-fetch-site
cross-site
sec-fetch-mode
navigate
sec-fetch-dest
iframe
referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
accept-encoding
gzip, deflate, br
accept-language
en-US
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8

Response headers

accept-ranges
bytes
vary
Accept-Encoding
content-encoding
gzip
content-type
text/html
cross-origin-resource-policy
cross-origin
timing-allow-origin
*
content-length
2973
date
Tue, 15 Dec 2020 12:45:37 GMT
expires
Wed, 15 Dec 2021 12:45:37 GMT
last-modified
Thu, 21 Nov 2019 16:01:11 GMT
x-content-type-options
nosniff
server
sffe
x-xss-protection
0
cache-control
public, immutable, max-age=31536000
age
4
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
unip
trc-events.taboola.com/1125455/log/3/
0
294 B
XHR
General
Full URL
https://trc-events.taboola.com/1125455/log/3/unip?en=pre_d_eng_tb&tos=4666&scd=20&ssd=1&est=1608036337115&ver=27&isls=true&src=i&invt=3000&tim=1608036341781&vi=1608036337111&ri=b6dc80672a17aca292567a573e6453e2&sd=v2_15bf3ddba6eb6e007097014d6bd5af7c_81242381-ab73-4352-8bed-9e7099c82ee1-tuct6d23571_1608036337_1608036337_CNawjgYQz9hEGNeLvbPmLiABKAEwoQE4l-oLQJWXEEj-0toDUP___________wFYAWAAaOKmqpGyrZficA&ui=81242381-ab73-4352-8bed-9e7099c82ee1-tuct6d23571&ref=null&cv=20201123-29-RELEASE
Requested by
Host: cdn.taboola.com
URL: https://cdn.taboola.com/libtrc/unip/1125455/tfa.js
Protocol
H2
Security
TLS 1.2, ECDHE_ECDSA, AES_128_GCM
Server
141.226.228.48 , Netherlands, ASN200478 (TABOOLA-AS, IL),
Reverse DNS
Software
nginx /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

pragma
no-cache
date
Tue, 15 Dec 2020 12:45:41 GMT
server
nginx
x-fastly-to-nlb-rtt
1903
p3p
policyref="http://trc.taboola.com/p3p.xml", CP="NOI DSP COR LAW NID CURa ADMa DEVa PSAa PSDa OUR BUS IND UNI COM NAV INT DEM"
access-control-allow-origin
https://www.dailymail.co.uk
cache-control
no-cache
access-control-allow-credentials
true
tbl-x-upstream
10.41.22.84:10213
adview
securepubads.g.doubleclick.net/pagead/ Frame 94F8
0
0
Image
General
Full URL
https://securepubads.g.doubleclick.net/pagead/adview?ai=CMGL79K_YX52gGNrpgAebhqDwCPDy19Re2b7t6I8M2tkeEAEgrNm4ImCRhJOF_BegAZm5rvwDyAEGqQK_PkaGZ2G0PuACAKgDAaoExAJP0GSMKwlb7jDhlmpFj3rP4HjldE7WkvrVEkyh79iIVWWL0hMM7rGfxn8NH2XPE6m5rqY-I0XO0obiSMw84lXzlI191Zp8Yc7nCv7EcXsFZYBTh04zGezRaWF_qu8_fn0HOMjIGrjnutE4_DgGef-ETDERv7TkgqeLnER-_DsCj6qgj3FDWD7udm0DakuMr0Z6E1xTFpol7Yrr85ui3yPW48Toh-xL8thLAkvm2r0ziNID66b_8DNKMgoglgcSG7BI5oIhhT_V78Tvk6xJrzyvt809IkqAbQUcgX7_EEnBjjgiS3HKG6GZlIvD8cpmdG68gZ_brj6Vavj9yl6p75xLUG4RTFc4n9Xowy3nZQmoDqBRsREHNVoDGrKsOxX2s-7wUoYDjItRh3z9HAE7E0gBpF5pM75FxiUqDrfEwsI8UnYdnqvABJThz5WoA-AEAaAGN4AHz8bRA6gH1ckbqAfw2RuoB_LZG6gHlJixAqgHpd8bqAeOzhuoB5PYG6gHugaoB-6WsQKoB6a-G6gH7NUb2AcB8gcEENC-CtIICQiA4YAQEAEYHYAKA8gLAdgTA7IXGgoYCAESFHB1Yi00MTgwODM1Njk0MTY2MjU1&sigh=i7aslFOBa_M&vt=1&template_id=492
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
172.217.22.2 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
fra16s14-in-f2.1e100.net
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
https://www.dailymail.co.uk/
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

activeview
pagead2.googlesyndication.com/pcs/ Frame 94F8
42 B
189 B
Image
General
Full URL
https://pagead2.googlesyndication.com/pcs/activeview?xai=AKAOjstnNKTd-HXGLCUhcXoJJ4ISHmdTLNdwOlZNaWAnQ0w7HQPflaabyWdLrouSpFicXbwJDn2myQeHwmB3Svjx8CEvFFKuoT-x6g2HJWGuc_9-D7cC_cJwEzrz2Y7Ktg&sai=AMfl-YQo3Ni9GdNDCOsvakA_F98DJ6ljnA51_VBaHKqM4cdNFTlxdVnuiFd2MRByCXi7-GZkjRb1CD7NIPVpnoUKno-v6Ji7ZSrQXY4tJxLVWGGOkXGHlQKvjNi-h6m5&sig=Cg0ArKJSzLG86nD-_GlDEAE&cid=CAASF-RoLvsKdjCPiZFSs8ODlMjwtmJ0uDgK&id=ampim&o=3,20&d=300,250&ss=1600,1200&bs=1600,1200&mcvt=1000&mtos=0,0,1000,1000,1000&tos=0,0,1000,0,0&tfs=197&tls=1197&g=100&h=100&tt=1197&r=v&avms=ampa&adk=1681991210
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:816::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
ef1955ae757c8b966c83248350331bd3a30f658ced11f387f8ebf05ab3368629
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

pragma
no-cache
date
Tue, 15 Dec 2020 12:45:41 GMT
x-content-type-options
nosniff
server
cafe
timing-allow-origin
*
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
access-control-allow-origin
*
cache-control
no-cache, must-revalidate
cross-origin-resource-policy
cross-origin
content-type
image/gif
alt-svc
h3-29="googleads.g.doubleclick.net:443"; ma=2592000,h3-29=":443"; ma=2592000,h3-T051="googleads.g.doubleclick.net:443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic="googleads.g.doubleclick.net:443"; ma=2592000; v="46,43",quic=":443"; ma=2592000; v="46,43"
content-length
42
x-xss-protection
0
expires
Fri, 01 Jan 1990 00:00:00 GMT
events
api.permutive.com/v2.0/batch/
101 B
370 B
XHR
General
Full URL
https://api.permutive.com/v2.0/batch/events?enrich=false&k=ed45e86d-a09e-4d2b-85c0-fbbd6857373e
Requested by
Host: cdn.permutive.com
URL: https://cdn.permutive.com/5f42864d-a421-4f37-9478-00266f871d68-web.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
34.107.254.252 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
Permutive /
Resource Hash
6da864841bb41c8e7a34ae6e775f3175530be21816c47a124bf095046b256fdd

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type
text/plain

Response headers

date
Tue, 15 Dec 2020 12:45:42 GMT
content-encoding
gzip
server
Permutive
vary
Origin,Access-Control-Request-Method
access-control-allow-methods
POST
content-type
application/json
access-control-allow-origin
https://www.dailymail.co.uk
access-control-expose-headers
*
access-control-allow-credentials
true
access-control-max-age
86400
alt-svc
clear
content-length
111
via
1.1 google
activeview
pagead2.googlesyndication.com/pcs/ Frame 4A6D
42 B
112 B
Image
General
Full URL
https://pagead2.googlesyndication.com/pcs/activeview?xai=AKAOjssxLziG3SRasx275Eg8uEHd19h4xPVjL_tKTtWTXXMyhyhhuYW3DSZlnFAt_fiQ6TBeM52J6yVbRJwnxYtuJr4DnAX9O-JNn45wc79B2v1XWXoyMw7kqFRbdJKn_-gakwgUh9G8xnkGpfWTM4krl_e5&sai=AMfl-YTLTOiZY_3e9JHXd30PITO7oUpEB8cGgVxNwALZrsMoEoTsJ19m2ZgjoUIDF3aB8wf1EQXnVpj_aaE9pj2mWr-sEkXxTRD03CxdWh9pcntoJHJQ5wg62BB8gBOK&sig=Cg0ArKJSzN7sOrKu41CQEAE&cid=CAASF-RorStPdWMCh8NOVb3dbbU9IJQ6VxOP&id=ampim&o=1297,20&d=300,600&ss=1600,1200&bs=1600,1200&mcvt=1000&mtos=0,0,1000,1000,1000&tos=0,0,1000,0,0&tfs=127&tls=1127&g=100&h=100&tt=1127&r=v&avms=ampa&adk=3607738367
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:816::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
ef1955ae757c8b966c83248350331bd3a30f658ced11f387f8ebf05ab3368629
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

pragma
no-cache
date
Tue, 15 Dec 2020 12:45:42 GMT
x-content-type-options
nosniff
server
cafe
timing-allow-origin
*
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
access-control-allow-origin
*
cache-control
no-cache, must-revalidate
cross-origin-resource-policy
cross-origin
content-type
image/gif
alt-svc
h3-29="googleads.g.doubleclick.net:443"; ma=2592000,h3-29=":443"; ma=2592000,h3-T051="googleads.g.doubleclick.net:443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic="googleads.g.doubleclick.net:443"; ma=2592000; v="46,43",quic=":443"; ma=2592000; v="46,43"
content-length
42
x-xss-protection
0
expires
Fri, 01 Jan 1990 00:00:00 GMT
/
crta.dailymail.co.uk/
8 B
450 B
Other
General
Full URL
https://crta.dailymail.co.uk/
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/static/mol-adverts/demo/mol-22070/19a28e0b/mol-adverts.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
2a02:26f0:6c00:2be::16c2 , Ascension Island, ASN20940 (AKAMAI-ASN1, EU),
Reverse DNS
Software
http-to-kafka/0.8.10 /
Resource Hash
a00fb0c50741f81bb51d35b4475a4357f8039aabd896a21036bc516839401595

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type
text/plain

Response headers

pragma
no-cache
date
Tue, 15 Dec 2020 12:45:47 GMT
server
http-to-kafka/0.8.10
etag
W/"8-YaBXLEiT7zQxEyDYTILfiL6oPhE"
content-type
text/plain; charset=utf-8
access-control-allow-origin
*
cache-control
max-age=0, no-cache, no-store
access-control-allow-credentials
true
content-length
8
expires
Tue, 15 Dec 2020 12:45:47 GMT
moatvideo.js
z.moatads.com/mailonlinejsvideo243552997523/
303 KB
102 KB
Script
General
Full URL
https://z.moatads.com/mailonlinejsvideo243552997523/moatvideo.js
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/static/videoplayer/6.11.0-pr-503.2312/scripts/mol-fe-videoplayer.min.js
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
104.111.216.96 , Netherlands, ASN16625 (AKAMAI-AS, US),
Reverse DNS
a104-111-216-96.deploy.static.akamaitechnologies.com
Software
AmazonS3 /
Resource Hash
98e5fa7e584ae32cf8038a77daffe47225b714a939bd685d36fb79993e0035c1

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:45:47 GMT
content-encoding
gzip
last-modified
Mon, 14 Dec 2020 16:26:20 GMT
server
AmazonS3
x-amz-request-id
14841A87A9D6AF00
etag
"5f18b9b8575ad8a6beca99c6ae94ec3e"
vary
Accept-Encoding
content-type
application/x-javascript
cache-control
max-age=27915
accept-ranges
bytes
content-length
104201
x-amz-id-2
4kPzCByCzO8XhbRgBH+DnnarFQuAbQ/CpyIL19mB4dnINhBE9DjprBq1pJRCe81AHXMmTHWclPM=
loader.js
imasdk.googleapis.com/js/sdkloader/ Frame DE86
52 KB
19 KB
Script
General
Full URL
https://imasdk.googleapis.com/js/sdkloader/loader.js
Requested by
Host: imasdk.googleapis.com
URL: https://imasdk.googleapis.com/js/sdkloader/ima3.js
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:825::200a Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
a54bce3233c930b9799a20a1b806eee59f74c318c0361da6755b27d84e67778e
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:37:53 GMT
content-encoding
gzip
x-content-type-options
nosniff
last-modified
Mon, 14 Dec 2020 09:15:17 GMT
server
sffe
age
469
vary
Accept-Encoding
content-type
text/javascript
cache-control
public, max-age=900
cross-origin-resource-policy
cross-origin
accept-ranges
bytes
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
18835
x-xss-protection
0
expires
Tue, 15 Dec 2020 12:52:53 GMT
vpaid-adapter.min.js
cdn.stickyadstv.com/mustang/ Frame DE86
327 KB
111 KB
Script
General
Full URL
https://cdn.stickyadstv.com/mustang/vpaid-adapter.min.js
Requested by
Host: imasdk.googleapis.com
URL: https://imasdk.googleapis.com/js/sdkloader/loader.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
2001:4de0:ac19::1:b:3b , Netherlands, ASN20446 (HIGHWINDS3, US),
Reverse DNS
Software
/
Resource Hash
dc989373165041ad828e64f33bb534395d2ec233f5949759c911862535e77658

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Date
Tue, 15 Dec 2020 12:45:44 GMT
Content-Encoding
gzip
Last-Modified
Wed, 09 Dec 2020 03:18:58 GMT
ETag
"1607483938"
X-HW
1608036344.dop213.fr8.t,1608036344.cds245.fr8.shn,1608036344.cds245.fr8.c
Content-Type
application/x-javascript
Access-Control-Allow-Origin
*
Cache-Control
max-age=86400
Access-Control-Allow-Credentials
true
Connection
Keep-Alive
Accept-Ranges
bytes
Content-Length
112809
events
api.permutive.com/v2.0/batch/
201 B
210 B
XHR
General
Full URL
https://api.permutive.com/v2.0/batch/events?enrich=false&k=ed45e86d-a09e-4d2b-85c0-fbbd6857373e
Requested by
Host: cdn.permutive.com
URL: https://cdn.permutive.com/5f42864d-a421-4f37-9478-00266f871d68-web.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
34.107.254.252 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
Permutive /
Resource Hash
ac0decd5d8a25db3a2454234200cbb7dcab2970f40a2a93b9082026313753fda

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type
text/plain

Response headers

date
Tue, 15 Dec 2020 12:45:43 GMT
content-encoding
gzip
server
Permutive
vary
Origin,Access-Control-Request-Method
access-control-allow-methods
POST
content-type
application/json
access-control-allow-origin
https://www.dailymail.co.uk
access-control-expose-headers
*
access-control-allow-credentials
true
access-control-max-age
86400
alt-svc
clear
content-length
142
via
1.1 google
creative_js.js
vidstat.taboola.com/vpaid/units/27_2_17/creatives/
4 KB
2 KB
Script
General
Full URL
https://vidstat.taboola.com/vpaid/units/27_2_17/creatives/creative_js.js
Requested by
Host: cdn.taboola.com
URL: https://cdn.taboola.com/libtrc/impl.20201214-6-RELEASE.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
151.101.13.44 Frankfurt am Main, Germany, ASN54113 (FASTLY, US),
Reverse DNS
Software
AmazonS3 /
Resource Hash
6258018e9f890f2383a09a2be6df7792affd977d856e7247ace8341f5b5487f0

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:45:44 GMT
via
1.1 8cdf0467c0468ddfe8e9873c6bb8304c.cloudfront.net (CloudFront), 1.1 varnish
age
2863743
x-amz-meta-mtime
1580720676
x-cache
Miss from cloudfront, HIT
x-amz-meta-ctime
1580720957
x-amz-meta-mode
33188
content-encoding
gzip
content-length
1904
x-served-by
cache-fra19144-FRA
last-modified
Mon, 03 Feb 2020 09:09:18 GMT
server
AmazonS3
x-timer
S1608036345.508619,VS0,VE0
etag
"d80eacb3ed43f93a2da80d76e65d19a8"
x-amz-meta-uid
0
vary
Accept-Encoding
access-control-allow-methods
GET, OPTIONS, HEAD
x-amz-meta-gid
0
access-control-allow-origin
*
cache-control
public, max-age=2592000
x-amz-cf-pop
FRA6-C1
accept-ranges
bytes
content-type
application/javascript
access-control-allow-headers
*
x-amz-cf-id
fAeHO52Fy78UbxheIVGwTQpabLzTVzA-RHX2HcKYyUH5P0SAs1-vKA==
x-cache-hits
1461102
metrics
api.permutive.com/v2.0/internal/
2 B
108 B
XHR
General
Full URL
https://api.permutive.com/v2.0/internal/metrics?k=ed45e86d-a09e-4d2b-85c0-fbbd6857373e
Requested by
Host: cdn.permutive.com
URL: https://cdn.permutive.com/5f42864d-a421-4f37-9478-00266f871d68-web.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
34.107.254.252 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
Permutive /
Resource Hash
2689367b205c16ce32ed4200942b8b8b1e262dfc70d9bc9fbc77c49699a4f1df

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type
text/plain

Response headers

date
Tue, 15 Dec 2020 12:45:43 GMT
content-encoding
gzip
server
Permutive
vary
Origin,Access-Control-Request-Method
access-control-allow-methods
POST
content-type
text/plain;charset=utf-8
access-control-allow-origin
https://www.dailymail.co.uk
access-control-expose-headers
*
access-control-allow-credentials
true
access-control-max-age
86400
alt-svc
clear
content-length
22
via
1.1 google
analytics-tags.js
cdn.userreport.com/
265 B
651 B
Script
General
Full URL
https://cdn.userreport.com/analytics-tags.js
Requested by
Host: cdn.userreport.com
URL: https://cdn.userreport.com/userreport.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2600:9000:21f3:8200:19:d208:7940:93a1 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
AmazonS3 /
Resource Hash
7d8c62049816b4a834204bb3a79b014f88a6c6dc916e7ab26abf0d40c2e69ed4

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

x-amz-version-id
BQ4neG9T5yHFyGCIm7yA158D1GNg0I81
via
1.1 2b2e2811e641703aebf776da39317b9c.cloudfront.net (CloudFront)
last-modified
Fri, 03 Aug 2018 07:14:09 GMT
server
AmazonS3
age
388
etag
"b9c284ba1fea2a6f6c2de5d0d9904ee9"
x-cache
Hit from cloudfront
content-type
application/javascript
cache-control
max-age=3600
date
Tue, 15 Dec 2020 12:39:17 GMT
x-amz-cf-pop
FRA2-C2
accept-ranges
bytes
content-length
265
x-amz-cf-id
HTXXA5w5GG-Ofc0pGLXvSYdZ3DUZyepiS20Epqhe2BLEAvBvOhIe9w==
AVmanager.js
player.aniview.com/script/6.1/ Frame 9E88
327 KB
93 KB
Script
General
Full URL
https://player.aniview.com/script/6.1/AVmanager.js?v=1.0&type=s&pid=5e3a966128a06134f417790e
Requested by
Host: player.aniview.com
URL: https://player.aniview.com/script/6.1/player.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
2a02:26f0:10c:48b::2c79 , Ascension Island, ASN20940 (AKAMAI-ASN1, EU),
Reverse DNS
Software
UploadServer /
Resource Hash
9a134b68d3b5bc4c3874da78175bdaee9cfd415937780c7e0e786ac3e689c2d7

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:45:43 GMT
content-encoding
gzip
x-guploader-uploadid
ABg5-Uzg6UK2fKz3A1ZYal2TeUnnQTILHs3YtQWRu_J5QK2UfWJq8DYI-WhmMj-Cdf7tSVBOV141tiW3B7lUjVueTw
x-goog-storage-class
MULTI_REGIONAL
x-goog-metageneration
2
x-goog-stored-content-encoding
gzip
content-length
94733
last-modified
Tue, 15 Dec 2020 08:43:51 GMT
server
UploadServer
etag
"49254afaf94e0199278b573fbf4b32ba"
vary
Accept-Encoding
x-goog-hash
crc32c=VYuz3g==, md5=SSVK+vlOAZkni1c/v0syug==
content-language
en
access-control-allow-origin
*
x-goog-generation
1608021831248560
access-control-expose-headers
Content-Type
cache-control
public, max-age=300
x-goog-stored-content-length
94733
accept-ranges
bytes
content-type
application/javascript
expires
Tue, 15 Dec 2020 12:50:43 GMT
track
track1.aniview.com/
0
70 B
Image
General
Full URL
https://track1.aniview.com/track?r=www.dailymail.co.uk&sn=&ic=0&tgt=0&app=&wi=480&he=270&test=&apppkg=&fv=3&proto=https&pid=5e3a966128a06134f417790e&cid=5e3a987528a0611c3444f80c&e=inventory&vi=100&cb=1608036343675
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
34.197.221.162 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:45:46 GMT
cache-control
max-age=0, no-cache, no-store
content-length
0
truncated
/
331 B
0
Image
General
Full URL
data:truncated
Protocol
DATA
Server
-, , ASN (),
Reverse DNS
Software
/
Resource Hash
c9e42e2c7cd3ec42f6febe248c715522b2e5f6bc92b389b101fbd33a069ee7ed

Request headers

Referer
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Content-Type
image/svg+xml
truncated
/
740 B
0
Image
General
Full URL
data:truncated
Protocol
DATA
Server
-, , ASN (),
Reverse DNS
Software
/
Resource Hash
7a9054758a4808c97c188f5be469879eef19a2f7cbd9bb0e740cee3199a6c747

Request headers

Referer
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Content-Type
image/svg+xml
truncated
/
384 B
0
Image
General
Full URL
data:truncated
Protocol
DATA
Server
-, , ASN (),
Reverse DNS
Software
/
Resource Hash
8030594b4999eca38901464b09383ca988c454a4f7ab6b963be75e6c42da011d

Request headers

Referer
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Content-Type
image/svg+xml
truncated
/
782 B
0
Image
General
Full URL
data:truncated
Protocol
DATA
Server
-, , ASN (),
Reverse DNS
Software
/
Resource Hash
5028f77ac0afdac1bb66eaeeef41e77cea0f2487a66cb1df354d8680db1bb64e

Request headers

Referer
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Content-Type
image/svg+xml
truncated
/
395 B
0
Image
General
Full URL
data:truncated
Protocol
DATA
Server
-, , ASN (),
Reverse DNS
Software
/
Resource Hash
f0d7d05ef7ae154e283b8c8e462aeb6e9b5bca53225c42743e2028c34828c08a

Request headers

Referer
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Content-Type
image/svg+xml
truncated
/
449 B
0
Image
General
Full URL
data:truncated
Protocol
DATA
Server
-, , ASN (),
Reverse DNS
Software
/
Resource Hash
f86a1105ed755e9ae9b75708a5b19d5c478212605b9f8d7c98796b451de18c63

Request headers

Referer
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Content-Type
image/svg+xml
truncated
/
480 B
0
Image
General
Full URL
data:truncated
Protocol
DATA
Server
-, , ASN (),
Reverse DNS
Software
/
Resource Hash
ee9a49aae5d1fc7602361ae5c6d69fc8eb128d007b4dee67d42ce19bbf2c87e0

Request headers

Referer
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Content-Type
image/svg+xml
truncated
/
577 B
0
Image
General
Full URL
data:truncated
Protocol
DATA
Server
-, , ASN (),
Reverse DNS
Software
/
Resource Hash
d23484cf0f36a73cc699ceffc6da8f0e9ffd6b372dcb615ec942cdc287845505

Request headers

Referer
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Content-Type
image/svg+xml
vidsplay_pass_pre.js
play.selectmedia.asia/58fcbed1073ef420086c9d08/5f50f97c29103948b5607078/
3 KB
2 KB
Script
General
Full URL
https://play.selectmedia.asia/58fcbed1073ef420086c9d08/5f50f97c29103948b5607078/vidsplay_pass_pre.js
Requested by
Host: player.aniview.com
URL: https://player.aniview.com/script/6.1/AVmanager.js?v=1.0&type=s&pid=5e3a966128a06134f417790e
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_256_GCM
Server
2a02:26f0:eb::214:bece , Ascension Island, ASN20940 (AKAMAI-ASN1, EU),
Reverse DNS
Software
UploadServer /
Resource Hash
05739efd89e90ee51ff01da4cc9218904c15bcc4b8ebef478e45e19ceb935314

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Date
Tue, 15 Dec 2020 12:45:45 GMT
Content-Encoding
gzip
X-GUploader-UploadID
ABg5-UyBR1J4LRtqoqTPLSXa6aY8Ja6I8DjcO6jZf_HWY7XbzhFsf47xxNV6PXSDL4bQt8Ixnv1K9FFROHQ1DaYowKYVixvchA
x-goog-storage-class
MULTI_REGIONAL
x-goog-metageneration
1
x-goog-stored-content-encoding
identity
Connection
keep-alive
Content-Length
1083
Last-Modified
Sun, 01 Nov 2020 14:36:25 GMT
Server
UploadServer
ETag
"101bdb042b1b6998da460a905ad8fee5"
Vary
Accept-Encoding
x-goog-hash
crc32c=oiZvmA==
x-goog-generation
1604241385418739
Access-Control-Allow-Origin
*
Access-Control-Expose-Headers
Content-Type
Cache-Control
public, max-age=1800
x-goog-stored-content-length
3384
Accept-Ranges
bytes
Content-Type
text/javascript
Expires
Tue, 15 Dec 2020 13:15:45 GMT
/
go1.aniview.com/api/adserver/tag/
16 KB
3 KB
XHR
General
Full URL
https://go1.aniview.com/api/adserver/tag/?AV_SECURED=1&AV_LANGUAGE=en&AV_URL=https%3A%2F%2Fwww.dailymail.co.uk%2Fsciencetech%2Farticle-9050821%2FRemdesivir-beneficial-patients-doctors-reveal.html%3F_hsmi%3D88974744%26_hsenc%3Dp2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8&AV_PUBLISHERID=5e3a966128a06134f417790e&AV_CHANNELID=5e3a987528a0611c3444f80c&format=json&tgt=0&AV_SUBID=&AV_CDIM1=&AV_CDIM2=&AV_CDIM3=&AV_ABT=&pce=1&npx=1&AV_DNT=0&AV_DETDOMAIN=www.dailymail.co.uk&AV_DADPOS=3&v=6.1.1.243&avtoken=343674&AV_WIDTH=480&AV_HEIGHT=270&cb=1608036343714
Requested by
Host: player.aniview.com
URL: https://player.aniview.com/script/6.1/AVmanager.js?v=1.0&type=s&pid=5e3a966128a06134f417790e
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
52.206.107.130 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
Software
/
Resource Hash
f27510b8fdc1bd705485daf28b12a967a005cb62b1556c6d1adb1674d0e45733

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:45:44 GMT
content-encoding
gzip
vary
Accept-Encoding
content-type
application/json
access-control-allow-origin
https://www.dailymail.co.uk
cache-control
no-cache
access-control-allow-credentials
true
expires
Thu, 03 Dec 2020 22:59:04 GMT
selectmedia-logo56x10.png
play.selectmedia.asia/58fcbed1073ef420086c9d08/5942ae55073ef42ccf4fae29/
2 KB
3 KB
Image
General
Full URL
https://play.selectmedia.asia/58fcbed1073ef420086c9d08/5942ae55073ef42ccf4fae29/selectmedia-logo56x10.png
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_256_GCM
Server
2a02:26f0:eb::214:bece , Ascension Island, ASN20940 (AKAMAI-ASN1, EU),
Reverse DNS
Software
UploadServer /
Resource Hash
f564399443d3c5b5169fe11e1ca826d562933353f3b08c8bb235bfd0b5a44867

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Date
Tue, 15 Dec 2020 12:45:43 GMT
X-GUploader-UploadID
ABg5-UxguBeyuhktb6OSLcp7-1s5yYYkpobRY1aSRUq8c2m6P4YaNTo33NJReAvQm49fULgsCQWGwscr9ohjuepJYvtN3YwVfA
x-goog-storage-class
MULTI_REGIONAL
x-goog-metageneration
1
x-goog-stored-content-encoding
identity
Connection
keep-alive
Content-Length
2342
Last-Modified
Thu, 18 Jul 2019 10:38:43 GMT
Server
UploadServer
ETag
"213172f2d54764531a0427b6f4a1357f"
x-goog-hash
crc32c=yrppbQ==
x-goog-generation
1563446323633469
Access-Control-Allow-Origin
*
Access-Control-Expose-Headers
Content-Type
Cache-Control
public, max-age=1800
x-goog-stored-content-length
2342
Accept-Ranges
bytes
Content-Type
image/png
Expires
Tue, 15 Dec 2020 13:15:43 GMT
publishertag.prebid.js
static.criteo.net/js/ld/
77 KB
25 KB
XHR
General
Full URL
https://static.criteo.net/js/ld/publishertag.prebid.js
Requested by
Host: static.criteo.net
URL: https://static.criteo.net/js/ld/publishertag.prebid.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a02:2638:1::3 , France, ASN44788 (ASN-CRITEO-EUROPE, FR),
Reverse DNS
Software
nginx /
Resource Hash
6d8ffd84868d7c4232e88167eb1adc0a83d4c1f5efb41d78eb1a03127dcdb625

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:45:43 GMT
content-encoding
gzip
last-modified
Tue, 17 Nov 2020 07:57:58 GMT
server
nginx
etag
W/"5fb38286-13244"
content-type
text/javascript
access-control-allow-origin
*
cache-control
max-age=86400, public
timing-allow-origin
*
expires
Wed, 16 Dec 2020 12:45:43 GMT
st
imprammp.taboola.com/ Frame 3DBA
0
0
Document
General
Full URL
https://imprammp.taboola.com/st?cijs=convusmp&ttype=0&cisd=convusmp&cipid=8060095&crid=4706985&dast=V7FEQCFgODwV-BG--R_QSDwV-BG--R_QUAAAAGBuIHHMYcMTcTFonBYO0Gq91muVvsZovdZDic7YawYcwRczNhkRgM1m6w2m2Ws81iONmtBpvRFDiEZfb7DgrK6ekxuwyiouttsTucZs9BMje5QQ1Np8Pnutfrfr-7yOE0O98Op9mu8dtVX7_m43TZPS7Ty2P0Kyynp8fscisHq8FwsthLWm6Ty_O0PS1vicvusjk9TofZLXiYni676fMW-T2mv-XzlrxsL4fZLjS9zXYAAAAAeAA4kk6F-AEEAIgAAAAAkAAAAACgCKj4txC4AAAAAMAAKBC90ACg5Eigo8sgdPhcL38AADwUgAAADCiQAAyoHZUASCgkngAAAAAAAAAAsPz____HAOjx_8oAXMj19wA8-AA8EBUoFjECAAAAyKVeHTqa1AmVRRUAAEG6FcAVAECAndnbUlwYAADAwNgCPSx-v9lh1_jdLgMAAAAAAAAAMPs_-0cTgpqZSQNKzNRU-wUEAFj7BQQAYFM3AIA3AbigI2jFYLC6AZosZgcAAABw9____68HQibTyDbbeIYLl2Pi3G1MHtfEN3GMPJ7ZZrIZDLZXq2f7rFzhAtjHISyz33dQUE5Pj9llEBVdb4vd4TR7DpK5yX4TthitJpPNcjhbLiaD4Wg4Gu1PADcDnKDhcLDYDRa7xWI4WUxGg-VggQIxmOCEDEebyWq0W-0my-FkNJptJhukaNVqNtoMhqvZZLbbrYaD4XI0QorWLGaTyWI2Wu42g-VkNBhOhkOEwcVkNNkMF2uFxbdZizaryVo4cZncypVvsFxujJOVy7EWvT6m28iyWe0WWxQMKNuL4CKdiBxOs_PtcJrdkr_vIpZoThbpRHbZl0ymkW228QwXLsfEuduYPK6Jb-IYeTyzzWQzGOyLi8loshku1gqLb7MWbVaTtXDiMrmVK99gudwYJyuXYy16fUy3kWWz2i32jdlgONjMNpvdvjEbDAeb2Waz23foDN_V52y0Rbvnjs4y0y6GtpnpoHAZjN7f0SKN3Xozo8ortlhUt2D0N7EK_X6_3-_3-_1-v3djNngMBsPPZTsOP-blWnN6HBSxRHC6SCeil_F0EUskT4t0IhmMPB6Ty7VyzWyzlWE5WE0mzt3EtHDOTLblZDERS5Smi3Si13ycLrvHZXp5jH6F5fT0mF1u5WA1GE4We8nLbXJ5nran5S1x2V02p8fpMLsFD9PTZTd93iK_x_S3fN6Sl-3lMNuFprfZov6jQwxXc8liMlfsFnPZbpUAAAAAAAAAAJYwZ94EAAAA4DSQyWa4WC0X4MFoT_dHNYX1jnM8cdcFm5Pt8szIpLjx4wZyOM3Ot8Npdkv-visDPBjdMW_2TBBrtVrWAAAABNgAAAAB3Lp5CxyL5AA!&cmcv=&pix=undefined&cb=1608036344043&uv=2853&tms=1608036344043&abt=dpr6_vA!expn_vF!heavyc_vA!ntvc_vA!spa2_vB!t45!ufm_vA&ft=0&su=0&unm=WIDGET_ITEM&aure=false&cirid=F9D93BEDAA570573971761728867&excid=e22lLINE_ITEM_ID_WILL_BE_HERE_ON_SERVINGc&tst=1&docw=0&cs=true&cias=1
Requested by
Host: vidstat.taboola.com
URL: https://vidstat.taboola.com/lite-unit/2.4.6/UnitWidgetItemDesktop.min.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
151.101.13.44 Frankfurt am Main, Germany, ASN54113 (FASTLY, US),
Reverse DNS
Software
nginx /
Resource Hash

Request headers

:method
GET
:authority
imprammp.taboola.com
:scheme
https
:path
/st?cijs=convusmp&ttype=0&cisd=convusmp&cipid=8060095&crid=4706985&dast=V7FEQCFgODwV-BG--R_QSDwV-BG--R_QUAAAAGBuIHHMYcMTcTFonBYO0Gq91muVvsZovdZDic7YawYcwRczNhkRgM1m6w2m2Ws81iONmtBpvRFDiEZfb7DgrK6ekxuwyiouttsTucZs9BMje5QQ1Np8Pnutfrfr-7yOE0O98Op9mu8dtVX7_m43TZPS7Ty2P0Kyynp8fscisHq8FwsthLWm6Ty_O0PS1vicvusjk9TofZLXiYni676fMW-T2mv-XzlrxsL4fZLjS9zXYAAAAAeAA4kk6F-AEEAIgAAAAAkAAAAACgCKj4txC4AAAAAMAAKBC90ACg5Eigo8sgdPhcL38AADwUgAAADCiQAAyoHZUASCgkngAAAAAAAAAAsPz____HAOjx_8oAXMj19wA8-AA8EBUoFjECAAAAyKVeHTqa1AmVRRUAAEG6FcAVAECAndnbUlwYAADAwNgCPSx-v9lh1_jdLgMAAAAAAAAAMPs_-0cTgpqZSQNKzNRU-wUEAFj7BQQAYFM3AIA3AbigI2jFYLC6AZosZgcAAABw9____68HQibTyDbbeIYLl2Pi3G1MHtfEN3GMPJ7ZZrIZDLZXq2f7rFzhAtjHISyz33dQUE5Pj9llEBVdb4vd4TR7DpK5yX4TthitJpPNcjhbLiaD4Wg4Gu1PADcDnKDhcLDYDRa7xWI4WUxGg-VggQIxmOCEDEebyWq0W-0my-FkNJptJhukaNVqNtoMhqvZZLbbrYaD4XI0QorWLGaTyWI2Wu42g-VkNBhOhkOEwcVkNNkMF2uFxbdZizaryVo4cZncypVvsFxujJOVy7EWvT6m28iyWe0WWxQMKNuL4CKdiBxOs_PtcJrdkr_vIpZoThbpRHbZl0ymkW228QwXLsfEuduYPK6Jb-IYeTyzzWQzGOyLi8loshku1gqLb7MWbVaTtXDiMrmVK99gudwYJyuXYy16fUy3kWWz2i32jdlgONjMNpvdvjEbDAeb2Waz23foDN_V52y0Rbvnjs4y0y6GtpnpoHAZjN7f0SKN3Xozo8ortlhUt2D0N7EK_X6_3-_3-_1-v3djNngMBsPPZTsOP-blWnN6HBSxRHC6SCeil_F0EUskT4t0IhmMPB6Ty7VyzWyzlWE5WE0mzt3EtHDOTLblZDERS5Smi3Si13ycLrvHZXp5jH6F5fT0mF1u5WA1GE4We8nLbXJ5nran5S1x2V02p8fpMLsFD9PTZTd93iK_x_S3fN6Sl-3lMNuFprfZov6jQwxXc8liMlfsFnPZbpUAAAAAAAAAAJYwZ94EAAAA4DSQyWa4WC0X4MFoT_dHNYX1jnM8cdcFm5Pt8szIpLjx4wZyOM3Ot8Npdkv-visDPBjdMW_2TBBrtVrWAAAABNgAAAAB3Lp5CxyL5AA!&cmcv=&pix=undefined&cb=1608036344043&uv=2853&tms=1608036344043&abt=dpr6_vA!expn_vF!heavyc_vA!ntvc_vA!spa2_vB!t45!ufm_vA&ft=0&su=0&unm=WIDGET_ITEM&aure=false&cirid=F9D93BEDAA570573971761728867&excid=e22lLINE_ITEM_ID_WILL_BE_HERE_ON_SERVINGc&tst=1&docw=0&cs=true&cias=1
pragma
no-cache
cache-control
no-cache
upgrade-insecure-requests
1
user-agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
accept
text/html,application/xhtml+xml,application/xml;q=0.9,image/avif,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3;q=0.9
sec-fetch-site
cross-site
sec-fetch-mode
navigate
sec-fetch-dest
iframe
referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
accept-encoding
gzip, deflate, br
accept-language
en-US
cookie
t_gid=81242381-ab73-4352-8bed-9e7099c82ee1-tuct6d23571
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8

Response headers

server
nginx
content-type
text/html;charset=ISO-8859-1
content-encoding
gzip
accept-ranges
bytes
date
Tue, 15 Dec 2020 12:45:44 GMT
via
1.1 varnish
x-served-by
cache-fra19144-FRA
x-cache
MISS
x-cache-hits
0
x-timer
S1608036344.059840,VS0,VE9
vary
Accept-Encoding
sync
am-match.taboola.com/ Frame 0CFB
0
0
Document
General
Full URL
https://am-match.taboola.com/sync?dast=V7FEQCFgODwV-BG--R_QSDwV-BG--R_QUAAAAGBuIHHMYcMTcTFonBYO0Gq91muVvsZovdZDic7YawYcwRczNhkRgM1m6w2m2Ws81iONmtBpvRFDiEZfb7DgrK6ekxuwyiouttsTucZs9BMje5QQ1Np8Pnutfrfr-7yOE0O98Op9mu8dtVX7_m43TZPS7Ty2P0Kyynp8fscisHq8FwsthLWm6Ty_O0PS1vicvusjk9TofZLXiYni676fMW-T2mv-XzlrxsL4fZLjS9zXYAAAAAeAA4kk6F-AEEAIgAAAAAkAAAAACgCKj4txC4AAAAAMAAKBC90ACg5Eigo8sgdPhcL38AADwUgAAADCiQAAyoHZUASCgkngAAAAAAAAAAsPz____HAOjx_8oAXMj19wA8-AA8EBUoFjECAAAAyKVeHTqa1AmVRRUAAEG6FcAVAECAndnbUlwYAADAwNgCPSx-v9lh1_jdLgMAAAAAAAAAMPs_-0cTgpqZSQNKzNRU-wUEAFj7BQQAYFM3AIA3AbigI2jFYLC6AZosZgcAAABw9____68HQibTyDbbeIYLl2Pi3G1MHtfEN3GMPJ7ZZrIZDLZXq2f7rFzhAtjHISyz33dQUE5Pj9llEBVdb4vd4TR7DpK5yX4TthitJpPNcjhbLiaD4Wg4Gu1PADcDnKDhcLDYDRa7xWI4WUxGg-VggQIxmOCEDEebyWq0W-0my-FkNJptJhukaNVqNtoMhqvZZLbbrYaD4XI0QorWLGaTyWI2Wu42g-VkNBhOhkOEwcVkNNkMF2uFxbdZizaryVo4cZncypVvsFxujJOVy7EWvT6m28iyWe0WWxQMKNuL4CKdiBxOs_PtcJrdkr_vIpZoThbpRHbZl0ymkW228QwXLsfEuduYPK6Jb-IYeTyzzWQzGOyLi8loshku1gqLb7MWbVaTtXDiMrmVK99gudwYJyuXYy16fUy3kWWz2i32jdlgONjMNpvdvjEbDAeb2Waz23foDN_V52y0Rbvnjs4y0y6GtpnpoHAZjN7f0SKN3Xozo8ortlhUt2D0N7EK_X6_3-_3-_1-v3djNngMBsPPZTsOP-blWnN6HBSxRHC6SCeil_F0EUskT4t0IhmMPB6Ty7VyzWyzlWE5WE0mzt3EtHDOTLblZDERS5Smi3Si13ycLrvHZXp5jH6F5fT0mF1u5WA1GE4We8nLbXJ5nran5S1x2V02p8fpMLsFD9PTZTd93iK_x_S3fN6Sl-3lMNuFprfZov6jQwxXc8liMlfsFnPZbpUAAAAAAAAAAJYwZ94EAAAA4DSQyWa4WC0X4MFoT_dHNYX1jnM8cdcFm5Pt8szIpLjx4wZyOM3Ot8Npdkv-visDPBjdMW_2TBBrtVrWAAAABNgAAAAB3Lp5CxyL5AA!&excid=22&docw=0&cijs=1&nlb=true
Requested by
Host: vidstat.taboola.com
URL: https://vidstat.taboola.com/lite-unit/2.4.6/UnitWidgetItemDesktop.min.js
Protocol
H2
Security
TLS 1.2, ECDHE_ECDSA, AES_128_GCM
Server
141.226.228.48 , Netherlands, ASN200478 (TABOOLA-AS, IL),
Reverse DNS
Software
nginx /
Resource Hash

Request headers

:method
GET
:authority
am-match.taboola.com
:scheme
https
:path
/sync?dast=V7FEQCFgODwV-BG--R_QSDwV-BG--R_QUAAAAGBuIHHMYcMTcTFonBYO0Gq91muVvsZovdZDic7YawYcwRczNhkRgM1m6w2m2Ws81iONmtBpvRFDiEZfb7DgrK6ekxuwyiouttsTucZs9BMje5QQ1Np8Pnutfrfr-7yOE0O98Op9mu8dtVX7_m43TZPS7Ty2P0Kyynp8fscisHq8FwsthLWm6Ty_O0PS1vicvusjk9TofZLXiYni676fMW-T2mv-XzlrxsL4fZLjS9zXYAAAAAeAA4kk6F-AEEAIgAAAAAkAAAAACgCKj4txC4AAAAAMAAKBC90ACg5Eigo8sgdPhcL38AADwUgAAADCiQAAyoHZUASCgkngAAAAAAAAAAsPz____HAOjx_8oAXMj19wA8-AA8EBUoFjECAAAAyKVeHTqa1AmVRRUAAEG6FcAVAECAndnbUlwYAADAwNgCPSx-v9lh1_jdLgMAAAAAAAAAMPs_-0cTgpqZSQNKzNRU-wUEAFj7BQQAYFM3AIA3AbigI2jFYLC6AZosZgcAAABw9____68HQibTyDbbeIYLl2Pi3G1MHtfEN3GMPJ7ZZrIZDLZXq2f7rFzhAtjHISyz33dQUE5Pj9llEBVdb4vd4TR7DpK5yX4TthitJpPNcjhbLiaD4Wg4Gu1PADcDnKDhcLDYDRa7xWI4WUxGg-VggQIxmOCEDEebyWq0W-0my-FkNJptJhukaNVqNtoMhqvZZLbbrYaD4XI0QorWLGaTyWI2Wu42g-VkNBhOhkOEwcVkNNkMF2uFxbdZizaryVo4cZncypVvsFxujJOVy7EWvT6m28iyWe0WWxQMKNuL4CKdiBxOs_PtcJrdkr_vIpZoThbpRHbZl0ymkW228QwXLsfEuduYPK6Jb-IYeTyzzWQzGOyLi8loshku1gqLb7MWbVaTtXDiMrmVK99gudwYJyuXYy16fUy3kWWz2i32jdlgONjMNpvdvjEbDAeb2Waz23foDN_V52y0Rbvnjs4y0y6GtpnpoHAZjN7f0SKN3Xozo8ortlhUt2D0N7EK_X6_3-_3-_1-v3djNngMBsPPZTsOP-blWnN6HBSxRHC6SCeil_F0EUskT4t0IhmMPB6Ty7VyzWyzlWE5WE0mzt3EtHDOTLblZDERS5Smi3Si13ycLrvHZXp5jH6F5fT0mF1u5WA1GE4We8nLbXJ5nran5S1x2V02p8fpMLsFD9PTZTd93iK_x_S3fN6Sl-3lMNuFprfZov6jQwxXc8liMlfsFnPZbpUAAAAAAAAAAJYwZ94EAAAA4DSQyWa4WC0X4MFoT_dHNYX1jnM8cdcFm5Pt8szIpLjx4wZyOM3Ot8Npdkv-visDPBjdMW_2TBBrtVrWAAAABNgAAAAB3Lp5CxyL5AA!&excid=22&docw=0&cijs=1&nlb=true
pragma
no-cache
cache-control
no-cache
upgrade-insecure-requests
1
user-agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
accept
text/html,application/xhtml+xml,application/xml;q=0.9,image/avif,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3;q=0.9
sec-fetch-site
cross-site
sec-fetch-mode
navigate
sec-fetch-dest
iframe
referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
accept-encoding
gzip, deflate, br
accept-language
en-US
cookie
t_gid=81242381-ab73-4352-8bed-9e7099c82ee1-tuct6d23571
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8

Response headers

server
nginx
date
Tue, 15 Dec 2020 12:45:44 GMT
content-type
text/html;charset=ISO-8859-1
machineid
3403
VideoBidRequestHandlerServlet
wf.taboola.com/
7 KB
5 KB
XHR
General
Full URL
https://wf.taboola.com/VideoBidRequestHandlerServlet?oid=15&width=420&height=236&pubid=169497&tagid=953497&crid=4706985&noaop=3&sortOrderType=0&cb=1608036344051&mimes=5,10,11,12&isvideo=0&plmd=2&mindur=1&maxdur=210&minbr=1&maxbr=10000&st=0&seq=1&pv=1170&pt=-1873020568&tz=60&viewable=true&ddast=V7FEQCFgODwV-BG--R_QSDwV-BG--R_QUAAAAGBuIHHMYcMTcTFonBYO0Gq91muVvsZovdZDic7YawYcwRczNhkRgM1m6w2m2Ws81iONmtBpvRFDiEZfb7DgrK6ekxuwyiouttsTucZs9BMje5QQ1Np8Pnutfrfr-7yOE0O98Op9mu8dtVX7_m43TZPS7Ty2P0Kyynp8fscisHq8FwsthLWm6Ty_O0PS1vicvusjk9TofZLXiYni676fMW-T2mv-XzlrxsL4fZLjS9zXYAAAAAeAA4kk6F-AEEAIgAAAAAkAAAAACgCKj4txC4AAAAAMAAKBC90ACg5Eigo8sgdPhcL38AADwUgAAADCiQAAyoHZUASCgkngAAAAAAAAAAsPz____HAOjx_8oAXMj19wA8-AA8EBUoFjECAAAAyKVeHTqa1AmVRRUAAEG6FcAVAECAndnbUlwYAADAwNgCPSx-v9lh1_jdLgMAAAAAAAAAMPs_-0cTgpqZSQNKzNRU-wUEAFj7BQQAYFM3AIA3AbigI2jFYLC6AZosZgcAAABw9____68HQibTyDbbeIYLl2Pi3G1MHtfEN3GMPJ7ZZrIZDLZXq2f7rFzhAtjHISyz33dQUE5Pj9llEBVdb4vd4TR7DpK5yX4TthitJpPNcjhbLiaD4Wg4Gu1PADcDnKDhcLDYDRa7xWI4WUxGg-VggQIxmOCEDEebyWq0W-0my-FkNJptJhukaNVqNtoMhqvZZLbbrYaD4XI0QorWLGaTyWI2Wu42g-VkNBhOhkOEwcVkNNkMF2uFxbdZizaryVo4cZncypVvsFxujJOVy7EWvT6m28iyWe0WWxQMKNuL4CKdiBxOs_PtcJrdkr_vIpZoThbpRHbZl0ymkW228QwXLsfEuduYPK6Jb-IYeTyzzWQzGOyLi8loshku1gqLb7MWbVaTtXDiMrmVK99gudwYJyuXYy16fUy3kWWz2i32jdlgONjMNpvdvjEbDAeb2Waz23foDN_V52y0Rbvnjs4y0y6GtpnpoHAZjN7f0SKN3Xozo8ortlhUt2D0N7EK_X6_3-_3-_1-v3djNngMBsPPZTsOP-blWnN6HBSxRHC6SCeil_F0EUskT4t0IhmMPB6Ty7VyzWyzlWE5WE0mzt3EtHDOTLblZDERS5Smi3Si13ycLrvHZXp5jH6F5fT0mF1u5WA1GE4We8nLbXJ5nran5S1x2V02p8fpMLsFD9PTZTd93iK_x_S3fN6Sl-3lMNuFprfZov6jQwxXc8liMlfsFnPZbpUAAAAAAAAAAJYwZ94EAAAA4DSQyWa4WC0X4MFoT_dHNYX1jnM8cdcFm5Pt8szIpLjx4wZyOM3Ot8Npdkv-visDPBjdMW_2TBBrtVrWAAAABNgAAAAB3Lp5CxyL5AA!&proto=2,3,5,6&encoded=1&pstn=vforce2&callback=&wfv=1&amp=0&qsz=6&ft=0&pb=0&pagg=1&dtagid=1182345&dpubid=223815&abtst=dpr6_vA!expn_vF!heavyc_vA!ntvc_vA!spa2_vB!t45!ufm_vA&mPre=0.033&cirf=https%3A%2F%2Fwww.dailymail.co.uk&en=1&subu=0&cdb=&gdprApplies=false
Requested by
Host: vidstat.taboola.com
URL: https://vidstat.taboola.com/lite-unit/2.4.6/UnitFeedManagerDesktop.min.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
151.101.13.44 Frankfurt am Main, Germany, ASN54113 (FASTLY, US),
Reverse DNS
Software
nginx /
Resource Hash
fe11e35971cdabf62176ed56487ee3320d1bc0c3c5215b259723ea5c5a62e557

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-type
text/plain

Response headers

date
Tue, 15 Dec 2020 12:45:44 GMT
content-encoding
gzip
access-control-allow-origin
https://www.dailymail.co.uk
machineid
1457
x-cache
MISS
x-cache-hits
0
x-served-by
cache-fra19144-FRA
pragma
no-cache
server
nginx
x-timer
S1608036344.063979,VS0,VE69
vary
Accept-Encoding
content-type
application/json;charset=utf-8
via
1.1 varnish
cache-control
no-cache,must-revalidate,no-store,max-age=0,s-maxage=0
access-control-allow-credentials
true
accept-ranges
bytes
link
<http://taboola-d.openx.net>; rel=preconnect,<http://taboola-d.openx.net>; rel=preconnect
expires
Sat, 26 Jul 1997 05:00:00 GMT
st
am-vid-events.taboola.com/
0
43 B
Image
General
Full URL
https://am-vid-events.taboola.com/st?cijs=convusmp&ttype=45&cisd=convusmp&cipid=8060095&crid=4706985&dast=V7FEQCFgODwV-BG--R_QSDwV-BG--R_QUAAAAGBuIHHMYcMTcTFonBYO0Gq91muVvsZovdZDic7YawYcwRczNhkRgM1m6w2m2Ws81iONmtBpvRFDiEZfb7DgrK6ekxuwyiouttsTucZs9BMje5QQ1Np8Pnutfrfr-7yOE0O98Op9mu8dtVX7_m43TZPS7Ty2P0Kyynp8fscisHq8FwsthLWm6Ty_O0PS1vicvusjk9TofZLXiYni676fMW-T2mv-XzlrxsL4fZLjS9zXYAAAAAeAA4kk6F-AEEAIgAAAAAkAAAAACgCKj4txC4AAAAAMAAKBC90ACg5Eigo8sgdPhcL38AADwUgAAADCiQAAyoHZUASCgkngAAAAAAAAAAsPz____HAOjx_8oAXMj19wA8-AA8EBUoFjECAAAAyKVeHTqa1AmVRRUAAEG6FcAVAECAndnbUlwYAADAwNgCPSx-v9lh1_jdLgMAAAAAAAAAMPs_-0cTgpqZSQNKzNRU-wUEAFj7BQQAYFM3AIA3AbigI2jFYLC6AZosZgcAAABw9____68HQibTyDbbeIYLl2Pi3G1MHtfEN3GMPJ7ZZrIZDLZXq2f7rFzhAtjHISyz33dQUE5Pj9llEBVdb4vd4TR7DpK5yX4TthitJpPNcjhbLiaD4Wg4Gu1PADcDnKDhcLDYDRa7xWI4WUxGg-VggQIxmOCEDEebyWq0W-0my-FkNJptJhukaNVqNtoMhqvZZLbbrYaD4XI0QorWLGaTyWI2Wu42g-VkNBhOhkOEwcVkNNkMF2uFxbdZizaryVo4cZncypVvsFxujJOVy7EWvT6m28iyWe0WWxQMKNuL4CKdiBxOs_PtcJrdkr_vIpZoThbpRHbZl0ymkW228QwXLsfEuduYPK6Jb-IYeTyzzWQzGOyLi8loshku1gqLb7MWbVaTtXDiMrmVK99gudwYJyuXYy16fUy3kWWz2i32jdlgONjMNpvdvjEbDAeb2Waz23foDN_V52y0Rbvnjs4y0y6GtpnpoHAZjN7f0SKN3Xozo8ortlhUt2D0N7EK_X6_3-_3-_1-v3djNngMBsPPZTsOP-blWnN6HBSxRHC6SCeil_F0EUskT4t0IhmMPB6Ty7VyzWyzlWE5WE0mzt3EtHDOTLblZDERS5Smi3Si13ycLrvHZXp5jH6F5fT0mF1u5WA1GE4We8nLbXJ5nran5S1x2V02p8fpMLsFD9PTZTd93iK_x_S3fN6Sl-3lMNuFprfZov6jQwxXc8liMlfsFnPZbpUAAAAAAAAAAJYwZ94EAAAA4DSQyWa4WC0X4MFoT_dHNYX1jnM8cdcFm5Pt8szIpLjx4wZyOM3Ot8Npdkv-visDPBjdMW_2TBBrtVrWAAAABNgAAAAB3Lp5CxyL5AA!&cmcv=&pix=31589837&cb=1608036344043&uv=2853&tms=1608036344043&abt=dpr6_vA!expn_vF!heavyc_vA!ntvc_vA!spa2_vB!t45!ufm_vA&ft=0&su=0&unm=WIDGET_ITEM&debug=pn:!sqg:!torgn:1608036333570.216!ts:1608036344043&mntl=1
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
Protocol
H2
Security
TLS 1.2, ECDHE_ECDSA, AES_128_GCM
Server
141.226.228.48 , Netherlands, ASN200478 (TABOOLA-AS, IL),
Reverse DNS
Software
nginx /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:45:45 GMT
content-length
0
server
nginx
st
imprammp.taboola.com/ Frame 910A
0
0
Document
General
Full URL
https://imprammp.taboola.com/st?cijs=convusmp&ttype=0&cisd=convusmp&cipid=8060095&crid=4901665&dast=V7_-gCFgODwV-BG--R_QSDwV-BG--R_QUAAAAGBvQHHUJZjiY0Em9DIu02o9FyMVkuZsPBZrhb7RZD4BDKcjShkXgbEmm3GY2Wi8lwNdkMVoPFYDKFDWO5TAa1QOTyfE1_w1vE8nxNf8Nb1zS53KCGptPhc93rdb_fXeRwmp1vh9Ns1_jtqq9f83G67B6X6eUx-hWW09NjdrmVg9VgOFnsJS23yeV52p6Wt8Rld9mcHqfD7BY8TE-X3fR5i_we09_yeUtetpfDbBea3mY7AAAAADwAKC2HQPwAAgBEAAAAAEgAAAAAUARU_FsIXAAAAABgABSINmgAUHIk0NFlEDp8rpc_AAAeCkAAAAYUSAAG1I5KACrKbk8AAAAAAAAAAFj-____YwD0-H9lADIO53oAHnwAHogKVosYAQAAAORSrw4dTeqEyqIKAIAg3QrgCgAgwM7sbWkuDAAAYGBsgR4Wv9_ssGv8bpcBAAAAAAAAAJj9n_2jCUHNzKQBJWZqqv0CAgCs_QICALCpGwDAmwBc0BG0YjBY3QBNFrMDAAAAuPv____XAyGTaWSbbTzDhcsxce42Jo9r4ps4Rh7PbDPZDAbbq9WzfVaucAHsqyCW52v6G966psllEB80DMvJIJjfhC1Gq8lksxzOlovJYDgajkb7E8DNACdoOBwsdoPFbrEYThaT0WA5WKBADCY4IcPRZrIa7Va7yXI4GY1mm8kGKVq1mo02g-FqNpntdqvhYLgcjZCiNYvZZLKYjZa7zWA5GQ2Gk-EQYXAxGU02w8VaYfFt1qLNarIWTlwmt3LlGyyXG-Nk5XKsRa-P6TaybFa7xRYFA8r2IrhIJyKH0-x8O5xmt-Tvu4glmpNFOpFd9iWTaWSbbTzDhcsxce42Jo9r4ps4Rh7PbDPZDAb74mIymmyGi7XC4tusRZvVZC2cuExu5co3WC43xsnK5ViLXh_TbWTZrHaLfWM2GA42s81mt2_MBsPBZrbZ7PYdOsN39TkbbdHuuaOzzLSLoW1mOihcBqP3d7RIY7fezKjyii0W1S0Y_U2sQr_f7_f7_X6_3-_dmA0eg8Hwc9mOw495udacHgdFLBGcLtKJ6GU8XcQSydMinQg2I99qttw4jKPFaGSZGRYbz8Y12RiWq81usthMxBKl6SKd6DUfp8vucZleHqNfYTk9PWaXWzlYDYaTxV7ycptcnqftaXlLXHaXzelxOsxuwcP0dNlNn7fI7zH9LZ-35GV7Ocx2oelttqj_6BDD1VyymMwVu8VctlslAAAAAAAAAIAlzJk3AQAAADgNZLIZLlbLBXgw2tP90Q5PnAA419h1weZkuzwzMilu_LiBHE6z8-1wmt2Sv-_KAA9Gd8ybPRPEWq2WNQAAAAE2AABAALdu3gLHIjk!&cmcv=&pix=undefined&cb=1608036344086&uv=2853&tms=1608036344086&abt=dpr6_vA!expn_vF!heavyc_vA!lapams_vA!ntvc_vA!spa2_vB!t45!ufm_vE&ft=0&su=6&unm=FEED_MANAGER&aure=false&agl=1&cirid=B294BFD7CD4734491291680387571&excid=e22lLINE_ITEM_ID_WILL_BE_HERE_ON_SERVINGc&tst=1&docw=0&cs=true&cias=1
Requested by
Host: vidstat.taboola.com
URL: https://vidstat.taboola.com/lite-unit/2.4.6/UnitFeedManagerDesktop.min.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
151.101.13.44 Frankfurt am Main, Germany, ASN54113 (FASTLY, US),
Reverse DNS
Software
nginx /
Resource Hash

Request headers

:method
GET
:authority
imprammp.taboola.com
:scheme
https
:path
/st?cijs=convusmp&ttype=0&cisd=convusmp&cipid=8060095&crid=4901665&dast=V7_-gCFgODwV-BG--R_QSDwV-BG--R_QUAAAAGBvQHHUJZjiY0Em9DIu02o9FyMVkuZsPBZrhb7RZD4BDKcjShkXgbEmm3GY2Wi8lwNdkMVoPFYDKFDWO5TAa1QOTyfE1_w1vE8nxNf8Nb1zS53KCGptPhc93rdb_fXeRwmp1vh9Ns1_jtqq9f83G67B6X6eUx-hWW09NjdrmVg9VgOFnsJS23yeV52p6Wt8Rld9mcHqfD7BY8TE-X3fR5i_we09_yeUtetpfDbBea3mY7AAAAADwAKC2HQPwAAgBEAAAAAEgAAAAAUARU_FsIXAAAAABgABSINmgAUHIk0NFlEDp8rpc_AAAeCkAAAAYUSAAG1I5KACrKbk8AAAAAAAAAAFj-____YwD0-H9lADIO53oAHnwAHogKVosYAQAAAORSrw4dTeqEyqIKAIAg3QrgCgAgwM7sbWkuDAAAYGBsgR4Wv9_ssGv8bpcBAAAAAAAAAJj9n_2jCUHNzKQBJWZqqv0CAgCs_QICALCpGwDAmwBc0BG0YjBY3QBNFrMDAAAAuPv____XAyGTaWSbbTzDhcsxce42Jo9r4ps4Rh7PbDPZDAbbq9WzfVaucAHsqyCW52v6G966psllEB80DMvJIJjfhC1Gq8lksxzOlovJYDgajkb7E8DNACdoOBwsdoPFbrEYThaT0WA5WKBADCY4IcPRZrIa7Va7yXI4GY1mm8kGKVq1mo02g-FqNpntdqvhYLgcjZCiNYvZZLKYjZa7zWA5GQ2Gk-EQYXAxGU02w8VaYfFt1qLNarIWTlwmt3LlGyyXG-Nk5XKsRa-P6TaybFa7xRYFA8r2IrhIJyKH0-x8O5xmt-Tvu4glmpNFOpFd9iWTaWSbbTzDhcsxce42Jo9r4ps4Rh7PbDPZDAb74mIymmyGi7XC4tusRZvVZC2cuExu5co3WC43xsnK5ViLXh_TbWTZrHaLfWM2GA42s81mt2_MBsPBZrbZ7PYdOsN39TkbbdHuuaOzzLSLoW1mOihcBqP3d7RIY7fezKjyii0W1S0Y_U2sQr_f7_f7_X6_3-_dmA0eg8Hwc9mOw495udacHgdFLBGcLtKJ6GU8XcQSydMinQg2I99qttw4jKPFaGSZGRYbz8Y12RiWq81usthMxBKl6SKd6DUfp8vucZleHqNfYTk9PWaXWzlYDYaTxV7ycptcnqftaXlLXHaXzelxOsxuwcP0dNlNn7fI7zH9LZ-35GV7Ocx2oelttqj_6BDD1VyymMwVu8VctlslAAAAAAAAAIAlzJk3AQAAADgNZLIZLlbLBXgw2tP90Q5PnAA419h1weZkuzwzMilu_LiBHE6z8-1wmt2Sv-_KAA9Gd8ybPRPEWq2WNQAAAAE2AABAALdu3gLHIjk!&cmcv=&pix=undefined&cb=1608036344086&uv=2853&tms=1608036344086&abt=dpr6_vA!expn_vF!heavyc_vA!lapams_vA!ntvc_vA!spa2_vB!t45!ufm_vE&ft=0&su=6&unm=FEED_MANAGER&aure=false&agl=1&cirid=B294BFD7CD4734491291680387571&excid=e22lLINE_ITEM_ID_WILL_BE_HERE_ON_SERVINGc&tst=1&docw=0&cs=true&cias=1
pragma
no-cache
cache-control
no-cache
upgrade-insecure-requests
1
user-agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
accept
text/html,application/xhtml+xml,application/xml;q=0.9,image/avif,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3;q=0.9
sec-fetch-site
cross-site
sec-fetch-mode
navigate
sec-fetch-dest
iframe
referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
accept-encoding
gzip, deflate, br
accept-language
en-US
cookie
t_gid=81242381-ab73-4352-8bed-9e7099c82ee1-tuct6d23571
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8

Response headers

server
nginx
content-type
text/html;charset=ISO-8859-1
content-encoding
gzip
accept-ranges
bytes
date
Tue, 15 Dec 2020 12:45:44 GMT
via
1.1 varnish
x-served-by
cache-fra19144-FRA
x-cache
MISS
x-cache-hits
0
x-timer
S1608036344.100189,VS0,VE9
vary
Accept-Encoding
sync
am-match.taboola.com/ Frame 5A5E
0
0
Document
General
Full URL
https://am-match.taboola.com/sync?dast=V7_-gCFgODwV-BG--R_QSDwV-BG--R_QUAAAAGBvQHHUJZjiY0Em9DIu02o9FyMVkuZsPBZrhb7RZD4BDKcjShkXgbEmm3GY2Wi8lwNdkMVoPFYDKFDWO5TAa1QOTyfE1_w1vE8nxNf8Nb1zS53KCGptPhc93rdb_fXeRwmp1vh9Ns1_jtqq9f83G67B6X6eUx-hWW09NjdrmVg9VgOFnsJS23yeV52p6Wt8Rld9mcHqfD7BY8TE-X3fR5i_we09_yeUtetpfDbBea3mY7AAAAADwAKC2HQPwAAgBEAAAAAEgAAAAAUARU_FsIXAAAAABgABSINmgAUHIk0NFlEDp8rpc_AAAeCkAAAAYUSAAG1I5KACrKbk8AAAAAAAAAAFj-____YwD0-H9lADIO53oAHnwAHogKVosYAQAAAORSrw4dTeqEyqIKAIAg3QrgCgAgwM7sbWkuDAAAYGBsgR4Wv9_ssGv8bpcBAAAAAAAAAJj9n_2jCUHNzKQBJWZqqv0CAgCs_QICALCpGwDAmwBc0BG0YjBY3QBNFrMDAAAAuPv____XAyGTaWSbbTzDhcsxce42Jo9r4ps4Rh7PbDPZDAbbq9WzfVaucAHsqyCW52v6G966psllEB80DMvJIJjfhC1Gq8lksxzOlovJYDgajkb7E8DNACdoOBwsdoPFbrEYThaT0WA5WKBADCY4IcPRZrIa7Va7yXI4GY1mm8kGKVq1mo02g-FqNpntdqvhYLgcjZCiNYvZZLKYjZa7zWA5GQ2Gk-EQYXAxGU02w8VaYfFt1qLNarIWTlwmt3LlGyyXG-Nk5XKsRa-P6TaybFa7xRYFA8r2IrhIJyKH0-x8O5xmt-Tvu4glmpNFOpFd9iWTaWSbbTzDhcsxce42Jo9r4ps4Rh7PbDPZDAb74mIymmyGi7XC4tusRZvVZC2cuExu5co3WC43xsnK5ViLXh_TbWTZrHaLfWM2GA42s81mt2_MBsPBZrbZ7PYdOsN39TkbbdHuuaOzzLSLoW1mOihcBqP3d7RIY7fezKjyii0W1S0Y_U2sQr_f7_f7_X6_3-_dmA0eg8Hwc9mOw495udacHgdFLBGcLtKJ6GU8XcQSydMinQg2I99qttw4jKPFaGSZGRYbz8Y12RiWq81usthMxBKl6SKd6DUfp8vucZleHqNfYTk9PWaXWzlYDYaTxV7ycptcnqftaXlLXHaXzelxOsxuwcP0dNlNn7fI7zH9LZ-35GV7Ocx2oelttqj_6BDD1VyymMwVu8VctlslAAAAAAAAAIAlzJk3AQAAADgNZLIZLlbLBXgw2tP90Q5PnAA419h1weZkuzwzMilu_LiBHE6z8-1wmt2Sv-_KAA9Gd8ybPRPEWq2WNQAAAAE2AABAALdu3gLHIjk!&excid=22&docw=0&cijs=1&nlb=true
Requested by
Host: vidstat.taboola.com
URL: https://vidstat.taboola.com/lite-unit/2.4.6/UnitFeedManagerDesktop.min.js
Protocol
H2
Security
TLS 1.2, ECDHE_ECDSA, AES_128_GCM
Server
141.226.228.48 , Netherlands, ASN200478 (TABOOLA-AS, IL),
Reverse DNS
Software
nginx /
Resource Hash

Request headers

:method
GET
:authority
am-match.taboola.com
:scheme
https
:path
/sync?dast=V7_-gCFgODwV-BG--R_QSDwV-BG--R_QUAAAAGBvQHHUJZjiY0Em9DIu02o9FyMVkuZsPBZrhb7RZD4BDKcjShkXgbEmm3GY2Wi8lwNdkMVoPFYDKFDWO5TAa1QOTyfE1_w1vE8nxNf8Nb1zS53KCGptPhc93rdb_fXeRwmp1vh9Ns1_jtqq9f83G67B6X6eUx-hWW09NjdrmVg9VgOFnsJS23yeV52p6Wt8Rld9mcHqfD7BY8TE-X3fR5i_we09_yeUtetpfDbBea3mY7AAAAADwAKC2HQPwAAgBEAAAAAEgAAAAAUARU_FsIXAAAAABgABSINmgAUHIk0NFlEDp8rpc_AAAeCkAAAAYUSAAG1I5KACrKbk8AAAAAAAAAAFj-____YwD0-H9lADIO53oAHnwAHogKVosYAQAAAORSrw4dTeqEyqIKAIAg3QrgCgAgwM7sbWkuDAAAYGBsgR4Wv9_ssGv8bpcBAAAAAAAAAJj9n_2jCUHNzKQBJWZqqv0CAgCs_QICALCpGwDAmwBc0BG0YjBY3QBNFrMDAAAAuPv____XAyGTaWSbbTzDhcsxce42Jo9r4ps4Rh7PbDPZDAbbq9WzfVaucAHsqyCW52v6G966psllEB80DMvJIJjfhC1Gq8lksxzOlovJYDgajkb7E8DNACdoOBwsdoPFbrEYThaT0WA5WKBADCY4IcPRZrIa7Va7yXI4GY1mm8kGKVq1mo02g-FqNpntdqvhYLgcjZCiNYvZZLKYjZa7zWA5GQ2Gk-EQYXAxGU02w8VaYfFt1qLNarIWTlwmt3LlGyyXG-Nk5XKsRa-P6TaybFa7xRYFA8r2IrhIJyKH0-x8O5xmt-Tvu4glmpNFOpFd9iWTaWSbbTzDhcsxce42Jo9r4ps4Rh7PbDPZDAb74mIymmyGi7XC4tusRZvVZC2cuExu5co3WC43xsnK5ViLXh_TbWTZrHaLfWM2GA42s81mt2_MBsPBZrbZ7PYdOsN39TkbbdHuuaOzzLSLoW1mOihcBqP3d7RIY7fezKjyii0W1S0Y_U2sQr_f7_f7_X6_3-_dmA0eg8Hwc9mOw495udacHgdFLBGcLtKJ6GU8XcQSydMinQg2I99qttw4jKPFaGSZGRYbz8Y12RiWq81usthMxBKl6SKd6DUfp8vucZleHqNfYTk9PWaXWzlYDYaTxV7ycptcnqftaXlLXHaXzelxOsxuwcP0dNlNn7fI7zH9LZ-35GV7Ocx2oelttqj_6BDD1VyymMwVu8VctlslAAAAAAAAAIAlzJk3AQAAADgNZLIZLlbLBXgw2tP90Q5PnAA419h1weZkuzwzMilu_LiBHE6z8-1wmt2Sv-_KAA9Gd8ybPRPEWq2WNQAAAAE2AABAALdu3gLHIjk!&excid=22&docw=0&cijs=1&nlb=true
pragma
no-cache
cache-control
no-cache
upgrade-insecure-requests
1
user-agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
accept
text/html,application/xhtml+xml,application/xml;q=0.9,image/avif,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3;q=0.9
sec-fetch-site
cross-site
sec-fetch-mode
navigate
sec-fetch-dest
iframe
referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
accept-encoding
gzip, deflate, br
accept-language
en-US
cookie
t_gid=81242381-ab73-4352-8bed-9e7099c82ee1-tuct6d23571
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8

Response headers

server
nginx
date
Tue, 15 Dec 2020 12:45:44 GMT
content-type
text/html;charset=ISO-8859-1
machineid
3401
st
am-vid-events.taboola.com/
0
43 B
Image
General
Full URL
https://am-vid-events.taboola.com/st?cijs=convusmp&ttype=45&cisd=convusmp&cipid=8060095&crid=4901665&dast=V7_-gCFgODwV-BG--R_QSDwV-BG--R_QUAAAAGBvQHHUJZjiY0Em9DIu02o9FyMVkuZsPBZrhb7RZD4BDKcjShkXgbEmm3GY2Wi8lwNdkMVoPFYDKFDWO5TAa1QOTyfE1_w1vE8nxNf8Nb1zS53KCGptPhc93rdb_fXeRwmp1vh9Ns1_jtqq9f83G67B6X6eUx-hWW09NjdrmVg9VgOFnsJS23yeV52p6Wt8Rld9mcHqfD7BY8TE-X3fR5i_we09_yeUtetpfDbBea3mY7AAAAADwAKC2HQPwAAgBEAAAAAEgAAAAAUARU_FsIXAAAAABgABSINmgAUHIk0NFlEDp8rpc_AAAeCkAAAAYUSAAG1I5KACrKbk8AAAAAAAAAAFj-____YwD0-H9lADIO53oAHnwAHogKVosYAQAAAORSrw4dTeqEyqIKAIAg3QrgCgAgwM7sbWkuDAAAYGBsgR4Wv9_ssGv8bpcBAAAAAAAAAJj9n_2jCUHNzKQBJWZqqv0CAgCs_QICALCpGwDAmwBc0BG0YjBY3QBNFrMDAAAAuPv____XAyGTaWSbbTzDhcsxce42Jo9r4ps4Rh7PbDPZDAbbq9WzfVaucAHsqyCW52v6G966psllEB80DMvJIJjfhC1Gq8lksxzOlovJYDgajkb7E8DNACdoOBwsdoPFbrEYThaT0WA5WKBADCY4IcPRZrIa7Va7yXI4GY1mm8kGKVq1mo02g-FqNpntdqvhYLgcjZCiNYvZZLKYjZa7zWA5GQ2Gk-EQYXAxGU02w8VaYfFt1qLNarIWTlwmt3LlGyyXG-Nk5XKsRa-P6TaybFa7xRYFA8r2IrhIJyKH0-x8O5xmt-Tvu4glmpNFOpFd9iWTaWSbbTzDhcsxce42Jo9r4ps4Rh7PbDPZDAb74mIymmyGi7XC4tusRZvVZC2cuExu5co3WC43xsnK5ViLXh_TbWTZrHaLfWM2GA42s81mt2_MBsPBZrbZ7PYdOsN39TkbbdHuuaOzzLSLoW1mOihcBqP3d7RIY7fezKjyii0W1S0Y_U2sQr_f7_f7_X6_3-_dmA0eg8Hwc9mOw495udacHgdFLBGcLtKJ6GU8XcQSydMinQg2I99qttw4jKPFaGSZGRYbz8Y12RiWq81usthMxBKl6SKd6DUfp8vucZleHqNfYTk9PWaXWzlYDYaTxV7ycptcnqftaXlLXHaXzelxOsxuwcP0dNlNn7fI7zH9LZ-35GV7Ocx2oelttqj_6BDD1VyymMwVu8VctlslAAAAAAAAAIAlzJk3AQAAADgNZLIZLlbLBXgw2tP90Q5PnAA419h1weZkuzwzMilu_LiBHE6z8-1wmt2Sv-_KAA9Gd8ybPRPEWq2WNQAAAAE2AABAALdu3gLHIjk!&cmcv=&pix=31589837&cb=1608036344086&uv=2853&tms=1608036344086&abt=dpr6_vA!expn_vF!heavyc_vA!lapams_vA!ntvc_vA!spa2_vB!t45!ufm_vE&ft=0&su=6&unm=FEED_MANAGER&debug=pn:!sqg:!torgn:1608036333570.216!ts:1608036344086&mntl=1
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
Protocol
H2
Security
TLS 1.2, ECDHE_ECDSA, AES_128_GCM
Server
141.226.228.48 , Netherlands, ASN200478 (TABOOLA-AS, IL),
Reverse DNS
Software
nginx /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:45:45 GMT
content-length
0
server
nginx
cmTagWIDGET_ITEM.js
vidstat.taboola.com/vpaid/units/28_5_3/infra/
710 KB
125 KB
Script
General
Full URL
https://vidstat.taboola.com/vpaid/units/28_5_3/infra/cmTagWIDGET_ITEM.js
Requested by
Host: vidstat.taboola.com
URL: https://vidstat.taboola.com/lite-unit/2.4.6/UnitWidgetItemDesktop.min.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
151.101.13.44 Frankfurt am Main, Germany, ASN54113 (FASTLY, US),
Reverse DNS
Software
AmazonS3-br /
Resource Hash
2f17c77d5bc3e1da8f068bef5af2bd4fe10aebaf829cce8a8dbc9bbe562c7606

Request headers

Origin
https://www.dailymail.co.uk
Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:45:46 GMT
via
1.1 varnish
age
752556
x-amz-meta-mtime
1607281997
x-cache
HIT
x-amz-meta-ctime
1607282123
x-amz-meta-mode
33188
content-encoding
br
content-length
127125
x-amz-id-2
1A5JfQEj0d3tgGGqnGA2caf0ScNoSYiMCpRxkIxVusXKkGgOsWO/GRSPhJgn4nTFvNEZqmlz1wA=
x-served-by
cache-fra19167-FRA
accept-ranges
bytes
last-modified
Sun, 06 Dec 2020 19:15:25 GMT
server
AmazonS3-br
x-timer
S1608036346.158848,VS0,VE0
etag
"58da0f7034e94cfd958908251f759491"
x-amz-meta-uid
0
vary
Accept-Encoding
access-control-allow-methods
GET, OPTIONS, HEAD
x-amz-request-id
4F24FA4BAF485165
access-control-allow-origin
*
cache-control
public, max-age=2592000
x-amz-meta-gid
0
content-type
application/javascript
access-control-allow-headers
*
x-cache-hits
198595
cmOsUnit.css
vidstat.taboola.com/vpaid/units/28_5_3/assets/css/
44 KB
7 KB
Stylesheet
General
Full URL
https://vidstat.taboola.com/vpaid/units/28_5_3/assets/css/cmOsUnit.css
Requested by
Host: vidstat.taboola.com
URL: https://vidstat.taboola.com/lite-unit/2.4.6/UnitWidgetItemDesktop.min.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
151.101.13.44 Frankfurt am Main, Germany, ASN54113 (FASTLY, US),
Reverse DNS
Software
AmazonS3-br /
Resource Hash
98922dfe09c8b58441d75ed77f262ddf02e6f9f30c4e9588239675b6a8e4dd06

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:45:44 GMT
via
1.1 varnish
age
752555
x-amz-meta-mtime
1607281997
x-cache
HIT
x-amz-meta-ctime
1607282075
x-amz-meta-mode
33188
content-encoding
br
content-length
6506
x-amz-id-2
KgQP4qa5f53ssW2Gmq7ZA7EkeyYS0xuAVjP+F+LVuCpseHOVL12OieXr/Q0VUrNOjaXYgV42BmE=
x-served-by
cache-fra19144-FRA
accept-ranges
bytes
last-modified
Sun, 06 Dec 2020 19:14:36 GMT
server
AmazonS3-br
x-timer
S1608036344.188005,VS0,VE0
etag
"b248e7634e81ba7c71725b68c25c3078"
x-amz-meta-uid
0
vary
Accept-Encoding
access-control-allow-methods
GET, OPTIONS, HEAD
x-amz-request-id
3D4C3002BE395C44
access-control-allow-origin
*
cache-control
public, max-age=2592000
x-amz-meta-gid
0
content-type
text/css
access-control-allow-headers
*
x-cache-hits
1018273
7197697
ads.stickyadstv.com/vast/vpaid-adapter/
1 KB
2 KB
XHR
General
Full URL
https://ads.stickyadstv.com/vast/vpaid-adapter/7197697?_fw_gdpr=1&_fw_gdpr_consent=&schain=1.0,1!selectmedia.asia,5e3a966128a06134f417790e,1,,Mail%20Metro%20Media,mailonline.co.uk&_fw_us_privacy=1---&cbb=8036344291
Requested by
Host: player.aniview.com
URL: https://player.aniview.com/script/6.1/AVmanager.js?v=1.0&type=s&pid=5e3a966128a06134f417790e
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
2.18.234.233 , Ascension Island, ASN16625 (AKAMAI-AS, US),
Reverse DNS
a2-18-234-233.deploy.static.akamaitechnologies.com
Software
nginx /
Resource Hash
b06cc30b61d3df065bd5c6438278b4126fc9f692ea2b090c29eca368bb3036d6

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Pragma
no-cache
Date
Tue, 15 Dec 2020 12:45:44 GMT
Server
nginx
Content-Type
application/xml;charset=ISO-8859-1
Access-Control-Allow-Origin
https://www.dailymail.co.uk
Cache-Control
max-age=0, no-cache, no-store
Access-Control-Allow-Credentials
true
Connection
keep-alive
Content-Length
1340
x-sticky-vk
1608036344325054-88
Expires
Tue, 15 Dec 2020 12:45:44 GMT
3pRrSx07Gk8Dl7mNKBWke3eC9D9nIm_aTuVZj2Zo7Wk=
ads.adaptv.advertising.com/a/h/
3 KB
2 KB
XHR
General
Full URL
https://ads.adaptv.advertising.com/a/h/3pRrSx07Gk8Dl7mNKBWke3eC9D9nIm_aTuVZj2Zo7Wk=?cb=8036344293&gdpr=1&gdpr_consent=&pet=preroll&pageUrl=https%3A%2F%2Fwww.dailymail.co.uk%2Fsciencetech%2Farticle-9050821%2FRemdesivir-beneficial-patients-doctors-reveal.html%3F_hsmi%3D88974744%26_hsenc%3Dp2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8&eov=eov&us_privacy=1---&scpid=58fcbed1073ef420086c9d08&scpid=5e3a966128a06134f417790e
Requested by
Host: player.aniview.com
URL: https://player.aniview.com/script/6.1/AVmanager.js?v=1.0&type=s&pid=5e3a966128a06134f417790e
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
52.59.160.25 Frankfurt am Main, Germany, ASN16509 (AMAZON-02, US),
Reverse DNS
ec2-52-59-160-25.eu-central-1.compute.amazonaws.com
Software
adaptv/1.0 /
Resource Hash
bdda249c8369e0e2a368fa1091eb9d16957d2e0b295e220bc9b5542978ac7e4b
Security Headers
Name Value
Strict-Transport-Security max-age=31536000

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

pragma
no-cache
strict-transport-security
max-age=31536000
content-encoding
gzip
server
adaptv/1.0
content-type
text/xml
access-control-allow-origin
https://www.dailymail.co.uk
cache-control
no-cache, no-store, must-revalidate
access-control-allow-credentials
true
Connection
keep-alive
Content-Length
1196
expires
0
avpb3.js
player.aniview.com/script/6.1/ Frame 9E88
241 KB
77 KB
Script
General
Full URL
https://player.aniview.com/script/6.1/avpb3.js
Requested by
Host: player.aniview.com
URL: https://player.aniview.com/script/6.1/AVmanager.js?v=1.0&type=s&pid=5e3a966128a06134f417790e
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
2a02:26f0:10c:48b::2c79 , Ascension Island, ASN20940 (AKAMAI-ASN1, EU),
Reverse DNS
Software
UploadServer /
Resource Hash
50c7f346e0521f5e4990a6442c179ed60970dac8eb4b6f5ae72b855fc9753a2d

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:45:44 GMT
content-encoding
gzip
x-guploader-uploadid
ABg5-UzRygS9q8csKcK67Xz6iKZgrWYSN36ak5NNzIRtCxFXl074kNTqWMoaeG25uR1gqdxBn6_MmvajH1ItfYnD5q4
x-goog-storage-class
MULTI_REGIONAL
x-goog-metageneration
2
x-goog-stored-content-encoding
gzip
content-length
78002
last-modified
Tue, 15 Dec 2020 08:43:24 GMT
server
UploadServer
etag
"ba91ab7edb7b6fabf6704889aaf459a5"
vary
Accept-Encoding
x-goog-hash
crc32c=Vh6Hvw==, md5=upGrftt7b6v2cEiJqvRZpQ==
content-language
en
access-control-allow-origin
*
x-goog-generation
1608021804134933
access-control-expose-headers
Content-Type
cache-control
public, max-age=300
x-goog-stored-content-length
78002
accept-ranges
bytes
content-type
application/javascript
expires
Tue, 15 Dec 2020 12:50:44 GMT
ixmatch.html
js-sec.indexww.com/um/
0
0
Image
General
Full URL
https://js-sec.indexww.com/um/ixmatch.html
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
104.111.215.135 , Netherlands, ASN16625 (AKAMAI-AS, US),
Reverse DNS
a104-111-215-135.deploy.static.akamaitechnologies.com
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

spotx-pixel.js
play.selectmedia.asia/58fcbed1073ef420086c9d08/5f1d77d19f2f1340cb280573/
417 B
417 B
Image
General
Full URL
https://play.selectmedia.asia/58fcbed1073ef420086c9d08/5f1d77d19f2f1340cb280573/spotx-pixel.js
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_256_GCM
Server
2a02:26f0:eb::214:bece , Ascension Island, ASN20940 (AKAMAI-ASN1, EU),
Reverse DNS
Software
UploadServer /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Date
Tue, 15 Dec 2020 12:45:45 GMT
X-GUploader-UploadID
ABg5-UxgvcL3IW6_NIdgpr0rFMqZcB2DV3SqMpQuqF1IvTDiyjJOFJgt2ajZ-xlZ8xTnNPX6fobheMJ0VeVqGSUdHDmZRLXR8A
x-goog-storage-class
MULTI_REGIONAL
x-goog-metageneration
1
x-goog-stored-content-encoding
identity
Connection
keep-alive
Content-Length
417
Last-Modified
Sun, 26 Jul 2020 12:32:25 GMT
Server
UploadServer
ETag
"f70554e00ba53d6687836b60f833456e"
x-goog-hash
crc32c=bH2gjQ==
x-goog-generation
1595766745952958
Access-Control-Allow-Origin
*
Access-Control-Expose-Headers
Content-Type
Cache-Control
public, max-age=1800
x-goog-stored-content-length
417
Accept-Ranges
bytes
Content-Type
text/javascript
Expires
Tue, 15 Dec 2020 13:15:45 GMT
pixel
cm.g.doubleclick.net/
Redirect Chain
  • https://ads.stickyadstv.com/user-matching?id=11
  • https://cm.g.doubleclick.net/pixel?google_nid=stickyxchange_dbm&google_hm=NTVkZGM1MTU2YmFiYTc1MGRhNTQ2MjIzOWJjZDBmZg==&gdpr=0&gdpr_consent=
170 B
224 B
Image
General
Full URL
https://cm.g.doubleclick.net/pixel?google_nid=stickyxchange_dbm&google_hm=NTVkZGM1MTU2YmFiYTc1MGRhNTQ2MjIzOWJjZDBmZg==&gdpr=0&gdpr_consent=
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:816::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
HTTP server (unknown) /
Resource Hash
0b8a20373c6dd04e091902226d922b3688143a8938afb9d283d889de7b55ceb5
Security Headers
Name Value
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

pragma
no-cache
date
Tue, 15 Dec 2020 12:45:46 GMT
server
HTTP server (unknown)
content-type
image/png
cache-control
no-cache, must-revalidate
cross-origin-resource-policy
cross-origin
alt-svc
h3-29="googleads.g.doubleclick.net:443"; ma=2592000,h3-29=":443"; ma=2592000,h3-T051="googleads.g.doubleclick.net:443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic="googleads.g.doubleclick.net:443"; ma=2592000; v="46,43",quic=":443"; ma=2592000; v="46,43"
content-length
170
x-xss-protection
0
expires
Fri, 01 Jan 1990 00:00:00 GMT

Redirect headers

Pragma
no-cache
Date
Tue, 15 Dec 2020 12:45:46 GMT
Server
nginx
Access-Control-Allow-Origin
*
Location
https://cm.g.doubleclick.net/pixel?google_nid=stickyxchange_dbm&google_hm=NTVkZGM1MTU2YmFiYTc1MGRhNTQ2MjIzOWJjZDBmZg==&gdpr=0&gdpr_consent=
Cache-Control
max-age=0, no-cache, no-store
Access-Control-Allow-Credentials
true
Connection
keep-alive
Content-Length
0
x-sticky-vk
1608036346238028-97
Expires
Tue, 15 Dec 2020 12:45:46 GMT
user-registering
ads.stickyadstv.com/
Redirect Chain
  • https://ads.stickyadstv.com/auto-user-sync
  • https://1f2e7.v.fwmrm.net/ad/u?_dv=2&dsp_user_mapping=true&127719=55ddc5156baba750da5462239bcd0ff&rdU=https%3A%2F%2Fads.stickyadstv.com%2Fuser-registering%3FdataProviderId%3D1169%26userId%3d%23%7bu...
  • https://ads.stickyadstv.com/user-registering?dataProviderId=1169&userId=g037_6906463516849950966
  • https://cm.g.doubleclick.net/pixel?google_nid=stickyxchange_dbm&google_cm=&google_sc&google_hm=NTVkZGM1MTU2YmFiYTc1MGRhNTQ2MjIzOWJjZDBmZg==&gdpr=0&gdpr_consent=
  • https://ads.stickyadstv.com/user-registering?dataProviderId=141&userId=CAESEL5FZqyURYBihCEEqGz1o34&google_cver=1&gdpr=0&gdpr_consent=
  • https://sync-tm.everesttech.net/upi/pid/wGbQAlJJ?gdpr=0&gdpr_consent=&redir=https%3A%2F%2Fads.stickyadstv.com%2Fuser-registering%3FdataProviderId%3D187%26userId%3D%24%7BTM_USER_ID%7D&gdpr=0&gdpr_co...
  • https://ads.stickyadstv.com/user-registering?dataProviderId=187&userId=X9iv9wAAAGMUcyrK&gdpr=0&gdpr_consent=
  • https://match.adsrvr.org/track/cmf/generic?ttd_pid=stickyads&ttd_tpi=1&gdpr=0&gdpr_consent=&gdpr=0&gdpr_consent=
  • https://ads.stickyadstv.com/user-registering?dataProviderId=208&userId=c1befdb7-5c1a-4d0f-b053-b3ef508e7ce4
  • https://sync.mathtag.com/sync/img?mt_exid=44&gdpr=0&gdpr_consent=&redir=https%3A%2F%2Fads.stickyadstv.com%2Fuser-registering%3FdataProviderId%3D183%26userId%3D%5BMM_UUID%5D
  • https://ads.stickyadstv.com/user-registering?dataProviderId=183&userId=2b0c5fd8-aff1-4b00-90a2-60308e3c734a&gdpr=0&gdpr_consent=
43 B
731 B
Image
General
Full URL
https://ads.stickyadstv.com/user-registering?dataProviderId=183&userId=2b0c5fd8-aff1-4b00-90a2-60308e3c734a&gdpr=0&gdpr_consent=
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
2.18.234.233 , Ascension Island, ASN16625 (AKAMAI-AS, US),
Reverse DNS
a2-18-234-233.deploy.static.akamaitechnologies.com
Software
nginx /
Resource Hash
a065920df8cc4016d67c3a464be90099c9d28ffe7c9e6ee3a18f257efc58cbd7

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Pragma
no-cache
Date
Tue, 15 Dec 2020 12:45:50 GMT
Server
nginx
Content-Type
image/gif
Access-Control-Allow-Origin
*
Cache-Control
max-age=0, no-cache, no-store
Access-Control-Allow-Credentials
true
Connection
keep-alive
Content-Length
43
x-sticky-vk
1608036350036065-165
Expires
Tue, 15 Dec 2020 12:45:50 GMT

Redirect headers

Date
Tue, 15 Dec 2020 12:45:45 GMT
Server
MT3 3428 4427dd6 master zrh-pixel-x24
P3P
CP="NOI DSP COR NID CURa ADMa DEVa PSAa PSDa OUR BUS COM INT OTC PUR STA"
location
https://ads.stickyadstv.com/user-registering?dataProviderId=183&userId=2b0c5fd8-aff1-4b00-90a2-60308e3c734a&gdpr=0&gdpr_consent=
Cache-Control
no-cache
Connection
keep-alive
Content-Type
image/gif
Keep-Alive
timeout=360
Content-Length
0
Expires
Tue, 15 Dec 2020 12:45:44 GMT
ecm3
s.amazon-adsystem.com/
Redirect Chain
  • https://ads.stickyadstv.com/user-matching?id=2545
  • https://s.amazon-adsystem.com/ecm3?id=55ddc5156baba750da5462239bcd0ff&ex=freewheel.tv&gdpr=0&gdpr_consent=
43 B
344 B
Image
General
Full URL
https://s.amazon-adsystem.com/ecm3?id=55ddc5156baba750da5462239bcd0ff&ex=freewheel.tv&gdpr=0&gdpr_consent=
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
52.94.232.32 Ashburn, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
Server /
Resource Hash
c21e2c1246fe45a6750ae6208db2b5965ff6ed63eb80d2ecec3be9c83813428e

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Pragma
no-cache
Date
Tue, 15 Dec 2020 12:45:46 GMT
Server
Server
Vary
User-Agent
Content-Type
image/gif
Cache-Control
max-age=0, no-cache, no-store, private, must-revalidate, s-maxage=0
Connection
keep-alive
Content-Length
43
Expires
Thu, 01 Jan 1970 00:00:00 GMT

Redirect headers

Pragma
no-cache
Date
Tue, 15 Dec 2020 12:45:46 GMT
Server
nginx
Access-Control-Allow-Origin
*
Location
https://s.amazon-adsystem.com/ecm3?id=55ddc5156baba750da5462239bcd0ff&ex=freewheel.tv&gdpr=0&gdpr_consent=
Cache-Control
max-age=0, no-cache, no-store
Access-Control-Allow-Credentials
true
Connection
keep-alive
Content-Length
0
x-sticky-vk
1608036346287097-73
Expires
Tue, 15 Dec 2020 12:45:46 GMT
track
track1.aniview.com/
0
70 B
Image
General
Full URL
https://track1.aniview.com/track?d=Chrome&cou=NL&cos=OSX&r=www.dailymail.co.uk&rs=www.dailymail.co.uk&sid=25906&t=1608036344&cip=185.212.171.67&sn=&tgt=0&osv=10.14.5&bv=83.0&brn=Chrome&wi=480&he=270&app=&AV_PUBLISHERID=5e3a966128a06134f417790e&test=&aafaid=&proto=https&uid=1608036344228-929692714160-015808-003-004909&imid=fe3cd17e40005b0c3b9a7b5f759fa98d15452790059172315660&cha=0.05&cb=40807090162&d9=1000&AV_WIDTH=480&AV_HEIGHT=270&ppid=5e3a966128a06134f417790e&nid=58fcbed1073ef420086c9d08&pcid=5e3a987528a0611c3444f80c&ncid=5ebbaa0fd5dbd82f9b0f9a69&pasid=5ebbaa68f985a05cae268384&e=request&cb=1608036344296&asid=5e43b72b28a06116af086105%2C5f5f89328761764d2a001b22%2C5c249de6073ef47e0c19572b%2C5fba6118230c015689192ce7%2C5c84e63128a06171521af324%2C5ee79c81c6d2274a5d4a428b%2C5eb677baafa269776667c5a6%2C5eeb836e0cb48833c651eaeb%2C5f46708a766d2d428339c9d3%2C5eb7e6462559631ad84a9a98&ofpr=2%2C2%2C%2C3%2C%2C2%2C3%2C3%2C2.4%2C1.25&fpo=%2C%2C%2C%2C%2C%2C%2C%2C%2C
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
34.197.221.162 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:45:46 GMT
cache-control
max-age=0, no-cache, no-store
content-length
0
cygnus
htlb.casalemedia.com/
24 B
374 B
XHR
General
Full URL
https://htlb.casalemedia.com/cygnus?s=506382&v=8.1&ac=j&sd=1&nf=1&r=%7B%22id%22%3A%22102d09baf1039d%22%2C%22site%22%3A%7B%22page%22%3A%22https%3A%2F%2Fwww.dailymail.co.uk%2Fsciencetech%2Farticle-9050821%2FRemdesivir-beneficial-patients-doctors-reveal.html%3F_hsmi%3D88974744%26_hsenc%3Dp2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8%22%7D%2C%22ext%22%3A%7B%22source%22%3A%22prebid%22%2C%22ixdiag%22%3A%7B%22msd%22%3A0%2C%22msi%22%3A0%7D%7D%2C%22source%22%3A%7B%22ext%22%3A%7B%22schain%22%3A%7B%22ver%22%3A%221.0%22%2C%22nodes%22%3A%5B%7B%22sid%22%3A%225e3a966128a06134f417790e%22%2C%22name%22%3A%22Mail%20Metro%20Media%22%2C%22hp%22%3A1%2C%22domain%22%3A%22mailonline.co.uk%22%2C%22asi%22%3A%22selectmedia.asia%22%7D%5D%2C%22complete%22%3A1%7D%7D%7D%2C%22imp%22%3A%5B%7B%22id%22%3A%222007373f97f9a9%22%2C%22ext%22%3A%7B%22siteID%22%3A%22506382%22%2C%22sid%22%3A%22480x270%22%7D%2C%22bidfloor%22%3A3%2C%22bidfloorcur%22%3A%22USD%22%2C%22video%22%3A%7B%22mimes%22%3A%5B%22video%2Fmp4%22%2C%22video%2Fwebm%22%2C%22application%2Fjavascript%22%5D%2C%22minduration%22%3A1%2C%22maxduration%22%3A120%2C%22api%22%3A%5B2%5D%2C%22protocols%22%3A%5B2%2C3%2C5%2C6%5D%2C%22w%22%3A480%2C%22h%22%3A270%2C%22placement%22%3A1%7D%7D%5D%7D
Requested by
Host: player.aniview.com
URL: https://player.aniview.com/script/6.1/avpb3.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
104.111.215.135 , Netherlands, ASN16625 (AKAMAI-AS, US),
Reverse DNS
a104-111-215-135.deploy.static.akamaitechnologies.com
Software
Apache /
Resource Hash
4cf2b5478af8ee619cdb9eec1a2c5b23a6b26abcef38fbe5a4a6c483afed57e2

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type
text/plain

Response headers

pragma
no-cache
date
Tue, 15 Dec 2020 12:45:44 GMT
content-encoding
gzip
x-ak-initial-geo
CC:[NL], RC:[], CN:[EU], CIP:[185.212.171.67], XFF:[]
server
Apache
vary
Is-Traffic-Invalid,Accept-Encoding
content-type
application/json
access-control-allow-origin
https://www.dailymail.co.uk
x-cs-client-geo
12
cache-control
max-age=0, no-cache, no-store
access-control-allow-credentials
true
content-length
44
x-ak-client-geo
12
expires
Tue, 15 Dec 2020 12:45:44 GMT
translator
hbopenbid.pubmatic.com/
0
63 B
XHR
General
Full URL
https://hbopenbid.pubmatic.com/translator?source=prebid-client
Requested by
Host: player.aniview.com
URL: https://player.aniview.com/script/6.1/avpb3.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
185.64.189.112 , United Kingdom, ASN62713 (AS-PUBMATIC, US),
Reverse DNS
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type
text/plain

Response headers

access-control-allow-origin
https://www.dailymail.co.uk
date
Tue, 15 Dec 2020 12:45:49 GMT
cache-control
no-cache, no-store, must-revalidate
access-control-allow-credentials
true
openrtb
ads.adaptv.advertising.com/rtb/
0
220 B
XHR
General
Full URL
https://ads.adaptv.advertising.com/rtb/openrtb?ext_id=SelectMedia
Requested by
Host: player.aniview.com
URL: https://player.aniview.com/script/6.1/avpb3.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
52.59.160.25 Frankfurt am Main, Germany, ASN16509 (AMAZON-02, US),
Reverse DNS
ec2-52-59-160-25.eu-central-1.compute.amazonaws.com
Software
adaptv/1.0 /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type
text/plain

Response headers

access-control-allow-origin
https://www.dailymail.co.uk
access-control-allow-credentials
true
server
adaptv/1.0
Connection
keep-alive
content-length
0
content-type
application/json
auction
prebid-server.rubiconproject.com/openrtb2/
0
0

prebid
ib.adnxs.com/ut/v3/
139 B
837 B
XHR
General
Full URL
https://ib.adnxs.com/ut/v3/prebid
Requested by
Host: player.aniview.com
URL: https://player.aniview.com/script/6.1/avpb3.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_ECDSA, AES_128_GCM
Server
185.33.221.13 , Netherlands, ASN29990 (ASN-APPNEX, US),
Reverse DNS
729.bm-nginx-loadbalancer.mgmt.ams1.adnexus.net
Software
nginx/1.17.9 /
Resource Hash
e84383153ce6bc4ffc8ac37e070e0c98c83198a81d31d71b4f02d2c5c94e14b5
Security Headers
Name Value
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type
text/plain

Response headers

Pragma
no-cache
Date
Tue, 15 Dec 2020 12:45:44 GMT
X-Proxy-Origin
185.212.171.67; 185.212.171.67; 729.bm-nginx-loadbalancer.mgmt.ams1; *.adnxs.com; 185.33.220.71:80
AN-X-Request-Uuid
c0eebc00-71a2-4c5e-bb65-eb76d28c61cc
Server
nginx/1.17.9
P3P
policyref="http://cdn.adnxs.com/w3c/policy/p3p.xml", CP="NOI DSP COR ADM PSAo PSDo OURo SAMo UNRo OTRo BUS COM NAV DEM STA PRE"
Access-Control-Allow-Origin
https://www.dailymail.co.uk
Cache-Control
no-store, no-cache, private
Access-Control-Allow-Credentials
true
Connection
keep-alive
Content-Type
application/json; charset=utf-8
Content-Length
139
X-XSS-Protection
0
Expires
Sat, 15 Nov 2008 16:00:00 GMT
280591
search.spotxchange.com/openrtb/2.3/dados/
0
1 KB
XHR
General
Full URL
https://search.spotxchange.com/openrtb/2.3/dados/280591
Requested by
Host: player.aniview.com
URL: https://player.aniview.com/script/6.1/avpb3.js
Protocol
HTTP/1.1
Security
TLS 1.2, RSA, AES_256_GCM
Server
185.94.180.124 , Netherlands, ASN35220 (SPOTX-AMS, NL),
Reverse DNS
Software
nginx /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type
text/plain

Response headers

Date
Tue, 15 Dec 2020 12:45:45 GMT
X-SpotX-Timing-Transform
0.000417
X-SpotX-Timing-SpotMarket
0.006535
X-SpotX-Timing-Page-Mux
0.000818
X-SpotX-Timing-Page-Require
0.000298
X-fe
098
Connection
keep-alive
X-SpotX-Timing-Page-Cookie
0.000028
X-SpotX-Timing-Page
0.010827
Pragma
no-cache
X-SpotX-Timing-Page-Context
0.000286
Last-Modified
Tue, 15 Dec 2020 12:45:45 GMT
Server
nginx
Cache-Control
no-cache, must-revalidate, post-check=0, pre-check=0
X-SpotX-Timing-SpotMarket-Primary
0.006535
Access-Control-Allow-Methods
POST, GET, PATCH, DELETE, OPTIONS
Content-Type
application/json
Access-Control-Allow-Origin
https://www.dailymail.co.uk
X-SpotX-Timing-Page-Misc
0.002302
X-SpotX-Timing-Page-Exception
0.000001
X-SpotX-Timing-SpotMarket-Secondary
0.000000
X-SpotX-Timing-Page-URI
0.000142
Access-Control-Allow-Credentials
true
Access-Control-Allow-Headers
Expires
Thu, 01 Jan 1970 00:00:00 GMT
translator
hbopenbid.pubmatic.com/
0
119 B
XHR
General
Full URL
https://hbopenbid.pubmatic.com/translator?source=prebid-client
Requested by
Host: player.aniview.com
URL: https://player.aniview.com/script/6.1/avpb3.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
185.64.189.112 , United Kingdom, ASN62713 (AS-PUBMATIC, US),
Reverse DNS
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type
text/plain

Response headers

access-control-allow-origin
https://www.dailymail.co.uk
date
Tue, 15 Dec 2020 12:45:49 GMT
cache-control
no-cache, no-store, must-revalidate
access-control-allow-credentials
true
avjp
select-d.openx.net/v/1.0/
92 B
282 B
XHR
General
Full URL
https://select-d.openx.net/v/1.0/avjp?ju=https%3A%2F%2Fwww.dailymail.co.uk%2Fsciencetech%2Farticle-9050821%2FRemdesivir-beneficial-patients-doctors-reveal.html%3F_hsmi%3D88974744%26_hsenc%3Dp2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8&ch=UTF-8&res=1600x1200x24&ifr=true&tz=-60&tws=1600x1200&be=1&bc=hb_pb_3.0.3&dddid=f652a775-fd51-42b5-8302-caf889d06d5c&nocache=1608036344356&schain=1.0%2C1!selectmedia.asia%2C5e3a966128a06134f417790e%2C1%2C%2CMail%20Metro%20Media%2Cmailonline.co.uk&openrtb=%7B%22imp%22%3A%5B%7B%22video%22%3A%7B%22mimes%22%3A%5B%22video%2Fx-ms-wmv%22%2C%22video%2Fmp4%22%2C%22application%2Fjavascript%22%5D%2C%22w%22%3A480%2C%22h%22%3A270%7D%7D%5D%2C%22w%22%3A480%2C%22v%22%3A270%7D&auid=541066210&vwd=480&vht=270&vos=101
Requested by
Host: player.aniview.com
URL: https://player.aniview.com/script/6.1/avpb3.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
35.244.159.8 Mountain View, United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
OXGW/16.199.0 /
Resource Hash
004e5faf0bf890f61697daeede9f21826affd1137fb2cb58eaf4719937a04a14

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type
text/plain

Response headers

pragma
no-cache
date
Tue, 15 Dec 2020 12:45:44 GMT
via
1.1 google
server
OXGW/16.199.0
p3p
CP="CUR ADM OUR NOR STA NID"
access-control-allow-origin
https://www.dailymail.co.uk
cache-control
private, max-age=0, no-cache
access-control-allow-credentials
true
content-type
application/json
alt-svc
clear
content-length
92
expires
Mon, 26 Jul 1997 05:00:00 GMT
bandwidth-test-25ko
cdn.stickyadstv.com/mustang/ Frame DE86
0
0

user-registering
ads.stickyadstv.com/
Redirect Chain
  • https://ads.stickyadstv.com/auto-user-sync?gdpr=0&gdpr_consent=null
  • https://sync.mathtag.com/sync/img?mt_exid=44&gdpr=0&gdpr_consent=null&redir=https%3A%2F%2Fads.stickyadstv.com%2Fuser-registering%3FdataProviderId%3D183%26userId%3D%5BMM_UUID%5D&gdpr=0&gdpr_consent=...
  • https://ads.stickyadstv.com/user-registering?dataProviderId=183&userId=2b0c5fd8-aff1-4b00-90a2-60308e3c734a&gdpr=0&gdpr_consent=null
43 B
731 B
Image
General
Full URL
https://ads.stickyadstv.com/user-registering?dataProviderId=183&userId=2b0c5fd8-aff1-4b00-90a2-60308e3c734a&gdpr=0&gdpr_consent=null
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
2.18.234.233 , Ascension Island, ASN16625 (AKAMAI-AS, US),
Reverse DNS
a2-18-234-233.deploy.static.akamaitechnologies.com
Software
nginx /
Resource Hash
a065920df8cc4016d67c3a464be90099c9d28ffe7c9e6ee3a18f257efc58cbd7

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Pragma
no-cache
Date
Tue, 15 Dec 2020 12:45:50 GMT
Server
nginx
Content-Type
image/gif
Access-Control-Allow-Origin
*
Cache-Control
max-age=0, no-cache, no-store
Access-Control-Allow-Credentials
true
Connection
keep-alive
Content-Length
43
x-sticky-vk
1608036350096014-165
Expires
Tue, 15 Dec 2020 12:45:50 GMT

Redirect headers

Date
Tue, 15 Dec 2020 12:45:45 GMT
Server
MT3 3428 4427dd6 master zrh-pixel-x5
P3P
CP="NOI DSP COR NID CURa ADMa DEVa PSAa PSDa OUR BUS COM INT OTC PUR STA"
location
https://ads.stickyadstv.com/user-registering?dataProviderId=183&userId=2b0c5fd8-aff1-4b00-90a2-60308e3c734a&gdpr=0&gdpr_consent=null
Cache-Control
no-cache
Connection
keep-alive
Content-Type
image/gif
Keep-Alive
timeout=360
Content-Length
0
Expires
Tue, 15 Dec 2020 12:45:44 GMT
/
ads.stickyadstv.com/additional-scripts/ Frame DE86
301 B
860 B
XHR
General
Full URL
https://ads.stickyadstv.com/additional-scripts/?zoneId=8796417&loc=https%3A%2F%2Fwww.dailymail.co.uk%2Fsciencetech%2Farticle-9050821%2FRemdesivir-beneficial-patients-doctors-reveal.html%3F_hsmi%3D88974744%26_hsenc%3Dp2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
Requested by
Host: cdn.stickyadstv.com
URL: https://cdn.stickyadstv.com/mustang/vpaid-adapter.min.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
2.18.234.233 , Ascension Island, ASN16625 (AKAMAI-AS, US),
Reverse DNS
a2-18-234-233.deploy.static.akamaitechnologies.com
Software
nginx /
Resource Hash
64a14c1566ed5e882e60ea9d6e3722949c5767823cd23dc1244503991661dc27

Request headers

Accept
application/xml, text/xml
Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Pragma
no-cache
Date
Tue, 15 Dec 2020 12:45:44 GMT
Server
nginx
Access-Control-Allow-Origin
https://www.dailymail.co.uk
Cache-Control
max-age=0, no-cache, no-store
Access-Control-Allow-Credentials
true
Connection
keep-alive
Content-Length
301
x-sticky-vk
1608036344553068-178
Expires
Tue, 15 Dec 2020 12:45:44 GMT
swfIndex.php
ads.stickyadstv.com/www/delivery/ Frame DE86
67 B
723 B
XHR
General
Full URL
https://ads.stickyadstv.com/www/delivery/swfIndex.php?zoneId=8796417&_fw_gdpr=1&_fw_gdpr_consent=&vav=96023693ff8d0756cb8d4f82ed16a03f&vaviv=a57767f4ea98244148bd9e5679ae929e&reqType=AdsSetup&protocolVersion=2.0&mustangVersion=1.11.6.1&focus=true&percentViewable=100&componentId=vpaid-adapter&loc=https%3A%2F%2Fwww.dailymail.co.uk%2Fsciencetech%2Farticle-9050821%2FRemdesivir-beneficial-patients-doctors-reveal.html%3F_hsmi%3D88974744%26_hsenc%3Dp2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8&playerSize=445x250&supportsFlash=false&supportsJavascript=true
Requested by
Host: cdn.stickyadstv.com
URL: https://cdn.stickyadstv.com/mustang/vpaid-adapter.min.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
2.18.234.233 , Ascension Island, ASN16625 (AKAMAI-AS, US),
Reverse DNS
a2-18-234-233.deploy.static.akamaitechnologies.com
Software
nginx /
Resource Hash
291437ea71e62b1c35d4ec5d3c5ad02cfa930343b41b1472fba70243089c8bbe

Request headers

Accept
application/xml, text/xml
Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Pragma
no-cache
Date
Tue, 15 Dec 2020 12:45:44 GMT
Server
nginx
Content-Type
application/xml;charset=UTF-8
Access-Control-Allow-Origin
https://www.dailymail.co.uk
Cache-Control
max-age=0, no-cache, no-store
Access-Control-Allow-Credentials
true
Connection
keep-alive
Content-Length
67
x-sticky-vk
1608036344588031-95
Expires
Tue, 15 Dec 2020 12:45:44 GMT
st
imprammp.taboola.com/ Frame C217
0
0
Document
General
Full URL
https://imprammp.taboola.com/st?cipid=7991117&ttype=0&cirid=80515B1666570536972027914918&cicmp=1337627&cijs=1&dast=V7_scCFgODwV-BG--R_QSDwV-BG--R_QUAAAAGBugHHDhYLVYTxmw2W-0Gq81suVpsZsvBYDYcTaZgsIXP6e5uQ6A-mk6Hz3Wv1_1-d5HDaXa-HU6zXeO3q75-zcfpsntcppfH6FdYTk-P2eVWDlaD4WSxl7TcJpfnaXta3hKX3WVzepwOs1vwMD1ddtPnLfJ7TH_L5y152V4Os11oepv9-6Ln7XQPh8vdaDcazfRFz8vucQ8uCzrjdH3re6XazeyvfEqdv-PI6POJnOPPZDfSWh3Tyzc6Vi-7ltHqo819fObd2vgx7m7VpfWs1PoeJ3Fr2fiOrrOJ8poxFw0i9TDZ8e6MD-tj2B1peypx2XOMWm0xv9H3sjZnS81MOxrnAAAAAPAAQNQSDbHj29AeAQAAACDBM3KtQBFQ8W8hcAEAAACAAUAgFq4BQMmRQEeXQejwuV7-AAB4KAABABhQIAEQSCwsAXC4WzwBAAA4qJN52mb5____jwHIe2-SAaBI27gx6AF48AF4EAIAALgYOiiYUWzi7G4iKkgsYgQAAACQS706dDSpEyqLqv___38rgCsAgAA7s7euxaybk2LWMAAAgIGxBXpY_H6zw67xu132_________2_2fwaAJgQ1M5MGlJipqcYzcq2w9gsIAMD2bgAAbwJwMQdgBwAAAHD3____nwcAAKC1R8n2Wo1nj7LeZ7CFz-nurt-ELUaryWSzHM6Wi8lgOBqORvsTwM0AJ2g4HCx2g8VusRhOFpPRYDlYoEAMJjghw9FmshrtVrvJcjgZjWabyQYpWrWajTaD4Wo2me12q-FguByNkKI1i9lkspiNlrvNYDkZDYaT4RBhcDEZTTbDxVph8W3Wos1qshZOXCa3cuUbLJcb42TlcqxFr4_pNrJsVrvFHh1iuJpLFpO5YreYy3arBAAAAAAAAACwhCnzJgAAAACnQcxmk91uxY03eyaItVotawAAAABu3cgB!&excid=22&tst=1&docw=0&cs=false
Requested by
Host: info.silobreaker.com
URL: https://info.silobreaker.com/e2t/sc2/MmZ-8yjYCXrW6zj2_M6nsGYsW7JzK5Y7LnJnQVd1GcC5Dg2KFdBBbG504
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
151.101.13.44 Frankfurt am Main, Germany, ASN54113 (FASTLY, US),
Reverse DNS
Software
nginx /
Resource Hash

Request headers

:method
GET
:authority
imprammp.taboola.com
:scheme
https
:path
/st?cipid=7991117&ttype=0&cirid=80515B1666570536972027914918&cicmp=1337627&cijs=1&dast=V7_scCFgODwV-BG--R_QSDwV-BG--R_QUAAAAGBugHHDhYLVYTxmw2W-0Gq81suVpsZsvBYDYcTaZgsIXP6e5uQ6A-mk6Hz3Wv1_1-d5HDaXa-HU6zXeO3q75-zcfpsntcppfH6FdYTk-P2eVWDlaD4WSxl7TcJpfnaXta3hKX3WVzepwOs1vwMD1ddtPnLfJ7TH_L5y152V4Os11oepv9-6Ln7XQPh8vdaDcazfRFz8vucQ8uCzrjdH3re6XazeyvfEqdv-PI6POJnOPPZDfSWh3Tyzc6Vi-7ltHqo819fObd2vgx7m7VpfWs1PoeJ3Fr2fiOrrOJ8poxFw0i9TDZ8e6MD-tj2B1peypx2XOMWm0xv9H3sjZnS81MOxrnAAAAAPAAQNQSDbHj29AeAQAAACDBM3KtQBFQ8W8hcAEAAACAAUAgFq4BQMmRQEeXQejwuV7-AAB4KAABABhQIAEQSCwsAXC4WzwBAAA4qJN52mb5____jwHIe2-SAaBI27gx6AF48AF4EAIAALgYOiiYUWzi7G4iKkgsYgQAAACQS706dDSpEyqLqv___38rgCsAgAA7s7euxaybk2LWMAAAgIGxBXpY_H6zw67xu132_________2_2fwaAJgQ1M5MGlJipqcYzcq2w9gsIAMD2bgAAbwJwMQdgBwAAAHD3____nwcAAKC1R8n2Wo1nj7LeZ7CFz-nurt-ELUaryWSzHM6Wi8lgOBqORvsTwM0AJ2g4HCx2g8VusRhOFpPRYDlYoEAMJjghw9FmshrtVrvJcjgZjWabyQYpWrWajTaD4Wo2me12q-FguByNkKI1i9lkspiNlrvNYDkZDYaT4RBhcDEZTTbDxVph8W3Wos1qshZOXCa3cuUbLJcb42TlcqxFr4_pNrJsVrvFHh1iuJpLFpO5YreYy3arBAAAAAAAAACwhCnzJgAAAACnQcxmk91uxY03eyaItVotawAAAABu3cgB!&excid=22&tst=1&docw=0&cs=false
pragma
no-cache
cache-control
no-cache
upgrade-insecure-requests
1
user-agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
accept
text/html,application/xhtml+xml,application/xml;q=0.9,image/avif,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3;q=0.9
sec-fetch-site
cross-site
sec-fetch-mode
navigate
sec-fetch-dest
iframe
referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
accept-encoding
gzip, deflate, br
accept-language
en-US
cookie
t_gid=81242381-ab73-4352-8bed-9e7099c82ee1-tuct6d23571
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8

Response headers

server
nginx
accept-ranges
bytes
date
Tue, 15 Dec 2020 12:45:44 GMT
via
1.1 varnish
x-served-by
cache-fra19144-FRA
x-cache
MISS
x-cache-hits
0
x-timer
S1608036345.605520,VS0,VE9
content-length
0
cmTagCUSTOM.js
vidstat.taboola.com/vpaid/units/28_3_10/infra/
727 KB
132 KB
Script
General
Full URL
https://vidstat.taboola.com/vpaid/units/28_3_10/infra/cmTagCUSTOM.js
Requested by
Host: vidstat.taboola.com
URL: https://vidstat.taboola.com/vpaid/units/27_2_17/creatives/creative_js.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
151.101.13.44 Frankfurt am Main, Germany, ASN54113 (FASTLY, US),
Reverse DNS
Software
AmazonS3-br /
Resource Hash
aa7c984cd510935c132345bc7d579dfcde68742f7b11b599b905310f7164718c

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:45:47 GMT
via
1.1 varnish
age
2335505
x-amz-meta-mtime
1605697226
x-cache
HIT
x-amz-meta-ctime
1605697428
x-amz-meta-mode
33188
content-encoding
br
content-length
135037
x-amz-id-2
pc8siNCq0g215b4hStDeSY16fknGSScFss2BWg8olHGasE2/Z7kJHcy3Apobl0Ck7+Uv6nOA26A=
x-served-by
cache-fra19144-FRA
accept-ranges
bytes
last-modified
Wed, 18 Nov 2020 11:03:50 GMT
server
AmazonS3-br
x-timer
S1608036347.028678,VS0,VE0
etag
"37b0b0415484e88063c945bde767ba70"
x-amz-meta-uid
0
vary
Accept-Encoding
access-control-allow-methods
GET, OPTIONS, HEAD
x-amz-request-id
E524C82DA07B55B8
access-control-allow-origin
*
cache-control
public, max-age=2592000
x-amz-meta-gid
0
content-type
application/javascript
access-control-allow-headers
*
x-cache-hits
14846
cmOsUnit.css
vidstat.taboola.com/vpaid/units/28_3_10/assets/css/
44 KB
7 KB
Stylesheet
General
Full URL
https://vidstat.taboola.com/vpaid/units/28_3_10/assets/css/cmOsUnit.css
Requested by
Host: vidstat.taboola.com
URL: https://vidstat.taboola.com/vpaid/units/27_2_17/creatives/creative_js.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
151.101.13.44 Frankfurt am Main, Germany, ASN54113 (FASTLY, US),
Reverse DNS
Software
AmazonS3-br /
Resource Hash
4e7681cdfb27c5d0457c58c9f0fe26a68bbf6a8dc88defd3c43826adb1fe6ca8

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:45:44 GMT
via
1.1 varnish
age
2335502
x-amz-meta-mtime
1605697226
x-cache
HIT
x-amz-meta-ctime
1605697397
x-amz-meta-mode
33188
content-encoding
br
content-length
6493
x-amz-id-2
eoIzRxCDNy2YAYSEEQPD+wzu1DoUWJxxdU/uhoUpiW6Fb6rwokktv94co4fCySraNLkkh22S5Y8=
x-served-by
cache-fra19144-FRA
accept-ranges
bytes
last-modified
Wed, 18 Nov 2020 11:03:19 GMT
server
AmazonS3-br
x-timer
S1608036345.605740,VS0,VE0
etag
"083925e970a05bed26a70ecbfde9c0ca"
x-amz-meta-uid
0
vary
Accept-Encoding
access-control-allow-methods
GET, OPTIONS, HEAD
x-amz-request-id
1N1KCM8K5R3K4V9G
access-control-allow-origin
*
cache-control
public, max-age=2592000
x-amz-meta-gid
0
content-type
text/css
access-control-allow-headers
*
x-cache-hits
288091
localization.js
cdn.userreport.com/localization/en-GB/
15 KB
6 KB
Script
General
Full URL
https://cdn.userreport.com/localization/en-GB/localization.js
Requested by
Host: cdn.userreport.com
URL: https://cdn.userreport.com/userreport.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2600:9000:21f3:8200:19:d208:7940:93a1 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
AmazonS3 /
Resource Hash
30311a810a74eeb3a0b984b719415e79ddab49902c2fd16fe9ef6811e1b60905

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

x-amz-version-id
68GR.Mw0BLnEBiB5ERb56lxSAYB4_3Di
content-encoding
gzip
last-modified
Wed, 03 Apr 2019 06:50:54 GMT
server
AmazonS3
age
1917
etag
"2f26a24afa8580b4e2e74e504d296b49"
x-cache
Hit from cloudfront
content-type
text/javascript
via
1.1 2b2e2811e641703aebf776da39317b9c.cloudfront.net (CloudFront)
cache-control
max-age=86400
date
Tue, 15 Dec 2020 12:13:51 GMT
x-amz-cf-pop
FRA2-C2
accept-ranges
bytes
content-length
5754
x-amz-cf-id
qrOp581Rr3q31b9Bk0QmVRvXrv3hpGUsjP-TFoPa9YoaDhzcEiJsbQ==
receive
cdw-dcl.userreport.com/gs/
Redirect Chain
  • https://cdw-dcl.userreport.com/gs/init/pixel.gif
  • https://cm.g.doubleclick.net/pixel?google_nid=userreport_ddp&google_cm&google_hm=YWQ2N2M5YjMtOTJlYTBjMjczYmE5LTc0MGI4MGMzZjAzNw==
  • https://cdw-dcl.userreport.com/gs/receive?google_gid=CAESEKyndV6hmDB3vvIQnDg26tg&google_cver=1
35 B
303 B
Image
General
Full URL
https://cdw-dcl.userreport.com/gs/receive?google_gid=CAESEKyndV6hmDB3vvIQnDg26tg&google_cver=1
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
99.84.89.98 Seattle, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-99-84-89-98.muc50.r.cloudfront.net
Software
nginx/1.16.1 /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:45:47 GMT
via
1.1 39ed76664123c3090231ff0882467152.cloudfront.net (CloudFront)
server
nginx/1.16.1
x-amz-cf-pop
MUC50-C1
x-cache
Miss from cloudfront
content-type
image/gif
cache-control
s-maxage=3600, max-age=0
content-length
35
x-amz-cf-id
ci5qtlarj7jJNr_A0DCxFT1GR_DYZYlbxSAIgBvwPzdK_Ikadc8hpw==

Redirect headers

pragma
no-cache
date
Tue, 15 Dec 2020 12:45:47 GMT
server
HTTP server (unknown)
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
location
https://cdw-dcl.userreport.com/gs/receive?google_gid=CAESEKyndV6hmDB3vvIQnDg26tg&google_cver=1
cache-control
no-cache, must-revalidate
cross-origin-resource-policy
cross-origin
content-type
text/html; charset=UTF-8
alt-svc
h3-29="googleads.g.doubleclick.net:443"; ma=2592000,h3-29=":443"; ma=2592000,h3-T051="googleads.g.doubleclick.net:443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic="googleads.g.doubleclick.net:443"; ma=2592000; v="46,43",quic=":443"; ma=2592000; v="46,43"
content-length
295
x-xss-protection
0
expires
Fri, 01 Jan 1990 00:00:00 GMT
adform
audex.userreport.com/sync/put/
Redirect Chain
  • https://dmp.adform.net/serving/cookie/match/?party=1001&cid=20db337f-3fcf-4396-a655-03712671226e
  • https://audex.userreport.com/sync/put/adform?adfusr=6011690696271797576
35 B
306 B
Image
General
Full URL
https://audex.userreport.com/sync/put/adform?adfusr=6011690696271797576
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
99.84.89.98 Seattle, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-99-84-89-98.muc50.r.cloudfront.net
Software
nginx/1.16.1 /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:45:44 GMT
via
1.1 39ed76664123c3090231ff0882467152.cloudfront.net (CloudFront)
server
nginx/1.16.1
x-amz-cf-pop
MUC50-C1
x-cache
Miss from cloudfront
content-type
image/gif
cache-control
s-maxage=79200, max-age=43200
content-length
35
x-amz-cf-id
urH7aWxHBHjzWmsd1T03UvvSr8OpNsNDetxz4vZtZ6NTUsczUvZhNg==

Redirect headers

pragma
no-cache
date
Tue, 15 Dec 2020 12:45:44 GMT
server
nginx
location
https://audex.userreport.com/sync/put/adform?adfusr=6011690696271797576
strict-transport-security
max-age=31536000; includeSubDomains
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate, no-transform
content-length
0
expires
-1
pixel
cm.g.doubleclick.net/
Redirect Chain
  • https://ads.stickyadstv.com/user-matching?id=11&_fw_gdpr=0&_fw_gdpr_consent=
  • https://cm.g.doubleclick.net/pixel?google_nid=stickyxchange_dbm&google_hm=NTVkZGM1MTU2YmFiYTc1MGRhNTQ2MjIzOWJjZDBmZg==&gdpr=0&gdpr_consent=
170 B
190 B
Image
General
Full URL
https://cm.g.doubleclick.net/pixel?google_nid=stickyxchange_dbm&google_hm=NTVkZGM1MTU2YmFiYTc1MGRhNTQ2MjIzOWJjZDBmZg==&gdpr=0&gdpr_consent=
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:816::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
HTTP server (unknown) /
Resource Hash
0b8a20373c6dd04e091902226d922b3688143a8938afb9d283d889de7b55ceb5
Security Headers
Name Value
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

pragma
no-cache
date
Tue, 15 Dec 2020 12:45:47 GMT
server
HTTP server (unknown)
content-type
image/png
cache-control
no-cache, must-revalidate
cross-origin-resource-policy
cross-origin
alt-svc
h3-29="googleads.g.doubleclick.net:443"; ma=2592000,h3-29=":443"; ma=2592000,h3-T051="googleads.g.doubleclick.net:443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic="googleads.g.doubleclick.net:443"; ma=2592000; v="46,43",quic=":443"; ma=2592000; v="46,43"
content-length
170
x-xss-protection
0
expires
Fri, 01 Jan 1990 00:00:00 GMT

Redirect headers

Pragma
no-cache
Date
Tue, 15 Dec 2020 12:45:47 GMT
Server
nginx
Access-Control-Allow-Origin
*
Location
https://cm.g.doubleclick.net/pixel?google_nid=stickyxchange_dbm&google_hm=NTVkZGM1MTU2YmFiYTc1MGRhNTQ2MjIzOWJjZDBmZg==&gdpr=0&gdpr_consent=
Cache-Control
max-age=0, no-cache, no-store
Access-Control-Allow-Credentials
true
Connection
keep-alive
Content-Length
0
x-sticky-vk
1608036347040055-97
Expires
Tue, 15 Dec 2020 12:45:47 GMT
ecm3
s.amazon-adsystem.com/
Redirect Chain
  • https://ads.stickyadstv.com/user-matching?id=2545&_fw_gdpr=0&_fw_gdpr_consent=
  • https://s.amazon-adsystem.com/ecm3?id=55ddc5156baba750da5462239bcd0ff&ex=freewheel.tv&gdpr=0&gdpr_consent=
43 B
344 B
Image
General
Full URL
https://s.amazon-adsystem.com/ecm3?id=55ddc5156baba750da5462239bcd0ff&ex=freewheel.tv&gdpr=0&gdpr_consent=
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
52.94.232.32 Ashburn, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
Server /
Resource Hash
c21e2c1246fe45a6750ae6208db2b5965ff6ed63eb80d2ecec3be9c83813428e

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Pragma
no-cache
Date
Tue, 15 Dec 2020 12:45:47 GMT
Server
Server
Vary
User-Agent
Content-Type
image/gif
Cache-Control
max-age=0, no-cache, no-store, private, must-revalidate, s-maxage=0
Connection
keep-alive
Content-Length
43
Expires
Thu, 01 Jan 1970 00:00:00 GMT

Redirect headers

Pragma
no-cache
Date
Tue, 15 Dec 2020 12:45:47 GMT
Server
nginx
Access-Control-Allow-Origin
*
Location
https://s.amazon-adsystem.com/ecm3?id=55ddc5156baba750da5462239bcd0ff&ex=freewheel.tv&gdpr=0&gdpr_consent=
Cache-Control
max-age=0, no-cache, no-store
Access-Control-Allow-Credentials
true
Connection
keep-alive
Content-Length
0
x-sticky-vk
1608036347206007-96
Expires
Tue, 15 Dec 2020 12:45:47 GMT
auction
prebid.adnxs.com/pbs/v1/openrtb2/
156 B
505 B
XHR
General
Full URL
https://prebid.adnxs.com/pbs/v1/openrtb2/auction
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/static/mol-adverts/demo/mol-22070/19a28e0b/mol-adverts.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
37.252.161.190 , Ascension Island, ASN29990 (ASN-APPNEX, US),
Reverse DNS
prebid.ams1.adnexus.net
Software
nginx/1.19.0 /
Resource Hash
6e782dacbba100e5d70d425d66bc03ad0af5cda9e984c50d0d5f7891bfd6f1f3

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type
text/plain

Response headers

Pragma
no-cache
Date
Tue, 15 Dec 2020 12:45:44 GMT
Server
nginx/1.19.0
Vary
Origin
Content-Type
application/json
Access-Control-Allow-Origin
https://www.dailymail.co.uk
Cache-Control
no-cache, no-store, must-revalidate
Access-Control-Allow-Credentials
true
Connection
keep-alive
Content-Length
156
Expires
0
arj
mailonline-uk-d.openx.net/w/1.0/
172 B
355 B
XHR
General
Full URL
https://mailonline-uk-d.openx.net/w/1.0/arj?ju=https%3A%2F%2Fwww.dailymail.co.uk%2Fsciencetech%2Farticle-9050821%2FRemdesivir-beneficial-patients-doctors-reveal.html%3F_hsmi%3D88974744%26_hsenc%3Dp2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8&ch=UTF-8&res=1600x1200x24&ifr=false&tz=-60&tws=1600x1200&be=1&bc=hb_pb_3.0.3&dddid=d7e4e794-de08-4ff6-ae7d-89f72e97136b&nocache=1608036344684&id5id=ID5-ZHMOqMhJTrldgGJIBsru2iINA62VBTrOOYCHIcZtjg&pubcid=84f1103b-a980-4860-8c6e-1866bcc8525c&ttduuid=c1befdb7-5c1a-4d0f-b053-b3ef508e7ce4&aus=300x250&divIds=mpu_player&auid=541063092
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/static/mol-adverts/demo/mol-22070/19a28e0b/mol-adverts.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
35.244.159.8 Mountain View, United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
OXGW/16.199.0 /
Resource Hash
9916b025c929643d03221c56e876215744d4e252dd274e3997c3aaeeb74d391d

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type
text/plain

Response headers

pragma
no-cache
date
Tue, 15 Dec 2020 12:45:44 GMT
content-encoding
gzip
server
OXGW/16.199.0
vary
Accept, Accept-Encoding
p3p
CP="CUR ADM OUR NOR STA NID"
access-control-allow-origin
https://www.dailymail.co.uk
cache-control
private, max-age=0, no-cache
access-control-allow-credentials
true
content-type
application/json
alt-svc
clear
content-length
163
via
1.1 google
expires
Mon, 26 Jul 1997 05:00:00 GMT
cygnus
htlb.casalemedia.com/
0
0

bidRequest
c2shb.ssp.yahoo.com/
62 B
390 B
XHR
General
Full URL
https://c2shb.ssp.yahoo.com/bidRequest?dcn=8a9691510171713aaede3c85d0ab0026&pos=desktop_mpu_player&cmd=bid&secure=1
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/static/mol-adverts/demo/mol-22070/19a28e0b/mol-adverts.js
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_256_GCM
Server
35.157.246.167 Frankfurt am Main, Germany, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
ATS/7.1.2.128 /
Resource Hash
9eec7af1b9d77828ae24cab804de5111de481edad0a99a9f1d6c7a875f87bf5a

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type
text/plain

Response headers

Date
Tue, 15 Dec 2020 12:45:45 GMT
Server
ATS/7.1.2.128
Age
0
Access-Control-Allow-Methods
POST,GET,HEAD,OPTIONS
Content-Type
application/json;charset=utf-8
Access-Control-Allow-Origin
https://www.dailymail.co.uk
Access-Control-Allow-Credentials
true
Connection
keep-alive
Content-Length
62
cdb
bidder.criteo.com/
123 B
344 B
XHR
General
Full URL
https://bidder.criteo.com/cdb?ptv=100&profileId=185&av=32&wv=4.13.0-mol-1&cb=58953291039
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/static/mol-adverts/demo/mol-22070/19a28e0b/mol-adverts.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
178.250.0.165 , France, ASN44788 (ASN-CRITEO-EUROPE, FR),
Reverse DNS
bidder.par.vip.prod.criteo.com
Software
Finatra /
Resource Hash
94a74bed06c5c29c23a6cccc20d55338fb94dd2a4ff6151ff57205628c0562be

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type
text/plain

Response headers

date
Tue, 15 Dec 2020 12:45:44 GMT
content-encoding
gzip
server
Finatra
vary
Origin
content-type
application/json; charset=utf-8
access-control-allow-origin
https://www.dailymail.co.uk
access-control-allow-credentials
true
timing-allow-origin
*
content-length
133
prebid
ib.adnxs.com/ut/v3/
0
0

fastlane.json
fastlane.rubiconproject.com/a/api/
260 B
2 KB
XHR
General
Full URL
https://fastlane.rubiconproject.com/a/api/fastlane.json?account_id=8625&site_id=124374&zone_id=1694080&size_id=15&tpid_tdid=c1befdb7-5c1a-4d0f-b053-b3ef508e7ce4&eid_pubcid.org=84f1103b-a980-4860-8c6e-1866bcc8525c%5E1&rf=https%3A%2F%2Fwww.dailymail.co.uk%2Fsciencetech%2Farticle-9050821%2FRemdesivir-beneficial-patients-doctors-reveal.html%3F_hsmi%3D88974744%26_hsenc%3Dp2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8&tg_i.area=sciencetech&tk_flint=pbjs_lite_v4.13.0-mol-1&x_source.tid=d7e4e794-de08-4ff6-ae7d-89f72e97136b&p_screen_res=1600x1200&rp_floor=0.01&rp_secure=1&slots=1&rand=0.6650992179046511
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/static/mol-adverts/demo/mol-22070/19a28e0b/mol-adverts.js
Protocol
HTTP/1.1
Security
TLS 1.2, RSA, AES_128_GCM
Server
213.19.162.31 , United Kingdom, ASN3356 (LEVEL3, US),
Reverse DNS
Software
nginx/1.16.0 /
Resource Hash
daa2cf338a4d1a353280f4a05d6d48703383f449e8603c6b22cf78ebd2b5be4f

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type
text/plain

Response headers

Pragma
no-cache
Date
Tue, 15 Dec 2020 12:45:45 GMT
Server
nginx/1.16.0
Vary
Accept-Encoding
P3P
CP="NOI CURa ADMa DEVa TAIa OUR BUS IND UNI COM NAV INT"
Access-Control-Allow-Origin
https://www.dailymail.co.uk
Cache-Control
no-cache, no-store, max-age=0, must-revalidate
Access-Control-Allow-Credentials
true
Connection
keep-alive
Content-Type
application/json
Keep-Alive
timeout=5
Content-Length
260
Expires
Wed, 17 Sep 1975 21:32:10 GMT
bid
c.amazon-adsystem.com/e/dtb/
24 B
374 B
XHR
General
Full URL
https://c.amazon-adsystem.com/e/dtb/bid?src=3065&u=https%3A%2F%2Fwww.dailymail.co.uk%2Fsciencetech%2Farticle-9050821%2FRemdesivir-beneficial-patients-doctors-reveal.html%3F_hsmi%3D88974744%26_hsenc%3Dp2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8&pid=qkqBHoBAnjHbV&cb=17&ws=1600x1200&v=7.58.01&t=2000&slots=%5B%7B%22sd%22%3A%22mpu_player%22%2C%22s%22%3A%5B%22300x250%22%5D%2C%22kv%22%3A%7B%22pubcid%22%3A%223093664108%22%7D%7D%5D&gdprl=%7B%22status%22%3A%22no-cmp%22%7D
Requested by
Host: c.amazon-adsystem.com
URL: https://c.amazon-adsystem.com/aax2/apstag.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
99.84.88.20 Seattle, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-99-84-88-20.muc50.r.cloudfront.net
Software
Server /
Resource Hash
c1059d522f4c639f77427fa309b77d7c5f02e42a44d45e2edc5113394cb51822

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:45:44 GMT
via
1.1 fe36c7f30c8ef2853edecc43f320092c.cloudfront.net (CloudFront)
server
Server
x-amz-cf-pop
MUC50-C1
vary
User-Agent
x-cache
Miss from cloudfront
content-type
text/javascript;charset=UTF-8
access-control-allow-origin
https://www.dailymail.co.uk
access-control-allow-credentials
true
timing-allow-origin
*
content-length
24
x-amz-cf-id
peNMqDLgWeY8pnn8n3AitSdAPEwhdIIvVArPxnpzgiH3IKLe5dHkZw==
2
www.dailymail.co.uk/abe/a9/price/
4 B
704 B
XHR
General
Full URL
https://www.dailymail.co.uk/abe/a9/price/2
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/static/mol-adverts/demo/mol-22070/19a28e0b/mol-adverts.js
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2a02:26f0:6c00:296::11ae , Ascension Island, ASN20940 (AKAMAI-ASN1, EU),
Reverse DNS
Software
AmazonS3 /
Resource Hash
561b2814d3c09e62a92442c946307918f7f63f833c84876c08bd4c406767e53b

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

x-amz-version-id
wDnvhJJXpo3tPt4.QtsManRqQALbFlHY
content-security-policy-report-only
block-all-mixed-content; report-uri https://mol.report-uri.io/r/default/csp/reportOnly
last-modified
Thu, 26 Jul 2018 09:55:16 GMT
server
AmazonS3
x-amz-request-id
2Z4KDQ1N7H5GAG6P
etag
"f7ddd489ab0a82567b241b05971cbdb3"
vary
User-Agent
content-type
text/plain
cache-control
public, max-age=1146249
date
Tue, 15 Dec 2020 12:45:44 GMT
x-amz-replication-status
COMPLETED
server-timing
cdn-cache; desc=HIT, edge; dur=1
accept-ranges
bytes
content-length
4
x-amz-id-2
TQa+V4AfiJ7Bmz5eGVXtXeerNKKqRrPt9yBoXYXtX5TNMag04HicxY48/1EyJyZRcnVJVxDSTyI=
events
bidder.criteo.com/csm/
0
149 B
Other
General
Full URL
https://bidder.criteo.com/csm/events
Requested by
Host: static.criteo.net
URL: https://static.criteo.net/js/ld/publishertag.prebid.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
178.250.0.165 , France, ASN44788 (ASN-CRITEO-EUROPE, FR),
Reverse DNS
bidder.par.vip.prod.criteo.com
Software
Finatra /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type
text/plain;charset=UTF-8

Response headers

access-control-allow-origin
https://www.dailymail.co.uk
date
Tue, 15 Dec 2020 12:45:46 GMT
access-control-allow-credentials
true
server
Finatra
timing-allow-origin
*
vary
Origin
hb_310028_7816.js
player.hb.selectmedia.asia/prebidlink/446676/ Frame C776
314 KB
99 KB
Script
General
Full URL
https://player.hb.selectmedia.asia/prebidlink/446676/hb_310028_7816.js
Requested by
Host: info.silobreaker.com
URL: https://info.silobreaker.com/e2t/sc2/MmZ-8yjYCXrW6zj2_M6nsGYsW7JzK5Y7LnJnQVd1GcC5Dg2KFdBBbG504
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
213.174.135.2 Ashburn, United States, ASN39572 (ADVANCEDHOSTERS-AS, NL),
Reverse DNS
Software
nginx /
Resource Hash
838dd22220890ec10ced23466e87d604e5d45acf5f103aa15634a8d4fa0e158b

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:45:47 GMT
content-encoding
gzip
last-modified
Tue, 15 Dec 2020 09:44:57 GMT
server
nginx
etag
W/"5fd88599-4e934"
content-type
application/javascript; charset=utf-8
access-control-allow-origin
*
cache-control
max-age=3600
expires
Tue, 15 Dec 2020 13:45:47 GMT
gpt.js
securepubads.g.doubleclick.net/tag/js/ Frame C776
54 KB
19 KB
Script
General
Full URL
https://securepubads.g.doubleclick.net/tag/js/gpt.js
Requested by
Host: info.silobreaker.com
URL: https://info.silobreaker.com/e2t/sc2/MmZ-8yjYCXrW6zj2_M6nsGYsW7JzK5Y7LnJnQVd1GcC5Dg2KFdBBbG504
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
172.217.22.2 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
fra16s14-in-f2.1e100.net
Software
sffe /
Resource Hash
d59bb3ed1515ef903ce58fc46f805b9cef3581d3af4d5ba852ae59b2399d68f7
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:45:45 GMT
content-encoding
gzip
x-content-type-options
nosniff
server
sffe
etag
"724 / 680 of 1000 / last-modified: 1608034737"
vary
Accept-Encoding
content-type
text/javascript
cache-control
private, max-age=900, stale-while-revalidate=3600
timing-allow-origin
*
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
18850
x-xss-protection
0
expires
Tue, 15 Dec 2020 12:45:45 GMT
wrapper_hb_310028_7816.js
player.hb.selectmedia.asia/prebidlink/446676/ Frame C776
252 KB
37 KB
Script
General
Full URL
https://player.hb.selectmedia.asia/prebidlink/446676/wrapper_hb_310028_7816.js
Requested by
Host: info.silobreaker.com
URL: https://info.silobreaker.com/e2t/sc2/MmZ-8yjYCXrW6zj2_M6nsGYsW7JzK5Y7LnJnQVd1GcC5Dg2KFdBBbG504
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
213.174.135.2 Ashburn, United States, ASN39572 (ADVANCEDHOSTERS-AS, NL),
Reverse DNS
Software
nginx /
Resource Hash
25d9ab4344e5c1eb4e8def288490bfc867c3be6acbce291dbf61af3fa317fed9

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:45:47 GMT
content-encoding
gzip
last-modified
Tue, 15 Dec 2020 09:44:57 GMT
server
nginx
etag
W/"5fd88599-3efdf"
content-type
application/javascript; charset=utf-8
access-control-allow-origin
*
cache-control
max-age=3600
expires
Tue, 15 Dec 2020 13:45:47 GMT
pubads_impl_2020120801.js
securepubads.g.doubleclick.net/gpt/ Frame C776
274 KB
97 KB
Script
General
Full URL
https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020120801.js
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/tag/js/gpt.js
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
172.217.22.2 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
fra16s14-in-f2.1e100.net
Software
sffe /
Resource Hash
5f02981bfcab6807a15ddfea1babc7cee05cd0f1f59abe712928de44fb6c1f0d
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:45:45 GMT
content-encoding
gzip
x-content-type-options
nosniff
last-modified
Tue, 08 Dec 2020 09:42:29 GMT
server
sffe
vary
Accept-Encoding
content-type
text/javascript
cache-control
private, immutable, max-age=31536000
cross-origin-resource-policy
cross-origin
accept-ranges
bytes
timing-allow-origin
*
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
98829
x-xss-protection
0
expires
Tue, 15 Dec 2020 12:45:45 GMT
/
crta.dailymail.co.uk/
8 B
449 B
Other
General
Full URL
https://crta.dailymail.co.uk/
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/static/mol-adverts/demo/mol-22070/19a28e0b/mol-adverts.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
2a02:26f0:6c00:2be::16c2 , Ascension Island, ASN20940 (AKAMAI-ASN1, EU),
Reverse DNS
Software
http-to-kafka/0.8.10 /
Resource Hash
a00fb0c50741f81bb51d35b4475a4357f8039aabd896a21036bc516839401595

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type
text/plain

Response headers

pragma
no-cache
date
Tue, 15 Dec 2020 12:45:47 GMT
server
http-to-kafka/0.8.10
etag
W/"8-YaBXLEiT7zQxEyDYTILfiL6oPhE"
content-type
text/plain; charset=utf-8
access-control-allow-origin
*
cache-control
max-age=0, no-cache, no-store
access-control-allow-credentials
true
content-length
8
expires
Tue, 15 Dec 2020 12:45:47 GMT
ads
securepubads.g.doubleclick.net/gampad/
51 KB
12 KB
XHR
General
Full URL
https://securepubads.g.doubleclick.net/gampad/ads?gdfp_req=1&pvsid=2639827676159032&correlator=2455119041695441&output=ldjh&impl=fif&adsid=NT&hxva=1&scor=4077711442053471&eid=21069142&vrg=2020120801&guci=1.2.0.0.2.2.0.0&sc=1&sfv=1-0-37&ecs=20201215&iu_parts=5765%2Cdailymail.uk%2Cdm_dmsciencetech_sciencetechart%2Cmpu_player&enc_prev_ius=%2F0%2F1%2F2%2F3&prev_iu_szs=300x250&prev_scp=pos%3Dmpu_player%26adx_channel%3D19%26nobids%3Dfalse%26refreshCount%3D0%26offset%3D0%26amznbid%3D2%26amznsz%3D0x0%26amznp%3D2&eri=4&cust_params=page%3Dart%26article%3D9050821%26area%3Dsciencetech%26subarea%3Dsciencetech%26environment%3Dproduction%26country%3Dde%26abv%3Dmol-22070%252F19a28e0b%26bot%3Dfalse%26random%3D9ceebda3-1911-4085-b4cd-4ef660466486%26impid%3Dc0338c30-9d3e-46d6-8db6-95c14a8ccbca%26browserResolution%3Dmin_1244px%26device%3Dother%26device_features%3D%26articlewithvideo%3Dtrue%26style%3Dwide%26session%3D1%26session_page_ID%3Dnone%26utm_source%3Dnone%26watershed%3Dfalse%26location%3Ddailymail_co_uk%26id5%3Dtrue%26permutive%3D10277%252C31736%252Crts%26puid%3Db77f6280-fced-4776-aef9-89e90021e68b%26ptime%3D1608036337226&cookie=ID%3Dc89640a04ff12e60%3AT%3D1608036337%3AS%3DALNI_MZBiwDRRckHEWK5W7eRS_Ma6FZZ9w&cdm=www.dailymail.co.uk&bc=31&abxe=1&dt=1608036346686&dlt=1608036336099&idt=1063&frm=20&biw=1600&bih=1200&oid=3&adxs=1223&adys=945&adks=3432249630&ucis=g&ifi=16&u_tz=60&u_his=2&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_sd=1&flash=0&url=www.dailymail.co.uk%2Fsciencetech%2Farticle-9050821%2FRemdesivir-beneficial-patients-doctors-reveal.html&loc=https%3A%2F%2Fwww.dailymail.co.uk%2Fsciencetech%2Farticle-9050821%2FRemdesivir-beneficial-patients-doctors-reveal.html%3F_hsmi%3D88974744%26_hsenc%3Dp2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8&vis=1&dmc=8&scr_x=0&scr_y=0&psz=445x-1&msz=445x-1&psts=AGkb-H9awlplzm3R5rYar7qljqzk%2CAGkb-H9awlplzm3R5rYar7qljqzk%2CAGkb-H8Ea__ROWP6iCtuJnTikfDqFvgEhdFS__bGkDqK7myRJiYdigEmc1U3zmUA-HbB_-yknenOJN1ffIdLQkho7xCYGVETkh6MjNNcBQB1GThq%2CAGkb-H_HHgb-ej7WoKrtrUjNTtfeo5G-OKX_xahMmESAuKTirTuTEVkjzEIiEag9li6aJ5kWuHJKepquTmpNYBXMcd801TqJUgY%2CAGkb-H_qks9dOj5iazk8dWvqXenEjE30c6uzBADN2FtppUjCVT_K0cEEZQh7HO-xLYAPnLaig-mi04Qzytr_pVk6JvH9KIMyZ88%2CAGkb-H_kLF1AY5tYs0PgmKkfZxautJ6ScGSg7NxOm3cfdQbwhwWLzXrHO7d42mAct108-47ZZJEFPWJ2EXtkfVrjCQ%2CAGkb-H_sHjbTd8z71RygOesyTGrmB1KCVtwZqlnVJfFtG-Xda2SCul8mNJBeYhCU0gsQOSZQjUS2AEbhgXvRTPqY-A&ga_vid=254203172.1608036337&ga_sid=1608036337&ga_hid=881620343&fws=516&ohw=445&btvi=0&tt_state=W3siaXNzdWVyT3JpZ2luIjoiaHR0cHM6Ly9hZHNlcnZpY2UuZ29vZ2xlLmNvbSIsInN0YXRlIjowfSx7Imlzc3Vlck9yaWdpbiI6Imh0dHBzOi8vYXR0ZXN0YXRpb24uYW5kcm9pZC5jb20iLCJzdGF0ZSI6MH1d
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020120801.js
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
172.217.22.2 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
fra16s14-in-f2.1e100.net
Software
cafe /
Resource Hash
2b7ffaf5a48c1be76de65c6cdf9dbc49e021bb08e9f9fb4fbbfa802a5305e18b
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:45:46 GMT
content-encoding
br
x-content-type-options
nosniff
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
cross-origin-resource-policy
cross-origin
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
11595
x-xss-protection
0
google-lineitem-id
-1
pragma
no-cache
server
cafe
google-creative-id
-1
content-type
text/plain; charset=UTF-8
access-control-allow-origin
https://www.dailymail.co.uk
access-control-expose-headers
x-google-amp-ad-validated-version
cache-control
no-cache, must-revalidate
access-control-allow-credentials
true
timing-allow-origin
*
expires
Fri, 01 Jan 1990 00:00:00 GMT
amp4ads-v0.mjs
cdn.ampproject.org/rtv/012010270040000/ Frame 9371
180 KB
51 KB
Script
General
Full URL
https://cdn.ampproject.org/rtv/012010270040000/amp4ads-v0.mjs
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020120801.js
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:81f::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
b2ab9ac436910017b9a2ca7db0e981bad3638db97f576d713eaa9b302e06c094
Security Headers
Name Value
Content-Security-Policy default-src * blob: data:; script-src blob: https://cdn.ampproject.org/esm/ https://cdn.ampproject.org/lts/ https://cdn.ampproject.org/mp/ https://cdn.ampproject.org/rtv/ https://cdn.ampproject.org/sp/ https://cdn.ampproject.org/sw/ https://cdn.ampproject.org/v0.js https://cdn.ampproject.org/v0.mjs https://cdn.ampproject.org/v0/ https://cdn.ampproject.org/viewer/; object-src 'none'; style-src 'unsafe-inline' https://cdn.ampproject.org/rtv/ https://cdn.materialdesignicons.com https://cloud.typography.com https://fast.fonts.net https://fonts.googleapis.com https://maxcdn.bootstrapcdn.com https://p.typekit.net https://pro.fontawesome.com https://use.fontawesome.com https://use.typekit.net; report-uri https://csp.withgoogle.com/csp/amp
Strict-Transport-Security max-age=31536000; includeSubDomains; preload
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

content-security-policy
default-src * blob: data:; script-src blob: https://cdn.ampproject.org/esm/ https://cdn.ampproject.org/lts/ https://cdn.ampproject.org/mp/ https://cdn.ampproject.org/rtv/ https://cdn.ampproject.org/sp/ https://cdn.ampproject.org/sw/ https://cdn.ampproject.org/v0.js https://cdn.ampproject.org/v0.mjs https://cdn.ampproject.org/v0/ https://cdn.ampproject.org/viewer/; object-src 'none'; style-src 'unsafe-inline' https://cdn.ampproject.org/rtv/ https://cdn.materialdesignicons.com https://cloud.typography.com https://fast.fonts.net https://fonts.googleapis.com https://maxcdn.bootstrapcdn.com https://p.typekit.net https://pro.fontawesome.com https://use.fontawesome.com https://use.typekit.net; report-uri https://csp.withgoogle.com/csp/amp
content-encoding
br
x-content-type-options
nosniff
age
397963
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
51478
x-xss-protection
0
server
sffe
date
Thu, 10 Dec 2020 22:13:03 GMT
strict-transport-security
max-age=31536000; includeSubDomains; preload
content-type
text/javascript
access-control-allow-origin
*
vary
Accept-Encoding
cache-control
public, max-age=31536000
etag
"0305d7d21a7fe4a1"
accept-ranges
bytes
timing-allow-origin
*
expires
Fri, 10 Dec 2021 22:13:03 GMT
amp-ad-exit-0.1.mjs
cdn.ampproject.org/rtv/012010270040000/v0/ Frame 9371
13 KB
5 KB
Script
General
Full URL
https://cdn.ampproject.org/rtv/012010270040000/v0/amp-ad-exit-0.1.mjs
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020120801.js
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:81f::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
ebab910fdc7c7e9e079caa9f7321177b135b2e1542f86ce36937ceb41865086d
Security Headers
Name Value
Content-Security-Policy default-src * blob: data:; script-src blob: https://cdn.ampproject.org/esm/ https://cdn.ampproject.org/lts/ https://cdn.ampproject.org/mp/ https://cdn.ampproject.org/rtv/ https://cdn.ampproject.org/sp/ https://cdn.ampproject.org/sw/ https://cdn.ampproject.org/v0.js https://cdn.ampproject.org/v0.mjs https://cdn.ampproject.org/v0/ https://cdn.ampproject.org/viewer/; object-src 'none'; style-src 'unsafe-inline' https://cdn.ampproject.org/rtv/ https://cdn.materialdesignicons.com https://cloud.typography.com https://fast.fonts.net https://fonts.googleapis.com https://maxcdn.bootstrapcdn.com https://p.typekit.net https://pro.fontawesome.com https://use.fontawesome.com https://use.typekit.net; report-uri https://csp.withgoogle.com/csp/amp
Strict-Transport-Security max-age=31536000; includeSubDomains; preload
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

content-security-policy
default-src * blob: data:; script-src blob: https://cdn.ampproject.org/esm/ https://cdn.ampproject.org/lts/ https://cdn.ampproject.org/mp/ https://cdn.ampproject.org/rtv/ https://cdn.ampproject.org/sp/ https://cdn.ampproject.org/sw/ https://cdn.ampproject.org/v0.js https://cdn.ampproject.org/v0.mjs https://cdn.ampproject.org/v0/ https://cdn.ampproject.org/viewer/; object-src 'none'; style-src 'unsafe-inline' https://cdn.ampproject.org/rtv/ https://cdn.materialdesignicons.com https://cloud.typography.com https://fast.fonts.net https://fonts.googleapis.com https://maxcdn.bootstrapcdn.com https://p.typekit.net https://pro.fontawesome.com https://use.fontawesome.com https://use.typekit.net; report-uri https://csp.withgoogle.com/csp/amp
content-encoding
br
x-content-type-options
nosniff
age
285474
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
4850
x-xss-protection
0
server
sffe
date
Sat, 12 Dec 2020 05:27:52 GMT
strict-transport-security
max-age=31536000; includeSubDomains; preload
content-type
text/javascript
access-control-allow-origin
*
vary
Accept-Encoding
cache-control
public, max-age=31536000
etag
"77bd676d834aaa8d"
accept-ranges
bytes
timing-allow-origin
*
expires
Sun, 12 Dec 2021 05:27:52 GMT
amp-analytics-0.1.mjs
cdn.ampproject.org/rtv/012010270040000/v0/ Frame 9371
90 KB
27 KB
Script
General
Full URL
https://cdn.ampproject.org/rtv/012010270040000/v0/amp-analytics-0.1.mjs
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020120801.js
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:81f::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
477549a4d5fb644cda6bf64af01631b8411022d88e608bbd8e5a06e327b391cb
Security Headers
Name Value
Content-Security-Policy default-src * blob: data:; script-src blob: https://cdn.ampproject.org/esm/ https://cdn.ampproject.org/lts/ https://cdn.ampproject.org/mp/ https://cdn.ampproject.org/rtv/ https://cdn.ampproject.org/sp/ https://cdn.ampproject.org/sw/ https://cdn.ampproject.org/v0.js https://cdn.ampproject.org/v0.mjs https://cdn.ampproject.org/v0/ https://cdn.ampproject.org/viewer/; object-src 'none'; style-src 'unsafe-inline' https://cdn.ampproject.org/rtv/ https://cdn.materialdesignicons.com https://cloud.typography.com https://fast.fonts.net https://fonts.googleapis.com https://maxcdn.bootstrapcdn.com https://p.typekit.net https://pro.fontawesome.com https://use.fontawesome.com https://use.typekit.net; report-uri https://csp.withgoogle.com/csp/amp
Strict-Transport-Security max-age=31536000; includeSubDomains; preload
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

content-security-policy
default-src * blob: data:; script-src blob: https://cdn.ampproject.org/esm/ https://cdn.ampproject.org/lts/ https://cdn.ampproject.org/mp/ https://cdn.ampproject.org/rtv/ https://cdn.ampproject.org/sp/ https://cdn.ampproject.org/sw/ https://cdn.ampproject.org/v0.js https://cdn.ampproject.org/v0.mjs https://cdn.ampproject.org/v0/ https://cdn.ampproject.org/viewer/; object-src 'none'; style-src 'unsafe-inline' https://cdn.ampproject.org/rtv/ https://cdn.materialdesignicons.com https://cloud.typography.com https://fast.fonts.net https://fonts.googleapis.com https://maxcdn.bootstrapcdn.com https://p.typekit.net https://pro.fontawesome.com https://use.fontawesome.com https://use.typekit.net; report-uri https://csp.withgoogle.com/csp/amp
content-encoding
br
x-content-type-options
nosniff
age
475644
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
27668
x-xss-protection
0
server
sffe
date
Thu, 10 Dec 2020 00:38:22 GMT
strict-transport-security
max-age=31536000; includeSubDomains; preload
content-type
text/javascript
access-control-allow-origin
*
vary
Accept-Encoding
cache-control
public, max-age=31536000
etag
"1304c1c0caf7ca3c"
accept-ranges
bytes
timing-allow-origin
*
expires
Fri, 10 Dec 2021 00:38:22 GMT
amp-fit-text-0.1.mjs
cdn.ampproject.org/rtv/012010270040000/v0/ Frame 9371
3 KB
1 KB
Script
General
Full URL
https://cdn.ampproject.org/rtv/012010270040000/v0/amp-fit-text-0.1.mjs
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020120801.js
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:81f::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
a86753d4effe5e607d4eaf03fe37eccb8cac743a528f874f736f4d7f35e094b1
Security Headers
Name Value
Content-Security-Policy default-src * blob: data:; script-src blob: https://cdn.ampproject.org/esm/ https://cdn.ampproject.org/lts/ https://cdn.ampproject.org/mp/ https://cdn.ampproject.org/rtv/ https://cdn.ampproject.org/sp/ https://cdn.ampproject.org/sw/ https://cdn.ampproject.org/v0.js https://cdn.ampproject.org/v0.mjs https://cdn.ampproject.org/v0/ https://cdn.ampproject.org/viewer/; object-src 'none'; style-src 'unsafe-inline' https://cdn.ampproject.org/rtv/ https://cdn.materialdesignicons.com https://cloud.typography.com https://fast.fonts.net https://fonts.googleapis.com https://maxcdn.bootstrapcdn.com https://p.typekit.net https://pro.fontawesome.com https://use.fontawesome.com https://use.typekit.net; report-uri https://csp.withgoogle.com/csp/amp
Strict-Transport-Security max-age=31536000; includeSubDomains; preload
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

content-security-policy
default-src * blob: data:; script-src blob: https://cdn.ampproject.org/esm/ https://cdn.ampproject.org/lts/ https://cdn.ampproject.org/mp/ https://cdn.ampproject.org/rtv/ https://cdn.ampproject.org/sp/ https://cdn.ampproject.org/sw/ https://cdn.ampproject.org/v0.js https://cdn.ampproject.org/v0.mjs https://cdn.ampproject.org/v0/ https://cdn.ampproject.org/viewer/; object-src 'none'; style-src 'unsafe-inline' https://cdn.ampproject.org/rtv/ https://cdn.materialdesignicons.com https://cloud.typography.com https://fast.fonts.net https://fonts.googleapis.com https://maxcdn.bootstrapcdn.com https://p.typekit.net https://pro.fontawesome.com https://use.fontawesome.com https://use.typekit.net; report-uri https://csp.withgoogle.com/csp/amp
content-encoding
br
x-content-type-options
nosniff
age
355566
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
1350
x-xss-protection
0
server
sffe
date
Fri, 11 Dec 2020 09:59:40 GMT
strict-transport-security
max-age=31536000; includeSubDomains; preload
content-type
text/javascript
access-control-allow-origin
*
vary
Accept-Encoding
cache-control
public, max-age=31536000
etag
"12c034eb739190af"
accept-ranges
bytes
timing-allow-origin
*
expires
Sat, 11 Dec 2021 09:59:40 GMT
amp-form-0.1.mjs
cdn.ampproject.org/rtv/012010270040000/v0/ Frame 9371
41 KB
13 KB
Script
General
Full URL
https://cdn.ampproject.org/rtv/012010270040000/v0/amp-form-0.1.mjs
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020120801.js
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:81f::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
b61eb57ae77f31b91b04781da33023ecd897fda21f6c817e6c27623204046f42
Security Headers
Name Value
Content-Security-Policy default-src * blob: data:; script-src blob: https://cdn.ampproject.org/esm/ https://cdn.ampproject.org/lts/ https://cdn.ampproject.org/mp/ https://cdn.ampproject.org/rtv/ https://cdn.ampproject.org/sp/ https://cdn.ampproject.org/sw/ https://cdn.ampproject.org/v0.js https://cdn.ampproject.org/v0.mjs https://cdn.ampproject.org/v0/ https://cdn.ampproject.org/viewer/; object-src 'none'; style-src 'unsafe-inline' https://cdn.ampproject.org/rtv/ https://cdn.materialdesignicons.com https://cloud.typography.com https://fast.fonts.net https://fonts.googleapis.com https://maxcdn.bootstrapcdn.com https://p.typekit.net https://pro.fontawesome.com https://use.fontawesome.com https://use.typekit.net; report-uri https://csp.withgoogle.com/csp/amp
Strict-Transport-Security max-age=31536000; includeSubDomains; preload
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

content-security-policy
default-src * blob: data:; script-src blob: https://cdn.ampproject.org/esm/ https://cdn.ampproject.org/lts/ https://cdn.ampproject.org/mp/ https://cdn.ampproject.org/rtv/ https://cdn.ampproject.org/sp/ https://cdn.ampproject.org/sw/ https://cdn.ampproject.org/v0.js https://cdn.ampproject.org/v0.mjs https://cdn.ampproject.org/v0/ https://cdn.ampproject.org/viewer/; object-src 'none'; style-src 'unsafe-inline' https://cdn.ampproject.org/rtv/ https://cdn.materialdesignicons.com https://cloud.typography.com https://fast.fonts.net https://fonts.googleapis.com https://maxcdn.bootstrapcdn.com https://p.typekit.net https://pro.fontawesome.com https://use.fontawesome.com https://use.typekit.net; report-uri https://csp.withgoogle.com/csp/amp
content-encoding
br
x-content-type-options
nosniff
age
353678
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
13075
x-xss-protection
0
server
sffe
date
Fri, 11 Dec 2020 10:31:08 GMT
strict-transport-security
max-age=31536000; includeSubDomains; preload
content-type
text/javascript
access-control-allow-origin
*
vary
Accept-Encoding
cache-control
public, max-age=31536000
etag
"1e8a1dae72af56cd"
accept-ranges
bytes
timing-allow-origin
*
expires
Sat, 11 Dec 2021 10:31:08 GMT
css
fonts.googleapis.com/ Frame 9371
4 KB
697 B
Stylesheet
General
Full URL
https://fonts.googleapis.com/css?family=Roboto:400,500&lang=nl
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020120801.js
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:802::200a Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
ESF /
Resource Hash
2190c16423c2557bcb20ccba2edc176fbeb16e6a3de2b2af297f650aae85a43e
Security Headers
Name Value
Strict-Transport-Security max-age=31536000
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

strict-transport-security
max-age=31536000
content-encoding
gzip
x-content-type-options
nosniff
cross-origin-resource-policy
cross-origin
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
x-xss-protection
0
last-modified
Tue, 15 Dec 2020 12:31:16 GMT
server
ESF
date
Tue, 15 Dec 2020 12:45:46 GMT
x-frame-options
SAMEORIGIN
content-type
text/css; charset=utf-8
access-control-allow-origin
*
cache-control
private, max-age=86400, stale-while-revalidate=604800
timing-allow-origin
*
link
<https://fonts.gstatic.com>; rel=preconnect; crossorigin
expires
Tue, 15 Dec 2020 12:45:46 GMT
css
fonts.googleapis.com/ Frame 9371
4 KB
651 B
Stylesheet
General
Full URL
https://fonts.googleapis.com/css?family=Roboto:400,500&text=
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020120801.js
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:802::200a Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
ESF /
Resource Hash
2190c16423c2557bcb20ccba2edc176fbeb16e6a3de2b2af297f650aae85a43e
Security Headers
Name Value
Strict-Transport-Security max-age=31536000
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

strict-transport-security
max-age=31536000
content-encoding
gzip
x-content-type-options
nosniff
cross-origin-resource-policy
cross-origin
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
x-xss-protection
0
last-modified
Tue, 15 Dec 2020 11:57:12 GMT
server
ESF
date
Tue, 15 Dec 2020 12:45:46 GMT
x-frame-options
SAMEORIGIN
content-type
text/css; charset=utf-8
access-control-allow-origin
*
cache-control
private, max-age=86400, stale-while-revalidate=604800
timing-allow-origin
*
link
<https://fonts.gstatic.com>; rel=preconnect; crossorigin
expires
Tue, 15 Dec 2020 12:45:46 GMT
downsize_200k_v1
tpc.googlesyndication.com/simgad/16735864853205177106/ Frame 9371
22 KB
22 KB
Image
General
Full URL
https://tpc.googlesyndication.com/simgad/16735864853205177106/downsize_200k_v1?sqp=4sqPyQSLAUKIAQgAEhQNzczMPhUAAABAHQAAAAAlAAAAABgAIgoNAACAPxUAAIA_Kk8IWhABHQAAtEIgASgBMAY4A0CAwtcvSABQAFgAYFpwAngAgAEAiAEAkAEAnQEAAIA_oAEAqAEAsAGAreIEuAH___________8BxQEtsp0-Mg8I2AQQ2AQYASABLQAAAD8&rs=AOga4qlj8veMEcMgJyJ3scP2ZNcBrbNI7w
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020120801.js
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:81d::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
1ae244e4b84167176433c6c5f10f51d0176ac0d43823bfc8202e22459b2d8df8
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 06:57:47 GMT
x-content-type-options
nosniff
last-modified
Tue, 24 Nov 2020 12:43:22 GMT
server
sffe
age
20879
content-type
image/png
access-control-allow-origin
*
cache-control
public, max-age=31536000
cross-origin-resource-policy
cross-origin
accept-ranges
bytes
timing-allow-origin
*
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
22631
x-xss-protection
0
expires
Wed, 15 Dec 2021 06:57:47 GMT
en.png
tpc.googlesyndication.com/pagead/images/adchoices/ Frame 9371
2 KB
3 KB
Image
General
Full URL
https://tpc.googlesyndication.com/pagead/images/adchoices/en.png
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020120801.js
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:81d::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
36133ca07927c88a7cc578fddbaed3c668ab75087834d0ca13dca5de4ec856c1
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

timing-allow-origin
*
date
Mon, 14 Dec 2020 23:34:27 GMT
x-content-type-options
nosniff
server
cafe
age
47479
etag
14819457070020093239
vary
Accept-Encoding
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
cache-control
public, max-age=86400
cross-origin-resource-policy
cross-origin
content-type
image/png
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
2502
x-xss-protection
0
expires
Tue, 15 Dec 2020 23:34:27 GMT
icon.png
tpc.googlesyndication.com/pagead/images/adchoices/ Frame 9371
295 B
389 B
Image
General
Full URL
https://tpc.googlesyndication.com/pagead/images/adchoices/icon.png
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020120801.js
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:81d::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
7fd59024b6ca83f11f7a3448ec148309a13b705725716df134f699e60a96eb1b
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

timing-allow-origin
*
date
Mon, 14 Dec 2020 21:53:21 GMT
x-content-type-options
nosniff
server
cafe
age
53545
etag
426692510519060060
vary
Accept-Encoding
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
cache-control
public, max-age=86400
cross-origin-resource-policy
cross-origin
content-type
image/png
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
295
x-xss-protection
0
expires
Tue, 15 Dec 2020 21:53:21 GMT
truncated
/ Frame 9371
212 B
0
Image
General
Full URL
data:truncated
Protocol
DATA
Server
-, , ASN (),
Reverse DNS
Software
/
Resource Hash
aa14d0e5f539867c8ebf10e346ad6499ad9c5920e28e56e502d928b10b5e5e4e

Request headers

Referer
https://www.dailymail.co.uk/
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Content-Type
image/png
downsize_200k_v1
tpc.googlesyndication.com/simgad/13224001414154803839/ Frame 9371
15 KB
15 KB
Image
General
Full URL
https://tpc.googlesyndication.com/simgad/13224001414154803839/downsize_200k_v1?sqp=4sqPyQSWAUKTAQgAEhQNzczMPhUAAABAHQAAAAAlAAAAABgAIgoNAACAPxUAAIA_Kk8IWhABHQAAtEIgASgBMAY4A0CAwtcvSABQAFgAYFpwAngAgAEAiAEAkAEAnQEAAIA_oAEAqAEAsAGAreIEuAH___________8BxQEtsp0-MhoIrAIQnQEYASABLQAAAD8wrAI4nQFFAACAPw&rs=AOga4qkt9RI759ZRR_3PqgwSxk4SQxFjag
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:81d::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
cb59294f2a3511eaff185bbef693f51e5e78ae1558ac5ae8a4380dcded8686b8
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:45:47 GMT
x-content-type-options
nosniff
last-modified
Tue, 24 Nov 2020 12:36:40 GMT
server
sffe
content-type
image/jpeg
access-control-allow-origin
*
cache-control
public, max-age=31536000
cross-origin-resource-policy
cross-origin
accept-ranges
bytes
timing-allow-origin
*
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
15672
x-xss-protection
0
expires
Wed, 15 Dec 2021 12:45:47 GMT
adview
securepubads.g.doubleclick.net/pagead/ Frame 9371
0
0
Image
General
Full URL
https://securepubads.g.doubleclick.net/pagead/adview?ai=CFJ4Q-q_YX8C0LdaN7gO00LWACaKo-KZgzOyKvrMMmJL4h7MCEAEgrNm4ImCRhJOF_BegAbe4t9kDyAEGqQIf2EjV3l60PuACAKgDAcgDCqoExwJP0D29q6RGqB8NVy17eg4RIlzedBinaMhYW53oJAWmtUKJ6DPmzQt2CZ25JZd0eDUMCXaJJO6RBDqZ8Q0vwWsC68DWTfkEJa9Xbv3Fi-DYPo3AsrPu44R6beJFYhsDg3yf4450HeXfwTPhrLY_z26ea5UvF2YxneAXCSXDnA7v-7UzlpKv0vfHY8UO8AQ_YKpsxmugzC-q9EJyE3ffczB-xvOj435-VzXjp7P_NY68McdX0UKz7XREvG4QCQKfqKhoaJVWfXgVD7NOllrNEq7-pIO4k-MtDi0zeIZVN9aAeyXSxkIsrP6mSbOSR6XcQr_KsC6hwWAwwruPouexXvWSDGqjT03_56aBcMxF4iO5aOK5dMXHEQbn3xYnf9cZWJK4on0P7h-Ar5HJrLATOM4mY9-OvMPAfEaNIVFNbhQYboijM_SxWqfABKTU_6e7A-AEAaAGN4AHscfIJqgH1ckbqAfw2RuoB_LZG6gHlJixAqgHpd8bqAeOzhuoB5PYG6gHugaoB-6WsQKoB6a-G6gH7NUb2AcB8gcEEN-PC9IICQiA4YAQEAEYHYAKA8gLAdgTA4gUAdAVAYAXAbIXGgoYCAESFHB1Yi00MTgwODM1Njk0MTY2MjU1&sigh=mIWiBRdFkhM&template_id=492&tpd=AGWhJmuWV3WEZV6C0jcqxHddJtClQFefdJmhS8U54sUROE3UAw
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
172.217.22.2 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
fra16s14-in-f2.1e100.net
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
https://www.dailymail.co.uk/
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

l
www.google.com/ads/measurement/ Frame 9371
0
0
Image
General
Full URL
https://www.google.com/ads/measurement/l?ebcid=ALh7CaQFqTc9RjmsXhR5GcAYCXRK2Q3BUSjEwPDKtcoCwn1m3Gl3oGsvraEavQEXSyDoEg_kjqsKIT2YTPDOPbZB2VQkMPmfcw
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:817::2004 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
https://www.dailymail.co.uk/
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

view
securepubads.g.doubleclick.net/pcs/ Frame 16BB
0
22 B
Image
General
Full URL
https://securepubads.g.doubleclick.net/pcs/view?xai=AKAOjssighSnsalzulE_ThtpvxwKYdXJtDhUIxcmjOZw4hThsn0t8qq3g6P3YNIrBaz-_S1Odj7CNvxxuaER1A8P9ORY_35tUjr1DKWmdz19g1JVQiDZXv1tPKtEGbIqSfEHLwTM6iC3voTDYA0z_teEqAQFfMbBEbwKvo_P_0I5TqzFTFgh31G_LGN65aLcdTXm5NQ3p6VxlWIB4sr0oqlFtoQYEvq_USl-s_7GjKWE8ayk-KjPfe_i38-s_pphanzm3M7FxbpS8rU77JE__kLXufrVZ2w1LTzQ5O1SUJXYIs1Vr3Avv75Miud-pXwcBeqGzrYqllLACuBXbefnmXo&sai=AMfl-YQOJqEH1lfE1_Y7_lZG03ukS87IZ5-S8L8m9_oPenwG8768aWPzMDZ6NgtF1JKtdXPJJStaepVlyInJZaJzllmOuP_ftLRCFzt5XMghYWxy5SIvkuYXJJcQOLQ6R1E&sig=Cg0ArKJSzPlf3JErqVInEAE&urlfix=1&adurl=
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
172.217.22.2 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
fra16s14-in-f2.1e100.net
Software
cafe /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

timing-allow-origin
*
date
Tue, 15 Dec 2020 12:45:47 GMT
x-content-type-options
nosniff
server
cafe
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
access-control-allow-origin
*
cache-control
private
cross-origin-resource-policy
cross-origin
content-type
image/gif
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
0
x-xss-protection
0
KFOmCnqEu92Fr1Mu4mxKKTU1Kg.woff2
fonts.gstatic.com/s/roboto/v20/ Frame 9371
11 KB
11 KB
Font
General
Full URL
https://fonts.gstatic.com/s/roboto/v20/KFOmCnqEu92Fr1Mu4mxKKTU1Kg.woff2
Requested by
Host: fonts.googleapis.com
URL: https://fonts.googleapis.com/css?family=Roboto:400,500&lang=nl
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:825::2003 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
5d1bc9b443f3f81fa4b4ad4634c1bb9702194c1898e3a9de0ab5e2cdc0e9f479
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Origin
https://www.dailymail.co.uk
Referer
https://fonts.googleapis.com/css?family=Roboto:400,500&lang=nl
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 08 Dec 2020 17:20:25 GMT
x-content-type-options
nosniff
last-modified
Wed, 24 Jul 2019 01:18:50 GMT
server
sffe
age
588322
content-type
font/woff2
access-control-allow-origin
*
cache-control
public, max-age=31536000
accept-ranges
bytes
timing-allow-origin
*
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
11016
x-xss-protection
0
expires
Wed, 08 Dec 2021 17:20:25 GMT
KFOlCnqEu92Fr1MmEU9fBBc4AMP6lQ.woff2
fonts.gstatic.com/s/roboto/v20/ Frame 9371
11 KB
11 KB
Font
General
Full URL
https://fonts.gstatic.com/s/roboto/v20/KFOlCnqEu92Fr1MmEU9fBBc4AMP6lQ.woff2
Requested by
Host: fonts.googleapis.com
URL: https://fonts.googleapis.com/css?family=Roboto:400,500&lang=nl
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:825::2003 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
ce897833ac6e362df7c91ac8223fe511c6defcf33964928a81004600a2dd4c2e
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Origin
https://www.dailymail.co.uk
Referer
https://fonts.googleapis.com/css?family=Roboto:400,500&lang=nl
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Mon, 14 Dec 2020 22:21:20 GMT
x-content-type-options
nosniff
last-modified
Wed, 24 Jul 2019 01:18:48 GMT
server
sffe
age
51867
content-type
font/woff2
access-control-allow-origin
*
cache-control
public, max-age=31536000
accept-ranges
bytes
timing-allow-origin
*
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
11056
x-xss-protection
0
expires
Tue, 14 Dec 2021 22:21:20 GMT
PMS.js
vidstat.taboola.com/PMS/2.2.1/
51 KB
16 KB
Script
General
Full URL
https://vidstat.taboola.com/PMS/2.2.1/PMS.js
Requested by
Host: vidstat.taboola.com
URL: https://vidstat.taboola.com/vpaid/units/28_3_10/infra/cmTagCUSTOM.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
151.101.13.44 Frankfurt am Main, Germany, ASN54113 (FASTLY, US),
Reverse DNS
Software
AmazonS3 /
Resource Hash
a9e402d2d19f1057cdea09b2152d8cfd35664182564595e19bb83916c1f00201

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:45:47 GMT
via
1.1 fdb19a60fef99ccf6faacc3588fcd922.cloudfront.net (CloudFront), 1.1 varnish
age
1828894
x-amz-meta-mtime
1542789750
x-cache
Miss from cloudfront, HIT
x-amz-meta-mode
33188
content-encoding
gzip
content-length
15795
x-served-by
cache-fra19144-FRA
last-modified
Wed, 21 Nov 2018 08:42:31 GMT
server
AmazonS3
x-timer
S1608036347.230637,VS0,VE0
etag
"57a7ebef371550a9ab54a2f0f82547af"
x-amz-meta-uid
0
vary
Accept-Encoding
access-control-allow-methods
GET, OPTIONS, HEAD
x-amz-meta-gid
0
access-control-allow-origin
*
cache-control
public, max-age=2592000
x-amz-cf-pop
FRA54
accept-ranges
bytes
content-type
application/javascript
access-control-allow-headers
*
x-amz-cf-id
V7kH1ThKPP2LD_fu2xrbkdFfAzbjrlgwNURJZzCnWgHJhBJkwvGG2A==
x-cache-hits
1048608
downsize_200k_v1
tpc.googlesyndication.com/simgad/16735864853205177106/ Frame 9371
22 KB
22 KB
Image
General
Full URL
https://tpc.googlesyndication.com/simgad/16735864853205177106/downsize_200k_v1?sqp=4sqPyQSLAUKIAQgAEhQNzczMPhUAAABAHQAAAAAlAAAAABgAIgoNAACAPxUAAIA_Kk8IWhABHQAAtEIgASgBMAY4A0CAwtcvSABQAFgAYFpwAngAgAEAiAEAkAEAnQEAAIA_oAEAqAEAsAGAreIEuAH___________8BxQEtsp0-Mg8I2AQQ2AQYASABLQAAAD8&rs=AOga4qlj8veMEcMgJyJ3scP2ZNcBrbNI7w
Requested by
Host: cdn.ampproject.org
URL: https://cdn.ampproject.org/rtv/012010270040000/amp4ads-v0.mjs
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:81d::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
1ae244e4b84167176433c6c5f10f51d0176ac0d43823bfc8202e22459b2d8df8
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 06:57:47 GMT
x-content-type-options
nosniff
last-modified
Tue, 24 Nov 2020 12:43:22 GMT
server
sffe
age
20880
content-type
image/png
access-control-allow-origin
*
cache-control
public, max-age=31536000
cross-origin-resource-policy
cross-origin
accept-ranges
bytes
timing-allow-origin
*
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
22631
x-xss-protection
0
expires
Wed, 15 Dec 2021 06:57:47 GMT
downsize_200k_v1
tpc.googlesyndication.com/simgad/13224001414154803839/ Frame 9371
15 KB
15 KB
Image
General
Full URL
https://tpc.googlesyndication.com/simgad/13224001414154803839/downsize_200k_v1?sqp=4sqPyQSWAUKTAQgAEhQNzczMPhUAAABAHQAAAAAlAAAAABgAIgoNAACAPxUAAIA_Kk8IWhABHQAAtEIgASgBMAY4A0CAwtcvSABQAFgAYFpwAngAgAEAiAEAkAEAnQEAAIA_oAEAqAEAsAGAreIEuAH___________8BxQEtsp0-MhoIrAIQnQEYASABLQAAAD8wrAI4nQFFAACAPw&rs=AOga4qkt9RI759ZRR_3PqgwSxk4SQxFjag
Requested by
Host: cdn.ampproject.org
URL: https://cdn.ampproject.org/rtv/012010270040000/amp4ads-v0.mjs
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:81d::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
cb59294f2a3511eaff185bbef693f51e5e78ae1558ac5ae8a4380dcded8686b8
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:45:47 GMT
x-content-type-options
nosniff
last-modified
Tue, 24 Nov 2020 12:36:40 GMT
server
sffe
age
0
content-type
image/jpeg
access-control-allow-origin
*
cache-control
public, max-age=31536000
cross-origin-resource-policy
cross-origin
accept-ranges
bytes
timing-allow-origin
*
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
15672
x-xss-protection
0
expires
Wed, 15 Dec 2021 12:45:47 GMT
en.png
tpc.googlesyndication.com/pagead/images/adchoices/ Frame 9371
2 KB
2 KB
Image
General
Full URL
https://tpc.googlesyndication.com/pagead/images/adchoices/en.png
Requested by
Host: cdn.ampproject.org
URL: https://cdn.ampproject.org/rtv/012010270040000/amp4ads-v0.mjs
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:81d::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
36133ca07927c88a7cc578fddbaed3c668ab75087834d0ca13dca5de4ec856c1
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

timing-allow-origin
*
date
Mon, 14 Dec 2020 23:34:27 GMT
x-content-type-options
nosniff
server
cafe
age
47480
etag
14819457070020093239
vary
Accept-Encoding
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
cache-control
public, max-age=86400
cross-origin-resource-policy
cross-origin
content-type
image/png
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
2502
x-xss-protection
0
expires
Tue, 15 Dec 2020 23:34:27 GMT
icon.png
tpc.googlesyndication.com/pagead/images/adchoices/ Frame 9371
295 B
325 B
Image
General
Full URL
https://tpc.googlesyndication.com/pagead/images/adchoices/icon.png
Requested by
Host: cdn.ampproject.org
URL: https://cdn.ampproject.org/rtv/012010270040000/amp4ads-v0.mjs
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:81d::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
7fd59024b6ca83f11f7a3448ec148309a13b705725716df134f699e60a96eb1b
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

timing-allow-origin
*
date
Mon, 14 Dec 2020 21:53:21 GMT
x-content-type-options
nosniff
server
cafe
age
53546
etag
426692510519060060
vary
Accept-Encoding
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
cache-control
public, max-age=86400
cross-origin-resource-policy
cross-origin
content-type
image/png
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
295
x-xss-protection
0
expires
Tue, 15 Dec 2020 21:53:21 GMT
csi
csi.gstatic.com/ Frame 9371
0
318 B
Other
General
Full URL
https://csi.gstatic.com/csi?s=ampad&ctx=2&puid=1~1608036347253&qqid=CMCZ75mC0O0CFdaGewodNGgNkA&rt=any.link.4.x.o.7.0.0.13z8.13py~any.script.4.k.7.b.0.0.3ro.3qq~any.script.5.y.k.c.0.0.lfc.lck~any.script.5.l.6.d.0.0.12g.11i~any.script.5.t.a.i.0.0.a45.a37~any.link.6.v.a.j.0.0.jd.gq~any.link.6.w.8.m.0.0.i3.gq~any.img.7.e.5.8.0.0.hjv.hgn~any.img.8.g.7.8.0.0.23a.1xi~any.img.8.g.7.8.0.0.at.87~any.img.b.2e.0.23.0.0.c62.c3c~any.img.b.1c.1o.0.0.0.0.0~any.img.c.16.1h.0.0.0.0.0~any.css.1l.8.1.6.0.0.8iu.8i0~any.css.1l.9.1.7.0.0.8jx.8j4~any.img.6t.7.1.6.0.0.hhh.hgn~any.img.6t.a.1.8.0.0.c43.c3c~any.img.6u.9.2.6.0.0.1yc.1xi~any.img.6u.8.1.7.0.0.91.87&met.a4a=dcl.1~ol.111~nvs.1608036346975~ini.1608036347254
Requested by
Host: cdn.ampproject.org
URL: https://cdn.ampproject.org/rtv/012010270040000/v0/amp-analytics-0.1.mjs
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4017:806::2003 , Ireland, ASN15169 (GOOGLE, US),
Reverse DNS
Software
Golfe2 /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
https://www.dailymail.co.uk/
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type
text/plain;charset=UTF-8

Response headers

pragma
no-cache
date
Tue, 15 Dec 2020 12:45:47 GMT
last-modified
Wed, 21 Jan 2004 19:51:30 GMT
server
Golfe2
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cross-origin-resource-policy
cross-origin
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
0
expires
Fri, 01 Jan 1990 00:00:00 GMT
b111bb10-cdc2-40fb-8116-a67ed872abd9
https://www.dailymail.co.uk/
1 KB
0
Media
General
Full URL
blob:https://www.dailymail.co.uk/b111bb10-cdc2-40fb-8116-a67ed872abd9
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
Protocol
BLOB
Server
-, , ASN (),
Reverse DNS
Software
/
Resource Hash
60ddc774c7b5fd0c01d169321a444da403d60c0042f6bee01b0c96f6e1535fda

Request headers

Referer
Accept-Encoding
identity;q=1, *;q=0
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Range
bytes=0-

Response headers

Content-Range
bytes 0-1492/1493
Content-Length
1493
Content-Type
video/mp4
43386364-1e50-4a6d-a101-f2819b7ee34c
https://www.dailymail.co.uk/
1 KB
0
Media
General
Full URL
blob:https://www.dailymail.co.uk/43386364-1e50-4a6d-a101-f2819b7ee34c
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
Protocol
BLOB
Server
-, , ASN (),
Reverse DNS
Software
/
Resource Hash
60ddc774c7b5fd0c01d169321a444da403d60c0042f6bee01b0c96f6e1535fda

Request headers

Referer
Accept-Encoding
identity;q=1, *;q=0
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Range
bytes=0-

Response headers

Content-Range
bytes 0-1492/1493
Content-Length
1493
Content-Type
video/mp4
jvgblwzncdo04h4dxahs.mp4
c3.taboola.com/libtrc/static/video/t_PERFORMANCE_VIDEO_DEFAULT/v1600355107/
249 KB
250 KB
Media
General
Full URL
https://c3.taboola.com/libtrc/static/video/t_PERFORMANCE_VIDEO_DEFAULT/v1600355107/jvgblwzncdo04h4dxahs.mp4
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
151.101.13.44 Frankfurt am Main, Germany, ASN54113 (FASTLY, US),
Reverse DNS
Software
AmazonS3 /
Resource Hash
c3c854b28f23996cbf155a883308d4604c09fb3331c5779d8659819ccfb6f40a

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
Accept-Encoding
identity;q=1, *;q=0
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Range
bytes=0-

Response headers

x-amz-version-id
TtR9OFNZAmJQCx8tVICw1btSL7Ivls2s
via
1.1 varnish
etag
"a6734e7423d565595522c7ac23c71038"
age
31
x-cache
HIT
Content-Range
bytes 0-255119/255120
x-amz-replication-status
COMPLETED
Content-Length
255120
x-amz-id-2
X4EQBPjuerDnckhiGB3cfYwGWV4vVkj7UYxrscidNcFXMeOzf2O97PeZBNa2SJC0RVPDQJXj+Io=
x-served-by
cache-fra19144-FRA
last-modified
Thu, 17 Sep 2020 15:05:16 GMT
server
AmazonS3
x-timer
S1608036347.391928,VS0,VE1
date
Tue, 15 Dec 2020 12:45:47 GMT
x-amz-request-id
7F90401627CB69C9
cache-control
private,max-age=31536000
accept-ranges
bytes
content-type
video/mp4;codecs=avc1
abp
94
x-cache-hits
0
/
hb.hb.selectmedia.asia/geo/ Frame C776
135 B
390 B
XHR
General
Full URL
https://hb.hb.selectmedia.asia/geo/
Requested by
Host: player.hb.selectmedia.asia
URL: https://player.hb.selectmedia.asia/prebidlink/446676/wrapper_hb_310028_7816.js
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_128_GCM
Server
23.227.137.155 Piscataway, United States, ASN55081 (24SHELLS, US),
Reverse DNS
Software
VertaMedia 1.0 /
Resource Hash
4a3df85d55116474794fc40635dd72ae4741f508ae198441039846d507b9016d

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Access-Control-Allow-Origin
https://www.dailymail.co.uk
Date
Tue, 15 Dec 2020 12:45:47 GMT
Access-Control-Allow-Credentials
true
Server
VertaMedia 1.0
Connection
Keep-Alive
Content-Length
135
Content-Type
application/json
tracking
hb.hb.selectmedia.asia/adunit/ Frame C776
43 B
425 B
XHR
General
Full URL
https://hb.hb.selectmedia.asia/adunit/tracking?event=11&type=0&client_id=310028&site_id=7816&full_page_url=https%3A%2F%2Fwww.dailymail.co.uk&adid=pzbmjy.ce&vpbv=0699&lifecycle_tte=3675
Requested by
Host: player.hb.selectmedia.asia
URL: https://player.hb.selectmedia.asia/prebidlink/446676/wrapper_hb_310028_7816.js
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_128_GCM
Server
23.227.137.155 Piscataway, United States, ASN55081 (24SHELLS, US),
Reverse DNS
Software
VertaMedia 1.0 /
Resource Hash
2dfe28cbdb83f01c940de6a88ab86200154fd772d568035ac568664e52068363

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Access-Control-Allow-Origin
https://www.dailymail.co.uk
Date
Tue, 15 Dec 2020 12:45:47 GMT
Access-Control-Allow-Credentials
true
Server
VertaMedia 1.0
Connection
Keep-Alive
Content-Length
43
Content-Type
image/gif
config.json
player.adtelligent.com/exchange_rates/305666/ Frame C776
26 KB
12 KB
XHR
General
Full URL
https://player.adtelligent.com/exchange_rates/305666/config.json?cb=https%3A%2F%2Fwww.dailymail.co.uk
Requested by
Host: player.hb.selectmedia.asia
URL: https://player.hb.selectmedia.asia/prebidlink/446676/hb_310028_7816.js
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
213.174.135.2 Ashburn, United States, ASN39572 (ADVANCEDHOSTERS-AS, NL),
Reverse DNS
Software
nginx /
Resource Hash
07922d6ee25f39bb9548a4efad40d22ac0b0fab3e37cda0e9eb83b2430c0a916

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type
text/plain

Response headers

date
Tue, 15 Dec 2020 12:45:47 GMT
content-encoding
gzip
last-modified
Tue, 15 Dec 2020 12:01:32 GMT
server
nginx
etag
W/"5fd8a59c-692c"
content-type
application/json
access-control-allow-origin
https://www.dailymail.co.uk
expires
Tue, 15 Dec 2020 13:45:47 GMT
cache-control
max-age=3600
x-proxy-cache
HIT
auction
prebid.adnxs.com/pbs/v1/openrtb2/
166 B
515 B
XHR
General
Full URL
https://prebid.adnxs.com/pbs/v1/openrtb2/auction
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/static/mol-adverts/demo/mol-22070/19a28e0b/mol-adverts.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
37.252.161.190 , Ascension Island, ASN29990 (ASN-APPNEX, US),
Reverse DNS
prebid.ams1.adnexus.net
Software
nginx/1.19.0 /
Resource Hash
22153ffa212dadf8a5d8504f9d7d4d3bf4844c49e00e488881d6c4ac6ee82864

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type
text/plain

Response headers

Pragma
no-cache
Date
Tue, 15 Dec 2020 12:45:49 GMT
Server
nginx/1.19.0
Vary
Origin
Content-Type
application/json
Access-Control-Allow-Origin
https://www.dailymail.co.uk
Cache-Control
no-cache, no-store, must-revalidate
Access-Control-Allow-Credentials
true
Connection
keep-alive
Content-Length
166
Expires
0
cygnus
htlb.casalemedia.com/
26 B
376 B
XHR
General
Full URL
https://htlb.casalemedia.com/cygnus?s=193648&v=7.2&r=%7B%22id%22%3A%222362e8693440d2f2%22%2C%22imp%22%3A%5B%7B%22id%22%3A%222379b0150c21067f%22%2C%22ext%22%3A%7B%22siteID%22%3A%22193648%22%2C%22sid%22%3A%22970x250%22%7D%2C%22banner%22%3A%7B%22w%22%3A970%2C%22h%22%3A250%2C%22topframe%22%3A1%7D%7D%2C%7B%22id%22%3A%222385db0cfd06ead6%22%2C%22ext%22%3A%7B%22siteID%22%3A%22193648%22%2C%22sid%22%3A%22900x250%22%7D%2C%22banner%22%3A%7B%22w%22%3A900%2C%22h%22%3A250%2C%22topframe%22%3A1%7D%7D%2C%7B%22id%22%3A%222390e0fd7917c579%22%2C%22ext%22%3A%7B%22siteID%22%3A%22193648%22%2C%22sid%22%3A%22728x90%22%7D%2C%22banner%22%3A%7B%22w%22%3A728%2C%22h%22%3A90%2C%22topframe%22%3A1%7D%7D%5D%2C%22site%22%3A%7B%22page%22%3A%22https%3A%2F%2Fwww.dailymail.co.uk%2Fsciencetech%2Farticle-9050821%2FRemdesivir-beneficial-patients-doctors-reveal.html%3F_hsmi%3D88974744%26_hsenc%3Dp2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8%22%7D%2C%22ext%22%3A%7B%22source%22%3A%22prebid%22%7D%7D&ac=j&sd=1
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/static/mol-adverts/demo/mol-22070/19a28e0b/mol-adverts.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
104.111.215.135 , Netherlands, ASN16625 (AKAMAI-AS, US),
Reverse DNS
a104-111-215-135.deploy.static.akamaitechnologies.com
Software
Apache /
Resource Hash
1c1b38bbb00b1320da1212cc3ee738678e35c0b2a81168c392115e13408f9dba

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type
text/plain

Response headers

pragma
no-cache
date
Tue, 15 Dec 2020 12:45:48 GMT
content-encoding
gzip
x-ak-initial-geo
CC:[NL], RC:[], CN:[EU], CIP:[185.212.171.67], XFF:[]
server
Apache
vary
Is-Traffic-Invalid,Accept-Encoding
content-type
application/json
access-control-allow-origin
https://www.dailymail.co.uk
x-cs-client-geo
12
cache-control
max-age=0, no-cache, no-store
access-control-allow-credentials
true
content-length
46
x-ak-client-geo
12
expires
Tue, 15 Dec 2020 12:45:48 GMT
prebid
ib.adnxs.com/ut/v3/
19 B
716 B
XHR
General
Full URL
https://ib.adnxs.com/ut/v3/prebid
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/static/mol-adverts/demo/mol-22070/19a28e0b/mol-adverts.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_ECDSA, AES_128_GCM
Server
185.33.221.13 , Netherlands, ASN29990 (ASN-APPNEX, US),
Reverse DNS
729.bm-nginx-loadbalancer.mgmt.ams1.adnexus.net
Software
nginx/1.17.9 /
Resource Hash
0c09c070833c786cb25be38bc30992b30bad578f817dbc9e34beacd8b8ea44c5
Security Headers
Name Value
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type
text/plain

Response headers

Pragma
no-cache
Date
Tue, 15 Dec 2020 12:45:48 GMT
X-Proxy-Origin
185.212.171.67; 185.212.171.67; 729.bm-nginx-loadbalancer.mgmt.ams1; *.adnxs.com; 185.33.223.50:80
AN-X-Request-Uuid
a8247658-7141-4ca0-9a8a-246d510b4e4a
Server
nginx/1.17.9
P3P
policyref="http://cdn.adnxs.com/w3c/policy/p3p.xml", CP="NOI DSP COR ADM PSAo PSDo OURo SAMo UNRo OTRo BUS COM NAV DEM STA PRE"
Access-Control-Allow-Origin
https://www.dailymail.co.uk
Cache-Control
no-store, no-cache, private
Access-Control-Allow-Credentials
true
Connection
keep-alive
Content-Type
application/json; charset=utf-8
Content-Length
19
X-XSS-Protection
0
Expires
Sat, 15 Nov 2008 16:00:00 GMT
cdb
bidder.criteo.com/
122 B
342 B
XHR
General
Full URL
https://bidder.criteo.com/cdb?ptv=100&profileId=185&av=32&wv=4.13.0-mol-1&cb=55635011742
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/static/mol-adverts/demo/mol-22070/19a28e0b/mol-adverts.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
178.250.0.165 , France, ASN44788 (ASN-CRITEO-EUROPE, FR),
Reverse DNS
bidder.par.vip.prod.criteo.com
Software
Finatra /
Resource Hash
9f22384daa88a2fed04353c09e5a247c76d603be9961f3f197294db73c3838bc

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type
text/plain

Response headers

date
Tue, 15 Dec 2020 12:45:47 GMT
content-encoding
gzip
server
Finatra
vary
Origin
content-type
application/json; charset=utf-8
access-control-allow-origin
https://www.dailymail.co.uk
access-control-allow-credentials
true
timing-allow-origin
*
content-length
131
v2
mfad.inskinad.com/api/
0
0

xhr
pre.ads.justpremium.com/v/2.0/t/
43 B
253 B
XHR
General
Full URL
https://pre.ads.justpremium.com/v/2.0/t/xhr?i=1608036347725
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/static/mol-adverts/demo/mol-22070/19a28e0b/mol-adverts.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
52.59.91.38 Frankfurt am Main, Germany, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
/
Resource Hash
d34e8a1a381b203e3d1f7c6ed4f077038e91782ea254c7a7e4785462147a385a

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type
text/plain

Response headers

access-control-allow-origin
https://www.dailymail.co.uk
date
Tue, 15 Dec 2020 12:45:48 GMT
cache-control
public, no-cache, no-store, must-revalidate
access-control-allow-credentials
true
content-encoding
gzip
content-type
application/json
bidRequest
c2shb.ssp.yahoo.com/
62 B
390 B
XHR
General
Full URL
https://c2shb.ssp.yahoo.com/bidRequest?dcn=8a9691510171713aaede3c85d0ab0026&pos=desktop_billboard&cmd=bid&secure=1
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/static/mol-adverts/demo/mol-22070/19a28e0b/mol-adverts.js
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_256_GCM
Server
35.157.246.167 Frankfurt am Main, Germany, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
ATS/7.1.2.128 /
Resource Hash
33dcdfab1fa912df4101f8a7ba5cfa6aa717754e113bce15bc55faa56a8831cd

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type
text/plain

Response headers

Date
Tue, 15 Dec 2020 12:45:50 GMT
Server
ATS/7.1.2.128
Age
0
Access-Control-Allow-Methods
POST,GET,HEAD,OPTIONS
Content-Type
application/json;charset=utf-8
Access-Control-Allow-Origin
https://www.dailymail.co.uk
Access-Control-Allow-Credentials
true
Connection
keep-alive
Content-Length
62
fastlane.json
fastlane.rubiconproject.com/a/api/
278 B
1 KB
XHR
General
Full URL
https://fastlane.rubiconproject.com/a/api/fastlane.json?account_id=8625&site_id=124374&zone_id=587732&size_id=2&alt_size_ids=57&p_pos=atf&tpid_tdid=c1befdb7-5c1a-4d0f-b053-b3ef508e7ce4&eid_pubcid.org=84f1103b-a980-4860-8c6e-1866bcc8525c%5E1&rf=https%3A%2F%2Fwww.dailymail.co.uk%2Fsciencetech%2Farticle-9050821%2FRemdesivir-beneficial-patients-doctors-reveal.html%3F_hsmi%3D88974744%26_hsenc%3Dp2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8&tg_i.area=sciencetech&tk_flint=pbjs_lite_v4.13.0-mol-1&x_source.tid=fd22dfe2-0a5d-4bf5-80fe-8696cf39e26c&p_screen_res=1600x1200&rp_floor=0.01&rp_secure=1&slots=1&rand=0.07524662449775676
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/static/mol-adverts/demo/mol-22070/19a28e0b/mol-adverts.js
Protocol
HTTP/1.1
Security
TLS 1.2, RSA, AES_128_GCM
Server
213.19.162.31 , United Kingdom, ASN3356 (LEVEL3, US),
Reverse DNS
Software
nginx/1.16.0 /
Resource Hash
1cd0a30ef271b938e9816e7e3079eacbe3c0f1863069cdb7c46c63bbf5af63f4

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type
text/plain

Response headers

Pragma
no-cache
Date
Tue, 15 Dec 2020 12:45:48 GMT
Server
nginx/1.16.0
Vary
Accept-Encoding
P3P
CP="NOI CURa ADMa DEVa TAIa OUR BUS IND UNI COM NAV INT"
Access-Control-Allow-Origin
https://www.dailymail.co.uk
Cache-Control
no-cache, no-store, max-age=0, must-revalidate
Access-Control-Allow-Credentials
true
Connection
keep-alive
Content-Type
application/json
Keep-Alive
timeout=5
Content-Length
278
Expires
Wed, 17 Sep 1975 21:32:10 GMT
bid-request
a.teads.tv/hb/
16 B
301 B
XHR
General
Full URL
https://a.teads.tv/hb/bid-request
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/static/mol-adverts/demo/mol-22070/19a28e0b/mol-adverts.js
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2.18.232.7 , Ascension Island, ASN16625 (AKAMAI-AS, US),
Reverse DNS
a2-18-232-7.deploy.static.akamaitechnologies.com
Software
/
Resource Hash
6a7b0c8bf87b2bd5ca31557f25cf2a6c80f93af72bf68a6085e9b55a87fe908c

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type
text/plain

Response headers

pragma
no-cache
date
Tue, 15 Dec 2020 12:45:47 GMT
content-encoding
gzip
vary
Accept-Encoding
content-type
application/json
access-control-allow-origin
https://www.dailymail.co.uk
cache-control
max-age=0, no-cache, no-store
access-control-allow-credentials
true
content-length
42
expires
Tue, 15 Dec 2020 12:45:47 GMT
bid
c.amazon-adsystem.com/e/dtb/
24 B
374 B
XHR
General
Full URL
https://c.amazon-adsystem.com/e/dtb/bid?src=3065&u=https%3A%2F%2Fwww.dailymail.co.uk%2Fsciencetech%2Farticle-9050821%2FRemdesivir-beneficial-patients-doctors-reveal.html%3F_hsmi%3D88974744%26_hsenc%3Dp2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8&pid=qkqBHoBAnjHbV&cb=18&ws=1600x1200&v=7.58.01&t=2000&slots=%5B%7B%22sd%22%3A%22billBoard%22%2C%22s%22%3A%5B%222000x1200%22%2C%22970x250%22%2C%22900x250%22%2C%22728x90%22%5D%2C%22kv%22%3A%7B%22pubcid%22%3A%223093664108%22%7D%7D%5D&gdprl=%7B%22status%22%3A%22no-cmp%22%7D
Requested by
Host: c.amazon-adsystem.com
URL: https://c.amazon-adsystem.com/aax2/apstag.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
99.84.88.20 Seattle, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-99-84-88-20.muc50.r.cloudfront.net
Software
Server /
Resource Hash
ffc733276efc796c146eccf6bc3b111f917b8e2203d25df67884786903b64c05

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:45:47 GMT
via
1.1 fe36c7f30c8ef2853edecc43f320092c.cloudfront.net (CloudFront)
server
Server
x-amz-cf-pop
MUC50-C1
vary
User-Agent
x-cache
Miss from cloudfront
content-type
text/javascript;charset=UTF-8
access-control-allow-origin
https://www.dailymail.co.uk
access-control-allow-credentials
true
timing-allow-origin
*
content-length
24
x-amz-cf-id
ttxQOzF3nNegF7TjVczhlYAcJ-4VEXIFCXt1Skq0VlwcqkedXJ817Q==
events
bidder.criteo.com/csm/
0
149 B
Other
General
Full URL
https://bidder.criteo.com/csm/events
Requested by
Host: static.criteo.net
URL: https://static.criteo.net/js/ld/publishertag.prebid.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
178.250.0.165 , France, ASN44788 (ASN-CRITEO-EUROPE, FR),
Reverse DNS
bidder.par.vip.prod.criteo.com
Software
Finatra /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type
text/plain;charset=UTF-8

Response headers

access-control-allow-origin
https://www.dailymail.co.uk
date
Tue, 15 Dec 2020 12:45:47 GMT
access-control-allow-credentials
true
server
Finatra
timing-allow-origin
*
vary
Origin
unip
trc-events.taboola.com/1125455/log/3/
0
295 B
XHR
General
Full URL
https://trc-events.taboola.com/1125455/log/3/unip?en=pre_d_eng_tb&tos=10667&scd=20&ssd=1&est=1608036337115&ver=27&isls=true&src=i&invt=6000&tim=1608036347782&vi=1608036337111&ri=b6dc80672a17aca292567a573e6453e2&sd=v2_15bf3ddba6eb6e007097014d6bd5af7c_81242381-ab73-4352-8bed-9e7099c82ee1-tuct6d23571_1608036337_1608036337_CNawjgYQz9hEGNeLvbPmLiABKAEwoQE4l-oLQJWXEEj-0toDUP___________wFYAWAAaOKmqpGyrZficA&ui=81242381-ab73-4352-8bed-9e7099c82ee1-tuct6d23571&ref=null&cv=20201123-29-RELEASE
Requested by
Host: cdn.taboola.com
URL: https://cdn.taboola.com/libtrc/unip/1125455/tfa.js
Protocol
H2
Security
TLS 1.2, ECDHE_ECDSA, AES_128_GCM
Server
141.226.228.48 , Netherlands, ASN200478 (TABOOLA-AS, IL),
Reverse DNS
Software
nginx /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

pragma
no-cache
date
Tue, 15 Dec 2020 12:45:47 GMT
server
nginx
x-fastly-to-nlb-rtt
10336
p3p
policyref="http://trc.taboola.com/p3p.xml", CP="NOI DSP COR LAW NID CURa ADMa DEVa PSAa PSDa OUR BUS IND UNI COM NAV INT DEM"
access-control-allow-origin
https://www.dailymail.co.uk
cache-control
no-cache
access-control-allow-credentials
true
tbl-x-upstream
10.41.22.84:10213
2
www.dailymail.co.uk/abe/a9/price/
4 B
703 B
XHR
General
Full URL
https://www.dailymail.co.uk/abe/a9/price/2
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/static/mol-adverts/demo/mol-22070/19a28e0b/mol-adverts.js
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2a02:26f0:6c00:296::11ae , Ascension Island, ASN20940 (AKAMAI-ASN1, EU),
Reverse DNS
Software
AmazonS3 /
Resource Hash
561b2814d3c09e62a92442c946307918f7f63f833c84876c08bd4c406767e53b

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

x-amz-version-id
wDnvhJJXpo3tPt4.QtsManRqQALbFlHY
content-security-policy-report-only
block-all-mixed-content; report-uri https://mol.report-uri.io/r/default/csp/reportOnly
last-modified
Thu, 26 Jul 2018 09:55:16 GMT
server
AmazonS3
x-amz-request-id
2Z4KDQ1N7H5GAG6P
etag
"f7ddd489ab0a82567b241b05971cbdb3"
vary
User-Agent
content-type
text/plain
cache-control
public, max-age=1146246
date
Tue, 15 Dec 2020 12:45:47 GMT
x-amz-replication-status
COMPLETED
server-timing
cdn-cache; desc=HIT, edge; dur=1
accept-ranges
bytes
content-length
4
x-amz-id-2
TQa+V4AfiJ7Bmz5eGVXtXeerNKKqRrPt9yBoXYXtX5TNMag04HicxY48/1EyJyZRcnVJVxDSTyI=
csyncs
hb.hb.selectmedia.asia/ Frame C776
282 B
549 B
XHR
General
Full URL
https://hb.hb.selectmedia.asia/csyncs?aid1=436894
Requested by
Host: player.hb.selectmedia.asia
URL: https://player.hb.selectmedia.asia/prebidlink/446676/wrapper_hb_310028_7816.js
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_128_GCM
Server
23.227.137.155 Piscataway, United States, ASN55081 (24SHELLS, US),
Reverse DNS
Software
VertaMedia 1.0 /
Resource Hash
1465578a2deef9b65ad03e92b095dbab03e6aa5b52028a1cf8e8a62eda2cbc31

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Date
Tue, 15 Dec 2020 12:45:47 GMT
Content-Encoding
gzip
Server
VertaMedia 1.0
Content-Type
application/json; charset=UTF-8
Access-Control-Allow-Origin
https://www.dailymail.co.uk
Access-Control-Allow-Credentials
true
Connection
Keep-Alive
Content-Length
255
bids
prebid-eu.creativecdn.com/bidder/prebid/ Frame C776
0
173 B
XHR
General
Full URL
https://prebid-eu.creativecdn.com/bidder/prebid/bids
Requested by
Host: player.hb.selectmedia.asia
URL: https://player.hb.selectmedia.asia/prebidlink/446676/hb_310028_7816.js
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
185.184.8.30 , Poland, ASN204995 (RTB-HOUSE-AMS, NL),
Reverse DNS
ip-185-184-8-30.rtbhouse.net
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type
text/plain

Response headers

access-control-allow-origin
https://www.dailymail.co.uk
date
Tue, 15 Dec 2020 12:45:48 GMT
access-control-allow-credentials
true
access-control-max-age
3600
access-control-allow-methods
POST
/
pub.admanmedia.com/ Frame C776
0
0

cygnus
htlb.casalemedia.com/ Frame C776
24 B
372 B
XHR
General
Full URL
https://htlb.casalemedia.com/cygnus?s=544669&v=7.2&ac=j&sd=1&r=%7B%22id%22%3A%2258458439f6560a%22%2C%22site%22%3A%7B%22page%22%3A%22https%3A%2F%2Fwww.dailymail.co.uk%2Fsciencetech%2Farticle-9050821%2FRemdesivir-beneficial-patients-doctors-reveal.html%3F_hsmi%3D88974744%26_hsenc%3Dp2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8%22%7D%2C%22ext%22%3A%7B%22source%22%3A%22prebid%22%2C%22ixdiag%22%3A%7B%22msd%22%3A0%2C%22msi%22%3A0%7D%7D%2C%22imp%22%3A%5B%7B%22id%22%3A%2268a575e983257d%22%2C%22ext%22%3A%7B%22siteID%22%3A%22544669%22%2C%22sid%22%3A%22300x250%22%7D%2C%22banner%22%3A%7B%22w%22%3A300%2C%22h%22%3A250%2C%22topframe%22%3A0%7D%7D%5D%7D
Requested by
Host: player.hb.selectmedia.asia
URL: https://player.hb.selectmedia.asia/prebidlink/446676/hb_310028_7816.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
104.111.215.135 , Netherlands, ASN16625 (AKAMAI-AS, US),
Reverse DNS
a104-111-215-135.deploy.static.akamaitechnologies.com
Software
Apache /
Resource Hash
f54599c33b1930a9f72c4a53dd5a718d2062495613ffa80423254d04779cd18c

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type
text/plain

Response headers

pragma
no-cache
date
Tue, 15 Dec 2020 12:45:48 GMT
content-encoding
gzip
x-ak-initial-geo
CC:[NL], RC:[], CN:[EU], CIP:[185.212.171.67], XFF:[]
server
Apache
vary
Is-Traffic-Invalid,Accept-Encoding
content-type
application/json
access-control-allow-origin
https://www.dailymail.co.uk
x-cs-client-geo
12
cache-control
max-age=0, no-cache, no-store
access-control-allow-credentials
true
content-length
42
x-ak-client-geo
12
expires
Tue, 15 Dec 2020 12:45:48 GMT
arj
select-d.openx.net/w/1.0/ Frame C776
173 B
356 B
XHR
General
Full URL
https://select-d.openx.net/w/1.0/arj?ju=https%3A%2F%2Fwww.dailymail.co.uk%2Fsciencetech%2Farticle-9050821%2FRemdesivir-beneficial-patients-doctors-reveal.html%3F_hsmi%3D88974744%26_hsenc%3Dp2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8&ch=UTF-8&res=1600x1200x24&ifr=true&tz=-60&tws=1600x1200&be=1&bc=hb_pb_3.0.3&dddid=3ff9fdea-3a20-4d8b-a796-e59d98c06727&nocache=1608036347984&aus=300x250&divIds=gpt-passback&auid=541148923
Requested by
Host: player.hb.selectmedia.asia
URL: https://player.hb.selectmedia.asia/prebidlink/446676/hb_310028_7816.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
35.244.159.8 Mountain View, United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
OXGW/16.199.0 /
Resource Hash
ff68fa412d40ddb702fa2d0e98f77e5d46d59ef7174df91de0bd04dcab7b77d9

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type
text/plain

Response headers

pragma
no-cache
date
Tue, 15 Dec 2020 12:45:48 GMT
content-encoding
gzip
server
OXGW/16.199.0
vary
Accept, Accept-Encoding
p3p
CP="CUR ADM OUR NOR STA NID"
access-control-allow-origin
https://www.dailymail.co.uk
cache-control
private, max-age=0, no-cache
access-control-allow-credentials
true
content-type
application/json
alt-svc
clear
content-length
164
via
1.1 google
expires
Mon, 26 Jul 1997 05:00:00 GMT
fastlane.json
fastlane.rubiconproject.com/a/api/ Frame C776
237 B
1 KB
XHR
General
Full URL
https://fastlane.rubiconproject.com/a/api/fastlane.json?account_id=20598&site_id=345700&zone_id=1828452&size_id=15&rf=https%3A%2F%2Fwww.dailymail.co.uk%2Fsciencetech%2Farticle-9050821%2FRemdesivir-beneficial-patients-doctors-reveal.html%3F_hsmi%3D88974744%26_hsenc%3Dp2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8&tk_flint=pbjs_lite_v4.15.0-pre&x_source.tid=3ff9fdea-3a20-4d8b-a796-e59d98c06727&p_screen_res=1600x1200&rp_floor=0.01&rp_secure=1&slots=1&rand=0.322955892700443
Requested by
Host: player.hb.selectmedia.asia
URL: https://player.hb.selectmedia.asia/prebidlink/446676/hb_310028_7816.js
Protocol
HTTP/1.1
Security
TLS 1.2, RSA, AES_128_GCM
Server
213.19.162.31 , United Kingdom, ASN3356 (LEVEL3, US),
Reverse DNS
Software
nginx/1.16.0 /
Resource Hash
5a5da33846226052910e5ed2b1a1e3e551cc239422e8b705613b54df51ee4cfd

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type
text/plain

Response headers

Pragma
no-cache
Date
Tue, 15 Dec 2020 12:45:48 GMT
Server
nginx/1.16.0
Vary
Accept-Encoding
P3P
CP="NOI CURa ADMa DEVa TAIa OUR BUS IND UNI COM NAV INT"
Access-Control-Allow-Origin
https://www.dailymail.co.uk
Cache-Control
no-cache, no-store, max-age=0, must-revalidate
Access-Control-Allow-Credentials
true
Connection
keep-alive
Content-Type
application/json
Keep-Alive
timeout=5
Content-Length
237
Expires
Wed, 17 Sep 1975 21:32:10 GMT
prebid
ib.adnxs.com/ut/v3/ Frame C776
19 B
716 B
XHR
General
Full URL
https://ib.adnxs.com/ut/v3/prebid
Requested by
Host: player.hb.selectmedia.asia
URL: https://player.hb.selectmedia.asia/prebidlink/446676/hb_310028_7816.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_ECDSA, AES_128_GCM
Server
185.33.221.13 , Netherlands, ASN29990 (ASN-APPNEX, US),
Reverse DNS
729.bm-nginx-loadbalancer.mgmt.ams1.adnexus.net
Software
nginx/1.17.9 /
Resource Hash
0c09c070833c786cb25be38bc30992b30bad578f817dbc9e34beacd8b8ea44c5
Security Headers
Name Value
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type
text/plain

Response headers

Pragma
no-cache
Date
Tue, 15 Dec 2020 12:45:48 GMT
X-Proxy-Origin
185.212.171.67; 185.212.171.67; 729.bm-nginx-loadbalancer.mgmt.ams1; *.adnxs.com; 185.33.220.38:80
AN-X-Request-Uuid
c1323c56-fde1-4eff-8c95-51992939364c
Server
nginx/1.17.9
P3P
policyref="http://cdn.adnxs.com/w3c/policy/p3p.xml", CP="NOI DSP COR ADM PSAo PSDo OURo SAMo UNRo OTRo BUS COM NAV DEM STA PRE"
Access-Control-Allow-Origin
https://www.dailymail.co.uk
Cache-Control
no-store, no-cache, private
Access-Control-Allow-Credentials
true
Connection
keep-alive
Content-Type
application/json; charset=utf-8
Content-Length
19
X-XSS-Protection
0
Expires
Sat, 15 Nov 2008 16:00:00 GMT
translator
hbopenbid.pubmatic.com/ Frame C776
0
63 B
XHR
General
Full URL
https://hbopenbid.pubmatic.com/translator?source=prebid-client
Requested by
Host: player.hb.selectmedia.asia
URL: https://player.hb.selectmedia.asia/prebidlink/446676/hb_310028_7816.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
185.64.189.112 , United Kingdom, ASN62713 (AS-PUBMATIC, US),
Reverse DNS
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type
text/plain

Response headers

access-control-allow-origin
https://www.dailymail.co.uk
date
Tue, 15 Dec 2020 12:45:49 GMT
cache-control
no-cache, no-store, must-revalidate
access-control-allow-credentials
true
/
crta.dailymail.co.uk/
8 B
451 B
Other
General
Full URL
https://crta.dailymail.co.uk/
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/static/mol-adverts/demo/mol-22070/19a28e0b/mol-adverts.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
2a02:26f0:6c00:2be::16c2 , Ascension Island, ASN20940 (AKAMAI-ASN1, EU),
Reverse DNS
Software
http-to-kafka/0.8.10 /
Resource Hash
a00fb0c50741f81bb51d35b4475a4357f8039aabd896a21036bc516839401595

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type
text/plain

Response headers

pragma
no-cache
date
Tue, 15 Dec 2020 12:45:48 GMT
server
http-to-kafka/0.8.10
etag
W/"8-YaBXLEiT7zQxEyDYTILfiL6oPhE"
content-type
text/plain; charset=utf-8
access-control-allow-origin
*
cache-control
max-age=0, no-cache, no-store
access-control-allow-credentials
true
content-length
8
expires
Tue, 15 Dec 2020 12:45:48 GMT
mcd
hb.hb.selectmedia.asia/ Frame C776
Redirect Chain
  • https://s.adtelli.com/mc?c=vmuid%3A227ab502478174c8&r2=hb.hb.selectmedia.asia
  • https://hb.hb.selectmedia.asia/mcd
43 B
412 B
Image
General
Full URL
https://hb.hb.selectmedia.asia/mcd
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_128_GCM
Server
23.227.137.155 Piscataway, United States, ASN55081 (24SHELLS, US),
Reverse DNS
Software
VertaMedia 1.0 /
Resource Hash
2dfe28cbdb83f01c940de6a88ab86200154fd772d568035ac568664e52068363

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Access-Control-Allow-Origin
https://www.dailymail.co.uk
Date
Tue, 15 Dec 2020 12:45:47 GMT
Access-Control-Allow-Credentials
true
Server
VertaMedia 1.0
Connection
Keep-Alive
Content-Length
43
Content-Type
image/gif

Redirect headers

Location
https://hb.hb.selectmedia.asia/mcd
Date
Tue, 15 Dec 2020 12:45:47 GMT
Access-Control-Allow-Credentials
true
Server
VertaMedia 1.0
Connection
Keep-Alive
Access-Control-Allow-Origin
https://www.dailymail.co.uk
Content-Length
0
csync
sync.ads.152media.com/ Frame C776
Redirect Chain
  • https://ib.adnxs.com/getuid?https%3A%2F%2Fsync.ads.152media.com%2Fcsync%3Ft%3Da%26ep%3D285868%26extuid%3D%24UID
  • https://ib.adnxs.com/bounce?%2Fgetuid%3Fhttps%253A%252F%252Fsync.ads.152media.com%252Fcsync%253Ft%253Da%2526ep%253D285868%2526extuid%253D%2524UID
  • https://sync.ads.152media.com/csync?t=a&ep=285868&extuid=4247283236299145
86 B
529 B
Image
General
Full URL
https://sync.ads.152media.com/csync?t=a&ep=285868&extuid=4247283236299145
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_128_GCM
Server
62.149.0.72 , Ukraine, ASN15497 (COLOCALL Internet Data Center _ColoCALL_, UA),
Reverse DNS
0-72.cc86365-03-tmp.cc.colocall.com
Software
VertaMedia 1.0 /
Resource Hash
1cc9e0ac0ff231ba3fc0c9c42b40ebcc6c5a3058722ca99eeb0fed41f3efb997

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Date
Tue, 15 Dec 2020 12:45:48 GMT
Cache-Control
no-cache, no-store, must-revalidate
Server
VertaMedia 1.0
Content-Length
86
Content-Type
image/gif

Redirect headers

Pragma
no-cache
Date
Tue, 15 Dec 2020 12:45:48 GMT
X-Proxy-Origin
185.212.171.67; 185.212.171.67; 729.bm-nginx-loadbalancer.mgmt.ams1; *.adnxs.com; 185.33.220.180:80
AN-X-Request-Uuid
442b55d7-8298-4399-b999-9cbddcad4e1a
Server
nginx/1.17.9
Access-Control-Allow-Origin
*
P3P
policyref="http://cdn.adnxs.com/w3c/policy/p3p.xml", CP="NOI DSP COR ADM PSAo PSDo OURo SAMo UNRo OTRo BUS COM NAV DEM STA PRE"
Location
https://sync.ads.152media.com/csync?t=a&ep=285868&extuid=4247283236299145
Cache-Control
no-store, no-cache, private
Access-Control-Allow-Credentials
true
Connection
keep-alive
Content-Type
text/html; charset=utf-8
Content-Length
0
X-XSS-Protection
0
Expires
Sat, 15 Nov 2008 16:00:00 GMT
adview
securepubads.g.doubleclick.net/pagead/ Frame 9371
0
0
Image
General
Full URL
https://securepubads.g.doubleclick.net/pagead/adview?ai=C_3Y--q_YX8C0LdaN7gO00LWACaKo-KZgzOyKvrMMmJL4h7MCEAEgrNm4ImCRhJOF_BegAbe4t9kDyAEGqQIf2EjV3l60PuACAKgDAaoExwJP0D29q6RGqB8NVy17eg4RIlzedBinaMhYW53oJAWmtUKJ6DPmzQt2CZ25JZd0eDUMCXaJJO6RBDqZ8Q0vwWsC68DWTfkEJa9Xbv3Fi-DYPo3AsrPu44R6beJFYhsDg3yf4450HeXfwTPhrLY_z26ea5UvF2YxneAXCSXDnA7v-7UzlpKv0vfHY8UO8AQ_YKpsxmugzC-q9EJyE3ffczB-xvOj435-VzXjp7P_NY68McdX0UKz7XREvG4QCQKfqKhoaJVWfXgVD7NOllrNEq7-pIO4k-MtDi0zeIZVN9aAeyXSxkIsrP6mSbOSR6XcQr_KsC6hwWAwwruPouexXvWSDGqjT03_56aBcMxF4iO5aOK5dMXHEQbn3xYnf9cZWJK4on0P7h-Ar5HJrLATOM4mY9-OvMPAfEaNIVFNbhQYboijM_SxWqfABKTU_6e7A-AEAaAGN4AHscfIJqgH1ckbqAfw2RuoB_LZG6gHlJixAqgHpd8bqAeOzhuoB5PYG6gHugaoB-6WsQKoB6a-G6gH7NUb2AcB8gcEEN-PC9IICQiA4YAQEAEYHYAKA8gLAdgTA4gUAdAVAYAXAbIXGgoYCAESFHB1Yi00MTgwODM1Njk0MTY2MjU1&sigh=ymQnwQRP3ms&vt=1&template_id=492
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
172.217.22.2 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
fra16s14-in-f2.1e100.net
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
https://www.dailymail.co.uk/
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

activeview
pagead2.googlesyndication.com/pcs/ Frame 9371
42 B
89 B
Image
General
Full URL
https://pagead2.googlesyndication.com/pcs/activeview?xai=AKAOjstIxNBQXkT2FI2HYEBn6nkn-j3pcTgnKgl4jDZhb9xNwUaUBFf9MpXQr3cFk5ZAMcYNM-Bn4vTqOKBU8lcR3hthbfoE4BGK3hcjppsc9wWv8wTtSLyrCNtgwcTXRmsdZISnrQhx-WjmJJJaA_Vvrhu5Yw&sai=AMfl-YRfnA04TcYPWoAUVPxk-MoqGEsKCgUGWj28lHg5ggQPaRZE10aFKA016sjhZPHsu_93AA8jw999oInlRu-oqc87B64sqE2pKRlJYok6fWIZ58LIUXDsdUkHaJIc&sig=Cg0ArKJSzIp71xOXh7owEAE&cid=CAASF-RooqkIca2FOXyY1JRJy2TbmcDk7U8V&id=ampim&o=1223,945&d=300,250&ss=1600,1200&bs=1600,1200&mcvt=1000&mtos=0,0,1000,1000,1000&tos=0,0,1000,0,0&tfs=222&tls=1222&g=100&h=100&tt=1222&r=v&avms=ampa&adk=3432249630
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:816::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
ef1955ae757c8b966c83248350331bd3a30f658ced11f387f8ebf05ab3368629
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

pragma
no-cache
date
Tue, 15 Dec 2020 12:45:48 GMT
x-content-type-options
nosniff
server
cafe
timing-allow-origin
*
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
access-control-allow-origin
*
cache-control
no-cache, must-revalidate
cross-origin-resource-policy
cross-origin
content-type
image/gif
alt-svc
h3-29="googleads.g.doubleclick.net:443"; ma=2592000,h3-29=":443"; ma=2592000,h3-T051="googleads.g.doubleclick.net:443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic="googleads.g.doubleclick.net:443"; ma=2592000; v="46,43",quic=":443"; ma=2592000; v="46,43"
content-length
42
x-xss-protection
0
expires
Fri, 01 Jan 1990 00:00:00 GMT
metrics
api.permutive.com/v2.0/internal/
2 B
87 B
XHR
General
Full URL
https://api.permutive.com/v2.0/internal/metrics?k=ed45e86d-a09e-4d2b-85c0-fbbd6857373e
Requested by
Host: cdn.permutive.com
URL: https://cdn.permutive.com/5f42864d-a421-4f37-9478-00266f871d68-web.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
34.107.254.252 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
Permutive /
Resource Hash
2689367b205c16ce32ed4200942b8b8b1e262dfc70d9bc9fbc77c49699a4f1df

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type
text/plain

Response headers

date
Tue, 15 Dec 2020 12:45:48 GMT
content-encoding
gzip
server
Permutive
vary
Origin,Access-Control-Request-Method
access-control-allow-methods
POST
content-type
text/plain;charset=utf-8
access-control-allow-origin
https://www.dailymail.co.uk
access-control-expose-headers
*
access-control-allow-credentials
true
access-control-max-age
86400
alt-svc
clear
content-length
22
via
1.1 google
segoerpb.css
sdsbucket.s3.amazonaws.com/fonts/
327 B
656 B
Stylesheet
General
Full URL
https://sdsbucket.s3.amazonaws.com/fonts/segoerpb.css
Requested by
Host: cdn.userreport.com
URL: https://cdn.userreport.com/userreport.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
52.218.109.178 Dublin, Ireland, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
AmazonS3 /
Resource Hash
74fe31bf13b20ce3c21c61bec859e560272c38f9bfe38975278f7bc9925bb485

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Date
Tue, 15 Dec 2020 12:45:49 GMT
Content-Encoding
gzip
Last-Modified
Mon, 16 Nov 2020 11:36:22 GMT
Server
AmazonS3
x-amz-request-id
9EFAF917CC6FE473
ETag
"e25b136cff66e8bfa3b3d919713add3f"
x-amz-version-id
nBphovvgTQhQQMjjUtiJdbNZGr7RcFir
Cache-Control
max-age=3600
Accept-Ranges
bytes
Content-Type
text/css
Content-Length
196
x-amz-id-2
5p972NjimaIFzZHGIt3m4DPObtzOGFJQrFEVc9cbW+qcQym6L0OJsebgvXH1jRadDSgbHkAlWUU=
fd7ab9c7-63a5-4ab2-b7fe-e4f051de850e.png
cdn.userreport.com/companies/841e7e17-dd2b-42bd-8780-05d018493983/files/images/
4 KB
4 KB
Image
General
Full URL
https://cdn.userreport.com/companies/841e7e17-dd2b-42bd-8780-05d018493983/files/images/fd7ab9c7-63a5-4ab2-b7fe-e4f051de850e.png
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2600:9000:21f3:8200:19:d208:7940:93a1 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
AmazonS3 /
Resource Hash
551f51a353adb9fec5e9df61ae62b8b11342fec988cb184d24fecbb625bba4e3

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Mon, 14 Dec 2020 17:35:11 GMT
via
1.1 2b2e2811e641703aebf776da39317b9c.cloudfront.net (CloudFront)
last-modified
Tue, 31 Mar 2020 09:26:52 GMT
server
AmazonS3
age
69038
etag
"44472e45f3755df3e4b7b04f438db94d"
x-cache
Hit from cloudfront
content-type
image/png
access-control-allow-origin
*
x-amz-cf-pop
FRA2-C2
accept-ranges
bytes
content-length
4091
x-amz-cf-id
V1MBmZINWAiOlGbgA4bgG2JYqkKsOycuOZITUR1DaiIJ_XXzBCOGDw==
fd7ab9c7-63a5-4ab2-b7fe-e4f051de850e.png
cdn.userreport.com/companies/841e7e17-dd2b-42bd-8780-05d018493983/files/images/ Frame FAB4
4 KB
4 KB
Image
General
Full URL
https://cdn.userreport.com/companies/841e7e17-dd2b-42bd-8780-05d018493983/files/images/fd7ab9c7-63a5-4ab2-b7fe-e4f051de850e.png
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2600:9000:21f3:8200:19:d208:7940:93a1 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
AmazonS3 /
Resource Hash
551f51a353adb9fec5e9df61ae62b8b11342fec988cb184d24fecbb625bba4e3

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Mon, 14 Dec 2020 17:35:11 GMT
via
1.1 2b2e2811e641703aebf776da39317b9c.cloudfront.net (CloudFront)
last-modified
Tue, 31 Mar 2020 09:26:52 GMT
server
AmazonS3
age
69038
etag
"44472e45f3755df3e4b7b04f438db94d"
x-cache
Hit from cloudfront
content-type
image/png
access-control-allow-origin
*
x-amz-cf-pop
FRA2-C2
accept-ranges
bytes
content-length
4091
x-amz-cf-id
5HF8FIMJFKY6DKB_WJKC-04dZoGYEw-_hrU6Ei21RY6gEz9MDG_71g==
json
relay.userreport.com/f/invitation/
14 B
149 B
XHR
General
Full URL
https://relay.userreport.com/f/invitation/json
Requested by
Host: cdn.userreport.com
URL: https://cdn.userreport.com/userreport.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
52.1.33.51 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
Software
/
Resource Hash
4300d4e45e836ccd4946ff5e566c14ed0f3cfe8be4c1f43966ff4ae0ae3bf9bb

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-type
application/json

Response headers

access-control-allow-origin
https://www.dailymail.co.uk
date
Tue, 15 Dec 2020 12:45:48 GMT
access-control-allow-credentials
true
content-type
application/json
json
relay.userreport.com/f/invitation/ Frame
0
0
Other
General
Full URL
https://relay.userreport.com/f/invitation/json
Protocol
H2
Server
52.1.33.51 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
Software
/
Resource Hash

Request headers

Accept
*/*
Access-Control-Request-Method
POST
Access-Control-Request-Headers
content-type
Origin
https://www.dailymail.co.uk
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Sec-Fetch-Mode
cors

Response headers

date
Tue, 15 Dec 2020 12:45:48 GMT
access-control-allow-credentials
true
access-control-allow-headers
content-type
access-control-allow-methods
POST
access-control-allow-origin
https://www.dailymail.co.uk
hit.gif
visitanalytics.userreport.com/
43 B
678 B
Image
General
Full URL
https://visitanalytics.userreport.com/hit.gif?t=USRinv-GB&event=impression&cid=841e7e17-dd2b-42bd-8780-05d018493983&mid=51248e61-3510-4ae9-b8a6-712be4dd155e&iid=47a5af19-0147-40da-9378-320bf942b581&cult=en-GB&dsu=1.20830ade642fb79c.808ec78b-2de3-47c8-848b-d558b73536cf.1.714.f5c3d815d3687b09&med=https%3A%2F%2Fwww.dailymail.co.uk%2Fsciencetech%2Farticle-9050821%2FRemdesivir-beneficial-patients-doctors-reveal.html%3F_hsmi%3D88974744%26_hsenc%3Dp2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8&sid=mol
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_128_GCM
Server
65.9.73.48 Seattle, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
AmazonS3 /
Resource Hash
cf4724b2f736ed1a0ae6bc28f1ead963d9cd2c1fd87b6ef32e7799fc1c5c8bda

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

x-amz-version-id
fZAqbzuxSGtIKd7g0Oj0VzvG4UrkztnT
Via
1.1 0186e9c41d0aebb13c1398b95b7f4757.cloudfront.net (CloudFront)
ETag
"ad4b0f606e0f8465bc4c4c170b37e1a3"
Age
87628
x-amz-meta-cb-modifiedtime
Tue, 14 Apr 2015 11:43:27 GMT
X-Cache
Hit from cloudfront
Connection
keep-alive
Content-Length
43
Last-Modified
Thu, 15 Oct 2015 11:22:45 GMT
Server
AmazonS3
Date
Mon, 14 Dec 2020 21:31:00 GMT
Content-Type
image/gif
Cache-Control
no-cache, no-store, must-revalidate
X-Amz-Cf-Pop
AMS1-C1
Accept-Ranges
bytes
X-Amz-Cf-Id
8qoPfKoSBly_BBcA8klQmMirENeZPR7T0wEI2bW-jlvtv14OLPrmVA==
Expires
0
track
track1.aniview.com/
0
94 B
XHR
General
Full URL
https://track1.aniview.com/track?r=www.dailymail.co.uk&sn=&ic=0&tgt=0&app=&wi=480&he=270&test=&apppkg=&fv=3&proto=https
Requested by
Host: player.aniview.com
URL: https://player.aniview.com/script/6.1/AVmanager.js?v=1.0&type=s&pid=5e3a966128a06134f417790e
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
34.197.221.162 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type
text/plain;charset=UTF-8

Response headers

access-control-allow-origin
*
date
Tue, 15 Dec 2020 12:45:49 GMT
cache-control
max-age=0, no-cache, no-store
content-length
0
segoeprb-webfont.woff
sdsbucket.s3.amazonaws.com/fonts/
37 KB
38 KB
Font
General
Full URL
https://sdsbucket.s3.amazonaws.com/fonts/segoeprb-webfont.woff
Requested by
Host: sdsbucket.s3.amazonaws.com
URL: https://sdsbucket.s3.amazonaws.com/fonts/segoerpb.css
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
52.218.109.178 Dublin, Ireland, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
AmazonS3 /
Resource Hash
a8a0726f85984d7120d3f4dbfc73fb23c38a89f59ba75279afc40dcbb8140d6b

Request headers

Origin
https://www.dailymail.co.uk
Referer
https://sdsbucket.s3.amazonaws.com/fonts/segoerpb.css
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Date
Tue, 15 Dec 2020 12:45:50 GMT
Last-Modified
Thu, 13 Nov 2014 13:49:17 GMT
Server
AmazonS3
x-amz-request-id
90A005C053199688
ETag
"8163381a634f4ce6100535f3ddbc3ff4"
Vary
Origin, Access-Control-Request-Headers, Access-Control-Request-Method
Access-Control-Allow-Methods
GET
x-amz-version-id
uyP5HBioSLx6psKWw6SXafShE13mzr3f
Access-Control-Allow-Origin
*
Access-Control-Max-Age
3000
Cache-Control
max-age=3600
Accept-Ranges
bytes
Content-Type
application/x-woff
Content-Length
38116
x-amz-id-2
BhYGmHaw+FJ2mSL68MRfZNDjk/7Y5C7C8wgJjyYFuHAKM+UU+zvCOx7unNfZGe1obDwh+6pHrCI=
events
api.permutive.com/v2.0/batch/
101 B
180 B
XHR
General
Full URL
https://api.permutive.com/v2.0/batch/events?enrich=false&k=ed45e86d-a09e-4d2b-85c0-fbbd6857373e
Requested by
Host: cdn.permutive.com
URL: https://cdn.permutive.com/5f42864d-a421-4f37-9478-00266f871d68-web.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
34.107.254.252 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
Permutive /
Resource Hash
4f5544ca746d79a39660285ae11347efbea414b82dbcc90af10681b991df242d

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type
text/plain

Response headers

date
Tue, 15 Dec 2020 12:45:48 GMT
content-encoding
gzip
server
Permutive
vary
Origin,Access-Control-Request-Method
access-control-allow-methods
POST
content-type
application/json
access-control-allow-origin
https://www.dailymail.co.uk
access-control-expose-headers
*
access-control-allow-credentials
true
access-control-max-age
86400
alt-svc
clear
content-length
112
via
1.1 google
multitracking
hb.hb.selectmedia.asia/adunit/ Frame C776
0
210 B
XHR
General
Full URL
https://hb.hb.selectmedia.asia/adunit/multitracking
Requested by
Host: player.hb.selectmedia.asia
URL: https://player.hb.selectmedia.asia/prebidlink/446676/wrapper_hb_310028_7816.js
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_128_GCM
Server
23.227.137.155 Piscataway, United States, ASN55081 (24SHELLS, US),
Reverse DNS
Software
VertaMedia 1.0 /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type
text/plain;charset=UTF-8

Response headers

Access-Control-Allow-Origin
https://www.dailymail.co.uk
Date
Tue, 15 Dec 2020 12:45:48 GMT
Access-Control-Allow-Credentials
true
Server
VertaMedia 1.0
Connection
Keep-Alive
ads
securepubads.g.doubleclick.net/gampad/
42 KB
11 KB
XHR
General
Full URL
https://securepubads.g.doubleclick.net/gampad/ads?gdfp_req=1&pvsid=2639827676159032&correlator=813972129893296&output=ldjh&impl=fif&adsid=NT&hxva=1&scor=4077711442053471&eid=21069142&vrg=2020120801&guci=1.2.0.0.2.2.0.0&sc=1&sfv=1-0-37&ecs=20201215&iu_parts=5765%2Cdailymail.uk%2Cdm_dmsciencetech_sciencetechart%2Cbillboard&enc_prev_ius=%2F0%2F1%2F2%2F3&prev_iu_szs=2000x1200%7C970x250%7C900x250%7C728x90&ris=12&rcs=1&prev_scp=amznbid%3D2%26amznp%3D2%26pos%3Dbillboard%26adx_channel%3D16%26nobids%3Dfalse%26refresh%3Dtrue%26refreshCount%3D1%26refreshReason%3Dsecondary%26amznsz%3D0x0&eri=5&cust_params=page%3Dart%26article%3D9050821%26area%3Dsciencetech%26subarea%3Dsciencetech%26environment%3Dproduction%26country%3Dde%26abv%3Dmol-22070%252F19a28e0b%26bot%3Dfalse%26random%3D9ceebda3-1911-4085-b4cd-4ef660466486%26impid%3Dc0338c30-9d3e-46d6-8db6-95c14a8ccbca%26browserResolution%3Dmin_1244px%26device%3Dother%26device_features%3D%26articlewithvideo%3Dtrue%26style%3Dwide%26session%3D1%26session_page_ID%3Dnone%26utm_source%3Dnone%26watershed%3Dfalse%26location%3Ddailymail_co_uk%26id5%3Dtrue%26permutive%3D10277%252C31736%252Crts%26puid%3Db77f6280-fced-4776-aef9-89e90021e68b%26ptime%3D1608036337226&cookie_enabled=1&cdm=www.dailymail.co.uk&bc=31&abxe=1&dt=1608036349735&dlt=1608036336099&idt=1063&frm=20&biw=1600&bih=1200&oid=3&adxs=315&adys=197&adks=1878184308&ucis=h&ifi=17&u_tz=60&u_his=2&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_sd=1&flash=0&url=www.dailymail.co.uk%2Fsciencetech%2Farticle-9050821%2FRemdesivir-beneficial-patients-doctors-reveal.html&loc=https%3A%2F%2Fwww.dailymail.co.uk%2Fsciencetech%2Farticle-9050821%2FRemdesivir-beneficial-patients-doctors-reveal.html%3F_hsmi%3D88974744%26_hsenc%3Dp2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8&vis=1&dmc=8&scr_x=0&scr_y=0&psz=964x250&msz=967x250&psts=AGkb-H9awlplzm3R5rYar7qljqzk%2CAGkb-H9awlplzm3R5rYar7qljqzk%2CAGkb-H8Ea__ROWP6iCtuJnTikfDqFvgEhdFS__bGkDqK7myRJiYdigEmc1U3zmUA-HbB_-yknenOJN1ffIdLQkho7xCYGVETkh6MjNNcBQB1GThq%2CAGkb-H_HHgb-ej7WoKrtrUjNTtfeo5G-OKX_xahMmESAuKTirTuTEVkjzEIiEag9li6aJ5kWuHJKepquTmpNYBXMcd801TqJUgY%2CAGkb-H_qks9dOj5iazk8dWvqXenEjE30c6uzBADN2FtppUjCVT_K0cEEZQh7HO-xLYAPnLaig-mi04Qzytr_pVk6JvH9KIMyZ88%2CAGkb-H_kLF1AY5tYs0PgmKkfZxautJ6ScGSg7NxOm3cfdQbwhwWLzXrHO7d42mAct108-47ZZJEFPWJ2EXtkfVrjCQ%2CAGkb-H_sHjbTd8z71RygOesyTGrmB1KCVtwZqlnVJfFtG-Xda2SCul8mNJBeYhCU0gsQOSZQjUS2AEbhgXvRTPqY-A&ga_vid=254203172.1608036337&ga_sid=1608036337&ga_hid=881620343&fws=4&ohw=967&btvi=0&tt_state=W3siaXNzdWVyT3JpZ2luIjoiaHR0cHM6Ly9hZHNlcnZpY2UuZ29vZ2xlLmNvbSIsInN0YXRlIjowfSx7Imlzc3Vlck9yaWdpbiI6Imh0dHBzOi8vYXR0ZXN0YXRpb24uYW5kcm9pZC5jb20iLCJzdGF0ZSI6MH1d
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020120801.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
172.217.22.2 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
fra16s14-in-f2.1e100.net
Software
cafe /
Resource Hash
125ab651e834c279abb5684166aac424dc3619b2bd445085e2f1c2733f7b8596
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:45:50 GMT
content-encoding
br
x-content-type-options
nosniff
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
cross-origin-resource-policy
cross-origin
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
10708
x-xss-protection
0
google-lineitem-id
-1
pragma
no-cache
server
cafe
google-creative-id
-1
content-type
text/plain; charset=UTF-8
access-control-allow-origin
https://www.dailymail.co.uk
access-control-expose-headers
x-google-amp-ad-validated-version
cache-control
no-cache, must-revalidate
access-control-allow-credentials
true
timing-allow-origin
*
expires
Fri, 01 Jan 1990 00:00:00 GMT
integrator.js
adservice.google.nl/adsid/ Frame C776
109 B
803 B
Script
General
Full URL
https://adservice.google.nl/adsid/integrator.js?domain=www.dailymail.co.uk
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020120801.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:825::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
0482a98d09daebc18a0d2e1ed8f748da5b0179e61223ed541101df1f4699f073
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

timing-allow-origin
*
date
Tue, 15 Dec 2020 12:45:50 GMT
content-encoding
gzip
x-content-type-options
nosniff
server
cafe
p3p
CP="This is not a P3P policy! See http://support.google.com/accounts/answer/151657 for more info."
cache-control
private, no-cache, no-store
cross-origin-resource-policy
cross-origin
content-disposition
attachment; filename="f.txt"
content-type
application/javascript; charset=UTF-8
alt-svc
h3-29="googleads.g.doubleclick.net:443"; ma=2592000,h3-29=":443"; ma=2592000,h3-T051="googleads.g.doubleclick.net:443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic="googleads.g.doubleclick.net:443"; ma=2592000; v="46,43",quic=":443"; ma=2592000; v="46,43"
content-length
104
x-xss-protection
0
integrator.js
adservice.google.com/adsid/ Frame C776
109 B
169 B
Script
General
Full URL
https://adservice.google.com/adsid/integrator.js?domain=www.dailymail.co.uk
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020120801.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:814::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
0482a98d09daebc18a0d2e1ed8f748da5b0179e61223ed541101df1f4699f073
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

timing-allow-origin
*
date
Tue, 15 Dec 2020 12:45:49 GMT
content-encoding
gzip
x-content-type-options
nosniff
server
cafe
p3p
CP="This is not a P3P policy! See http://support.google.com/accounts/answer/151657 for more info."
cache-control
private, no-cache, no-store
cross-origin-resource-policy
cross-origin
content-disposition
attachment; filename="f.txt"
content-type
application/javascript; charset=UTF-8
alt-svc
h3-29="googleads.g.doubleclick.net:443"; ma=2592000,h3-29=":443"; ma=2592000,h3-T051="googleads.g.doubleclick.net:443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic="googleads.g.doubleclick.net:443"; ma=2592000; v="46,43",quic=":443"; ma=2592000; v="46,43"
content-length
104
x-xss-protection
0
ads
securepubads.g.doubleclick.net/gampad/ Frame C776
80 KB
25 KB
XHR
General
Full URL
https://securepubads.g.doubleclick.net/gampad/ads?gdfp_req=1&pvsid=4276847570814136&correlator=1071249441061179&output=ldjh&impl=fifs&eid=21064370%2C21068812%2C21069710&vrg=2020120801&guci=1.2.0.0.2.2.0.0&sc=1&sfv=1-0-37&ecs=20201215&iu_parts=84772874%2CVidsplay_300X250_EBDA&enc_prev_ius=%2F0%2F1&prev_iu_szs=300x250&prev_scp=excl_cat%3DPREPOST&eri=1&cookie_enabled=1&cdm=www.dailymail.co.uk&bc=31&abxe=1&lmt=1608036349&dt=1608036349986&dlt=1608036343703&idt=1439&ea=0&frm=23&biw=1600&bih=1200&isw=480&ish=270&oid=3&adxs=486&adys=1167&adks=596843069&ucis=4jnk6rci5mnc&ifi=1&ifk=3804922819&u_tz=60&u_his=2&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_sd=1&flash=0&nhd=1&url=https%3A%2F%2Fwww.dailymail.co.uk%2Fsciencetech%2Farticle-9050821%2FRemdesivir-beneficial-patients-doctors-reveal.html%3F_hsmi%3D88974744%26_hsenc%3Dp2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8&top=https%3A%2F%2Fwww.dailymail.co.uk%2Fsciencetech%2Farticle-9050821%2FRemdesivir-beneficial-patients-doctors-reveal.html%3F_hsmi%3D88974744%26_hsenc%3Dp2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8&vis=1&dmc=8&scr_x=0&scr_y=0&psz=480x270&msz=300x250&ga_vid=1411682477.1608036350&ga_sid=1608036350&ga_hid=231746364&fws=256&ohw=0&tt_state=W3siaXNzdWVyT3JpZ2luIjoiaHR0cHM6Ly9hZHNlcnZpY2UuZ29vZ2xlLmNvbSIsInN0YXRlIjowfSx7Imlzc3Vlck9yaWdpbiI6Imh0dHBzOi8vYXR0ZXN0YXRpb24uYW5kcm9pZC5jb20iLCJzdGF0ZSI6MH1d
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020120801.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
172.217.22.2 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
fra16s14-in-f2.1e100.net
Software
cafe /
Resource Hash
07efdd2bbc755a75c3f37743621c1cdfde1c786d9dab0929602cc99ac835c8db
Security Headers
Name Value
Content-Security-Policy child-src 'unsafe-inline' cm.g.doubleclick.net googleads.g.doubleclick.net www.google.com accounts.google.com pagead2.googlesyndication.com/pagead/s/cookie_push.html gmsg: https://tpc.googlesyndication.com/sadbundle/$csp%3Der3$/14432073143463343022/headph-300x250px-nl/headph-300x250px-nl.html;frame-src 'unsafe-inline' cm.g.doubleclick.net googleads.g.doubleclick.net www.google.com accounts.google.com pagead2.googlesyndication.com/pagead/s/cookie_push.html gmsg: https://tpc.googlesyndication.com/sadbundle/$csp%3Der3$/14432073143463343022/headph-300x250px-nl/headph-300x250px-nl.html;report-uri https://pagead2.googlesyndication.com/pagead/gen_csp?id=adbundle&qqi=CLPdt5uC0O0CFUVL4AodcWkMCA&gqi=&layout=/sadbundle/%24csp%253Der3%24/14432073143463343022/headph-300x250px-nl/headph-300x250px-nl.html
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

content-security-policy
child-src 'unsafe-inline' cm.g.doubleclick.net googleads.g.doubleclick.net www.google.com accounts.google.com pagead2.googlesyndication.com/pagead/s/cookie_push.html gmsg: https://tpc.googlesyndication.com/sadbundle/$csp%3Der3$/14432073143463343022/headph-300x250px-nl/headph-300x250px-nl.html;frame-src 'unsafe-inline' cm.g.doubleclick.net googleads.g.doubleclick.net www.google.com accounts.google.com pagead2.googlesyndication.com/pagead/s/cookie_push.html gmsg: https://tpc.googlesyndication.com/sadbundle/$csp%3Der3$/14432073143463343022/headph-300x250px-nl/headph-300x250px-nl.html;report-uri https://pagead2.googlesyndication.com/pagead/gen_csp?id=adbundle&qqi=CLPdt5uC0O0CFUVL4AodcWkMCA&gqi=&layout=/sadbundle/%24csp%253Der3%24/14432073143463343022/headph-300x250px-nl/headph-300x250px-nl.html
content-encoding
br
x-content-type-options
nosniff
google-creative-id
-1
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
cross-origin-resource-policy
cross-origin
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
25130
x-xss-protection
0
google-lineitem-id
-1
pragma
no-cache
server
cafe
date
Tue, 15 Dec 2020 12:45:50 GMT
content-type
text/plain; charset=UTF-8
access-control-allow-origin
https://www.dailymail.co.uk
cache-control
no-cache, must-revalidate
access-control-allow-credentials
true
timing-allow-origin
*
expires
Fri, 01 Jan 1990 00:00:00 GMT
container.html
9983081ac8e174582a7b6a6acc4b473e.safeframe.googlesyndication.com/safeframe/1-0-37/html/ Frame C776
0
0
Other
General
Full URL
https://9983081ac8e174582a7b6a6acc4b473e.safeframe.googlesyndication.com/safeframe/1-0-37/html/container.html?n=1
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020120801.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:801::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
/
Resource Hash

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

container.html
tpc.googlesyndication.com/safeframe/1-0-37/html/ Frame C776
0
0
Other
General
Full URL
https://tpc.googlesyndication.com/safeframe/1-0-37/html/container.html?n=1
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020120801.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:81d::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
/
Resource Hash

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

amp4ads-v0.mjs
cdn.ampproject.org/rtv/012010270040000/ Frame CD23
180 KB
50 KB
Script
General
Full URL
https://cdn.ampproject.org/rtv/012010270040000/amp4ads-v0.mjs
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020120801.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:81f::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
b2ab9ac436910017b9a2ca7db0e981bad3638db97f576d713eaa9b302e06c094
Security Headers
Name Value
Content-Security-Policy default-src * blob: data:; script-src blob: https://cdn.ampproject.org/esm/ https://cdn.ampproject.org/lts/ https://cdn.ampproject.org/mp/ https://cdn.ampproject.org/rtv/ https://cdn.ampproject.org/sp/ https://cdn.ampproject.org/sw/ https://cdn.ampproject.org/v0.js https://cdn.ampproject.org/v0.mjs https://cdn.ampproject.org/v0/ https://cdn.ampproject.org/viewer/; object-src 'none'; style-src 'unsafe-inline' https://cdn.ampproject.org/rtv/ https://cdn.materialdesignicons.com https://cloud.typography.com https://fast.fonts.net https://fonts.googleapis.com https://maxcdn.bootstrapcdn.com https://p.typekit.net https://pro.fontawesome.com https://use.fontawesome.com https://use.typekit.net; report-uri https://csp.withgoogle.com/csp/amp
Strict-Transport-Security max-age=31536000; includeSubDomains; preload
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

content-security-policy
default-src * blob: data:; script-src blob: https://cdn.ampproject.org/esm/ https://cdn.ampproject.org/lts/ https://cdn.ampproject.org/mp/ https://cdn.ampproject.org/rtv/ https://cdn.ampproject.org/sp/ https://cdn.ampproject.org/sw/ https://cdn.ampproject.org/v0.js https://cdn.ampproject.org/v0.mjs https://cdn.ampproject.org/v0/ https://cdn.ampproject.org/viewer/; object-src 'none'; style-src 'unsafe-inline' https://cdn.ampproject.org/rtv/ https://cdn.materialdesignicons.com https://cloud.typography.com https://fast.fonts.net https://fonts.googleapis.com https://maxcdn.bootstrapcdn.com https://p.typekit.net https://pro.fontawesome.com https://use.fontawesome.com https://use.typekit.net; report-uri https://csp.withgoogle.com/csp/amp
content-encoding
br
x-content-type-options
nosniff
age
397967
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
51478
x-xss-protection
0
server
sffe
date
Thu, 10 Dec 2020 22:13:03 GMT
strict-transport-security
max-age=31536000; includeSubDomains; preload
content-type
text/javascript
access-control-allow-origin
*
vary
Accept-Encoding
cache-control
public, max-age=31536000
etag
"0305d7d21a7fe4a1"
accept-ranges
bytes
timing-allow-origin
*
expires
Fri, 10 Dec 2021 22:13:03 GMT
amp-ad-exit-0.1.mjs
cdn.ampproject.org/rtv/012010270040000/v0/ Frame CD23
13 KB
5 KB
Script
General
Full URL
https://cdn.ampproject.org/rtv/012010270040000/v0/amp-ad-exit-0.1.mjs
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020120801.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:81f::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
ebab910fdc7c7e9e079caa9f7321177b135b2e1542f86ce36937ceb41865086d
Security Headers
Name Value
Content-Security-Policy default-src * blob: data:; script-src blob: https://cdn.ampproject.org/esm/ https://cdn.ampproject.org/lts/ https://cdn.ampproject.org/mp/ https://cdn.ampproject.org/rtv/ https://cdn.ampproject.org/sp/ https://cdn.ampproject.org/sw/ https://cdn.ampproject.org/v0.js https://cdn.ampproject.org/v0.mjs https://cdn.ampproject.org/v0/ https://cdn.ampproject.org/viewer/; object-src 'none'; style-src 'unsafe-inline' https://cdn.ampproject.org/rtv/ https://cdn.materialdesignicons.com https://cloud.typography.com https://fast.fonts.net https://fonts.googleapis.com https://maxcdn.bootstrapcdn.com https://p.typekit.net https://pro.fontawesome.com https://use.fontawesome.com https://use.typekit.net; report-uri https://csp.withgoogle.com/csp/amp
Strict-Transport-Security max-age=31536000; includeSubDomains; preload
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

content-security-policy
default-src * blob: data:; script-src blob: https://cdn.ampproject.org/esm/ https://cdn.ampproject.org/lts/ https://cdn.ampproject.org/mp/ https://cdn.ampproject.org/rtv/ https://cdn.ampproject.org/sp/ https://cdn.ampproject.org/sw/ https://cdn.ampproject.org/v0.js https://cdn.ampproject.org/v0.mjs https://cdn.ampproject.org/v0/ https://cdn.ampproject.org/viewer/; object-src 'none'; style-src 'unsafe-inline' https://cdn.ampproject.org/rtv/ https://cdn.materialdesignicons.com https://cloud.typography.com https://fast.fonts.net https://fonts.googleapis.com https://maxcdn.bootstrapcdn.com https://p.typekit.net https://pro.fontawesome.com https://use.fontawesome.com https://use.typekit.net; report-uri https://csp.withgoogle.com/csp/amp
content-encoding
br
x-content-type-options
nosniff
age
285478
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
4850
x-xss-protection
0
server
sffe
date
Sat, 12 Dec 2020 05:27:52 GMT
strict-transport-security
max-age=31536000; includeSubDomains; preload
content-type
text/javascript
access-control-allow-origin
*
vary
Accept-Encoding
cache-control
public, max-age=31536000
etag
"77bd676d834aaa8d"
accept-ranges
bytes
timing-allow-origin
*
expires
Sun, 12 Dec 2021 05:27:52 GMT
amp-analytics-0.1.mjs
cdn.ampproject.org/rtv/012010270040000/v0/ Frame CD23
90 KB
27 KB
Script
General
Full URL
https://cdn.ampproject.org/rtv/012010270040000/v0/amp-analytics-0.1.mjs
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020120801.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:81f::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
477549a4d5fb644cda6bf64af01631b8411022d88e608bbd8e5a06e327b391cb
Security Headers
Name Value
Content-Security-Policy default-src * blob: data:; script-src blob: https://cdn.ampproject.org/esm/ https://cdn.ampproject.org/lts/ https://cdn.ampproject.org/mp/ https://cdn.ampproject.org/rtv/ https://cdn.ampproject.org/sp/ https://cdn.ampproject.org/sw/ https://cdn.ampproject.org/v0.js https://cdn.ampproject.org/v0.mjs https://cdn.ampproject.org/v0/ https://cdn.ampproject.org/viewer/; object-src 'none'; style-src 'unsafe-inline' https://cdn.ampproject.org/rtv/ https://cdn.materialdesignicons.com https://cloud.typography.com https://fast.fonts.net https://fonts.googleapis.com https://maxcdn.bootstrapcdn.com https://p.typekit.net https://pro.fontawesome.com https://use.fontawesome.com https://use.typekit.net; report-uri https://csp.withgoogle.com/csp/amp
Strict-Transport-Security max-age=31536000; includeSubDomains; preload
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

content-security-policy
default-src * blob: data:; script-src blob: https://cdn.ampproject.org/esm/ https://cdn.ampproject.org/lts/ https://cdn.ampproject.org/mp/ https://cdn.ampproject.org/rtv/ https://cdn.ampproject.org/sp/ https://cdn.ampproject.org/sw/ https://cdn.ampproject.org/v0.js https://cdn.ampproject.org/v0.mjs https://cdn.ampproject.org/v0/ https://cdn.ampproject.org/viewer/; object-src 'none'; style-src 'unsafe-inline' https://cdn.ampproject.org/rtv/ https://cdn.materialdesignicons.com https://cloud.typography.com https://fast.fonts.net https://fonts.googleapis.com https://maxcdn.bootstrapcdn.com https://p.typekit.net https://pro.fontawesome.com https://use.fontawesome.com https://use.typekit.net; report-uri https://csp.withgoogle.com/csp/amp
content-encoding
br
x-content-type-options
nosniff
age
475648
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
27668
x-xss-protection
0
server
sffe
date
Thu, 10 Dec 2020 00:38:22 GMT
strict-transport-security
max-age=31536000; includeSubDomains; preload
content-type
text/javascript
access-control-allow-origin
*
vary
Accept-Encoding
cache-control
public, max-age=31536000
etag
"1304c1c0caf7ca3c"
accept-ranges
bytes
timing-allow-origin
*
expires
Fri, 10 Dec 2021 00:38:22 GMT
amp-fit-text-0.1.mjs
cdn.ampproject.org/rtv/012010270040000/v0/ Frame CD23
3 KB
1 KB
Script
General
Full URL
https://cdn.ampproject.org/rtv/012010270040000/v0/amp-fit-text-0.1.mjs
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020120801.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:81f::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
a86753d4effe5e607d4eaf03fe37eccb8cac743a528f874f736f4d7f35e094b1
Security Headers
Name Value
Content-Security-Policy default-src * blob: data:; script-src blob: https://cdn.ampproject.org/esm/ https://cdn.ampproject.org/lts/ https://cdn.ampproject.org/mp/ https://cdn.ampproject.org/rtv/ https://cdn.ampproject.org/sp/ https://cdn.ampproject.org/sw/ https://cdn.ampproject.org/v0.js https://cdn.ampproject.org/v0.mjs https://cdn.ampproject.org/v0/ https://cdn.ampproject.org/viewer/; object-src 'none'; style-src 'unsafe-inline' https://cdn.ampproject.org/rtv/ https://cdn.materialdesignicons.com https://cloud.typography.com https://fast.fonts.net https://fonts.googleapis.com https://maxcdn.bootstrapcdn.com https://p.typekit.net https://pro.fontawesome.com https://use.fontawesome.com https://use.typekit.net; report-uri https://csp.withgoogle.com/csp/amp
Strict-Transport-Security max-age=31536000; includeSubDomains; preload
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

content-security-policy
default-src * blob: data:; script-src blob: https://cdn.ampproject.org/esm/ https://cdn.ampproject.org/lts/ https://cdn.ampproject.org/mp/ https://cdn.ampproject.org/rtv/ https://cdn.ampproject.org/sp/ https://cdn.ampproject.org/sw/ https://cdn.ampproject.org/v0.js https://cdn.ampproject.org/v0.mjs https://cdn.ampproject.org/v0/ https://cdn.ampproject.org/viewer/; object-src 'none'; style-src 'unsafe-inline' https://cdn.ampproject.org/rtv/ https://cdn.materialdesignicons.com https://cloud.typography.com https://fast.fonts.net https://fonts.googleapis.com https://maxcdn.bootstrapcdn.com https://p.typekit.net https://pro.fontawesome.com https://use.fontawesome.com https://use.typekit.net; report-uri https://csp.withgoogle.com/csp/amp
content-encoding
br
x-content-type-options
nosniff
age
355570
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
1350
x-xss-protection
0
server
sffe
date
Fri, 11 Dec 2020 09:59:40 GMT
strict-transport-security
max-age=31536000; includeSubDomains; preload
content-type
text/javascript
access-control-allow-origin
*
vary
Accept-Encoding
cache-control
public, max-age=31536000
etag
"12c034eb739190af"
accept-ranges
bytes
timing-allow-origin
*
expires
Sat, 11 Dec 2021 09:59:40 GMT
amp-form-0.1.mjs
cdn.ampproject.org/rtv/012010270040000/v0/ Frame CD23
41 KB
13 KB
Script
General
Full URL
https://cdn.ampproject.org/rtv/012010270040000/v0/amp-form-0.1.mjs
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020120801.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:81f::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
b61eb57ae77f31b91b04781da33023ecd897fda21f6c817e6c27623204046f42
Security Headers
Name Value
Content-Security-Policy default-src * blob: data:; script-src blob: https://cdn.ampproject.org/esm/ https://cdn.ampproject.org/lts/ https://cdn.ampproject.org/mp/ https://cdn.ampproject.org/rtv/ https://cdn.ampproject.org/sp/ https://cdn.ampproject.org/sw/ https://cdn.ampproject.org/v0.js https://cdn.ampproject.org/v0.mjs https://cdn.ampproject.org/v0/ https://cdn.ampproject.org/viewer/; object-src 'none'; style-src 'unsafe-inline' https://cdn.ampproject.org/rtv/ https://cdn.materialdesignicons.com https://cloud.typography.com https://fast.fonts.net https://fonts.googleapis.com https://maxcdn.bootstrapcdn.com https://p.typekit.net https://pro.fontawesome.com https://use.fontawesome.com https://use.typekit.net; report-uri https://csp.withgoogle.com/csp/amp
Strict-Transport-Security max-age=31536000; includeSubDomains; preload
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

content-security-policy
default-src * blob: data:; script-src blob: https://cdn.ampproject.org/esm/ https://cdn.ampproject.org/lts/ https://cdn.ampproject.org/mp/ https://cdn.ampproject.org/rtv/ https://cdn.ampproject.org/sp/ https://cdn.ampproject.org/sw/ https://cdn.ampproject.org/v0.js https://cdn.ampproject.org/v0.mjs https://cdn.ampproject.org/v0/ https://cdn.ampproject.org/viewer/; object-src 'none'; style-src 'unsafe-inline' https://cdn.ampproject.org/rtv/ https://cdn.materialdesignicons.com https://cloud.typography.com https://fast.fonts.net https://fonts.googleapis.com https://maxcdn.bootstrapcdn.com https://p.typekit.net https://pro.fontawesome.com https://use.fontawesome.com https://use.typekit.net; report-uri https://csp.withgoogle.com/csp/amp
content-encoding
br
x-content-type-options
nosniff
age
353682
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
13075
x-xss-protection
0
server
sffe
date
Fri, 11 Dec 2020 10:31:08 GMT
strict-transport-security
max-age=31536000; includeSubDomains; preload
content-type
text/javascript
access-control-allow-origin
*
vary
Accept-Encoding
cache-control
public, max-age=31536000
etag
"1e8a1dae72af56cd"
accept-ranges
bytes
timing-allow-origin
*
expires
Sat, 11 Dec 2021 10:31:08 GMT
en.png
tpc.googlesyndication.com/pagead/images/adchoices/ Frame CD23
2 KB
2 KB
Image
General
Full URL
https://tpc.googlesyndication.com/pagead/images/adchoices/en.png
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020120801.js
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:81d::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
36133ca07927c88a7cc578fddbaed3c668ab75087834d0ca13dca5de4ec856c1
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

timing-allow-origin
*
date
Mon, 14 Dec 2020 23:34:27 GMT
x-content-type-options
nosniff
server
cafe
age
47483
etag
14819457070020093239
vary
Accept-Encoding
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
cache-control
public, max-age=86400
cross-origin-resource-policy
cross-origin
content-type
image/png
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
2502
x-xss-protection
0
expires
Tue, 15 Dec 2020 23:34:27 GMT
icon.png
tpc.googlesyndication.com/pagead/images/adchoices/ Frame CD23
295 B
327 B
Image
General
Full URL
https://tpc.googlesyndication.com/pagead/images/adchoices/icon.png
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020120801.js
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:81d::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
7fd59024b6ca83f11f7a3448ec148309a13b705725716df134f699e60a96eb1b
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

timing-allow-origin
*
date
Mon, 14 Dec 2020 21:53:21 GMT
x-content-type-options
nosniff
server
cafe
age
53549
etag
426692510519060060
vary
Accept-Encoding
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
cache-control
public, max-age=86400
cross-origin-resource-policy
cross-origin
content-type
image/png
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
295
x-xss-protection
0
expires
Tue, 15 Dec 2020 21:53:21 GMT
truncated
/ Frame CD23
213 B
0
Image
General
Full URL
data:truncated
Protocol
DATA
Server
-, , ASN (),
Reverse DNS
Software
/
Resource Hash
cfd2b0bf5bc5abafd174f7378fbe85ac7d8fd953badfed254a5eefa22c57347c

Request headers

Referer
https://www.dailymail.co.uk/
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Content-Type
image/png
14683404087166138179
tpc.googlesyndication.com/simgad/ Frame CD23
93 KB
93 KB
Image
General
Full URL
https://tpc.googlesyndication.com/simgad/14683404087166138179?sqp=4sqPyQQ7QjkqNxABHQAAtEIgASgBMAk4A0DwkwlYAWBfcAKAAQGIAQGdAQAAgD-oAQGwAYCt4gS4AV_FAS2ynT4&rs=AOga4qlxnr7_2IRwy5rWwZIVpGswXBEHRg
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:81d::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
750f0c5de4dd187580704cedee6071c300f2587dce24c39b88647c4802e81855
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 06:27:23 GMT
x-content-type-options
nosniff
last-modified
Tue, 15 Dec 2020 01:24:32 GMT
server
sffe
age
22707
content-type
image/png
access-control-allow-origin
*
cache-control
public, max-age=31536000
cross-origin-resource-policy
cross-origin
accept-ranges
bytes
timing-allow-origin
*
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
94809
x-xss-protection
0
expires
Wed, 15 Dec 2021 06:27:23 GMT
l
www.google.com/ads/measurement/ Frame CD23
0
0
Image
General
Full URL
https://www.google.com/ads/measurement/l?ebcid=ALh7CaQ5-QUuTsWKGmMXshfUrwYxSLRlqIGZkl5Qmh2wmzBagxyyMs8eN6X0OuPf5Uk_OpsAbaAF
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:824::2004 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
https://www.dailymail.co.uk/
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

adview
securepubads.g.doubleclick.net/pagead/ Frame CD23
0
0
Image
General
Full URL
https://securepubads.g.doubleclick.net/pagead/adview?ai=Coho8_a_YX8eMMMyHgAeZ8YjoDpKzuctgxImm3YIN2tkeEAEgrNm4ImCRhJOF_BfIAQLgAgCoAwHIAwiqBLgCT9DUPN4kXFCYtLSPHBmBiloM3WPbJfRczGmeP15RRKbEnIrk4BQKoZtngtBuda7JhizPqKW_NOrpdLR_i3VjS5ovqk-Q6CcMy5Pjlujk-dy4S43J5BcJCRvFuTRqG-flpT7_drz4zR8sepN9Vr7qk_GyPfswJ1Tz7gv09rilXnOSOOpXHkHT57NPXoU9ZOOv6L_2GtD_riJ7uCOMUJqKmvEBv8n6XhfQXm6lIId2Eob4s3T4_8vD4raIDXIdx3TidNtZX2z8l53O42u3VJQzf6_D-4h6cDJwOp36Xzzt2NmJ24hvY6yEOlHI7DQEpJMSHAvRA-jnXXUj-LDnrw_UPSJEuzVTtQI0FrDpbL5jSMhe8RoWPE8b7nYweHlVoF7Pq31zsdugqp80dO2cn3cgrxQFo-wqb60uwASalfqBsgPgBAGSBQQIBBgBkgUECAUYBKAGAoAHj8u3ywGoB9XJG6gH8NkbqAfy2RuoB5SYsQKoB6XfG6gHjs4bqAeT2BuoB7oGqAfulrECqAemvhuoB-zVG9gHAfIHBBDa1RfSCAkIgOGAUBABGB2ACgPICwHYEwKyFxoKGAgBEhRwdWItNDE4MDgzNTY5NDE2NjI1NQ&sigh=dXwHWrBYYMI&tpd=AGWhJmsOj1acC8rP94jTLCbkCu5r7G8W6nVjTxFp6C9Xr1n02A
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
172.217.22.2 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
fra16s14-in-f2.1e100.net
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
https://www.dailymail.co.uk/
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

si
googleads.g.doubleclick.net/pagead/drt/ Frame CD23
Redirect Chain
  • https://www.google.com/pagead/drt/ui
  • https://googleads.g.doubleclick.net/pagead/drt/si
0
0
Image
General
Full URL
https://googleads.g.doubleclick.net/pagead/drt/si
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:814::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Redirect headers

date
Tue, 15 Dec 2020 12:45:50 GMT
x-content-type-options
nosniff
server
safe
content-type
text/html; charset=UTF-8
location
https://googleads.g.doubleclick.net/pagead/drt/si
cache-control
private
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
246
x-xss-protection
0
container.html
9983081ac8e174582a7b6a6acc4b473e.safeframe.googlesyndication.com/safeframe/1-0-37/html/ Frame 6BFB
0
0
Document
General
Full URL
https://9983081ac8e174582a7b6a6acc4b473e.safeframe.googlesyndication.com/safeframe/1-0-37/html/container.html?n=1
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020120801.js
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:801::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

:method
GET
:authority
9983081ac8e174582a7b6a6acc4b473e.safeframe.googlesyndication.com
:scheme
https
:path
/safeframe/1-0-37/html/container.html?n=1
pragma
no-cache
cache-control
no-cache
upgrade-insecure-requests
1
user-agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
accept
text/html,application/xhtml+xml,application/xml;q=0.9,image/avif,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3;q=0.9
sec-fetch-site
cross-site
sec-fetch-mode
navigate
sec-fetch-dest
iframe
referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
accept-encoding
gzip, deflate, br
accept-language
en-US
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8

Response headers

accept-ranges
bytes
vary
Accept-Encoding
content-encoding
gzip
content-type
text/html
cross-origin-resource-policy
cross-origin
timing-allow-origin
*
content-length
2973
date
Tue, 15 Dec 2020 12:45:50 GMT
expires
Wed, 15 Dec 2021 12:45:50 GMT
last-modified
Thu, 21 Nov 2019 16:01:11 GMT
x-content-type-options
nosniff
server
sffe
x-xss-protection
0
cache-control
public, immutable, max-age=31536000
age
0
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
osd.js
www.googletagservices.com/activeview/js/current/ Frame C776
74 KB
28 KB
Script
General
Full URL
https://www.googletagservices.com/activeview/js/current/osd.js?cb=%2Fr20100101
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020120801.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:814::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
c1c9310eb6a56101c2133db372cfbe9cefb5ff6b90a02ded916984c975b813b2
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:45:50 GMT
content-encoding
gzip
x-content-type-options
nosniff
server
sffe
etag
"1607690616793149"
vary
Accept-Encoding
content-type
text/javascript
cache-control
private, max-age=3000
accept-ranges
bytes
alt-svc
h3-29="googleads.g.doubleclick.net:443"; ma=2592000,h3-29=":443"; ma=2592000,h3-T051="googleads.g.doubleclick.net:443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic="googleads.g.doubleclick.net:443"; ma=2592000; v="46,43",quic=":443"; ma=2592000; v="46,43"
content-length
28334
x-xss-protection
0
expires
Tue, 15 Dec 2020 12:45:50 GMT
sodar
pagead2.googlesyndication.com/getconfig/ Frame C776
8 KB
7 KB
XHR
General
Full URL
https://pagead2.googlesyndication.com/getconfig/sodar?sv=200&tid=gpt&tv=2020120801&st=env
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020120801.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:825::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
192211804c1afac33b756b06f904791a797c07d53eb2966e3fe87c15a4b2efbc
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

timing-allow-origin
*
date
Tue, 15 Dec 2020 12:45:50 GMT
content-encoding
gzip
x-content-type-options
nosniff
server
cafe
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
access-control-allow-origin
*
cache-control
private
cross-origin-resource-policy
cross-origin
content-disposition
attachment; filename="f.txt"
content-type
application/json; charset=UTF-8
alt-svc
h3-29="googleads.g.doubleclick.net:443"; ma=2592000,h3-29=":443"; ma=2592000,h3-T051="googleads.g.doubleclick.net:443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic="googleads.g.doubleclick.net:443"; ma=2592000; v="46,43",quic=":443"; ma=2592000; v="46,43"
content-length
6600
x-xss-protection
0
v2_310028_7816.json
player.hb.selectmedia.asia/prebidlink/2680060/ Frame C776
229 KB
18 KB
XHR
General
Full URL
https://player.hb.selectmedia.asia/prebidlink/2680060/v2_310028_7816.json?cb=www.dailymail.co.uk
Requested by
Host: player.hb.selectmedia.asia
URL: https://player.hb.selectmedia.asia/prebidlink/446676/wrapper_hb_310028_7816.js
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
213.174.135.2 Ashburn, United States, ASN39572 (ADVANCEDHOSTERS-AS, NL),
Reverse DNS
Software
nginx /
Resource Hash
d46945c2f739cd0c340a53811937643b8755d5d9d5630a342b0021feb8c60f3f

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:45:51 GMT
content-encoding
gzip
last-modified
Tue, 15 Dec 2020 09:44:57 GMT
server
nginx
etag
W/"5fd88599-393fc"
content-type
application/json
access-control-allow-origin
https://www.dailymail.co.uk
cache-control
max-age=3600
expires
Tue, 15 Dec 2020 13:45:51 GMT
sodar2.js
tpc.googlesyndication.com/sodar/ Frame C776
16 KB
6 KB
Script
General
Full URL
https://tpc.googlesyndication.com/sodar/sodar2.js
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020120801.js
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:81d::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
66bfa6dd42535b06a283b3844a0bddcfd7f1aca1368baae035a7cda89a6b97fd
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:45:50 GMT
content-encoding
gzip
x-content-type-options
nosniff
server
sffe
etag
"1603823857801521"
vary
Accept-Encoding
content-type
text/javascript
cache-control
private, max-age=3000
accept-ranges
bytes
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
6015
x-xss-protection
0
expires
Tue, 15 Dec 2020 12:45:50 GMT
runner.html
tpc.googlesyndication.com/sodar/sodar2/219/ Frame 2CDB
0
0
Document
General
Full URL
https://tpc.googlesyndication.com/sodar/sodar2/219/runner.html
Requested by
Host: tpc.googlesyndication.com
URL: https://tpc.googlesyndication.com/sodar/sodar2.js
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:81d::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

:method
GET
:authority
tpc.googlesyndication.com
:scheme
https
:path
/sodar/sodar2/219/runner.html
pragma
no-cache
cache-control
no-cache
upgrade-insecure-requests
1
user-agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
accept
text/html,application/xhtml+xml,application/xml;q=0.9,image/avif,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3;q=0.9
sec-fetch-site
cross-site
sec-fetch-mode
navigate
sec-fetch-dest
iframe
referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
accept-encoding
gzip, deflate, br
accept-language
en-US
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8

Response headers

accept-ranges
bytes
vary
Accept-Encoding
content-encoding
gzip
content-type
text/html
cross-origin-resource-policy
cross-origin
content-length
4867
date
Tue, 15 Dec 2020 12:37:19 GMT
expires
Wed, 15 Dec 2021 12:37:19 GMT
last-modified
Mon, 05 Oct 2020 22:33:01 GMT
x-content-type-options
nosniff
server
sffe
x-xss-protection
0
cache-control
public, max-age=31536000
age
511
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
multitracking
hb.hb.selectmedia.asia/adunit/ Frame C776
0
210 B
XHR
General
Full URL
https://hb.hb.selectmedia.asia/adunit/multitracking
Requested by
Host: player.hb.selectmedia.asia
URL: https://player.hb.selectmedia.asia/prebidlink/446676/wrapper_hb_310028_7816.js
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_128_GCM
Server
23.227.137.155 Piscataway, United States, ASN55081 (24SHELLS, US),
Reverse DNS
Software
VertaMedia 1.0 /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type
text/plain;charset=UTF-8

Response headers

Access-Control-Allow-Origin
https://www.dailymail.co.uk
Date
Tue, 15 Dec 2020 12:45:50 GMT
Access-Control-Allow-Credentials
true
Server
VertaMedia 1.0
Connection
Keep-Alive
gen_204
pagead2.googlesyndication.com/pagead/ Frame C776
0
199 B
Image
General
Full URL
https://pagead2.googlesyndication.com/pagead/gen_204?id=sodar2&v=219&t=2&li=gpt_2020120801&jk=4276847570814136&bg=!YWKlYkLNAAXKjztBylhhk5EPxMY-OwIAAAD5UgAAABhoAQcKAOMPElrngOSKm5xM7IbCoeWueYpBeZkoxoEqIsXJnTZroPlwTjPX7l04Hk2wVzS2DX9rRgnPylrRBnHvnBxe1eU_4HSzRn_fVuNzXvORFEBkvTpKAZ0JqOcrrksN5OBBgoV53SUddwQgs_nJ54N9QwF5WIBUea7IVdAqxjT5jksEyipnGJBxN9D65QMMPRF2fdAvZJbsaFGZhJ8NNG2CPFppahcEnlmrqwsXmjFnIJy87UzT03YUCBvNjDXTSCRIiJQPFBCIpBAxiiuTKgseLgpxPlQWObxwhwYwZxb7Pr9DBkow6ZkB_k3DJdZJG7o7jLpIS1oo8pqg5Wx--rmC22ey6QgnJJiQ8Yv3xi0PvkpMpXl3QdwCN8Nel7oxV30zzc0uAgNtdJ5zS2MCOujFTPfTWoYZGFc0YlUQEWnsnDWFDFG8A0xu76eqP8NKDMw9X40crnMzs_LEFsn3E1umFoIF8ut0rOQJ04uo09dGsKxmWSQgeEAcBzgSLL64YR85x5FmrzQSYPS_HS435Xy7UX8Fill4XODKV2Q7LaKnHAO-3V2lKjSEhVEkSyHDBQqB039EMtGKwSetmhtsFT4lQjCIG3acgqP_VvPA_CbsmnRtPiazPKvvO1lPm0cNb-kNJ4VVZnYVG8ZAX0ggQlGe-m2kpBw9NfCrJKwUmycrR33PSOC66TaKv4s93rTApO-Q9zmE09RPT0EUlfginc4BzBXkWxdxuQsPLDQouVvkLVWta9bxX5JO9TNMjHxDjz_Bz3thCuu-zbKkdpLt80hBc0P2iNrIJCHQOI54Q6dV0aEaTldetec4O5LCKHIOqnBUYf9Gt0B5wULsHqdTN1lOX70Rp7d5qvmxejdzdT2OU6G7CQnq6b_9FEbJ7lVkuIe90bYDCMTuD16YgxIO6qjsIMYcgso6OlO9JEwru3nyQZEnn-CIFynhOh5HRx0mnOBY26UWfwu8F3hNiqL68rnj3THr80i0pg
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:816::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

pragma
no-cache
date
Tue, 15 Dec 2020 12:45:50 GMT
x-content-type-options
nosniff
server
cafe
timing-allow-origin
*
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
cache-control
no-cache, must-revalidate
cross-origin-resource-policy
cross-origin
content-type
image/gif
alt-svc
h3-29="googleads.g.doubleclick.net:443"; ma=2592000,h3-29=":443"; ma=2592000,h3-T051="googleads.g.doubleclick.net:443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic="googleads.g.doubleclick.net:443"; ma=2592000; v="46,43",quic=":443"; ma=2592000; v="46,43"
content-length
0
x-xss-protection
0
expires
Fri, 01 Jan 1990 00:00:00 GMT
/
crta.dailymail.co.uk/
8 B
574 B
Other
General
Full URL
https://crta.dailymail.co.uk/
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/static/mol-adverts/demo/mol-22070/19a28e0b/mol-adverts.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
2a02:26f0:6c00:2be::16c2 , Ascension Island, ASN20940 (AKAMAI-ASN1, EU),
Reverse DNS
Software
http-to-kafka/0.8.10 /
Resource Hash
a00fb0c50741f81bb51d35b4475a4357f8039aabd896a21036bc516839401595

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type
text/plain

Response headers

pragma
no-cache
date
Tue, 15 Dec 2020 12:45:51 GMT
server
http-to-kafka/0.8.10
etag
W/"8-YaBXLEiT7zQxEyDYTILfiL6oPhE"
content-type
text/plain; charset=utf-8
access-control-allow-origin
*
cache-control
max-age=0, no-cache, no-store
access-control-allow-credentials
true
content-length
8
expires
Tue, 15 Dec 2020 12:45:51 GMT
activeview
pagead2.googlesyndication.com/pcs/ Frame CD23
42 B
125 B
Image
General
Full URL
https://pagead2.googlesyndication.com/pcs/activeview?xai=AKAOjsvKAVkrVqor-ZEwTzgGOcs0m3DtovQIzEcwN_Ocsbt54EQDjqeiicnhsl_vkLuSjTcaFshAp1AZ3pTh7n9rwDQEKLb1ACSo7I2cIoGmZBbD2azI&sai=AMfl-YQZHE8YaDXRM_aXXsWZW7I1CmxKyz2UnadSxPltVJL9uGYgUY1RU0CP55EblpEh1XHEdQE1AyPgGppDrG6WwoOWyphjRV51kFCOi0EZ9REyUPy_cc51yPSEtKAcsYby&sig=Cg0ArKJSzGBbApsz4GS4EAE&cid=CAASPeRoD1-xg9UIqLqKUHr5We7kdWR0bBzvthpwE_mBtbLqokpLSOUHPJkMh-msm1JjLWRr6oqHBDvoF6IRVZo&id=ampim&o=315,197&d=970,250&ss=1600,1200&bs=1600,1200&mcvt=1001&mtos=0,0,0,1001,1001&tos=0,0,0,1001,0&tfs=110&tls=1111&g=99.69072341918945&h=99.69072341918945&tt=1111&r=v&avms=ampa&adk=1878184308
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:816::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
ef1955ae757c8b966c83248350331bd3a30f658ced11f387f8ebf05ab3368629
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

pragma
no-cache
date
Tue, 15 Dec 2020 12:45:51 GMT
x-content-type-options
nosniff
server
cafe
timing-allow-origin
*
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
access-control-allow-origin
*
cache-control
no-cache, must-revalidate
cross-origin-resource-policy
cross-origin
content-type
image/gif
alt-svc
h3-29="googleads.g.doubleclick.net:443"; ma=2592000,h3-29=":443"; ma=2592000,h3-T051="googleads.g.doubleclick.net:443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic="googleads.g.doubleclick.net:443"; ma=2592000; v="46,43",quic=":443"; ma=2592000; v="46,43"
content-length
42
x-xss-protection
0
expires
Fri, 01 Jan 1990 00:00:00 GMT
events
api.permutive.com/v2.0/batch/
101 B
176 B
XHR
General
Full URL
https://api.permutive.com/v2.0/batch/events?enrich=false&k=ed45e86d-a09e-4d2b-85c0-fbbd6857373e
Requested by
Host: cdn.permutive.com
URL: https://cdn.permutive.com/5f42864d-a421-4f37-9478-00266f871d68-web.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
34.107.254.252 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
Permutive /
Resource Hash
13eff504f89d8af422564e3b549458063a4ff175199da16dcb28b8e6f0519e37

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type
text/plain

Response headers

date
Tue, 15 Dec 2020 12:45:51 GMT
content-encoding
gzip
server
Permutive
vary
Origin,Access-Control-Request-Method
access-control-allow-methods
POST
content-type
application/json
access-control-allow-origin
https://www.dailymail.co.uk
access-control-expose-headers
*
access-control-allow-credentials
true
access-control-max-age
86400
alt-svc
clear
content-length
111
via
1.1 google
480x270_MP4_105387676350826941.mp4
video.dailymail.co.uk/video/mol/2020/10/13/105387676350826941/
2 MB
2 MB
Media
General
Full URL
https://video.dailymail.co.uk/video/mol/2020/10/13/105387676350826941/480x270_MP4_105387676350826941.mp4
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2a02:26f0:6c00:288::11ae , Ascension Island, ASN20940 (AKAMAI-ASN1, EU),
Reverse DNS
Software
AkamaiNetStorage /
Resource Hash
cf4f8c5687a4e7447ce00b5d2331c61eb90b1adaf7c4b35d962a1b9d94b5841a

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
Accept-Encoding
identity;q=1, *;q=0
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Range
bytes=65536-

Response headers

date
Tue, 15 Dec 2020 12:45:52 GMT
last-modified
Tue, 13 Oct 2020 13:58:50 GMT
server
AkamaiNetStorage
etag
"10d05f799add804eb49f119edc3bdb85:1602597530.421767"
content-type
video/mp4
Content-Range
bytes 65536-2668555/2668556
accept-ranges
bytes
Content-Length
2603020
events
api.permutive.com/v2.0/batch/
201 B
208 B
XHR
General
Full URL
https://api.permutive.com/v2.0/batch/events?enrich=false&k=ed45e86d-a09e-4d2b-85c0-fbbd6857373e
Requested by
Host: cdn.permutive.com
URL: https://cdn.permutive.com/5f42864d-a421-4f37-9478-00266f871d68-web.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
34.107.254.252 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
Permutive /
Resource Hash
8c62c79786e83d381ac77ace90a9e3a2708dfc78fb4f87a10caa0a306b651568

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type
text/plain

Response headers

date
Tue, 15 Dec 2020 12:45:52 GMT
content-encoding
gzip
server
Permutive
vary
Origin,Access-Control-Request-Method
access-control-allow-methods
POST
content-type
application/json
access-control-allow-origin
https://www.dailymail.co.uk
access-control-expose-headers
*
access-control-allow-credentials
true
access-control-max-age
86400
alt-svc
clear
content-length
140
via
1.1 google
video_info
context.iris.tv/
0
337 B
XHR
General
Full URL
https://context.iris.tv/video_info?access_token=1d9f05c8b00daddfbffcf5afa8a0691bf6370c0cd9dfc8bc6fb38e13c4474dab&global=GlobalIrisPlayer&client_token=W491AUI45FTTFWD&platform_id=6866502909138809394
Requested by
Host: ovp.iris.tv
URL: https://ovp.iris.tv/libs/context/iris-context.min.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
65.9.73.71 Seattle, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
Zer01ne /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:39:13 GMT
via
1.1 3ffec0ecfde687fb371812ad42f5cfc2.cloudfront.net (CloudFront)
response
Unable to find platform_id
server
Zer01ne
age
399
x-cache
Hit from cloudfront
access-control-allow-origin
*
cache-control
max-age=800, stale-while-revalidate=600, stale-if-error=600
x-amz-cf-pop
AMS1-C1
x-robots-tag
noindex, follow
x-amz-cf-id
cN1vbFrcF2gHd0IkzYJqxTHWagkV3iE2v5KoVnOoet2EDVWlShpZpA==
video_info
context.iris.tv/
0
339 B
XHR
General
Full URL
https://context.iris.tv/video_info?access_token=1d9f05c8b00daddfbffcf5afa8a0691bf6370c0cd9dfc8bc6fb38e13c4474dab&global=GlobalIrisPlayer&client_token=W491AUI45FTTFWD&platform_id=6866502909138809394
Requested by
Host: ovp.iris.tv
URL: https://ovp.iris.tv/libs/context/iris-context.min.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
65.9.73.71 Seattle, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
Zer01ne /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:39:13 GMT
via
1.1 3ffec0ecfde687fb371812ad42f5cfc2.cloudfront.net (CloudFront)
response
Unable to find platform_id
server
Zer01ne
age
399
x-cache
Hit from cloudfront
access-control-allow-origin
*
cache-control
max-age=800, stale-while-revalidate=600, stale-if-error=600
x-amz-cf-pop
AMS1-C1
x-robots-tag
noindex, follow
x-amz-cf-id
nACOYkldHhvbvXCmm-fCV0WZhsuASc5OkLjrNQ_Fzq_tb7yjPflmNQ==
partner
sync.search.spotxchange.com/
Redirect Chain
  • https://sync.search.spotxchange.com/partner?source=dados
  • https://sync.search.spotxchange.com/partner?source=dados&__user_check__=1&sync_id=7723a40a-3ed3-11eb-8a2f-1f932c7f4206
0
589 B
Image
General
Full URL
https://sync.search.spotxchange.com/partner?source=dados&__user_check__=1&sync_id=7723a40a-3ed3-11eb-8a2f-1f932c7f4206
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
185.94.180.126 , Netherlands, ASN35220 (SPOTX-AMS, NL),
Reverse DNS
Software
nginx /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

x-spotx-halt-type
Audience Dsp sync Priority Sync endpoint Source ID is not on enabled source whitelist
Date
Tue, 15 Dec 2020 12:45:52 GMT
Server
nginx
Access-Control-Allow-Methods
GET, POST, OPTIONS
Content-Type
text/plain
Access-Control-Allow-Origin
*
Cache-Control
no-store, no-cache, must-revalidate, proxy-revalidate, max-age=0
Access-Control-Allow-Credentials
false
X-fe
107
Connection
keep-alive
Content-Length
0

Redirect headers

Date
Tue, 15 Dec 2020 12:45:52 GMT
Server
nginx
Location
/partner?source=dados&__user_check__=1&sync_id=7723a40a-3ed3-11eb-8a2f-1f932c7f4206
Access-Control-Allow-Methods
GET, POST, OPTIONS
Content-Type
text/plain
Access-Control-Allow-Origin
*
Cache-Control
no-store, no-cache, must-revalidate, proxy-revalidate, max-age=0
Access-Control-Allow-Credentials
false
X-fe
103
Connection
keep-alive
Content-Length
0
bid
c.amazon-adsystem.com/e/dtb/
24 B
374 B
XHR
General
Full URL
https://c.amazon-adsystem.com/e/dtb/bid?src=3065&u=https%3A%2F%2Fwww.dailymail.co.uk%2Fsciencetech%2Farticle-9050821%2FRemdesivir-beneficial-patients-doctors-reveal.html%3F_hsmi%3D88974744%26_hsenc%3Dp2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8&pid=qkqBHoBAnjHbV&cb=19&ws=1600x1200&v=7.58.01&t=2000&slots=%5B%7B%22id%22%3A%22jw_video_desktop%22%2C%22mt%22%3A%22v%22%2C%22kv%22%3A%7B%22pubcid%22%3A%223093664108%22%7D%7D%5D&gdprl=%7B%22status%22%3A%22no-cmp%22%7D
Requested by
Host: c.amazon-adsystem.com
URL: https://c.amazon-adsystem.com/aax2/apstag.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
99.84.88.20 Seattle, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-99-84-88-20.muc50.r.cloudfront.net
Software
Server /
Resource Hash
09cdbf90e836b623c22eb7f0a7f2e3765e7635ac989caf88229b29b54ec691be

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:45:52 GMT
via
1.1 fe36c7f30c8ef2853edecc43f320092c.cloudfront.net (CloudFront)
server
Server
x-amz-cf-pop
MUC50-C1
vary
User-Agent
x-cache
Miss from cloudfront
content-type
text/javascript;charset=UTF-8
access-control-allow-origin
https://www.dailymail.co.uk
access-control-allow-credentials
true
timing-allow-origin
*
content-length
24
x-amz-cf-id
_U5CWEAh0r5HpMv7cV6obJzm4AGMxsN4HoUYubruqrxjVBfdB3Ubrw==
auction
prebid.adnxs.com/pbs/v1/openrtb2/
150 B
499 B
XHR
General
Full URL
https://prebid.adnxs.com/pbs/v1/openrtb2/auction
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/static/mol-adverts/demo/mol-22070/19a28e0b/mol-adverts.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
37.252.161.190 , Ascension Island, ASN29990 (ASN-APPNEX, US),
Reverse DNS
prebid.ams1.adnexus.net
Software
nginx/1.19.0 /
Resource Hash
335d660009a9cfd12b1959580701453400f22bac020f7d62ae71b416aa72269e

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type
text/plain

Response headers

Pragma
no-cache
Date
Tue, 15 Dec 2020 12:45:52 GMT
Server
nginx/1.19.0
Vary
Origin
Content-Type
application/json
Access-Control-Allow-Origin
https://www.dailymail.co.uk
Cache-Control
no-cache, no-store, must-revalidate
Access-Control-Allow-Credentials
true
Connection
keep-alive
Content-Length
150
Expires
0
avjp
mailonline-uk-d.openx.net/v/1.0/
92 B
282 B
XHR
General
Full URL
https://mailonline-uk-d.openx.net/v/1.0/avjp?ju=https%3A%2F%2Fwww.dailymail.co.uk%2Fsciencetech%2Farticle-9050821%2FRemdesivir-beneficial-patients-doctors-reveal.html%3F_hsmi%3D88974744%26_hsenc%3Dp2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8&ch=UTF-8&res=1600x1200x24&ifr=false&tz=-60&tws=1600x1200&be=1&bc=hb_pb_3.0.3&dddid=d0ebe455-3693-484b-951e-b1d7b886f0b5&nocache=1608036352279&id5id=ID5-ZHMOqMhJTrldgGJIBsru2iINA62VBTrOOYCHIcZtjg&pubcid=84f1103b-a980-4860-8c6e-1866bcc8525c&ttduuid=c1befdb7-5c1a-4d0f-b053-b3ef508e7ce4&auid=540675388&vwd=401&vht=225
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/static/mol-adverts/demo/mol-22070/19a28e0b/mol-adverts.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
35.244.159.8 Mountain View, United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
OXGW/16.199.0 /
Resource Hash
004e5faf0bf890f61697daeede9f21826affd1137fb2cb58eaf4719937a04a14

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type
text/plain

Response headers

pragma
no-cache
date
Tue, 15 Dec 2020 12:45:52 GMT
via
1.1 google
server
OXGW/16.199.0
p3p
CP="CUR ADM OUR NOR STA NID"
access-control-allow-origin
https://www.dailymail.co.uk
cache-control
private, max-age=0, no-cache
access-control-allow-credentials
true
content-type
application/json
alt-svc
clear
content-length
92
expires
Mon, 26 Jul 1997 05:00:00 GMT
prebid
ib.adnxs.com/ut/v3/
19 B
717 B
XHR
General
Full URL
https://ib.adnxs.com/ut/v3/prebid
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/static/mol-adverts/demo/mol-22070/19a28e0b/mol-adverts.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_ECDSA, AES_128_GCM
Server
185.33.221.13 , Netherlands, ASN29990 (ASN-APPNEX, US),
Reverse DNS
729.bm-nginx-loadbalancer.mgmt.ams1.adnexus.net
Software
nginx/1.17.9 /
Resource Hash
0c09c070833c786cb25be38bc30992b30bad578f817dbc9e34beacd8b8ea44c5
Security Headers
Name Value
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type
text/plain

Response headers

Pragma
no-cache
Date
Tue, 15 Dec 2020 12:45:52 GMT
X-Proxy-Origin
185.212.171.67; 185.212.171.67; 729.bm-nginx-loadbalancer.mgmt.ams1; *.adnxs.com; 185.33.220.141:80
AN-X-Request-Uuid
cac24c7e-583d-449d-8735-59637b04dc00
Server
nginx/1.17.9
P3P
policyref="http://cdn.adnxs.com/w3c/policy/p3p.xml", CP="NOI DSP COR ADM PSAo PSDo OURo SAMo UNRo OTRo BUS COM NAV DEM STA PRE"
Access-Control-Allow-Origin
https://www.dailymail.co.uk
Cache-Control
no-store, no-cache, private
Access-Control-Allow-Credentials
true
Connection
keep-alive
Content-Type
application/json; charset=utf-8
Content-Length
19
X-XSS-Protection
0
Expires
Sat, 15 Nov 2008 16:00:00 GMT
cygnus
htlb.casalemedia.com/
26 B
376 B
XHR
General
Full URL
https://htlb.casalemedia.com/cygnus?s=293354&v=8.1&r=%7B%22id%22%3A%22261fd1171adc93e2%22%2C%22imp%22%3A%5B%7B%22id%22%3A%2226277c0cd02dc25a%22%2C%22ext%22%3A%7B%22siteID%22%3A%22293354%22%2C%22sid%22%3A%22401x225%22%7D%2C%22video%22%3A%7B%22startdelay%22%3A0%2C%22mimes%22%3A%5B%22video%2Fmp4%22%2C%22video%2Fwebm%22%2C%22application%2Fjavascript%22%5D%2C%22minduration%22%3A0%2C%22maxduration%22%3A30%2C%22protocols%22%3A%5B1%2C2%2C3%2C4%2C5%2C6%5D%2C%22api%22%3A%5B1%2C2%5D%2C%22w%22%3A401%2C%22h%22%3A225%2C%22placement%22%3A1%7D%7D%5D%2C%22site%22%3A%7B%22page%22%3A%22https%3A%2F%2Fwww.dailymail.co.uk%2Fsciencetech%2Farticle-9050821%2FRemdesivir-beneficial-patients-doctors-reveal.html%3F_hsmi%3D88974744%26_hsenc%3Dp2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8%22%7D%2C%22ext%22%3A%7B%22source%22%3A%22prebid%22%7D%7D&ac=j&sd=1&nf=1
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/static/mol-adverts/demo/mol-22070/19a28e0b/mol-adverts.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
104.111.215.135 , Netherlands, ASN16625 (AKAMAI-AS, US),
Reverse DNS
a104-111-215-135.deploy.static.akamaitechnologies.com
Software
Apache /
Resource Hash
6bcd7729d4acd0bbb9286300cb6f6c7e0e3890d887da5b0e0c9390a509026069

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type
text/plain

Response headers

pragma
no-cache
date
Tue, 15 Dec 2020 12:45:52 GMT
content-encoding
gzip
x-ak-initial-geo
CC:[NL], RC:[], CN:[EU], CIP:[185.212.171.67], XFF:[]
server
Apache
vary
Is-Traffic-Invalid,Accept-Encoding
content-type
application/json
access-control-allow-origin
https://www.dailymail.co.uk
x-cs-client-geo
12
cache-control
max-age=0, no-cache, no-store
access-control-allow-credentials
true
content-length
46
x-ak-client-geo
12
expires
Tue, 15 Dec 2020 12:45:52 GMT
openrtb
ads.adaptv.advertising.com/rtb/
0
220 B
XHR
General
Full URL
https://ads.adaptv.advertising.com/rtb/openrtb?ext_id=MailOnline
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/static/mol-adverts/demo/mol-22070/19a28e0b/mol-adverts.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
52.59.160.25 Frankfurt am Main, Germany, ASN16509 (AMAZON-02, US),
Reverse DNS
ec2-52-59-160-25.eu-central-1.compute.amazonaws.com
Software
adaptv/1.0 /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type
text/plain

Response headers

access-control-allow-origin
https://www.dailymail.co.uk
access-control-allow-credentials
true
server
adaptv/1.0
Connection
keep-alive
content-length
0
content-type
application/json
track
track1.aniview.com/
0
70 B
Image
General
Full URL
https://track1.aniview.com/track?d=Chrome&cou=NL&cos=OSX&r=www.dailymail.co.uk&rs=www.dailymail.co.uk&sid=25906&t=1608036344&cip=185.212.171.67&sn=&tgt=0&osv=10.14.5&bv=83.0&brn=Chrome&wi=480&he=270&app=&AV_PUBLISHERID=5e3a966128a06134f417790e&test=&aafaid=&proto=https&uid=1608036344228-929692714160-015808-003-004909&imid=fe3cd17e40005b0c3b9a7b5f759fa98d15452790059172315660&cha=0.05&cb=40807090162&d9=1000&AV_WIDTH=480&AV_HEIGHT=270&ppid=5e3a966128a06134f417790e&nid=58fcbed1073ef420086c9d08&pcid=5e3a987528a0611c3444f80c&ncid=5ebbaa0fd5dbd82f9b0f9a69&pasid=5ebbaa68f985a05cae268384&e=bid&cb=1608036352362&asid=5c249de6073ef47e0c19572b%2C5c84e63128a06171521af324&ofpr=%2C&fpo=%2C
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
34.197.221.162 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:45:52 GMT
cache-control
max-age=0, no-cache, no-store
content-length
0
vpaid-adapter.min.js
cdn.stickyadstv.com/mustang/ Frame 1347
327 KB
111 KB
Script
General
Full URL
https://cdn.stickyadstv.com/mustang/vpaid-adapter.min.js
Requested by
Host: player.aniview.com
URL: https://player.aniview.com/script/6.1/AVmanager.js?v=1.0&type=s&pid=5e3a966128a06134f417790e
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
2001:4de0:ac19::1:b:3b , Netherlands, ASN20446 (HIGHWINDS3, US),
Reverse DNS
Software
/
Resource Hash
dc989373165041ad828e64f33bb534395d2ec233f5949759c911862535e77658

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Date
Tue, 15 Dec 2020 12:45:52 GMT
Content-Encoding
gzip
Last-Modified
Wed, 09 Dec 2020 03:18:58 GMT
ETag
"1607483938"
X-HW
1608036352.dop213.fr8.shc,1608036352.dop213.fr8.t,1608036352.cds006.fr8.c
Content-Type
application/x-javascript
Access-Control-Allow-Origin
*
Cache-Control
max-age=86400
Access-Control-Allow-Credentials
true
Connection
Keep-Alive
Accept-Ranges
bytes
Content-Length
112809
o2shim
acds.prod.vidible.tv/ Frame 9466
15 KB
7 KB
Script
General
Full URL
https://acds.prod.vidible.tv/o2shim?companionId=&cpmPassback=&placementId=1206795&orgId=28230&injectCompanionDummy=&pauseOnClick=&d.vw=&d.app=&r=https%3A%2F%2Fwww.dailymail.co.uk%2Fsciencetech%2Farticle-9050821%2FRemdesivir-beneficial-patients-doctors-reveal.html%3F_hsmi%3D88974744%26_hsenc%3Dp2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8&vrid=0861bd3c-8d98-41a8-aae4-85046d00ae5f&pblob=
Requested by
Host: player.aniview.com
URL: https://player.aniview.com/script/6.1/AVmanager.js?v=1.0&type=s&pid=5e3a966128a06134f417790e
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
54.195.94.143 Dublin, Ireland, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
/
Resource Hash
9da9bdb18a232ee60dcafdee131309240cab2126890243d49ef648400ca1c632

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:45:52 GMT
content-encoding
gzip
access-control-max-age
3600
access-control-allow-methods
POST, GET, HEAD, PUT, PATCH, DELETE
content-type
application/javascript
access-control-allow-origin
*
access-control-allow-headers
content-length
6839
bandwidth-test-25ko
cdn.stickyadstv.com/mustang/ Frame 1347
25 KB
25 KB
XHR
General
Full URL
https://cdn.stickyadstv.com/mustang/bandwidth-test-25ko?cachebuster=1608036352487
Requested by
Host: cdn.stickyadstv.com
URL: https://cdn.stickyadstv.com/mustang/vpaid-adapter.min.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
2001:4de0:ac19::1:b:3b , Netherlands, ASN20446 (HIGHWINDS3, US),
Reverse DNS
Software
/
Resource Hash
9f995b1c42942ededcce16bba381a19d3b30e0e75a36e0ea956f6a54e040dffe

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Date
Tue, 15 Dec 2020 12:45:52 GMT
Last-Modified
Wed, 09 Dec 2020 03:18:58 GMT
ETag
"1607483938"
X-HW
1608036352.dop002.fr8.shc,1608036352.dop002.fr8.t,1608036352.cds248.fr8.c
Content-Type
application/octet-stream
Access-Control-Allow-Origin
https://www.dailymail.co.uk
Cache-Control
max-age=86400
Access-Control-Allow-Credentials
true
Connection
Keep-Alive
Accept-Ranges
bytes
Content-Length
25600
auto-user-sync
ads.stickyadstv.com/ Frame 1347
0
0

user-registering
ads.stickyadstv.com/
Redirect Chain
  • https://ads.stickyadstv.com/auto-user-sync?gdpr=0&gdpr_consent=null
  • https://1f2e7.v.fwmrm.net/ad/u?_dv=2&dsp_user_mapping=true&127719=59b88bb7e5c7986e844256cfcefb115&rdU=https%3A%2F%2Fads.stickyadstv.com%2Fuser-registering%3FdataProviderId%3D1169%26userId%3d%23%7bu...
  • https://ads.stickyadstv.com/user-registering?dataProviderId=1169&userId=g003_6906463559799745575
  • https://cm.g.doubleclick.net/pixel?google_nid=stickyxchange_dbm&google_cm=&google_sc&google_hm=NTliODhiYjdlNWM3OTg2ZTg0NDI1NmNmY2VmYjExNQ==&gdpr=0&gdpr_consent=
  • https://ads.stickyadstv.com/user-registering?dataProviderId=141&userId=CAESEO0TRxlhhWFEztSREysYkUs&google_cver=1&gdpr=0&gdpr_consent=
  • https://match.adsrvr.org/track/cmf/generic?ttd_pid=stickyads&ttd_tpi=1&gdpr=0&gdpr_consent=&gdpr=0&gdpr_consent=
  • https://ads.stickyadstv.com/user-registering?dataProviderId=208&userId=eaff8365-3920-49ce-bdca-8f674a0df29a
  • https://sync-tm.everesttech.net/upi/pid/wGbQAlJJ?gdpr=0&gdpr_consent=&redir=https%3A%2F%2Fads.stickyadstv.com%2Fuser-registering%3FdataProviderId%3D187%26userId%3D%24%7BTM_USER_ID%7D
  • https://ads.stickyadstv.com/user-registering?dataProviderId=187&userId=X9iwAAAAAI9TozoG
  • https://c1.adform.net/serving/cookie/match/?party=18
  • https://ads.stickyadstv.com/user-registering?dataProviderId=189&userId=8494150580545336307
43 B
713 B
Image
General
Full URL
https://ads.stickyadstv.com/user-registering?dataProviderId=189&userId=8494150580545336307
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
2.18.234.233 , Ascension Island, ASN16625 (AKAMAI-AS, US),
Reverse DNS
a2-18-234-233.deploy.static.akamaitechnologies.com
Software
nginx /
Resource Hash
a065920df8cc4016d67c3a464be90099c9d28ffe7c9e6ee3a18f257efc58cbd7

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Pragma
no-cache
Date
Tue, 15 Dec 2020 12:45:58 GMT
Server
nginx
Content-Type
image/gif
Access-Control-Allow-Origin
*
Cache-Control
max-age=0, no-cache, no-store
Access-Control-Allow-Credentials
true
Connection
keep-alive
Content-Length
43
x-sticky-vk
1608036358213000-73
Expires
Tue, 15 Dec 2020 12:45:58 GMT

Redirect headers

pragma
no-cache
date
Tue, 15 Dec 2020 12:45:58 GMT
server
nginx
location
https://ads.stickyadstv.com/user-registering?dataProviderId=189&userId=8494150580545336307
strict-transport-security
max-age=31536000; includeSubDomains
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate, no-transform
content-length
0
expires
-1
/
ads.stickyadstv.com/additional-scripts/ Frame 1347
301 B
859 B
XHR
General
Full URL
https://ads.stickyadstv.com/additional-scripts/?zoneId=7197697&loc=https%3A%2F%2Fwww.dailymail.co.uk%2Fsciencetech%2Farticle-9050821%2FRemdesivir-beneficial-patients-doctors-reveal.html%3F_hsmi%3D88974744%26_hsenc%3Dp2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
Requested by
Host: cdn.stickyadstv.com
URL: https://cdn.stickyadstv.com/mustang/vpaid-adapter.min.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
2.18.234.233 , Ascension Island, ASN16625 (AKAMAI-AS, US),
Reverse DNS
a2-18-234-233.deploy.static.akamaitechnologies.com
Software
nginx /
Resource Hash
64a14c1566ed5e882e60ea9d6e3722949c5767823cd23dc1244503991661dc27

Request headers

Accept
application/xml, text/xml
Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Pragma
no-cache
Date
Tue, 15 Dec 2020 12:45:53 GMT
Server
nginx
Access-Control-Allow-Origin
https://www.dailymail.co.uk
Cache-Control
max-age=0, no-cache, no-store
Access-Control-Allow-Credentials
true
Connection
keep-alive
Content-Length
301
x-sticky-vk
1608036353502080-71
Expires
Tue, 15 Dec 2020 12:45:53 GMT
swfIndex.php
ads.stickyadstv.com/www/delivery/ Frame 1347
67 B
723 B
XHR
General
Full URL
https://ads.stickyadstv.com/www/delivery/swfIndex.php?zoneId=7197697&_fw_gdpr=1&cbb=8036344291&_fw_us_privacy=1---&_fw_gdpr_consent=&schain=1.0%2C1!selectmedia.asia%2C5e3a966128a06134f417790e%2C1%2C%2CMail%2BMetro%2BMedia%2Cmailonline.co.uk&vav=2949493a239e703e1d246b1c92a0b9cd&vaviv=53b138801f4632079e9a09e263e95c6c&reqType=AdsSetup&protocolVersion=2.0&mustangVersion=1.11.6.1&focus=true&percentViewable=15&componentId=vpaid-adapter&loc=https%3A%2F%2Fwww.dailymail.co.uk%2Fsciencetech%2Farticle-9050821%2FRemdesivir-beneficial-patients-doctors-reveal.html%3F_hsmi%3D88974744%26_hsenc%3Dp2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8&playerSize=480x270&supportsFlash=false&supportsJavascript=true
Requested by
Host: cdn.stickyadstv.com
URL: https://cdn.stickyadstv.com/mustang/vpaid-adapter.min.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
2.18.234.233 , Ascension Island, ASN16625 (AKAMAI-AS, US),
Reverse DNS
a2-18-234-233.deploy.static.akamaitechnologies.com
Software
nginx /
Resource Hash
291437ea71e62b1c35d4ec5d3c5ad02cfa930343b41b1472fba70243089c8bbe

Request headers

Accept
application/xml, text/xml
Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Pragma
no-cache
Date
Tue, 15 Dec 2020 12:45:53 GMT
Server
nginx
Content-Type
application/xml;charset=UTF-8
Access-Control-Allow-Origin
https://www.dailymail.co.uk
Cache-Control
max-age=0, no-cache, no-store
Access-Control-Allow-Credentials
true
Connection
keep-alive
Content-Length
67
x-sticky-vk
1608036353532085-326
Expires
Tue, 15 Dec 2020 12:45:53 GMT
0.js
cdn-ssl.vidible.tv/prod/ad-client/js/10.2.59/ Frame 9466
321 KB
104 KB
Script
General
Full URL
https://cdn-ssl.vidible.tv/prod/ad-client/js/10.2.59/0.js
Requested by
Host: acds.prod.vidible.tv
URL: https://acds.prod.vidible.tv/o2shim?companionId=&cpmPassback=&placementId=1206795&orgId=28230&injectCompanionDummy=&pauseOnClick=&d.vw=&d.app=&r=https%3A%2F%2Fwww.dailymail.co.uk%2Fsciencetech%2Farticle-9050821%2FRemdesivir-beneficial-patients-doctors-reveal.html%3F_hsmi%3D88974744%26_hsenc%3Dp2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8&vrid=0861bd3c-8d98-41a8-aae4-85046d00ae5f&pblob=
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1288:f03d:1fa::2000 , United Kingdom, ASN10310 (YAHOO-1, US),
Reverse DNS
Software
ATS /
Resource Hash
66dd5033bfecfeef06d05c3c5115bdba91710813b07c6635f91f0424223d43b4
Security Headers
Name Value
Strict-Transport-Security max-age=15552000
X-Content-Type-Options nosniff
X-Xss-Protection 1; mode=block

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

ats-carp-promotion
1
date
Thu, 10 Dec 2020 16:50:10 GMT
content-encoding
gzip
x-content-type-options
nosniff
age
417343
x-amz-server-side-encryption
AES256
vary
Accept-Encoding
content-length
105542
x-amz-id-2
JK6DbToHOkJJcBvdK9U6wYGNLZ6FUDO7czFNweK/dVGehi/VGqJL5+SB0q/eQG6PBsLEmZqmF3U=
referrer-policy
no-referrer-when-downgrade
last-modified
Thu, 10 Dec 2020 16:21:44 GMT
server
ATS
etag
"d3e6dcf5eb86c562a4a5c5fa218f09fe-df"
expect-ct
max-age=31536000, report-uri="http://csp.yahoo.com/beacon/csp?src=yahoocom-expect-ct-report-only"
strict-transport-security
max-age=15552000
access-control-allow-methods
GET
x-amz-request-id
BF7B5BFBB675E914
access-control-allow-origin
*
x-xss-protection
1; mode=block
cache-control
max-age=1209600
x-amz-version-id
null
accept-ranges
bytes
content-type
application/javascript
impression.gif
trk.vidible.tv/trk/ Frame 9466
43 B
246 B
Image
General
Full URL
https://trk.vidible.tv/trk/impression.gif?pid=59947c0544a64b1a49e52a48&bcid=5c6c7f1c17e0e151b5b9cb66&s=true&pv=10.2.59&ifr=true&cb=0.6939128840859008&pt=o2unit&sid=cb4b0531-0d5b-47bb-8bd8-54c94ff185ed&r=https%3A%2F%2Fwww.dailymail.co.uk%2Fsciencetech%2Farticle-9050821%2FRemdesivir-beneficial-patients-doctors-reveal.html%3F_hsmi%3D88974744%26_hsenc%3Dp2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
54.93.70.53 Frankfurt am Main, Germany, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
nginx/1.19.4 /
Resource Hash
cf4724b2f736ed1a0ae6bc28f1ead963d9cd2c1fd87b6ef32e7799fc1c5c8bda

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:45:52 GMT
cache-control
max-age=0, no-cache, no-store, must-revalidate
last-modified
Mon, 28 Sep 1970 06:00:00 GMT
server
nginx/1.19.4
content-type
image/gif
content-length
43
expires
Tue, 15 Dec 2020 12:45:52 GMT
events
api.permutive.com/v2.0/batch/
2 B
87 B
XHR
General
Full URL
https://api.permutive.com/v2.0/batch/events?enrich=false&k=ed45e86d-a09e-4d2b-85c0-fbbd6857373e
Requested by
Host: cdn.permutive.com
URL: https://cdn.permutive.com/5f42864d-a421-4f37-9478-00266f871d68-web.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
34.107.254.252 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
Permutive /
Resource Hash
4f53cda18c2baa0c0354bb5f9a3ecbe5ed12ab4d8e11ba873c2f11161202b945

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type
text/plain

Response headers

date
Tue, 15 Dec 2020 12:45:52 GMT
content-encoding
gzip
server
Permutive
vary
Origin,Access-Control-Request-Method
access-control-allow-methods
POST
content-type
application/json
access-control-allow-origin
https://www.dailymail.co.uk
access-control-expose-headers
*
access-control-allow-credentials
true
access-control-max-age
86400
alt-svc
clear
content-length
22
via
1.1 google
moatapi.js
z.moatads.com/aolvidibleapi29384728347/
133 KB
44 KB
Script
General
Full URL
https://z.moatads.com/aolvidibleapi29384728347/moatapi.js
Requested by
Host: cdn-ssl.vidible.tv
URL: https://cdn-ssl.vidible.tv/prod/ad-client/js/10.2.59/0.js
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
104.111.216.96 , Netherlands, ASN16625 (AKAMAI-AS, US),
Reverse DNS
a104-111-216-96.deploy.static.akamaitechnologies.com
Software
AmazonS3 /
Resource Hash
90542f9de6cab010087ab4bcab0e3b0a2ec1e449e445434dc1bb5c852033f046

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:45:52 GMT
content-encoding
gzip
last-modified
Tue, 25 Feb 2020 18:37:38 GMT
server
AmazonS3
x-amz-request-id
844FF664DE0AB17A
etag
"d678022569896f7b7293494e3a69c8c7"
vary
Accept-Encoding
content-type
application/x-javascript
cache-control
max-age=27247
accept-ranges
bytes
content-length
44266
x-amz-id-2
KrpVRZD3M0T4g9xUncS5g3siU6Z/qnTuCp2KYOKEtN/tCl8UaA8yn/9PP1OCFx0nXyimfljs5VQ=
local-storage.html
cdn-ssl.vidible.tv/prod/player/ad-time/ Frame 818C
0
0
Document
General
Full URL
https://cdn-ssl.vidible.tv/prod/player/ad-time/local-storage.html
Requested by
Host: player.aniview.com
URL: https://player.aniview.com/script/6.1/AVmanager.js?v=1.0&type=s&pid=5e3a966128a06134f417790e
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1288:f03d:1fa::2000 , United Kingdom, ASN10310 (YAHOO-1, US),
Reverse DNS
Software
ATS /
Resource Hash
Security Headers
Name Value
Strict-Transport-Security max-age=15552000
X-Content-Type-Options nosniff
X-Xss-Protection 1; mode=block

Request headers

:method
GET
:authority
cdn-ssl.vidible.tv
:scheme
https
:path
/prod/player/ad-time/local-storage.html
pragma
no-cache
cache-control
no-cache
upgrade-insecure-requests
1
user-agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
accept
text/html,application/xhtml+xml,application/xml;q=0.9,image/avif,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3;q=0.9
sec-fetch-site
cross-site
sec-fetch-mode
navigate
sec-fetch-dest
iframe
referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
accept-encoding
gzip, deflate, br
accept-language
en-US
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8

Response headers

x-amz-id-2
2b+yoqtBDbk1PsCVy5A7YhUh7ow48EGB0kImPHla6A4SSd7DkyxF6OTZZMgapfqaB3RTcAGFFd4=
x-amz-request-id
ATFW0PCVCK9R5T4M
date
Tue, 15 Dec 2020 10:37:02 GMT
last-modified
Wed, 19 Feb 2020 12:29:18 GMT
etag
"3ba0167f9f40b17c70af8074ec7b3c55-df"
x-amz-server-side-encryption
AES256
x-amz-version-id
null
accept-ranges
bytes
content-type
text/html
server
ATS
referrer-policy
no-referrer-when-downgrade
cache-control
max-age=1209600
access-control-allow-methods
GET
access-control-allow-origin
*
content-encoding
gzip
vary
Accept-Encoding
content-length
557
age
7731
strict-transport-security
max-age=15552000
expect-ct
max-age=31536000, report-uri="http://csp.yahoo.com/beacon/csp?src=yahoocom-expect-ct-report-only"
x-xss-protection
1; mode=block
x-content-type-options
nosniff
3pRrSx07Gk8Dl7mNKBWke3eC9D9nIm_aTuVZj2Zo7Wk=
ads.adaptv.advertising.com/a/h/ Frame 9466
249 B
549 B
XHR
General
Full URL
https://ads.adaptv.advertising.com/a/h/3pRrSx07Gk8Dl7mNKBWke3eC9D9nIm_aTuVZj2Zo7Wk=?cb=8036344293&gdpr=1&gdpr_consent=&pet=preroll&pageUrl=https%3A%2F%2Fwww.dailymail.co.uk%2Fsciencetech%2Farticle-9050821%2FRemdesivir-beneficial-patients-doctors-reveal.html%3F_hsmi%3D88974744%26_hsenc%3Dp2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8&eov=eov&us_privacy=1---&scpid=58fcbed1073ef420086c9d08&scpid=5e3a966128a06134f417790e&a.cluster=0&a.pvt=0&a.d.pageUrl=https%3A%2F%2Fwww.dailymail.co.uk%2Fsciencetech%2Farticle-9050821%2FRemdesivir-beneficial-patients-doctors-reveal.html%3F_hsmi%3D88974744%26_hsenc%3Dp2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8&a.hasAppInfo=2&a.sdk=o2unit&a.sdkType=js&depth=0&height=270&moatViewableOpportunity=100&p.vw.active=1&p.vw.psize=2&p.vw.viewable=1&p.vw.viewableOpportunity=1&referrerUrl=&width=480
Requested by
Host: cdn-ssl.vidible.tv
URL: https://cdn-ssl.vidible.tv/prod/ad-client/js/10.2.59/0.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
52.59.160.25 Frankfurt am Main, Germany, ASN16509 (AMAZON-02, US),
Reverse DNS
ec2-52-59-160-25.eu-central-1.compute.amazonaws.com
Software
adaptv/1.0 /
Resource Hash
6c138576e7381d3ab0aa7b511adc3a7cbb7fe3a3d33768bad05577f5dfc60cad
Security Headers
Name Value
Strict-Transport-Security max-age=31536000

Request headers

Accept
text/javascript, application/json, text/html, application/xml, text/xml, */*
Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type
application/x-www-form-urlencoded

Response headers

pragma
no-cache
strict-transport-security
max-age=31536000
content-encoding
gzip
server
adaptv/1.0
content-type
text/xml
access-control-allow-origin
https://www.dailymail.co.uk
cache-control
no-cache, no-store, must-revalidate
access-control-allow-credentials
true
Connection
keep-alive
Content-Length
192
expires
0
display.gif
trk.vidible.tv/trk/ Frame 9466
43 B
245 B
Image
General
Full URL
https://trk.vidible.tv/trk/display.gif?bcid=5c6c7f1c17e0e151b5b9cb66&bid=56bcd17de4b0a5976ac0da12&pid=59947c0544a64b1a49e52a48&pt=o2unit&pv=10.2.59&r=https%3A%2F%2Fwww.dailymail.co.uk%2Fsciencetech%2Farticle-9050821%2FRemdesivir-beneficial-patients-doctors-reveal.html%3F_hsmi%3D88974744%26_hsenc%3Dp2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8&s=true&sid=cb4b0531-0d5b-47bb-8bd8-54c94ff185ed&vvuid=75294a9f-7693-4eb4-9cb9-ccf8c1f598bd&orgId=28230&plcid=1206795&vrid=0861bd3c-8d98-41a8-aae4-85046d00ae5f&ab=0&dt=189&h=270&spaceid=793604934&w=480&cb=0.6098864313497896
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
54.93.70.53 Frankfurt am Main, Germany, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
nginx/1.19.4 /
Resource Hash
cf4724b2f736ed1a0ae6bc28f1ead963d9cd2c1fd87b6ef32e7799fc1c5c8bda

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:45:52 GMT
cache-control
max-age=0, no-cache, no-store, must-revalidate
last-modified
Mon, 28 Sep 1970 06:00:00 GMT
server
nginx/1.19.4
content-type
image/gif
content-length
43
expires
Tue, 15 Dec 2020 12:45:52 GMT
ad-request.gif
trk.vidible.tv/trk/ Frame 9466
43 B
245 B
Image
General
Full URL
https://trk.vidible.tv/trk/ad-request.gif?bcid=5c6c7f1c17e0e151b5b9cb66&bid=56bcd17de4b0a5976ac0da12&pid=59947c0544a64b1a49e52a48&pt=o2unit&pv=10.2.59&r=https%3A%2F%2Fwww.dailymail.co.uk%2Fsciencetech%2Farticle-9050821%2FRemdesivir-beneficial-patients-doctors-reveal.html%3F_hsmi%3D88974744%26_hsenc%3Dp2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8&s=true&sid=cb4b0531-0d5b-47bb-8bd8-54c94ff185ed&vvuid=75294a9f-7693-4eb4-9cb9-ccf8c1f598bd&orgId=28230&plcid=1206795&vrid=0861bd3c-8d98-41a8-aae4-85046d00ae5f&at=preroll&ps=html5-vpaid&spaceid=793604934&p.vw.active=1&p.vw.sound=0&vwa=100&vwm=-1&cb=0.43585081919455226
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
54.93.70.53 Frankfurt am Main, Germany, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
nginx/1.19.4 /
Resource Hash
cf4724b2f736ed1a0ae6bc28f1ead963d9cd2c1fd87b6ef32e7799fc1c5c8bda

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:45:52 GMT
cache-control
max-age=0, no-cache, no-store, must-revalidate
last-modified
Mon, 28 Sep 1970 06:00:00 GMT
server
nginx/1.19.4
content-type
image/gif
content-length
43
expires
Tue, 15 Dec 2020 12:45:52 GMT
ad-engine-request.gif
trk.vidible.tv/trk/ Frame 9466
43 B
245 B
Image
General
Full URL
https://trk.vidible.tv/trk/ad-engine-request.gif?bcid=5c6c7f1c17e0e151b5b9cb66&bid=56bcd17de4b0a5976ac0da12&pid=59947c0544a64b1a49e52a48&pt=o2unit&pv=10.2.59&r=https%3A%2F%2Fwww.dailymail.co.uk%2Fsciencetech%2Farticle-9050821%2FRemdesivir-beneficial-patients-doctors-reveal.html%3F_hsmi%3D88974744%26_hsenc%3Dp2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8&s=true&sid=cb4b0531-0d5b-47bb-8bd8-54c94ff185ed&vvuid=75294a9f-7693-4eb4-9cb9-ccf8c1f598bd&orgId=28230&plcid=1206795&vrid=0861bd3c-8d98-41a8-aae4-85046d00ae5f&at=preroll&adIdx=-1&pbl=true&ps=html5-vpaid&seq=-1&spaceid=793604934&v=593fb311c214e33ec50202f0&w=480&p.vw.active=1&p.vw.sound=0&vwa=100&vwm=-1&h=270&cb=0.27096423084730925
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
54.93.70.53 Frankfurt am Main, Germany, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
nginx/1.19.4 /
Resource Hash
cf4724b2f736ed1a0ae6bc28f1ead963d9cd2c1fd87b6ef32e7799fc1c5c8bda

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:45:52 GMT
cache-control
max-age=0, no-cache, no-store, must-revalidate
last-modified
Mon, 28 Sep 1970 06:00:00 GMT
server
nginx/1.19.4
content-type
image/gif
content-length
43
expires
Tue, 15 Dec 2020 12:45:52 GMT
225114
search.spotxchange.com/openrtb/2.3/dados/
0
1 KB
XHR
General
Full URL
https://search.spotxchange.com/openrtb/2.3/dados/225114
Requested by
Host: js.spotx.tv
URL: https://js.spotx.tv/directsdk/v1/234272.js
Protocol
HTTP/1.1
Security
TLS 1.2, RSA, AES_256_GCM
Server
185.94.180.124 , Netherlands, ASN35220 (SPOTX-AMS, NL),
Reverse DNS
Software
nginx /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
x-openrtb-version
2.3
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type
application/json

Response headers

Date
Tue, 15 Dec 2020 12:45:56 GMT
X-SpotX-Timing-Transform
0.000377
X-SpotX-Timing-SpotMarket
0.021151
X-SpotX-Timing-Page-Mux
0.001797
X-SpotX-Timing-Page-Require
0.000393
X-fe
069
Connection
keep-alive
X-SpotX-Timing-Page-Cookie
0.000041
X-SpotX-Timing-Page
0.027081
Pragma
no-cache
X-SpotX-Timing-Page-Context
0.000356
Last-Modified
Tue, 15 Dec 2020 12:45:56 GMT
Server
nginx
Cache-Control
no-cache, must-revalidate, post-check=0, pre-check=0
X-SpotX-Timing-SpotMarket-Primary
0.021151
Access-Control-Allow-Methods
POST, GET, PATCH, DELETE, OPTIONS
Content-Type
application/json
Access-Control-Allow-Origin
https://www.dailymail.co.uk
X-SpotX-Timing-Page-Misc
0.002945
X-SpotX-Timing-Page-Exception
0.000001
X-SpotX-Timing-SpotMarket-Secondary
0.000000
X-SpotX-Timing-Page-URI
0.000020
Access-Control-Allow-Credentials
true
Access-Control-Allow-Headers
Expires
Thu, 01 Jan 1970 00:00:00 GMT
225114
search.spotxchange.com/openrtb/2.3/dados/ Frame
0
0
Other
General
Full URL
https://search.spotxchange.com/openrtb/2.3/dados/225114
Protocol
HTTP/1.1
Server
185.94.180.124 , Netherlands, ASN35220 (SPOTX-AMS, NL),
Reverse DNS
Software
nginx /
Resource Hash

Request headers

Accept
*/*
Access-Control-Request-Method
POST
Access-Control-Request-Headers
content-type,x-openrtb-version
Origin
https://www.dailymail.co.uk
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Sec-Fetch-Mode
cors

Response headers

Server
nginx
Date
Tue, 15 Dec 2020 12:45:56 GMT
Content-Type
text/plain;charset=UTF-8
Content-Length
0
Connection
keep-alive
Expires
Thu, 01 Jan 1970 00:00:00 GMT
Last-Modified
Tue, 15 Dec 2020 12:45:56 GMT
Cache-Control
no-cache, must-revalidate post-check=0, pre-check=0
Pragma
no-cache
Access-Control-Allow-Origin
https://www.dailymail.co.uk
Access-Control-Allow-Methods
POST, GET, PATCH, DELETE, OPTIONS
Access-Control-Allow-Headers
content-type,x-openrtb-version
Access-Control-Allow-Credentials
true
Access-Control-Max-Age
2592000
rid
match.adsrvr.org/track/
109 B
545 B
XHR
General
Full URL
https://match.adsrvr.org/track/rid?ttd_pid=v5zyp9g&fmt=json
Requested by
Host: player.aniview.com
URL: https://player.aniview.com/script/6.1/avpb3.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
54.171.98.69 Dublin, Ireland, ASN16509 (AMAZON-02, US),
Reverse DNS
ec2-54-171-98-69.eu-west-1.compute.amazonaws.com
Software
/
Resource Hash
bdcc76958e9beaba2478c661579365f9878c99c35b962a100a7ddbdc81803ad4

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type
text/plain

Response headers

date
Tue, 15 Dec 2020 12:45:52 GMT
x-aspnet-version
4.0.30319
vary
Origin
content-type
application/json; charset=utf-8
access-control-allow-origin
https://www.dailymail.co.uk
cache-control
private
access-control-allow-credentials
true
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Content-Length, Content-Encoding, Vary, Cache-Control, Accept
content-length
109
expires
Thu, 14 Jan 2021 12:45:52 GMT
ixmatch.html
js-sec.indexww.com/um/ Frame BB10
0
0
Document
General
Full URL
https://js-sec.indexww.com/um/ixmatch.html
Requested by
Host: player.aniview.com
URL: https://player.aniview.com/script/6.1/avpb3.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
104.111.215.135 , Netherlands, ASN16625 (AKAMAI-AS, US),
Reverse DNS
a104-111-215-135.deploy.static.akamaitechnologies.com
Software
Apache /
Resource Hash

Request headers

:method
GET
:authority
js-sec.indexww.com
:scheme
https
:path
/um/ixmatch.html
pragma
no-cache
cache-control
no-cache
upgrade-insecure-requests
1
user-agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
accept
text/html,application/xhtml+xml,application/xml;q=0.9,image/avif,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3;q=0.9
sec-fetch-site
cross-site
sec-fetch-mode
navigate
sec-fetch-dest
iframe
referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
accept-encoding
gzip, deflate, br
accept-language
en-US
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8

Response headers

server
Apache
last-modified
Tue, 06 Oct 2020 14:04:48 GMT
etag
"e20015-8f4-5b10114f2003a"
accept-ranges
bytes
p3p
policyref="/w3c/p3p.xml", CP="NOI DSP COR DEVa TAIa OUR BUS UNI"
content-type
text/html; charset=UTF-8
vary
Accept-Encoding
content-encoding
gzip
content-length
1136
date
Tue, 15 Dec 2020 12:45:52 GMT
usync.html
eus.rubiconproject.com/ Frame D266
0
0
Document
General
Full URL
https://eus.rubiconproject.com/usync.html
Requested by
Host: player.aniview.com
URL: https://player.aniview.com/script/6.1/avpb3.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
104.108.50.124 , Netherlands, ASN16625 (AKAMAI-AS, US),
Reverse DNS
a104-108-50-124.deploy.static.akamaitechnologies.com
Software
Apache/2.2.15 (CentOS) /
Resource Hash

Request headers

Host
eus.rubiconproject.com
Connection
keep-alive
Pragma
no-cache
Cache-Control
no-cache
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Accept
text/html,application/xhtml+xml,application/xml;q=0.9,image/avif,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3;q=0.9
Sec-Fetch-Site
cross-site
Sec-Fetch-Mode
navigate
Sec-Fetch-Dest
iframe
Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
Accept-Encoding
gzip, deflate, br
Accept-Language
en-US
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8

Response headers

Server
Apache/2.2.15 (CentOS)
Last-Modified
Mon, 28 Sep 2020 17:02:39 GMT
ETag
"4000c-123-5b062a240e9c0"
Accept-Ranges
bytes
Content-Encoding
gzip
Content-Length
238
Content-Type
text/html; charset=UTF-8
Date
Tue, 15 Dec 2020 12:46:00 GMT
Connection
keep-alive
Vary
Accept-Encoding
showad.js
ads.pubmatic.com/AdServer/js/ Frame 0E4A
0
0
Document
General
Full URL
https://ads.pubmatic.com/AdServer/js/showad.js
Requested by
Host: player.aniview.com
URL: https://player.aniview.com/script/6.1/avpb3.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
104.111.215.68 , Netherlands, ASN16625 (AKAMAI-AS, US),
Reverse DNS
a104-111-215-68.deploy.static.akamaitechnologies.com
Software
Apache/2.2.15 (CentOS) /
Resource Hash

Request headers

Host
ads.pubmatic.com
Connection
keep-alive
Pragma
no-cache
Cache-Control
no-cache
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Accept
text/html,application/xhtml+xml,application/xml;q=0.9,image/avif,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3;q=0.9
Sec-Fetch-Site
cross-site
Sec-Fetch-Mode
navigate
Sec-Fetch-Dest
iframe
Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
Accept-Encoding
gzip, deflate, br
Accept-Language
en-US
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8

Response headers

Last-Modified
Wed, 21 Oct 2020 18:57:52 GMT
ETag
"13006b6-94f8-5b232eca8cf5e"
Server
Apache/2.2.15 (CentOS)
Accept-Ranges
bytes
Content-Encoding
gzip
P3P
CP="NOI DSP COR LAW CUR ADMo DEVo TAIo PSAo PSDo IVAo IVDo HISo OTPo OUR SAMo BUS UNI COM NAV INT DEM CNT STA PRE LOC", CP="NOI DSP COR LAW CUR ADMo DEVo TAIo PSAo PSDo IVAo IVDo HISo OTPo OUR SAMo BUS UNI COM NAV INT DEM CNT STA PRE LOC"
Content-Length
13837
Content-Type
text/html; charset=UTF-8
Cache-Control
public, max-age=92048
Expires
Wed, 16 Dec 2020 14:20:01 GMT
Date
Tue, 15 Dec 2020 12:45:53 GMT
Connection
keep-alive
Vary
Accept-Encoding
showad.js
ads.pubmatic.com/AdServer/js/ Frame 1917
0
0
Document
General
Full URL
https://ads.pubmatic.com/AdServer/js/showad.js
Requested by
Host: player.aniview.com
URL: https://player.aniview.com/script/6.1/avpb3.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
104.111.215.68 , Netherlands, ASN16625 (AKAMAI-AS, US),
Reverse DNS
a104-111-215-68.deploy.static.akamaitechnologies.com
Software
Apache/2.2.15 (CentOS) /
Resource Hash

Request headers

Host
ads.pubmatic.com
Connection
keep-alive
Pragma
no-cache
Cache-Control
no-cache
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Accept
text/html,application/xhtml+xml,application/xml;q=0.9,image/avif,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3;q=0.9
Sec-Fetch-Site
cross-site
Sec-Fetch-Mode
navigate
Sec-Fetch-Dest
iframe
Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
Accept-Encoding
gzip, deflate, br
Accept-Language
en-US
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8

Response headers

Last-Modified
Wed, 21 Oct 2020 18:57:52 GMT
ETag
"13006b6-94f8-5b232eca8cf5e"
Server
Apache/2.2.15 (CentOS)
Accept-Ranges
bytes
Content-Encoding
gzip
P3P
CP="NOI DSP COR LAW CUR ADMo DEVo TAIo PSAo PSDo IVAo IVDo HISo OTPo OUR SAMo BUS UNI COM NAV INT DEM CNT STA PRE LOC", CP="NOI DSP COR LAW CUR ADMo DEVo TAIo PSAo PSDo IVAo IVDo HISo OTPo OUR SAMo BUS UNI COM NAV INT DEM CNT STA PRE LOC"
Content-Length
13837
Content-Type
text/html; charset=UTF-8
Cache-Control
public, max-age=92048
Expires
Wed, 16 Dec 2020 14:20:01 GMT
Date
Tue, 15 Dec 2020 12:45:53 GMT
Connection
keep-alive
Vary
Accept-Encoding
pd
u.openx.net/w/1.0/ Frame 9FFD
0
0
Document
General
Full URL
https://u.openx.net/w/1.0/pd
Requested by
Host: player.aniview.com
URL: https://player.aniview.com/script/6.1/avpb3.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
35.244.159.8 Mountain View, United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
OXGW/16.199.0 /
Resource Hash

Request headers

:method
GET
:authority
u.openx.net
:scheme
https
:path
/w/1.0/pd
pragma
no-cache
cache-control
no-cache
upgrade-insecure-requests
1
user-agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
accept
text/html,application/xhtml+xml,application/xml;q=0.9,image/avif,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3;q=0.9
sec-fetch-site
cross-site
sec-fetch-mode
navigate
sec-fetch-dest
iframe
referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
accept-encoding
gzip, deflate, br
accept-language
en-US
cookie
i=84f1103b-a980-4860-8c6e-1866bcc8525c|1608036352
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8

Response headers

vary
Accept, Accept-Encoding
set-cookie
i=84f1103b-a980-4860-8c6e-1866bcc8525c|1608036352; Version=1; Expires=Wed, 15-Dec-2021 12:45:52 GMT; Max-Age=31536000; Secure; Domain=.openx.net; Path=/; SameSite=None pd=v2|1608036352|gekin0vNiygu; Version=1; Expires=Wed, 30-Dec-2020 12:45:52 GMT; Max-Age=1296000; Secure; Domain=.openx.net; Path=/; SameSite=None
server
OXGW/16.199.0
p3p
CP="CUR ADM OUR NOR STA NID"
date
Tue, 15 Dec 2020 12:45:52 GMT
content-type
text/html
content-length
417
content-encoding
gzip
via
1.1 google
alt-svc
clear
async_usersync.html
acdn.adnxs.com/dmp/ Frame 8994
0
0
Document
General
Full URL
https://acdn.adnxs.com/dmp/async_usersync.html
Requested by
Host: player.aniview.com
URL: https://player.aniview.com/script/6.1/avpb3.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
151.101.113.108 Frankfurt am Main, Germany, ASN54113 (FASTLY, US),
Reverse DNS
Software
nginx/1.13.10 /
Resource Hash

Request headers

Host
acdn.adnxs.com
Connection
keep-alive
Pragma
no-cache
Cache-Control
no-cache
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Accept
text/html,application/xhtml+xml,application/xml;q=0.9,image/avif,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3;q=0.9
Sec-Fetch-Site
cross-site
Sec-Fetch-Mode
navigate
Sec-Fetch-Dest
iframe
Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
Accept-Encoding
gzip, deflate, br
Accept-Language
en-US
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8

Response headers

Connection
keep-alive
Content-Length
17053
Server
nginx/1.13.10
Content-Type
text/html
Last-Modified
Wed, 02 Dec 2020 20:56:47 GMT
ETag
W/"5fc7ff8f-cf34"
Expires
Thu, 03 Dec 2020 21:09:36 GMT
Cache-Control
max-age=86402
Access-Control-Allow-Origin
*
Content-Encoding
gzip
Via
1.1 varnish, 1.1 varnish
Accept-Ranges
bytes
Date
Tue, 15 Dec 2020 12:45:53 GMT
Age
56154
X-Served-By
cache-lga21951-LGA, cache-hhn4081-HHN
X-Cache
HIT, HIT
X-Cache-Hits
5, 523534
X-Timer
S1608036353.079820,VS0,VE0
Vary
Accept-Encoding
sync
pixel.advertising.com/ups/55953/
Redirect Chain
  • https://match.adsrvr.org/track/cmf/generic?ttd_pid=adaptv&ttd_tpi=1
  • https://match.adsrvr.org/track/cmb/generic?ttd_pid=adaptv&ttd_tpi=1
  • https://pixel.advertising.com/ups/55953/sync?uid=eaff8365-3920-49ce-bdca-8f674a0df29a&_origin=1&gdpr=1&gdpr_consent=&piggybackCookie=eaff8365-3920-49ce-bdca-8f674a0df29a
0
124 B
Image
General
Full URL
https://pixel.advertising.com/ups/55953/sync?uid=eaff8365-3920-49ce-bdca-8f674a0df29a&_origin=1&gdpr=1&gdpr_consent=&piggybackCookie=eaff8365-3920-49ce-bdca-8f674a0df29a
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
18.197.99.6 Frankfurt am Main, Germany, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
Strict-Transport-Security max-age=31536000

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:45:53 GMT
strict-transport-security
max-age=31536000
p3p
CP=NOI DSP COR LAW CURa DEVa TAIa PSAa PSDa OUR BUS UNI COM NAV

Redirect headers

pragma
no-cache
date
Tue, 15 Dec 2020 12:45:53 GMT
x-aspnet-version
4.0.30319
p3p
CP="NOI DSP COR CUR ADMo DEVo PSAo PSDo OUR SAMo BUS UNI NAV"
location
https://pixel.advertising.com/ups/55953/sync?uid=eaff8365-3920-49ce-bdca-8f674a0df29a&_origin=1&gdpr=1&gdpr_consent=&piggybackCookie=eaff8365-3920-49ce-bdca-8f674a0df29a
cache-control
private,no-cache, must-revalidate
content-type
text/html
content-length
369
sync
ups.analytics.yahoo.com/ups/55986/
Redirect Chain
  • https://sync-tm.everesttech.net/upi/pid/m7y5t93k?gdpr=0&gdpr_consent=&redir=https%3A%2F%2Fpixel.advertising.com%2Fups%2F55986%2Fsync%3Fuid%3D%24%7BUSER_ID%7D%26_origin%3D0&gdpr=0&gdpr_consent=
  • https://sync-tm.everesttech.net/ct/upi/pid/m7y5t93k?gdpr=0&gdpr_consent=&redir=https%3A%2F%2Fpixel.advertising.com%2Fups%2F55986%2Fsync%3Fuid%3D%24%7BUSER_ID%7D%26_origin%3D0&gdpr=0&gdpr_consent=&_...
  • https://pixel.advertising.com/ups/55986/sync?uid=X9iwAAAAAI9TozoG&_origin=0&gdpr=0&gdpr_consent=&_test=X9iwAAAAAI9TozoG
  • https://ups.analytics.yahoo.com/ups/55986/sync?uid=X9iwAAAAAI9TozoG&_origin=0&gdpr=0&gdpr_consent=&_test=X9iwAAAAAI9TozoG&apid=UP77852cb2-3ed3-11eb-950c-02ffdefff428
  • https://ups.analytics.yahoo.com/ups/55986/sync?uid=X9iwAAAAAI9TozoG&_origin=0&gdpr=0&gdpr_consent=&_test=X9iwAAAAAI9TozoG&apid=UP77852cb2-3ed3-11eb-950c-02ffdefff428&verify=true
0
964 B
Image
General
Full URL
https://ups.analytics.yahoo.com/ups/55986/sync?uid=X9iwAAAAAI9TozoG&_origin=0&gdpr=0&gdpr_consent=&_test=X9iwAAAAAI9TozoG&apid=UP77852cb2-3ed3-11eb-950c-02ffdefff428&verify=true
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_256_GCM
Server
18.156.0.31 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
ec2-18-156-0-31.eu-central-1.compute.amazonaws.com
Software
ATS/7.1.2.128 /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
Strict-Transport-Security max-age=31536000

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Date
Tue, 15 Dec 2020 12:45:53 GMT
Server
ATS/7.1.2.128
Connection
keep-alive
Age
0
Strict-Transport-Security
max-age=31536000
P3P
CP=NOI DSP COR LAW CURa DEVa TAIa PSAa PSDa OUR BUS UNI COM NAV

Redirect headers

Date
Tue, 15 Dec 2020 12:45:53 GMT
Server
ATS/7.1.2.128
Age
0
Strict-Transport-Security
max-age=31536000
P3P
CP=NOI DSP COR LAW CURa DEVa TAIa PSAa PSDa OUR BUS UNI COM NAV
Location
https://ups.analytics.yahoo.com/ups/55986/sync?uid=X9iwAAAAAI9TozoG&_origin=0&gdpr=0&gdpr_consent=&_test=X9iwAAAAAI9TozoG&apid=UP77852cb2-3ed3-11eb-950c-02ffdefff428&verify=true
Connection
keep-alive
Content-Length
0
sync
ups.analytics.yahoo.com/ups/57304/
Redirect Chain
  • https://pixel.advertising.com/ups/57304/sync?gdpr=&gdpr_consent=&_origin=0&redir=true
  • https://pixel.advertising.com/ups/57304/sync?gdpr=&gdpr_consent=&_origin=0&redir=true&verify=true
  • https://ups.analytics.yahoo.com/ups/57304/sync?gdpr=&gdpr_consent=&_origin=0&redir=true&apid=UP77852cb2-3ed3-11eb-950c-02ffdefff428
  • https://ups.analytics.yahoo.com/ups/57304/sync?gdpr=&gdpr_consent=&_origin=0&redir=true&apid=UP77852cb2-3ed3-11eb-950c-02ffdefff428&verify=true
  • https://cm.g.doubleclick.net/pixel?google_nid=adaptv_dbm&google_cm&google_hm=VVA3Nzg1MmNiMi0zZWQzLTExZWItOTUwYy0wMmZmZGVmZmY0Mjg%3D
  • https://pixel.advertising.com/ups/57304/sync?uid=CAESEN4Tt7gyEIW7MubauRbVXVk&google_cver=1
  • https://ups.analytics.yahoo.com/ups/57304/sync?uid=CAESEN4Tt7gyEIW7MubauRbVXVk&google_cver=1&apid=UP77852cb2-3ed3-11eb-950c-02ffdefff428
0
986 B
Image
General
Full URL
https://ups.analytics.yahoo.com/ups/57304/sync?uid=CAESEN4Tt7gyEIW7MubauRbVXVk&google_cver=1&apid=UP77852cb2-3ed3-11eb-950c-02ffdefff428
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_256_GCM
Server
18.156.0.31 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
ec2-18-156-0-31.eu-central-1.compute.amazonaws.com
Software
ATS/7.1.2.128 /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
Strict-Transport-Security max-age=31536000

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Date
Tue, 15 Dec 2020 12:45:54 GMT
Server
ATS/7.1.2.128
Connection
keep-alive
Age
0
Strict-Transport-Security
max-age=31536000
P3P
CP=NOI DSP COR LAW CURa DEVa TAIa PSAa PSDa OUR BUS UNI COM NAV

Redirect headers

location
https://ups.analytics.yahoo.com/ups/57304/sync?uid=CAESEN4Tt7gyEIW7MubauRbVXVk&google_cver=1&apid=UP77852cb2-3ed3-11eb-950c-02ffdefff428
date
Tue, 15 Dec 2020 12:45:54 GMT
content-length
0
strict-transport-security
max-age=31536000
p3p
CP=NOI DSP COR LAW CURa DEVa TAIa PSAa PSDa OUR BUS UNI COM NAV
pixel.gif
px.moatads.com/
43 B
253 B
Image
General
Full URL
https://px.moatads.com/pixel.gif?e=0&ac=1&bq=7&i=AOL_VIDIBLE_API1&t=1608036352991&de=257997094736&d=106%3A-%3A-%3A-&bo=dailymail.co.uk&bd=dailymail.co.uk&f=0&cs=0
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
104.111.216.96 , Netherlands, ASN16625 (AKAMAI-AS, US),
Reverse DNS
a104-111-216-96.deploy.static.akamaitechnologies.com
Software
Apache /
Resource Hash
cf4724b2f736ed1a0ae6bc28f1ead963d9cd2c1fd87b6ef32e7799fc1c5c8bda

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

pragma
no-cache
date
Tue, 15 Dec 2020 12:45:53 GMT
last-modified
Fri, 20 May 2016 15:16:00 GMT
server
Apache
etag
"ad4b0f606e0f8465bc4c4c170b37e1a3:1463757360"
content-type
image/gif
cache-control
max-age=0, no-cache, no-store
accept-ranges
bytes
content-length
43
expires
Tue, 15 Dec 2020 12:45:53 GMT
ad-engine-response.gif
trk.vidible.tv/trk/ Frame 9466
43 B
245 B
Image
General
Full URL
https://trk.vidible.tv/trk/ad-engine-response.gif?bcid=5c6c7f1c17e0e151b5b9cb66&bid=56bcd17de4b0a5976ac0da12&pid=59947c0544a64b1a49e52a48&pt=o2unit&pv=10.2.59&r=https%3A%2F%2Fwww.dailymail.co.uk%2Fsciencetech%2Farticle-9050821%2FRemdesivir-beneficial-patients-doctors-reveal.html%3F_hsmi%3D88974744%26_hsenc%3Dp2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8&s=true&sid=cb4b0531-0d5b-47bb-8bd8-54c94ff185ed&vvuid=75294a9f-7693-4eb4-9cb9-ccf8c1f598bd&orgId=28230&plcid=1206795&vrid=0861bd3c-8d98-41a8-aae4-85046d00ae5f&at=preroll&adIdx=-1&pbl=true&ps=html5-vpaid&seq=-1&spaceid=793604934&v=593fb311c214e33ec50202f0&w=480&aert=296&ar=no&fo=0&ft=0&h=270&cb=0.8342368599817056
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
54.93.70.53 Frankfurt am Main, Germany, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
nginx/1.19.4 /
Resource Hash
cf4724b2f736ed1a0ae6bc28f1ead963d9cd2c1fd87b6ef32e7799fc1c5c8bda

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:45:53 GMT
cache-control
max-age=0, no-cache, no-store, must-revalidate
last-modified
Mon, 28 Sep 1970 06:00:00 GMT
server
nginx/1.19.4
content-type
image/gif
content-length
43
expires
Tue, 15 Dec 2020 12:45:53 GMT
metrics
api.permutive.com/v2.0/internal/
2 B
287 B
XHR
General
Full URL
https://api.permutive.com/v2.0/internal/metrics?k=ed45e86d-a09e-4d2b-85c0-fbbd6857373e
Requested by
Host: cdn.permutive.com
URL: https://cdn.permutive.com/5f42864d-a421-4f37-9478-00266f871d68-web.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
34.107.254.252 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
Permutive /
Resource Hash
2689367b205c16ce32ed4200942b8b8b1e262dfc70d9bc9fbc77c49699a4f1df

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type
text/plain

Response headers

date
Tue, 15 Dec 2020 12:45:53 GMT
content-encoding
gzip
server
Permutive
vary
Origin,Access-Control-Request-Method
access-control-allow-methods
POST
content-type
text/plain;charset=utf-8
access-control-allow-origin
https://www.dailymail.co.uk
access-control-expose-headers
*
access-control-allow-credentials
true
access-control-max-age
86400
alt-svc
clear
content-length
22
via
1.1 google
user-matching
ads.stickyadstv.com/ Frame 1347
0
0

pixel
cm.g.doubleclick.net/
Redirect Chain
  • https://ads.stickyadstv.com/user-matching?id=11&_fw_gdpr=0&_fw_gdpr_consent=
  • https://cm.g.doubleclick.net/pixel?google_nid=stickyxchange_dbm&google_hm=NTliODhiYjdlNWM3OTg2ZTg0NDI1NmNmY2VmYjExNQ==&gdpr=0&gdpr_consent=
170 B
201 B
Image
General
Full URL
https://cm.g.doubleclick.net/pixel?google_nid=stickyxchange_dbm&google_hm=NTliODhiYjdlNWM3OTg2ZTg0NDI1NmNmY2VmYjExNQ==&gdpr=0&gdpr_consent=
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:816::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
HTTP server (unknown) /
Resource Hash
0b8a20373c6dd04e091902226d922b3688143a8938afb9d283d889de7b55ceb5
Security Headers
Name Value
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

pragma
no-cache
date
Tue, 15 Dec 2020 12:45:53 GMT
server
HTTP server (unknown)
content-type
image/png
cache-control
no-cache, must-revalidate
cross-origin-resource-policy
cross-origin
alt-svc
h3-29="googleads.g.doubleclick.net:443"; ma=2592000,h3-29=":443"; ma=2592000,h3-T051="googleads.g.doubleclick.net:443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic="googleads.g.doubleclick.net:443"; ma=2592000; v="46,43",quic=":443"; ma=2592000; v="46,43"
content-length
170
x-xss-protection
0
expires
Fri, 01 Jan 1990 00:00:00 GMT

Redirect headers

Pragma
no-cache
Date
Tue, 15 Dec 2020 12:45:53 GMT
Server
nginx
Access-Control-Allow-Origin
*
Location
https://cm.g.doubleclick.net/pixel?google_nid=stickyxchange_dbm&google_hm=NTliODhiYjdlNWM3OTg2ZTg0NDI1NmNmY2VmYjExNQ==&gdpr=0&gdpr_consent=
Cache-Control
max-age=0, no-cache, no-store
Access-Control-Allow-Credentials
true
Connection
keep-alive
Content-Length
0
x-sticky-vk
1608036353680001-326
Expires
Tue, 15 Dec 2020 12:45:53 GMT
user-matching
ads.stickyadstv.com/ Frame 1347
0
0

ecm3
s.amazon-adsystem.com/
Redirect Chain
  • https://ads.stickyadstv.com/user-matching?id=2545&_fw_gdpr=0&_fw_gdpr_consent=
  • https://s.amazon-adsystem.com/ecm3?id=59b88bb7e5c7986e844256cfcefb115&ex=freewheel.tv&gdpr=0&gdpr_consent=
43 B
344 B
Image
General
Full URL
https://s.amazon-adsystem.com/ecm3?id=59b88bb7e5c7986e844256cfcefb115&ex=freewheel.tv&gdpr=0&gdpr_consent=
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
52.94.232.32 Ashburn, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
Server /
Resource Hash
c21e2c1246fe45a6750ae6208db2b5965ff6ed63eb80d2ecec3be9c83813428e

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Pragma
no-cache
Date
Tue, 15 Dec 2020 12:45:53 GMT
Server
Server
Vary
User-Agent
Content-Type
image/gif
Cache-Control
max-age=0, no-cache, no-store, private, must-revalidate, s-maxage=0
Connection
keep-alive
Content-Length
43
Expires
Thu, 01 Jan 1970 00:00:00 GMT

Redirect headers

Pragma
no-cache
Date
Tue, 15 Dec 2020 12:45:53 GMT
Server
nginx
Access-Control-Allow-Origin
*
Location
https://s.amazon-adsystem.com/ecm3?id=59b88bb7e5c7986e844256cfcefb115&ex=freewheel.tv&gdpr=0&gdpr_consent=
Cache-Control
max-age=0, no-cache, no-store
Access-Control-Allow-Credentials
true
Connection
keep-alive
Content-Length
0
x-sticky-vk
1608036353680041-326
Expires
Tue, 15 Dec 2020 12:45:53 GMT
track
track1.aniview.com/
0
71 B
Image
General
Full URL
https://track1.aniview.com/track?d=Chrome&cou=NL&cos=OSX&r=www.dailymail.co.uk&rs=www.dailymail.co.uk&sid=25906&t=1608036344&cip=185.212.171.67&sn=&tgt=0&osv=10.14.5&bv=83.0&brn=Chrome&wi=480&he=270&app=&AV_PUBLISHERID=5e3a966128a06134f417790e&test=&aafaid=&proto=https&uid=1608036344228-929692714160-015808-003-004909&imid=fe3cd17e40005b0c3b9a7b5f759fa98d15452790059172315660&cha=0.05&cb=40807090162&d9=1000&AV_WIDTH=480&AV_HEIGHT=270&ppid=5e3a966128a06134f417790e&nid=58fcbed1073ef420086c9d08&pcid=5e3a987528a0611c3444f80c&ncid=5ebbaa0fd5dbd82f9b0f9a69&pasid=5ebbaa68f985a05cae268384&e=request&cb=1608036353626&asid=5eeb836e0cb48833c651eaeb&ofpr=3&fpo=
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
34.197.221.162 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:45:53 GMT
cache-control
max-age=0, no-cache, no-store
content-length
0
auction
prebid-server.rubiconproject.com/openrtb2/
173 B
385 B
XHR
General
Full URL
https://prebid-server.rubiconproject.com/openrtb2/auction
Requested by
Host: player.aniview.com
URL: https://player.aniview.com/script/6.1/avpb3.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
54.93.170.20 Frankfurt am Main, Germany, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
/
Resource Hash
2951f96e5a951ced13983e5e59de40850927f9e7d395b95060db8f48ac1074ee

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type
text/plain

Response headers

pragma
no-cache
date
Tue, 15 Dec 2020 12:45:53 GMT
content-encoding
gzip
content-type
application/json
access-control-allow-origin
https://www.dailymail.co.uk
cache-control
no-cache, no-store, must-revalidate
access-control-allow-credentials
true
content-length
167
expires
0
track
track1.aniview.com/
0
94 B
XHR
General
Full URL
https://track1.aniview.com/track?d=Chrome&cou=NL&cos=OSX&r=www.dailymail.co.uk&rs=www.dailymail.co.uk&sid=25906&t=1608036344&cip=185.212.171.67&sn=&tgt=0&osv=10.14.5&bv=83.0&brn=Chrome&wi=480&he=270&app=&AV_PUBLISHERID=5e3a966128a06134f417790e&test=&aafaid=&proto=https&uid=1608036344228-929692714160-015808-003-004909&imid=fe3cd17e40005b0c3b9a7b5f759fa98d15452790059172315660&cha=0.05&cb=40807090162&d9=1000&AV_WIDTH=480&AV_HEIGHT=270
Requested by
Host: player.aniview.com
URL: https://player.aniview.com/script/6.1/AVmanager.js?v=1.0&type=s&pid=5e3a966128a06134f417790e
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
34.197.221.162 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type
text/plain;charset=UTF-8

Response headers

access-control-allow-origin
*
date
Tue, 15 Dec 2020 12:45:57 GMT
cache-control
max-age=0, no-cache, no-store
content-length
0
7197697
ads.stickyadstv.com/vast/vpaid-adapter/
1 KB
2 KB
XHR
General
Full URL
https://ads.stickyadstv.com/vast/vpaid-adapter/7197697?_fw_gdpr=1&_fw_gdpr_consent=&schain=1.0,1!selectmedia.asia,5e3a966128a06134f417790e,1,,Mail%20Metro%20Media,mailonline.co.uk&_fw_us_privacy=1---&cbb=8036358972
Requested by
Host: player.aniview.com
URL: https://player.aniview.com/script/6.1/AVmanager.js?v=1.0&type=s&pid=5e3a966128a06134f417790e
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
2.18.234.233 , Ascension Island, ASN16625 (AKAMAI-AS, US),
Reverse DNS
a2-18-234-233.deploy.static.akamaitechnologies.com
Software
nginx /
Resource Hash
340d1a0a02160202f4a3712a66af0e7db0b05dcc063c1fe46ca8998accda45db

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Pragma
no-cache
Date
Tue, 15 Dec 2020 12:45:58 GMT
Server
nginx
Content-Type
application/xml;charset=ISO-8859-1
Access-Control-Allow-Origin
https://www.dailymail.co.uk
Cache-Control
max-age=0, no-cache, no-store
Access-Control-Allow-Credentials
true
Connection
keep-alive
Content-Length
1340
x-sticky-vk
1608036358955063-165
Expires
Tue, 15 Dec 2020 12:45:58 GMT
track
track1.aniview.com/
0
70 B
Image
General
Full URL
https://track1.aniview.com/track?d=Chrome&cou=NL&cos=OSX&r=www.dailymail.co.uk&rs=www.dailymail.co.uk&sid=25906&t=1608036344&cip=185.212.171.67&sn=&tgt=0&osv=10.14.5&bv=83.0&brn=Chrome&wi=480&he=270&app=&AV_PUBLISHERID=5e3a966128a06134f417790e&test=&aafaid=&proto=https&uid=1608036344228-929692714160-015808-003-004909&imid=fe3cd17e40005b0c3b9a7b5f759fa98d15452790059172315660&cha=0.05&cb=40807090162&d9=1000&AV_WIDTH=480&AV_HEIGHT=270&ppid=5e3a966128a06134f417790e&nid=58fcbed1073ef420086c9d08&pcid=5e3a987528a0611c3444f80c&ncid=5ebbaa0fd5dbd82f9b0f9a69&pasid=5ebbaa68f985a05cae268384&e=request&cb=1608036358973&asid=5f5f89328761764d2a001b22%2C5c249de6073ef47e0c19572b%2C5eb7e6462559631ad84a9a98&ofpr=2%2C%2C1.25&fpo=%2C%2C
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
34.197.221.162 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:45:59 GMT
cache-control
max-age=0, no-cache, no-store
content-length
0
translator
hbopenbid.pubmatic.com/
0
119 B
XHR
General
Full URL
https://hbopenbid.pubmatic.com/translator?source=prebid-client
Requested by
Host: player.aniview.com
URL: https://player.aniview.com/script/6.1/avpb3.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
185.64.189.112 , United Kingdom, ASN62713 (AS-PUBMATIC, US),
Reverse DNS
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type
text/plain

Response headers

access-control-allow-origin
https://www.dailymail.co.uk
date
Tue, 15 Dec 2020 12:45:59 GMT
cache-control
no-cache, no-store, must-revalidate
access-control-allow-credentials
true
avjp
select-d.openx.net/v/1.0/
92 B
345 B
XHR
General
Full URL
https://select-d.openx.net/v/1.0/avjp?ju=https%3A%2F%2Fwww.dailymail.co.uk%2Fsciencetech%2Farticle-9050821%2FRemdesivir-beneficial-patients-doctors-reveal.html%3F_hsmi%3D88974744%26_hsenc%3Dp2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8&ch=UTF-8&res=1600x1200x24&ifr=true&tz=-60&tws=1600x1200&be=1&bc=hb_pb_3.0.3&dddid=3194e84f-85e3-4356-ace6-9f89389b7cf0&nocache=1608036358977&ttduuid=eaff8365-3920-49ce-bdca-8f674a0df29a&schain=1.0%2C1!selectmedia.asia%2C5e3a966128a06134f417790e%2C1%2C%2CMail%20Metro%20Media%2Cmailonline.co.uk&openrtb=%7B%22imp%22%3A%5B%7B%22video%22%3A%7B%22mimes%22%3A%5B%22video%2Fx-ms-wmv%22%2C%22video%2Fmp4%22%2C%22application%2Fjavascript%22%5D%2C%22w%22%3A480%2C%22h%22%3A270%7D%7D%5D%2C%22w%22%3A480%2C%22v%22%3A270%7D&auid=541066210&vwd=480&vht=270&vos=101
Requested by
Host: player.aniview.com
URL: https://player.aniview.com/script/6.1/avpb3.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
34.98.64.218 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
218.64.98.34.bc.googleusercontent.com
Software
OXGW/16.199.0 /
Resource Hash
004e5faf0bf890f61697daeede9f21826affd1137fb2cb58eaf4719937a04a14

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type
text/plain

Response headers

pragma
no-cache
date
Tue, 15 Dec 2020 12:45:58 GMT
via
1.1 google
server
OXGW/16.199.0
p3p
CP="CUR ADM OUR NOR STA NID"
access-control-allow-origin
https://www.dailymail.co.uk
cache-control
private, max-age=0, no-cache
access-control-allow-credentials
true
content-type
application/json
alt-svc
clear
content-length
92
expires
Mon, 26 Jul 1997 05:00:00 GMT
track
track1.aniview.com/
0
70 B
Image
General
Full URL
https://track1.aniview.com/track?d=Chrome&cou=NL&cos=OSX&r=www.dailymail.co.uk&rs=www.dailymail.co.uk&sid=25906&t=1608036344&cip=185.212.171.67&sn=&tgt=0&osv=10.14.5&bv=83.0&brn=Chrome&wi=480&he=270&app=&AV_PUBLISHERID=5e3a966128a06134f417790e&test=&aafaid=&proto=https&uid=1608036344228-929692714160-015808-003-004909&imid=fe3cd17e40005b0c3b9a7b5f759fa98d15452790059172315660&cha=0.05&cb=40807090162&d9=1000&AV_WIDTH=480&AV_HEIGHT=270&ppid=5e3a966128a06134f417790e&nid=58fcbed1073ef420086c9d08&pcid=5e3a987528a0611c3444f80c&ncid=5ebbaa0fd5dbd82f9b0f9a69&pasid=5ebbaa68f985a05cae268384&e=bid&cb=1608036359056&asid=5c249de6073ef47e0c19572b&ofpr=&fpo=
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
34.197.221.162 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:45:59 GMT
cache-control
max-age=0, no-cache, no-store
content-length
0
vpaid-adapter.min.js
cdn.stickyadstv.com/mustang/ Frame 7392
327 KB
111 KB
Script
General
Full URL
https://cdn.stickyadstv.com/mustang/vpaid-adapter.min.js
Requested by
Host: player.aniview.com
URL: https://player.aniview.com/script/6.1/AVmanager.js?v=1.0&type=s&pid=5e3a966128a06134f417790e
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
2001:4de0:ac19::1:b:3b , Netherlands, ASN20446 (HIGHWINDS3, US),
Reverse DNS
Software
/
Resource Hash
dc989373165041ad828e64f33bb534395d2ec233f5949759c911862535e77658

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Date
Tue, 15 Dec 2020 12:45:59 GMT
Content-Encoding
gzip
Last-Modified
Wed, 09 Dec 2020 03:18:58 GMT
ETag
"1607483938"
X-HW
1608036359.dop131.fr8.shc,1608036359.dop131.fr8.t,1608036359.cds006.fr8.c
Content-Type
application/x-javascript
Access-Control-Allow-Origin
*
Cache-Control
max-age=86400
Access-Control-Allow-Credentials
true
Connection
Keep-Alive
Accept-Ranges
bytes
Content-Length
112809
bandwidth-test-25ko
cdn.stickyadstv.com/mustang/ Frame 7392
25 KB
25 KB
XHR
General
Full URL
https://cdn.stickyadstv.com/mustang/bandwidth-test-25ko?cachebuster=1608036359107
Requested by
Host: cdn.stickyadstv.com
URL: https://cdn.stickyadstv.com/mustang/vpaid-adapter.min.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
2001:4de0:ac19::1:b:3b , Netherlands, ASN20446 (HIGHWINDS3, US),
Reverse DNS
Software
/
Resource Hash
9f995b1c42942ededcce16bba381a19d3b30e0e75a36e0ea956f6a54e040dffe

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Date
Tue, 15 Dec 2020 12:45:59 GMT
Last-Modified
Wed, 09 Dec 2020 03:18:58 GMT
ETag
"1607483938"
X-HW
1608036359.dop002.fr8.shc,1608036359.dop002.fr8.t,1608036359.cds248.fr8.c
Content-Type
application/octet-stream
Access-Control-Allow-Origin
https://www.dailymail.co.uk
Cache-Control
max-age=86400
Access-Control-Allow-Credentials
true
Connection
Keep-Alive
Accept-Ranges
bytes
Content-Length
25600
auto-user-sync
ads.stickyadstv.com/ Frame 7392
0
0

getuid
ib.adnxs.com/
Redirect Chain
  • https://ads.stickyadstv.com/auto-user-sync?gdpr=0&gdpr_consent=null
  • https://1f2e7.v.fwmrm.net/ad/u?_dv=2&dsp_user_mapping=true&127719=d513c8dd79aaf14d3c36359165d320a7&rdU=https%3A%2F%2Fads.stickyadstv.com%2Fuser-registering%3FdataProviderId%3D1169%26userId%3d%23%7b...
  • https://ads.stickyadstv.com/user-registering?dataProviderId=1169&userId=g018_6906463572684681576
  • https://cm.g.doubleclick.net/pixel?google_nid=stickyxchange_dbm&google_cm=&google_sc&google_hm=ZDUxM2M4ZGQ3OWFhZjE0ZDNjMzYzNTkxNjVkMzIwYTc=&gdpr=0&gdpr_consent=
  • https://cm.g.doubleclick.net/pixel?google_nid=stickyxchange_dbm&google_cm=&google_sc=&google_hm=ZDUxM2M4ZGQ3OWFhZjE0ZDNjMzYzNTkxNjVkMzIwYTc=&gdpr=0&gdpr_consent=&google_tc=
  • https://ads.stickyadstv.com/user-registering?dataProviderId=141&userId=CAESELJbIhymIgHJSLxuaiPIW6I&google_cver=1&gdpr=0&gdpr_consent=
  • https://sync-tm.everesttech.net/upi/pid/wGbQAlJJ?gdpr=0&gdpr_consent=&redir=https%3A%2F%2Fads.stickyadstv.com%2Fuser-registering%3FdataProviderId%3D187%26userId%3D%24%7BTM_USER_ID%7D&gdpr=0&gdpr_co...
  • https://sync-tm.everesttech.net/ct/upi/pid/wGbQAlJJ?gdpr=0&gdpr_consent=&redir=https%3A%2F%2Fads.stickyadstv.com%2Fuser-registering%3FdataProviderId%3D187%26userId%3D%24%7BTM_USER_ID%7D&gdpr=0&gdpr...
  • https://ads.stickyadstv.com/user-registering?dataProviderId=187&userId=X9iwCAAAAF5Mz1LS&gdpr=0&gdpr_consent=&_test=X9iwCAAAAF5Mz1LS
  • https://match.adsrvr.org/track/cmf/generic?ttd_pid=stickyads&ttd_tpi=1&gdpr=0&gdpr_consent=&gdpr=0&gdpr_consent=
  • https://match.adsrvr.org/track/cmb/generic?ttd_pid=stickyads&ttd_tpi=1&gdpr=0&gdpr_consent=&gdpr=0&gdpr_consent=
  • https://ads.stickyadstv.com/user-registering?dataProviderId=208&userId=a54550d3-e3b0-4b54-9941-4dc299eefd3e
  • https://sync.mathtag.com/sync/img?mt_exid=44&gdpr=0&gdpr_consent=&redir=https%3A%2F%2Fads.stickyadstv.com%2Fuser-registering%3FdataProviderId%3D183%26userId%3D%5BMM_UUID%5D
  • https://ads.stickyadstv.com/user-registering?dataProviderId=183&userId=30105fd8-b007-4200-ae74-c9a6af44008d&gdpr=0&gdpr_consent=
  • https://pr-bh.ybp.yahoo.com/sync/stickyads/d513c8dd79aaf14d3c36359165d320a7&gdpr=0&gdpr_consent=?gdpr=0&gdpr_consent=
  • https://ads.stickyadstv.com/user-registering?dataProviderId=199&userId=y-oC2Olah1lwTw2zU9Fq5SGDw4BZYXA9DLlvAP0O35
  • https://ad.turn.com/r/cs?pid=34&gdpr=0&gdpr_consent=
  • https://ads.stickyadstv.com/user-registering?dataProviderId=147&userId=2675167110638126630
  • https://sync.ipredictive.com/d/sync/cookie/generic?partner=stickyadstv&append=1&cb=6219189&redirect=https%3A%2F%2Fads.stickyadstv.com%2Fuser-registering%3FdataProviderId%3D690%26userId%3D
  • https://ads.stickyadstv.com/user-registering?dataProviderId=690&userId=7c125685-3ed3-11eb-aa79-379d7bda4b4c
  • https://ib.adnxs.com/getuid?https%3A%2F%2Fads.stickyadstv.com%2Fuser-registering%3FdataProviderId%3D209&gdpr=0&gdpr_consent=%26userId%3D$UID
0
0

/
ads.stickyadstv.com/additional-scripts/ Frame 7392
301 B
860 B
XHR
General
Full URL
https://ads.stickyadstv.com/additional-scripts/?zoneId=7197697&loc=https%3A%2F%2Fwww.dailymail.co.uk%2Fsciencetech%2Farticle-9050821%2FRemdesivir-beneficial-patients-doctors-reveal.html%3F_hsmi%3D88974744%26_hsenc%3Dp2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
Requested by
Host: cdn.stickyadstv.com
URL: https://cdn.stickyadstv.com/mustang/vpaid-adapter.min.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
2.18.234.233 , Ascension Island, ASN16625 (AKAMAI-AS, US),
Reverse DNS
a2-18-234-233.deploy.static.akamaitechnologies.com
Software
nginx /
Resource Hash
64a14c1566ed5e882e60ea9d6e3722949c5767823cd23dc1244503991661dc27

Request headers

Accept
application/xml, text/xml
Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Pragma
no-cache
Date
Tue, 15 Dec 2020 12:45:59 GMT
Server
nginx
Access-Control-Allow-Origin
https://www.dailymail.co.uk
Cache-Control
max-age=0, no-cache, no-store
Access-Control-Allow-Credentials
true
Connection
keep-alive
Content-Length
301
x-sticky-vk
1608036359646074-326
Expires
Tue, 15 Dec 2020 12:45:59 GMT
swfIndex.php
ads.stickyadstv.com/www/delivery/ Frame 7392
67 B
722 B
XHR
General
Full URL
https://ads.stickyadstv.com/www/delivery/swfIndex.php?zoneId=7197697&_fw_gdpr=1&cbb=8036358972&_fw_us_privacy=1---&_fw_gdpr_consent=&schain=1.0%2C1!selectmedia.asia%2C5e3a966128a06134f417790e%2C1%2C%2CMail%2BMetro%2BMedia%2Cmailonline.co.uk&vav=b674614ff1406d3bfb880b5b24c68490&vaviv=7b16b47b694c725550a396d66f01fa0b&reqType=AdsSetup&protocolVersion=2.0&mustangVersion=1.11.6.1&focus=true&percentViewable=15&componentId=vpaid-adapter&loc=https%3A%2F%2Fwww.dailymail.co.uk%2Fsciencetech%2Farticle-9050821%2FRemdesivir-beneficial-patients-doctors-reveal.html%3F_hsmi%3D88974744%26_hsenc%3Dp2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8&playerSize=480x270&supportsFlash=false&supportsJavascript=true
Requested by
Host: cdn.stickyadstv.com
URL: https://cdn.stickyadstv.com/mustang/vpaid-adapter.min.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
2.18.234.233 , Ascension Island, ASN16625 (AKAMAI-AS, US),
Reverse DNS
a2-18-234-233.deploy.static.akamaitechnologies.com
Software
nginx /
Resource Hash
291437ea71e62b1c35d4ec5d3c5ad02cfa930343b41b1472fba70243089c8bbe

Request headers

Accept
application/xml, text/xml
Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Pragma
no-cache
Date
Tue, 15 Dec 2020 12:45:59 GMT
Server
nginx
Content-Type
application/xml;charset=UTF-8
Access-Control-Allow-Origin
https://www.dailymail.co.uk
Cache-Control
max-age=0, no-cache, no-store
Access-Control-Allow-Credentials
true
Connection
keep-alive
Content-Length
67
x-sticky-vk
1608036359695033-97
Expires
Tue, 15 Dec 2020 12:45:59 GMT
user-matching
ads.stickyadstv.com/ Frame 7392
0
0

pixel
cm.g.doubleclick.net/
Redirect Chain
  • https://ads.stickyadstv.com/user-matching?id=11&_fw_gdpr=0&_fw_gdpr_consent=
  • https://cm.g.doubleclick.net/pixel?google_nid=stickyxchange_dbm&google_hm=ZDUxM2M4ZGQ3OWFhZjE0ZDNjMzYzNTkxNjVkMzIwYTc=&gdpr=0&gdpr_consent=
  • https://cm.g.doubleclick.net/pixel?google_nid=stickyxchange_dbm&google_hm=ZDUxM2M4ZGQ3OWFhZjE0ZDNjMzYzNTkxNjVkMzIwYTc=&gdpr=0&gdpr_consent=&google_tc=
170 B
190 B
Image
General
Full URL
https://cm.g.doubleclick.net/pixel?google_nid=stickyxchange_dbm&google_hm=ZDUxM2M4ZGQ3OWFhZjE0ZDNjMzYzNTkxNjVkMzIwYTc=&gdpr=0&gdpr_consent=&google_tc=
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:816::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
HTTP server (unknown) /
Resource Hash
0b8a20373c6dd04e091902226d922b3688143a8938afb9d283d889de7b55ceb5
Security Headers
Name Value
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

pragma
no-cache
date
Tue, 15 Dec 2020 12:45:59 GMT
server
HTTP server (unknown)
content-type
image/png
cache-control
no-cache, must-revalidate
cross-origin-resource-policy
cross-origin
alt-svc
h3-29="googleads.g.doubleclick.net:443"; ma=2592000,h3-29=":443"; ma=2592000,h3-T051="googleads.g.doubleclick.net:443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic="googleads.g.doubleclick.net:443"; ma=2592000; v="46,43",quic=":443"; ma=2592000; v="46,43"
content-length
170
x-xss-protection
0
expires
Fri, 01 Jan 1990 00:00:00 GMT

Redirect headers

pragma
no-cache
date
Tue, 15 Dec 2020 12:45:59 GMT
server
HTTP server (unknown)
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
location
https://cm.g.doubleclick.net/pixel?google_nid=stickyxchange_dbm&google_hm=ZDUxM2M4ZGQ3OWFhZjE0ZDNjMzYzNTkxNjVkMzIwYTc=&gdpr=0&gdpr_consent=&google_tc=
cache-control
no-cache, must-revalidate
cross-origin-resource-policy
cross-origin
content-type
text/html; charset=UTF-8
alt-svc
h3-29="googleads.g.doubleclick.net:443"; ma=2592000,h3-29=":443"; ma=2592000,h3-T051="googleads.g.doubleclick.net:443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic="googleads.g.doubleclick.net:443"; ma=2592000; v="46,43",quic=":443"; ma=2592000; v="46,43"
content-length
363
x-xss-protection
0
expires
Fri, 01 Jan 1990 00:00:00 GMT
user-matching
ads.stickyadstv.com/ Frame 7392
0
0

ecm3
s.amazon-adsystem.com/
Redirect Chain
  • https://ads.stickyadstv.com/user-matching?id=2545&_fw_gdpr=0&_fw_gdpr_consent=
  • https://s.amazon-adsystem.com/ecm3?id=d513c8dd79aaf14d3c36359165d320a7&ex=freewheel.tv&gdpr=0&gdpr_consent=
43 B
344 B
Image
General
Full URL
https://s.amazon-adsystem.com/ecm3?id=d513c8dd79aaf14d3c36359165d320a7&ex=freewheel.tv&gdpr=0&gdpr_consent=
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
52.94.232.32 Ashburn, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
Server /
Resource Hash
c21e2c1246fe45a6750ae6208db2b5965ff6ed63eb80d2ecec3be9c83813428e

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Pragma
no-cache
Date
Tue, 15 Dec 2020 12:45:59 GMT
Server
Server
Vary
User-Agent
Content-Type
image/gif
Cache-Control
max-age=0, no-cache, no-store, private, must-revalidate, s-maxage=0
Connection
keep-alive
Content-Length
43
Expires
Thu, 01 Jan 1970 00:00:00 GMT

Redirect headers

Pragma
no-cache
Date
Tue, 15 Dec 2020 12:45:59 GMT
Server
nginx
Access-Control-Allow-Origin
*
Location
https://s.amazon-adsystem.com/ecm3?id=d513c8dd79aaf14d3c36359165d320a7&ex=freewheel.tv&gdpr=0&gdpr_consent=
Cache-Control
max-age=0, no-cache, no-store
Access-Control-Allow-Credentials
true
Connection
keep-alive
Content-Length
0
x-sticky-vk
1608036359756019-97
Expires
Tue, 15 Dec 2020 12:45:59 GMT
unip
trc-events.taboola.com/1125455/log/3/
0
295 B
XHR
General
Full URL
https://trc-events.taboola.com/1125455/log/3/unip?en=pre_d_eng_tb&tos=22669&scd=20&ssd=1&est=1608036337115&ver=27&isls=true&src=i&invt=12000&tim=1608036359784&vi=1608036337111&ri=b6dc80672a17aca292567a573e6453e2&sd=v2_15bf3ddba6eb6e007097014d6bd5af7c_81242381-ab73-4352-8bed-9e7099c82ee1-tuct6d23571_1608036337_1608036337_CNawjgYQz9hEGNeLvbPmLiABKAEwoQE4l-oLQJWXEEj-0toDUP___________wFYAWAAaOKmqpGyrZficA&ui=81242381-ab73-4352-8bed-9e7099c82ee1-tuct6d23571&ref=null&cv=20201123-29-RELEASE
Requested by
Host: cdn.taboola.com
URL: https://cdn.taboola.com/libtrc/unip/1125455/tfa.js
Protocol
H2
Security
TLS 1.2, ECDHE_ECDSA, AES_128_GCM
Server
141.226.228.48 , Netherlands, ASN200478 (TABOOLA-AS, IL),
Reverse DNS
Software
nginx /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

pragma
no-cache
date
Tue, 15 Dec 2020 12:46:00 GMT
server
nginx
x-fastly-to-nlb-rtt
1786
p3p
policyref="http://trc.taboola.com/p3p.xml", CP="NOI DSP COR LAW NID CURa ADMa DEVa PSAa PSDa OUR BUS IND UNI COM NAV INT DEM"
access-control-allow-origin
https://www.dailymail.co.uk
cache-control
no-cache
access-control-allow-credentials
true
tbl-x-upstream
10.41.30.18:10213
01-12818-radar10.min.js
s3.amazonaws.com/cdx-radar/
162 B
651 B
Script
General
Full URL
https://s3.amazonaws.com/cdx-radar/01-12818-radar10.min.js
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
54.231.40.226 Ashburn, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
s3-1.amazonaws.com
Software
AmazonS3 /
Resource Hash
78e1f5b2988a32d2708b78fbdca3e2e5b06507a15db283d99a8ca2fa3a58e559

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Date
Tue, 15 Dec 2020 12:46:03 GMT
Last-Modified
Fri, 07 Nov 2014 19:45:34 GMT
Server
AmazonS3
x-amz-request-id
E8EA9B228DB7C68D
ETag
"e3b6b423a47df7469f6b45760c77dbbd"
x-amz-version-id
null
x-amz-storage-class
REDUCED_REDUNDANCY
x-amz-meta-md5-hash
e3b6b423a47df7469f6b45760c77dbbd
Accept-Ranges
bytes
Content-Type
application/javascript
Content-Length
162
x-amz-id-2
p4s81vkXcPrnXyZnDAY6aKUAWxWED4Vf4k0xehQM2y6RPxgbw0gTDSl+kif3+sPhNxFkTqHzjPk=
sodar
pagead2.googlesyndication.com/getconfig/
8 KB
7 KB
XHR
General
Full URL
https://pagead2.googlesyndication.com/getconfig/sodar?sv=200&tid=gpt&tv=2020120801&st=env
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020120801.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:825::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
9d3a9195946944cfebc561dd6f750bd3ebef1cd201a5421d98843bc392d94d98
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

timing-allow-origin
*
date
Tue, 15 Dec 2020 12:46:02 GMT
content-encoding
gzip
x-content-type-options
nosniff
server
cafe
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
access-control-allow-origin
*
cache-control
private
cross-origin-resource-policy
cross-origin
content-disposition
attachment; filename="f.txt"
content-type
application/json; charset=UTF-8
alt-svc
h3-29="googleads.g.doubleclick.net:443"; ma=2592000,h3-29=":443"; ma=2592000,h3-T051="googleads.g.doubleclick.net:443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic="googleads.g.doubleclick.net:443"; ma=2592000; v="46,43",quic=":443"; ma=2592000; v="46,43"
content-length
6344
x-xss-protection
0
syncframe
gum.criteo.com/ Frame AE1F
0
0
Document
General
Full URL
https://gum.criteo.com/syncframe?topUrl=www.dailymail.co.uk
Requested by
Host: static.criteo.net
URL: https://static.criteo.net/js/ld/publishertag.prebid.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a02:2638::1c , France, ASN44788 (ASN-CRITEO-EUROPE, FR),
Reverse DNS
Software
/
Resource Hash
Security Headers
Name Value
Strict-Transport-Security max-age=31536000

Request headers

:method
GET
:authority
gum.criteo.com
:scheme
https
:path
/syncframe?topUrl=www.dailymail.co.uk
pragma
no-cache
cache-control
no-cache
upgrade-insecure-requests
1
user-agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
accept
text/html,application/xhtml+xml,application/xml;q=0.9,image/avif,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3;q=0.9
sec-fetch-site
cross-site
sec-fetch-mode
navigate
sec-fetch-dest
iframe
referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
accept-encoding
gzip, deflate, br
accept-language
en-US
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8

Response headers

cache-control
private, max-age=0
content-type
text/html; charset=utf-8
strict-transport-security
max-age=31536000
server-processing-duration-in-ticks
479
date
Tue, 15 Dec 2020 12:46:01 GMT
content-length
0
sodar2.js
tpc.googlesyndication.com/sodar/
16 KB
6 KB
Script
General
Full URL
https://tpc.googlesyndication.com/sodar/sodar2.js
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020120801.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:81d::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
66bfa6dd42535b06a283b3844a0bddcfd7f1aca1368baae035a7cda89a6b97fd
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:46:02 GMT
content-encoding
gzip
x-content-type-options
nosniff
server
sffe
etag
"1603823857801521"
vary
Accept-Encoding
content-type
text/javascript
cache-control
private, max-age=3000
accept-ranges
bytes
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
6015
x-xss-protection
0
expires
Tue, 15 Dec 2020 12:46:02 GMT
content14_10_18m.js
vidstat.taboola.com/
37 KB
8 KB
Script
General
Full URL
https://vidstat.taboola.com/content14_10_18m.js
Requested by
Host: vidstat.taboola.com
URL: https://vidstat.taboola.com/vpaid/units/28_5_3/infra/cmTagWIDGET_ITEM.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
151.101.13.44 Frankfurt am Main, Germany, ASN54113 (FASTLY, US),
Reverse DNS
Software
AmazonS3 /
Resource Hash
ab8bbbaf028510d8b119cce741f0c2cc94816dcc113d83cac81a6aade6a76fa9

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:46:02 GMT
via
1.1 09f4ecc806a7e34780fd19a93b984724.cloudfront.net (CloudFront), 1.1 varnish
age
3170563
x-cache
Hit from cloudfront, HIT
content-encoding
gzip
content-length
7638
x-served-by
cache-fra19158-FRA
last-modified
Sun, 14 Oct 2018 13:31:31 GMT
server
AmazonS3
x-timer
S1608036362.395495,VS0,VE0
etag
"d8d81221ec6e604811ce469d899c9c8b"
vary
Accept-Encoding
access-control-allow-methods
GET, OPTIONS, HEAD
content-type
application/javascript
access-control-allow-origin
*
cache-control
public, max-age=2592000
x-amz-cf-pop
FRA54
accept-ranges
bytes
access-control-allow-headers
*
x-amz-cf-id
-TROi2rJAwAJZGjvQ1UUl45pz7OKYS6cCd8hK2LTON4-GEHuquvUjw==
x-cache-hits
2101226
oppsula.js
vidstat.taboola.com/oppsula/1.3.8/
15 KB
5 KB
Script
General
Full URL
https://vidstat.taboola.com/oppsula/1.3.8/oppsula.js
Requested by
Host: vidstat.taboola.com
URL: https://vidstat.taboola.com/vpaid/units/28_5_3/infra/cmTagWIDGET_ITEM.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
151.101.13.44 Frankfurt am Main, Germany, ASN54113 (FASTLY, US),
Reverse DNS
Software
AmazonS3 /
Resource Hash
f60c4600705d04f5c55db54f646fec728f9458c4fbba35adb4ac114077cb2391

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:46:02 GMT
via
1.1 14484a063800eaed878a3068abf4dfac.cloudfront.net (CloudFront), 1.1 varnish
age
1633145
x-cache
Hit from cloudfront, HIT
content-encoding
gzip
content-length
5164
x-served-by
cache-fra19158-FRA
last-modified
Tue, 14 Apr 2020 06:07:12 GMT
server
AmazonS3
x-timer
S1608036362.396717,VS0,VE0
etag
"328b70146f77a19d2bc0172c656d921e"
vary
Accept-Encoding
access-control-allow-methods
GET, OPTIONS, HEAD
content-type
application/javascript
access-control-allow-origin
*
cache-control
public, max-age=2592000
x-amz-cf-pop
FRA54
accept-ranges
bytes
access-control-allow-headers
*
x-amz-cf-id
X58DtJ9G880Goq2mc64lS6V5DgqRG5getHSEDxdPo0n0rdFZmFVunw==
x-cache-hits
81765
OvaMediaPlayer.js
vidstat.taboola.com/vpaid/vPlayer/player/v11.7.0/
566 KB
145 KB
Script
General
Full URL
https://vidstat.taboola.com/vpaid/vPlayer/player/v11.7.0/OvaMediaPlayer.js
Requested by
Host: vidstat.taboola.com
URL: https://vidstat.taboola.com/vpaid/units/28_5_3/infra/cmTagWIDGET_ITEM.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
151.101.13.44 Frankfurt am Main, Germany, ASN54113 (FASTLY, US),
Reverse DNS
Software
AmazonS3 /
Resource Hash
3accfca186cd34ad3596ea4f8fecbf6e67a932877ab65ccc8d8e361f9be542c4

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:46:02 GMT
via
1.1 71b147cd3102755b55ba8b6fd34e3f4a.cloudfront.net (CloudFront), 1.1 varnish
age
96987
x-amz-meta-mtime
1607939340
x-cache
Miss from cloudfront, HIT
x-amz-meta-ctime
1607939340
x-amz-meta-mode
33188
content-encoding
gzip
content-length
147734
x-served-by
cache-fra19158-FRA
last-modified
Mon, 14 Dec 2020 09:49:05 GMT
server
AmazonS3
x-timer
S1608036362.420507,VS0,VE0
etag
"d897db4ccb1c161bffa6e872872f068a"
x-amz-meta-uid
0
vary
Accept-Encoding
access-control-allow-methods
GET, OPTIONS, HEAD
x-amz-meta-gid
0
access-control-allow-origin
*
cache-control
public, max-age=2592000
x-amz-cf-pop
FRA6-C1
accept-ranges
bytes
content-type
application/javascript
access-control-allow-headers
*
x-amz-cf-id
V_OSMBk6MrCioNxjl2RagcAh6PHhS737TtxjYY9tzEpW-Q4F-FkPpg==
x-cache-hits
50673
sync
am-match.taboola.com/ Frame 3229
0
0
Document
General
Full URL
https://am-match.taboola.com/sync?dast=V7FEQCFgODwV-BG--R_QSDwV-BG--R_QUAAAAGBuIHHMYcMTcTFonBYO0Gq91muVvsZovdZDic7YawYcwRczNhkRgM1m6w2m2Ws81iONmtBpvRFDiEZfb7DgrK6ekxuwyiouttsTucZs9BMje5QQ1Np8Pnutfrfr-7yOE0O98Op9mu8dtVX7_m43TZPS7Ty2P0Kyynp8fscisHq8FwsthLWm6Ty_O0PS1vicvusjk9TofZLXiYni676fMW-T2mv-XzlrxsL4fZLjS9zXYAAAAAeAA4kk6F-AEEAIgAAAAAkAAAAACgCKj4txC4AAAAAMAAKBC90ACg5Eigo8sgdPhcL38AADwUgAAADCiQAAyoHZUASCgkngAAAAAAAAAAsPz____HAOjx_8oAXMj19wA8-AA8EBUoFjECAAAAyKVeHTqa1AmVRRUAAEG6FcAVAECAndnbUlwYAADAwNgCPSx-v9lh1_jdLgMAAAAAAAAAMPs_-0cTgpqZSQNKzNRU-wUEAFj7BQQAYFM3AIA3AbigI2jFYLC6AZosZgcAAABw9____68HQibTyDbbeIYLl2Pi3G1MHtfEN3GMPJ7ZZrIZDLZXq2f7rFzhAtjHISyz33dQUE5Pj9llEBVdb4vd4TR7DpK5yX4TthitJpPNcjhbLiaD4Wg4Gu1PADcDnKDhcLDYDRa7xWI4WUxGg-VggQIxmOCEDEebyWq0W-0my-FkNJptJhukaNVqNtoMhqvZZLbbrYaD4XI0QorWLGaTyWI2Wu42g-VkNBhOhkOEwcVkNNkMF2uFxbdZizaryVo4cZncypVvsFxujJOVy7EWvT6m28iyWe0WWxQMKNuL4CKdiBxOs_PtcJrdkr_vIpZoThbpRHbZl0ymkW228QwXLsfEuduYPK6Jb-IYeTyzzWQzGOyLi8loshku1gqLb7MWbVaTtXDiMrmVK99gudwYJyuXYy16fUy3kWWz2i32jdlgONjMNpvdvjEbDAeb2Waz23foDN_V52y0Rbvnjs4y0y6GtpnpoHAZjN7f0SKN3Xozo8ortlhUt2D0N7EK_X6_3-_3-_1-v3djNngMBsPPZTsOP-blWnN6HBSxRHC6SCeil_F0EUskT4t0IhmMPB6Ty7VyzWyzlWE5WE0mzt3EtHDOTLblZDERS5Smi3Si13ycLrvHZXp5jH6F5fT0mF1u5WA1GE4We8nLbXJ5nran5S1x2V02p8fpMLsFD9PTZTd93iK_x_S3fN6Sl-3lMNuFprfZov6jQwxXc8liMlfsFnPZbpUAAAAAAAAAAJYwZ94EAAAA4DSQyWa4WC0X4MFoT_dHNYX1jnM8cdcFm5Pt8szIpLjx4wZyOM3Ot8Npdkv-visDPBjdMW_2TBBrtVrWAAAABNgAAAAB3Lp5CxyL5AA!&excid=22&docw=0&cijs=1&nlb=true
Requested by
Host: vidstat.taboola.com
URL: https://vidstat.taboola.com/vpaid/units/28_5_3/infra/cmTagWIDGET_ITEM.js
Protocol
H2
Security
TLS 1.2, ECDHE_ECDSA, AES_128_GCM
Server
141.226.228.48 , Netherlands, ASN200478 (TABOOLA-AS, IL),
Reverse DNS
Software
nginx /
Resource Hash

Request headers

:method
GET
:authority
am-match.taboola.com
:scheme
https
:path
/sync?dast=V7FEQCFgODwV-BG--R_QSDwV-BG--R_QUAAAAGBuIHHMYcMTcTFonBYO0Gq91muVvsZovdZDic7YawYcwRczNhkRgM1m6w2m2Ws81iONmtBpvRFDiEZfb7DgrK6ekxuwyiouttsTucZs9BMje5QQ1Np8Pnutfrfr-7yOE0O98Op9mu8dtVX7_m43TZPS7Ty2P0Kyynp8fscisHq8FwsthLWm6Ty_O0PS1vicvusjk9TofZLXiYni676fMW-T2mv-XzlrxsL4fZLjS9zXYAAAAAeAA4kk6F-AEEAIgAAAAAkAAAAACgCKj4txC4AAAAAMAAKBC90ACg5Eigo8sgdPhcL38AADwUgAAADCiQAAyoHZUASCgkngAAAAAAAAAAsPz____HAOjx_8oAXMj19wA8-AA8EBUoFjECAAAAyKVeHTqa1AmVRRUAAEG6FcAVAECAndnbUlwYAADAwNgCPSx-v9lh1_jdLgMAAAAAAAAAMPs_-0cTgpqZSQNKzNRU-wUEAFj7BQQAYFM3AIA3AbigI2jFYLC6AZosZgcAAABw9____68HQibTyDbbeIYLl2Pi3G1MHtfEN3GMPJ7ZZrIZDLZXq2f7rFzhAtjHISyz33dQUE5Pj9llEBVdb4vd4TR7DpK5yX4TthitJpPNcjhbLiaD4Wg4Gu1PADcDnKDhcLDYDRa7xWI4WUxGg-VggQIxmOCEDEebyWq0W-0my-FkNJptJhukaNVqNtoMhqvZZLbbrYaD4XI0QorWLGaTyWI2Wu42g-VkNBhOhkOEwcVkNNkMF2uFxbdZizaryVo4cZncypVvsFxujJOVy7EWvT6m28iyWe0WWxQMKNuL4CKdiBxOs_PtcJrdkr_vIpZoThbpRHbZl0ymkW228QwXLsfEuduYPK6Jb-IYeTyzzWQzGOyLi8loshku1gqLb7MWbVaTtXDiMrmVK99gudwYJyuXYy16fUy3kWWz2i32jdlgONjMNpvdvjEbDAeb2Waz23foDN_V52y0Rbvnjs4y0y6GtpnpoHAZjN7f0SKN3Xozo8ortlhUt2D0N7EK_X6_3-_3-_1-v3djNngMBsPPZTsOP-blWnN6HBSxRHC6SCeil_F0EUskT4t0IhmMPB6Ty7VyzWyzlWE5WE0mzt3EtHDOTLblZDERS5Smi3Si13ycLrvHZXp5jH6F5fT0mF1u5WA1GE4We8nLbXJ5nran5S1x2V02p8fpMLsFD9PTZTd93iK_x_S3fN6Sl-3lMNuFprfZov6jQwxXc8liMlfsFnPZbpUAAAAAAAAAAJYwZ94EAAAA4DSQyWa4WC0X4MFoT_dHNYX1jnM8cdcFm5Pt8szIpLjx4wZyOM3Ot8Npdkv-visDPBjdMW_2TBBrtVrWAAAABNgAAAAB3Lp5CxyL5AA!&excid=22&docw=0&cijs=1&nlb=true
pragma
no-cache
cache-control
no-cache
upgrade-insecure-requests
1
user-agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
accept
text/html,application/xhtml+xml,application/xml;q=0.9,image/avif,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3;q=0.9
sec-fetch-site
cross-site
sec-fetch-mode
navigate
sec-fetch-dest
iframe
referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
accept-encoding
gzip, deflate, br
accept-language
en-US
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8

Response headers

server
nginx
date
Tue, 15 Dec 2020 12:46:02 GMT
content-type
text/html;charset=ISO-8859-1
machineid
3403
st
am-vid-events.taboola.com/
0
43 B
Image
General
Full URL
https://am-vid-events.taboola.com/st?cijs=convusmp&ttype=120&cisd=convusmp&cipid=8060095&crid=4706985&dast=V7FEQCFgODwV-BG--R_QSDwV-BG--R_QUAAAAGBuIHHMYcMTcTFonBYO0Gq91muVvsZovdZDic7YawYcwRczNhkRgM1m6w2m2Ws81iONmtBpvRFDiEZfb7DgrK6ekxuwyiouttsTucZs9BMje5QQ1Np8Pnutfrfr-7yOE0O98Op9mu8dtVX7_m43TZPS7Ty2P0Kyynp8fscisHq8FwsthLWm6Ty_O0PS1vicvusjk9TofZLXiYni676fMW-T2mv-XzlrxsL4fZLjS9zXYAAAAAeAA4kk6F-AEEAIgAAAAAkAAAAACgCKj4txC4AAAAAMAAKBC90ACg5Eigo8sgdPhcL38AADwUgAAADCiQAAyoHZUASCgkngAAAAAAAAAAsPz____HAOjx_8oAXMj19wA8-AA8EBUoFjECAAAAyKVeHTqa1AmVRRUAAEG6FcAVAECAndnbUlwYAADAwNgCPSx-v9lh1_jdLgMAAAAAAAAAMPs_-0cTgpqZSQNKzNRU-wUEAFj7BQQAYFM3AIA3AbigI2jFYLC6AZosZgcAAABw9____68HQibTyDbbeIYLl2Pi3G1MHtfEN3GMPJ7ZZrIZDLZXq2f7rFzhAtjHISyz33dQUE5Pj9llEBVdb4vd4TR7DpK5yX4TthitJpPNcjhbLiaD4Wg4Gu1PADcDnKDhcLDYDRa7xWI4WUxGg-VggQIxmOCEDEebyWq0W-0my-FkNJptJhukaNVqNtoMhqvZZLbbrYaD4XI0QorWLGaTyWI2Wu42g-VkNBhOhkOEwcVkNNkMF2uFxbdZizaryVo4cZncypVvsFxujJOVy7EWvT6m28iyWe0WWxQMKNuL4CKdiBxOs_PtcJrdkr_vIpZoThbpRHbZl0ymkW228QwXLsfEuduYPK6Jb-IYeTyzzWQzGOyLi8loshku1gqLb7MWbVaTtXDiMrmVK99gudwYJyuXYy16fUy3kWWz2i32jdlgONjMNpvdvjEbDAeb2Waz23foDN_V52y0Rbvnjs4y0y6GtpnpoHAZjN7f0SKN3Xozo8ortlhUt2D0N7EK_X6_3-_3-_1-v3djNngMBsPPZTsOP-blWnN6HBSxRHC6SCeil_F0EUskT4t0IhmMPB6Ty7VyzWyzlWE5WE0mzt3EtHDOTLblZDERS5Smi3Si13ycLrvHZXp5jH6F5fT0mF1u5WA1GE4We8nLbXJ5nran5S1x2V02p8fpMLsFD9PTZTd93iK_x_S3fN6Sl-3lMNuFprfZov6jQwxXc8liMlfsFnPZbpUAAAAAAAAAAJYwZ94EAAAA4DSQyWa4WC0X4MFoT_dHNYX1jnM8cdcFm5Pt8szIpLjx4wZyOM3Ot8Npdkv-visDPBjdMW_2TBBrtVrWAAAABNgAAAAB3Lp5CxyL5AA!&cmcv=&pix=&cb=1608036362381&uv=2853&tms=1608036362381&su=&abt=dpr6_vA!expn_vF!heavyc_vA!ntvc_vA!spa2_vB!t120!t45!ufm_vA&ft=0&unm=WIDGET_ITEM&mntl=1&
Protocol
H2
Security
TLS 1.2, ECDHE_ECDSA, AES_128_GCM
Server
141.226.228.48 , Netherlands, ASN200478 (TABOOLA-AS, IL),
Reverse DNS
Software
nginx /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:46:02 GMT
content-length
0
server
nginx
runner.html
tpc.googlesyndication.com/sodar/sodar2/219/ Frame 3EE3
0
0
Document
General
Full URL
https://tpc.googlesyndication.com/sodar/sodar2/219/runner.html
Requested by
Host: tpc.googlesyndication.com
URL: https://tpc.googlesyndication.com/sodar/sodar2.js
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:81d::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

:method
GET
:authority
tpc.googlesyndication.com
:scheme
https
:path
/sodar/sodar2/219/runner.html
pragma
no-cache
cache-control
no-cache
upgrade-insecure-requests
1
user-agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
accept
text/html,application/xhtml+xml,application/xml;q=0.9,image/avif,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3;q=0.9
sec-fetch-site
cross-site
sec-fetch-mode
navigate
sec-fetch-dest
iframe
referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
accept-encoding
gzip, deflate, br
accept-language
en-US
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8

Response headers

accept-ranges
bytes
vary
Accept-Encoding
content-encoding
gzip
content-type
text/html
cross-origin-resource-policy
cross-origin
content-length
4867
date
Tue, 15 Dec 2020 12:37:19 GMT
expires
Wed, 15 Dec 2021 12:37:19 GMT
last-modified
Mon, 05 Oct 2020 22:33:01 GMT
x-content-type-options
nosniff
server
sffe
x-xss-protection
0
cache-control
public, max-age=31536000
age
523
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
VideoBidRequestHandlerServlet
wf.taboola.com/
7 KB
5 KB
XHR
General
Full URL
https://wf.taboola.com/VideoBidRequestHandlerServlet?oid=15&width=420&height=236&pubid=169497&tagid=953497&crid=4706985&noaop=3&sortOrderType=0&cb=1608036362565&mimes=5,10,11,12&isvideo=0&plmd=2&mindur=1&maxdur=210&minbr=1&maxbr=10000&st=0&seq=2&pv=1170&pt=651451702&tz=60&viewable=true&ddast=V7FEQCFgODwV-BG--R_QSDwV-BG--R_QUAAAAGBuIHHMYcMTcTFonBYO0Gq91muVvsZovdZDic7YawYcwRczNhkRgM1m6w2m2Ws81iONmtBpvRFDiEZfb7DgrK6ekxuwyiouttsTucZs9BMje5QQ1Np8Pnutfrfr-7yOE0O98Op9mu8dtVX7_m43TZPS7Ty2P0Kyynp8fscisHq8FwsthLWm6Ty_O0PS1vicvusjk9TofZLXiYni676fMW-T2mv-XzlrxsL4fZLjS9zXYAAAAAeAA4kk6F-AEEAIgAAAAAkAAAAACgCKj4txC4AAAAAMAAKBC90ACg5Eigo8sgdPhcL38AADwUgAAADCiQAAyoHZUASCgkngAAAAAAAAAAsPz____HAOjx_8oAXMj19wA8-AA8EBUoFjECAAAAyKVeHTqa1AmVRRUAAEG6FcAVAECAndnbUlwYAADAwNgCPSx-v9lh1_jdLgMAAAAAAAAAMPs_-0cTgpqZSQNKzNRU-wUEAFj7BQQAYFM3AIA3AbigI2jFYLC6AZosZgcAAABw9____68HQibTyDbbeIYLl2Pi3G1MHtfEN3GMPJ7ZZrIZDLZXq2f7rFzhAtjHISyz33dQUE5Pj9llEBVdb4vd4TR7DpK5yX4TthitJpPNcjhbLiaD4Wg4Gu1PADcDnKDhcLDYDRa7xWI4WUxGg-VggQIxmOCEDEebyWq0W-0my-FkNJptJhukaNVqNtoMhqvZZLbbrYaD4XI0QorWLGaTyWI2Wu42g-VkNBhOhkOEwcVkNNkMF2uFxbdZizaryVo4cZncypVvsFxujJOVy7EWvT6m28iyWe0WWxQMKNuL4CKdiBxOs_PtcJrdkr_vIpZoThbpRHbZl0ymkW228QwXLsfEuduYPK6Jb-IYeTyzzWQzGOyLi8loshku1gqLb7MWbVaTtXDiMrmVK99gudwYJyuXYy16fUy3kWWz2i32jdlgONjMNpvdvjEbDAeb2Waz23foDN_V52y0Rbvnjs4y0y6GtpnpoHAZjN7f0SKN3Xozo8ortlhUt2D0N7EK_X6_3-_3-_1-v3djNngMBsPPZTsOP-blWnN6HBSxRHC6SCeil_F0EUskT4t0IhmMPB6Ty7VyzWyzlWE5WE0mzt3EtHDOTLblZDERS5Smi3Si13ycLrvHZXp5jH6F5fT0mF1u5WA1GE4We8nLbXJ5nran5S1x2V02p8fpMLsFD9PTZTd93iK_x_S3fN6Sl-3lMNuFprfZov6jQwxXc8liMlfsFnPZbpUAAAAAAAAAAJYwZ94EAAAA4DSQyWa4WC0X4MFoT_dHNYX1jnM8cdcFm5Pt8szIpLjx4wZyOM3Ot8Npdkv-visDPBjdMW_2TBBrtVrWAAAABNgAAAAB3Lp5CxyL5AA!&proto=2,3,5,6&encoded=1&pstn=vforce2&callback=&wfv=1&amp=0&qsz=6&ft=0&pb=0&pagg=1&dtagid=1182345&dpubid=223815&abtst=dpr6_vA!expn_vF!heavyc_vA!ntvc_vA!spa2_vB!t120!t45!ufm_vA&mPre=0.033&cirf=https%3A%2F%2Fwww.dailymail.co.uk&en=1&subu=0&cdb=&gdprApplies=true
Requested by
Host: vidstat.taboola.com
URL: https://vidstat.taboola.com/vpaid/vPlayer/player/v11.7.0/OvaMediaPlayer.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
151.101.13.44 Frankfurt am Main, Germany, ASN54113 (FASTLY, US),
Reverse DNS
Software
nginx /
Resource Hash
8e0e333fb5b4055d2f4d9d1289563043f76f3404adef61e25e4e07d89da7131e

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-type
text/plain

Response headers

date
Tue, 15 Dec 2020 12:46:02 GMT
content-encoding
gzip
access-control-allow-origin
https://www.dailymail.co.uk
machineid
1435
x-cache
MISS
x-cache-hits
0
x-served-by
cache-fra19158-FRA
pragma
no-cache
server
nginx
x-timer
S1608036363.578563,VS0,VE46
vary
Accept-Encoding
content-type
application/json;charset=utf-8
via
1.1 varnish
cache-control
no-cache,must-revalidate,no-store,max-age=0,s-maxage=0
access-control-allow-credentials
true
accept-ranges
bytes
link
<http://taboola-d.openx.net>; rel=preconnect,<http://taboola-d.openx.net>; rel=preconnect
expires
Sat, 26 Jul 1997 05:00:00 GMT
pixel
cm.g.doubleclick.net/
Redirect Chain
  • https://taboola-d.openx.net/v/1.0/av?auid=541033703&gdpr=0&us_privacy=1---
  • https://cm.g.doubleclick.net/pixel?google_nid=openx&google_cm&google_sc
0
0

pixel
cm.g.doubleclick.net/
Redirect Chain
  • https://taboola-d.openx.net/v/1.0/av?auid=540790697&gdpr=0&us_privacy=1---
  • https://cm.g.doubleclick.net/pixel?google_nid=openx&google_hm=ZjUxMWQ1YTktOGM4OS02YmI3LTRjMmYtNDA0MjRkYWFjYzVm
0
0

av
taboola-d.openx.net/v/1.0/
48 B
250 B
XHR
General
Full URL
https://taboola-d.openx.net/v/1.0/av?auid=541033703&gdpr=1&us_privacy=1---
Requested by
Host: vidstat.taboola.com
URL: https://vidstat.taboola.com/vpaid/vPlayer/player/v11.7.0/OvaMediaPlayer.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
34.98.64.218 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
218.64.98.34.bc.googleusercontent.com
Software
OXGW/16.199.0 /
Resource Hash
a355f2718a8d0b7444670aca6fd1dfdc126f9b8e9931a34a52cac9c343a68e3f

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-type
application/x-www-form-urlencoded

Response headers

pragma
no-cache
date
Tue, 15 Dec 2020 12:46:02 GMT
content-encoding
gzip
server
OXGW/16.199.0
vary
Accept-Encoding
p3p
CP="CUR ADM OUR NOR STA NID"
access-control-allow-origin
https://www.dailymail.co.uk
cache-control
private, max-age=0, no-cache
access-control-allow-credentials
true
content-type
text/xml
alt-svc
clear
content-length
56
via
1.1 google
expires
Mon, 26 Jul 1997 05:00:00 GMT
av
taboola-d.openx.net/v/1.0/
48 B
247 B
XHR
General
Full URL
https://taboola-d.openx.net/v/1.0/av?auid=540790697&gdpr=1&us_privacy=1---
Requested by
Host: vidstat.taboola.com
URL: https://vidstat.taboola.com/vpaid/vPlayer/player/v11.7.0/OvaMediaPlayer.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
34.98.64.218 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
218.64.98.34.bc.googleusercontent.com
Software
OXGW/16.199.0 /
Resource Hash
a355f2718a8d0b7444670aca6fd1dfdc126f9b8e9931a34a52cac9c343a68e3f

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-type
application/x-www-form-urlencoded

Response headers

pragma
no-cache
date
Tue, 15 Dec 2020 12:46:02 GMT
content-encoding
gzip
server
OXGW/16.199.0
vary
Accept-Encoding
p3p
CP="CUR ADM OUR NOR STA NID"
access-control-allow-origin
https://www.dailymail.co.uk
cache-control
private, max-age=0, no-cache
access-control-allow-credentials
true
content-type
text/xml
alt-svc
clear
content-length
56
via
1.1 google
expires
Mon, 26 Jul 1997 05:00:00 GMT
av
taboola-d.openx.net/v/1.0/
Redirect Chain
  • https://taboola-d.openx.net/v/1.0/av?auid=540790697&gdpr=0&us_privacy=1---
  • https://taboola-d.openx.net/v/1.0/av?cc=1&auid=540790697&gdpr=0&us_privacy=1---
48 B
247 B
XHR
General
Full URL
https://taboola-d.openx.net/v/1.0/av?cc=1&auid=540790697&gdpr=0&us_privacy=1---
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
35.244.159.8 Mountain View, United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
OXGW/16.199.0 /
Resource Hash
a355f2718a8d0b7444670aca6fd1dfdc126f9b8e9931a34a52cac9c343a68e3f

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

pragma
no-cache
date
Tue, 15 Dec 2020 12:46:02 GMT
content-encoding
gzip
server
OXGW/16.199.0
vary
Accept-Encoding
p3p
CP="CUR ADM OUR NOR STA NID"
access-control-allow-origin
https://www.dailymail.co.uk
cache-control
private, max-age=0, no-cache
access-control-allow-credentials
true
content-type
text/xml
alt-svc
clear
content-length
56
via
1.1 google
expires
Mon, 26 Jul 1997 05:00:00 GMT

Redirect headers

date
Tue, 15 Dec 2020 12:46:02 GMT
via
1.1 google
server
OXGW/16.199.0
location
https://taboola-d.openx.net/v/1.0/av?cc=1&auid=540790697&gdpr=0&us_privacy=1---
p3p
CP="CUR ADM OUR NOR STA NID"
access-control-allow-origin
https://www.dailymail.co.uk
access-control-allow-credentials
true
alt-svc
clear
content-length
0
radar.js
radar.cedexis.com/1593429750/
Redirect Chain
  • https://radar.cedexis.com/1/12818/radar.js
  • https://radar.cedexis.com/1593429750/radar.js
44 KB
19 KB
Script
General
Full URL
https://radar.cedexis.com/1593429750/radar.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
35.241.57.45 , Ascension Island, ASN15169 (GOOGLE, US),
Reverse DNS
Software
nginx /
Resource Hash
79541fbd5863b789f16e341208642f1b47bb3bc939121ed63426dd7969714390

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:46:02 GMT
content-encoding
gzip
last-modified
Mon, 29 Jun 2020 11:30:33 GMT
server
nginx
etag
W/"5ef9d0d9-af5c"
vary
Accept-Encoding
content-type
application/javascript
via
1.1 google
cache-control
max-age=1209600, public
alt-svc
clear
expires
Tue, 29 Dec 2020 12:46:02 GMT

Redirect headers

date
Tue, 15 Dec 2020 12:46:02 GMT
via
1.1 google
server
nginx
vary
User-Agent,DNT
content-type
text/html
location
/1593429750/radar.js
cache-control
max-age=600
alt-svc
clear
content-length
154
expires
Tue, 15 Dec 2020 12:56:02 GMT
av
taboola-d.openx.net/v/1.0/
Redirect Chain
  • https://taboola-d.openx.net/v/1.0/av?auid=541033703&gdpr=0&us_privacy=1---
  • https://taboola-d.openx.net/v/1.0/av?cc=1&auid=541033703&gdpr=0&us_privacy=1---
48 B
332 B
XHR
General
Full URL
https://taboola-d.openx.net/v/1.0/av?cc=1&auid=541033703&gdpr=0&us_privacy=1---
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
35.244.159.8 Mountain View, United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
OXGW/16.199.0 /
Resource Hash
a355f2718a8d0b7444670aca6fd1dfdc126f9b8e9931a34a52cac9c343a68e3f

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

pragma
no-cache
date
Tue, 15 Dec 2020 12:46:02 GMT
content-encoding
gzip
server
OXGW/16.199.0
vary
Accept-Encoding
p3p
CP="CUR ADM OUR NOR STA NID"
access-control-allow-origin
https://www.dailymail.co.uk
cache-control
private, max-age=0, no-cache
access-control-allow-credentials
true
content-type
text/xml
alt-svc
clear
content-length
56
via
1.1 google
expires
Mon, 26 Jul 1997 05:00:00 GMT

Redirect headers

date
Tue, 15 Dec 2020 12:46:02 GMT
via
1.1 google
server
OXGW/16.199.0
location
https://taboola-d.openx.net/v/1.0/av?cc=1&auid=541033703&gdpr=0&us_privacy=1---
p3p
CP="CUR ADM OUR NOR STA NID"
access-control-allow-origin
https://www.dailymail.co.uk
access-control-allow-credentials
true
alt-svc
clear
content-length
0
providers.json
i2-ltqwbihpujgydttmgcfzxjuwvheozf.init.cedexis-radar.net/i2/1/12818/j1/20/122/1608036362/0/0/
952 B
1 KB
XHR
General
Full URL
https://i2-ltqwbihpujgydttmgcfzxjuwvheozf.init.cedexis-radar.net/i2/1/12818/j1/20/122/1608036362/0/0/providers.json?imagesok=1&n=1&p=1&r=1&s=1&t=1
Requested by
Host: radar.cedexis.com
URL: https://radar.cedexis.com/1/12818/radar.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
104.225.98.130 West Hollywood, United States, ASN36236 (NETACTUATE, US),
Reverse DNS
130.98.225.104.ptr.anycast.net
Software
nginx/1.10.3 /
Resource Hash
c7c50c82cf98abe997b628e96a084299809a7d1eed686ee7462705e3c11b1be9

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Date
Tue, 15 Dec 2020 12:46:02 GMT
Server
nginx/1.10.3
Content-Type
application/json
Access-Control-Allow-Origin
*
Access-Control-Allow-Credentials
true
Connection
keep-alive
Timing-Allow-Origin
*
Keep-Alive
timeout=1
Content-Length
952
/
6852bd0f.akstat.io/
0
360 B
Other
General
Full URL
https://6852bd0f.akstat.io/
Requested by
Host: s.go-mpulse.net
URL: https://s.go-mpulse.net/boomerang/RQAJ2-Q4TGF-HEKJL-TAEAK-5V3VD
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_ECDSA, AES_256_GCM
Server
2a02:26f0:6c00:287::11a6 , Ascension Island, ASN20940 (AKAMAI-ASN1, EU),
Reverse DNS
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type
application/x-www-form-urlencoded

Response headers

Pragma
no-cache
Date
Tue, 15 Dec 2020 12:46:02 GMT
Content-Type
image/gif
Access-Control-Allow-Origin
https://www.dailymail.co.uk
Cache-Control
max-age=0, no-cache, no-store
Access-Control-Allow-Credentials
true
Connection
keep-alive
Timing-Allow-Origin
*
X-XSS-Protection
0
Expires
Tue, 15 Dec 2020 12:46:02 GMT
1608036336745
rpt.cedexis.com/n1/0/1608036333570/0/0/0/0/1608036334502/1608036334503/1608036334504/1608036334504/1608036334517/1608036334509/1608036334517/1608036336092/1608036336103/1608036336099/1608036337973/...
16 B
283 B
XHR
General
Full URL
https://rpt.cedexis.com/n1/0/1608036333570/0/0/0/0/1608036334502/1608036334503/1608036334504/1608036334504/1608036334517/1608036334509/1608036334517/1608036336092/1608036336103/1608036336099/1608036337973/1608036338052/1608036338212/1608036362224/1608036362227/1608036362244/_CgJqMRAUGHoiBQgBEJJkKLe2lOIDMIrg4v4FOIrg4v4FQNiMrxxKEAgDEDUY7MIBIAAo7oOAoARQAFoKCAAQABgAIAAoAGABahNidXR0b24yLmFtcy5odi5wcm9kggEQCAMQnQEYsUYgACi2jICgBIgBuamvnQSQAQCYAQA/0/1608036336745
Requested by
Host: radar.cedexis.com
URL: https://radar.cedexis.com/1/12818/radar.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
2607:f740:e619::1 , United States, ASN63911 (NETACTUATE-AS-AP NetActuate, Inc, US),
Reverse DNS
Software
nginx/1.10.3 /
Resource Hash
8aed5e340cf6a71108b30bd80e05ea7abfb02b5b9ccf9439cae12382df68d2a4

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Date
Tue, 15 Dec 2020 12:46:02 GMT
Server
nginx/1.10.3
Content-Type
text/plain
Access-Control-Allow-Origin
*
Access-Control-Allow-Credentials
true
Connection
keep-alive
Timing-Allow-Origin
*
Keep-Alive
timeout=1
Content-Length
16
gen_204
pagead2.googlesyndication.com/pagead/
0
143 B
Image
General
Full URL
https://pagead2.googlesyndication.com/pagead/gen_204?id=sodar2&v=219&t=2&li=gpt_2020120801&jk=2639827676159032&bg=!v7ylvJzNAAUbEDgJG1h27zHma7XAhgIAAAELUgAAABJoAQcKANR58wEL_csJXjw420GcybSy4rCHXpTXShiZqSiVXEsug_PMytudBQ5wRd_3r6q2LufR7FMRM2YWYe7YJYqBl8d2CpvREhDQ0rtYT-YhvD8q6MUr83ElQNaNX_eKV3HGsHV2XOz2jz0YNr6qYNS670QxJnICV58wf3ORf9HBal57cTp_q-p-FwSYWCNxcN1Zpb3jGCo11hpIeJbcPimLfKVHz-GPFwd6AJ9oWqo_FUyRIX1M8TNy4CtcQrAslh9bBRsZeHWB_dYsa2hNruSIKqzz2hwYOJkBvOotvvwUThkKpEtWjo3-6-zjHfouuwRu_rD7q0b_ZK-vRFCFJe8JycgJhwDhCDErhjhdLgKrlcd569ECsqKQ1inrdd4LKJjGUEabK7P0vI_NYs7_SgkEIJ9ziIje6HXrvP0oWfxV8igbAhPbkoAa98eHpNDLR7_1sdc4HJeQGRpsjA-R02SxZrNq3hdif3-3JA_zCav6mUSG7Y_dNbirrKgUC3lpipFsTIWudOZrr2b9X6ZMkdoSAYXJeOOHQUPnc8XwFADOWthgudcNowHeaQq-F41YpiGHvkzAHGwN1lRhY5tXxrTx0FiW1-GUyMEWr-EPOWNP0xzlB-Mta3y59cxqqrzi2elu0kEd4_wh-xQjdtFziTdPJTcb2XM5yR-bRmV-VHEFjatyEVv48JQzFtGlcjp9WAa4CjeuyP10XISwncQQ5lnT5sobQFk8bMhk3U5XnYLGvFvdVyyHWGSb6WBCJvItrKiQyAn68HjI7hwSRkdXFv-xd1aDpbCGSTNiVS7nSnfgSf2h-8JS4zd_vc0ea09h_Wyvfk2tzC40D_zNv_Vp39CyHjCih7Qjddnek7liC5XG3srQx_0s9A
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:816::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

pragma
no-cache
date
Tue, 15 Dec 2020 12:46:02 GMT
x-content-type-options
nosniff
server
cafe
timing-allow-origin
*
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
cache-control
no-cache, must-revalidate
cross-origin-resource-policy
cross-origin
content-type
image/gif
alt-svc
h3-29="googleads.g.doubleclick.net:443"; ma=2592000,h3-29=":443"; ma=2592000,h3-T051="googleads.g.doubleclick.net:443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic="googleads.g.doubleclick.net:443"; ma=2592000; v="46,43",quic=":443"; ma=2592000; v="46,43"
content-length
0
x-xss-protection
0
expires
Fri, 01 Jan 1990 00:00:00 GMT
/
crta.dailymail.co.uk/
8 B
576 B
Other
General
Full URL
https://crta.dailymail.co.uk/
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/static/mol-adverts/demo/mol-22070/19a28e0b/mol-adverts.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
2a02:26f0:6c00:2be::16c2 , Ascension Island, ASN20940 (AKAMAI-ASN1, EU),
Reverse DNS
Software
http-to-kafka/0.8.10 /
Resource Hash
a00fb0c50741f81bb51d35b4475a4357f8039aabd896a21036bc516839401595

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type
text/plain

Response headers

pragma
no-cache
date
Tue, 15 Dec 2020 12:46:03 GMT
server
http-to-kafka/0.8.10
etag
W/"8-YaBXLEiT7zQxEyDYTILfiL6oPhE"
content-type
text/plain; charset=utf-8
access-control-allow-origin
*
cache-control
max-age=0, no-cache, no-store
access-control-allow-credentials
true
content-length
8
expires
Tue, 15 Dec 2020 12:46:03 GMT
r20.gif
cdnetworks.cedexis-test.com/img/17653/
43 B
556 B
Image
General
Full URL
https://cdnetworks.cedexis-test.com/img/17653/r20.gif?rnd=1-1-12818-0-0-17653-1011161911-_CgJqMRAUGHoiBQgBEJJkKLe2lOIDMIrg4v4FOIrg4v4FQNiMrxxKEAgDEDUY7MIBIAAo7oOAoARQAFoKCAAQABgAIAAoAGABahNidXR0b24yLmFtcy5odi5wcm9kggEQCAMQnQEYsUYgACi2jICgBIgBuamvnQSQAQCYAQA
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
163.171.128.148 , Germany, ASN54994 (QUANTILNETWORKS, US),
Reverse DNS
Software
PWS/8.3.1.0.8 /
Resource Hash
4e0705327480ad2323cb03d9c450ffcae4a98bf3a5382fa0c7882145ed620e49

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Date
Tue, 15 Dec 2020 12:46:03 GMT
Via
1.1 PSdgflkfFRA1bc200:4 (W), 1.1 PSdgflkfFRA1dm92:6 (W)
Age
1110596
X-Cache-Spec
Yes
X-Px
ht PSdgflkfFRA1dm92FRA
Connection
keep-alive
Content-Length
43
Last-Modified
Tue, 21 Aug 2018 21:30:28 GMT
Server
PWS/8.3.1.0.8
ETag
"5b7c8474-2b"
X-Ws-Request-Id
5fd8b00b_PSdgflkfFRA1dm9_25796-55938
Content-Type
image/gif
Access-Control-Allow-Origin
*
Cache-Control
max-age=2629743, public
Accept-Ranges
bytes
Timing-Allow-Origin
*
iuni4.html
cdnetworks.cedexis-test.com/img/17653/ Frame 8552
0
0
Document
General
Full URL
https://cdnetworks.cedexis-test.com/img/17653/iuni4.html?rnd=-1-1-12818-0-0-17653-1011161911-_CgJqMRAUGHoiBQgBEJJkKLe2lOIDMIrg4v4FOIrg4v4FQNiMrxxKEAgDEDUY7MIBIAAo7oOAoARQAFoKCAAQABgAIAAoAGABahNidXR0b24yLmFtcy5odi5wcm9kggEQCAMQnQEYsUYgACi2jICgBIgBuamvnQSQAQCYAQA
Requested by
Host: radar.cedexis.com
URL: https://radar.cedexis.com/1/12818/radar.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
163.171.128.148 , Germany, ASN54994 (QUANTILNETWORKS, US),
Reverse DNS
Software
PWS/8.3.1.0.8 /
Resource Hash

Request headers

Host
cdnetworks.cedexis-test.com
Connection
keep-alive
Pragma
no-cache
Cache-Control
no-cache
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Accept
text/html,application/xhtml+xml,application/xml;q=0.9,image/avif,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3;q=0.9
Sec-Fetch-Site
cross-site
Sec-Fetch-Mode
navigate
Sec-Fetch-Dest
iframe
Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
Accept-Encoding
gzip, deflate, br
Accept-Language
en-US
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8

Response headers

Date
Tue, 15 Dec 2020 12:46:03 GMT
Content-Type
text/html
Content-Length
2011
Connection
keep-alive
Accept-Ranges
bytes
Access-Control-Allow-Origin
*
Cache-Control
max-age=2629743, public
ETag
"5b7c8475-7db"
Last-Modified
Tue, 21 Aug 2018 21:30:29 GMT
Server
PWS/8.3.1.0.8
Timing-Allow-Origin
*
X-Cache-Spec
Yes
Age
25356
Via
1.1 PSdgflkfFRA1hb199:9 (W), 1.1 PSdgflkfFRA1vg90:1 (W)
X-Px
ht PSdgflkfFRA1vg90FRA
X-Ws-Request-Id
5fd8b00b_PSdgflkfFRA1dm9_25796-55941
0
rpt.cedexis.com/f1/_CgJqMRAUGHoiBQgBEJJkKLe2lOIDMIrg4v4FOIrg4v4FQNiMrxxKEAgDEDUY7MIBIAAo7oOAoARQAFoKCAAQABgAIAAoAGABahNidXR0b24yLmFtcy5odi5wcm9kggEQCAMQnQEYsUYgACi2jICgBIgBuamvnQSQAQCYAQA/0/0/17653...
16 B
283 B
XHR
General
Full URL
https://rpt.cedexis.com/f1/_CgJqMRAUGHoiBQgBEJJkKLe2lOIDMIrg4v4FOIrg4v4FQNiMrxxKEAgDEDUY7MIBIAAo7oOAoARQAFoKCAAQABgAIAAoAGABahNidXR0b24yLmFtcy5odi5wcm9kggEQCAMQnQEYsUYgACi2jICgBIgBuamvnQSQAQCYAQA/0/0/17653/1,2/0/23/ht%20PSdgflkfFRA1vg90FRA/0
Requested by
Host: radar.cedexis.com
URL: https://radar.cedexis.com/1/12818/radar.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
2607:f740:e619::1 , United States, ASN63911 (NETACTUATE-AS-AP NetActuate, Inc, US),
Reverse DNS
Software
nginx/1.10.3 /
Resource Hash
8aed5e340cf6a71108b30bd80e05ea7abfb02b5b9ccf9439cae12382df68d2a4

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Date
Tue, 15 Dec 2020 12:46:03 GMT
Server
nginx/1.10.3
Content-Type
text/plain
Access-Control-Allow-Origin
*
Access-Control-Allow-Credentials
true
Connection
keep-alive
Timing-Allow-Origin
*
Keep-Alive
timeout=1
Content-Length
16
r20.gif
cdnetworks.cedexis-test.com/img/17653/
43 B
556 B
Image
General
Full URL
https://cdnetworks.cedexis-test.com/img/17653/r20.gif?rnd=0-1-12818-0-0-17653-1011161911-_CgJqMRAUGHoiBQgBEJJkKLe2lOIDMIrg4v4FOIrg4v4FQNiMrxxKEAgDEDUY7MIBIAAo7oOAoARQAFoKCAAQABgAIAAoAGABahNidXR0b24yLmFtcy5odi5wcm9kggEQCAMQnQEYsUYgACi2jICgBIgBuamvnQSQAQCYAQA
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
163.171.128.148 , Germany, ASN54994 (QUANTILNETWORKS, US),
Reverse DNS
Software
PWS/8.3.1.0.8 /
Resource Hash
4e0705327480ad2323cb03d9c450ffcae4a98bf3a5382fa0c7882145ed620e49

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Date
Tue, 15 Dec 2020 12:46:03 GMT
Via
1.1 PSdgflkfFRA1bc200:4 (W), 1.1 PSdgflkfFRA1vg90:4 (W)
Age
1110780
X-Cache-Spec
Yes
X-Px
ht PSdgflkfFRA1vg90FRA
Connection
keep-alive
Content-Length
43
Last-Modified
Tue, 21 Aug 2018 21:30:28 GMT
Server
PWS/8.3.1.0.8
ETag
"5b7c8474-2b"
X-Ws-Request-Id
5fd8b00b_PSdgflkfFRA1dm9_25796-55944
Content-Type
image/gif
Access-Control-Allow-Origin
*
Cache-Control
max-age=2629743, public
Accept-Ranges
bytes
Timing-Allow-Origin
*
0
rpt.cedexis.com/f1/_CgJqMRAUGHoiBQgBEJJkKLe2lOIDMIrg4v4FOIrg4v4FQNiMrxxKEAgDEDUY7MIBIAAo7oOAoARQAFoKCAAQABgAIAAoAGABahNidXR0b24yLmFtcy5odi5wcm9kggEQCAMQnQEYsUYgACi2jICgBIgBuamvnQSQAQCYAQA/0/0/17653...
16 B
283 B
XHR
General
Full URL
https://rpt.cedexis.com/f1/_CgJqMRAUGHoiBQgBEJJkKLe2lOIDMIrg4v4FOIrg4v4FQNiMrxxKEAgDEDUY7MIBIAAo7oOAoARQAFoKCAAQABgAIAAoAGABahNidXR0b24yLmFtcy5odi5wcm9kggEQCAMQnQEYsUYgACi2jICgBIgBuamvnQSQAQCYAQA/0/0/17653/0,2/0/22/ht%20PSdgflkfFRA1vg90FRA/0
Requested by
Host: radar.cedexis.com
URL: https://radar.cedexis.com/1/12818/radar.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
2607:f740:e619::1 , United States, ASN63911 (NETACTUATE-AS-AP NetActuate, Inc, US),
Reverse DNS
Software
nginx/1.10.3 /
Resource Hash
8aed5e340cf6a71108b30bd80e05ea7abfb02b5b9ccf9439cae12382df68d2a4

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Date
Tue, 15 Dec 2020 12:46:03 GMT
Server
nginx/1.10.3
Content-Type
text/plain
Access-Control-Allow-Origin
*
Access-Control-Allow-Credentials
true
Connection
keep-alive
Timing-Allow-Origin
*
Keep-Alive
timeout=1
Content-Length
16
r20-100KB.png
cdnetworks.cedexis-test.com/img/17653/
100 KB
101 KB
Image
General
Full URL
https://cdnetworks.cedexis-test.com/img/17653/r20-100KB.png?rnd=14-1-12818-0-0-17653-1011161911-_CgJqMRAUGHoiBQgBEJJkKLe2lOIDMIrg4v4FOIrg4v4FQNiMrxxKEAgDEDUY7MIBIAAo7oOAoARQAFoKCAAQABgAIAAoAGABahNidXR0b24yLmFtcy5odi5wcm9kggEQCAMQnQEYsUYgACi2jICgBIgBuamvnQSQAQCYAQA
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
163.171.128.148 , Germany, ASN54994 (QUANTILNETWORKS, US),
Reverse DNS
Software
PWS/8.3.1.0.8 /
Resource Hash
27bce9e85eaf3567a4695ba2b612e32615394d80d0a3a2dcb07b1fbfdfababc7

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Date
Tue, 15 Dec 2020 12:46:03 GMT
Via
1.1 PSdgflkfFRA1ox201:0 (W), 1.1 PSdgflkfFRA1vg90:12 (W)
Age
22053
X-Cache-Spec
Yes
X-Px
ht PSdgflkfFRA1vg90FRA
Connection
keep-alive
Content-Length
102400
Last-Modified
Tue, 21 Aug 2018 21:30:29 GMT
Server
PWS/8.3.1.0.8
ETag
"5b7c8475-19000"
X-Ws-Request-Id
5fd8b00b_PSdgflkfFRA1dm9_25796-55955
Content-Type
image/png
Access-Control-Allow-Origin
*
Cache-Control
max-age=2629743, public
Accept-Ranges
bytes
Timing-Allow-Origin
*
track
track1.aniview.com/
0
93 B
XHR
General
Full URL
https://track1.aniview.com/track?d=Chrome&cou=NL&cos=OSX&r=www.dailymail.co.uk&rs=www.dailymail.co.uk&sid=25906&t=1608036344&cip=185.212.171.67&sn=&tgt=0&osv=10.14.5&bv=83.0&brn=Chrome&wi=480&he=270&app=&AV_PUBLISHERID=5e3a966128a06134f417790e&test=&aafaid=&proto=https&uid=1608036344228-929692714160-015808-003-004909&imid=fe3cd17e40005b0c3b9a7b5f759fa98d15452790059172315660&cha=0.05&cb=40807090162&d9=1000&AV_WIDTH=480&AV_HEIGHT=270
Requested by
Host: player.aniview.com
URL: https://player.aniview.com/script/6.1/AVmanager.js?v=1.0&type=s&pid=5e3a966128a06134f417790e
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
34.197.221.162 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type
text/plain;charset=UTF-8

Response headers

access-control-allow-origin
*
date
Tue, 15 Dec 2020 12:46:04 GMT
cache-control
max-age=0, no-cache, no-store
content-length
0
0
rpt.cedexis.com/f1/_CgJqMRAUGHoiBQgBEJJkKLe2lOIDMIrg4v4FOIrg4v4FQNiMrxxKEAgDEDUY7MIBIAAo7oOAoARQAFoKCAAQABgAIAAoAGABahNidXR0b24yLmFtcy5odi5wcm9kggEQCAMQnQEYsUYgACi2jICgBIgBuamvnQSQAQCYAQA/0/0/17653...
16 B
283 B
XHR
General
Full URL
https://rpt.cedexis.com/f1/_CgJqMRAUGHoiBQgBEJJkKLe2lOIDMIrg4v4FOIrg4v4FQNiMrxxKEAgDEDUY7MIBIAAo7oOAoARQAFoKCAAQABgAIAAoAGABahNidXR0b24yLmFtcy5odi5wcm9kggEQCAMQnQEYsUYgACi2jICgBIgBuamvnQSQAQCYAQA/0/0/17653/14,2/0/15175/ht%20PSdgflkfFRA1vg90FRA/0
Requested by
Host: radar.cedexis.com
URL: https://radar.cedexis.com/1/12818/radar.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
2607:f740:e619::1 , United States, ASN63911 (NETACTUATE-AS-AP NetActuate, Inc, US),
Reverse DNS
Software
nginx/1.10.3 /
Resource Hash
8aed5e340cf6a71108b30bd80e05ea7abfb02b5b9ccf9439cae12382df68d2a4

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Date
Tue, 15 Dec 2020 12:46:04 GMT
Server
nginx/1.10.3
Content-Type
text/plain
Access-Control-Allow-Origin
*
Access-Control-Allow-Credentials
true
Connection
keep-alive
Timing-Allow-Origin
*
Keep-Alive
timeout=1
Content-Length
16
r20.gif
p29.cedexis-test.com/img/
43 B
556 B
Image
General
Full URL
https://p29.cedexis-test.com/img/r20.gif?rnd=1-1-12818-0-0-29-1011161911-_CgJqMRAUGHoiBQgBEJJkKLe2lOIDMIrg4v4FOIrg4v4FQNiMrxxKEAgDEDUY7MIBIAAo7oOAoARQAFoKCAAQABgAIAAoAGABahNidXR0b24yLmFtcy5odi5wcm9kggEQCAMQnQEYsUYgACi2jICgBIgBuamvnQSQAQCYAQA
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_128_GCM
Server
2600:9000:21a1:6a00:1b:9b5:7e00:93a1 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
nginx /
Resource Hash
4e0705327480ad2323cb03d9c450ffcae4a98bf3a5382fa0c7882145ed620e49

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Date
Mon, 16 Nov 2020 03:30:36 GMT
Via
1.1 4ba96a90f7d60adc01e4c55ab697c00e.cloudfront.net (CloudFront)
Connection
keep-alive
Last-Modified
Tue, 21 Aug 2018 21:30:28 GMT
Server
nginx
Age
2538928
ETag
"5b7c8474-2b"
X-Cache
Hit from cloudfront
Content-Type
image/gif
Access-Control-Allow-Origin
*
Cache-Control
max-age=2629743, public
X-Amz-Cf-Pop
MUC51-C1
Timing-Allow-Origin
*
Content-Length
43
X-Amz-Cf-Id
Q84w7DzhbT77jaHVa07Y9KHFGKcOSFQY-VFhYmusJXMH0PrXanOWRQ==
iuni4.html
p29.cedexis-test.com/img/29/ Frame F107
0
0
Document
General
Full URL
https://p29.cedexis-test.com/img/29/iuni4.html?rnd=-1-1-12818-0-0-29-1011161911-_CgJqMRAUGHoiBQgBEJJkKLe2lOIDMIrg4v4FOIrg4v4FQNiMrxxKEAgDEDUY7MIBIAAo7oOAoARQAFoKCAAQABgAIAAoAGABahNidXR0b24yLmFtcy5odi5wcm9kggEQCAMQnQEYsUYgACi2jICgBIgBuamvnQSQAQCYAQA
Requested by
Host: radar.cedexis.com
URL: https://radar.cedexis.com/1/12818/radar.js
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_128_GCM
Server
2600:9000:21a1:6a00:1b:9b5:7e00:93a1 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
nginx /
Resource Hash

Request headers

Host
p29.cedexis-test.com
Connection
keep-alive
Pragma
no-cache
Cache-Control
no-cache
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Accept
text/html,application/xhtml+xml,application/xml;q=0.9,image/avif,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3;q=0.9
Sec-Fetch-Site
cross-site
Sec-Fetch-Mode
navigate
Sec-Fetch-Dest
iframe
Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
Accept-Encoding
gzip, deflate, br
Accept-Language
en-US
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8

Response headers

Content-Type
text/html
Content-Length
2011
Connection
keep-alive
Accept-Ranges
bytes
Access-Control-Allow-Origin
*
Cache-Control
max-age=2629743, public
Date
Wed, 18 Nov 2020 11:18:51 GMT
ETag
"5b7c8474-7db"
Last-Modified
Tue, 21 Aug 2018 21:30:28 GMT
Server
nginx
Timing-Allow-Origin
*
X-Cache
Hit from cloudfront
Via
1.1 4ba96a90f7d60adc01e4c55ab697c00e.cloudfront.net (CloudFront)
X-Amz-Cf-Pop
MUC51-C1
X-Amz-Cf-Id
IdLA3lvnt8DuggIuZRPMQUR2iBB25g8OFgzoKD1uO0xuHrDurQEAsw==
Age
2338033
0
rpt.cedexis.com/f1/_CgJqMRAUGHoiBQgBEJJkKLe2lOIDMIrg4v4FOIrg4v4FQNiMrxxKEAgDEDUY7MIBIAAo7oOAoARQAFoKCAAQABgAIAAoAGABahNidXR0b24yLmFtcy5odi5wcm9kggEQCAMQnQEYsUYgACi2jICgBIgBuamvnQSQAQCYAQA/0/0/29/1,...
16 B
283 B
XHR
General
Full URL
https://rpt.cedexis.com/f1/_CgJqMRAUGHoiBQgBEJJkKLe2lOIDMIrg4v4FOIrg4v4FQNiMrxxKEAgDEDUY7MIBIAAo7oOAoARQAFoKCAAQABgAIAAoAGABahNidXR0b24yLmFtcy5odi5wcm9kggEQCAMQnQEYsUYgACi2jICgBIgBuamvnQSQAQCYAQA/0/0/29/1,2/0/12/x-amz-cf-pop%3AMUC51-C1%40x-amz-cf-id%3AIdLA3lvnt8DuggIuZRPMQUR2iBB25g8OFgzoKD1uO0xuHrDurQEAsw%3D%3D%40via%3A1.1%204ba96a90f7d60adc01e4c55ab697c00e.cloudfront.net%20(CloudFront)/0
Requested by
Host: radar.cedexis.com
URL: https://radar.cedexis.com/1/12818/radar.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
2607:f740:e619::1 , United States, ASN63911 (NETACTUATE-AS-AP NetActuate, Inc, US),
Reverse DNS
Software
nginx/1.10.3 /
Resource Hash
8aed5e340cf6a71108b30bd80e05ea7abfb02b5b9ccf9439cae12382df68d2a4

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Date
Tue, 15 Dec 2020 12:46:04 GMT
Server
nginx/1.10.3
Content-Type
text/plain
Access-Control-Allow-Origin
*
Access-Control-Allow-Credentials
true
Connection
keep-alive
Timing-Allow-Origin
*
Keep-Alive
timeout=1
Content-Length
16
r20.gif
p29.cedexis-test.com/img/
43 B
556 B
Image
General
Full URL
https://p29.cedexis-test.com/img/r20.gif?rnd=0-1-12818-0-0-29-1011161911-_CgJqMRAUGHoiBQgBEJJkKLe2lOIDMIrg4v4FOIrg4v4FQNiMrxxKEAgDEDUY7MIBIAAo7oOAoARQAFoKCAAQABgAIAAoAGABahNidXR0b24yLmFtcy5odi5wcm9kggEQCAMQnQEYsUYgACi2jICgBIgBuamvnQSQAQCYAQA
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_128_GCM
Server
2600:9000:21a1:6a00:1b:9b5:7e00:93a1 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
nginx /
Resource Hash
4e0705327480ad2323cb03d9c450ffcae4a98bf3a5382fa0c7882145ed620e49

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Date
Mon, 16 Nov 2020 03:30:36 GMT
Via
1.1 4ba96a90f7d60adc01e4c55ab697c00e.cloudfront.net (CloudFront)
Connection
keep-alive
Last-Modified
Tue, 21 Aug 2018 21:30:28 GMT
Server
nginx
Age
2538928
ETag
"5b7c8474-2b"
X-Cache
Hit from cloudfront
Content-Type
image/gif
Access-Control-Allow-Origin
*
Cache-Control
max-age=2629743, public
X-Amz-Cf-Pop
MUC51-C1
Timing-Allow-Origin
*
Content-Length
43
X-Amz-Cf-Id
i3V5cUI7UFvJlezym7mQRvrJY_2IWy52pFGBW4dzLLsfCSkMBKgHmw==
sync
am-match.taboola.com/ Frame 454D
0
0
Document
General
Full URL
https://am-match.taboola.com/sync?dast=V7_-gCFgODwV-BG--R_QSDwV-BG--R_QUAAAAGBvQHHUJZjiY0Em9DIu02o9FyMVkuZsPBZrhb7RZD4BDKcjShkXgbEmm3GY2Wi8lwNdkMVoPFYDKFDWO5TAa1QOTyfE1_w1vE8nxNf8Nb1zS53KCGptPhc93rdb_fXeRwmp1vh9Ns1_jtqq9f83G67B6X6eUx-hWW09NjdrmVg9VgOFnsJS23yeV52p6Wt8Rld9mcHqfD7BY8TE-X3fR5i_we09_yeUtetpfDbBea3mY7AAAAADwAKC2HQPwAAgBEAAAAAEgAAAAAUARU_FsIXAAAAABgABSINmgAUHIk0NFlEDp8rpc_AAAeCkAAAAYUSAAG1I5KACrKbk8AAAAAAAAAAFj-____YwD0-H9lADIO53oAHnwAHogKVosYAQAAAORSrw4dTeqEyqIKAIAg3QrgCgAgwM7sbWkuDAAAYGBsgR4Wv9_ssGv8bpcBAAAAAAAAAJj9n_2jCUHNzKQBJWZqqv0CAgCs_QICALCpGwDAmwBc0BG0YjBY3QBNFrMDAAAAuPv____XAyGTaWSbbTzDhcsxce42Jo9r4ps4Rh7PbDPZDAbbq9WzfVaucAHsqyCW52v6G966psllEB80DMvJIJjfhC1Gq8lksxzOlovJYDgajkb7E8DNACdoOBwsdoPFbrEYThaT0WA5WKBADCY4IcPRZrIa7Va7yXI4GY1mm8kGKVq1mo02g-FqNpntdqvhYLgcjZCiNYvZZLKYjZa7zWA5GQ2Gk-EQYXAxGU02w8VaYfFt1qLNarIWTlwmt3LlGyyXG-Nk5XKsRa-P6TaybFa7xRYFA8r2IrhIJyKH0-x8O5xmt-Tvu4glmpNFOpFd9iWTaWSbbTzDhcsxce42Jo9r4ps4Rh7PbDPZDAb74mIymmyGi7XC4tusRZvVZC2cuExu5co3WC43xsnK5ViLXh_TbWTZrHaLfWM2GA42s81mt2_MBsPBZrbZ7PYdOsN39TkbbdHuuaOzzLSLoW1mOihcBqP3d7RIY7fezKjyii0W1S0Y_U2sQr_f7_f7_X6_3-_dmA0eg8Hwc9mOw495udacHgdFLBGcLtKJ6GU8XcQSydMinQg2I99qttw4jKPFaGSZGRYbz8Y12RiWq81usthMxBKl6SKd6DUfp8vucZleHqNfYTk9PWaXWzlYDYaTxV7ycptcnqftaXlLXHaXzelxOsxuwcP0dNlNn7fI7zH9LZ-35GV7Ocx2oelttqj_6BDD1VyymMwVu8VctlslAAAAAAAAAIAlzJk3AQAAADgNZLIZLlbLBXgw2tP90Q5PnAA419h1weZkuzwzMilu_LiBHE6z8-1wmt2Sv-_KAA9Gd8ybPRPEWq2WNQAAAAE2AABAALdu3gLHIjk!&excid=22&docw=0&cijs=1&nlb=true
Requested by
Host: vidstat.taboola.com
URL: https://vidstat.taboola.com/lite-unit/2.4.6/UnitFeedManagerDesktop.min.js
Protocol
H2
Security
TLS 1.2, ECDHE_ECDSA, AES_128_GCM
Server
141.226.228.48 , Netherlands, ASN200478 (TABOOLA-AS, IL),
Reverse DNS
Software
nginx /
Resource Hash

Request headers

:method
GET
:authority
am-match.taboola.com
:scheme
https
:path
/sync?dast=V7_-gCFgODwV-BG--R_QSDwV-BG--R_QUAAAAGBvQHHUJZjiY0Em9DIu02o9FyMVkuZsPBZrhb7RZD4BDKcjShkXgbEmm3GY2Wi8lwNdkMVoPFYDKFDWO5TAa1QOTyfE1_w1vE8nxNf8Nb1zS53KCGptPhc93rdb_fXeRwmp1vh9Ns1_jtqq9f83G67B6X6eUx-hWW09NjdrmVg9VgOFnsJS23yeV52p6Wt8Rld9mcHqfD7BY8TE-X3fR5i_we09_yeUtetpfDbBea3mY7AAAAADwAKC2HQPwAAgBEAAAAAEgAAAAAUARU_FsIXAAAAABgABSINmgAUHIk0NFlEDp8rpc_AAAeCkAAAAYUSAAG1I5KACrKbk8AAAAAAAAAAFj-____YwD0-H9lADIO53oAHnwAHogKVosYAQAAAORSrw4dTeqEyqIKAIAg3QrgCgAgwM7sbWkuDAAAYGBsgR4Wv9_ssGv8bpcBAAAAAAAAAJj9n_2jCUHNzKQBJWZqqv0CAgCs_QICALCpGwDAmwBc0BG0YjBY3QBNFrMDAAAAuPv____XAyGTaWSbbTzDhcsxce42Jo9r4ps4Rh7PbDPZDAbbq9WzfVaucAHsqyCW52v6G966psllEB80DMvJIJjfhC1Gq8lksxzOlovJYDgajkb7E8DNACdoOBwsdoPFbrEYThaT0WA5WKBADCY4IcPRZrIa7Va7yXI4GY1mm8kGKVq1mo02g-FqNpntdqvhYLgcjZCiNYvZZLKYjZa7zWA5GQ2Gk-EQYXAxGU02w8VaYfFt1qLNarIWTlwmt3LlGyyXG-Nk5XKsRa-P6TaybFa7xRYFA8r2IrhIJyKH0-x8O5xmt-Tvu4glmpNFOpFd9iWTaWSbbTzDhcsxce42Jo9r4ps4Rh7PbDPZDAb74mIymmyGi7XC4tusRZvVZC2cuExu5co3WC43xsnK5ViLXh_TbWTZrHaLfWM2GA42s81mt2_MBsPBZrbZ7PYdOsN39TkbbdHuuaOzzLSLoW1mOihcBqP3d7RIY7fezKjyii0W1S0Y_U2sQr_f7_f7_X6_3-_dmA0eg8Hwc9mOw495udacHgdFLBGcLtKJ6GU8XcQSydMinQg2I99qttw4jKPFaGSZGRYbz8Y12RiWq81usthMxBKl6SKd6DUfp8vucZleHqNfYTk9PWaXWzlYDYaTxV7ycptcnqftaXlLXHaXzelxOsxuwcP0dNlNn7fI7zH9LZ-35GV7Ocx2oelttqj_6BDD1VyymMwVu8VctlslAAAAAAAAAIAlzJk3AQAAADgNZLIZLlbLBXgw2tP90Q5PnAA419h1weZkuzwzMilu_LiBHE6z8-1wmt2Sv-_KAA9Gd8ybPRPEWq2WNQAAAAE2AABAALdu3gLHIjk!&excid=22&docw=0&cijs=1&nlb=true
pragma
no-cache
cache-control
no-cache
upgrade-insecure-requests
1
user-agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
accept
text/html,application/xhtml+xml,application/xml;q=0.9,image/avif,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3;q=0.9
sec-fetch-site
cross-site
sec-fetch-mode
navigate
sec-fetch-dest
iframe
referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
accept-encoding
gzip, deflate, br
accept-language
en-US
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8

Response headers

server
nginx
date
Tue, 15 Dec 2020 12:46:04 GMT
content-type
text/html;charset=ISO-8859-1
machineid
3404
0
rpt.cedexis.com/f1/_CgJqMRAUGHoiBQgBEJJkKLe2lOIDMIrg4v4FOIrg4v4FQNiMrxxKEAgDEDUY7MIBIAAo7oOAoARQAFoKCAAQABgAIAAoAGABahNidXR0b24yLmFtcy5odi5wcm9kggEQCAMQnQEYsUYgACi2jICgBIgBuamvnQSQAQCYAQA/0/0/29/0,...
16 B
283 B
XHR
General
Full URL
https://rpt.cedexis.com/f1/_CgJqMRAUGHoiBQgBEJJkKLe2lOIDMIrg4v4FOIrg4v4FQNiMrxxKEAgDEDUY7MIBIAAo7oOAoARQAFoKCAAQABgAIAAoAGABahNidXR0b24yLmFtcy5odi5wcm9kggEQCAMQnQEYsUYgACi2jICgBIgBuamvnQSQAQCYAQA/0/0/29/0,2/0/12/x-amz-cf-pop%3AMUC51-C1%40x-amz-cf-id%3AIdLA3lvnt8DuggIuZRPMQUR2iBB25g8OFgzoKD1uO0xuHrDurQEAsw%3D%3D%40via%3A1.1%204ba96a90f7d60adc01e4c55ab697c00e.cloudfront.net%20(CloudFront)/0
Requested by
Host: radar.cedexis.com
URL: https://radar.cedexis.com/1/12818/radar.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
2607:f740:e619::1 , United States, ASN63911 (NETACTUATE-AS-AP NetActuate, Inc, US),
Reverse DNS
Software
nginx/1.10.3 /
Resource Hash
8aed5e340cf6a71108b30bd80e05ea7abfb02b5b9ccf9439cae12382df68d2a4

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Date
Tue, 15 Dec 2020 12:46:04 GMT
Server
nginx/1.10.3
Content-Type
text/plain
Access-Control-Allow-Origin
*
Access-Control-Allow-Credentials
true
Connection
keep-alive
Timing-Allow-Origin
*
Keep-Alive
timeout=1
Content-Length
16
r20-100KB.png
p29.cedexis-test.com/img/
100 KB
101 KB
Image
General
Full URL
https://p29.cedexis-test.com/img/r20-100KB.png?rnd=14-1-12818-0-0-29-1011161911-_CgJqMRAUGHoiBQgBEJJkKLe2lOIDMIrg4v4FOIrg4v4FQNiMrxxKEAgDEDUY7MIBIAAo7oOAoARQAFoKCAAQABgAIAAoAGABahNidXR0b24yLmFtcy5odi5wcm9kggEQCAMQnQEYsUYgACi2jICgBIgBuamvnQSQAQCYAQA
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_128_GCM
Server
2600:9000:21a1:6a00:1b:9b5:7e00:93a1 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
nginx /
Resource Hash
27bce9e85eaf3567a4695ba2b612e32615394d80d0a3a2dcb07b1fbfdfababc7

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Date
Thu, 19 Nov 2020 11:45:53 GMT
Via
1.1 4ba96a90f7d60adc01e4c55ab697c00e.cloudfront.net (CloudFront)
Age
2250011
X-Cache
Hit from cloudfront
Connection
keep-alive
Content-Length
102400
Last-Modified
Tue, 21 Aug 2018 21:30:29 GMT
Server
nginx
ETag
"5b7c8475-19000"
Content-Type
image/png
Access-Control-Allow-Origin
*
Cache-Control
max-age=2629743, public
X-Amz-Cf-Pop
MUC51-C1
Accept-Ranges
bytes
Timing-Allow-Origin
*
X-Amz-Cf-Id
BXOOJYERb0HtuGCpdqXNmhGBzn9JytYH6ejZdFIlGOJcPk15tKULmg==
0
rpt.cedexis.com/f1/_CgJqMRAUGHoiBQgBEJJkKLe2lOIDMIrg4v4FOIrg4v4FQNiMrxxKEAgDEDUY7MIBIAAo7oOAoARQAFoKCAAQABgAIAAoAGABahNidXR0b24yLmFtcy5odi5wcm9kggEQCAMQnQEYsUYgACi2jICgBIgBuamvnQSQAQCYAQA/0/0/29/14...
16 B
283 B
XHR
General
Full URL
https://rpt.cedexis.com/f1/_CgJqMRAUGHoiBQgBEJJkKLe2lOIDMIrg4v4FOIrg4v4FQNiMrxxKEAgDEDUY7MIBIAAo7oOAoARQAFoKCAAQABgAIAAoAGABahNidXR0b24yLmFtcy5odi5wcm9kggEQCAMQnQEYsUYgACi2jICgBIgBuamvnQSQAQCYAQA/0/0/29/14,2/0/20655/x-amz-cf-pop%3AMUC51-C1%40x-amz-cf-id%3AIdLA3lvnt8DuggIuZRPMQUR2iBB25g8OFgzoKD1uO0xuHrDurQEAsw%3D%3D%40via%3A1.1%204ba96a90f7d60adc01e4c55ab697c00e.cloudfront.net%20(CloudFront)/0
Requested by
Host: radar.cedexis.com
URL: https://radar.cedexis.com/1/12818/radar.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
2607:f740:e619::1 , United States, ASN63911 (NETACTUATE-AS-AP NetActuate, Inc, US),
Reverse DNS
Software
nginx/1.10.3 /
Resource Hash
8aed5e340cf6a71108b30bd80e05ea7abfb02b5b9ccf9439cae12382df68d2a4

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Date
Tue, 15 Dec 2020 12:46:04 GMT
Server
nginx/1.10.3
Content-Type
text/plain
Access-Control-Allow-Origin
*
Access-Control-Allow-Credentials
true
Connection
keep-alive
Timing-Allow-Origin
*
Keep-Alive
timeout=1
Content-Length
16

Failed requests

These URLs were requested, but there was no response received. You will also see them in the list above.

Domain
cm.g.doubleclick.net
URL
https://cm.g.doubleclick.net/pixel?google_nid=lotame_dmp&google_hm=OTYwYWEyYzIyNzNmNmI0OTI5NThmOTZkMzZiZjYzMDQ&google_redir=https://id5-sync.com/c/167/398/2/8.gif?puid=OTYwYWEyYzIyNzNmNmI0OTI5NThmOTZkMzZiZjYzMDQ&gdpr=1&gdpr_consent=
Domain
prebid-server.rubiconproject.com
URL
https://prebid-server.rubiconproject.com/openrtb2/auction
Domain
cdn.stickyadstv.com
URL
https://cdn.stickyadstv.com/mustang/bandwidth-test-25ko?cachebuster=1608036344519
Domain
htlb.casalemedia.com
URL
https://htlb.casalemedia.com/cygnus?s=503172&v=7.2&r=%7B%22id%22%3A%22222ea991e0d209a%22%2C%22imp%22%3A%5B%7B%22id%22%3A%222232cde5f98d062d%22%2C%22ext%22%3A%7B%22siteID%22%3A%22503172%22%2C%22sid%22%3A%22300x250%22%7D%2C%22banner%22%3A%7B%22w%22%3A300%2C%22h%22%3A250%2C%22topframe%22%3A1%7D%7D%5D%2C%22site%22%3A%7B%22page%22%3A%22https%3A%2F%2Fwww.dailymail.co.uk%2Fsciencetech%2Farticle-9050821%2FRemdesivir-beneficial-patients-doctors-reveal.html%3F_hsmi%3D88974744%26_hsenc%3Dp2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8%22%7D%2C%22ext%22%3A%7B%22source%22%3A%22prebid%22%7D%7D&ac=j&sd=1
Domain
ib.adnxs.com
URL
https://ib.adnxs.com/ut/v3/prebid
Domain
mfad.inskinad.com
URL
https://mfad.inskinad.com/api/v2
Domain
pub.admanmedia.com
URL
https://pub.admanmedia.com/?c=o&m=multi
Domain
ads.stickyadstv.com
URL
https://ads.stickyadstv.com/auto-user-sync?gdpr=0&gdpr_consent=null
Domain
ads.stickyadstv.com
URL
https://ads.stickyadstv.com/user-matching?id=11&_fw_gdpr=0&_fw_gdpr_consent=
Domain
ads.stickyadstv.com
URL
https://ads.stickyadstv.com/user-matching?id=2545&_fw_gdpr=0&_fw_gdpr_consent=
Domain
ads.stickyadstv.com
URL
https://ads.stickyadstv.com/auto-user-sync?gdpr=0&gdpr_consent=null
Domain
ib.adnxs.com
URL
https://ib.adnxs.com/getuid?https%3A%2F%2Fads.stickyadstv.com%2Fuser-registering%3FdataProviderId%3D209&gdpr=0&gdpr_consent=%26userId%3D$UID
Domain
ads.stickyadstv.com
URL
https://ads.stickyadstv.com/user-matching?id=11&_fw_gdpr=0&_fw_gdpr_consent=
Domain
ads.stickyadstv.com
URL
https://ads.stickyadstv.com/user-matching?id=2545&_fw_gdpr=0&_fw_gdpr_consent=
Domain
cm.g.doubleclick.net
URL
https://cm.g.doubleclick.net/pixel?google_nid=openx&google_cm&google_sc
Domain
cm.g.doubleclick.net
URL
https://cm.g.doubleclick.net/pixel?google_nid=openx&google_hm=ZjUxMWQ1YTktOGM4OS02YmI3LTRjMmYtNDA0MjRkYWFjYzVm

Verdicts & Comments Add Verdict or Comment

420 JavaScript Global Variables

These are the non-standard "global" variables defined on the window object. These can be helpful in identifying possible client-side frameworks and code.

object| 0 object| 1 object| 2 object| 3 object| 4 object| 5 object| 6 object| 7 object| 8 object| 9 object| 10 object| 11 object| 12 object| 13 object| 14 object| 15 object| 16 object| 17 object| 18 object| 19 object| 20 object| 21 object| 22 object| 23 object| 24 object| 25 object| 26 object| 27 object| 28 object| 29 object| 30 object| 31 object| 32 object| 33 object| 34 object| 35 object| 36 object| 37 object| 38 object| 39 object| 40 object| 41 object| 42 object| 43 object| 44 object| 45 object| 46 object| 47 object| 48 object| 49 object| 50 object| 51 object| 52 object| 53 object| ontransitionrun object| ontransitionstart object| ontransitioncancel object| cookieStore function| showDirectoryPicker function| showOpenFilePicker function| showSaveFilePicker object| trustedTypes boolean| crossOriginIsolated boolean| disableAds object| PageCriteria string| PUSHLY_DOMAIN_KEY boolean| useGpt object| adTrackingConfig boolean| ANDDebugOn string| s_account string| s_account15 boolean| haveRenderedSponsoredPollOnPage boolean| useRtp string| twitterVia string| adReferrer string| adType string| dartSiteId string| adAreaSiteId string| adAreaId string| adSubareaId string| adPageType string| adContent string| adSection string| adArticleId string| adEnvironment boolean| enableAds object| webVitals object| RTA function| setImmediate function| clearImmediate object| regeneratorRuntime number| s_objectID number| s_giq function| AppMeasurement function| AppMeasurement_Module_Media function| s_gi function| s_pgicq object| s_c_il number| s_c_in object| DM object| _ object| MobileUtils string| searchTerms object| dm string| refererHost undefined| docReferrerHostMatches undefined| docReferrerHost object| pagemeta object| s_i_anddailymailprod string| molMVTest object| adListLoader object| adsDescriptions object| adsRenderer object| DfpServer object| adsTrackers object| AdIntegrator object| AdBehaviour object| AdImpression function| AdEvents function| require function| openAdsControlPanel object| permutive object| googletag object| pubcid_options object| _tfa object| __gcp function| pbjsChunk object| pbjs object| _pbjsGlobals object| Criteo string| currentChannelTwitterFollow string| inlineModules object| BOOMR_mq string| BOOMR_API_key object| BOOMR object| _gaq object| ggeac object| google_js_reporting_queue object| Ext string| id function| $ function| jQuery object| _google_rum_ns_ object| google_persistent_state_async number| google_global_correlator number| google_srt function| mb function| Goog_AdSense_Lidar_sendVastEvent function| Goog_AdSense_Lidar_getViewability function| Goog_AdSense_Lidar_getUrlSignalsArray function| Goog_AdSense_Lidar_getUrlSignalsList object| module$contents$ima$CompanionAdSelectionSettings_CompanionAdSelectionSettings object| ima object| module$contents$ima$AdsRenderingSettings_AdsRenderingSettings object| module$contents$ima$AdCuePoints_AdCuePoints object| module$contents$ima$AdError_AdError object| module$contents$ima$AdErrorEvent_AdErrorEvent object| module$contents$ima$AdEvent_AdEvent object| module$contents$ima$AdsManagerLoadedEvent_AdsManagerLoadedEvent object| google object| PublisherCommonId object| hulk string| articleShortUrl object| _taboola function| IrisContextAPI object| IrisContextGlobal object| _fbq object| _gat object| gaGlobal object| audienceProjectLayer object| _urq object| __sak boolean| DotMetricsInitScript function| BOOMR_check_doc_domain object| ErrorStackParser object| UserTimingCompression object| TFASC object| TRC number| taboola_view_id object| TRCImpl function| __trcError boolean| apstagLOADED object| apstag function| Goog_AdSense_getAdAdapterInstance function| Goog_AdSense_OsdAdapter undefined| google_measure_js_timing boolean| CLOSURE_NO_DEPS object| SpotX object| _tblConsole undefined| msg object| _bvt object| $__BPN function| $__Protocol function| __trcCopyProps function| __trcFromError function| __trcClientTimestamp function| __trcLog function| __trcDebug function| __trcInfo function| __trcWarn function| __trcDOMWalker function| __trcJSONify function| __trcUnJSONify function| __trcTrim function| __trcGetElementsByClass function| __trcToArray function| __trcObjectCreate function| PageManager function| addHashParam number| trc_debug_level string| trc_article_id object| googleToken object| googleIMState function| processGoogleToken number| __google_ad_urls_id number| google_unique_id object| FFF object| adBlockQueue object| ABE object| DMS function| emailArticle function| postToDiggit function| postToFark function| postToFB function| postToLinkedIn function| postToPinterest function| postToReddit function| postToTWTTR function| ArticlePage object| DMArticleDefer object| DMDefer function| videojs object| pkcs7 object| Mustache object| TINY object| FFFOverlayHelpers object| s object| closure_lm_364513 function| submitReportAbuseFunction undefined| initialData object| DotMetricsSettings object| __google_ad_urls boolean| google_osd_loaded boolean| google_onload_fired string| nam object| placementData object| closure_lm_57872 function| get_real_link object| __SKIM_JS_GLOBAL__ object| skimlinksAPI object| DotmetricsJSON object| CryptoJS object| DotMetricsObj object| aniplayerPos function| Goog_Osd_UnloadAdBlock function| Goog_Osd_UpdateElementToMeasure function| google_osd_amcb object| ampInaboxPositionObserver object| ampInaboxFrameOverlayManager object| ampInaboxIframes object| ampInaboxPendingMessages object| _moatApi20020635 object| closure_lm_180018 function| avPlayer object| storageAni object| cmTag object| criteo_pubtag object| _cm_wfCounters string| lastWfUrl object| yhmgIfram undefined| define function| startCMTagMain object| uid undefined| GLOBAL_VAR undefined| ct undefined| et undefined| hourElapsed undefined| pixelDomain undefined| isDomless undefined| documentReferrer undefined| isBeta undefined| viewHash undefined| pxSrc undefined| moat_px object| Moat#G26 object| MoatSuperV26 object| Moat#PML#26#1.2 boolean| Moat#EVA object| $div1 object| $div2 object| $div3 number| j undefined| moatApiInit1608036352725 undefined| px string| prop object| callbacks object| time number| BOOMR_onload object| GoogleGcLKhOms string| category function| webpackHotUpdate function| shuffle object| arrToUse object| travel object| news object| mobilecontent1 object| mobilecontent1_new object| travelmuted object| movietrailersHD object| movietrailersHDmuted object| widescreen object| movietrailerslight object| landscapeHD object| landscapeHDmuted object| blank object| blankblack object| blankblack7 object| blankblack5 object| blankblack_mob object| blankwhiteHDmpg object| blankblack10 object| blankwhite object| blankwhiteHD object| black_loader object| lightweight object| lightweight_single object| lightweight300600 object| bonnier object| home object| lipstick object| shoes object| art object| infiltrator object| glass object| lemurs object| NBAshoes object| Sunglasses object| Hummus object| Short_food object| Short_swim object| Euro_news object| Automoto_TV object| Uzoo object| SmartDuvet object| Tiger object| Chocolate object| Logan object| Jacket object| Bike object| Kanye object| Cancun object| Smartwatch object| Helicopter object| dogshampoo object| icetea object| charger object| blueysmoothie object| ShortContent object| carbsandwich object| pisatower object| Food1 object| Food2 object| Food3 object| Food4 object| Food5 object| Food6 object| Food7 object| Fashion object| Lifestyle1 object| Lifestyle2 object| Technology1 object| Technology2 object| Technology3 object| Entertainment object| Scrambledeggs object| Spinach object| Bub1 object| Pokemon object| style_hacks object| Motorcycle object| IceCracking object| Manatees object| Daiving object| Fishing_Lure object| Shark object| HundredsManatees object| TigerShark object| MandelaPrize object| Bertram35 object| bushfire object| Snow object| Delta object| Wheels object| Yellowfin object| Grip object| Kawasaki object| Yoga object| Cat object| Chickens object| RZR object| bitcoin object| bmw object| wombat object| koala object| Marsupial object| puppy object| bitcoinMuted object| bmwMuted object| Wallabies object| Bunny object| Pumpkins object| Dogs_Stress object| Dogs_Stress_image object| lightweight300600_short object| playlist string| vpaidId function| OvaMediaPlayer object| cedexis object| closure_lm_224173 object| google_image_requests

16 Cookies

Domain/Path Name / Value
.pubmatic.com/ Name: PugT
Value: 1608036361
.pubmatic.com/ Name: PUBMDCID
Value: 3
.adform.net/ Name: uid
Value: 8494150580545336307
.pubmatic.com/ Name: KRTBCOOKIE_466
Value: 16530-1279044b-b64a-49d5-aed8-a81f0bd96cb6
.casalemedia.com/ Name: CMST
Value: X9iwBl-YsAYA
.openx.net/ Name: i
Value: 0ad2393a-ec79-0ae4-0319-d213e36f31c2|1608036358
.dailymail.co.uk/ Name: RT
Value: "z=1&dm=dailymail.co.uk&si=43692dbc-d44e-4087-81ed-7b14949f6669&ss=kipzbbwi&sl=1&tt=m4i&bcn=%2F%2F6852bd0f.akstat.io%2F&ld=m5j"
.adnxs.com/ Name: uuid2
Value: 4576201062530507709
.casalemedia.com/ Name: CMRUM3
Value: 5a5fd8b0062760948E35EE522C4AAC806C3B1B70DF5AE3
.doubleclick.net/ Name: IDE
Value: AHWqTUlH7gsk3j6ym9y6ymFVDfTAP6NP267MJPlNjWWDE434mHZZ-X_lAvrxadIo
.casalemedia.com/ Name: CMPS
Value: 3164
.casalemedia.com/ Name: CMPRO
Value: 1213
.casalemedia.com/ Name: CMID
Value: X9iwBtW4KqaFkOAqzs9dUwAA
.pubmatic.com/ Name: KRTBCOOKIE_391
Value: 22924-8494150580545336307
www.dailymail.co.uk/ Name: GED_PLAYLIST_ACTIVITY
Value: W3sidSI6Im1ja1kiLCJ0c2wiOjE2MDgwMzYzNjIsIm52IjowLCJ1cHQiOjE2MDgwMzYzMzYsImx0IjoxNjA4MDM2MzM2fV0.
www.dailymail.co.uk/ Name: freewheel-detected-bandwidth
Value: 926

18 Console Messages

Source Level URL
Text
console-api debug URL: https://info.silobreaker.com/e2t/sc2/MmZ-8yjYCXrW6zj2_M6nsGYsW7JzK5Y7LnJnQVd1GcC5Dg2KFdBBbG504(Line 13)
Message:
toS
console-api info URL: https://www.dailymail.co.uk/static/mol-fe/static/mol-fe-sync-bundle/5.9.0/desktop.js(Line 1)
Message:
Current log level: ERROR
console-api log URL: https://ovp.iris.tv/libs/context/iris-context.min.js(Line 1)
Message:
[Iris Context API] v1.0.5
console-api info URL: https://cdn.ampproject.org/rtv/012010270040000/amp4ads-v0.mjs(Line 9)
Message:
Powered by AMP ⚡ HTML – Version 2010270040000 https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
console-api info URL: https://cdn.ampproject.org/rtv/012010270040000/amp4ads-v0.mjs(Line 9)
Message:
Powered by AMP ⚡ HTML – Version 2010270040000 https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
console-api info URL: https://cdn.ampproject.org/rtv/012010270040000/amp4ads-v0.mjs(Line 9)
Message:
Powered by AMP ⚡ HTML – Version 2010270040000 https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
console-api info URL: https://cdn.ampproject.org/rtv/012010270040000/amp4ads-v0.mjs(Line 9)
Message:
Powered by AMP ⚡ HTML – Version 2010270040000 https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
console-api info URL: https://cdn.ampproject.org/rtv/052012102342000/amp4ads-v0.mjs(Line 9)
Message:
Powered by AMP ⚡ HTML – Version 2012102342000 https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
console-api info URL: https://cdn.ampproject.org/rtv/052012102342000/amp4ads-v0.mjs(Line 9)
Message:
Powered by AMP ⚡ HTML – Version 2012102342000 https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
console-api warning URL: https://cdn.stickyadstv.com/mustang/vpaid-adapter.min.js(Line 61)
Message:
13:45:44,517 com.stickyadstv.utils.Browser GDPR 2.0 - TCFAPI function cannot be found. _fw_gdpr: null, _fw_gdpr_consent: null
console-api error URL: https://www.dailymail.co.uk/static/videoplayer/6.11.0-pr-503.2312/scripts/mol-fe-videoplayer.min.js(Line 6)
Message:
### Video ads error [object Object]
console-api info URL: https://cdn.ampproject.org/rtv/012010270040000/amp4ads-v0.mjs(Line 9)
Message:
Powered by AMP ⚡ HTML – Version 2010270040000 https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
console-api warning URL: https://player.hb.selectmedia.asia/prebidlink/446676/hb_310028_7816.js(Line 3)
Message:
fun-hooks: referenced 'registerAdserver' but it was never created
console-api info URL: https://cdn.ampproject.org/rtv/012010270040000/amp4ads-v0.mjs(Line 9)
Message:
Powered by AMP ⚡ HTML – Version 2010270040000 https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz-_WTvfl_rSTsoqHQOOHsxgdnHVUcte7tXz2WehjG6nGOynZqGqn-uRuYRVocI8k2cwhulDr5F9QAHz02GwNqCuc0wH6OJ8Yg1TU-L_QoK5slRfLvh8
console-api warning URL: https://cdn.stickyadstv.com/mustang/vpaid-adapter.min.js(Line 61)
Message:
13:45:52,482 com.stickyadstv.utils.Browser GDPR 2.0 - TCFAPI function cannot be found. _fw_gdpr: null, _fw_gdpr_consent: null
console-api error URL: https://cdn-ssl.vidible.tv/prod/ad-client/js/10.2.59/0.js(Line 55)
Message:
13:45:53.081 [ERROR] EventBus: TypeError: Cannot read property 'length' of undefined event [object Object]
console-api error URL: https://cdn-ssl.vidible.tv/prod/ad-client/js/10.2.59/0.js(Line 55)
Message:
13:45:53.081 [ERROR] EventBus: TypeError: Cannot read property 'length' of undefined event [object Object]
console-api warning URL: https://cdn.stickyadstv.com/mustang/vpaid-adapter.min.js(Line 61)
Message:
13:45:59,106 com.stickyadstv.utils.Browser GDPR 2.0 - TCFAPI function cannot be found. _fw_gdpr: null, _fw_gdpr_consent: null

Indicators

This is a term in the security industry to describe indicators such as IPs, Domains, Hashes, etc. This does not imply that any of these indicate malicious activity.

15.taboola.com
1f2e7.v.fwmrm.net
6852bd0f.akstat.io
9983081ac8e174582a7b6a6acc4b473e.safeframe.googlesyndication.com
a.sportradarserving.com
a.teads.tv
aa.agkn.com
acdn.adnxs.com
acds.prod.vidible.tv
ads.adaptv.advertising.com
ads.avct.cloud
ads.avocet.io
ads.betweendigital.com
ads.creative-serving.com
ads.pubmatic.com
ads.stickyadstv.com
adservice.google.com
adservice.google.de
adservice.google.nl
aka.spotxcdn.com
am-match.taboola.com
am-vid-events.taboola.com
api.permutive.com
api.skimlinks.mgr.consensu.org
aud.pubmatic.com
audex.userreport.com
b1c90d68092b57f74adceeec8a58c68a.safeframe.googlesyndication.com
bh.contextweb.com
bidder.criteo.com
bttrack.com
c.amazon-adsystem.com
c.go-mpulse.net
c1.adform.net
c2shb.ssp.yahoo.com
c3.taboola.com
cdn-ssl.vidible.tv
cdn.ampproject.org
cdn.jsdelivr.net
cdn.permutive.com
cdn.stickyadstv.com
cdn.taboola.com
cdn.userreport.com
cdnetworks.cedexis-test.com
cds.taboola.com
cdw-dcl.userreport.com
ce.lijit.com
cm.g.doubleclick.net
connect.facebook.net
context.iris.tv
creative.dailymail.co.uk
crta.dailymail.co.uk
csi.gstatic.com
d3tsytm1wtjqo2.cloudfront.net
dis.criteo.com
dmp.adform.net
dpm.demdex.net
dsp.adkernel.com
e.serverbid.com
e1.emxdgt.com
eb2.3lift.com
eu-u.openx.net
eus.rubiconproject.com
fastlane.rubiconproject.com
fff.dailymail.co.uk
fonts.googleapis.com
fonts.gstatic.com
go1.aniview.com
google-analytics.com
googleads.g.doubleclick.net
googlesync.permutive.com
grid.bidswitch.net
gum.criteo.com
hb.hb.selectmedia.asia
hbopenbid.pubmatic.com
htlb.casalemedia.com
hulkprod.anm.co.uk
i.dailymail.co.uk
i.liadm.com
i2-ltqwbihpujgydttmgcfzxjuwvheozf.init.cedexis-radar.net
i6.liadm.com
ib.adnxs.com
id5-sync.com
idsync.rlcdn.com
image2.pubmatic.com
images.taboola.com
imasdk.googleapis.com
imprammp.taboola.com
info.silobreaker.com
js-sec.indexww.com
js.spotx.tv
loada.exelator.com
loadeu.exelator.com
loadm.exelator.com
mailonline-uk-d.openx.net
match.adsrvr.org
match.taboola.com
mfad.inskinad.com
ml314.com
mwzeom.zeotap.com
odr.mookie1.com
ovp.iris.tv
p.skimresources.com
p29.cedexis-test.com
pagead2.googlesyndication.com
pixel.advertising.com
pixel.onaudience.com
pixel.rubiconproject.com
pixel.tapad.com
play.selectmedia.asia
player.adtelligent.com
player.aniview.com
player.hb.selectmedia.asia
pr-bh.ybp.yahoo.com
pre.ads.justpremium.com
prebid-eu.creativecdn.com
prebid-server.rubiconproject.com
prebid.adnxs.com
pub.admanmedia.com
px.moatads.com
r.skimresources.com
radar.cedexis.com
relay.userreport.com
rpt.cedexis.com
rtb-csync.smartadserver.com
rtb.gumgum.com
rtb.mfadsrvr.com
s.adtelli.com
s.amazon-adsystem.com
s.c.appier.net
s.go-mpulse.net
s.skimresources.com
s0.2mdn.net
s3.amazonaws.com
sak.userreport.com
sb.scorecardresearch.com
scripts.dailymail.co.uk
sdsbucket.s3.amazonaws.com
search.spotxchange.com
secured.dailymail.co.uk
securepubads.g.doubleclick.net
select-d.openx.net
simage2.pubmatic.com
ssl.google-analytics.com
ssum-sec.casalemedia.com
ssum.casalemedia.com
static.criteo.net
stats.g.doubleclick.net
swa.and.co.uk
sync-t1.taboola.com
sync-tm.everesttech.net
sync.1dmp.io
sync.ads.152media.com
sync.crwdcntrl.net
sync.mathtag.com
sync.search.spotxchange.com
sync.sxp.smartclip.net
sync.taboola.com
t.dailymail.co.uk
t.skimresources.com
taboola-d.openx.net
tag.userreport.com
tags.bluekai.com
ted.dailymail.co.uk
tlx.3lift.com
tpc.googlesyndication.com
track1.aniview.com
trc-events.taboola.com
trc.taboola.com
trk.vidible.tv
u.openx.net
uipglob.semasio.net
uk-script.dotmetrics.net
ups.analytics.yahoo.com
video.dailymail.co.uk
vidstat.taboola.com
visitanalytics.userreport.com
wf.taboola.com
www.dailymail.co.uk
www.facebook.com
www.google.com
www.googletagservices.com
www.storygize.net
x.bidswitch.net
x.skimresources.com
z.moatads.com
ads.stickyadstv.com
cdn.stickyadstv.com
cm.g.doubleclick.net
htlb.casalemedia.com
ib.adnxs.com
mfad.inskinad.com
prebid-server.rubiconproject.com
pub.admanmedia.com
104.108.50.124
104.111.215.135
104.111.215.68
104.111.216.96
104.111.238.139
104.111.246.202
104.19.150.54
104.225.98.130
141.226.224.32
141.226.228.48
147.75.102.200
15.237.136.106
151.101.113.108
151.101.114.49
151.101.13.44
151.139.128.11
154.57.158.51
163.171.128.148
165.227.252.242
172.104.121.22
172.217.22.2
174.137.133.49
178.250.0.163
178.250.0.165
18.156.0.31
18.158.93.70
18.159.79.175
18.194.183.62
18.195.155.181
18.195.225.18
18.195.7.149
18.197.99.6
185.184.8.30
185.29.132.30
185.33.221.13
185.64.189.110
185.64.189.112
185.64.190.106
185.64.190.80
185.86.139.89
185.94.180.124
185.94.180.126
185.94.180.127
188.42.196.115
192.132.33.46
198.148.27.140
199.60.103.254
2.18.232.7
2.18.234.233
2.21.36.138
2001:4de0:ac19::1:b:3b
213.174.135.2
213.19.162.31
216.58.205.226
23.227.137.155
2600:1f18:444a:4680:1ed9:60e9:aafd:7d9f
2600:9000:20eb:b000:15:d134:4e40:93a1
2600:9000:2156:2800:11:af01:b40:93a1
2600:9000:2156:4200:1:91d6:b080:21
2600:9000:21a1:6a00:1b:9b5:7e00:93a1
2600:9000:21f3:8200:19:d208:7940:93a1
2606:4700:10::6816:1857
2607:f740:e619::1
2a00:1288:110:c305::8000
2a00:1288:f03d:1fa::2000
2a00:1450:4001:801::2001
2a00:1450:4001:802::200a
2a00:1450:4001:809::2003
2a00:1450:4001:814::2002
2a00:1450:4001:816::2002
2a00:1450:4001:817::2004
2a00:1450:4001:81a::2004
2a00:1450:4001:81b::2006
2a00:1450:4001:81d::2001
2a00:1450:4001:81d::2008
2a00:1450:4001:81f::2001
2a00:1450:4001:81f::2002
2a00:1450:4001:824::2004
2a00:1450:4001:824::200a
2a00:1450:4001:825::2002
2a00:1450:4001:825::2003
2a00:1450:4001:825::200a
2a00:1450:400c:c0c::9b
2a00:1450:4017:806::2003
2a02:2638:1::3
2a02:2638::1c
2a02:26f0:10c:48b::2c79
2a02:26f0:6c00:191::11a6
2a02:26f0:6c00:287::11a6
2a02:26f0:6c00:288::11ae
2a02:26f0:6c00:296::11ae
2a02:26f0:6c00:2be::16c2
2a02:26f0:6c00::210:bb21
2a02:26f0:eb::214:bece
2a03:2880:f02d:12:face:b00c:0:3
2a03:2880:f12d:83:face:b00c:0:25de
2a04:4e42:1b::621
2a0c:5c81:5160::2
34.107.254.252
34.120.207.148
34.197.221.162
34.250.60.119
34.250.65.236
34.251.167.52
34.98.64.218
34.98.67.61
35.157.246.167
35.161.8.247
35.190.40.172
35.190.59.101
35.190.91.160
35.201.67.47
35.227.248.159
35.241.57.45
35.244.159.8
35.244.255.22
37.157.6.251
37.252.161.190
51.210.112.63
51.89.7.198
52.1.33.51
52.206.107.130
52.218.109.178
52.28.82.26
52.29.22.19
52.29.85.133
52.3.7.54
52.30.234.204
52.59.160.25
52.59.91.38
52.94.232.32
54.171.43.242
54.171.98.69
54.194.211.3
54.195.94.143
54.225.161.250
54.231.40.226
54.93.170.20
54.93.70.53
62.149.0.72
65.9.68.128
65.9.73.48
65.9.73.71
69.173.144.139
72.251.249.14
77.243.60.138
88.99.214.77
99.84.88.20
99.84.89.98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